0.28076172.12042316.html.plaintext.txt	0	apolipoprotein e apoe isoform dependent lipid release astrocytes prepared human apoe3 apoe4 knock mice jian sheng gong mariko kobayashi hideki hayashi kun zou naoya sawamura shinobu c fujita katsuhiko yanagisawa makoto michikawa
0.28076172.12042316.html.plaintext.txt	1	apolipoprotein e apoe isoform dependent lipid release astrocytes prepared human apoe3 apoe4 knock mice jian sheng gong mariko kobayashi hideki hayashi kun zou naoya sawamura shinobu c fujita katsuhiko yanagisawa makoto michikawa
0.28076172.12042316.html.plaintext.txt	2	department dementia research national institute longevity sciences 36 3 gengo morioka obu aichi 474 8522 japan organization pharmaceutical safety research japan tokyo 100 0013 japan mitsubishi kagaku institute life sciences 11 minamiooya machida tokyo 194 8511 japan japan society promotion science jsps tokyo 102 8471 japan
0.28076172.12042316.html.plaintext.txt	3	received publication april 23 2002 revised form may 31 2002
0.28076172.12042316.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	5	reported previously michikawa m fan q w isobe yanagisawa k 2000 j neurochem 74 1008 1016 exogenously added recombinant human apolipoprotein e apoe promotes cholesterol release isoform dependent manner however molecular mechanism underlying isoform dependent promotion cholesterol release remains undetermined study demonstrate cholesterol release mediated endogenously synthesized secreted apoe isoforms clarify mechanism underlying apoe isoform dependent cholesterol release using cultured astrocytes prepared human apoe3 apoe4 knock mice cholesterol phospholipids released culture media resulting generation two types high density lipoprotein hdl like particles one associated apoe apoj amount cholesterol released culture media apoe3 expressing astrocytes 25 fold greater apoe4 expressing astrocytes contrast amount apoe3 released association hdl like particles similar apoe4 sizes hdl like particles released apoe3 apoe4 expressing astrocytes similar molar ratios cholesterol apoe hdl fraction culture media apoe3 apoe4 expressing astrocytes 250 plus minus 60 119 plus minus 51 respectively data indicate apoe3 ability generate similarly sized lipid particles less number apoe molecules apoe4 suggesting apoe3 expressing astrocytes supply cholesterol neurons apoe4 expressing astrocytes findings provide new insight issue concerning putative alteration apoe related cholesterol metabolism alzheimers disease introduction top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	6	previous epidemiological studies show elevated serum cholesterol level risk factor development alzheimers disease ad1 1 3 statin therapy reduces frequency ad 4 dementia 5 decreased levels cellular cholesterol shown reduce production vitro 6 vivo 7 previous studies also shown association cholesterol accumulation mature senile plaques 8 neurofibrillary tangle bearing neurons 9 additionally recent study 10 suggested increased cholesterol level membrane facilitates amyloid fibril formation formation gm1 ganglioside bound putative endogenous seed findings suggest increased cellular cholesterol levels induce high amyloid protein production subsequent ad development
0.28076172.12042316.html.plaintext.txt	7	previous epidemiological studies show elevated serum cholesterol level risk factor development alzheimers disease ad1 1 3 statin therapy reduces frequency ad 4 dementia 5 decreased levels cellular cholesterol shown reduce production vitro 6 vivo 7 previous studies also shown association cholesterol accumulation mature senile plaques 8 neurofibrillary tangle bearing neurons 9 additionally recent study 10 suggested increased cholesterol level membrane facilitates amyloid fibril formation formation gm1 ganglioside bound putative endogenous seed findings suggest increased cellular cholesterol levels induce high amyloid protein production subsequent ad development
0.28076172.12042316.html.plaintext.txt	8	however several studies 11 14 shown opposing evidence indicating cholesterol levels serum cell membranes brains cerebrospinal fluid decreased ad patients compared controls previous studies shown increased dietary cholesterol levels reduce secretion 15 increased cellular cholesterol levels inhibit mediated cell toxicity 16 17 hand effect cellular cholesterol metabolism also investigated 18 recent studies shown monomeric oligomeric affects cholesterol metabolism 19 eventually reduces cellular cholesterol levels 20 addition cholesterol deficiency shown promote tau phosphorylation vitro 21 22 vivo 23 findings suggest involvement cholesterol pathogenesis ad dualistic elevated levels cellular cholesterol contribute ad development elevating secretion however increasing amount oligomerized reduces cellular cholesterol levels turn may promote progression ad pathologies
0.28076172.12042316.html.plaintext.txt	9	however several studies 11 14 shown opposing evidence indicating cholesterol levels serum cell membranes brains cerebrospinal fluid decreased ad patients compared controls previous studies shown increased dietary cholesterol levels reduce secretion 15 increased cellular cholesterol levels inhibit mediated cell toxicity 16 17 hand effect cellular cholesterol metabolism also investigated 18 recent studies shown monomeric oligomeric affects cholesterol metabolism 19 eventually reduces cellular cholesterol levels 20 addition cholesterol deficiency shown promote tau phosphorylation vitro 21 22 vivo 23 findings suggest involvement cholesterol pathogenesis ad dualistic elevated levels cellular cholesterol contribute ad development elevating secretion however increasing amount oligomerized reduces cellular cholesterol levels turn may promote progression ad pathologies
0.28076172.12042316.html.plaintext.txt	10	apoe one major apolipoproteins central nervous system regulating lipid metabolisms 24 27 astrocytes microglia known synthesize apoe 28 29 generates hdl like particles cellular lipids cerebrospinal fluid csf culture media 25 26 30 31 apoe lipid particles assumed supply cholesterol neurons apoe receptor mediated manner 32 33 previously reported 34 exogenously added recombinant human apoe promotes cholesterol release isoform dependent manner however mechanism underlying isoform dependent cholesterol release mediated apoe remains undetermined known majority apoe csf conditioned culture media associated lipids 31 35 characteristics lipid particles generated addition exogenous apolipoprotein generated endogenous apolipoprotein different hdl like particles generated addition exogenous apolipoprotein ai apoai 36 apoe 34 low amount cholesterol whereas hdl like particles formed endogenous apoe cholesterol rich 37 lines evidence led us determine whether endogenous apoe mediated cholesterol release cultured astrocytes isoform specific case characterize molecular mechanism underlying isoform dependent lipid release study investigated endogenous apoe mediated cholesterol release astrocytes isolated human apoe3 apoe4 knock mouse brains found apoe3 ability generate similarly sized hdl like particles less amount apoe apoe4 findings may provide basis studies relate cholesterol ad pathogenesis experimental procedures top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	11	apoe one major apolipoproteins central nervous system regulating lipid metabolisms 24 27 astrocytes microglia known synthesize apoe 28 29 generates hdl like particles cellular lipids cerebrospinal fluid csf culture media 25 26 30 31 apoe lipid particles assumed supply cholesterol neurons apoe receptor mediated manner 32 33 previously reported 34 exogenously added recombinant human apoe promotes cholesterol release isoform dependent manner however mechanism underlying isoform dependent cholesterol release mediated apoe remains undetermined known majority apoe csf conditioned culture media associated lipids 31 35 characteristics lipid particles generated addition exogenous apolipoprotein generated endogenous apolipoprotein different hdl like particles generated addition exogenous apolipoprotein ai apoai 36 apoe 34 low amount cholesterol whereas hdl like particles formed endogenous apoe cholesterol rich 37 lines evidence led us determine whether endogenous apoe mediated cholesterol release cultured astrocytes isoform specific case characterize molecular mechanism underlying isoform dependent lipid release study investigated endogenous apoe mediated cholesterol release astrocytes isolated human apoe3 apoe4 knock mouse brains found apoe3 ability generate similarly sized hdl like particles less amount apoe apoe4 findings may provide basis studies relate cholesterol ad pathogenesis experimental procedures top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	12	animals mice expressing human apoe4 place mouse apoe generated gene targeting technique taking advantage homologous recombination embryonic stem cells knock described previously 38 apoe3 knock mice produced manner except transgene carried apoe3 cdna place apoe4 cdna details generation apoe3 mice described elsewhere postnatal day 2 mice possess homozygous 3 33 4 44 allele correctly expressing human apoe3 apoe4 proteins respectively used study
0.28076172.12042316.html.plaintext.txt	13	animals mice expressing human apoe4 place mouse apoe generated gene targeting technique taking advantage homologous recombination embryonic stem cells knock described previously 38 apoe3 knock mice produced manner except transgene carried apoe3 cdna place apoe4 cdna details generation apoe3 mice described elsewhere postnatal day 2 mice possess homozygous 3 33 4 44 allele correctly expressing human apoe3 apoe4 proteins respectively used study
0.28076172.12042316.html.plaintext.txt	14	cell culture highly astrocyte rich cultures prepared according method described previously 39 40 brief brains postnatal day 2 mice removed anesthesia cerebral cortices mouse brains dissected freed meninges diced small pieces cortical fragments incubated 025 trypsin 20 mgml dnase phosphate buffered saline pbs 81 mm na2hpo4 15 mm kh2po4 137 mm nacl 27 mm kcl ph 74 37 degrees c 20 min fragments dissociated single cells pipetting dissociated cells seeded 75 cm2 dishes cell density 1 x 107 dmem containing 10 fbs 10 days incubation vitro astrocytes monolayer trypsinized 01 reseeded onto 6 well dishes astrocyte rich cultures maintained dmem containing 10 fbs use
0.28076172.12042316.html.plaintext.txt	15	cell culture highly astrocyte rich cultures prepared according method described previously 39 40 brief brains postnatal day 2 mice removed anesthesia cerebral cortices mouse brains dissected freed meninges diced small pieces cortical fragments incubated 025 trypsin 20 mgml dnase phosphate buffered saline pbs 81 mm na2hpo4 15 mm kh2po4 137 mm nacl 27 mm kcl ph 74 37 degrees c 20 min fragments dissociated single cells pipetting dissociated cells seeded 75 cm2 dishes cell density 1 x 107 dmem containing 10 fbs 10 days incubation vitro astrocytes monolayer trypsinized 01 reseeded onto 6 well dishes astrocyte rich cultures maintained dmem containing 10 fbs use
0.28076172.12042316.html.plaintext.txt	16	neuron rich cultures prepared rat cerebral cortices described previously 19 dissociated cells suspended feeding medium plated onto poly d lysine coated 6 well plates cell density 2 x 105cm2 feeding medium consisted dulbeccos modified eagles medium nutrient mixture dmemf 12 5050 n2 supplements 99 cultured cells identified neurons immunocytochemical analysis using monoclonal antibody microtubule associated protein 2 neuron specific marker day 3 culture 41
0.28076172.12042316.html.plaintext.txt	17	neuron rich cultures prepared rat cerebral cortices described previously 19 dissociated cells suspended feeding medium plated onto poly d lysine coated 6 well plates cell density 2 x 105cm2 feeding medium consisted dulbeccos modified eagles medium nutrient mixture dmemf 12 5050 n2 supplements 99 cultured cells identified neurons immunocytochemical analysis using monoclonal antibody microtubule associated protein 2 neuron specific marker day 3 culture 41
0.28076172.12042316.html.plaintext.txt	18	quantification released intracellular cholesterols phosphatidylcholines astrocytes 6 well plates washed dmem three times incubated 2 ml dmem 1 3 5 days 37 degrees c conditioned culture media removed processed lipid extraction astrocytes monolayer washed pbs three times air dried room temperature lipids conditioned culture media extracted according methods reported previously 34 41 modifications brief aliquots 10 ml conditioned culture media transferred clean glass tubes containing 40 ml chloroformmethanol 21 vv organic phase separated aqueous phase washed twice vigorous mixing 3 ml water re separated aqueous phase centrifugation dried n2 gas extraction intracellular lipids dried cells incubated hexaneisopropyl alcohol 32 vv 1 h room temperature solvent plate removed dried n2 gas organic phases redissolved 400 microl chloroform 150 microl sample transferred onto 96 well polypropylene plates corning glass dried air flow dried lipids dissolved 20 microl isopropyl alcohol contents cholesterol phospholipids determined using cholesterol wako osaka japan phospholipid kyowa medix tokyo japan determiner kits respectively
0.28076172.12042316.html.plaintext.txt	19	quantification released intracellular cholesterols phosphatidylcholines astrocytes 6 well plates washed dmem three times incubated 2 ml dmem 1 3 5 days 37 degrees c conditioned culture media removed processed lipid extraction astrocytes monolayer washed pbs three times air dried room temperature lipids conditioned culture media extracted according methods reported previously 34 41 modifications brief aliquots 10 ml conditioned culture media transferred clean glass tubes containing 40 ml chloroformmethanol 21 vv organic phase separated aqueous phase washed twice vigorous mixing 3 ml water re separated aqueous phase centrifugation dried n2 gas extraction intracellular lipids dried cells incubated hexaneisopropyl alcohol 32 vv 1 h room temperature solvent plate removed dried n2 gas organic phases redissolved 400 microl chloroform 150 microl sample transferred onto 96 well polypropylene plates corning glass dried air flow dried lipids dissolved 20 microl isopropyl alcohol contents cholesterol phospholipids determined using cholesterol wako osaka japan phospholipid kyowa medix tokyo japan determiner kits respectively
0.28076172.12042316.html.plaintext.txt	20	determination amount 14cacetate incorporated cholesterol phosphatidylcholine astrocytes cultured dmem plus 10 fbs washed pbs three times recultured dmem cultures treated 37 kbqml 14cacetate perkinelmer life sciences 1 3 5 days indicated time points culture medium quickly removed cells washed three times cold pbs dried room temperature aliquots 05 ml conditioned culture media transferred clean glass tubes containing 25 ml chloroformmethanol 21 vv extraction intracellular lipids dried cells incubated hexaneisopropyl alcohol 32 vv 1 h room temperature solvent plate removed dried n2 gas organic phases redissolved 50 microl chloroform 10 microl sample spotted activated silica gel high performance thin layer chromatography plates merck lipids separated sequential one dimensional chromatography using chloroformmethanolacetic acidwater 251542 vv followed another run hexanediethyl etheracetic acid 80301 14ccholesterol 14cphosphatidylcholine used standards chromatography plates exposed radiosensitive films lipid visualized quantified bas2500 fuji film tokyo japan determination protein concentration astrocytes cultured 1 ml distilled water containing 01 naoh 1 h 10 microl sample processed determination protein concentration using bca kit
0.28076172.12042316.html.plaintext.txt	21	determination amount 14cacetate incorporated cholesterol phosphatidylcholine astrocytes cultured dmem plus 10 fbs washed pbs three times recultured dmem cultures treated 37 kbqml 14cacetate perkinelmer life sciences 1 3 5 days indicated time points culture medium quickly removed cells washed three times cold pbs dried room temperature aliquots 05 ml conditioned culture media transferred clean glass tubes containing 25 ml chloroformmethanol 21 vv extraction intracellular lipids dried cells incubated hexaneisopropyl alcohol 32 vv 1 h room temperature solvent plate removed dried n2 gas organic phases redissolved 50 microl chloroform 10 microl sample spotted activated silica gel high performance thin layer chromatography plates merck lipids separated sequential one dimensional chromatography using chloroformmethanolacetic acidwater 251542 vv followed another run hexanediethyl etheracetic acid 80301 14ccholesterol 14cphosphatidylcholine used standards chromatography plates exposed radiosensitive films lipid visualized quantified bas2500 fuji film tokyo japan determination protein concentration astrocytes cultured 1 ml distilled water containing 01 naoh 1 h 10 microl sample processed determination protein concentration using bca kit
0.28076172.12042316.html.plaintext.txt	22	density gradient ultracentrifugation incubation dmem 5 days astrocyte culture medium collected centrifuged 1600 x g 15 min 50 ml plastic tube exclude cell debris adjusted discontinuous sucrose gradient discontinuous sucrose gradient prepared 14 x 89 mm ultracentrifuge tube ultraclear beckman instruments palo alto ca bottom top 2 ml sucrose density 130 gml 3 ml 120 gml 3 ml 110 gml 4 ml 1006 gml medium sample sucrose gradient centrifuged sw41 ti swing rotor beckman instruments palo alto ca 4 degrees c 48 h 160000 x gav following density gradient centrifugation 12 10 ml fractions collected micropipette top gradient densities fractions determined measuring weight 100 microl fraction using micropipette final fraction stirred resuspend pellet lipid content fraction determined described density fraction determined using density meter dma35n anton paar graz austria
0.28076172.12042316.html.plaintext.txt	23	density gradient ultracentrifugation incubation dmem 5 days astrocyte culture medium collected centrifuged 1600 x g 15 min 50 ml plastic tube exclude cell debris adjusted discontinuous sucrose gradient discontinuous sucrose gradient prepared 14 x 89 mm ultracentrifuge tube ultraclear beckman instruments palo alto ca bottom top 2 ml sucrose density 130 gml 3 ml 120 gml 3 ml 110 gml 4 ml 1006 gml medium sample sucrose gradient centrifuged sw41 ti swing rotor beckman instruments palo alto ca 4 degrees c 48 h 160000 x gav following density gradient centrifugation 12 10 ml fractions collected micropipette top gradient densities fractions determined measuring weight 100 microl fraction using micropipette final fraction stirred resuspend pellet lipid content fraction determined described density fraction determined using density meter dma35n anton paar graz austria
0.28076172.12042316.html.plaintext.txt	24	immunoblot analysis samples fraction dissolved sampling buffer consisting 100 mm tris hcl ph 74 10 glycerol 4 sds 10 mercaptoethanol 001 bromphenol blue analyzed 125 tristricine sds page reported previously 42 separated proteins transferred onto immobilon membranes semidry electrophoretic transfer apparatus nihon eido tokyo japan using transfer buffer 01 m tris 0192 m glycine 20 methanol blots probed 4 h room temperature goat anti apoe polyclonal antibody ab947 12000 chemicon temecula ca goat anti apoj antibody 1 2000 rockland gilbertsville pa band detection carried ecl kit amersham biosciences determination concentration apoe released culture medium signals corresponding apoe sample immunoblot membrane quantified densitometry nih image software varying concentrations synthetic apoe protein wako tokyo japan standards standard signals demonstrated linear range apoe protein amounts 0 2 microg per lane apoe concentrations conditioned culture media within range used analysis detection oligomeric apoe protein conditioned culture media western blot analysis performed nonreducing conditions aliquots conditioned culture medium apoe3 apoe4 expressing astrocytes mixed volume 2 x nonreducing laemmli buffer consisting 100 mm tris hcl ph 74 10 glycerol 4 sds 001 bromphenol blue mercaptoethanol analyzed western blotting described
0.28076172.12042316.html.plaintext.txt	25	immunoblot analysis samples fraction dissolved sampling buffer consisting 100 mm tris hcl ph 74 10 glycerol 4 sds 10 mercaptoethanol 001 bromphenol blue analyzed 125 tristricine sds page reported previously 42 separated proteins transferred onto immobilon membranes semidry electrophoretic transfer apparatus nihon eido tokyo japan using transfer buffer 01 m tris 0192 m glycine 20 methanol blots probed 4 h room temperature goat anti apoe polyclonal antibody ab947 12000 chemicon temecula ca goat anti apoj antibody 1 2000 rockland gilbertsville pa band detection carried ecl kit amersham biosciences determination concentration apoe released culture medium signals corresponding apoe sample immunoblot membrane quantified densitometry nih image software varying concentrations synthetic apoe protein wako tokyo japan standards standard signals demonstrated linear range apoe protein amounts 0 2 microg per lane apoe concentrations conditioned culture media within range used analysis detection oligomeric apoe protein conditioned culture media western blot analysis performed nonreducing conditions aliquots conditioned culture medium apoe3 apoe4 expressing astrocytes mixed volume 2 x nonreducing laemmli buffer consisting 100 mm tris hcl ph 74 10 glycerol 4 sds 001 bromphenol blue mercaptoethanol analyzed western blotting described
0.28076172.12042316.html.plaintext.txt	26	size determination lipoprotein particles conditioned culture media astrocytes expressing human apoe3 apoe4 concentrated 5 fold using centriprep ym10 tube millipore bedford ma centrifugation ja 12 rotor using beckman j 25i ultracentrifuge 4 degrees c 40 min 3000 x g centrifugation sample subjected density gradient ultracentrifugation discontinuous sucrose gradient described two milliliters hdl fraction fraction number 4 centricon ym10 tube millipore concentrated 200 microl ja 201 rotor using beckman j 25i ultracentrifuge 4 degrees c 2 h 5000 x g concentrated conditioned culture medium subjected nondenaturing 4 20 tbe ph 83 buffered page evaluate particle size heterogeneity apoe fractions ten microliters apoe lipid particles unboiled nonreduced containing 10 sucrose 002 bromphenol blue applied onto 4 20 gradient gel native high molecular weight protein standards amersham biosciences used size standards 43 electrophoresis performed 4 degrees c prerun 15 min 125 v entry samples stacking gel followed migration 100 v 8 h separated apoe migrated lipid apoe complex transferred onto immobilon membrane semidry electrophoretic transfer apparatus nihon eido tokyo japan using transfer buffer 01 m tris 0192 m glycine 20 methanol separated proteins probed 4 h room temperature goat anti apoe polyclonal antibody ab947 chemicon temecula ca 12000 apoe protein detected using ecl kit amersham biosciences mean apoe lipid particle size obtained based migration size standards stained 05 ponceau sigma 1 acetic acid distilled water
0.28076172.12042316.html.plaintext.txt	27	size determination lipoprotein particles conditioned culture media astrocytes expressing human apoe3 apoe4 concentrated 5 fold using centriprep ym10 tube millipore bedford ma centrifugation ja 12 rotor using beckman j 25i ultracentrifuge 4 degrees c 40 min 3000 x g centrifugation sample subjected density gradient ultracentrifugation discontinuous sucrose gradient described two milliliters hdl fraction fraction number 4 centricon ym10 tube millipore concentrated 200 microl ja 201 rotor using beckman j 25i ultracentrifuge 4 degrees c 2 h 5000 x g concentrated conditioned culture medium subjected nondenaturing 4 20 tbe ph 83 buffered page evaluate particle size heterogeneity apoe fractions ten microliters apoe lipid particles unboiled nonreduced containing 10 sucrose 002 bromphenol blue applied onto 4 20 gradient gel native high molecular weight protein standards amersham biosciences used size standards 43 electrophoresis performed 4 degrees c prerun 15 min 125 v entry samples stacking gel followed migration 100 v 8 h separated apoe migrated lipid apoe complex transferred onto immobilon membrane semidry electrophoretic transfer apparatus nihon eido tokyo japan using transfer buffer 01 m tris 0192 m glycine 20 methanol separated proteins probed 4 h room temperature goat anti apoe polyclonal antibody ab947 chemicon temecula ca 12000 apoe protein detected using ecl kit amersham biosciences mean apoe lipid particle size obtained based migration size standards stained 05 ponceau sigma 1 acetic acid distilled water
0.28076172.12042316.html.plaintext.txt	28	statistical analysis statview computer software macintosh used statistical analysis statistical significance differences samples evaluated students test results top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	29	statistical analysis statview computer software macintosh used statistical analysis statistical significance differences samples evaluated students test results top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	30	apoe3 apoe4 expressing astrocytes became confluent 7 days replating appeared morphologically comparable time dependent curves release cholesterol phospholipids cultured astrocytes expressing human apoe3 apoe4 shown fig 1 b respectively found amounts cholesterol fig 1a phospholipids fig 1b released cells genotypes increased time dependent manner amounts lipids released apoe3 expressing astrocytes significantly higher apoe4 expressing astrocytes days 3 5 compared basis cellular protein contrast levels 14cacetate incorporation cholesterol phosphatidylcholine apoe3 apoe4 expressing astrocytes similar time point fig 1 c d similarly total amounts cellular cholesterol phospholipids genotypes astrocytes similar time point fig 1 e f
0.28076172.12042316.html.plaintext.txt	31	apoe3 apoe4 expressing astrocytes became confluent 7 days replating appeared morphologically comparable time dependent curves release cholesterol phospholipids cultured astrocytes expressing human apoe3 apoe4 shown fig 1 b respectively found amounts cholesterol fig 1a phospholipids fig 1b released cells genotypes increased time dependent manner amounts lipids released apoe3 expressing astrocytes significantly higher apoe4 expressing astrocytes days 3 5 compared basis cellular protein contrast levels 14cacetate incorporation cholesterol phosphatidylcholine apoe3 apoe4 expressing astrocytes similar time point fig 1 c d similarly total amounts cellular cholesterol phospholipids genotypes astrocytes similar time point fig 1 e f
0.28076172.12042316.html.plaintext.txt	32	view larger version 35k fig 1 characterization lipid metabolism cultured astrocytes prepared human apoe3 apoe4 knock mouse brains astrocyte rich cultures prepared described experimental procedures three week cultured astrocytes washed three times dmem incubated dmem time points indicated lipids released medium intracellular lipids extracted analyzed described experimental procedures b e f determination synthesis rates cholesterol phospholipids cultured astrocytes washed three times dmem followed incubation 14cacetate 2 h 37 degrees c cells washed cold pbs three times amount 14cacetate incorporated cholesterol phosphatidylcholine determined described experimental procedures c d amounts cholesterol phospholipids b apoe3 expressing astrocytes significantly greater apoe4 expressing astrocytes respectively significant differences cellular cholesterolphospholipids concentrations e f rate cholesterolphosphatidylcholine synthesis c d apoe3 apoe4 expressing astrocytes data means plus minus se 4 samples p 0001 versus apoe4 expressing astrocytes six independent experiments show similar results
0.28076172.12042316.html.plaintext.txt	33	next determined amounts apoe3 apoe4 released culture medium western blot analysis conditioned culture media apoe3 apoe4 expressing astrocytes culture days 1 3 5 shows total amount apoe released culture media apoe3 apoe4 expressing astrocytes increased culture time fig 2 b densitometric analysis signals shows comparative amounts apoe released apoe3 apoe4 expressing astrocytes fig 2b
0.28076172.12042316.html.plaintext.txt	34	next determined amounts apoe3 apoe4 released culture medium western blot analysis conditioned culture media apoe3 apoe4 expressing astrocytes culture days 1 3 5 shows total amount apoe released culture media apoe3 apoe4 expressing astrocytes increased culture time fig 2 b densitometric analysis signals shows comparative amounts apoe released apoe3 apoe4 expressing astrocytes fig 2b
0.28076172.12042316.html.plaintext.txt	35	view larger version 26k fig 2 amount apoe protein released conditioned culture media apoe3 apoe4 expressing astrocytes astrocyte rich cultures prepared described experimental procedures experiments cells washed three times dmem cultured dmem time points indicated lipids released medium extracted analyzed described experimental procedures aliquots 5 microl sample subjected immunoblot analysis using polyclonal anti apoe antibody ab947 primary antibody intensity band quantified densitometric analysis using nih imaging software macintosh b amount apoe released culture media apoe3 expressing astrocytes similar apoe4 expressing astrocytes four independent experiments show similar results
0.28076172.12042316.html.plaintext.txt	36	characteristics lipid particles released serum free media cultured astrocytes examined results density gradient ultracentrifugation cultured media apoe3 apoe4 expressing astrocytes shown fig 3 indicate lipid distribution sample contains two peaks show cholesterol phospholipids distributed similarly fractions densities 104 113 fractions 3 5 also show smaller amounts cholesterol phospholipids distributed fractions densities 114 121 gml fractions 8 9 results show major parts cholesterol phospholipids present lighter density fractions 3 5 minor parts lipids present heavier density fractions 8 9 densities corresponded hdl next performed immunoblot analysis fraction using anti apoe anti apoj antibodies apoe3 apoe4 detected mainly fractions 4 5 sample conditioned culture media apoe3 apoe4 expressing astrocytes consistent major peak lipid distribution shown fig 4 b respectively contrast apoj sample conditioned culture media apoe3 apoe4 expressing astrocytes detected fractions 6 11 distinct containing apoe fig 4 b distributions apoe apoj across fractions sample quantified densitometric analysis shown fig 4c indicating difference distribution apoe apoj
0.28076172.12042316.html.plaintext.txt	37	characteristics lipid particles released serum free media cultured astrocytes examined results density gradient ultracentrifugation cultured media apoe3 apoe4 expressing astrocytes shown fig 3 indicate lipid distribution sample contains two peaks show cholesterol phospholipids distributed similarly fractions densities 104 113 fractions 3 5 also show smaller amounts cholesterol phospholipids distributed fractions densities 114 121 gml fractions 8 9 results show major parts cholesterol phospholipids present lighter density fractions 3 5 minor parts lipids present heavier density fractions 8 9 densities corresponded hdl next performed immunoblot analysis fraction using anti apoe anti apoj antibodies apoe3 apoe4 detected mainly fractions 4 5 sample conditioned culture media apoe3 apoe4 expressing astrocytes consistent major peak lipid distribution shown fig 4 b respectively contrast apoj sample conditioned culture media apoe3 apoe4 expressing astrocytes detected fractions 6 11 distinct containing apoe fig 4 b distributions apoe apoj across fractions sample quantified densitometric analysis shown fig 4c indicating difference distribution apoe apoj
0.28076172.12042316.html.plaintext.txt	38	view larger version 29k fig 3 density gradient analysis lipid particles released astrocytes three week cultured astrocytes plated 6 well dishes maintained dmem containing 10 fbs 324 microgml cholesterol astrocytes rinsed three times fresh dmem incubated dmem 5 days culture medium collected centrifuged 1600 x g 15 min exclude cell debris supernatant collected subjected initial discontinuous density gradient prepared sucrose solutions described experimental procedures centrifugation fractions collected analyzed cholesterol phospholipid b contents density fraction also determined using density meter dma35n apoe3 ast apoe3 expressing astrocytes apoe4 ast apoe4 expressing astrocytes six independent experiments showed similar results
0.28076172.12042316.html.plaintext.txt	39	view larger version 32k fig 4 distribution apoe3 apoe4 across fractions separated density gradient ultracentrifugation twelve fractions obtained culture media apoe3 apoe4 expressing astrocytes described fig 3 used determination distribution apoe apoj aliquots 10 microl fraction mixed volume sample buffer subjected sds page separated proteins culture media apoe3 apoe4 expressing astrocytes b immunoblotted anti apoe antibody anti apoj antibody determine distribution pattern apoe apoj across fractions immunoblot membranes subjected scanning intensity band determined densitometric analysis using computer software c apoe3 ast apoe3 expressing astrocytes apoe4 ast apoe4 expressing astrocytes six independent experiments show similar results
0.28076172.12042316.html.plaintext.txt	40	addition found neurons synthesize secrete apoj form hdl like particles without secretion apoe characterized apoj mediated lipid release neurons compare astrocytes apoj mediated lipid release conditioned media cultured neurons found distributed across fractions densities 1092 1180 gml similar apoj mediated lipid release astrocyte cultures fig 5 distribution peaks apoj fig 5a cholesterol fig 5b phospholipids fig 5c across fraction densities found identical 1127 gml results show apoj containing lipoproteins conditioned media cultured neurons astrocytes heavier generated apoe conditioned media cultured astrocytes characteristics apoj containing lipoproteins generated neurons astrocytes examined study comparable
0.28076172.12042316.html.plaintext.txt	41	addition found neurons synthesize secrete apoj form hdl like particles without secretion apoe characterized apoj mediated lipid release neurons compare astrocytes apoj mediated lipid release conditioned media cultured neurons found distributed across fractions densities 1092 1180 gml similar apoj mediated lipid release astrocyte cultures fig 5 distribution peaks apoj fig 5a cholesterol fig 5b phospholipids fig 5c across fraction densities found identical 1127 gml results show apoj containing lipoproteins conditioned media cultured neurons astrocytes heavier generated apoe conditioned media cultured astrocytes characteristics apoj containing lipoproteins generated neurons astrocytes examined study comparable
0.28076172.12042316.html.plaintext.txt	42	view larger version 24k fig 5 comparison distribution pattern apolipoproteins lipids conditioned media cultured astrocytes neurons density gradient ultracentrifugation conditioned culture media neurons performed obtain 12 fractions neurons cultured serum free n2 supplemented dmemf 12 medium n2 medium 2 days washed fresh dmem incubated n2 medium another 2 days culture medium centrifuged 1600 x g 15 min supernatant collected subjected initial discontinuous density gradient analysis using sucrose solutions described experimental procedures centrifugation fractions collected analyzed cholesterol phospholipids contents aliquots 10 microl fraction mixed volume sample buffer subjected sds page separated proteins immunoblotted anti apoe antibody anti apoj antibody apoe signal detected conditioned culture medium neurons intensities apoj signals detected western blotting determined densitometric analysis described experimental procedures comparison results distribution apoe3 lipids across fractions conditioned culture media astrocytes used values parameter expressed terms density fraction x axis distributions apoe3 apoj across density conditioned culture medium astrocytes apoj conditioned culture medium neurons shown distributions cholesterol phospholipids astrocyte culture medium shown open circles b c neuronal culture medium shown closed circles b c astro cm conditioned culture medium astrocytes neuron cm conditioned culture medium neurons
0.28076172.12042316.html.plaintext.txt	43	results indicate apoe lipid complexes isoform dependent stoichiometry lipids apoe thus next determined molar weight ratios cholesterol phospholipids apoe quantification apoe given fraction carried western blot analysis followed densitometric analysis using recombinant human apoe3 apoe4 standards shown table molar ratio cholesterol apoe apoe3 lipid particles 21 fold greater apoe4 lipid particles hand weight ratio phospholipids apoe apoe3 lipid particles 23 fold greater apoe4 lipid particles values comparable difference amount lipids released apoe3 apoe4 expressing astrocytes fig 1
0.28076172.12042316.html.plaintext.txt	44	results indicate apoe lipid complexes isoform dependent stoichiometry lipids apoe thus next determined molar weight ratios cholesterol phospholipids apoe quantification apoe given fraction carried western blot analysis followed densitometric analysis using recombinant human apoe3 apoe4 standards shown table molar ratio cholesterol apoe apoe3 lipid particles 21 fold greater apoe4 lipid particles hand weight ratio phospholipids apoe apoe3 lipid particles 23 fold greater apoe4 lipid particles values comparable difference amount lipids released apoe3 apoe4 expressing astrocytes fig 1
0.28076172.12042316.html.plaintext.txt	45	view table table molar weight ratios cholesterol phospholipids apoe associated lipid complex released cultured media culture media astrocytes expressing human apoe3 apoe4 changed dmem without serum cultures incubated 5 days conditioned media culture collected conditioned culture media fractionated density gradient ultracentrifugation amounts cholesterol phospholipids hdl fraction fraction number 4 determined described experimental procedures amount apoe fraction determined quantitative western blot analysis described experimental procedures nd determined
0.28076172.12042316.html.plaintext.txt	46	view table table molar weight ratios cholesterol phospholipids apoe associated lipid complex released cultured media culture media astrocytes expressing human apoe3 apoe4 changed dmem without serum cultures incubated 5 days conditioned media culture collected conditioned culture media fractionated density gradient ultracentrifugation amounts cholesterol phospholipids hdl fraction fraction number 4 determined described experimental procedures amount apoe fraction determined quantitative western blot analysis described experimental procedures nd determined
0.28076172.12042316.html.plaintext.txt	47	results show ability apoe3 form lipid particles greater apoe4 indicating lipid particles generated stable form apoe3 less number apoe molecules apoe4 determined compared sizes particles associated apoe3 apoe4 sizes apoe lipid particles hdl fraction 4 analyzed nondenaturing gradient gel electrophoresis sample conditioned culture media apoe3 apoe4 expressing astrocytes separated electrophoresis subsequently analyzed apoe western blotting fig 6 two populations prominent apoe lipid particles diameters 63 897 nm present fraction 4 conditioned culture medium apoe3 apoe4 expressing astrocytes equivalent amounts aliquots used western blot analysis anti apoj antibody signal detected data shown apoe lipid particle sizes determined calculation size band based size standards particle sizes apoe3 expressing astrocytes similar apoe4 expressing astrocytes table ii
0.28076172.12042316.html.plaintext.txt	48	results show ability apoe3 form lipid particles greater apoe4 indicating lipid particles generated stable form apoe3 less number apoe molecules apoe4 determined compared sizes particles associated apoe3 apoe4 sizes apoe lipid particles hdl fraction 4 analyzed nondenaturing gradient gel electrophoresis sample conditioned culture media apoe3 apoe4 expressing astrocytes separated electrophoresis subsequently analyzed apoe western blotting fig 6 two populations prominent apoe lipid particles diameters 63 897 nm present fraction 4 conditioned culture medium apoe3 apoe4 expressing astrocytes equivalent amounts aliquots used western blot analysis anti apoj antibody signal detected data shown apoe lipid particle sizes determined calculation size band based size standards particle sizes apoe3 expressing astrocytes similar apoe4 expressing astrocytes table ii
0.28076172.12042316.html.plaintext.txt	49	view larger version 45k fig 6 native nondenaturing gradient gel electrophoresis apoe3 apoe4 expressing astrocyte lipoprotein particles followed western blot analysis apoe rich fraction 4 conditioned culture media apoe3 apoe4 expressing astrocytes nondenaturing nonreducing conditions electrophoresed nondenaturing 4 20 tbe gradient gel followed western blot analysis using anti apoe antibody amersham biosciences native high molecular weight standards used hydrated diameter assessment lanes 1 2 samples fraction 4 different conditioned culture media apoe3 expressing astrocytes lanes 3 4 samples fraction 4 different conditioned culture media apoe4 expressing astrocytes four independent experiments showed similar results
0.28076172.12042316.html.plaintext.txt	50	view table table ii particle size apoe lipid complex conditioned culture media mouse astrocytes expressing human apoe3 apoe4 conditioned culture media astrocytes expressing human apoe3 apoe4 concentrated 5 fold using centriprep 10 millipore bedford ma prior fractionation two milliliters hdl fraction fraction number 4 concentrated 200 microl using centricon ym10 millipore samples electrophoresed nondenaturing 4 20 gradient gel separated proteins transferred onto polyvinylidene difluoride membrane millipore probed anti apoe antibody ab947 shown fig 6 apoe associated hdl like particles visualized separated bands sizes determined comparison migration standard proteins known diameters hmw calibration kit amersham biosciences significant difference size lipid particles obtained apoe3 apoe4 expressing astrocytes n 3 sample
0.28076172.12042316.html.plaintext.txt	51	view table table ii particle size apoe lipid complex conditioned culture media mouse astrocytes expressing human apoe3 apoe4 conditioned culture media astrocytes expressing human apoe3 apoe4 concentrated 5 fold using centriprep 10 millipore bedford ma prior fractionation two milliliters hdl fraction fraction number 4 concentrated 200 microl using centricon ym10 millipore samples electrophoresed nondenaturing 4 20 gradient gel separated proteins transferred onto polyvinylidene difluoride membrane millipore probed anti apoe antibody ab947 shown fig 6 apoe associated hdl like particles visualized separated bands sizes determined comparison migration standard proteins known diameters hmw calibration kit amersham biosciences significant difference size lipid particles obtained apoe3 apoe4 expressing astrocytes n 3 sample
0.28076172.12042316.html.plaintext.txt	52	suggested disulfide linked dimeric apoa ii exhibits stronger ability promote lipid release monomeric apoa ii increased number helical segments 44 apoe3 contains cysteine residue 112 apoe4 higher ability apoe3 promote lipid release may caused increased number helical segments due formation disulfide linked dimers examine possibility performed immunoblot analysis conditioned culture media apoe3 apoe4 expressing astrocytes reducing nonreducing conditions absence mercaptoethanol conditioned culture media apoe3 expressing astrocytes contained oligomers mainly dimers less amount tetramers addition monomers whereas apoe4 expressing astrocytes contained monomers fig 7a obviously band representing apoe3 dimer higher expected one mr 68400 known serum apoe3 forms homodimers migrate anomalously sds gel nonreducing conditions 45 may also case apoe3 dimer conditioned culture media oligomers found conditioned culture media apoe3 expressing astrocytes found monomers samples incubated 10 mercaptoethanol fig 7b
0.28076172.12042316.html.plaintext.txt	53	suggested disulfide linked dimeric apoa ii exhibits stronger ability promote lipid release monomeric apoa ii increased number helical segments 44 apoe3 contains cysteine residue 112 apoe4 higher ability apoe3 promote lipid release may caused increased number helical segments due formation disulfide linked dimers examine possibility performed immunoblot analysis conditioned culture media apoe3 apoe4 expressing astrocytes reducing nonreducing conditions absence mercaptoethanol conditioned culture media apoe3 expressing astrocytes contained oligomers mainly dimers less amount tetramers addition monomers whereas apoe4 expressing astrocytes contained monomers fig 7a obviously band representing apoe3 dimer higher expected one mr 68400 known serum apoe3 forms homodimers migrate anomalously sds gel nonreducing conditions 45 may also case apoe3 dimer conditioned culture media oligomers found conditioned culture media apoe3 expressing astrocytes found monomers samples incubated 10 mercaptoethanol fig 7b
0.28076172.12042316.html.plaintext.txt	54	view larger version 59k fig 7 time course apoe release conditioned medium cultured apoe3 apoe4 expressing astrocytes shown results western blot analysis nonreducing reducing conditions apoe3 apoe4 conditioned culture medium apoe3 apoe4 expressing astrocytes respectively oligomeric apoe mainly dimers less amount tetramers found samples apoe3 expressing astrocyte cultures apoe4 expressing astrocyte cultures samples incubated laemmli buffer containing 10 mercaptoethanol oligomers detected samples b five independent experiments show similar results discussion top abstract introduction experimental procedures results discussion references
0.28076172.12042316.html.plaintext.txt	55	demonstrate apoe isoform dependent lipid release cultured astrocytes prepared apoe3 apoe4 knock mice although found apoe isoform dependent differences size apoe3 apoe4 lipid particles total amount released apoe apoe3 apoe4 astrocytes apoe3 specific enhancement lipid release cells observed results indicate apoe3 higher ability generate apoe lipid particles less numbers apoe molecules per particle apoe4 suggesting apoe3 expressing astrocytes could supply cholesterol neurons apoe4 expressing astrocytes thereby supporting neuronal plasticity promoting neuronal regeneration
0.28076172.12042316.html.plaintext.txt	56	demonstrate apoe isoform dependent lipid release cultured astrocytes prepared apoe3 apoe4 knock mice although found apoe isoform dependent differences size apoe3 apoe4 lipid particles total amount released apoe apoe3 apoe4 astrocytes apoe3 specific enhancement lipid release cells observed results indicate apoe3 higher ability generate apoe lipid particles less numbers apoe molecules per particle apoe4 suggesting apoe3 expressing astrocytes could supply cholesterol neurons apoe4 expressing astrocytes thereby supporting neuronal plasticity promoting neuronal regeneration
0.28076172.12042316.html.plaintext.txt	57	reported apolipoproteins multiple helix segments 20 30 amino acid residues hydrophobic hydrophilic residues aligned opposite sides axis induce cholesterol efflux cells added culture medium 44 46 50 apoe one apolipoproteins effects apoe cholesterol release examined various cell systems 51 54 apolipoprotein mediated cholesterol release results generation pre hdl contains apolipoproteins cellular cholesterol phosphatidylcholine recent studies 31 37 demonstrated hdl like particles association exogenous endogenous apoe also generated cultured medium central nervous system cells astrocytes neurons addition found addition exogenous apoe promotes lipid release central nervous system cells generating hdl like particles apoe isoform dependent manner 34 consistent previous findings using exogenous apoe present study also shows amount lipids released apoe3 apoe4 expressing astrocytes apoe isoform dependent order potency apoe3 apoe4 however mechanism underlying isoform dependent cholesterol release remains undetermined
0.28076172.12042316.html.plaintext.txt	58	reported apolipoproteins multiple helix segments 20 30 amino acid residues hydrophobic hydrophilic residues aligned opposite sides axis induce cholesterol efflux cells added culture medium 44 46 50 apoe one apolipoproteins effects apoe cholesterol release examined various cell systems 51 54 apolipoprotein mediated cholesterol release results generation pre hdl contains apolipoproteins cellular cholesterol phosphatidylcholine recent studies 31 37 demonstrated hdl like particles association exogenous endogenous apoe also generated cultured medium central nervous system cells astrocytes neurons addition found addition exogenous apoe promotes lipid release central nervous system cells generating hdl like particles apoe isoform dependent manner 34 consistent previous findings using exogenous apoe present study also shows amount lipids released apoe3 apoe4 expressing astrocytes apoe isoform dependent order potency apoe3 apoe4 however mechanism underlying isoform dependent cholesterol release remains undetermined
0.28076172.12042316.html.plaintext.txt	59	therefore next question addressed mechanism underlying apoe isoform dependent cholesterol release found amount lipids released apoe3 expressing astrocytes 25 fold greater apoe4 expressing astrocytes whereas amount apoe3 released similar apoe4 one possible explanation may particle contains equal amount apoe proteins however particles containing apoe3 contain 25 fold greater amounts lipids containing apoe4 another possible explanation may particle contains equal amounts lipids apoe3 containing particles contain lower numbers apoe molecules apoe4 containing particles implies apoe3 ability form lipid particles lower number apoe molecules apoe4 thus generate 25 fold greater numbers apoe lipid particles apoe4 number apoe molecules two possibilities experiment favors latter shown fig 6 table ii sizes particles conditioned culture media apoe3 apoe4 expressing astrocytes similar
0.28076172.12042316.html.plaintext.txt	60	therefore next question addressed mechanism underlying apoe isoform dependent cholesterol release found amount lipids released apoe3 expressing astrocytes 25 fold greater apoe4 expressing astrocytes whereas amount apoe3 released similar apoe4 one possible explanation may particle contains equal amount apoe proteins however particles containing apoe3 contain 25 fold greater amounts lipids containing apoe4 another possible explanation may particle contains equal amounts lipids apoe3 containing particles contain lower numbers apoe molecules apoe4 containing particles implies apoe3 ability form lipid particles lower number apoe molecules apoe4 thus generate 25 fold greater numbers apoe lipid particles apoe4 number apoe molecules two possibilities experiment favors latter shown fig 6 table ii sizes particles conditioned culture media apoe3 apoe4 expressing astrocytes similar
0.28076172.12042316.html.plaintext.txt	61	apoe isoform dependent difference association lipoprotein particles may explained terms mechanism underlying apoe isoform specific formation apoe oligomers apoe3 protein forms dimers apoe4 difference may apoe3 cysteine position 112 n terminal domain whereas apoe4 arginine position previous studies shown number length amphiphilic helices responsible determining ability given apolipoprotein promote lipid release 44 49 55 interestingly human apoa ii known form disulfide linked dimers exhibit stronger ability promote lipid release monomeric apoa ii 44 lines evidence allow us postulate higher ability apoe dimers apoe monomers promote lipid release may explain greater amounts lipids released conditioned culture media apoe3 expressing astrocytes apoe4 expressing astrocytes based assumption propose model isoform dependent association apoe lipid particles fig 8 consistent present results previous studies revealed conformational adaptability apoe n terminal domain function lipid availability 56 presence competitor apolipoproteins review see ref 57 studies model two possible conformations apoe spherical lipid particles proposed high apoe concentration n terminal domain displaced lipid surface form helix bundle closed conformation whereas low concentration surface four helix bundles n terminal domain open conformation helices contact lipid surface based lines evidence together findings apoe3 containing hdl like particle contains approximately one half number apoe molecules compared apoe4 containing particle may possible apoe isoform dependent conformational change occurs surface lipid particles n terminal domain apoe3 open conformation whereas apoe4 closed helix bundle conformation
0.28076172.12042316.html.plaintext.txt	62	apoe isoform dependent difference association lipoprotein particles may explained terms mechanism underlying apoe isoform specific formation apoe oligomers apoe3 protein forms dimers apoe4 difference may apoe3 cysteine position 112 n terminal domain whereas apoe4 arginine position previous studies shown number length amphiphilic helices responsible determining ability given apolipoprotein promote lipid release 44 49 55 interestingly human apoa ii known form disulfide linked dimers exhibit stronger ability promote lipid release monomeric apoa ii 44 lines evidence allow us postulate higher ability apoe dimers apoe monomers promote lipid release may explain greater amounts lipids released conditioned culture media apoe3 expressing astrocytes apoe4 expressing astrocytes based assumption propose model isoform dependent association apoe lipid particles fig 8 consistent present results previous studies revealed conformational adaptability apoe n terminal domain function lipid availability 56 presence competitor apolipoproteins review see ref 57 studies model two possible conformations apoe spherical lipid particles proposed high apoe concentration n terminal domain displaced lipid surface form helix bundle closed conformation whereas low concentration surface four helix bundles n terminal domain open conformation helices contact lipid surface based lines evidence together findings apoe3 containing hdl like particle contains approximately one half number apoe molecules compared apoe4 containing particle may possible apoe isoform dependent conformational change occurs surface lipid particles n terminal domain apoe3 open conformation whereas apoe4 closed helix bundle conformation
0.28076172.12042316.html.plaintext.txt	63	view larger version 40k fig 8 model apoe lipid particles generated apoe3 apoe4 expressing astrocytes present data indicate apoe3 ability generate similarly sized apoe lipid particles less number apoe molecules apoe4 based findings propose model showing one apoe4 containing lipid particle contains 2 fold numbers apoe molecules compared apoe3 containing lipid particle
0.28076172.12042316.html.plaintext.txt	64	another possible explanation may preferential association apoe isoforms lipoproteins apoe4 preferentially associates low density lipoprotein whereas apoe3 associates hdl assumption based facts n terminal domain modulates lipid binding preference elicited c terminal domain 58 59 interaction n c terminal domains responsible isoform preference 60 61 suggested apoe4 interaction arginine 61 glutamic acid 255 may stabilize extended helical structure carboxyl terminus best accommodated less curved low density lipoprotein surface whereas interaction exist apoe3 therefore lacks stability shorter helices preference hdl 61 62 based lines evidence apoe3 may preferentially bind hdl particle lower number apoe molecules stabilize particle whereas apoe4 less binding efficacy hdl particle requires higher numbers apoe molecules stabilize particle physical properties apoe assumed influence functions ie associates lipid particles stabilizes apoe isoform dependent difference stability among 22 kda n terminal fragments apoe 63 may involved isoform dependent binding efficacy apoe hdl particles
0.28076172.12042316.html.plaintext.txt	65	another possible explanation may preferential association apoe isoforms lipoproteins apoe4 preferentially associates low density lipoprotein whereas apoe3 associates hdl assumption based facts n terminal domain modulates lipid binding preference elicited c terminal domain 58 59 interaction n c terminal domains responsible isoform preference 60 61 suggested apoe4 interaction arginine 61 glutamic acid 255 may stabilize extended helical structure carboxyl terminus best accommodated less curved low density lipoprotein surface whereas interaction exist apoe3 therefore lacks stability shorter helices preference hdl 61 62 based lines evidence apoe3 may preferentially bind hdl particle lower number apoe molecules stabilize particle whereas apoe4 less binding efficacy hdl particle requires higher numbers apoe molecules stabilize particle physical properties apoe assumed influence functions ie associates lipid particles stabilizes apoe isoform dependent difference stability among 22 kda n terminal fragments apoe 63 may involved isoform dependent binding efficacy apoe hdl particles
0.28076172.12042316.html.plaintext.txt	66	previous studies 48 50 54 demonstrated various cells generate cholesterol rich hdl like particles exogenous apolipoproteins however case astrocytes researchers found generation hdl endogenous apoe exogenous apoe differently regulated cultured astrocytes hdl like particles generated exogenous apolipoproteins low amounts cholesterol 34 37 whereas hdl like particles generated endogenous apoe cholesterol rich 37 support findings present study shown apoe lipid particles generated endogenously synthesized released apoe cholesterol rich compared generated addition exogenous apoe 34 amount apoe free lipid particles cultured medium csf detection limit see ref 31 study fig 4 b results suggest physiological conditions cholesterol rich lipid particles associated endogenous apoe major cholesterol source neurons central nervous system regard interest note apoe3 expressing astrocytes could supply cholesterol form apoe lipid particles cells including neurons comparable levels apoe secretion apoe4 expressing astrocytes steady state conditions lipid metabolisms central nervous system appear similar brains apoe3 apoe4 knock mice concentrations free esterified cholesterol postnuclear supernatant plasma membrane endoplasmic reticulum brain homogenate similar 64 however different conditions recovery phases brain injury cell damage endogenous apoe mediated generation hdl like particles could play critical role cholesterol delivery neurons essential material axonal regeneration synapse formation 65 68 actually previous studies 69 70 demonstrated traumatic brain injury robust environmental risk factor development ad lines evidence may allow us postulate apoe isoform dependence development ad may explained apoe isoform dependent ability cholesterol supply neurons injury cell damage leading neuroregeneration footnotes
0.28076172.12042316.html.plaintext.txt	67	previous studies 48 50 54 demonstrated various cells generate cholesterol rich hdl like particles exogenous apolipoproteins however case astrocytes researchers found generation hdl endogenous apoe exogenous apoe differently regulated cultured astrocytes hdl like particles generated exogenous apolipoproteins low amounts cholesterol 34 37 whereas hdl like particles generated endogenous apoe cholesterol rich 37 support findings present study shown apoe lipid particles generated endogenously synthesized released apoe cholesterol rich compared generated addition exogenous apoe 34 amount apoe free lipid particles cultured medium csf detection limit see ref 31 study fig 4 b results suggest physiological conditions cholesterol rich lipid particles associated endogenous apoe major cholesterol source neurons central nervous system regard interest note apoe3 expressing astrocytes could supply cholesterol form apoe lipid particles cells including neurons comparable levels apoe secretion apoe4 expressing astrocytes steady state conditions lipid metabolisms central nervous system appear similar brains apoe3 apoe4 knock mice concentrations free esterified cholesterol postnuclear supernatant plasma membrane endoplasmic reticulum brain homogenate similar 64 however different conditions recovery phases brain injury cell damage endogenous apoe mediated generation hdl like particles could play critical role cholesterol delivery neurons essential material axonal regeneration synapse formation 65 68 actually previous studies 69 70 demonstrated traumatic brain injury robust environmental risk factor development ad lines evidence may allow us postulate apoe isoform dependence development ad may explained apoe isoform dependent ability cholesterol supply neurons injury cell damage leading neuroregeneration footnotes
0.28076172.12042316.html.plaintext.txt	68	work supported research grant longevity sciences 8a 1 program promotion fundamental studies health sciences organization pharmaceutical safety research research brain science ministry health welfare crest japanthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.28076172.12042316.html.plaintext.txt	69	work supported research grant longevity sciences 8a 1 program promotion fundamental studies health sciences organization pharmaceutical safety research research brain science ministry health welfare crest japanthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.28076172.12042316.html.plaintext.txt	70	correspondence addressed dept dementia research national institute longevity sciences 36 3 gengo morioka obu aichi 474 8522 japan tel 81 562 46 2311 fax 81 562 46 3157 e mail michinilsgojp
0.28076172.12042316.html.plaintext.txt	71	correspondence addressed dept dementia research national institute longevity sciences 36 3 gengo morioka obu aichi 474 8522 japan tel 81 562 46 2311 fax 81 562 46 3157 e mail michinilsgojp
0.28076172.12042316.html.plaintext.txt	72	published jbc papers press may 31 2002 doi 101074jbcm203934200
0.28076172.12042316.html.plaintext.txt	73	abbreviations used ad alzheimers disease hdl high density lipoprotein apoe apolipoprotein e apoa ii apolipoprotein ii csf cerebrospinal fluid dmem dulbeccos modified eagles medium fbs fetal bovine serum pbs phosphate buffered saline tricine n 2 hydroxy 11 bishydroxymethylethylglycine amyloid protein
0.28076172.12042316.html.plaintext.txt	74	references top abstract introduction experimental procedures results discussion references 1 jarvik g p wijsman e m kukull w schellenberg g d yu c larson e b 1995 neurology 45 1092 1096abstract 2 notkola l sulkava r pekkanen j erkinjuntti ehnholm c kivinen p tuomilehto j nissinen 1998 neuroepidemiology 17 14 20crossrefmedline order article via infotrieve 3 kivipelto m helkala e l hanninen laakso m p hallikainen m alhainen k soininen h tuomilehto j nissinen 2001 neurology 56 1683 1689abstractfree full text 4 wolozin b kellman w ruosseau p celesia g g siegel g 2000 arch neurol 57 1439 1443abstractfree full text 5 jick h zornberg g l jick seshadri drachman d 2000 lancet 356 1627 1631crossrefmedline order article via infotrieve 6 simons m keller p de strooper b beyreuther k dotti c g simons k 1998 proc natl acad sci u 95 6460 6464abstractfree full text 7 fassbender k simons m bergmann c stroick m lutjohann d keller p runz h kuhl bertsch von bergmann k hennerici m beyreuther k hartmann 2001 proc natl acad sci u 98 5856 5861abstractfree full text 8 mori paris d town rojiani m sparks d l delledonne crawford f abdullah l humphrey j dickson d w mullan m j 2001 j neuropathol exp neurol 60 778 785medline order article via infotrieve 9 distl r meske v ohm g 2001 acta neuropathol 101 547 554medline order article via infotrieve 10 kakio nishimoto yanagisawa k kozutsumi y matsuzaki k 2001 j biol chem 276 24985 24990abstractfree full text 11 czyzewski k lalowski m m pfeffer barcikowska m 2001 acta neurobiol exp 61 21 26medline order article via infotrieve 12 roth g joseph j mason r p 1995 trends neurosci 18 203 206crossrefmedline order article via infotrieve 13 mulder m ravid r swaab d f de kloet e r haasdijk e d julk j van der boom j j havekes l m 1998 alzheimer dis assoc disord 12 198 203medline order article via infotrieve 14 mason r p shoemaker w j shajenko l chambers e herbette l g 1992 neurobiol aging 13 413 419crossrefmedline order article via infotrieve 15 howland d trusko p savage m j reaume g lang d m hirsch j d maeda n siman r greenberg b d scott r w flood d g 1998 j biol chem 273 16576 16582abstractfree full text 16 yip c m elton e darabie morrison m r mclaurin j 2001 j mol biol 311 723 734crossrefmedline order article via infotrieve 17 ji r wu y sui f 2002 j biol chem 277 6273 6279abstractfree full text 18 liu y peterson d schubert d 1998 proc natl acad sci u 95 13266 13271abstractfree full text 19 michikawa m gong j fan q w sawamura n yanagisawa k 2001 j neurosci 21 7226 7235abstractfree full text 20 gong j sawamura n zou k sakai j yanagisawa k michikawa m 2002 j neurosci res press 21 fan q w yu w senda yanagisawa k michikawa m 2001 j neurochem 76 391 400crossrefmedline order article via infotrieve 22 koudinov r koudinova n v 2001 faseb j 15 1858 1860abstractfree full text 23 sawamura n gong j garver w heidenreich r ninomiya h ohno k yanagisawa k michikawa m 2001 j biol chem 276 10314 10319abstractfree full text 24 roheim p carey m forte vega g l 1979 proc natl acad sci u 76 4646 4649abstract 25 pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text 26 borghini barja f pometta d james r w 1995 biochim biophys acta 1255 192 200medline order article via infotrieve 27 weisgraber k h roses d strittmatter w j 1994 curr opin lipidol 5 110 116medline order article via infotrieve 28 boyles j k pitas r e wilson e mahley r w taylor j m 1985 j clin invest 76 1501 1513medline order article via infotrieve 29 nakai m kawamata taniguchi maeda k tanaka c 1996 neurosci lett 211 41 44crossrefmedline order article via infotrieve 30 pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917 148 161medline order article via infotrieve 31 ladu m j gilligan m lukens j r cabana v g reardon c van eldik l j holtzman d m 1998 j neurochem 70 2070 2081medline order article via infotrieve 32 beffert u danik m krzywkowski p ramassamy c berrada f poirier j 1998 brain res brain res rev 27 119 142medline order article via infotrieve 33 fan q w isobe asou h yanagisawa k michikawa m 2001 j aging assoc 24 1 10 34 michikawa m fan q w isobe yanagisawa k 2000 j neurochem 74 1008 1016crossrefmedline order article via infotrieve 35 fagan m holtzman d m munson g mathur schneider d chang l k getz g reardon c lukens j shah j ladu m j 1999 j biol chem 274 30001 30007abstractfree full text 36 li q komaba yokoyama 1993 biochemistry 32 4597 4603medline order article via infotrieve 37 ito j zhang l y asai m yokoyama 1999 j neurochem 72 2362 2369crossrefmedline order article via infotrieve 38 hamanaka h katoh fukui y suzuki k kobayashi m suzuki r motegi y nakahara y takeshita kawai m ishiguro k yokoyama m fujita c 2000 hum mol genet 9 353 361abstractfree full text 39 isobe michikawa m yanagisawa k 1999 neurosci lett 266 129 132crossrefmedline order article via infotrieve 40 isobe yanagisawa k michikawa m 2000 exp neurol 162 51 60crossrefmedline order article via infotrieve 41 michikawa m yanagisawa k 1999 j neurochem 72 2278 2285crossrefmedline order article via infotrieve 42 laemmli u k 1970 nature 227 680 685medline order article via infotrieve 43 mccall m r forte m shore v g 1988 j lipid res 29 1127 1137abstract 44 hara h komaba yokoyama 1992 lipids 27 302 304medline order article via infotrieve 45 weisgraber k h shinto l h 1991 j biol chem 266 12029 12034abstractfree full text 46 mendez j 1997 j lipid res 38 1807 1821abstract 47 yokoyama 1998 biochim biophys acta 1392 1 15medline order article via infotrieve 48 hara h yokoyama 1992 biochemistry 31 2040 2046medline order article via infotrieve 49 bielicki j k johnson w j weinberg r b glick j m rothblat g h 1992 j lipid res 33 1699 1709abstract 50 forte m goth goldstein r nordhausen r w mccall m r 1993 j lipid res 34 317 324abstract 51 basu k goldstein j l brown m 1983 science 219 871 873medline order article via infotrieve 52 huang y von eckardstein wu maeda n assmann g 1994 proc natl acad sci u 91 1834 1838abstract 53 zhang w y gaynor p m kruth h 1996 j biol chem 271 28641 28646abstractfree full text 54 hara h yokoyama 1991 j biol chem 266 3080 3086abstractfree full text 55 segrest j p jones m k de loof h brouillette c g venkatachalapathi y v anantharamaiah g m 1992 j lipid res 33 141 166abstract 56 saito h dhanasekaran p baldwin f weisgraber k h lund katz phillips m c 2001 j biol chem 276 40949 40954abstractfree full text 57 narayanaswami v ryan r o 2000 biochim biophys acta 1483 15 36medline order article via infotrieve 58 sparrow j sparrow d fernando g culwell r kovar m gotto m jr 1992 biochemistry 31 1065 1068medline order article via infotrieve 59 de pauw m vanloo b weisgraber k rosseneu m 1995 biochemistry 34 10953 10966medline order article via infotrieve 60 dong l m wilson c wardell m r simmons mahley r w weisgraber k h agard d 1994 j biol chem 269 22358 22365abstractfree full text 61 dong l m weisgraber k h 1996 j biol chem 271 19053 19057abstractfree full text 62 raffai r l dong l m farese r v jr weisgraber k h 2001 proc natl acad sci u 98 11587 11591abstractfree full text 63 morrow j segall m l lund katz phillips m c knapp m rupp b weisgraber k h 2000 biochemistry 39 11657 11666crossrefmedline order article via infotrieve 64 hayashi h igbavboa u hamanaka h kobayashi m fujita c gibson wood w yanagisawa k 2002 neuroreport 13 383 386crossrefmedline order article via infotrieve 65 poirier j 1994 trends neurosci 17 525 530crossrefmedline order article via infotrieve 66 posse de chaves e rusinol e vance d e campenot r b vance j e 1997 j biol chem 272 30766 30773abstractfree full text 67 posse de chaves e vance d e campenot r b kiss r vance j e 2000 j biol chem 275 19883 19890abstractfree full text 68 mauch d h nagler k schumacher goritz c muller e c otto pfrieger f w 2001 science 294 1354 1357abstractfree full text 69 roberts g w allsop d bruton c 1990 j neurol neurosurg psychiatry 53 373 378abstract 70 nicoll j roberts g w graham d 1995 nat med 1 135 137medline order article via infotrieve
0.28076172.12042316.html.plaintext.txt	75	copyright 2002 american society biochemistry molecular biology inc
0.28218916.14764623.html.plaintext.txt	0	alzheimers disease one disorder many genes lars bertram rudolph e tanzi
0.28218916.14764623.html.plaintext.txt	1	genetics aging research unit department neurology massgeneral institute neurodegenerative diseases massachusetts general hospital harvard medical school charlestown ma usa
0.28218916.14764623.html.plaintext.txt	2	received january 13 2004 accepted january 26 2004
0.28218916.14764623.html.plaintext.txt	3	abstract top abstract introduction 2003 good vintage conclusion references research alzheimers disease ad genetics extremely prolific past decade currently 10 genes reported show either positive negative evidence disease association per month review 90 studies 2003 reporting total 127 association findings candidate genes ad positive results largely contradictory identified three loci chromosomes 6p21 10q24 11q23 yielded positive results three independent studies addition well established ad association gene encoding apolipoprotein e apoe based data suggest may prudent investigators pay closer attention issues power replicability haplotype structure prior initial publication serve greatly decrease likelihood false positive false negative findings reported future years
0.28218916.14764623.html.plaintext.txt	4	introduction top abstract introduction 2003 good vintage conclusion references several characteristics make search novel alzheimers disease ad genes particularly promising first importantly heritability ad high demonstrated various studies examining familial segregation disease past decades 1 3 accordingly probability actually finding relevant disease causing predisposing genes relatively high well possibly even genetically complex neuropsychiatric disorders like parkinsons disease schizophrenia affective disorders 4 thus far ad achieved four genes app psen1 psen2 apoe variation latter also plays significant role common late onset form disorder see fully penetrant mutations app psen1 psen2 hand lead rare early onset familial forms ad via increased generation ass42 ss amyloid deposition major neuropathological hallmark disease secondly direct evidence based simulation well empirical data presence additional ad risk genes besides apoe instance recent simulation study predicted existence four seven additional ad genes searching age onset modifiers simulating variety different disease inheritance models 3 number corresponds well empirical data obtained full genome searches overlap 11 chromosomes six show significant results least one study table 1 finally progressive neurodegeneration gradually leading cognitive decline dementia ad patients exhibits distinct well established histopathological features upon post mortem examination allowing verification clinical ad 5 currently accuracy clinical ad diagnosis near beyond 90 academic centers 6 8 allows significant reduction number phenocopies study populations using published research criteria thereby increases power subsequent genetic epidemiological analyses
0.28218916.14764623.html.plaintext.txt	5	view table table 1 overview concordant linkageassociation regions observed full genome screens published 2003 disease specific characteristics together advent relatively inexpensive powerful high throughput genotyping technologies near completion human genome sequence led steep increase number laboratories studying genetics ad worldwide date less 12 full genome screens using linkage association based methodologies published ad using overlapping identical samples employing different sets genetic markers andor analytic strategies 8 19 table 1 hand number locus specific candidate gene based ad association studies become nearly intractable course 2003 10 genes reported show either positive negative evidence association different ad phenotypes per month peer reviewed journals listed ncbis pubmed despite vast efforts single gene yet emerged attain nearly degree replication consistency observed literally hundreds laboratories studying association apoe 4 ad review present discuss findings genetic ad association studies published 2003 excluding explicitly searching causes early onset familial ad cases ie private mutations using data example attempt pinpoint methodological difficulties likely underlie remarkable failure replicate genetic findings using current approaches
0.28218916.14764623.html.plaintext.txt	6	2003 good vintage ad genetics top abstract introduction 2003 good vintage conclusion references genome screens outlined year 2003 almost unprecedented terms number studies attempting unravel causes ad genetics three full genome screens 81819 using association genetic linkage methods added nine studies already reported literature late onset ad study study comparison using p value 001 cut reveals total 16 regions 11 chromosomes yield positive signals across least two studies markers 25 mb apart table 1 interestingly chromosomes strongest consistent signals ie 6 9 10 12 19 21 already implicated least 3 years earlier received support 2003 based criteria new ad region emerge 2003 chromosome 2p23 24 position 19 29 mb interestingly region implicated studies using association methods fairly isolated homogeneous populations ie finns wadi ara 1418 note inclusion exclusion criteria applied arbitrary may overestimate total number positive signals however allow comparison across multitude methodologically divergent approaches facilitate interpretation analyses based actual candidate genes
0.28218916.14764623.html.plaintext.txt	7	candidate gene studies searching pubmed wwwncbinlmnihgovpubmed keywords alzheimer association associated papers published january 1 december 31 2003 retrieved total 1037 studies december 28 2003 90 directly deal genetic association candidate polymorphisms ad seen table 2 studies examined total 55 genetic loci locus set markers within 5 mb genomic interval 20 different chromosomes total 55 analyzed genes within loci found positive judged authors 68 tested negative interestingly even 10 years discovery largest number n18 reports focusing single gene dealt association apoe ad using new polymorphisms new samplesethnic groups new phenotypes studies considered total 38 positive 67 negative papers remained
0.28218916.14764623.html.plaintext.txt	8	view table table 2 overview chromosomal loci tested genetic association ad 2003 2003 represents one prolific vintages late onset ad genetic studies next pressing question large quantity studies also dilute quality product perhaps even making unpalatable quaff answer opinion yes least majority cases growing consensus success rate reliability genetic association studies complex diseases depend fulfillment several criteria 2021 three discussed detail addition classic requirements least plausible biological andor positional candidacy investigated locus well direct proof pathophysiological consequences positive disease association former criterion fulfilled vast majority ad candidate genes investigated thus far latter condition elusive due several factors generally bedevil study genetic association complex diseases linkage disequilibrium actual functionally relevant disease modifying variant small effect sizes impede detection significant effects using basic molecular biochemical assays possibly involvement yet unknown pathophysiological mechanisms situation apoe 4 ad serves good example genetic association per se extremely well established past decade still consensus association translates pathophysiologically 2223
0.28218916.14764623.html.plaintext.txt	9	thus attempting uncover functional consequences putative new disease association propose emphasis must placed criteria allow better distinction false positive well false negative findings prior initial publication
0.28218916.14764623.html.plaintext.txt	10	power sample size structure enable investigators detect effect sizes moderate small extent obvious concern reports negative outcome power study also governs rate false positive findings ie probability observed significant association indeed genuine observed chance 24 26 factors influencing ability detect meaningful effects include attributable risk polymorphism overall genetic variance degree linkage disequilibrium ld associated allele actual disease predisposing variant mode inheritance lesser extent disease prevalence variables course difficult estimate true disease gene unknown power given sample size fairly easily calculated variety possible plausible scenarios practice however still remains exception recent study estimated minimal number cases controls sufficient achieve 80 power 005 usually far greater 200 actual disease allele tested directly even favorable circumstances 26 interesting regardless estimates 20 studies published 2003 still used smaller sample sizes thus probably suitable use reaching reliable conclusion
0.28218916.14764623.html.plaintext.txt	11	replicability result validatedreplicated independent sample sufficient size reports significant associations putative candidate genes ad every chromosome human genome past 10 years 27 none findings exception apoe 4 yet replicated consistently many seemingly positive result could validated independent dataset prior first publication several authors long suggesting guidelines proper quality control genetic association findings 2021252829 current inflation probable false positive reports may avoided independent replication sought earlier independent sample cannot found house establishment least temporary consortia collaborative laboratories test others positive signals prior publication would represent easy effective means restore credibility upon review 2003 ad genetics literature less 20 studies either referred findings two independent samples published tandem independent reports investigating candidate genes andor genetic variants
0.28218916.14764623.html.plaintext.txt	12	replicability result validatedreplicated independent sample sufficient size reports significant associations putative candidate genes ad every chromosome human genome past 10 years 27 none findings exception apoe 4 yet replicated consistently many seemingly positive result could validated independent dataset prior first publication several authors long suggesting guidelines proper quality control genetic association findings 2021252829 current inflation probable false positive reports may avoided independent replication sought earlier independent sample cannot found house establishment least temporary consortia collaborative laboratories test others positive signals prior publication would represent easy effective means restore credibility upon review 2003 ad genetics literature less 20 studies either referred findings two independent samples published tandem independent reports investigating candidate genes andor genetic variants
0.28218916.14764623.html.plaintext.txt	13	haplotype structure authors made attempts elucidate structure underlying haplotype architecture current systematic assessment haplotype structures various regions throughout genome past 3 4 years emphasized importance performing haplotype systematic ld analyses searching novel complex disease genes 3031 especially effect sizes expected lower conferred apoe 4 addition increasing power analyses approach also reduces number statistical tests need performed lead decrease false positive findings several recently published complex disease associations would impossible observe without thorough assessment underlying haplotype architecture 32 34 along lines recent studies apoe shown locus would easily identified means haplotype analysis alone even without prior knowledge 4 polymorphism 3536 yet 2003 one third studies investigated one polymorphism per locus half carried less thorough assessment haplotype structure ie four polymorphisms per gene
0.28218916.14764623.html.plaintext.txt	14	haplotype structure authors made attempts elucidate structure underlying haplotype architecture current systematic assessment haplotype structures various regions throughout genome past 3 4 years emphasized importance performing haplotype systematic ld analyses searching novel complex disease genes 3031 especially effect sizes expected lower conferred apoe 4 addition increasing power analyses approach also reduces number statistical tests need performed lead decrease false positive findings several recently published complex disease associations would impossible observe without thorough assessment underlying haplotype architecture 32 34 along lines recent studies apoe shown locus would easily identified means haplotype analysis alone even without prior knowledge 4 polymorphism 3536 yet 2003 one third studies investigated one polymorphism per locus half carried less thorough assessment haplotype structure ie four polymorphisms per gene
0.28218916.14764623.html.plaintext.txt	15	90 papers published 2003 topic genetic association candidate genes different ad phenotypes 21 23 fulfilled least two criteria likely many observed discrepancies across studies could explained lack methodological thoroughness nonetheless three loci addition apoe tested positive across least three studies chromosomes 6p21 10q24 11q23 table 2 loci covered remainder review
0.28218916.14764623.html.plaintext.txt	16	90 papers published 2003 topic genetic association candidate genes different ad phenotypes 21 23 fulfilled least two criteria likely many observed discrepancies across studies could explained lack methodological thoroughness nonetheless three loci addition apoe tested positive across least three studies chromosomes 6p21 10q24 11q23 table 2 loci covered remainder review
0.28218916.14764623.html.plaintext.txt	17	chromosome 6p21 chromosomal region implicated harboring putative ad gene early 1980 based association finding variants highly polymorphic major histocompatibility complex region hla 30 mb ad small case control study 37 two potential ad candidates map within 5 mb interval genes encoding hereditary haemochromatosis protein hfe 26 mb tumor necrosis factor alpha tnfa 31 mb 2003 two studies reported significant evidence association latter two genes 3839 two studies confirm findings 4041 another candidate gene located region hapa1b found associated certain neuropsychological variables 42 disease risk 43 finally one study investigated variation onset age function hla a2 allele small sample ad patients find significant effects 44 literature search association studies genes including years 2003 yielded least 15 positive studies 10 reports found evidence genetic involvement factors evidence direct involvement tnfa ass production toxicity 45 direct proof pathogenetic relevance genesproteins remains seen furthermore full genome screens ad genes consistently yielded signals 6p21 residing 39 42 mb whereas associated genes map 10 mb proximal thus increasing evidence supporting existence putative ad locus 6p21 general possibility actual disease gene yet identified cannot excluded despite overlapping positive results year past studies
0.28218916.14764623.html.plaintext.txt	18	chromosome 6p21 chromosomal region implicated harboring putative ad gene early 1980 based association finding variants highly polymorphic major histocompatibility complex region hla 30 mb ad small case control study 37 two potential ad candidates map within 5 mb interval genes encoding hereditary haemochromatosis protein hfe 26 mb tumor necrosis factor alpha tnfa 31 mb 2003 two studies reported significant evidence association latter two genes 3839 two studies confirm findings 4041 another candidate gene located region hapa1b found associated certain neuropsychological variables 42 disease risk 43 finally one study investigated variation onset age function hla a2 allele small sample ad patients find significant effects 44 literature search association studies genes including years 2003 yielded least 15 positive studies 10 reports found evidence genetic involvement factors evidence direct involvement tnfa ass production toxicity 45 direct proof pathogenetic relevance genesproteins remains seen furthermore full genome screens ad genes consistently yielded signals 6p21 residing 39 42 mb whereas associated genes map 10 mb proximal thus increasing evidence supporting existence putative ad locus 6p21 general possibility actual disease gene yet identified cannot excluded despite overlapping positive results year past studies
0.28218916.14764623.html.plaintext.txt	19	chromosome 10q24 six candidate loci analyzed region 10q21 10q25 2003 three reported associated ad phenotypes across multiple samples ie cdc2vr22 tnfrsf6ide gsto12 locus found associated one group investigators located 90 94 mb encompasses genes tnfrsf6 90 mb idekiff11hhex 46 48 probably best candidate biological grounds ide encoding insulin degrading enzyme protein ide metalloprotease shown degrade monomeric ass aggregate oligomeric forms ultimately ss amyloid plaques 49 several issues proposed mode action still remain controversial eg precise cellular location ass cleavage relevance ide functiondysfunction development ad number animal models available showing predicted effects vivo 50 52 2003 two papers published showing allelic association microsatellite markers region 5354 two reports find association ide variants nearby markers ad 5556 note data one negative studies 55 actually largely overlaps positive paper edland et al 46 important exception authors first paper account potential interactions ide apoe 4 status may crucial since latter study found significant effect ide ad risk individuals lacking apoe 4 allele clearly studies independent samples sufficient size necessary elucidate potential role ide variants development ad general population
0.28218916.14764623.html.plaintext.txt	20	addition ide locus total four genes long arm chromosome 10 found associated ad two cdc2 vr22 map 30 mb proximal ide two gsto12 prss11 map 10 30 mb distal none associations yet confirmed independent ad samples noteworthy two genes also found associated neurodegenerative illnesses frontotemporal dementia cdc2 57 parkinsons disease gsto12 58 potentially suggesting common pathway leading neuronal cell death across syndromes cdc2 encodes cell division cycle 2 protein involved phosphorylation tau app found neurons bearing neurofibrillary tangles gsto1 2 encode glutathione transferase omega 1 2 involved physiological response oxidative stress may particular responsible regulating expression inflammatory cytokines like il1 ss thus plausible ad candidate genes positional well biologicalbiochemical grounds studies still necessary elucidate proposed roles influencing risk andor age onset ad general population
0.28218916.14764623.html.plaintext.txt	21	addition ide locus total four genes long arm chromosome 10 found associated ad two cdc2 vr22 map 30 mb proximal ide two gsto12 prss11 map 10 30 mb distal none associations yet confirmed independent ad samples noteworthy two genes also found associated neurodegenerative illnesses frontotemporal dementia cdc2 57 parkinsons disease gsto12 58 potentially suggesting common pathway leading neuronal cell death across syndromes cdc2 encodes cell division cycle 2 protein involved phosphorylation tau app found neurons bearing neurofibrillary tangles gsto1 2 encode glutathione transferase omega 1 2 involved physiological response oxidative stress may particular responsible regulating expression inflammatory cytokines like il1 ss thus plausible ad candidate genes positional well biologicalbiochemical grounds studies still necessary elucidate proposed roles influencing risk andor age onset ad general population
0.28218916.14764623.html.plaintext.txt	22	chromosome 11q23 region near tip long arm chromosome 11 implicated one full genome screens published date 8 therefore appear table 1 yet total three studies showing significant association ad candidate gene 2003 bace encoding ss site app cleaving enzyme ss secretase 59 61 protein excellent ad candidate biochemical grounds ss secretase cleavage app ass liberated precursor via secretase cleavage interestingly contrast putative ad associations discussed appears high degree consistency respect site allelic nature underlying findings positive studies including initial report nowotny colleagues published 2001 62 observe representations g allele synonymous snp located codon 262 exon 5 ad cases compared healthy controls furthermore studies observed effect pronounced carriers apoe 4 allele yielding significantly elevated odds ratios ranging 2 7
0.28218916.14764623.html.plaintext.txt	23	chromosome 11q23 region near tip long arm chromosome 11 implicated one full genome screens published date 8 therefore appear table 1 yet total three studies showing significant association ad candidate gene 2003 bace encoding ss site app cleaving enzyme ss secretase 59 61 protein excellent ad candidate biochemical grounds ss secretase cleavage app ass liberated precursor via secretase cleavage interestingly contrast putative ad associations discussed appears high degree consistency respect site allelic nature underlying findings positive studies including initial report nowotny colleagues published 2001 62 observe representations g allele synonymous snp located codon 262 exon 5 ad cases compared healthy controls furthermore studies observed effect pronounced carriers apoe 4 allele yielding significantly elevated odds ratios ranging 2 7
0.28218916.14764623.html.plaintext.txt	24	contrast four positive associations equal number studies literature showing apparent effects bace polymorphism ad however must pointed one studied early onset familial ad cases 63 remaining studies account potential interaction apoe 4 allele 64 66 unless done similar situation encountered variants tested ide see firm conclusions reached whether exon 5 polymorphism bace genetic risk factor ad samples thus three known app cleaving enzymes associated proteins adam910 17 ss bace bace2 secretase psen1 aph1a ncstn pen2 already tested genetic association ad phenotypes bace currently shows promise genuine relevant risk factor late onset ad case putative ad genes studies using sufficiently sized samples appropriate analytic strategies need performed general conclusions reached note first study examining putative genetic role bace late onset ad 2004 also reports significant effect exon 5 polymorphism case control sample chinese origin 67
0.28218916.14764623.html.plaintext.txt	25	contrast four positive associations equal number studies literature showing apparent effects bace polymorphism ad however must pointed one studied early onset familial ad cases 63 remaining studies account potential interaction apoe 4 allele 64 66 unless done similar situation encountered variants tested ide see firm conclusions reached whether exon 5 polymorphism bace genetic risk factor ad samples thus three known app cleaving enzymes associated proteins adam910 17 ss bace bace2 secretase psen1 aph1a ncstn pen2 already tested genetic association ad phenotypes bace currently shows promise genuine relevant risk factor late onset ad case putative ad genes studies using sufficiently sized samples appropriate analytic strategies need performed general conclusions reached note first study examining putative genetic role bace late onset ad 2004 also reports significant effect exon 5 polymorphism case control sample chinese origin 67
0.28218916.14764623.html.plaintext.txt	26	conclusion top abstract introduction 2003 good vintage conclusion references year 2003 extremely productive terms studies examining potential associations candidate genes ad phenotypes vast majority results previous years remains controversial cases could due factors disease specific eg larger anticipated genetic heterogeneity andor small effect sizes individual risk alleles good proportion controversies probably caused methodological issues based recent empirical simulation data regarding genetic make complex diseases power association studies general propose attention paid providing power estimates based structure analyzed sample variety effect sizes allele frequencies ii replicating positive signal least one independent population sufficient size power prior initial publication iii thoroughly assessing haplotype structure investigated locus especially reaching negative conclusions together statistical techniques take account potential interactions genetic non genetic factors allow adequate correction multiple comparisons adherence criteria ensure successful distinction clinically relevant irrelevantfalse positive findings eventually good vintage wine strategy elevate quality ad genetics research par quantity
0.28218916.14764623.html.plaintext.txt	27	acknowledgements work sponsored grants nimh nia adrc alzheimer association lb fellow harvard center neurodegeneration repair hcnr fellow deutsche forschungsgemeinschaft dfg
0.28218916.14764623.html.plaintext.txt	28	footnotes correspondence addressed genetics aging research unit department neurology massachusetts general hospital 114 16th street charlestown ma 02129 usa tel 1 6177266845 fax 1 6177241823 email tanziathelixmghharvardedu
0.28218916.14764623.html.plaintext.txt	29	footnotes correspondence addressed genetics aging research unit department neurology massachusetts general hospital 114 16th street charlestown ma 02129 usa tel 1 6177266845 fax 1 6177241823 email tanziathelixmghharvardedu
0.28218916.14764623.html.plaintext.txt	30	references top abstract introduction 2003 good vintage conclusion references rao vs cupples van duijn cm kurz green rc chui h duara r auerbach sa volicer l wells j et al 1996 evidence major gene inheritance alzheimer disease families patients without apolipoprotein e epsilon 4 j hum genet 59 664 675isimedline
0.28218916.14764623.html.plaintext.txt	31	poirier j 2000 apolipoprotein e alzheimers disease role amyloid catabolism ann ny acad sci 924 81 90abstractfree full text
0.29108343.15269218.html.plaintext.txt	0	deficiency abca1 impairs apolipoprotein e metabolism brain veronica hirsch reinshagen steven zhou braydon l burgess lise bernier sean mcisaac jeniffer y chan gavin h tansley jeffrey cohn michael r hayden cheryl l wellington
0.29108343.15269218.html.plaintext.txt	1	deficiency abca1 impairs apolipoprotein e metabolism brain veronica hirsch reinshagen steven zhou braydon l burgess lise bernier sean mcisaac jeniffer y chan gavin h tansley jeffrey cohn michael r hayden cheryl l wellington
0.29108343.15269218.html.plaintext.txt	2	department pathology laboratory medicine university british columbia vancouver v5z 4h4 canada clinical research institute montreal montreal h2w 1r7 canada centre molecular medicine therapeutics university british columbia vancouver v5z 4h4 canada
0.29108343.15269218.html.plaintext.txt	3	received publication july 14 2004
0.29108343.15269218.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references abca1 cholesterol transporter widely expressed throughout body outside central nervous system cns abca1 functions biogenesis high density lipoprotein hdl mediates efflux cholesterol phospholipids apolipoprotein apo deficiency abca1 results lack circulating hdl greatly reduced levels apoa abca1 also expressed cells within cns roles brain lipid metabolism yet fully understood brain glia synthesize apolipoproteins involved cns lipid metabolism demonstrate glial abca1 required cholesterol efflux apoa plays key role facilitating cholesterol efflux apoe major apolipoprotein brain astrocytes microglia abca1 deficiency reduces lipid efflux exogenous apoe impaired ability efflux lipids abca1 glia results lipid accumulation astrocytes microglia normal culture conditions additionally apoe secretion compromised abca1 astrocytes microglia vivo deficiency abca1 results 65 decrease apoe levels whole brain 75 80 decrease apoe levels hippocampus striatum additionally effect abca1 apoe selective apoj levels unchanged brains abca1 mice taken together results show glial abca1 key influence apoe metabolism cns
0.29108343.15269218.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references abca1 cholesterol transporter widely expressed throughout body outside central nervous system cns abca1 functions biogenesis high density lipoprotein hdl mediates efflux cholesterol phospholipids apolipoprotein apo deficiency abca1 results lack circulating hdl greatly reduced levels apoa abca1 also expressed cells within cns roles brain lipid metabolism yet fully understood brain glia synthesize apolipoproteins involved cns lipid metabolism demonstrate glial abca1 required cholesterol efflux apoa plays key role facilitating cholesterol efflux apoe major apolipoprotein brain astrocytes microglia abca1 deficiency reduces lipid efflux exogenous apoe impaired ability efflux lipids abca1 glia results lipid accumulation astrocytes microglia normal culture conditions additionally apoe secretion compromised abca1 astrocytes microglia vivo deficiency abca1 results 65 decrease apoe levels whole brain 75 80 decrease apoe levels hippocampus striatum additionally effect abca1 apoe selective apoj levels unchanged brains abca1 mice taken together results show glial abca1 key influence apoe metabolism cns
0.29108343.15269218.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references abca1 member atp binding cassette superfamily transporters transport substrates across membranes 1 3 major biochemical function abca1 transport cholesterol phospholipids plasma membrane peripheral cells lipid free lipid poor apolipoprotein apoa reverse cholesterol transport 1 process constitutes initial step biogenesis high density lipoproteins hdl1 peripheral circulation mutation one abca1 allele causes familial hypoalphalipoproteinemia fha mild disorder lipid metabolism characterized reduced plasma hdl levels 4 mutation alleles abca1 results tangier disease td characterized nearly complete absence plasma hdl deposition intracellular cholesterol esters increased risk cardiovascular disease 4 6 conversely overexpression abca1 mice increases plasma hdl protects atherosclerosis 7 9
0.29108343.15269218.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references abca1 member atp binding cassette superfamily transporters transport substrates across membranes 1 3 major biochemical function abca1 transport cholesterol phospholipids plasma membrane peripheral cells lipid free lipid poor apolipoprotein apoa reverse cholesterol transport 1 process constitutes initial step biogenesis high density lipoproteins hdl1 peripheral circulation mutation one abca1 allele causes familial hypoalphalipoproteinemia fha mild disorder lipid metabolism characterized reduced plasma hdl levels 4 mutation alleles abca1 results tangier disease td characterized nearly complete absence plasma hdl deposition intracellular cholesterol esters increased risk cardiovascular disease 4 6 conversely overexpression abca1 mice increases plasma hdl protects atherosclerosis 7 9
0.29108343.15269218.html.plaintext.txt	8	abca1 abundant liver macrophages expression induced agonists liver x receptorretinoid x receptor lxrrxr pathways 10 16 abca1 also expressed glia neurons central nervous system cns particularly abundant purkinje cells large pyramidal cortical neurons 10 17 18 similar non cns cells abca1 induced lxrrxr stimulation primary neurons astrocytes microglia 18 20
0.29108343.15269218.html.plaintext.txt	9	abca1 abundant liver macrophages expression induced agonists liver x receptorretinoid x receptor lxrrxr pathways 10 16 abca1 also expressed glia neurons central nervous system cns particularly abundant purkinje cells large pyramidal cortical neurons 10 17 18 similar non cns cells abca1 induced lxrrxr stimulation primary neurons astrocytes microglia 18 20
0.29108343.15269218.html.plaintext.txt	10	importance lipid homeostasis cns underscored fact brain cholesterol rich organ body contains 25 total body cholesterol 2 total body weight 21 nearly brain cholesterol synthesized situ quantitative analyses show essentially cholesterol crosses blood brain barrier 21 contrast brain cannot degrade cholesterol excess cholesterol must delivered peripheral circulation eventual excretion via liver approximately 6 7 mg cholesterol leaves human brain day conversion 24s hydroxycholesterol easily traverses blood brain barrier 22 24
0.29108343.15269218.html.plaintext.txt	11	importance lipid homeostasis cns underscored fact brain cholesterol rich organ body contains 25 total body cholesterol 2 total body weight 21 nearly brain cholesterol synthesized situ quantitative analyses show essentially cholesterol crosses blood brain barrier 21 contrast brain cannot degrade cholesterol excess cholesterol must delivered peripheral circulation eventual excretion via liver approximately 6 7 mg cholesterol leaves human brain day conversion 24s hydroxycholesterol easily traverses blood brain barrier 22 24
0.29108343.15269218.html.plaintext.txt	12	glial cells play crucial roles regulating lipid homeostasis cns astrocytes microglia cells within cns synthesize secrete apolipoproteins transport lipids within brain cerebrospinal fluid csf 25 27 apolipoprotein e apoe major apolipoprotein brain also component several lipoproteins peripheral circulation including hdl low density lipoproteins vldl chylomicrons 28 30 humans apoe exists one three allelic variants contain either cysteine arginine residue amino acids 112 158 31 liver transplantation experiments humans shown allelic variant apoe plasma converted donor whereas apoe csf retains allelic identity recipient illustrating cns non cns apoe pools synthesized independently 32 additionally brain perfusion experiments guinea pigs shown radiolabeled apoe administered peripheral circulation demonstrates low blood brain transport 33 providing additional support independent regulation cns non cns apoe pools apoj second major cns lipoprotein unlike apoe easily traverses blood brain barrier associates hdl periphery 26 33 34 apoe apoj synthesized secreted astrocytes microglia expression apoe apoj induced response cns injury disease 24 26 apoe thought coordinate mobilization redistribution cholesterol repair maintenance neuronal membranes myelin 35 37 whereas apoj may function cytoprotective extracellular chaperone 38 contrast apoe apoj apoa primarily taken brain outside cns believed involved maturation lipoprotein particles csf 26 39
0.29108343.15269218.html.plaintext.txt	13	glial cells play crucial roles regulating lipid homeostasis cns astrocytes microglia cells within cns synthesize secrete apolipoproteins transport lipids within brain cerebrospinal fluid csf 25 27 apolipoprotein e apoe major apolipoprotein brain also component several lipoproteins peripheral circulation including hdl low density lipoproteins vldl chylomicrons 28 30 humans apoe exists one three allelic variants contain either cysteine arginine residue amino acids 112 158 31 liver transplantation experiments humans shown allelic variant apoe plasma converted donor whereas apoe csf retains allelic identity recipient illustrating cns non cns apoe pools synthesized independently 32 additionally brain perfusion experiments guinea pigs shown radiolabeled apoe administered peripheral circulation demonstrates low blood brain transport 33 providing additional support independent regulation cns non cns apoe pools apoj second major cns lipoprotein unlike apoe easily traverses blood brain barrier associates hdl periphery 26 33 34 apoe apoj synthesized secreted astrocytes microglia expression apoe apoj induced response cns injury disease 24 26 apoe thought coordinate mobilization redistribution cholesterol repair maintenance neuronal membranes myelin 35 37 whereas apoj may function cytoprotective extracellular chaperone 38 contrast apoe apoj apoa primarily taken brain outside cns believed involved maturation lipoprotein particles csf 26 39
0.29108343.15269218.html.plaintext.txt	14	1993 apoe discovered important genetic risk factor alzheimers disease ad finding replicated 100 studies inheritance apoe4 increases risk ad dosage specific manner may act decreasing age onset ad 40 41 contrast inheritance apoe2 appears protect ad associated later age onset 42 many hypotheses proposed explain apoe participates pathogenesis ad including roles apoe formation deposition clearance peptides constitute amyloid plaques 43 51 example apoe binds vivo required amyloid deposition 50 53 furthermore apoe affects deposition isoform specific manner mice expressing human apoe4 develop least 25 fold deposits mice expressing human apoe3 per unit area 45 49 53 54 interestingly replacement murine apoe human apoe isoforms completely suppresses deposition compared wild type mice expressing endogenous murine apoe 49 55 suggesting distinctions human murine apoe may play important roles deposition andor clearance compared apoe role apoj ad less well understood although known apoj also binds suggested play major role transporting across blood brain barrier 33 34
0.29108343.15269218.html.plaintext.txt	15	1993 apoe discovered important genetic risk factor alzheimers disease ad finding replicated 100 studies inheritance apoe4 increases risk ad dosage specific manner may act decreasing age onset ad 40 41 contrast inheritance apoe2 appears protect ad associated later age onset 42 many hypotheses proposed explain apoe participates pathogenesis ad including roles apoe formation deposition clearance peptides constitute amyloid plaques 43 51 example apoe binds vivo required amyloid deposition 50 53 furthermore apoe affects deposition isoform specific manner mice expressing human apoe4 develop least 25 fold deposits mice expressing human apoe3 per unit area 45 49 53 54 interestingly replacement murine apoe human apoe isoforms completely suppresses deposition compared wild type mice expressing endogenous murine apoe 49 55 suggesting distinctions human murine apoe may play important roles deposition andor clearance compared apoe role apoj ad less well understood although known apoj also binds suggested play major role transporting across blood brain barrier 33 34
0.29108343.15269218.html.plaintext.txt	16	abca1 apoe shown induced response lxrrxr stimulation 15 16 20 56 57 repressed zn202 58 peripheral macrophages previous work demonstrated apoe robust acceptor lipids abca1 59 60 raising question whether abca1 mediated lipid efflux may play important roles brain apoe predominant apolipoprotein furthermore antisense inhibition abca1 observed inhibit secretion apoe monocyte derived macrophages 61 raising second question whether abca1 may also regulate apoe synthesis secretion apoe producing cells astrocytes microglia
0.29108343.15269218.html.plaintext.txt	17	abca1 apoe shown induced response lxrrxr stimulation 15 16 20 56 57 repressed zn202 58 peripheral macrophages previous work demonstrated apoe robust acceptor lipids abca1 59 60 raising question whether abca1 mediated lipid efflux may play important roles brain apoe predominant apolipoprotein furthermore antisense inhibition abca1 observed inhibit secretion apoe monocyte derived macrophages 61 raising second question whether abca1 may also regulate apoe synthesis secretion apoe producing cells astrocytes microglia
0.29108343.15269218.html.plaintext.txt	18	address two questions sought determine relationship abca1 cholesterol efflux apoe metabolism specifically glia study report abca1 deficient primary astrocytes microglia impaired ability efflux lipids exogenous apoe results lipid accumulation normal culture conditions furthermore lack abca1 expression decreases apoe secretion glial cells vitro vivo impairment apoe secretion astrocytes microglia results decrease apoe levels 65 whole brain lysates abca1 deficient mice hippocampus striatum severely affected regions observations show abca1 plays key roles cholesterol transport apoe metabolism cns
0.29108343.15269218.html.plaintext.txt	19	address two questions sought determine relationship abca1 cholesterol efflux apoe metabolism specifically glia study report abca1 deficient primary astrocytes microglia impaired ability efflux lipids exogenous apoe results lipid accumulation normal culture conditions furthermore lack abca1 expression decreases apoe secretion glial cells vitro vivo impairment apoe secretion astrocytes microglia results decrease apoe levels 65 whole brain lysates abca1 deficient mice hippocampus striatum severely affected regions observations show abca1 plays key roles cholesterol transport apoe metabolism cns
0.29108343.15269218.html.plaintext.txt	20	experimental procedures top abstract introduction experimental procedures results discussion references mice abca1 deficient mice generously provided dr omar francone pfizer global research development groton wild type dba1j c57bl6 apoe deficient apoa deficient mice obtained jackson laboratories animals maintained regular chow pmi lab diet experiments procedures involving experimental animals performed accordance protocols canadian council animal care university british columbia animal care committees
0.29108343.15269218.html.plaintext.txt	21	experimental procedures top abstract introduction experimental procedures results discussion references mice abca1 deficient mice generously provided dr omar francone pfizer global research development groton wild type dba1j c57bl6 apoe deficient apoa deficient mice obtained jackson laboratories animals maintained regular chow pmi lab diet experiments procedures involving experimental animals performed accordance protocols canadian council animal care university british columbia animal care committees
0.29108343.15269218.html.plaintext.txt	22	animal tissues murine brains harvested immediately sacrifice dissected individual regions indicated stored 80 degrees c use tissues homogenized buffer containing 10 glycerol 1 triton x 100 protease inhibitor roche applied science phosphate buffered saline pbs protein concentration determined lowry assay
0.29108343.15269218.html.plaintext.txt	23	animal tissues murine brains harvested immediately sacrifice dissected individual regions indicated stored 80 degrees c use tissues homogenized buffer containing 10 glycerol 1 triton x 100 protease inhibitor roche applied science phosphate buffered saline pbs protein concentration determined lowry assay
0.29108343.15269218.html.plaintext.txt	24	culture primary astrocytes microglia primary mixed glial cultures prepared postnatal day 1 2 mice brains individual animals placed ice cold hanks buffered salt solution canadian life technologies containing 6 mgml glucose 10 mm hepes meninges removed frontal cortices dissected cells dissociated repeated passage series wide fine bored pipettes dissociated cells plated dulbeccos modified eagles medium dmem canadian life technologies 10 fetal bovine serum 10 horse serum 2 mm l glutamine canadian life technologies 100 unitsml penicillin streptomycin canadian life technologies one t75 flask per mouse cells cultured presence 5 co2 14 days 3 medium changes reaching confluence microglia isolated gently tapping culture flasks collecting medium detached cells subsequently attached microglia separated astrocytes mild trypsinization previously described 62 added previously isolated cells microglia enriched astrocytes reseeded needed
0.29108343.15269218.html.plaintext.txt	25	culture primary astrocytes microglia primary mixed glial cultures prepared postnatal day 1 2 mice brains individual animals placed ice cold hanks buffered salt solution canadian life technologies containing 6 mgml glucose 10 mm hepes meninges removed frontal cortices dissected cells dissociated repeated passage series wide fine bored pipettes dissociated cells plated dulbeccos modified eagles medium dmem canadian life technologies 10 fetal bovine serum 10 horse serum 2 mm l glutamine canadian life technologies 100 unitsml penicillin streptomycin canadian life technologies one t75 flask per mouse cells cultured presence 5 co2 14 days 3 medium changes reaching confluence microglia isolated gently tapping culture flasks collecting medium detached cells subsequently attached microglia separated astrocytes mild trypsinization previously described 62 added previously isolated cells microglia enriched astrocytes reseeded needed
0.29108343.15269218.html.plaintext.txt	26	immunofluorescence cells seeded poly d lysine coated coverslips washed twice pbs fixed 4 paraformaldehyde pbs 20 min room temperature washed twice permeabilized 05 triton x 100 pbs 5 min room temperature washing three times pbs cells blocked 4 normal goat serum pbs 30 min room temperature stained astrocyte marker gfap cy3 1250 sigma microglial marker f480 1200 serotec 1 h f480 stained cells visualized incubation alexa 488 conjugated secondary antibody transduction laboratories 30 min finally cell nuclei stained 46 diamidine 2 phenylindole dihydrochloride dapi coverslips mounted vectashield vector laboratories percentage stained cells determined least 200 cells cells viewed zeiss axioplan 2 microscope images captured using ccd camera equipped metamorph universal imaging corporation imaging software
0.29108343.15269218.html.plaintext.txt	27	immunofluorescence cells seeded poly d lysine coated coverslips washed twice pbs fixed 4 paraformaldehyde pbs 20 min room temperature washed twice permeabilized 05 triton x 100 pbs 5 min room temperature washing three times pbs cells blocked 4 normal goat serum pbs 30 min room temperature stained astrocyte marker gfap cy3 1250 sigma microglial marker f480 1200 serotec 1 h f480 stained cells visualized incubation alexa 488 conjugated secondary antibody transduction laboratories 30 min finally cell nuclei stained 46 diamidine 2 phenylindole dihydrochloride dapi coverslips mounted vectashield vector laboratories percentage stained cells determined least 200 cells cells viewed zeiss axioplan 2 microscope images captured using ccd camera equipped metamorph universal imaging corporation imaging software
0.29108343.15269218.html.plaintext.txt	28	western blotting equal amounts protein electrophoresed 75 10 sds polyacrylamide gels electrophoretically transferred polyvinylidene fluoride membrane millipore immunodetected using monoclonal anti abca1 antibody raised second nucleotide binding domain nbd2 abca1 10 murine specific apoe antibody santa cruz biotechnology 1500 polyclonal antibody murine apoj 1250 generously provided dr david holtzman washington university school medicine anti gapdh antibody chemicon 110000 loading control blots developed using enhanced chemiluminescence amersham biosciences according manufacturers recommendations bands quantitated densitometry using nih image j applicable apoe apoj abca1 levels normalized gapdh levels control protein loading
0.29108343.15269218.html.plaintext.txt	29	western blotting equal amounts protein electrophoresed 75 10 sds polyacrylamide gels electrophoretically transferred polyvinylidene fluoride membrane millipore immunodetected using monoclonal anti abca1 antibody raised second nucleotide binding domain nbd2 abca1 10 murine specific apoe antibody santa cruz biotechnology 1500 polyclonal antibody murine apoj 1250 generously provided dr david holtzman washington university school medicine anti gapdh antibody chemicon 110000 loading control blots developed using enhanced chemiluminescence amersham biosciences according manufacturers recommendations bands quantitated densitometry using nih image j applicable apoe apoj abca1 levels normalized gapdh levels control protein loading
0.29108343.15269218.html.plaintext.txt	30	purification recombinant apoe proteins apoe isoforms purified escherichia coli harboring recombinant glutathione transferase gst apoe2 apoe3 apoe4 fusion proteins described 63 briefly logarithmic phase cells induced 05 mm isopropyl 1 thio d galactopyranoside 1 h harvested centrifugation lysed sonication 10 triton x 100 10 glycerol pbs 200 microgml lysozyme cleared centrifugation gst apoe fusion proteins cleared lysates purified glutathione sepharose 4b beads eluted upon cleavage gst moiety precision protease amersham biosciences indicated purified apoe proteins delipidated 6 m urea followed dialysis several changes pbs
0.29108343.15269218.html.plaintext.txt	31	purification recombinant apoe proteins apoe isoforms purified escherichia coli harboring recombinant glutathione transferase gst apoe2 apoe3 apoe4 fusion proteins described 63 briefly logarithmic phase cells induced 05 mm isopropyl 1 thio d galactopyranoside 1 h harvested centrifugation lysed sonication 10 triton x 100 10 glycerol pbs 200 microgml lysozyme cleared centrifugation gst apoe fusion proteins cleared lysates purified glutathione sepharose 4b beads eluted upon cleavage gst moiety precision protease amersham biosciences indicated purified apoe proteins delipidated 6 m urea followed dialysis several changes pbs
0.29108343.15269218.html.plaintext.txt	32	cholesterol efflux microglia enriched astrocytes seeded 50000 cellswell 96 well plates labeled 1 microciml 3h cholesterol perkinelmer life sciences 18 24 h labeled cells washed equilibrated dmemf12 1 h 10 microgml lipid free apoa calbiochem recombinant apoe2 apoe3 apoe4 added 8 h media collected centrifuged 2000 rpm 5 min cells lysed addition 50 microl 01 m naoh 02 sds followed incubation room temperature 20 min 50 microl media cell lysate added scintillation vials quantified percent cholesterol efflux calculated total counts medium divided sum counts medium plus cell lysate previously described 64
0.29108343.15269218.html.plaintext.txt	33	cholesterol efflux microglia enriched astrocytes seeded 50000 cellswell 96 well plates labeled 1 microciml 3h cholesterol perkinelmer life sciences 18 24 h labeled cells washed equilibrated dmemf12 1 h 10 microgml lipid free apoa calbiochem recombinant apoe2 apoe3 apoe4 added 8 h media collected centrifuged 2000 rpm 5 min cells lysed addition 50 microl 01 m naoh 02 sds followed incubation room temperature 20 min 50 microl media cell lysate added scintillation vials quantified percent cholesterol efflux calculated total counts medium divided sum counts medium plus cell lysate previously described 64
0.29108343.15269218.html.plaintext.txt	34	lipid staining cells seeded 24 well plates poly d lysine coated coverslips 100000 cellswell microglia 200000 cellswell astrocytes least 18 h dmem containing 10 fetal bovine serum 10 horse serum cells air dried fixed neutral buffered formalin stained oil red o nuclei counterstained hematoxylin cells photographed zeiss axioplan 2 microscope using ccd camera equipped metamorph universal imaging corporation imaging software
0.29108343.15269218.html.plaintext.txt	35	lipid staining cells seeded 24 well plates poly d lysine coated coverslips 100000 cellswell microglia 200000 cellswell astrocytes least 18 h dmem containing 10 fetal bovine serum 10 horse serum cells air dried fixed neutral buffered formalin stained oil red o nuclei counterstained hematoxylin cells photographed zeiss axioplan 2 microscope using ccd camera equipped metamorph universal imaging corporation imaging software
0.29108343.15269218.html.plaintext.txt	36	measurement apolipoprotein secretion microglia astrocytes seeded 96 well plates 50000 cellswell 100000 cellswell respectively 18 h cells washed pbs cultured serum free dmemf12 canadian life technologies 6 h microglia 8 h astrocytes conditioned medium collected centrifuged 2000 rpm 4 min supernatant stored 80 degrees c use cells scraped lysed buffer containing 10 glycerol 1 triton x 100 protease inhibitor roche applied science pbs centrifuged 9000 rpm 10 min supernatant stored 80 degrees c use media cell lysate samples analyzed apoe apoj abca1 gapdh expression western blot described intracellular gapdh levels used normalize measurements cellular secreted apoe
0.29108343.15269218.html.plaintext.txt	37	measurement apolipoprotein secretion microglia astrocytes seeded 96 well plates 50000 cellswell 100000 cellswell respectively 18 h cells washed pbs cultured serum free dmemf12 canadian life technologies 6 h microglia 8 h astrocytes conditioned medium collected centrifuged 2000 rpm 4 min supernatant stored 80 degrees c use cells scraped lysed buffer containing 10 glycerol 1 triton x 100 protease inhibitor roche applied science pbs centrifuged 9000 rpm 10 min supernatant stored 80 degrees c use media cell lysate samples analyzed apoe apoj abca1 gapdh expression western blot described intracellular gapdh levels used normalize measurements cellular secreted apoe
0.29108343.15269218.html.plaintext.txt	38	statistical analysis one way anova newman keuls post test two tailed unpaired students tests used statistical analyses students test analyses welchs correction unequal variances applied variances significantly different groups indicated apoe abca1 levels correlated using linear regression analyses statistical analyses performed using graphpad prism version 30 graphpad software science inc san diego ca
0.29108343.15269218.html.plaintext.txt	39	statistical analysis one way anova newman keuls post test two tailed unpaired students tests used statistical analyses students test analyses welchs correction unequal variances applied variances significantly different groups indicated apoe abca1 levels correlated using linear regression analyses statistical analyses performed using graphpad prism version 30 graphpad software science inc san diego ca
0.29108343.15269218.html.plaintext.txt	40	results top abstract introduction experimental procedures results discussion references glial abca1 mediates cholesterol efflux apoa facilitates efflux apoe several studies non cns cells established abca1 promotes cholesterol phospholipid efflux lipid deficient apolipoproteins including apoa apoe others 59 65 66 whether abca1 functions similarly cns cells yet completely understood previous work shown abca1 expressed glia neurons brain 10 17 lxrrxr stimulation primary glia promotes cholesterol efflux apoa apoe3 18 however specific role abca1 promoting cholesterol efflux glial cells yet clear expression genes addition abca1 also induced lxrrxr treatment 56 67 68 selectively address role abca1 cholesterol efflux glial cells primary cultures astrocytes microglia prepared abca1 mice wild type littermate controls maintained absence lxrrxr treatment cholesterol loading presence abca1 protein wild type abca1 cultures first confirmed using immunoblotting fig 1a purity astrocyte microglial cultures used experiments evaluated immunofluorescent staining using anti gfap anti f480 specifically label astrocytes microglia respectively experimental cultures least 85 pure astrocytes 98 pure microglia data shown
0.29108343.15269218.html.plaintext.txt	41	results top abstract introduction experimental procedures results discussion references glial abca1 mediates cholesterol efflux apoa facilitates efflux apoe several studies non cns cells established abca1 promotes cholesterol phospholipid efflux lipid deficient apolipoproteins including apoa apoe others 59 65 66 whether abca1 functions similarly cns cells yet completely understood previous work shown abca1 expressed glia neurons brain 10 17 lxrrxr stimulation primary glia promotes cholesterol efflux apoa apoe3 18 however specific role abca1 promoting cholesterol efflux glial cells yet clear expression genes addition abca1 also induced lxrrxr treatment 56 67 68 selectively address role abca1 cholesterol efflux glial cells primary cultures astrocytes microglia prepared abca1 mice wild type littermate controls maintained absence lxrrxr treatment cholesterol loading presence abca1 protein wild type abca1 cultures first confirmed using immunoblotting fig 1a purity astrocyte microglial cultures used experiments evaluated immunofluorescent staining using anti gfap anti f480 specifically label astrocytes microglia respectively experimental cultures least 85 pure astrocytes 98 pure microglia data shown
0.29108343.15269218.html.plaintext.txt	42	view larger version 17k fig 1 cholesterol efflux impaired abca1 glial cells abca1 expression wild type abca1 primary astrocytes left microglia right first determined western blotting using abca1 specific antibody gapdh lower panels served control equal protein loading efflux 8 h presence absence 10 microgml exogenous apoa1 apoe2 apoe3 apoe4 evaluated wild type abca1 astrocytes b microglia c graphs represent means se least two independent experiments least six individual mice per genotype one way anova newman keuls post test used determine significant increases cholesterol efflux baseline represents p 005 represents p 001 represents p 0001 ko knock
0.29108343.15269218.html.plaintext.txt	43	role glial abca1 cholesterol efflux exogenous apoa apoe isoforms apoe2 apoe3 apoe4 determined primary wild type abca1 astrocytes microglia cholesterol efflux measured absence apolipoprotein acceptors presence recombinant human apoa apoe2 apoe3 apoe4 8 h preliminary experiments mixed glial cultures showed difference cholesterol efflux presence either native delipidated apoe3 data shown native apoe proteins used subsequent experiments
0.29108343.15269218.html.plaintext.txt	44	role glial abca1 cholesterol efflux exogenous apoa apoe isoforms apoe2 apoe3 apoe4 determined primary wild type abca1 astrocytes microglia cholesterol efflux measured absence apolipoprotein acceptors presence recombinant human apoa apoe2 apoe3 apoe4 8 h preliminary experiments mixed glial cultures showed difference cholesterol efflux presence either native delipidated apoe3 data shown native apoe proteins used subsequent experiments
0.29108343.15269218.html.plaintext.txt	45	effect different apolipoprotein acceptors cholesterol efflux wild type abca1 astrocytes microglia illustrated fig 1 summarized table expected abca1 required astrocytes efflux cholesterol exogenous apoa experimental conditions wild type astrocytes displayed 25 fold increase cholesterol efflux upon apoa addition whereas abca1 astrocytes show higher efflux apoa compared baseline p 005 fig 1b table wild type astrocytes addition apoe2 apoe3 apoe4 resulted 23 26 fold increase cholesterol efflux similar magnitude elicited apoa contrast cholesterol efflux elicited apoe isoform 30 less abca1 cells compared wild type astrocytes corrected differences baseline efflux table observations suggest abca1 astrocytes facilitates lipid efflux exogenous apoe however abca1 absolutely required efflux cholesterol apoe residual efflux activity 15 18 fold remained absence abca1 observations suggest genes addition abca1 also contribute cholesterol efflux astrocytes comparison among apoe isoforms suggested apoe2 less effective cholesterol acceptor apoe3 apoe4 wild type abca1 astrocytes whereas significant differences observed efflux apoe3 apoe4 fig 1b compared wild type astrocytes abca1 astrocytes significantly impaired ability efflux cholesterol apoa apoe isoform p 0001 table
0.29108343.15269218.html.plaintext.txt	46	view table table cholesterol efflux different apolipoproteins wt abca1 glia
0.29108343.15269218.html.plaintext.txt	47	noted fold increase cholesterol efflux apoa consistently greater wild type astrocytes compared microglia cultured animals 25 fold versus 12 fold fig 1 table experiments conducted absence lxrrxr stimulation order selectively examine effect abca1 cholesterol efflux possible conditions astrocytes express components pathway necessary efficient cholesterol efflux apoa whereas additional factors may required elicit strong efflux response apoa microglia
0.29108343.15269218.html.plaintext.txt	48	although surprisingly low efflux exogenous apoa 12 fold observed primary wild type microglia cells display significant cholesterol efflux apoe2 16 fold apoe3 18 fold wild type microglia showed poor efflux presence apoe4 15 fold reach statistical significance baseline fig 1c table deficiency abca1 microglia blocked efflux apoa impaired cholesterol efflux 15 apoe2 apoe3 p 005 compared wild type cells apoe isoform still able elicit residual efflux activity 13 16 fold abca1 microglia fig 1c table suggesting microglia also contain abca1 independent pathways efflux lipid apoe wild type abca1 microglia apoe3 tended best acceptor although statistically significant difference observed among apoe isoform tested
0.29108343.15269218.html.plaintext.txt	49	although surprisingly low efflux exogenous apoa 12 fold observed primary wild type microglia cells display significant cholesterol efflux apoe2 16 fold apoe3 18 fold wild type microglia showed poor efflux presence apoe4 15 fold reach statistical significance baseline fig 1c table deficiency abca1 microglia blocked efflux apoa impaired cholesterol efflux 15 apoe2 apoe3 p 005 compared wild type cells apoe isoform still able elicit residual efflux activity 13 16 fold abca1 microglia fig 1c table suggesting microglia also contain abca1 independent pathways efflux lipid apoe wild type abca1 microglia apoe3 tended best acceptor although statistically significant difference observed among apoe isoform tested
0.29108343.15269218.html.plaintext.txt	50	taken together results suggest abca1 facilitates cholesterol efflux apoe required cholesterol efflux apoa astrocytes microglia additionally astrocytes microglia appear contain abca1 independent pathways efflux cholesterol apoe astrocytes apoe good cholesterol acceptor apoa whereas apoe appears preferred acceptor microglia
0.29108343.15269218.html.plaintext.txt	51	taken together results suggest abca1 facilitates cholesterol efflux apoe required cholesterol efflux apoa astrocytes microglia additionally astrocytes microglia appear contain abca1 independent pathways efflux cholesterol apoe astrocytes apoe good cholesterol acceptor apoa whereas apoe appears preferred acceptor microglia
0.29108343.15269218.html.plaintext.txt	52	lack abca1 results lipid accumulation astrocytes microglia determine elimination abca1 dependent efflux pathways results cellular lipid accumulation glia subjected wild type abca1 primary astrocytes microglia oil red o staining normal culture conditions lipids accumulate efflux competent wild type astrocytes fig 2a small lipid droplets observed wild type microglia fig 2c contrast abca1 astrocytes microglia accumulated numerous cytoplasmic lipid droplets particularly abundant microglia fig 2 b d observations suggest abca1 required prevent excessive accumulation lipids glial cells even absence cholesterol loading
0.29108343.15269218.html.plaintext.txt	53	lack abca1 results lipid accumulation astrocytes microglia determine elimination abca1 dependent efflux pathways results cellular lipid accumulation glia subjected wild type abca1 primary astrocytes microglia oil red o staining normal culture conditions lipids accumulate efflux competent wild type astrocytes fig 2a small lipid droplets observed wild type microglia fig 2c contrast abca1 astrocytes microglia accumulated numerous cytoplasmic lipid droplets particularly abundant microglia fig 2 b d observations suggest abca1 required prevent excessive accumulation lipids glial cells even absence cholesterol loading
0.29108343.15269218.html.plaintext.txt	54	view larger version 124k fig 2 abca1 deficient glia accumulate lipids primary wild type wt abca1 astrocytes b microglia c d stained oil red o reveal accumulated neutral lipids nuclei counterstained hematoxylin blue images taken x200 magnification b compared wild type astrocytes abca1 astrocytes show increased intracellular levels neutral lipids red droplets c d microglia showing marked accumulation lipid droplets absence abca1 compared wild type cells
0.29108343.15269218.html.plaintext.txt	55	abca1 facilitates apoe secretion astrocytes microglia antisense inhibition abca1 expression previously reported reduce apoe secretion peripheral macrophages 61 assess role abca1 apoe secretion glial cells first determined levels intracellular apoe well levels apoe secreted conditioned medium initial experiments conducted using medium conditioned 72 h differences secreted apoe levels observed wild type abca1 glia data shown astrocytes microglia express apoe receptors known take resecrete apoe hypothesized 72 h apoe medium may arisen newly synthesized apoe well resecreted apoe therefore examined apoe secretion astrocytes microglia 6 8 h respectively order minimize effect resecreted apoe well intracellular gapdh levels used control small variations total number cells per well intracellular levels apoe equivalent wild type abca1 astrocytes fig 3 b p 072 contrast abca1 conditioned media contained 50 less apoe wild type fig 3 c p 00005 well proportion total apoe released 8 h conditioned medium primary wild type abca1 astrocytes determined value defined apoe medium divided sum intracellular extracellular apoe thus correcting variations intracellular apoe levels proportion total apoe secreted conditioned medium reduced 30 abca1 compared wild type astrocytes fig 3d p 001
0.29108343.15269218.html.plaintext.txt	56	abca1 facilitates apoe secretion astrocytes microglia antisense inhibition abca1 expression previously reported reduce apoe secretion peripheral macrophages 61 assess role abca1 apoe secretion glial cells first determined levels intracellular apoe well levels apoe secreted conditioned medium initial experiments conducted using medium conditioned 72 h differences secreted apoe levels observed wild type abca1 glia data shown astrocytes microglia express apoe receptors known take resecrete apoe hypothesized 72 h apoe medium may arisen newly synthesized apoe well resecreted apoe therefore examined apoe secretion astrocytes microglia 6 8 h respectively order minimize effect resecreted apoe well intracellular gapdh levels used control small variations total number cells per well intracellular levels apoe equivalent wild type abca1 astrocytes fig 3 b p 072 contrast abca1 conditioned media contained 50 less apoe wild type fig 3 c p 00005 well proportion total apoe released 8 h conditioned medium primary wild type abca1 astrocytes determined value defined apoe medium divided sum intracellular extracellular apoe thus correcting variations intracellular apoe levels proportion total apoe secreted conditioned medium reduced 30 abca1 compared wild type astrocytes fig 3d p 001
0.29108343.15269218.html.plaintext.txt	57	view larger version 24k fig 3 abca1 facilitates apoe secretion astrocytes apoe levels conditioned medium upper panel whole cell lysates middle panel wild type abca1 primary astrocytes determined using polyclonal antibody murine apoe intracellular gapdh lower panel detected control equal protein loading normalize small variations cell number measurement secreted apoe bands quantitated densitometry graphs illustrate four independent experiments n indicating number cultures prepared individual mice data represent mean se apoe levels whole cell lysates b conditioned medium c astrocytes well proportion total apoe secreted medium d students test used determine significant differences apoe levels welchs correction applied necessary represents p 001 represents p 0001 ko knock
0.29108343.15269218.html.plaintext.txt	58	abca1 pronounced effect apoe metabolism microglia compared wild type microglia deficiency abca1 resulted 35 decrease intracellular apoe levels fig 4 b p 006 90 decrease secreted apoe levels fig 4 c p 005 resulted 60 overall reduction proportion total apoe secreted conditioned media fig 4d p 0001
0.29108343.15269218.html.plaintext.txt	59	abca1 pronounced effect apoe metabolism microglia compared wild type microglia deficiency abca1 resulted 35 decrease intracellular apoe levels fig 4 b p 006 90 decrease secreted apoe levels fig 4 c p 005 resulted 60 overall reduction proportion total apoe secreted conditioned media fig 4d p 0001
0.29108343.15269218.html.plaintext.txt	60	view larger version 22k fig 4 abca1 microglia impaired apoe secretion apoe levels conditioned medium upper panel whole cell lysates middle panel wild type abca1 primary microglia determined using polyclonal antibody murine apoe intracellular gapdh lower panel detected control equal protein loading normalize variations total cell number measurements secreted apoe bands quantitated densitometry graphs illustrate least two independent experiments n indicates number cultures prepared individual mice data represent mean se apoe levels microglial whole cell lysates b conditioned medium c well proportion total apoe secreted medium d students test used determine significant differences apoe levels welchs correction applied necessary represents p 005 represents p 0001 ko knock
0.29108343.15269218.html.plaintext.txt	61	apoe secretion wild type microglia correlates abca1 expression levels despite consistent culture conditions noted wild type microglia cultured individual animals displayed surprisingly large variability apoe levels particularly apoe secreted medium abca1 previously shown affect apoe secretion macrophages 61 hypothesized abca1 expression levels may influence extent apoe secreted microglia derived lineage peripheral macrophages assess possibility abca1 expression levels microglia determined immunoblotting basal abca1 protein levels wild type microglia found highly variable among equivalent amounts wild type microglia prepared individual mice furthermore abca1 levels correlated highly apoe secretion r2 092 p 00001 fig 5a apoe intracellular levels r2 082 p 0001 fig 5b contrast microglia intracellular medium apoe levels abca1 expression levels far consistent among independent primary cultures wild type astrocytes however slight variations levels abca1 protein positively correlated medium r2 042 p 0005 fig 5c cellular r2 049 p 0001 fig 5d apoe levels taken together results provide support role abca1 secretion apoe particularly microglia finally microglia showed far greater range abca1 apoe levels media cells compared astrocytes fig 5
0.29108343.15269218.html.plaintext.txt	62	apoe secretion wild type microglia correlates abca1 expression levels despite consistent culture conditions noted wild type microglia cultured individual animals displayed surprisingly large variability apoe levels particularly apoe secreted medium abca1 previously shown affect apoe secretion macrophages 61 hypothesized abca1 expression levels may influence extent apoe secreted microglia derived lineage peripheral macrophages assess possibility abca1 expression levels microglia determined immunoblotting basal abca1 protein levels wild type microglia found highly variable among equivalent amounts wild type microglia prepared individual mice furthermore abca1 levels correlated highly apoe secretion r2 092 p 00001 fig 5a apoe intracellular levels r2 082 p 0001 fig 5b contrast microglia intracellular medium apoe levels abca1 expression levels far consistent among independent primary cultures wild type astrocytes however slight variations levels abca1 protein positively correlated medium r2 042 p 0005 fig 5c cellular r2 049 p 0001 fig 5d apoe levels taken together results provide support role abca1 secretion apoe particularly microglia finally microglia showed far greater range abca1 apoe levels media cells compared astrocytes fig 5
0.29108343.15269218.html.plaintext.txt	63	view larger version 24k fig 5 abca1 expression correlated secreted intracellular apoe levels wild type glia abca1 apoe levels wild type microglia b astrocytes c d normalized intracellular gapdh levels correlated using linear regression analysis graphs secreted c intracellular b d apoe represent pooled data least three independent experiments n indicating number cultures prepared individual mice
0.29108343.15269218.html.plaintext.txt	64	apoe levels reduced brain abca1 deficient mice results presented led us hypothesize abca1 may play prominent role regulation apoe homeostasis murine brain assess impact abca1 deficiency apoe levels vivo first compared apoe protein levels whole brain extracts prepared age sex matched abca1 mice wild type littermate controls dba1j genetic background genetic strain profound effects murine lipids lipoproteins 69 70 whole brain extracts age sex matched apoe deficient wild type controls pure c57bl6 genetic background also prepared additional controls western blot analysis showed apoe levels whole brains male abca1 mice reduced 65 compared wild type dba1j littermate controls p 001 well age sex matched wild type c57bl6 mice p 001 fig 6 b significant differences total brain apoe levels wild type dba1j c57bl6 mice fig 6 b identical results obtained mice evaluated 25 months well 6 months age data shown compared wild type mice abca1 mice also 75 less apoe plasma data shown similar results reported warhle et al 84
0.29108343.15269218.html.plaintext.txt	65	apoe levels reduced brain abca1 deficient mice results presented led us hypothesize abca1 may play prominent role regulation apoe homeostasis murine brain assess impact abca1 deficiency apoe levels vivo first compared apoe protein levels whole brain extracts prepared age sex matched abca1 mice wild type littermate controls dba1j genetic background genetic strain profound effects murine lipids lipoproteins 69 70 whole brain extracts age sex matched apoe deficient wild type controls pure c57bl6 genetic background also prepared additional controls western blot analysis showed apoe levels whole brains male abca1 mice reduced 65 compared wild type dba1j littermate controls p 001 well age sex matched wild type c57bl6 mice p 001 fig 6 b significant differences total brain apoe levels wild type dba1j c57bl6 mice fig 6 b identical results obtained mice evaluated 25 months well 6 months age data shown compared wild type mice abca1 mice also 75 less apoe plasma data shown similar results reported warhle et al 84
0.29108343.15269218.html.plaintext.txt	66	view larger version 26k fig 6 apoe levels reduced brain abca1 deficient mice b male mice wt dba1j abca1 dba1j apoe c57bl6 wt c57bl6 sacrificed 25 months age gels representative total protein lysates prepared whole brain two individual mice per genotype tissue blots immunodetected abca1 upper panel apoe second panel gapdh third panel apoj fourth panel gapdh levels used control equal protein loading bands quantitated densitometry graph represents pooled data least four mice per genotype measured duplicate one way anova newman keuls post test used determine significant differences brain apoe levels represents p 001
0.29108343.15269218.html.plaintext.txt	67	apoj second major brain lipoprotein synthesized secreted astrocytes microglia assess whether loss abca1 also affected metabolism apoj total brain extracts wild type abca1 mice immunoblotted apoj contrast apoe apoj levels indistinguishable among abca1 wild type dba1j littermate controls well apoe deficient wild type littermate c57bl6 controls fig 6a lower panel demonstrating abca1 selectively influences apoe metabolism vivo
0.29108343.15269218.html.plaintext.txt	68	apoj second major brain lipoprotein synthesized secreted astrocytes microglia assess whether loss abca1 also affected metabolism apoj total brain extracts wild type abca1 mice immunoblotted apoj contrast apoe apoj levels indistinguishable among abca1 wild type dba1j littermate controls well apoe deficient wild type littermate c57bl6 controls fig 6a lower panel demonstrating abca1 selectively influences apoe metabolism vivo
0.29108343.15269218.html.plaintext.txt	69	determine abca1 affected apoe levels region specific manner individual brain regions age sex matched abca1 mice wild type littermate controls examined fig 7 lack abca1 affected apoe levels severely hippocampus striatum apoe levels reduced 76 79 respectively fig 7 b apoe levels reduced 61 thalamus 41 cortex fig 7 b contrast abca1 least impact cerebellum apoe levels reduced 35 abca1 compared wild type mice fig 7 b
0.29108343.15269218.html.plaintext.txt	70	view larger version 31k fig 7 abca1 deficiency affects brain apoe levels region specific manner male mice wt dba1j abca1 dba1j sacrificed 3 months age individual brain regions dissected abca1 upper panels apoe middle panels detected region western blot quantitated densitometry normalized gapdh lower panels internal protein loading control b graph represents mean se two micegenotype measured duplicate students test used determine significant differences regional apoe levels represents p 0001 ko knock
0.29108343.15269218.html.plaintext.txt	71	abca1 mice used studies lack circulating hdl apoa loss peripheral abca1 activity 71 formally possible changes apoe levels observed brains abca1 mice simply due loss hdl apoa primarily taken brain peripheral circulation 26 address possibility apoe levels compared total brain extracts prepared age sex matched wild type apoa deficient mice model characterized absent hdl apoa deficiency apoa impact apoe levels brain fig 8 demonstrating lack circulating hdl apoa abca1 mice sufficient alter brain apoe levels vivo
0.29108343.15269218.html.plaintext.txt	72	abca1 mice used studies lack circulating hdl apoa loss peripheral abca1 activity 71 formally possible changes apoe levels observed brains abca1 mice simply due loss hdl apoa primarily taken brain peripheral circulation 26 address possibility apoe levels compared total brain extracts prepared age sex matched wild type apoa deficient mice model characterized absent hdl apoa deficiency apoa impact apoe levels brain fig 8 demonstrating lack circulating hdl apoa abca1 mice sufficient alter brain apoe levels vivo
0.29108343.15269218.html.plaintext.txt	73	view larger version 48k fig 8 apoe levels affected apoa deficiency total brain lysates 2 month old male mice wt c57bl6 apoa1 c57bl6 apoe c57bl6 immunodetected apoe upper panel gapdh lower panel control equal protein loading western blot representative two micegenotype single apoe control
0.29108343.15269218.html.plaintext.txt	74	discussion top abstract introduction experimental procedures results discussion references identification abca1 essential protein production hdl generated great interest understanding abca1 function particularly tissues liver macrophages relevant hdl metabolism atherosclerosis however nearly ubiquitous expression abca1 suggests may also play roles lipid transport cell types tissues lipid metabolism cns largely independent outside cns although several points intersection may highly relevant neurodegenerative diseases particularly ad
0.29108343.15269218.html.plaintext.txt	75	discussion top abstract introduction experimental procedures results discussion references identification abca1 essential protein production hdl generated great interest understanding abca1 function particularly tissues liver macrophages relevant hdl metabolism atherosclerosis however nearly ubiquitous expression abca1 suggests may also play roles lipid transport cell types tissues lipid metabolism cns largely independent outside cns although several points intersection may highly relevant neurodegenerative diseases particularly ad
0.29108343.15269218.html.plaintext.txt	76	study provide evidence lack glial abca1 activity results 65 decrease apoe levels vivo likely due reduced apoe secretion astrocytes microglia diminished pool intracellular apoe microglia additionally show abca1 facilitates cholesterol efflux exogenous apoe primary astrocytes microglia efflux reduced absence abca1 cell types however astrocytes microglia may also contain abca1 independent pathways efflux cholesterol apoe residual efflux remains abca1 cells findings agreement previous studies showing macrophage abca1 facilitates cholesterol efflux exogenous apoe 60 72
0.29108343.15269218.html.plaintext.txt	77	study provide evidence lack glial abca1 activity results 65 decrease apoe levels vivo likely due reduced apoe secretion astrocytes microglia diminished pool intracellular apoe microglia additionally show abca1 facilitates cholesterol efflux exogenous apoe primary astrocytes microglia efflux reduced absence abca1 cell types however astrocytes microglia may also contain abca1 independent pathways efflux cholesterol apoe residual efflux remains abca1 cells findings agreement previous studies showing macrophage abca1 facilitates cholesterol efflux exogenous apoe 60 72
0.29108343.15269218.html.plaintext.txt	78	experimental conditions used efflux studies observe marked apoe isoform specificity pattern consistent astrocyte microglial cultures astrocyte cultures apoe2 slightly less potent acceptor apoe3 apoe4 trend observed microglial cultures significant differences observed efflux among apoe isoforms findings contrast previous study suggesting apoe2 elicits cholesterol efflux apoe3 apoe4 73 reasons findings differ previous work clear may due subtle differences culture preparation efflux protocol
0.29108343.15269218.html.plaintext.txt	79	experimental conditions used efflux studies observe marked apoe isoform specificity pattern consistent astrocyte microglial cultures astrocyte cultures apoe2 slightly less potent acceptor apoe3 apoe4 trend observed microglial cultures significant differences observed efflux among apoe isoforms findings contrast previous study suggesting apoe2 elicits cholesterol efflux apoe3 apoe4 73 reasons findings differ previous work clear may due subtle differences culture preparation efflux protocol
0.29108343.15269218.html.plaintext.txt	80	study show abca1 plays critical role secretion apoe astrocytes microglia observations confirm extend previous study abca1 found facilitate apoe secretion human monocyte derived macrophages 61 also demonstrate abca1 positively correlated steady state levels intracellular apoe well apoe secreted medium measures dynamic processes steady state intracellular apoe levels reflect balance apoe synthesis degradation newly synthesized recycled apoe whereas secreted apoe levels reflect balance apoe released cell coupled reuptake apoe apoe receptors expressed astrocytes microglia although mechanisms abca1 affect apoe metabolism glial cells yet understood clear lack abca1 impairs proportion total apoe secreted medium astrocytes microglia
0.29108343.15269218.html.plaintext.txt	81	study show abca1 plays critical role secretion apoe astrocytes microglia observations confirm extend previous study abca1 found facilitate apoe secretion human monocyte derived macrophages 61 also demonstrate abca1 positively correlated steady state levels intracellular apoe well apoe secreted medium measures dynamic processes steady state intracellular apoe levels reflect balance apoe synthesis degradation newly synthesized recycled apoe whereas secreted apoe levels reflect balance apoe released cell coupled reuptake apoe apoe receptors expressed astrocytes microglia although mechanisms abca1 affect apoe metabolism glial cells yet understood clear lack abca1 impairs proportion total apoe secreted medium astrocytes microglia
0.29108343.15269218.html.plaintext.txt	82	several potential mechanisms abca1 may affect apoe metabolism may may linked functionally lipid efflux abca1 known cycle plasma membrane late endosomal compartments 74 addition plasma membrane suggested abca1 may efflux cholesterol late endosomes lysosomes 65 moreover apoa recently reported internalized resecreted abca1 mediated cholesterol efflux 75 increasing body evidence indicates internalized apoe undergo complete degradation resecreted 75 77 example nascent lipoproteins recovered livers apoe mice transplanted wild type bone marrow model circulating apoe derived exclusively macrophages showed 60 internalized apoe may reutilized physiological conditions 78 recently hdl3 shown stimulate recycling internalized apoe act extracellular acceptor recycled apoe hepatoma cells 76 study apoe recycling accompanied cholesterol efflux involved internalization hdl3 derived apoa targeting endosomes containing cholesterol apoe 76 taken together observations suggest possibility apoe secretion recycling may coupled cholesterol efflux abca1 may play role process
0.29108343.15269218.html.plaintext.txt	83	several potential mechanisms abca1 may affect apoe metabolism may may linked functionally lipid efflux abca1 known cycle plasma membrane late endosomal compartments 74 addition plasma membrane suggested abca1 may efflux cholesterol late endosomes lysosomes 65 moreover apoa recently reported internalized resecreted abca1 mediated cholesterol efflux 75 increasing body evidence indicates internalized apoe undergo complete degradation resecreted 75 77 example nascent lipoproteins recovered livers apoe mice transplanted wild type bone marrow model circulating apoe derived exclusively macrophages showed 60 internalized apoe may reutilized physiological conditions 78 recently hdl3 shown stimulate recycling internalized apoe act extracellular acceptor recycled apoe hepatoma cells 76 study apoe recycling accompanied cholesterol efflux involved internalization hdl3 derived apoa targeting endosomes containing cholesterol apoe 76 taken together observations suggest possibility apoe secretion recycling may coupled cholesterol efflux abca1 may play role process
0.29108343.15269218.html.plaintext.txt	84	also possible speculate abca1 could influence apoe secretion affecting trafficking secretory recycling pathways respect plasma membrane associated abca1 may distinct function compared intracytoplasmic abca1 example plasma membrane associated abca1 may function transport cholesterol phospholipids various extracellular apolipoprotein acceptors whereas intracytoplasmic abca1 may primarily participate intracellular lipid trafficking additionally known apoe requires prenylation order efficiently secreted 79 suggesting possibility impact abca1 prenylation pathways might also affect apoe secretion although much remains learned results provide support role abca1 apoe secretion furthermore wahrle et al reported nascent particles released conditioned medium abca1 astrocytes contain less cholesterol wild type particles suggesting abca1 affects secretion lipidation apoe cns
0.29108343.15269218.html.plaintext.txt	85	also possible speculate abca1 could influence apoe secretion affecting trafficking secretory recycling pathways respect plasma membrane associated abca1 may distinct function compared intracytoplasmic abca1 example plasma membrane associated abca1 may function transport cholesterol phospholipids various extracellular apolipoprotein acceptors whereas intracytoplasmic abca1 may primarily participate intracellular lipid trafficking additionally known apoe requires prenylation order efficiently secreted 79 suggesting possibility impact abca1 prenylation pathways might also affect apoe secretion although much remains learned results provide support role abca1 apoe secretion furthermore wahrle et al reported nascent particles released conditioned medium abca1 astrocytes contain less cholesterol wild type particles suggesting abca1 affects secretion lipidation apoe cns
0.29108343.15269218.html.plaintext.txt	86	vivo total apoe levels reduced 65 whole brains abca1 compared wild type animals indicating critical role abca1 maintaining normal apoe homeostasis cns physiological conditions loss abca1 affects apoe levels severely hippocampus striatum whereas cortex thalamus moderately affected abca1 deficiency apoe levels cerebellum minimally reduced abca1 mice compared wild type controls hypothesize defective secretion apoe astrocytes microglia key factor underlies reduced apoe levels vivo absence abca1 astrocytes microglia secrete less apoe intracellular pool microglial apoe available secretion also lower interestingly elimination abca1 effect apoj levels suggesting abca1 selectively regulates apoe metabolism rather general effect brain derived apolipoproteins knowledge whether deficiency human abca1 results changes cns csf levels apoe determined
0.29108343.15269218.html.plaintext.txt	87	vivo total apoe levels reduced 65 whole brains abca1 compared wild type animals indicating critical role abca1 maintaining normal apoe homeostasis cns physiological conditions loss abca1 affects apoe levels severely hippocampus striatum whereas cortex thalamus moderately affected abca1 deficiency apoe levels cerebellum minimally reduced abca1 mice compared wild type controls hypothesize defective secretion apoe astrocytes microglia key factor underlies reduced apoe levels vivo absence abca1 astrocytes microglia secrete less apoe intracellular pool microglial apoe available secretion also lower interestingly elimination abca1 effect apoj levels suggesting abca1 selectively regulates apoe metabolism rather general effect brain derived apolipoproteins knowledge whether deficiency human abca1 results changes cns csf levels apoe determined
0.29108343.15269218.html.plaintext.txt	88	vivo reduction brain apoe levels coupled reduced ability abca1 glia maintain normal levels cholesterol efflux apoe secretion vitro suggests abca1 deficiency may impair normal brain function particularly response injury disease apoe expression known induced glial cells response neuronal injury believed participate lipid transport processes involved repairing neuronal membranes 36 80 abca1 deficiency results region specific reductions apoe levels brain possible speculate abca1 may play role recovery variety neurological insults facilitating lipid mobilization via apoe
0.29108343.15269218.html.plaintext.txt	89	vivo reduction brain apoe levels coupled reduced ability abca1 glia maintain normal levels cholesterol efflux apoe secretion vitro suggests abca1 deficiency may impair normal brain function particularly response injury disease apoe expression known induced glial cells response neuronal injury believed participate lipid transport processes involved repairing neuronal membranes 36 80 abca1 deficiency results region specific reductions apoe levels brain possible speculate abca1 may play role recovery variety neurological insults facilitating lipid mobilization via apoe
0.29108343.15269218.html.plaintext.txt	90	observation abca1 mice significant reduction apoe levels brain creates paradox predictions role abca1 ad study provide first direct evidence glial abca1 affects apoe metabolism vivo vitro reduced levels apoe abca1 brains may predict greater susceptibility neuronal injury due decreased lipid mediated repair pathways yet lower levels apoe may also delay amyloid deposition addition glial abca1 neuronal abca1 may also participate ad affecting generation present controversial whether abca1 increases decreases generation two vitro studies reported increased abca1 expression reduced production 18 81 whereas third study reported opposite finding 19 genetic variations abca1 reported alter susceptibility ad 82 83 although additional studies necessary fully validate results clearly understanding contributions abca1 ad require vivo studies contribution glial neuronal abca1 pathogenesis ad evaluated appropriate physiological context
0.29108343.15269218.html.plaintext.txt	91	observation abca1 mice significant reduction apoe levels brain creates paradox predictions role abca1 ad study provide first direct evidence glial abca1 affects apoe metabolism vivo vitro reduced levels apoe abca1 brains may predict greater susceptibility neuronal injury due decreased lipid mediated repair pathways yet lower levels apoe may also delay amyloid deposition addition glial abca1 neuronal abca1 may also participate ad affecting generation present controversial whether abca1 increases decreases generation two vitro studies reported increased abca1 expression reduced production 18 81 whereas third study reported opposite finding 19 genetic variations abca1 reported alter susceptibility ad 82 83 although additional studies necessary fully validate results clearly understanding contributions abca1 ad require vivo studies contribution glial neuronal abca1 pathogenesis ad evaluated appropriate physiological context
0.29108343.15269218.html.plaintext.txt	92	summary demonstrate glial abca1 key participant apoe metabolism show selective disruption abca1 reduces cholesterol efflux exogenous apoe impairs apoe secretion astrocytes microglia result abca1 glia accumulate lipids normal culture conditions vivo abca1 required maintain normal levels apoe brain effect abca1 specific apoe independent hdl apoa levels taken together observations provide clear direct link abca1 apoe metabolism brain
0.29108343.15269218.html.plaintext.txt	93	summary demonstrate glial abca1 key participant apoe metabolism show selective disruption abca1 reduces cholesterol efflux exogenous apoe impairs apoe secretion astrocytes microglia result abca1 glia accumulate lipids normal culture conditions vivo abca1 required maintain normal levels apoe brain effect abca1 specific apoe independent hdl apoa levels taken together observations provide clear direct link abca1 apoe metabolism brain
0.29108343.15269218.html.plaintext.txt	94	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29108343.15269218.html.plaintext.txt	95	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29108343.15269218.html.plaintext.txt	96	supported british columbia research institute childrens womens health bcricwh
0.29108343.15269218.html.plaintext.txt	97	supported operating grant canadian institutes health research cihr cihrpfizer investigator salary award
0.29108343.15269218.html.plaintext.txt	98	holds canada research chair human genetics supported grants heart stroke foundation bc yukon hsfbcy cihr
0.29108343.15269218.html.plaintext.txt	99	supported cihr new investigator salary award operating grants cihr alzheimers society canadacihrastrazeneca correspondence addressed dept pathology laboratory medicine university british columbia 980 w 28th ave vancouver bc v5z 4h4 canada tel 604 875 2000 ext 6825 fax 604 875 3819 e mail cherylatcmmtubcca u d
0.29108343.15269218.html.plaintext.txt	100	supported cihr new investigator salary award operating grants cihr alzheimers society canadacihrastrazeneca correspondence addressed dept pathology laboratory medicine university british columbia 980 w 28th ave vancouver bc v5z 4h4 canada tel 604 875 2000 ext 6825 fax 604 875 3819 e mail cherylatcmmtubcca u d
0.29108343.15269218.html.plaintext.txt	101	1 abbreviations used hdl high density lipoprotein ad alzheimers disease pbs phosphate buffered saline dmem dulbeccos modified eagles medium gst glutathione transferase anova analysis variance gapdh glyceraldehyde 3 phosphate dehydrogenase cns central nervous system apoe apolipoprotein e wt wild type
0.29108343.15269218.html.plaintext.txt	102	acknowledgments thank omar francone providing abca1 deficient mice dave holtzman john cirrito apoj antibody anita kwok yu zhou yang hayden laboratory abca1 antibody leonardo basso members research groups many insightful comments suggestions throughout course work
0.29108343.15269218.html.plaintext.txt	103	references top abstract introduction experimental procedures results discussion references hayden m r clee m brooks wilson genest j jr attie kastelein j j p 2000 curr opin lipidol 11 117 122crossrefmedline order article via infotrieve broccardo c luciani m chimini g 1999 biochim biophys acta 1461 395 404medline order article via infotrieve dean m hamon y chimini g 2001 j lipid res 42 1007 1017abstractfree full text brooks wilson marcil m clee m zhang l roomp k van dam m yu l brewer c collins j molhuizen h o f loubser o ouellette b f f fichter k ashbourne excoffon k j d sensen c w scherer mott denis m martindale d frohlich j morgan k koop b pimstone n kastelein j j p genest j jr hayden m r 1999 nat genet 22 336 345crossrefmedline order article via infotrieve rust rosier m funke h amoura z piette j c deleuze j f brewer h b jr duverger n denefle p assmann g 1999 nat genet 22 352 355crossrefmedline order article via infotrieve bodzioch m orso e klucken j langmann bottcher diederich w drobnik w barlage buchler c porsch ozcurumez m kaminski w e hahmann h w oette k rothe g aslanidis c lackner k j schmitz g 1999 nat genet 22 347 351crossrefmedline order article via infotrieve singaraja r r bocher v james e r clee m zhang l h leavitt b r tan b brooks wilson kwok bissada n yang y z liu g tafuri r fievet c wellington c l staels b hayden m r 2001 j biol chem 276 33969 33979abstractfree full text singaraja r fievet c castro g jamers e r hennuyer n clee m bissada n choy j c fruchart j c mcmanus b m hayden m r 2002 j clin investig 110 35 42abstractfree full text vaisman b l lambert g amar m joyce c ito shamburek r d cain w j fruchart najib j neufeld e d remaley brewer h b jr santamarinao fojo 2001 j clin investig 108 303 309abstractfree full text wellington c l walker e k suarez kwok bissada n singaraja r yang y z zhang l h james e wilson j e francone o mcmanus b m hayden m r 2002 lab investig 82 273 283crossrefmedline order article via infotrieve van eck m bos kaminski w e orso e rothe g twisk j van amersfoort e christiansen weber fung leung w p van berkel j c schmitz g 2002 proc natl acad sci u 99 6298 6303abstractfree full text oram j f lawn r m garvin m r wade d p 2000 j biol chem 275 34508 34511abstractfree full text repa j j turley d lobaccaro j medina j li l lustig k shan b heyman r dietschy j m mangelsdorf d j 2000 science 289 1524 1529abstractfree full text venkateswaran laffitte b joseph b mak p wilpitz d c edwards p tontonoz p 2000 proc natl acad sci u 97 12097 12102abstractfree full text schwartz k lawn r m wade d p 2000 biochem biophys res commun 274 794 802crossrefmedline order article via infotrieve chawla boisvert w lee c h laffitte b barak y joseph b liao d nagy p edwards p curtiss l k evans r m tontonoz p 2001 mol cell 7 161 171medline order article via infotrieve lawn r m wade d p couse l wilcox j n 2001 arterioscler thromb vasc biol 21 378 385abstractfree full text koldamova r p lefterov m ikonomovic m d skoko j lefterov p isanski b dekosky lazo j 2003 j biol chem 278 13244 13256abstractfree full text fukumoto h deng irizarry m c fitzgerald m l rebeck g w 2002 j biol chem 277 48508 48513abstractfree full text liang y lin beyer p zhang y wu x bales k r demattos r b may p c li d jiang x c eacho p cao g paul m 2004 j neurochem 88 623 634crossrefmedline order article via infotrieve dietschy j m turley d 2001 curr opin lipidol 12 105 112crossrefmedline order article via infotrieve bjorkhem lutjohann d breuer o sakinis wennmalm 1997 j biol chem 273 30178 30184crossref bjorkhem lutjohann d diczfalusy u stahle l ahlborg g wahren j 1998 j lipid res 39 1594 1600abstractfree full text pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917 148 161medline order article via infotrieve pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text ladu m j reardon c van eldik l fagan m bu g holtzmann d getz g 2000 ann n y acad sci 903 167 175abstractfree full text koch beisiegel u 2000 lipoproteins brain new frontier lipids vascular disease betteridge d j ed pp 51 64 martin dunitz london mahley r w rall c jr 2000 annu rev genom hum genet 1 507 537crossrefmedline order article via infotrieve mahley r w 1998 science 240 622 630crossref curtiss l k boisvert w 2000 curr opin lipidol 11 243 251crossrefmedline order article via infotrieve strittmatter w j roses d 1995 proc natl acad sci 92 4725 4727abstract linton m f gish r hubl butler e esquivel c bry w boyles j k wardell m r young g 1991 j clin investig 88 270 281medline order article via infotrieve zlokovic b v martel c l mackic j b matsubara e wisniewski mccomb j g frangione b ghiso j 1994 biochem biophys res commun 205 1431 1437crossrefmedline order article via infotrieve zlokovic b v martel c l matsubara e mccomb j g zheng g mccluskey r frangione b ghiso j 1996 proc natl acad sci u 93 4229 4234abstractfree full text ignatius m j gebicke harter p j skene j h schilling j w weisgraber k h 1986 proc natl acad sci u 83 1125 1129abstract ignatius m j gebicke harter p j pitas r e shooter e m 1987 prog brain res 71 177 184medline order article via infotrieve poon treweek m wilson m r easterbrook smith b carver j 2002 febs lett 513 259 266crossrefmedline order article via infotrieve lakins j n poon easterbrook smith b carver j tenniswood m p r wilson m r 2002 biochemistry 41 282 291crossrefmedline order article via infotrieve ladu m j gilligan m lukens j r cabana v g reardon c van eldik l j holtzman d 1998 j neurochem 70 2081 corder e h saunders m strittmatter w j schmechel d e gaskell p c small g w roses d haines j l pericak vance m 1993 science 261 921 923medline order article via infotrieve strittmatter w j saunders m schmechel d pericak vance m enghild j salveson g roses d 1993 proc natl acad sci 90 1977 1981abstract corder e h saunders m risch n j strittmatter w j schmechel d e gaskell p c rimmler j b locke p conneally p m schmader k e small g w roses d haines j l pericak vance m 1994 nat genet 7 180 184medline order article via infotrieve selkoe d j schenk d 2003 annu rev pharmacol toxicol 43 545 584crossrefmedline order article via infotrieve fagan m holtzman d m 2000 microscop res tech 50 297 30430co2 c 2 hlinktypedoi crossrefmedline order article via infotrieve holtzman d m bales k r tenkova fagan m parsadanian m sartorius l j mackey b olney j mckeel d wozniak d paul m 2000 proc natl acad sci 97 2892 2897abstractfree full text bales k r verina dodel r du y alsteil l bender m hyslop p johnstone e m little p cummins d j piccardo p ghetti b paul m 1997 nat genet 17 263 264medline order article via infotrieve bales k r verina cummins d j du y dodel r c saura j fishman c e delong c piccardo p petegnief v ghetti b paul m 1999 proc natl acad sci u 96 15233 15238abstractfree full text irizarry m c rebeck g w cheung b bales k paul m holzman d hyman b 2000 ann n y acad sci 920 171 178abstractfree full text bales k r du y holtzman d cordell b paul m 2000 neurobiol aging 21 427 432crossrefmedline order article via infotrieve carter d b dunn e mckinley d d stratman n c boyle p kuiper l oostveen j weaver r j boller j gurney m e 2001 ann neurol 50 468 475crossrefmedline order article via infotrieve holtzman d m bales k r wu bhat p parsadanian m fagan m chang l k sun y paul m 1999 j clin investig 103 r15 r21medline order article via infotrieve costet p luo y wang n tall r 2000 j biol chem 275 28240 28245abstractfree full text mak p laffitte b desrumaux c joseph b curtiss l k mangelsdorf d j tontonoz p edwards p 2002 j biol chem 277 31900 31908abstractfree full text langmann schumacher c morham g honer c heimerl moehle c schmitz g 2003 j lipid res 44 968 977abstractfree full text remaley stonik j demosky j neufeld e d bocharov v vishnyakova g eggerman l patterson p duverger n j santamarina fojo brewer h b 2001 biochem biophys res commun 289 818 823crossref bortnick e rothblat g h stoudt g hoppe k l royer l j mcneish j francone o l 2000 j biol chem 275 28634 28640abstractfree full text von eckardstein langer c engel schaukal cignarella reinhardt j lorkowski li z zhou x cullen p assmann g 2001 faseb j 15 1555 1561abstractfree full text saura j tusell j m serratosa j 2003 glia 44 183 189crossrefmedline order article via infotrieve mabile l lefebvre c lavigne j boulet l davignon j lussier cacan bernier l 2003 j cell biochem 90 766 776crossrefmedline order article via infotrieve wellington c l yang y z zhou clee m tan b hirano k zwarts k kwok gelfer marcil m newman roomp k singaraja r collins j zhang l h groen k hovingh k brownlie tafuri genest j jr kastelein j j hayden m r 2002 j lipid res 43 1939 1949abstractfree full text chen w sun y welch c gorelik leventhal r tabas tall r 2001 j biol chem 276 43564 43569abstractfree full text wang n silver d l theile c tall r 2001 j biol chem 276 23742 23747abstractfree full text repa j j mangelsdorf d j 2000 annu rev cell dev biol 16 459 481crossrefmedline order article via infotrieve repa j j berge k e pomajzl c richardson j hobbs h mangelsdorf d j 2002 j biol chem 277 18793 18800abstractfree full text allayee h ghazalpour lusis j 2003 arterioscler thromb vasc biol 23 1501 1509abstractfree full text paigen b morrow brandon c mitchell d holmes p 1985 atheroscler 57 65 73 mcneish j aiello r j guyot d turi gabel c aldinger c hoppe k l roach m l royer l j de wet j broccardo c chimini g francone o l 2000 proc natl acad sci u 97 4245 4250abstractfree full text huang z h lin c y oram j f mazzone 2001 arterioscler thromb vasc biol 21 2019 2025abstractfree full text michikawa m fan q w isobe yanagisawa k 2000 j neurochem 74 1008 1016crossrefmedline order article via infotrieve neufeld e b remaley demosky j stonik j cooney m comly m dwyer n k zhang m blanchette mackie j e santamarina fojo brewer h b jr 2001 j biol chem 276 27584 27590abstractfree full text takahashi y smith j d 1999 proc natl acad sci u 96 11358 11363abstractfree full text heeren j grewal laatsch rottke d rinninger f enrich c beisiegel u 2003 j biol chem 278 14370 14378abstractfree full text fazio linton m f swift l l 2000 tins 10 23 30 swift l l farkas m h major valyi nagy k linton m f fazio 2001 j biol chem 276 22965 22970abstractfree full text naidu xu q catalano r cordell b 2002 brain res 958 100 111crossrefmedline order article via infotrieve poirier j 1994 trends neurosci 17 525 530crossrefmedline order article via infotrieve sun y yao j kim w tall r 2003 j biol chem 278 27688 27694abstractfree full text wollmer m streffer j r lutjohann d tsolaki m iakovidou v hegi pasch jung h h bergmann k nitsch r m hock c papassotiropoulos 2003 neurobiol aging 24 421 426crossrefmedline order article via infotrieve katzov h chalmers k palmgren j andreasen n johansson b cairns n j gatz m wilcock g k love pedersen n l brookes j blennow k kehoe p g prince j 2004 hum mut 23 358 367crossrefmedline order article via infotrieve wahrle jiang h parsadanian m legleiter j han x fryer j d kowalewski holtzman d m 2004 j biol chem press
0.29569125.7721816.html.plaintext.txt	0	1995 american society biochemistry molecular biology inc purification apolipoprotein e attenuates isoform specific binding amyloid
0.29569125.7721816.html.plaintext.txt	1	1995 american society biochemistry molecular biology inc purification apolipoprotein e attenuates isoform specific binding amyloid
0.29569125.7721816.html.plaintext.txt	2	1 neuroscience discovery pharmaceutical products division abbott laboratories abbott park illinois 60064 2 department pathology university chicago chicago illinois 60637 abstract introduction materials methods results discussion footnotes acknowledgements references
0.29569125.7721816.html.plaintext.txt	3	apolipoprotein e apoe particularly e4 allele genetically linked incidence alzheimers disease vitro apoe shown bind amyloid amyloidogenic peptide aggregates form primary component senile plaques previous work demonstrated apoe3 tissue culture medium binds greater avidity apoe4 ladu m j falduto m manelli m reardon c getz g frail d e 1994 j biol chem 269 23403 23406 contrast data using purified apoe isoforms substrate strittmatter w j weisgraber k h huang d y dong l m salvesen g pericak vance m schmechel d saunders m goldgaber d roses d 1993 proc natl acad sci u 90 8098 8102 resolve apparent discrepancy demonstrating preferential binding apoe3 attenuated even abolished purification process includes delipidation denaturation compared binding capacity unpurified apoe isoforms tissue culture medium intact human low density lipoproteins apoe purified two sources interaction human 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 peptide apoe analyzed nonreducing sds polyacrylamide gel electrophoresis followed western immunoblotting either apoe immunoreactivity level apoe3a complex 20 fold greater compared apoe4a complex unpurified conditioned medium apoe3 apoe4 purified medium bound comparable avidity moreover using endogenous apoe low density lipoproteins plasma apoe33 apoe44 homozygotes apoe3 better substrate apoe4 however apoe purified plasma lipoproteins exhibited little isoform specificity binding results suggest native preparations apoe may physiologically relevant substrate binding purified apoe underscore importance subtle differences apoe conformation biological activity
0.29569125.7721816.html.plaintext.txt	4	apolipoprotein e apoe particularly e4 allele genetically linked incidence alzheimers disease vitro apoe shown bind amyloid amyloidogenic peptide aggregates form primary component senile plaques previous work demonstrated apoe3 tissue culture medium binds greater avidity apoe4 ladu m j falduto m manelli m reardon c getz g frail d e 1994 j biol chem 269 23403 23406 contrast data using purified apoe isoforms substrate strittmatter w j weisgraber k h huang d y dong l m salvesen g pericak vance m schmechel d saunders m goldgaber d roses d 1993 proc natl acad sci u 90 8098 8102 resolve apparent discrepancy demonstrating preferential binding apoe3 attenuated even abolished purification process includes delipidation denaturation compared binding capacity unpurified apoe isoforms tissue culture medium intact human low density lipoproteins apoe purified two sources interaction human 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 peptide apoe analyzed nonreducing sds polyacrylamide gel electrophoresis followed western immunoblotting either apoe immunoreactivity level apoe3a complex 20 fold greater compared apoe4a complex unpurified conditioned medium apoe3 apoe4 purified medium bound comparable avidity moreover using endogenous apoe low density lipoproteins plasma apoe33 apoe44 homozygotes apoe3 better substrate apoe4 however apoe purified plasma lipoproteins exhibited little isoform specificity binding results suggest native preparations apoe may physiologically relevant substrate binding purified apoe underscore importance subtle differences apoe conformation biological activity
0.29569125.7721816.html.plaintext.txt	5	apolipoprotein e apoe component several classes lipoproteins acts ligand lipoprotein receptors thus regulating lipid transport clearance apoe also expressed brain 1 response injury peripheral 2 central nervous 3 systems humans apoe three major isoforms e2 cys cys e3 cys arg e4 arg arg products three alleles single gene locus presence cysteine apoe2 apoe3 allow isoforms form disulfide linked dimers recently demonstrated apoe e4 allele present increased frequency patients sporadic 4 late onset familial 5 alzheimers disease ad due primarily genetic linkage role apoe pathogenesis ad actively pursued
0.29569125.7721816.html.plaintext.txt	6	apolipoprotein e apoe component several classes lipoproteins acts ligand lipoprotein receptors thus regulating lipid transport clearance apoe also expressed brain 1 response injury peripheral 2 central nervous 3 systems humans apoe three major isoforms e2 cys cys e3 cys arg e4 arg arg products three alleles single gene locus presence cysteine apoe2 apoe3 allow isoforms form disulfide linked dimers recently demonstrated apoe e4 allele present increased frequency patients sporadic 4 late onset familial 5 alzheimers disease ad due primarily genetic linkage role apoe pathogenesis ad actively pursued
0.29569125.7721816.html.plaintext.txt	7	major neuropathological feature ad presence extracellular senile plaques composed predominantly aggregated amyloid peptide physiological mechanism apoe contributes ad pathology may means isoform specific interaction apoe colocalize senile plaques 6 synthetic peptides bind vitro apoe tissue culture medium 7 cerebrospinal fluid 5 8 9 well purified apoe 9 10 however studies involving apoe isoform specificity binding limited contradictory previous work demonstrated apoe3 tissue culture medium binds greater avidity apoe4 7 contrast data strittmatter et al 10 used apoe isoforms purified human plasma substrate resolve apparent discrepancy studies demonstrating previously observed preferential association apoe3 attenuated abolished purification process includes delipidation denaturation
0.29569125.7721816.html.plaintext.txt	8	major neuropathological feature ad presence extracellular senile plaques composed predominantly aggregated amyloid peptide physiological mechanism apoe contributes ad pathology may means isoform specific interaction apoe colocalize senile plaques 6 synthetic peptides bind vitro apoe tissue culture medium 7 cerebrospinal fluid 5 8 9 well purified apoe 9 10 however studies involving apoe isoform specificity binding limited contradictory previous work demonstrated apoe3 tissue culture medium binds greater avidity apoe4 7 contrast data strittmatter et al 10 used apoe isoforms purified human plasma substrate resolve apparent discrepancy studies demonstrating previously observed preferential association apoe3 attenuated abolished purification process includes delipidation denaturation
0.29569125.7721816.html.plaintext.txt	9	expression human apoe cultured cells human apoe3 apoe4 expressed hek 293 cells stably transfected human apoe3 apoe4 products e3 e4 alleles respectively cdna described previously 7 conditioned medium containing apoe concentrated centriprep amicon inc 50 fold prior binding reactions purification
0.29569125.7721816.html.plaintext.txt	10	expression human apoe cultured cells human apoe3 apoe4 expressed hek 293 cells stably transfected human apoe3 apoe4 products e3 e4 alleles respectively cdna described previously 7 conditioned medium containing apoe concentrated centriprep amicon inc 50 fold prior binding reactions purification
0.29569125.7721816.html.plaintext.txt	11	purification apoe human plasma screened apoe genotype using modification method hixson vernier 11 intermediate low density lipoprotein vldl particles d 102 gml isolated 12 plasma individuals homozygous apoe3 apoe4 unpurified preparations vldl used within 2 weeks isolation purification apoe lipoprotein fraction concentrated conditioned medium carried according standard procedures 13 briefly conditioned medium lipoproteins dialyzed 001 edta lyophilized delipidated chclmeoh 21 delipidated proteins pelleted meoh solubilized 6 m guanidine 01 m tris 001 edta ph 74 1 2 mercaptoethanol proteins fractionated sephacryl 300 column pharmacia biotech inc equilibrated 4 m guanidine 01 m tris 001 edta ph 74 01 2 mercaptoethanol fractions containing apoe dialyzed 5 m m nhhco lyophilized resuspended 01 m nhhco unpurified purified apoe proteins quantified sds polyacrylamide gel electrophoresis protein staining densitometry molecular dynamics inc serial dilutions apoe containing samples using purified apoe standard
0.29569125.7721816.html.plaintext.txt	12	purification apoe human plasma screened apoe genotype using modification method hixson vernier 11 intermediate low density lipoprotein vldl particles d 102 gml isolated 12 plasma individuals homozygous apoe3 apoe4 unpurified preparations vldl used within 2 weeks isolation purification apoe lipoprotein fraction concentrated conditioned medium carried according standard procedures 13 briefly conditioned medium lipoproteins dialyzed 001 edta lyophilized delipidated chclmeoh 21 delipidated proteins pelleted meoh solubilized 6 m guanidine 01 m tris 001 edta ph 74 1 2 mercaptoethanol proteins fractionated sephacryl 300 column pharmacia biotech inc equilibrated 4 m guanidine 01 m tris 001 edta ph 74 01 2 mercaptoethanol fractions containing apoe dialyzed 5 m m nhhco lyophilized resuspended 01 m nhhco unpurified purified apoe proteins quantified sds polyacrylamide gel electrophoresis protein staining densitometry molecular dynamics inc serial dilutions apoe containing samples using purified apoe standard
0.29569125.7721816.html.plaintext.txt	13	apoea complex formation detection binding reactions synthetic human 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 peptide purified high performance liquid chromatography resuspended 5 m m 100 meso apoe 25 microgml 700 n m incubated 2 h except noted legend fig 4 room temperature 250 micro m ph 74 described previously 7 control reactions without contained 5 meso reactions stopped addition 2 nonreducing laemmli buffer 14 4 sds 2 mercaptoethanol frozen 20 degrees c samples boiled 5 min electrophoresed 10 20 sds tricine gels transferred immobilon p membranes millipore corp probed antibodies apoe 11000 dilution monoclonal antibody 4g8 amino acids 17 24 provided drs h m wisniewski k kim 15 apoe antiserum obtained immunizing rabbits apoe purified human serum proteins western blots visualized enhanced chemiluminescence amersham corp quantified densitometry
0.29569125.7721816.html.plaintext.txt	14	apoea complex formation detection binding reactions synthetic human 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 peptide purified high performance liquid chromatography resuspended 5 m m 100 meso apoe 25 microgml 700 n m incubated 2 h except noted legend fig 4 room temperature 250 micro m ph 74 described previously 7 control reactions without contained 5 meso reactions stopped addition 2 nonreducing laemmli buffer 14 4 sds 2 mercaptoethanol frozen 20 degrees c samples boiled 5 min electrophoresed 10 20 sds tricine gels transferred immobilon p membranes millipore corp probed antibodies apoe 11000 dilution monoclonal antibody 4g8 amino acids 17 24 provided drs h m wisniewski k kim 15 apoe antiserum obtained immunizing rabbits apoe purified human serum proteins western blots visualized enhanced chemiluminescence amersham corp quantified densitometry
0.29569125.7721816.html.plaintext.txt	15	figure 4 time course binding apoe isoforms purified human plasma shown western blots apoea binding reactions assayed conditions described legend fig 1 probed 4g8 antibody apoe antiserum b apoe purified human plasma apoe33 lanes 1 6 apoe44 lanes 7 12 homozygotes lanes 1 7 apoe alone lanes 2 6 8 12 apoe 2 min 10 min 2 h 8 h 24 h respectively
0.29569125.7721816.html.plaintext.txt	16	figure 4 time course binding apoe isoforms purified human plasma shown western blots apoea binding reactions assayed conditions described legend fig 1 probed 4g8 antibody apoe antiserum b apoe purified human plasma apoe33 lanes 1 6 apoe44 lanes 7 12 homozygotes lanes 1 7 apoe alone lanes 2 6 8 12 apoe 2 min 10 min 2 h 8 h 24 h respectively
0.29569125.7721816.html.plaintext.txt	17	genetic data defined presence e4 allele apoe major risk factor occurrence sporadic 4 late onset familial 5 alzheimers disease however physiological mechanism apoe isoform specificity contributes pathogenesis disease unknown previously using unpurified apoe conditioned medium showed amount apoe3a complex much greater compared apoe4a complex 7 results contrast data published strittmatter et al 10 using apoe purified human plasma reported apoe4 binds rapidly apoe3 however level binding apoe3 apoe4 several hours incubation comparable major differences two studies source apoe plasma versus secreted cultured cells whether apoe protein purified prior use binding assays study examined whether differences could account discrepancy two reports regarding apoe isoform specific binding compared binding capacity unpurified apoe conditioned medium intact human vldl plasma apoe33 apoe44 homozygotes binding capacity apoe purified two sources purification procedure 13 used used strittmatter et al 10
0.29569125.7721816.html.plaintext.txt	18	genetic data defined presence e4 allele apoe major risk factor occurrence sporadic 4 late onset familial 5 alzheimers disease however physiological mechanism apoe isoform specificity contributes pathogenesis disease unknown previously using unpurified apoe conditioned medium showed amount apoe3a complex much greater compared apoe4a complex 7 results contrast data published strittmatter et al 10 using apoe purified human plasma reported apoe4 binds rapidly apoe3 however level binding apoe3 apoe4 several hours incubation comparable major differences two studies source apoe plasma versus secreted cultured cells whether apoe protein purified prior use binding assays study examined whether differences could account discrepancy two reports regarding apoe isoform specific binding compared binding capacity unpurified apoe conditioned medium intact human vldl plasma apoe33 apoe44 homozygotes binding capacity apoe purified two sources purification procedure 13 used used strittmatter et al 10
0.29569125.7721816.html.plaintext.txt	19	first examined effect purification apoe conditioned medium formation apoea complexes apoe3 apoe4 purified medium transfected hek 293 cells binding material compared binding unpurified apoe medium fig 1 prior purification amount apoe3a complex fig 1 b lane 2 20 fold greater compared apoe4a complex lane 4 results consistent previous data demonstrated preferential binding apoe3 maintained time ph range concentration apoe 7 purification apoe isoforms medium resulted decrease binding apoe3 fig 1 b lane 6 increase binding apoe4 lane 8 determine whether auxiliary component influences isoform specificity apoe binding present medium hek 293 cells reconstituted purified apoe mock transfected conditioned medium isoform specificity apoe binding restored pre purification levels indicating purification remove component present medium confers preferential binding apoe3 compare figs 2 1 lanes 5 8
0.29569125.7721816.html.plaintext.txt	20	first examined effect purification apoe conditioned medium formation apoea complexes apoe3 apoe4 purified medium transfected hek 293 cells binding material compared binding unpurified apoe medium fig 1 prior purification amount apoe3a complex fig 1 b lane 2 20 fold greater compared apoe4a complex lane 4 results consistent previous data demonstrated preferential binding apoe3 maintained time ph range concentration apoe 7 purification apoe isoforms medium resulted decrease binding apoe3 fig 1 b lane 6 increase binding apoe4 lane 8 determine whether auxiliary component influences isoform specificity apoe binding present medium hek 293 cells reconstituted purified apoe mock transfected conditioned medium isoform specificity apoe binding restored pre purification levels indicating purification remove component present medium confers preferential binding apoe3 compare figs 2 1 lanes 5 8
0.29569125.7721816.html.plaintext.txt	21	figure 1 apoea binding effect purifying apoe isoforms conditioned medium shown western blots binding reactions using 25 microgml apoe 700 n m incubated lanes 2 4 6 8 without lanes 1 3 5 7 250 micro m 1 40 peptide 2 h room temperature sources apoe follows conditioned medium transfected cells apoe3 lanes 1 2 apoe4 lanes 3 4 purified conditioned medium apoe3 lanes 5 6 apoe4 lanes 7 8 samples run nonreducing laemmli buffer 10 20 sds tricine gels transferred immobilon p membrane probed 4g8 antibody apoe antiserum b
0.29569125.7721816.html.plaintext.txt	22	figure 1 apoea binding effect purifying apoe isoforms conditioned medium shown western blots binding reactions using 25 microgml apoe 700 n m incubated lanes 2 4 6 8 without lanes 1 3 5 7 250 micro m 1 40 peptide 2 h room temperature sources apoe follows conditioned medium transfected cells apoe3 lanes 1 2 apoe4 lanes 3 4 purified conditioned medium apoe3 lanes 5 6 apoe4 lanes 7 8 samples run nonreducing laemmli buffer 10 20 sds tricine gels transferred immobilon p membrane probed 4g8 antibody apoe antiserum b
0.29569125.7721816.html.plaintext.txt	23	examine binding unpurified plasma apoe isoforms vldl isolated plasma apoe33 apoe44 homozygotes used binding reactions similar results using unpurified apoe conditioned medium observed 20 fold difference amount apoe3a complex fig 3 b lane 2 compared apoe4a complex lane 4 using intact vldl particles source apoe purification apoe medium purification apoe vldl fraction human plasma attenuated preferential binding apoe3 fig 3 b lanes 6 8 level binding apoe4 apoe3 dimer increased purification apoe plasma apoe33 plasma apoe immunoreactive species migrating slightly higher apoea complex 55 kda apoe3 apolipoprotein ii heterodimer fig 3 b lanes 1 2 autoradiographs shown figs 1 3 representative several experiments similar results using different apoe containing preparations variation purification mediated loss preferential apoe3 binding observed general purification apoe medium plasma abolished isoform specific binding
0.29569125.7721816.html.plaintext.txt	24	examine binding unpurified plasma apoe isoforms vldl isolated plasma apoe33 apoe44 homozygotes used binding reactions similar results using unpurified apoe conditioned medium observed 20 fold difference amount apoe3a complex fig 3 b lane 2 compared apoe4a complex lane 4 using intact vldl particles source apoe purification apoe medium purification apoe vldl fraction human plasma attenuated preferential binding apoe3 fig 3 b lanes 6 8 level binding apoe4 apoe3 dimer increased purification apoe plasma apoe33 plasma apoe immunoreactive species migrating slightly higher apoea complex 55 kda apoe3 apolipoprotein ii heterodimer fig 3 b lanes 1 2 autoradiographs shown figs 1 3 representative several experiments similar results using different apoe containing preparations variation purification mediated loss preferential apoe3 binding observed general purification apoe medium plasma abolished isoform specific binding
0.29569125.7721816.html.plaintext.txt	25	figure 3 apoea binding effect purifying apoe isoforms human plasma shown western blots apoea binding reactions assayed conditions described legend fig 1 sources apoe follows intact vldl apoe33 lanes 1 2 apoe44 lanes 3 4 homozygotes purified vldl apoe33 lanes 5 6 apoe44 lanes 7 8 homozygotes samples run described legend fig 1 probed 4g8 antibody apoe antiserum b apoe3 vldl total protein 95 ng microl triglyceride 600 ng microl apoe4 vldl total protein 110 ng microl triglyceride 400 ng microl
0.29569125.7721816.html.plaintext.txt	26	figure 3 apoea binding effect purifying apoe isoforms human plasma shown western blots apoea binding reactions assayed conditions described legend fig 1 sources apoe follows intact vldl apoe33 lanes 1 2 apoe44 lanes 3 4 homozygotes purified vldl apoe33 lanes 5 6 apoe44 lanes 7 8 homozygotes samples run described legend fig 1 probed 4g8 antibody apoe antiserum b apoe3 vldl total protein 95 ng microl triglyceride 600 ng microl apoe4 vldl total protein 110 ng microl triglyceride 400 ng microl
0.29569125.7721816.html.plaintext.txt	27	strittmatter et al 10 used apoe purified plasma show binds apoe4 monomer faster rate apoe3 monomer however contribution apoe3 complex time course data difficult discern since blots probed apoe immunoreactivity simultaneously 10 therefore repeated time course study using purified plasma apoe isoforms probed fig 4 apoe fig 4 b immunoreactivity individually similar results obtained strittmatter et al 10 apoe4 monomer form complex faster rate compared apoe3 monomer however apoe3 dimer complex taken account total binding apoe3 apoe4 remained comparable across time
0.29569125.7721816.html.plaintext.txt	28	several possibilities could account loss isoform specificity binding purified apoe purification may result change oxidative state apoe influences binding although apoe isoforms subject conditions undergoing purification oxidation could specific cysin apoe3 could affect conformation dependent binding apoe either directly via interaction amino acids residue however apoe3 dimer particularly purified form readily binds indicating least oxidation cysteine seem adversely affect apoe3 complex formation addition oxidation provides obvious explanation increase binding purified apoe4 monomer
0.29569125.7721816.html.plaintext.txt	29	several possibilities could account loss isoform specificity binding purified apoe purification may result change oxidative state apoe influences binding although apoe isoforms subject conditions undergoing purification oxidation could specific cysin apoe3 could affect conformation dependent binding apoe either directly via interaction amino acids residue however apoe3 dimer particularly purified form readily binds indicating least oxidation cysteine seem adversely affect apoe3 complex formation addition oxidation provides obvious explanation increase binding purified apoe4 monomer
0.29569125.7721816.html.plaintext.txt	30	another likely explanation apoe acquires conformation lipid associated confers isoform specific binding purification includes delipidation may increase binding apoe3 dimer apoe4 monomer disrupting endogenous conformation apoe species unpurified preparations used apoe lipid associated apoe human plasma vldl fraction majority apoe conditioned medium high density lipid fraction purified apoe shown require lipid restore biological activity assay systems presumably allowing denatured protein refold functional conformation apoe activity assays include diverse functions receptor binding modulation neuritic growth purified apoe unable displace labeled low density lipoprotein ldl ldl receptors 16 high affinity binding restored apoe added presence variety lipid particles including phospholipid vesicles 17 similarly binding purified apoe ldl receptor related protein enhanced addition migrating vldl 18 primary dorsal root ganglia cultures purified apoe3 apoe4 effect neuritic growth however added presence migrating vldl apoe isoforms affect neuritic growth apoe3 increasing neuritic extension decreasing branching apoe4 decreasing branching extension 19 experiments progress using assay system described determine nature interaction lipid associated apoe using endogenous lipoproteins reconstituted lipid vesicles
0.29569125.7721816.html.plaintext.txt	31	another likely explanation apoe acquires conformation lipid associated confers isoform specific binding purification includes delipidation may increase binding apoe3 dimer apoe4 monomer disrupting endogenous conformation apoe species unpurified preparations used apoe lipid associated apoe human plasma vldl fraction majority apoe conditioned medium high density lipid fraction purified apoe shown require lipid restore biological activity assay systems presumably allowing denatured protein refold functional conformation apoe activity assays include diverse functions receptor binding modulation neuritic growth purified apoe unable displace labeled low density lipoprotein ldl ldl receptors 16 high affinity binding restored apoe added presence variety lipid particles including phospholipid vesicles 17 similarly binding purified apoe ldl receptor related protein enhanced addition migrating vldl 18 primary dorsal root ganglia cultures purified apoe3 apoe4 effect neuritic growth however added presence migrating vldl apoe isoforms affect neuritic growth apoe3 increasing neuritic extension decreasing branching apoe4 decreasing branching extension 19 experiments progress using assay system described determine nature interaction lipid associated apoe using endogenous lipoproteins reconstituted lipid vesicles
0.29569125.7721816.html.plaintext.txt	32	data presented consistent function apoe pathogenesis ad sequestering avid binding apoe3 soluble neuropil could lead enhanced clearance altered fibril formation could prevent conversion neurotoxic species since lipid associated apoe3 apoe4 bind ldl receptor ldl receptor related protein equal affinity 18 efficient uptake clearance may depend preferential binding apoe3 alternatively purified apoe3 apoe4 known differ respect effect fibril formation 20 21 22 suggesting native apoe may play even greater isoform specific role extracellular aggregation due differences binding characteristics finally evidence induced toxicity hippocampal neurons attenuated addition rabbit apoe 23 leading intriguing possibility human apoe may contribute induced toxicity isoform specific manner
0.29569125.7721816.html.plaintext.txt	33	data presented consistent function apoe pathogenesis ad sequestering avid binding apoe3 soluble neuropil could lead enhanced clearance altered fibril formation could prevent conversion neurotoxic species since lipid associated apoe3 apoe4 bind ldl receptor ldl receptor related protein equal affinity 18 efficient uptake clearance may depend preferential binding apoe3 alternatively purified apoe3 apoe4 known differ respect effect fibril formation 20 21 22 suggesting native apoe may play even greater isoform specific role extracellular aggregation due differences binding characteristics finally evidence induced toxicity hippocampal neurons attenuated addition rabbit apoe 23 leading intriguing possibility human apoe may contribute induced toxicity isoform specific manner
0.29569125.7721816.html.plaintext.txt	34	summary using unpurified apoe tissue culture medium intact vldl particles apoe3a complex 20 fold abundant apoe4a complex isoform specificity attenuated abolished apoe purified two sources used binding reactions apoe apolipoprotein endogenous conformation requires lipid therefore surprising type apoe preparation used affect results avidity binding apoe3 compared apoe4 demonstrated may involved isoform specific effect underlying genetic correlation apoe e4 allele ad physiological relevance complex plaque formation neurodegeneration awaits investigation
0.29569125.7721816.html.plaintext.txt	35	summary using unpurified apoe tissue culture medium intact vldl particles apoe3a complex 20 fold abundant apoe4a complex isoform specificity attenuated abolished apoe purified two sources used binding reactions apoe apolipoprotein endogenous conformation requires lipid therefore surprising type apoe preparation used affect results avidity binding apoe3 compared apoe4 demonstrated may involved isoform specific effect underlying genetic correlation apoe e4 allele ad physiological relevance complex plaque formation neurodegeneration awaits investigation
0.29569125.7721816.html.plaintext.txt	36	work supported part national institutes health grant hl15062 specialized center research atherosclerosis abbott laboratories costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29569125.7721816.html.plaintext.txt	37	work supported part national institutes health grant hl15062 specialized center research atherosclerosis abbott laboratories costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29569125.7721816.html.plaintext.txt	38	supported national institutes health grant 1f32 hl08833 01 correspondence addressed dept pathology mc 6079 university chicago 5841 maryland chicago il 60637 tel 312 702 1273 fax 312 702 3778
0.29569125.7721816.html.plaintext.txt	39	supported national institutes health grant 1f32 hl08833 01 correspondence addressed dept pathology mc 6079 university chicago 5841 maryland chicago il 60637 tel 312 702 1273 fax 312 702 3778
0.29569125.7721816.html.plaintext.txt	40	present address womens health research inst wyeth ayerst research 145 king prussia rd radnor pa 19087
0.29569125.7721816.html.plaintext.txt	41	present address womens health research inst wyeth ayerst research 145 king prussia rd radnor pa 19087
0.29569125.7721816.html.plaintext.txt	42	abbreviations used apoe apolipoprotein e ad alzheimers disease amyloid vldl low density lipoprotein tricine n 2 hydroxy 11 bishydroxymethylethylglycine ldl low density lipoprotein
0.29569125.7721816.html.plaintext.txt	43	thank warren wade richard perner synthesis peptides randy metzger genotyping plasma sources john lukens lipoprotein isolation also thank brad hyman bill rebeck helpful discussions providing apoe44 plasma
0.29569125.7721816.html.plaintext.txt	44	thank warren wade richard perner synthesis peptides randy metzger genotyping plasma sources john lukens lipoprotein isolation also thank brad hyman bill rebeck helpful discussions providing apoe44 plasma
0.29722524.9461617.html.plaintext.txt	0	minimally lipidated form cell derived apolipoprotein e exhibits isoform specific stimulation neurite outgrowth absence exogenous lipids lipoproteins ronald b demattos linda k curtiss david l williams
0.29722524.9461617.html.plaintext.txt	1	department pharmacological sciences university medical center state university new york stony brook new york 11794 departments immunology vascular biology scripps research institute la jolla california 92037
0.29722524.9461617.html.plaintext.txt	2	abstract top abstract introduction procedures results discussion references
0.29722524.9461617.html.plaintext.txt	3	within central nervous system apolipoprotein e apoe synthesis increased response nerve injury finding may reflect role apoe neuronal remodeling recent studies show apoe3 promotes apoe4 inhibits neurite outgrowth cultured neuronal cells interestingly isoform specific effects observed apoe presented cells presence exogenous lipid source rabbit low density lipoprotein vldl making difficult discern biologically active form apoe understand role lipid source present study tested whether cell derived lipidated form apoe alter neurite outgrowth absence vldl constructing neuro 2a cell lines expressing high levels apoe results showed endogenous apoe3 stimulated neurite outgrowth whereas endogenous apoe4 isoform neutral furthermore vldl antagonized stimulatory effects endogenous apoe3 characterization secreted apoe3 indicated neurite outgrowth stimulating activity could recovered culture medium anti apoe immunoaffinity column present poorly lipidated particle density 119 126 gml results indicated biological activity apoe3 stimulating neurite outgrowth inherent cell derived apoe particle dependent either interaction apoe3 artificial lipid source b independent actions apoe3 vldl
0.29722524.9461617.html.plaintext.txt	4	within central nervous system apolipoprotein e apoe synthesis increased response nerve injury finding may reflect role apoe neuronal remodeling recent studies show apoe3 promotes apoe4 inhibits neurite outgrowth cultured neuronal cells interestingly isoform specific effects observed apoe presented cells presence exogenous lipid source rabbit low density lipoprotein vldl making difficult discern biologically active form apoe understand role lipid source present study tested whether cell derived lipidated form apoe alter neurite outgrowth absence vldl constructing neuro 2a cell lines expressing high levels apoe results showed endogenous apoe3 stimulated neurite outgrowth whereas endogenous apoe4 isoform neutral furthermore vldl antagonized stimulatory effects endogenous apoe3 characterization secreted apoe3 indicated neurite outgrowth stimulating activity could recovered culture medium anti apoe immunoaffinity column present poorly lipidated particle density 119 126 gml results indicated biological activity apoe3 stimulating neurite outgrowth inherent cell derived apoe particle dependent either interaction apoe3 artificial lipid source b independent actions apoe3 vldl
0.29722524.9461617.html.plaintext.txt	5	introduction top abstract introduction procedures results discussion references
0.29722524.9461617.html.plaintext.txt	6	apolipoprotein e apoe1 299 amino acid glycoprotein 1 first identified 1973 constituent human low density lipoprotein vldl subsequently found lipoprotein classes apoe plays key role cholesterol homeostasis mediating hepatic clearance plasma cholesteryl ester rich vldl chylomicron remnants contrast apolipoproteins synthesized liver gut apoe expressed variety tissues cell types including abundant expression steroidogenic cells astrocytes brain 1 4 apoe present cerebrospinal fluid csf 5 10 microgml approximately 5 10 plasma concentration 5 6 endogenous lipoproteins csf predominantly hdl like particles arise astrocyte derived apoe addition apoai presumably crosses blood brain barrier 7 8 role brain apoe known although expression appears correlated nerve injury neuronal remodeling 8 13
0.29722524.9461617.html.plaintext.txt	7	apolipoprotein e apoe1 299 amino acid glycoprotein 1 first identified 1973 constituent human low density lipoprotein vldl subsequently found lipoprotein classes apoe plays key role cholesterol homeostasis mediating hepatic clearance plasma cholesteryl ester rich vldl chylomicron remnants contrast apolipoproteins synthesized liver gut apoe expressed variety tissues cell types including abundant expression steroidogenic cells astrocytes brain 1 4 apoe present cerebrospinal fluid csf 5 10 microgml approximately 5 10 plasma concentration 5 6 endogenous lipoproteins csf predominantly hdl like particles arise astrocyte derived apoe addition apoai presumably crosses blood brain barrier 7 8 role brain apoe known although expression appears correlated nerve injury neuronal remodeling 8 13
0.29722524.9461617.html.plaintext.txt	8	three common isoforms human apoe result cysteine arginine interchanges residues 112 158 14 apoe3 contains cysteine residue 112 arginine residue 158 apoe2 contains 2 cysteines whereas apoe4 contains arginines residues correlation apoe 4 allele late onset familial alzheimers disease identified 15 17 however role apoe pathology alzheimers disease still unknown evidence apoe interacts protein components pathologic features alzheimers disease amyloid plaques neurofibrillary tangles isoform specific manner 18 19 addition purified delipidated apoe stimulate isoform specific differences neurite outgrowth added neuronal cells culture 14 20 21 murine neuroblastoma cell line neuro 2a exposed delipidated apoe3 significantly longer neurite extensions compared either control cells cells treated apoe4 14 delipidated apoe4 isoform inhibitory effect neurite outgrowth correlates destabilization microtubular arrays 14 interestingly isoform specific differences observed exogenous lipid source rabbit vldl added along delipidated apoe isoforms neither rabbit vldl contains abundant rabbit apoe human apoe alone alters neurite outgrowth
0.29722524.9461617.html.plaintext.txt	9	three common isoforms human apoe result cysteine arginine interchanges residues 112 158 14 apoe3 contains cysteine residue 112 arginine residue 158 apoe2 contains 2 cysteines whereas apoe4 contains arginines residues correlation apoe 4 allele late onset familial alzheimers disease identified 15 17 however role apoe pathology alzheimers disease still unknown evidence apoe interacts protein components pathologic features alzheimers disease amyloid plaques neurofibrillary tangles isoform specific manner 18 19 addition purified delipidated apoe stimulate isoform specific differences neurite outgrowth added neuronal cells culture 14 20 21 murine neuroblastoma cell line neuro 2a exposed delipidated apoe3 significantly longer neurite extensions compared either control cells cells treated apoe4 14 delipidated apoe4 isoform inhibitory effect neurite outgrowth correlates destabilization microtubular arrays 14 interestingly isoform specific differences observed exogenous lipid source rabbit vldl added along delipidated apoe isoforms neither rabbit vldl contains abundant rabbit apoe human apoe alone alters neurite outgrowth
0.29722524.9461617.html.plaintext.txt	10	neuro 2a cell lines expressing low quantities apoe isoforms display similar isoform specific differences presence rabbit vldl yet indistinguishable control cells lack apoe expression absence exogenous lipid source 22 multiple lipid sources vldl triglyceride rich emulsions hdl hdl like csf lipoproteins substitute vldl propagate similar isoform specific differences 21 23 however puzzling aspect studies csf lipoproteins fail induce difference neuritogenesis unless enriched exogenous human apoe 23 even though csf hdl like particles already contain apoe 7 23 importantly studies identify physiologically significant biologically active form apoe require artificial lipid sources observe apoe induced stimulated neurite outgrowth
0.29722524.9461617.html.plaintext.txt	11	neuro 2a cell lines expressing low quantities apoe isoforms display similar isoform specific differences presence rabbit vldl yet indistinguishable control cells lack apoe expression absence exogenous lipid source 22 multiple lipid sources vldl triglyceride rich emulsions hdl hdl like csf lipoproteins substitute vldl propagate similar isoform specific differences 21 23 however puzzling aspect studies csf lipoproteins fail induce difference neuritogenesis unless enriched exogenous human apoe 23 even though csf hdl like particles already contain apoe 7 23 importantly studies identify physiologically significant biologically active form apoe require artificial lipid sources observe apoe induced stimulated neurite outgrowth
0.29722524.9461617.html.plaintext.txt	12	apoe mediated alterations neurite outgrowth relevant neuronal remodeling events vivo likely biologically active form apoe cell derived lipidated complex act absence vldl artificial lipid sources test possibility constructed neuro 2a cell lines secrete higher levels apoe isoforms cells produced minimally lipidated apoe3 stimulated neurite outgrowth absence exogenous lipid identical conditions apoe4 effect neurite outgrowth indicating e4 isoform neutral inhibitory furthermore exogenous vldl antagonized stimulatory effects cell derived apoe3 thus studies identified minimally lipidated form apoe biologically active promoting neurite outgrowth
0.29722524.9461617.html.plaintext.txt	13	apoe mediated alterations neurite outgrowth relevant neuronal remodeling events vivo likely biologically active form apoe cell derived lipidated complex act absence vldl artificial lipid sources test possibility constructed neuro 2a cell lines secrete higher levels apoe isoforms cells produced minimally lipidated apoe3 stimulated neurite outgrowth absence exogenous lipid identical conditions apoe4 effect neurite outgrowth indicating e4 isoform neutral inhibitory furthermore exogenous vldl antagonized stimulatory effects cell derived apoe3 thus studies identified minimally lipidated form apoe biologically active promoting neurite outgrowth
0.29722524.9461617.html.plaintext.txt	14	experimental procedures top abstract introduction procedures results discussion references apolipoprotein e expression vectors
0.29722524.9461617.html.plaintext.txt	15	high expression apoe3 vector constructed inserting pcr generated apoe3 cdna pcdna3 invitrogen apoe3 insert produced following pcr conditions 17 ng template phe54 generous gift john taylor david walker gladstone institute cardiovascular disease 5 units taq polymerase 50 microm dntps 15 mm mgcl 001 gelatin 10 me2so 50 mm kcl 10 mm tris hcl ph 83 5 microm high annealing temperature primers incorporating unique 5 restriction enzyme site translational enhancer alpha mosaic virus expression plasmid pcmv4 24 inserted 4 bases upstream apoe3 cdna yield pc1e3 apoe4 expression vector pc1e4 made substituting sacii fsei fragment pc1e3 corresponding fragment apoe4 sequence plasmid pfe 25 pcr inserts junctions verified standard sequencing techniques
0.29722524.9461617.html.plaintext.txt	16	high expression apoe3 vector constructed inserting pcr generated apoe3 cdna pcdna3 invitrogen apoe3 insert produced following pcr conditions 17 ng template phe54 generous gift john taylor david walker gladstone institute cardiovascular disease 5 units taq polymerase 50 microm dntps 15 mm mgcl 001 gelatin 10 me2so 50 mm kcl 10 mm tris hcl ph 83 5 microm high annealing temperature primers incorporating unique 5 restriction enzyme site translational enhancer alpha mosaic virus expression plasmid pcmv4 24 inserted 4 bases upstream apoe3 cdna yield pc1e3 apoe4 expression vector pc1e4 made substituting sacii fsei fragment pc1e3 corresponding fragment apoe4 sequence plasmid pfe 25 pcr inserts junctions verified standard sequencing techniques
0.29722524.9461617.html.plaintext.txt	17	production stable apoe3 apoe4 transfected neuro 2a cell lines
0.29722524.9461617.html.plaintext.txt	18	neuro 2a cells maintained 37 degrees c humidified 95 air 5 co2 incubator medium dulbeccos modified eagles mediumhams f12 11 supplemented 10 heat inactivated fetal bovine serum fbs atlanta biologicals 4 mm glutamine 100 unitsml penicillin 100 unitsml streptomycin sulfate 025 microgml amphotericin b neuro 2a cells plated 10 x 106 cells 10 ml medium per 10 cm dish transfected 20 microg plasmid using standard calcium phosphate precipitation protocol 26 stable integrants selected maintained medium b medium plus 350 microgml g418 life technologies inc
0.29722524.9461617.html.plaintext.txt	19	characterization parental apoe3 apoe4 neuro 2a cell lines
0.29722524.9461617.html.plaintext.txt	20	northern blotting analysis total rna isolated confluent 10 cm plates parental apoe3 apoe4 cell lines using stat 60 tel test reagent protocol total rna 25 microg denatured subjected electrophoresis 12 agarose gel containing 22 m formaldehyde transferred nylon membrane overnight capillary transfer membrane probed 32p random primed apoe fragment nucleotides 209 653 hybridization visualized molecular dynamics phosphorimager
0.29722524.9461617.html.plaintext.txt	21	northern blotting analysis total rna isolated confluent 10 cm plates parental apoe3 apoe4 cell lines using stat 60 tel test reagent protocol total rna 25 microg denatured subjected electrophoresis 12 agarose gel containing 22 m formaldehyde transferred nylon membrane overnight capillary transfer membrane probed 32p random primed apoe fragment nucleotides 209 653 hybridization visualized molecular dynamics phosphorimager
0.29722524.9461617.html.plaintext.txt	22	western blotting analysis cells plated 10 x 107 cells 10 ml medium per 10 cm dish incubated overnight 37 degrees c washed twice medium incubated additional 24 h 10 ml fresh medium conditioned medium removed cells washed 2 times pbs solubilized 05 ml 2 sds pbs total protein determination conditioned medium run 10 sds polyacrylamide gel electrophoretically transferred nitrocellulose blocked 1 h room temperature 20 mm tris hcl ph 74 150 mm nacl tbs containing 7 nonfat milk 005 tween 20 blocked membrane incubated affinity purified polyclonal goat anti human apoe antibody biodesign international 2 microgml overnight room temperature tbs containing 1 nonfat milk 02 tween 20 membrane washed three times tbs containing 005 tween 20 incubated horseradish peroxidase conjugated anti goat igg sigma 1 h room temperature tbs containing 1 nonfat milk 005 tween 20 bands visualized enhanced chemiluminescence amersham corp
0.29722524.9461617.html.plaintext.txt	23	western blotting analysis cells plated 10 x 107 cells 10 ml medium per 10 cm dish incubated overnight 37 degrees c washed twice medium incubated additional 24 h 10 ml fresh medium conditioned medium removed cells washed 2 times pbs solubilized 05 ml 2 sds pbs total protein determination conditioned medium run 10 sds polyacrylamide gel electrophoretically transferred nitrocellulose blocked 1 h room temperature 20 mm tris hcl ph 74 150 mm nacl tbs containing 7 nonfat milk 005 tween 20 blocked membrane incubated affinity purified polyclonal goat anti human apoe antibody biodesign international 2 microgml overnight room temperature tbs containing 1 nonfat milk 02 tween 20 membrane washed three times tbs containing 005 tween 20 incubated horseradish peroxidase conjugated anti goat igg sigma 1 h room temperature tbs containing 1 nonfat milk 005 tween 20 bands visualized enhanced chemiluminescence amersham corp
0.29722524.9461617.html.plaintext.txt	24	neuro 2a cells plated onto 18 mm glass circle coverslips 12 well tissue culture plates 50 x 103 cells 4 ml medium per well allowed adhere overnight 37 degrees c cells washed twice pbs fixed ice cold pbs containing 3 paraformaldehyde 30 min cells washed twice pbs permeabilized ice cold pbs containing 05 triton x 100 15 min blocked pbs containing 10 fbs 05 triton x 100 additional 15 min 37 degrees c cells incubated affinity purified polyclonal goat anti human apoe antibody 2 microgml pbs containing 1 fbs 05 triton x 100 1 h 37 degrees c cells washed three times pbs containing 05 triton x 100 incubated rhodamine conjugated donkey anti goat igg antibody jackson immuno research 12000 pbs containing 1 fbs 05 triton x 100 1 h 37 degrees c glass slips washed three times pbs containing 05 triton x 100 mounted slowfade molecular probes analyzed bio rad mrc 600 scanning confocal system mounted nikon diaphot inverted microscope images saved bio rad pic files subsequently converted tif files
0.29722524.9461617.html.plaintext.txt	25	neuro 2a cells plated onto 18 mm glass circle coverslips 12 well tissue culture plates 50 x 103 cells 4 ml medium per well allowed adhere overnight 37 degrees c cells washed twice pbs fixed ice cold pbs containing 3 paraformaldehyde 30 min cells washed twice pbs permeabilized ice cold pbs containing 05 triton x 100 15 min blocked pbs containing 10 fbs 05 triton x 100 additional 15 min 37 degrees c cells incubated affinity purified polyclonal goat anti human apoe antibody 2 microgml pbs containing 1 fbs 05 triton x 100 1 h 37 degrees c cells washed three times pbs containing 05 triton x 100 incubated rhodamine conjugated donkey anti goat igg antibody jackson immuno research 12000 pbs containing 1 fbs 05 triton x 100 1 h 37 degrees c glass slips washed three times pbs containing 05 triton x 100 mounted slowfade molecular probes analyzed bio rad mrc 600 scanning confocal system mounted nikon diaphot inverted microscope images saved bio rad pic files subsequently converted tif files
0.29722524.9461617.html.plaintext.txt	26	apoe concentration conditioned medium determined elisa follows 96 well plates coated 100 microl affinity purified goat anti human apoe antibody 5 microgml pbs overnight 4 degrees c plate washed twice pbs blocked 400 microl pbs containing 7 non fat milk 1 h 37 degrees c washed twice coated plate incubated 37 degrees c 1 h 100 microl conditioned medium washed twice 100 microl biotin labeled affinity purified goat anti human apoe polyclonal diluted 11000 pbs containing 05 non fat milk added incubated 37 degrees c 30 min washing four times 100 microl streptavidinhorseradish peroxidase life technologies inc diluted 11000 pbs containing 05 non fat milk added plate incubated 37 degrees c 30 min plate washed six times 150 microl 3355 tetramethylbenzidine liquid substrate sigma added color development monitored 650 nm standard curve generated purified human apoe panvera concentrations ranging 1 50 ng samples assayed triplicate
0.29722524.9461617.html.plaintext.txt	27	apoe concentration conditioned medium determined elisa follows 96 well plates coated 100 microl affinity purified goat anti human apoe antibody 5 microgml pbs overnight 4 degrees c plate washed twice pbs blocked 400 microl pbs containing 7 non fat milk 1 h 37 degrees c washed twice coated plate incubated 37 degrees c 1 h 100 microl conditioned medium washed twice 100 microl biotin labeled affinity purified goat anti human apoe polyclonal diluted 11000 pbs containing 05 non fat milk added incubated 37 degrees c 30 min washing four times 100 microl streptavidinhorseradish peroxidase life technologies inc diluted 11000 pbs containing 05 non fat milk added plate incubated 37 degrees c 30 min plate washed six times 150 microl 3355 tetramethylbenzidine liquid substrate sigma added color development monitored 650 nm standard curve generated purified human apoe panvera concentrations ranging 1 50 ng samples assayed triplicate
0.29722524.9461617.html.plaintext.txt	28	parental apoe3 apoe4 neuro 2a cell lines trypsinized plated low cell densities days 4 2 time 0 cells trypsinized exactly 2 min subsequently plated medium density 20 x 104 cells per 60 mm dish 2 h 37 degrees c medium removed dish washed twice basal medium medium lacking fbs freshly made basal medium plus n2 growth supplement life technologies inc either without rabbit vldl 40 microg cholesterolml added cells incubated 96 h 37 degrees c 1 medium change 48 h 96 h cells fixed pbs containing 25 glutaraldehyde 30 min room temperature nonspecifically stained 0002 acridine orange pbs 30 min cells washed three times pbs coverslipped images captured 20 x objective filter group specific rhodamine fluorescence system stated images converted tif format analyzed uthscsa image tool program developed university texas health science center san antonio tx2 every cell contained process longer cell diameter measured longest neurite initial samples contained microsphere calibration standards duke scientific corp mean diameter 9975 plus minus 0061 microm
0.29722524.9461617.html.plaintext.txt	29	parental apoe3 apoe4 neuro 2a cell lines trypsinized plated low cell densities days 4 2 time 0 cells trypsinized exactly 2 min subsequently plated medium density 20 x 104 cells per 60 mm dish 2 h 37 degrees c medium removed dish washed twice basal medium medium lacking fbs freshly made basal medium plus n2 growth supplement life technologies inc either without rabbit vldl 40 microg cholesterolml added cells incubated 96 h 37 degrees c 1 medium change 48 h 96 h cells fixed pbs containing 25 glutaraldehyde 30 min room temperature nonspecifically stained 0002 acridine orange pbs 30 min cells washed three times pbs coverslipped images captured 20 x objective filter group specific rhodamine fluorescence system stated images converted tif format analyzed uthscsa image tool program developed university texas health science center san antonio tx2 every cell contained process longer cell diameter measured longest neurite initial samples contained microsphere calibration standards duke scientific corp mean diameter 9975 plus minus 0061 microm
0.29722524.9461617.html.plaintext.txt	30	affinity purification apolipoprotein e lipid particles
0.29722524.9461617.html.plaintext.txt	31	affinity chromatography isolation procedure utilizing human apoe specific monoclonal antibody 1e employed purified 1e antibody coupled cnbr activated sepharose 4b sigma incubating 10 mg antibody 01 m nahco3 ph 83 05 m nacl 2 ml pre swelled cnbr activated sepharose 4b rotary shaker overnight 4 degrees c gel washed 10 ml 01 m nahco3 ph 83 05 m nacl remaining active groups blocked 2 h 1 m ethanolamine ph 80 gel washed three cycles alternating ph using 10 ml 01 m acetate ph 40 05 m nacl 01 m tris hcl ph 80 05 m nacl coupled gel packed glass column conditioned media cells secreting apoe3 recycled 1 mlmin overnight 4 degrees c column washed 100 ml pbs apoe3 containing particles eluted 60 ml 100 mm triethylamine ph 115 immediately neutralized 20 ml 1 m sodium phosphate ph 68 apoe3 particles dialyzed concentrated pbs subsequently basal medium using centriprep 50 concentrators amicon final apoe3 preparation sterilized filtration pre blocked 1 bovine serum albumin pbs 02 microm filter schleicher schuell apoe3 preparation analyzed western blotting quantified elisa described
0.29722524.9461617.html.plaintext.txt	32	affinity chromatography isolation procedure utilizing human apoe specific monoclonal antibody 1e employed purified 1e antibody coupled cnbr activated sepharose 4b sigma incubating 10 mg antibody 01 m nahco3 ph 83 05 m nacl 2 ml pre swelled cnbr activated sepharose 4b rotary shaker overnight 4 degrees c gel washed 10 ml 01 m nahco3 ph 83 05 m nacl remaining active groups blocked 2 h 1 m ethanolamine ph 80 gel washed three cycles alternating ph using 10 ml 01 m acetate ph 40 05 m nacl 01 m tris hcl ph 80 05 m nacl coupled gel packed glass column conditioned media cells secreting apoe3 recycled 1 mlmin overnight 4 degrees c column washed 100 ml pbs apoe3 containing particles eluted 60 ml 100 mm triethylamine ph 115 immediately neutralized 20 ml 1 m sodium phosphate ph 68 apoe3 particles dialyzed concentrated pbs subsequently basal medium using centriprep 50 concentrators amicon final apoe3 preparation sterilized filtration pre blocked 1 bovine serum albumin pbs 02 microm filter schleicher schuell apoe3 preparation analyzed western blotting quantified elisa described
0.29722524.9461617.html.plaintext.txt	33	trans addition analysis affinity purified apoe particles
0.29722524.9461617.html.plaintext.txt	34	parental neuro 2a cells plated density 20 x 103 cells per well 24 well tissue culture plate costar medium 2 h 37 degrees c medium removed dish washed twice basal medium medium lacking fbs incubation continued 48 h 37 degrees c either basal medium plus n2 supplement alone immunopurified apoe3 30 microgml basal medium plus n2 supplements cells fixed stained analyzed stated microscopy experiments coded confocal image analysis neurite measurements using double blind coding procedures
0.29722524.9461617.html.plaintext.txt	35	parental neuro 2a cells plated density 20 x 103 cells per well 24 well tissue culture plate costar medium 2 h 37 degrees c medium removed dish washed twice basal medium medium lacking fbs incubation continued 48 h 37 degrees c either basal medium plus n2 supplement alone immunopurified apoe3 30 microgml basal medium plus n2 supplements cells fixed stained analyzed stated microscopy experiments coded confocal image analysis neurite measurements using double blind coding procedures
0.29722524.9461617.html.plaintext.txt	36	preparation rabbit vldl described 27 except protease inhibitors omitted rabbit vldl stored 4 degrees c nitrogen used within 2 weeks isolation hdl3 1125 gml 1225 gml isolated standard ultracentrifugation techniques 28 lipidation state apoe secreted neuro 2a cells determined ultracentrifugation using kbr density adjustment conditioned medium 4 ml adjusted 120 gml underlaid 4 ml 134 gml overlaid 4 ml 1 10 gml gradients centrifuged 38000 rpm sw41 rotor 48 h 18 degrees c fractions collected top tube density measured weight apoe content determined elisa secreted apoe delipidated diethyl etherethanol described 29
0.29722524.9461617.html.plaintext.txt	37	preparation rabbit vldl described 27 except protease inhibitors omitted rabbit vldl stored 4 degrees c nitrogen used within 2 weeks isolation hdl3 1125 gml 1225 gml isolated standard ultracentrifugation techniques 28 lipidation state apoe secreted neuro 2a cells determined ultracentrifugation using kbr density adjustment conditioned medium 4 ml adjusted 120 gml underlaid 4 ml 134 gml overlaid 4 ml 1 10 gml gradients centrifuged 38000 rpm sw41 rotor 48 h 18 degrees c fractions collected top tube density measured weight apoe content determined elisa secreted apoe delipidated diethyl etherethanol described 29
0.29722524.9461617.html.plaintext.txt	38	protein measured igg standard 30 statistical significance determined students test
0.29722524.9461617.html.plaintext.txt	39	protein measured igg standard 30 statistical significance determined students test
0.29722524.9461617.html.plaintext.txt	40	results top abstract introduction procedures results discussion references
0.29722524.9461617.html.plaintext.txt	41	high capacity expression vectors stable expression human apoe constructed incorporating alpha mosaic virus translational enhancer apoe 5 untranslated region within pcdna3 vector expression driven strong cytomegalovirus promoterenhancer invitrogen multiple cell lines apoe isoform isolated characterized apoe production northern blot fig 1 shows similar levels apoe3 apoe4 mrnas representative cell lines expressing transfected apoe cdna whereas apoe mrna detected parental cell line conditioned media cell lines analyzed western blotting using affinity purified apoe polyclonal antibody shown fig 2 parent neuro 2a cell line completely devoid apoe immunoreactivity whereas apoe3 apoe4 cell lines showed expected 36 kda apoe band quantification apoe accumulation conditioned medium showed high levels expression apoe3 apoe4 cell lines table values approximately 100 fold greater previously reported apoe expressing neuro 2a cell lines 22
0.29722524.9461617.html.plaintext.txt	42	high capacity expression vectors stable expression human apoe constructed incorporating alpha mosaic virus translational enhancer apoe 5 untranslated region within pcdna3 vector expression driven strong cytomegalovirus promoterenhancer invitrogen multiple cell lines apoe isoform isolated characterized apoe production northern blot fig 1 shows similar levels apoe3 apoe4 mrnas representative cell lines expressing transfected apoe cdna whereas apoe mrna detected parental cell line conditioned media cell lines analyzed western blotting using affinity purified apoe polyclonal antibody shown fig 2 parent neuro 2a cell line completely devoid apoe immunoreactivity whereas apoe3 apoe4 cell lines showed expected 36 kda apoe band quantification apoe accumulation conditioned medium showed high levels expression apoe3 apoe4 cell lines table values approximately 100 fold greater previously reported apoe expressing neuro 2a cell lines 22
0.29722524.9461617.html.plaintext.txt	43	view larger version 40k fig 1 northern blotting apoe mrna stably transfected cell lines total rna 25 microglane prepared parental neuro 2a line apoe3 expressing apoe4 expressing neuro 2a cell lines denatured separated electrophoresis 12 agarose gel transfer nylon membrane rna visualized ethidium bromide staining verify equal amounts intact rna present membrane probed 32p random primed apoe fragment nucleotides 209 653 hybridization visualized molecular dynamics phosphorimager b
0.29722524.9461617.html.plaintext.txt	44	view larger version 55k fig 2 western blotting apoe secreted stably transfected cell lines conditioned media 100 microg protein separated sds 10 polyacrylamide gel electrophoresis electroblotted nitrocellulose membrane membrane probed affinity purified polyclonal goat anti human apoe antibody incubation horseradish peroxidase conjugated anti goat igg bands visualized enhanced chemiluminescence slight difference mobility apoe3 apoe4 bands due curvature running front seen experiments
0.29722524.9461617.html.plaintext.txt	45	view table table apolipoprotein e secretion apoe concentration measured two clones expressing apoe isoform parental neuro 2a cells cell line plated 20 x 104 cells per 60 mm dish medium incubated 37 degrees c 2 h plates washed basal medium 4 ml medium b basal n2 supplements added plates incubated 37 degrees c 48 h triplicate plates cell line analyzed apoe accumulation medium elisa total cell protein determined 48 h triplicate plates cell line also allowed continue another 48 h fresh medium b prior measurements apoe total cell protein apoe values means plus minus standard deviation neurite extensions measured cell line described legend fig 5 nd none detected
0.29722524.9461617.html.plaintext.txt	46	view table table apolipoprotein e secretion apoe concentration measured two clones expressing apoe isoform parental neuro 2a cells cell line plated 20 x 104 cells per 60 mm dish medium incubated 37 degrees c 2 h plates washed basal medium 4 ml medium b basal n2 supplements added plates incubated 37 degrees c 48 h triplicate plates cell line analyzed apoe accumulation medium elisa total cell protein determined 48 h triplicate plates cell line also allowed continue another 48 h fresh medium b prior measurements apoe total cell protein apoe values means plus minus standard deviation neurite extensions measured cell line described legend fig 5 nd none detected
0.29722524.9461617.html.plaintext.txt	47	immunocytochemical localization neuro 2a associated apoe showed punctate staining pattern throughout entire cell exception nucleus devoid staining fig 3 c d apoe staining particularly concentrated within growth cones extending neurites apoe3 apoe4 expressing cells analyses indicated detectable apoe expression parental cell line importantly similar levels apoe expression apoe3 apoe4 cell lines
0.29722524.9461617.html.plaintext.txt	48	view larger version 64k fig 3 immunocytochemical detection apoe stably transfected cell lines neuro 2a parental cells b neuro 2a apoe3 secreting cells c neuro 2a apoe4 secreting cells d grown glass coverslips apoe localization detected affinity purified polyclonal goat anti human apoe antibody rhodamine conjugated secondary antibody c d white arrows highlight concentrated localization apoe growth cone domains apoe isoform expressing neuro 2a cells b transmitted light image parental neuro 2a cells found black arrows highlight 2 neuro 2a cells images collected confocal microscopy 40 x oil immersion lens
0.29722524.9461617.html.plaintext.txt	49	cell lines analyzed neurite extension assay fig 4a shows representative confocal images three cell lines conclusion 96 h assay absence vldl strikingly cells secreting apoe3 substantially longer neurite extensions either apoe4 control cells quantify differences multiple images saved three independent experiments analyzed neurite length fig 5a demonstrates apoe3 secreting cell line significantly longer neurites 214 p 00001 versus control either control set 100 apoe4 secreting cells 114 absence vldl data analyzed ascertain whether observed mean differences indicative uniform behavior within cell population due minor subpopulation cells dramatically longer neurites fig 5b illustrates distribution neurite lengths shifted throughout cell population apoe3 secreting cells whereas apoe4 secreting cells nearly indistinguishable control cells
0.29722524.9461617.html.plaintext.txt	50	view larger version 91k fig 4 cell derived apoe isoform effects neurite outgrowth absence presence vldl cells grown 96 h n2 supplemented basal medium alone presence vldl 40 microg cholesterolml b cells fixed permeabilized nonspecifically stained acridine orange conclusion 96 h assay confocal images captured using 20 x objective filter group specific rhodamine fluorescence figure shows negative images transformed image tool program
0.29722524.9461617.html.plaintext.txt	51	view larger version 17k fig 5 quantification cell derived apoe isoform effects neurite outgrowth absence presence vldl cells grown 96 h n2 supplemented basal medium alone presence vldl 40 microg cholesterolml cells fixed permeabilized nonspecifically stained acridine orange multiple confocal images treatment three cell lines captured using 20 x objective analyzed image tool program neurite extensions determined measuring longest neurite outgrowth 60 90 responsive cells cells containing neurite least 1 cell diameter length shows average neurite extensions three independent experiments absence presence vldl error bars indicate standard error level significance differences calculated apoe3 secreting cells compared control neuro 2a cells absence vldl p 00001 apoe3 secreting cells absence vldl compared apoe3 secreting cells presence vldl p 00005 data analyzed determine percentage total cells n expressing neurites defined lengths absence vldl b presence vldl c error bars b c indicate standard deviation error bars shown within area symbol
0.29722524.9461617.html.plaintext.txt	52	apoe concentration medium 48 96 h extension assay measured two clonal lines expressing apoe isoform table shows variation secreted apoe yet neurite extension results clones consistent isoform specific modulation relatively unaffected small differences secreted apoe example 1c 1e4c clones showed identical apoe concentrations 48 h 1e4c apoe concentration differed 1c concentration 20 96 h nevertheless apoe3 expressing 1c clone showed stimulation neurite outgrowth p 00001 whereas apoe4 expressing 1e4c clone data indicate cell derived apoe3 stimulated neurite outgrowth absence vldl whereas identical conditions apoe4 neutral
0.29722524.9461617.html.plaintext.txt	53	apoe concentration medium 48 96 h extension assay measured two clonal lines expressing apoe isoform table shows variation secreted apoe yet neurite extension results clones consistent isoform specific modulation relatively unaffected small differences secreted apoe example 1c 1e4c clones showed identical apoe concentrations 48 h 1e4c apoe concentration differed 1c concentration 20 96 h nevertheless apoe3 expressing 1c clone showed stimulation neurite outgrowth p 00001 whereas apoe4 expressing 1e4c clone data indicate cell derived apoe3 stimulated neurite outgrowth absence vldl whereas identical conditions apoe4 neutral
0.29722524.9461617.html.plaintext.txt	54	fig 4b shows images cell lines 96 h exposure vldl surprisingly addition vldl extension assays reduced apoe3 neurite extensions compared apoe3 extensions absence vldl shown fig 5a vldl reduced neurite outgrowth apoe3 expressing cells 214 control 128 control p 00005 whereas vldl significant effect p 005 neurite outgrowth control neruo 2a apoe4 expressing cell lines shown fig 5c vldl appeared normalize neurite length distribution three cell lines thus vldl inhibited neurite outgrowth apoe3 expressing cells p 00005 effect control apoe4 expressing cells p 005
0.29722524.9461617.html.plaintext.txt	55	important question results whether effect apoe3 neurite outgrowth reflected extracellular action secreted protein alternative possibilities effect due intracellular apoe indirect result high level apolipoprotein secretion might perturb lipid homeostasis within cell test possibilities isolated secreted apoe3 conditioned medium affinity chromatography monoclonal antibody 1e series five trans addition experiments performed isolated apoe3 30 microgml incubated parental neuro 2a cells 48 h extension assay fig 6a illustrates immunopurified apoe3 maintained ability stimulate significant increase average neurite length 154 control p 00002 furthermore population distribution neurite lengths cells treated purified apoe3 closely resembled distribution seen transfected apoe3 cell line absence vldl fig 6b
0.29722524.9461617.html.plaintext.txt	56	important question results whether effect apoe3 neurite outgrowth reflected extracellular action secreted protein alternative possibilities effect due intracellular apoe indirect result high level apolipoprotein secretion might perturb lipid homeostasis within cell test possibilities isolated secreted apoe3 conditioned medium affinity chromatography monoclonal antibody 1e series five trans addition experiments performed isolated apoe3 30 microgml incubated parental neuro 2a cells 48 h extension assay fig 6a illustrates immunopurified apoe3 maintained ability stimulate significant increase average neurite length 154 control p 00002 furthermore population distribution neurite lengths cells treated purified apoe3 closely resembled distribution seen transfected apoe3 cell line absence vldl fig 6b
0.29722524.9461617.html.plaintext.txt	57	view larger version 16k fig 6 effect immunopurified apoe3 neurite outgrowth neuro 2a cells neuro 2a cells incubated n2 supplemented basal medium alone presence 30 microgml cell derived apoe3 48 h cells fixed permeabilized nonspecifically stained acridine orange multiple confocal images either treatment captured using 20 x objective analyzed image tool program average neurite extensions determined measuring longest neurite 30 80 responsive cells five independent experiments error bars indicate standard error level significance difference p 00002 data analyzed determine percentage neuro 2a cells n expressing neurites defined lengths b error bars indicate standard deviation
0.29722524.9461617.html.plaintext.txt	58	previous studies shown apoe secreted non hepatic cells poorly lipidated 31 32 therefore lipidation state apoe secreted neuro 2a cells determined density gradient ultracentrifugation secreted apoe isoforms floated density 119 126 gml indicating poorly lipidated particle fig 7 b none secreted apoe density typical apoe containing plasma hdl fig 7c secreted apoe shifted higher density upon delipidation fig 7d results indicate physiologically relevant lipid poor form secreted apoe3 enhanced neurite outgrowth
0.29722524.9461617.html.plaintext.txt	59	previous studies shown apoe secreted non hepatic cells poorly lipidated 31 32 therefore lipidation state apoe secreted neuro 2a cells determined density gradient ultracentrifugation secreted apoe isoforms floated density 119 126 gml indicating poorly lipidated particle fig 7 b none secreted apoe density typical apoe containing plasma hdl fig 7c secreted apoe shifted higher density upon delipidation fig 7d results indicate physiologically relevant lipid poor form secreted apoe3 enhanced neurite outgrowth
0.29722524.9461617.html.plaintext.txt	60	view larger version 25k fig 7 density distribution neuro 2a derived apoe cell derived apoe isoforms analyzed density distribution density gradient ultracentrifugation conditioned media apoe3 apoe4 expressing neuro 2a cells centrifuged kbr density gradients 48 h fractions taken top tube fractions assayed elisa apoe content densities determined weight graphs show percent total apoe3 apoe4 b apoe hdl3 c delipidated apoe3 comparison apoe3 conditioned medium d per fraction
0.29722524.9461617.html.plaintext.txt	61	discussion top abstract introduction procedures results discussion references
0.29722524.9461617.html.plaintext.txt	62	produced high expressing apoe3 apoe4 neuro 2a cell lines test whether cell derived apoe could exhibit isoform specific stimulation neurite outgrowth absence exogenous lipid source apoe3 stimulated neurite outgrowth absence vldl exogenous lipid sources furthermore cell derived lipidated apoe3 isolated immunoaffinity chromatography active promoting neurite outgrowth parental neuro 2a cells nathan et al 14 discovered co addition purified delipidated apoe vldl neuro 2a cells elicits isoform specific differences neurite outgrowth effects also seen cell lines primary neuronal cultures 20 23 33 interestingly isoform specific effects could duplicated apoe addition alone similarly neuro 2a cell lines express low amounts apoe isoforms also required vldl elicit effects neurite outgrowth 22 unclear studies whether apoe3 stimulates neurite outgrowth independently concert exogenous lipid whether active form apoe formed combined exogenous lipid source results indicated biological activity apoe3 stimulating neurite outgrowths inherent cell derived lipidated particle dependent either interaction apoe3 artificial lipid source b independent actions apoe3 vldl neuro 2a cells
0.29722524.9461617.html.plaintext.txt	63	produced high expressing apoe3 apoe4 neuro 2a cell lines test whether cell derived apoe could exhibit isoform specific stimulation neurite outgrowth absence exogenous lipid source apoe3 stimulated neurite outgrowth absence vldl exogenous lipid sources furthermore cell derived lipidated apoe3 isolated immunoaffinity chromatography active promoting neurite outgrowth parental neuro 2a cells nathan et al 14 discovered co addition purified delipidated apoe vldl neuro 2a cells elicits isoform specific differences neurite outgrowth effects also seen cell lines primary neuronal cultures 20 23 33 interestingly isoform specific effects could duplicated apoe addition alone similarly neuro 2a cell lines express low amounts apoe isoforms also required vldl elicit effects neurite outgrowth 22 unclear studies whether apoe3 stimulates neurite outgrowth independently concert exogenous lipid whether active form apoe formed combined exogenous lipid source results indicated biological activity apoe3 stimulating neurite outgrowths inherent cell derived lipidated particle dependent either interaction apoe3 artificial lipid source b independent actions apoe3 vldl neuro 2a cells
0.29722524.9461617.html.plaintext.txt	64	demonstrated cell derived apoe4 neutral challenged neurite extension assay absence vldl although studies implicated apoe4 inhibitory neurite outgrowth presence artificial lipid source 14 22 studies support conclusion apoe4 neutral holtzman et al 21 showed apoe3 enhancement neurite outgrowth neuronal cell line gt1 1 trk9 presence vldl nerve growth factor significant difference apoe4 treated cells controls conditions experiments gt1 1 trk9 cells give similar results hdl sized particles human csf substituted vldl 23 studies puttfarcken et al 34 showed bulk conditioned medium hek 293 cells stably expressing either apoe3 apoe4 isoforms moderately stimulatory primary hippocampal cultures experiments 21 34 well present results argue apoe4 isoform devoid neurite stimulating activity inhibitory presented cells alone combination exogenous lipids cell derived lipidated particle
0.29722524.9461617.html.plaintext.txt	65	demonstrated cell derived apoe4 neutral challenged neurite extension assay absence vldl although studies implicated apoe4 inhibitory neurite outgrowth presence artificial lipid source 14 22 studies support conclusion apoe4 neutral holtzman et al 21 showed apoe3 enhancement neurite outgrowth neuronal cell line gt1 1 trk9 presence vldl nerve growth factor significant difference apoe4 treated cells controls conditions experiments gt1 1 trk9 cells give similar results hdl sized particles human csf substituted vldl 23 studies puttfarcken et al 34 showed bulk conditioned medium hek 293 cells stably expressing either apoe3 apoe4 isoforms moderately stimulatory primary hippocampal cultures experiments 21 34 well present results argue apoe4 isoform devoid neurite stimulating activity inhibitory presented cells alone combination exogenous lipids cell derived lipidated particle
0.29722524.9461617.html.plaintext.txt	66	present neurite extension assay vldl antagonized stimulatory effect apoe3 effect detected previous studies vldl required effect delipidated apoe 14 20 23 33 may experiments delipidated apoe vldl acts lipid source facilitate formation active apoe particle time antagonizes action lipidated apoe case level apoe3 stimulated neurite outgrowth would depend balance two factors furthermore unlikely antagonism observed present study nonspecific cytotoxic effect vldl alone modestly stimulated neurite outgrowth 111 effect also observed others 14 20 22 antagonism vldl may reflect sequestration secreted apoe competition cellular receptor site
0.29722524.9461617.html.plaintext.txt	67	present neurite extension assay vldl antagonized stimulatory effect apoe3 effect detected previous studies vldl required effect delipidated apoe 14 20 23 33 may experiments delipidated apoe vldl acts lipid source facilitate formation active apoe particle time antagonizes action lipidated apoe case level apoe3 stimulated neurite outgrowth would depend balance two factors furthermore unlikely antagonism observed present study nonspecific cytotoxic effect vldl alone modestly stimulated neurite outgrowth 111 effect also observed others 14 20 22 antagonism vldl may reflect sequestration secreted apoe competition cellular receptor site
0.29722524.9461617.html.plaintext.txt	68	cell derived apoe occurred poorly lipidated particle density 119 126 gml minimally lipidated form apoe biologically active absence exogenous lipid source unlikely neurite outgrowth stimulation reflects action apoe simply deliver lipid cell membrane formation speculate apoe acted extracellularly direct neurite extension paracrine factor stimulate neurite growth
0.29722524.9461617.html.plaintext.txt	69	lipidated apoe3 particle stimulate neurite outgrowth although apoe4 remains neutral ldl receptor ldl receptor related protein lrp bind apoe containing lipoproteins expressed neuronal cells 35 37 evidence several studies implicate lrp apoe isoform specific stimulation neurite outgrowth 21 22 38 particular inhibition apoe3 effect neurite outgrowth anti lrp antibodies provides strong evidence involvement lrp however binding studies lrp show isoform specific differences apoe3 apoe4 27 discrepancy may resolved recent reports apoe receptors new apoe receptor described localizes neurons high homology ldl receptor 39 additional brain specific receptors high homology lrp 40 ldl receptor 41 also identified present findings cell derived form apoe3 active stimulating neurite outgrowth permit physical characterization particles analysis isoform specific interactions recently described neuronal receptors
0.29722524.9461617.html.plaintext.txt	70	lipidated apoe3 particle stimulate neurite outgrowth although apoe4 remains neutral ldl receptor ldl receptor related protein lrp bind apoe containing lipoproteins expressed neuronal cells 35 37 evidence several studies implicate lrp apoe isoform specific stimulation neurite outgrowth 21 22 38 particular inhibition apoe3 effect neurite outgrowth anti lrp antibodies provides strong evidence involvement lrp however binding studies lrp show isoform specific differences apoe3 apoe4 27 discrepancy may resolved recent reports apoe receptors new apoe receptor described localizes neurons high homology ldl receptor 39 additional brain specific receptors high homology lrp 40 ldl receptor 41 also identified present findings cell derived form apoe3 active stimulating neurite outgrowth permit physical characterization particles analysis isoform specific interactions recently described neuronal receptors
0.29722524.9461617.html.plaintext.txt	71	thank miguel berrios william theurkauf advice confocal microscopy david colflesh katherine richards anna demian technical assistance
0.29722524.9461617.html.plaintext.txt	72	work supported grants hl 32868 hl 35297 nhlbi national institutes healththe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29722524.9461617.html.plaintext.txt	73	work supported grants hl 32868 hl 35297 nhlbi national institutes healththe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.29722524.9461617.html.plaintext.txt	74	correspondence addressed dept pharmacological sciences university medical center state university new york stony brook ny 11794 tel 516 444 3083 fax 516 444 3218 e mail daveatpharmsomsunysbedu u d
0.29722524.9461617.html.plaintext.txt	75	correspondence addressed dept pharmacological sciences university medical center state university new york stony brook ny 11794 tel 516 444 3083 fax 516 444 3218 e mail daveatpharmsomsunysbedu u d
0.29722524.9461617.html.plaintext.txt	76	1 abbreviations used apoe apolipoprotein e vldl low density lipoprotein ldl low density lipoprotein hdl high density lipoprotein csf cerebrospinal fluid pbs phosphate buffered saline tbs tris buffered saline elisa enzyme linked immunosorbent assay lrp ldl receptor related protein fbs fetal bovine serum pcr polymerase chain reaction
0.29722524.9461617.html.plaintext.txt	77	2 available internet anonymous ftp ftpmaxrad6uthscsaedu
0.29722524.9461617.html.plaintext.txt	78	references top abstract introduction procedures results discussion references weisgraber k h 1994 adv protein chem 45 249 302medline order article via infotrieve blue m l williams d l zucker khan blum c b 1983 proc natl acad sci u 80 283 287abstract williams d l dawson p newman c rudel l l 1985 j biol chem 260 2444 2451abstract newman c dawson p rudel l l williams d l 1985 j biol chem 260 2452 2457abstract roheim p carey m forte vega g l 1979 proc natl acad sci u 76 4646 4649abstract carlsson j armstrong v w reiber h felgenhauer k seidel d 1991 clin chim acta 196 167 176medline order article via infotrieve pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text boyles j k notterpek l m anderson l j 1990 j biol chem 265 17805 17815abstractfree full text snipes g j mcguire c b norden j j freeman j 1986 proc natl acad sci u 83 1130 1134abstract boyles j k pitas r e wilson e mahley r w taylor j m 1985 j clin invest 76 1501 1513medline order article via infotrieve pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917 148 161medline order article via infotrieve ignatius m j gebickle harter p j skene j h p schilling j w weisgraber k h mahley r w shooter e m 1986 proc natl acad sci u 83 1125 1129abstract dawson p schechter n williams d l 1986 j biol chem 261 5681 5684abstractfree full text nathan b p chang k c bellosta brisch e ge n mahley r w pitas r e 1995 j biol chem 270 19791 19799abstractfree full text strittmatter w j saunders m schmechel d pericak vance m enghild j salvessen g roses d 1993 proc natl acad sci u 90 1977 1981abstract goedert m strittmatter w roses 1994 nature 372 45 46medline order article via infotrieve strittmatter w weisgraber k goedert m saunders huang d corder e dong l m jakes r alberts m gilbert j han h hulette c einstein g schmechel d pericak vance m roses 1994 exp neurol 125 163 171crossrefmedline order article via infotrieve schmechel d e saunders m strittmatter w j crain b j hulette c m joo h pericak vance m goldgaber d roses d 1993 proc natl acad sci u 90 9649 9653abstract strittmatter w saunders goedert m weisgraber k dong l m jakes r huang d pericak vance m schmechel d roses 1994 proc natl acad sci u 91 11183 11186abstractfree full text nathan b p bellosta sanan d weisgraber k h mahley r w pitas r e 1994 science 264 850 852medline order article via infotrieve holtzman d m pitas r e kilbridge j nathan b mahley r w bu g scwartz l 1995 proc natl acad sci u 92 9480 9484abstract bellosta nathan b p orth m dong l m mahley r w pitas r e 1995 j biol chem 270 27063 27071abstractfree full text fagan m bu g sun y daugherty holtzman d m 1996 j biol chem 271 30121 30125abstractfree full text andersson davis d l dahlback h jornvall h russell d w 1989 j biol chem 264 8222 8229abstractfree full text reyland m e gwynne j forgez p prack m m williams d l 1991 proc natl acad sci u 88 2375 2379abstract chen c okayama h 1987 mol cell biol 7 2745 2752medline order article via infotrieve kowal r c herz j weisgraber k h mahley r w brown m goldstein j l 1990 j biol chem 265 10771 10779abstractfree full text havel r j eder h bragdon j h 1955 j clin invest 34 1345 1353medline order article via infotrieve shore v shore b 1967 biochemistry 6 1962 1969medline order article via infotrieve lowry o h rosebrough n j farr l randall r j 1951 j biol chem 193 265 275free full text basu k brown m ho y k havel r j goldstein j l 1981 proc natl acad sci u 78 7545 7549abstract herscivutzm h gantz d tercyak m zannis v small d m 1992 j lipid res 33 791 803abstract huang d y weisgraber k h strittmatter w j matthew w d 1995 exp neurol 136 251 257crossrefmedline order article via infotrieve puttfarcken p manelli m falduto m getz g ladu m j 1997 j neurochem 68 760 769medline order article via infotrieve handelmann g e boyles j k weisgraber k h mahley r w pitas r e 1992 j lipid res 33 1677 1688abstract zheng g bachinsky d r stamenkovic strickland d k brown d andres g mccluskey r 1994 j histochem cytochem 42 531 542abstractfree full text moestrup k gliemann j pallesen g 1992 cell tissue res 269 375 382medline order article via infotrieve narita m bu g holtzman d m schwartz l 1997 j neurochem 68 587 595medline order article via infotrieve kim d h iijima h goto k sakai j ishii h kim h j suzuki h kondo h saeki yamamoto 1996 j biol chem 271 8373 8380abstractfree full text jacobsen l madsen p moestrup k lund h tommerup n nykjaer sottrup jensen l gliemann j petersen c m 1996 j biol chem 271 31379 31383abstractfree full text novak hiesberger schneider w j nimpf j 1996 j biol chem 271 11732 11736abstractfree full text
0.29722524.9461617.html.plaintext.txt	79	copyright 1998 american society biochemistry molecular biology inc
0.30754375.9787187.html.plaintext.txt	0	apolipoprotein e 4 allele genetic risk factor left ventricular failure homozygous thalassemia
0.30754375.9787187.html.plaintext.txt	1	effrosini economou petersen athanassios aessopos athina kladi panagiota flevari fotis karabatsos christina fragodimitri peter nicolaidis helen vrettou dimitris vassilopoulos markissia karagiorga lagana dimitrios th kremastinos michael b petersen
0.30754375.9787187.html.plaintext.txt	2	hellenic red cross hospital athens eginition university hospital athens laiko university hospital athens onassis cardiac surgery center piraeus aghia sophia childrens hospital athens mitera maternity hospital athens institute child health athens greece
0.30754375.9787187.html.plaintext.txt	3	abstract abstract introduction methods results discussion references
0.30754375.9787187.html.plaintext.txt	4	homozygous thalassemia organ damage mainly attributed excessive iron deposition formation oxygen free radicals despite appropriate transfusion chelation therapy low ferritin levels patients still develop organ failure heart failure main cause death study designed determine whether decreased antioxidant activity apolipoprotein e apoe 4 allele could represent genetic risk factor development left ventricular failure lvf thalassemia homozygotes total 251 greek thalassemia homozygotes studied patients divided three groups group n 151 cardiac impairment group c n 47 lvf 53 patients lv dilatation normal lv systolic function constituted group b dna obtained patients polymerase chain reaction used analyze polymorphism apoe locus apoe allele frequencies compared greek control sample 216 healthy blood donors patients cardiac impairment apoe 4 allele frequency 79 different population controls 65 p 05 patients lvf significantly higher frequency apoe 4 128 controls p 05 odds ratio 211 95 confidence interval 103 432 apoe 4 allele may represent important genetic risk factor development organ damage homozygous thalassemia
0.30754375.9787187.html.plaintext.txt	5	homozygous thalassemia organ damage mainly attributed excessive iron deposition formation oxygen free radicals despite appropriate transfusion chelation therapy low ferritin levels patients still develop organ failure heart failure main cause death study designed determine whether decreased antioxidant activity apolipoprotein e apoe 4 allele could represent genetic risk factor development left ventricular failure lvf thalassemia homozygotes total 251 greek thalassemia homozygotes studied patients divided three groups group n 151 cardiac impairment group c n 47 lvf 53 patients lv dilatation normal lv systolic function constituted group b dna obtained patients polymerase chain reaction used analyze polymorphism apoe locus apoe allele frequencies compared greek control sample 216 healthy blood donors patients cardiac impairment apoe 4 allele frequency 79 different population controls 65 p 05 patients lvf significantly higher frequency apoe 4 128 controls p 05 odds ratio 211 95 confidence interval 103 432 apoe 4 allele may represent important genetic risk factor development organ damage homozygous thalassemia
0.30754375.9787187.html.plaintext.txt	6	1998 american society hematology
0.30754375.9787187.html.plaintext.txt	7	introduction abstract introduction methods results discussion references
0.30754375.9787187.html.plaintext.txt	8	hemoglobinopathies common monogenic disorders world population first diseases analyzed recombinant dna technology1 3 known molecular pathology genetic disease possible trace almost diverse pathophysiologic features back primary molecular defects single genes4 monogenic disorders phenotypic variability expected due allelic heterogeneity although siblings genotype show big phenotypic differences molecular basis difference clinical expression yet fully understood
0.30754375.9787187.html.plaintext.txt	9	hemoglobinopathies common monogenic disorders world population first diseases analyzed recombinant dna technology1 3 known molecular pathology genetic disease possible trace almost diverse pathophysiologic features back primary molecular defects single genes4 monogenic disorders phenotypic variability expected due allelic heterogeneity although siblings genotype show big phenotypic differences molecular basis difference clinical expression yet fully understood
0.30754375.9787187.html.plaintext.txt	10	homozygous thalassemia characterized severe hemolytic anemia associated chronic tissue damage disease treatment related organ failure premature death
0.30754375.9787187.html.plaintext.txt	11	heart failure remains main cause death traditionally attributed iron overload regular transfusions increased iron intestinal absorption ineffective erythropoiesis life span patients56 last two decades striking improvement life quality life expectancy observed mainly due proper transfusion effective chelation therapy prevent secondary hemosiderosis7
0.30754375.9787187.html.plaintext.txt	12	heart failure remains main cause death traditionally attributed iron overload regular transfusions increased iron intestinal absorption ineffective erythropoiesis life span patients56 last two decades striking improvement life quality life expectancy observed mainly due proper transfusion effective chelation therapy prevent secondary hemosiderosis7
0.30754375.9787187.html.plaintext.txt	13	regular chelation therapy deferoxamine mesylate naturally occurring trihydroxamic acid produced streptomyces pilosus increases urinary fecal iron excretion resulting amelioration cardiac dysfunction89 increased survival7 although many patients benefit therapy others continue organ dysfunction die sometimes despite intensive treatment deferoxamine10 thus hypothesized either deferoxamine therapy effective patients reduced defense mechanisms iron overload present study designed test hypothesis whether postulated genetically determined decreased antioxidant iron binding activity patients homozygous thalassemia could represent independent risk factor development heart failure
0.30754375.9787187.html.plaintext.txt	14	regular chelation therapy deferoxamine mesylate naturally occurring trihydroxamic acid produced streptomyces pilosus increases urinary fecal iron excretion resulting amelioration cardiac dysfunction89 increased survival7 although many patients benefit therapy others continue organ dysfunction die sometimes despite intensive treatment deferoxamine10 thus hypothesized either deferoxamine therapy effective patients reduced defense mechanisms iron overload present study designed test hypothesis whether postulated genetically determined decreased antioxidant iron binding activity patients homozygous thalassemia could represent independent risk factor development heart failure
0.30754375.9787187.html.plaintext.txt	15	apolipoprotein e apoe plasma protein known functions cholesterol transport metabolism alzheimers disease1112 apoe gene located chromosome 19 polymorphism exists apoe locus three common alleles designated 2 3 4 corresponding three isoforms apoe protein13 recently shown apoe physiologic levels isoform specific effects protecting rat neuronal cell line oxidative cell death effects correlated apoes antioxidant activity vitro assays ranked e2 e3 e414 demonstrated metal binding ability including iron apoe postulated one mechanism accounting antioxidant properties14 hypothesized decreased antioxidant activity apoe4 thalassemia homozygotes might genetic risk factor development left ventricular failure lvf tested hypothesis comparing frequency apoe allele 4 thalassemia major patients divided three groups according cardiac status 4 frequency greek control sample
0.30754375.9787187.html.plaintext.txt	16	apolipoprotein e apoe plasma protein known functions cholesterol transport metabolism alzheimers disease1112 apoe gene located chromosome 19 polymorphism exists apoe locus three common alleles designated 2 3 4 corresponding three isoforms apoe protein13 recently shown apoe physiologic levels isoform specific effects protecting rat neuronal cell line oxidative cell death effects correlated apoes antioxidant activity vitro assays ranked e2 e3 e414 demonstrated metal binding ability including iron apoe postulated one mechanism accounting antioxidant properties14 hypothesized decreased antioxidant activity apoe4 thalassemia homozygotes might genetic risk factor development left ventricular failure lvf tested hypothesis comparing frequency apoe allele 4 thalassemia major patients divided three groups according cardiac status 4 frequency greek control sample
0.30754375.9787187.html.plaintext.txt	17	materials methods abstract introduction methods results discussion references subjects subjects 251 thalassemia major patients greek origin 117 men 134 women followed systematically three major thalassemia treatment units athens area belonging public health system transfusion therapy started patients age 5 years patient receiving blood transfusions every 15 25 days maintain hemoglobin level 9 gdl years follow patients receiving chelation therapy subcutaneous deferoxamine therapy initiated patient serum ferritin level reached 2000 ngml evaluate transfusion therapy hemosiderosis level obtained mean pretransfusion hemoglobin level mean serum ferritin level patient last 2 5 years follow respectively serum ferritin measured two times per year patient enzyme linked immunosorbent assay elisa method abbott chicago il values rounded nearest 10
0.30754375.9787187.html.plaintext.txt	18	materials methods abstract introduction methods results discussion references subjects subjects 251 thalassemia major patients greek origin 117 men 134 women followed systematically three major thalassemia treatment units athens area belonging public health system transfusion therapy started patients age 5 years patient receiving blood transfusions every 15 25 days maintain hemoglobin level 9 gdl years follow patients receiving chelation therapy subcutaneous deferoxamine therapy initiated patient serum ferritin level reached 2000 ngml evaluate transfusion therapy hemosiderosis level obtained mean pretransfusion hemoglobin level mean serum ferritin level patient last 2 5 years follow respectively serum ferritin measured two times per year patient enzyme linked immunosorbent assay elisa method abbott chicago il values rounded nearest 10
0.30754375.9787187.html.plaintext.txt	19	clinical laboratory cardiac evaluation included medical history clinical examination electrocardiographic ecg well echocardiographic studies echocardiographic examination performed follows two dimensional m mode echocardiograms obtained using instruments 3 mhz transducer two dimensional study first performed identify overall cardiac anatomy motion long axis parasternal short axis views midventricular level used derive following m mode measurements left ventricular end systolic end diastolic dimensions left atrial right ventricular cavity dimensions thickness interventricular septum posterior left ventricular wall according recommendations american society echocardiography15 four two chamber apical views used estimate ventricular systolic diastolic volumes calculated using discs method16 left ventricular ejection fraction lvef calculated end diastolic volume minus end systolic volume divided end diastolic volume multiplied 100
0.30754375.9787187.html.plaintext.txt	20	clinical laboratory cardiac evaluation included medical history clinical examination electrocardiographic ecg well echocardiographic studies echocardiographic examination performed follows two dimensional m mode echocardiograms obtained using instruments 3 mhz transducer two dimensional study first performed identify overall cardiac anatomy motion long axis parasternal short axis views midventricular level used derive following m mode measurements left ventricular end systolic end diastolic dimensions left atrial right ventricular cavity dimensions thickness interventricular septum posterior left ventricular wall according recommendations american society echocardiography15 four two chamber apical views used estimate ventricular systolic diastolic volumes calculated using discs method16 left ventricular ejection fraction lvef calculated end diastolic volume minus end systolic volume divided end diastolic volume multiplied 100
0.30754375.9787187.html.plaintext.txt	21	patients divided three groups according severity heart disease based clinical evaluation echocardiographic findings group patients symptoms signs heart failure echocardiographic study within normal limits group c patients symptoms signs lvf concomitant echocardiographic findings patients exhibited dyspnea exertion new york heart association nyha functional class iv fulfilled least two major framingham criteria heart failure diagnosis finally patients group b asymptomatic exhibited lv dilatation lv end diastolic diameter index lveddi higher 30 mmm2 without left ventricular systolic dysfunction lv fractional shortening fs higher 28 assessed echocardiographically patients group receive treatment
0.30754375.9787187.html.plaintext.txt	22	patients divided three groups according severity heart disease based clinical evaluation echocardiographic findings group patients symptoms signs heart failure echocardiographic study within normal limits group c patients symptoms signs lvf concomitant echocardiographic findings patients exhibited dyspnea exertion new york heart association nyha functional class iv fulfilled least two major framingham criteria heart failure diagnosis finally patients group b asymptomatic exhibited lv dilatation lv end diastolic diameter index lveddi higher 30 mmm2 without left ventricular systolic dysfunction lv fractional shortening fs higher 28 assessed echocardiographically patients group receive treatment
0.30754375.9787187.html.plaintext.txt	23	another type heart failure thalassemia major associated right ventricular dilatation patients kind excluded study right ventricular failure thalassemia major due different pathophysiologic reasons1718
0.30754375.9787187.html.plaintext.txt	24	another type heart failure thalassemia major associated right ventricular dilatation patients kind excluded study right ventricular failure thalassemia major due different pathophysiologic reasons1718
0.30754375.9787187.html.plaintext.txt	25	apoe genotyping genomic dna extracted edta blood samples salting procedure19 genotyping polymorphic apoe alleles done polymerase chain reaction amplification genomic dna digestion hha restriction enzyme agarose gel electrophoresis described previously2021 control sample data apoe genotype available consisted random sample 216 voluntary healthy greek blood donors22 blood donors 146 men 70 women mean age 356 years range 19 64 years22
0.30754375.9787187.html.plaintext.txt	26	statistical analysis used analysis variance anova multiple groups assess differences regarding echocardiographic measurements three patient groups 2 test compare 4 allele frequency different patient groups population controls
0.30754375.9787187.html.plaintext.txt	27	results abstract introduction methods results discussion references
0.30754375.9787187.html.plaintext.txt	28	251 patients studied 151 belonged group 53 group b 47 group c three cases excluded study presented clinical picture congestive heart failure echocardiographic findings profound right ventricular dilatation good lv function pulmonary hypertension doppler study
0.30754375.9787187.html.plaintext.txt	29	251 patients studied 151 belonged group 53 group b 47 group c three cases excluded study presented clinical picture congestive heart failure echocardiographic findings profound right ventricular dilatation good lv function pulmonary hypertension doppler study
0.30754375.9787187.html.plaintext.txt	30	hematologic hemosiderosis parameters patients shown table 1 statistically significant differences found hemoglobin ferritin levels patient groups
0.30754375.9787187.html.plaintext.txt	31	hematologic hemosiderosis parameters patients shown table 1 statistically significant differences found hemoglobin ferritin levels patient groups
0.30754375.9787187.html.plaintext.txt	32	view table table 1 hematologic characteristics patients thalassemia major stratified cardiac status
0.30754375.9787187.html.plaintext.txt	33	cardiologic characteristics three patient groups depicted table 2 twenty eight patients group c severe cardiac failure nyha class iii iv 19 class ii patients groups b c lv dilatation lveddi higher 30 mmm2 groups b good lv function significant difference fractional shortening ejection fraction group c table 2 47 patients group c receiving treatment angiotensin converting enzyme ace inhibitors diuretics plus minus digitalis 53 patients group b 151 patients group cardiac failure echocardiographically normal lv function
0.30754375.9787187.html.plaintext.txt	34	cardiologic characteristics three patient groups depicted table 2 twenty eight patients group c severe cardiac failure nyha class iii iv 19 class ii patients groups b c lv dilatation lveddi higher 30 mmm2 groups b good lv function significant difference fractional shortening ejection fraction group c table 2 47 patients group c receiving treatment angiotensin converting enzyme ace inhibitors diuretics plus minus digitalis 53 patients group b 151 patients group cardiac failure echocardiographically normal lv function
0.30754375.9787187.html.plaintext.txt	35	view table table 2 clinical echocardiographic characteristics patients thalassemia major
0.30754375.9787187.html.plaintext.txt	36	table 3 gives apoe allele frequencies three patient groups well controls apoe 3 allele highest frequency three patient groups 2 allele frequency 56 patient group 64 group c show statistical difference control group apoe 4 allele frequency thalassemia homozygotes without cardiac impairment 79 different frequency population controls 65 2 058 p 05 4 frequency patients heart failure 128 significantly higher controls 2 434 p 05 odds ratio 211 95 confidence interval 103 432 4 frequency group b patients 123 2 404 p 05 taking patient groups b c together 4 frequency 125 significantly higher controls 2 645 p 02 thalassemia homozygotes irrespective cardiac diagnosis 4 frequency 98 different population healthy blood donors 2 330 p 05 four patients homozygous 4 allele three belonged group c one group b
0.30754375.9787187.html.plaintext.txt	37	table 3 gives apoe allele frequencies three patient groups well controls apoe 3 allele highest frequency three patient groups 2 allele frequency 56 patient group 64 group c show statistical difference control group apoe 4 allele frequency thalassemia homozygotes without cardiac impairment 79 different frequency population controls 65 2 058 p 05 4 frequency patients heart failure 128 significantly higher controls 2 434 p 05 odds ratio 211 95 confidence interval 103 432 4 frequency group b patients 123 2 404 p 05 taking patient groups b c together 4 frequency 125 significantly higher controls 2 645 p 02 thalassemia homozygotes irrespective cardiac diagnosis 4 frequency 98 different population healthy blood donors 2 330 p 05 four patients homozygous 4 allele three belonged group c one group b
0.30754375.9787187.html.plaintext.txt	38	view table table 3 apoe allele frequencies patients thalassemia major controls stratified cardiac status
0.30754375.9787187.html.plaintext.txt	39	discussion abstract introduction methods results discussion references
0.30754375.9787187.html.plaintext.txt	40	severity iron toxicity thalassemia major seems related magnitude body iron burden2324 exact mechanism iron overload toxicity uncertain many years via iron driven fenton haber weiss reactions nontransferrin plasma iron bivalent trivalent form high toxicity formation hydroxyl radicals oh25 leads peroxidative damage membrane lipids proteins imbalance production oxygen free radicals antioxidant defense mechanisms result oxidative stress human disease26 heart imbalance free radicals antioxidant mechanisms manifested impaired function mitochondrial inner membrane respiratory chain resulting abnormal energy metabolism expressed clinically fatal cardiomyopathy apart iron overload recently shown group myocarditis appears involved pathogenesis lvf certain number patients homozygous thalassemia27 shown animal models oxygen free radicals may also contribute pathogenesis infectious myocarditis2829
0.30754375.9787187.html.plaintext.txt	41	severity iron toxicity thalassemia major seems related magnitude body iron burden2324 exact mechanism iron overload toxicity uncertain many years via iron driven fenton haber weiss reactions nontransferrin plasma iron bivalent trivalent form high toxicity formation hydroxyl radicals oh25 leads peroxidative damage membrane lipids proteins imbalance production oxygen free radicals antioxidant defense mechanisms result oxidative stress human disease26 heart imbalance free radicals antioxidant mechanisms manifested impaired function mitochondrial inner membrane respiratory chain resulting abnormal energy metabolism expressed clinically fatal cardiomyopathy apart iron overload recently shown group myocarditis appears involved pathogenesis lvf certain number patients homozygous thalassemia27 shown animal models oxygen free radicals may also contribute pathogenesis infectious myocarditis2829
0.30754375.9787187.html.plaintext.txt	42	present study categorized patients three groups according severity heart disease normal cases group severely affected cases group c clear clinical echocardiographic characteristics easily distinguished patients group b characterized lv dilatation good lv function cases lv left atrial la dilatation could possibly represent first step lv dysfunction without overt lv decreased contractility compensatory mechanism due anemia patients eventually develop lvf
0.30754375.9787187.html.plaintext.txt	43	present study categorized patients three groups according severity heart disease normal cases group severely affected cases group c clear clinical echocardiographic characteristics easily distinguished patients group b characterized lv dilatation good lv function cases lv left atrial la dilatation could possibly represent first step lv dysfunction without overt lv decreased contractility compensatory mechanism due anemia patients eventually develop lvf
0.30754375.9787187.html.plaintext.txt	44	results functional polymorphism apoe locus study suggest 4 allele may genetic risk factor development lvf organ damage homozygous thalassemia represents first demonstration genetic factor unlinked globin gene cluster contributing clinical manifestations disease 4 allele could represent predictive marker development lvf patients thalassemia major lv dilatation patient group b suggesting closer follow patients apoe 4 frequency found 128 patients homozygous thalassemia lvf obvious genetic environmental factors instance number transfusions iron overload chelation therapy viral myocardial inflammation play role development organ damage fact patients groups b c shown table 1 either higher ferritin levels transfused inadequately without cardiac impairment supports role apoe 4 allele genetic risk factor lvf development furthermore patients group 4 allele could still develop lvf additional evidence relationship 4 allele heart disease comes analysis patients homozygous 4 allele three lvf one lv dilatation numbers category small increase 4 allele frequency among patients cardiac disease comes reduction 3 rather 2 allele frequency 2 allele frequency already low greek population22 factors may influence level allele
0.30754375.9787187.html.plaintext.txt	45	results functional polymorphism apoe locus study suggest 4 allele may genetic risk factor development lvf organ damage homozygous thalassemia represents first demonstration genetic factor unlinked globin gene cluster contributing clinical manifestations disease 4 allele could represent predictive marker development lvf patients thalassemia major lv dilatation patient group b suggesting closer follow patients apoe 4 frequency found 128 patients homozygous thalassemia lvf obvious genetic environmental factors instance number transfusions iron overload chelation therapy viral myocardial inflammation play role development organ damage fact patients groups b c shown table 1 either higher ferritin levels transfused inadequately without cardiac impairment supports role apoe 4 allele genetic risk factor lvf development furthermore patients group 4 allele could still develop lvf additional evidence relationship 4 allele heart disease comes analysis patients homozygous 4 allele three lvf one lv dilatation numbers category small increase 4 allele frequency among patients cardiac disease comes reduction 3 rather 2 allele frequency 2 allele frequency already low greek population22 factors may influence level allele
0.30754375.9787187.html.plaintext.txt	46	apoe 4 allele found patients advanced age cardiac impairment presence 4 allele guarantee development lvf thalassemia addition 85 patients lvf carry 4 allele neither necessary prerequisite development lvf equivalent association apoe 4 alzheimers disease association confirmed almost 100 studies around world30 consensus statement apoe genotyping alzheimers disease concluded apoe genotyping used adjunct diagnostic tests prospective investigations dementia function apoe genotype needed31 something similar might apply thalassemia
0.30754375.9787187.html.plaintext.txt	47	apoe 4 allele found patients advanced age cardiac impairment presence 4 allele guarantee development lvf thalassemia addition 85 patients lvf carry 4 allele neither necessary prerequisite development lvf equivalent association apoe 4 alzheimers disease association confirmed almost 100 studies around world30 consensus statement apoe genotyping alzheimers disease concluded apoe genotyping used adjunct diagnostic tests prospective investigations dementia function apoe genotype needed31 something similar might apply thalassemia
0.30754375.9787187.html.plaintext.txt	48	allelic variation apoe locus studied many populations significant differences observed caucasian chinese japanese black races also among caucasian populations significant variation allele frequencies32 average allele frequencies caucasians show 4 allele frequency 150 low 4 frequency greek population22 agreement gradient found frequency allele europe supported similar low frequency 70 greek cypriots33 finding association apoe 4 allele lvf greek thalassemia homozygotes needs confirmation populations using appropriate population controls
0.30754375.9787187.html.plaintext.txt	49	allelic variation apoe locus studied many populations significant differences observed caucasian chinese japanese black races also among caucasian populations significant variation allele frequencies32 average allele frequencies caucasians show 4 allele frequency 150 low 4 frequency greek population22 agreement gradient found frequency allele europe supported similar low frequency 70 greek cypriots33 finding association apoe 4 allele lvf greek thalassemia homozygotes needs confirmation populations using appropriate population controls
0.30754375.9787187.html.plaintext.txt	50	well known isoform specific influence apoe plasma cholesterol level atherosclerosis32 cannot explain association found apoe allele 4 lvf thalassemia homozygotes atherosclerosis general feature pathophysiology disorder
0.30754375.9787187.html.plaintext.txt	51	recognized severity monogenic disorder may modified second locus depending genetic background34 genes involved pathogenic pathway represent candidate modifier genes35 boundaries monogenic polygenic disorders might always clear cut previously thought34 genes gene interactions become known progress human genome project
0.30754375.9787187.html.plaintext.txt	52	recognized severity monogenic disorder may modified second locus depending genetic background34 genes involved pathogenic pathway represent candidate modifier genes35 boundaries monogenic polygenic disorders might always clear cut previously thought34 genes gene interactions become known progress human genome project
0.30754375.9787187.html.plaintext.txt	53	finding increased frequency apoe 4 allele thalassemia homozygotes lvf provides additional evidence theory oxygen free radicals contributing organ damage due recently demonstrated antioxidant iron binding activity apoe14 suggests several genetic loci could potential relevance oxidative damage organs thalassemia loci include genes modulating genesis oxygen free radicals ie cytochrome c oxidase genes scavenger enzymes superoxide dismutases catalase genes regulating mitochondrial dna replication structural genes membrane lipoproteins genes involved dna repair mechanisms36 noteworthy mutant mice lacking mn superoxide dismutase enzyme suffer neonatal lethality due dilated cardiomyopathy37 functional polymorphisms genes could examined association organ failure thalassemia also believed genetic susceptibility majority common diseases associated relatively common alleles one several loci38
0.30754375.9787187.html.plaintext.txt	54	finding increased frequency apoe 4 allele thalassemia homozygotes lvf provides additional evidence theory oxygen free radicals contributing organ damage due recently demonstrated antioxidant iron binding activity apoe14 suggests several genetic loci could potential relevance oxidative damage organs thalassemia loci include genes modulating genesis oxygen free radicals ie cytochrome c oxidase genes scavenger enzymes superoxide dismutases catalase genes regulating mitochondrial dna replication structural genes membrane lipoproteins genes involved dna repair mechanisms36 noteworthy mutant mice lacking mn superoxide dismutase enzyme suffer neonatal lethality due dilated cardiomyopathy37 functional polymorphisms genes could examined association organ failure thalassemia also believed genetic susceptibility majority common diseases associated relatively common alleles one several loci38
0.30754375.9787187.html.plaintext.txt	55	submitted september 29 1997 accepted june 30 1998 address reprint requests effrosini economou petersen md hellenic red cross hospital 4 alkibiadou gr 10439 athens greece publication costs article defrayed part page charge payment article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.30754375.9787187.html.plaintext.txt	56	submitted september 29 1997 accepted june 30 1998 address reprint requests effrosini economou petersen md hellenic red cross hospital 4 alkibiadou gr 10439 athens greece publication costs article defrayed part page charge payment article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.30754375.9787187.html.plaintext.txt	57	references abstract introduction methods results discussion references 1 kan yw dozy polymorphism dna sequence adjacent human globin structural gene relationship sickle mutation proc natl acad sci usa 755631 1978abstract 2 boehm cd antonarakis se phillips ja stetten g kazazian hh jr prenatal diagnosis using dna polymorphisms report 95 pregnancies risk sickle cell disease thalassemia n engl j med 3081054 1983abstract 3 pirastu m kan yw cao conner bj teplitz rl wallace rb prenatal diagnosis thalassemia detection single nucleotide mutation dna n engl j med 309284 1983abstract 4 wood wg hemoglobinopathies scriver cr beaudet al sly ws valle d eds metabolic molecular bases inherited disease new york ny mcgraw hill 1995 p 3417 5 sapoznikov d lewis n rachmilewitz ea gotsman ms lewis bs left ventricular filling emptying patterns anemia due beta thalassemia computer assisted echocardiographic study cardiology 69276 1982medline order article via infotrieve 6 lau kc li amc hui pw yeung cy left ventricular function thalassemia major arch dis child 641046 1989abstract 7 olivieri nf nathan dg macmillan jh wayne liu pp mcgee martin m koren g cohen ar survival medically treated patients homozygous thalassemia n engl j med 331574 1994abstractfree full text 8 freeman ap giles rw berdoukas va walsh wf choy d murray pc early left ventricular dysfunction chelation therapy thalassemia major ann intern med 99450 1983medline order article via infotrieve 9 wolfe l olivieri n sallan d colan rose v propper r freedman mh nathan dg prevention cardiac disease subcutaneous deferoxamine patients thalassemia major n engl j med 3121600 1985abstract 10 marcus re davies sc bantock hm underwood sr walton huehns er desferrioxamine improve cardiac function iron overloaded patients thalassaemia major lancet 1392 1984medline order article via infotrieve 11 mahley rw apolipoprotein e cholesterol transport protein expanding role cell biology science 240622 1988medline order article via infotrieve 12 strittmatter wj saunders schmechel d pericak vance m enghild j salvesen gs roses ad apolipoprotein e high avidity binding amyloid increased frequency type 4 allele late onset familial alzheimer disease proc natl acad sci usa 901977 1993abstract 13 zannis vi breslow jl utermann g mahley rw weisgraber kh havel rj goldstein jl brown ms schonfeld g hazzard wr blum c proposed nomenclature apoe isoproteins apoe genotypes phenotypes j lipid res 23911 1982medline order article via infotrieve 14 miyata m smith jd apolipoprotein e allele specific antioxidant activity effects cytotoxicity oxidative insults amyloid peptides nat genet 1455 1996medline order article via infotrieve 15 sahn dj de maria kisslo j weyman committee m mode standardization american society echocardiography results survey echocardiographic measurements circulation 581072 1978abstract 16 schiller nb shah pm crawford m demaria devereux r fligenbaum h gutgesell h reicher n sahn d schnittger silverman nh tajih aj recommendations quantitation left ventricle two dimensional echocardiography american society echocardiography committee standards subcommittee quantitation two dimensional echocardiography j soc echocardiogr 2358 1989medline order article via infotrieve 17 crisaru d rachmilewitz ea mosseri m gotsman m latair js okon e goldfard hasin y cardiopulmonary assessment thalassemia major chest 981138 1990abstract 18 aessopos stamatelos g skoumas v vassilopoulos g mantzourani m loukopoulos d pulmonary hypertension right ventricle failure patients beta thalassemia intermedia chest 10750 1995abstractfree full text 19 miller sa dykes dd polesky hf simple salting procedure extracting dna human nucleated cells nucleic acids res 161215 1988medline order article via infotrieve 20 wenham pr price wh blundell g apolipoprotein e genotyping one stage pcr lancet 3371158 1991medline order article via infotrieve 21 avramopoulos d mikkelsen m vassilopoulos d grigoriadou m petersen mb apolipoprotein e allele distribution parents downs syndrome children lancet 347862 1996medline order article via infotrieve 22 sklavounou e economou petersen e karadima g panas m avramopoulos d varsou vassilopoulos d petersen mb apolipoprotein e polymorphism greek population clin genet 52216 1997medline order article via infotrieve 23 leon mb borer js bacharach sl green mv benz ej jr griffith p nienhuis aw detection early cardiac dysfunction patients severe beta thalassemia chronic iron overload n engl j med 3011143 1979abstract 24 brittenham gm griffith pm nienhuis aw mclaren ce young ns tucker ee allen cj farrell de harris jw efficacy deferoxamine preventing complications iron overload patients thalassemia major n engl j med 331567 1994abstractfree full text 25 halliwell b role oxygen radicals human disease particular reference vascular system haemostasis 23118 1993medline order article via infotrievesuppl 1 26 kukreja rc hess ml oxygen free radical system equations membrane protein interactions cardiovascular injury protection cardiovasc res 26641 1992medline order article via infotrieve 27 kremastinos dth tiniakos g theodorakis gn katritsis dg toutouzas pk myocarditis thalassemia major cause heart failure circulation 9166 1995abstractfree full text 28 hiraoka y kishimoto c takada h kurokawa m ochiai h shiraki k sasayama role oxygen derived free radicals pathogenesis coxsackievirus b3 myocarditis mice cardiovasc res 27957 1993medline order article via infotrieve 29 suzuki h matsumori matoba y kyu bs tanaka fujita j sasayama enhanced expression superoxide dismutase messenger rna viral myocarditis sh dependent reduction expression myocardial injury j clin invest 912727 1993medline order article via infotrieve 30 roses ad apolipoprotein e genotyping differential diagnosis prediction alzheimers disease ann neurol 386 1995medline order article via infotrieve 31 national institute agingalzheimers association working group apolipoprotein e genotyping alzheimers disease lancet 3471091 1996medline order article via infotrieve 32 davignon j gregg re sing cf apolipoprotein e polymorphism atherosclerosis arteriosclerosis 81 1988abstract 33 cariolou ma kakkofitou manoli p christou karagrigoriou middleton l underexpression apolipoprotein e2 e4 alleles greek cypriot population cyprus genet epidemiol 12489 1995medline order article via infotrieve 34 estivill x complexity monogenic disease nat genet 12348 1996medline order article via infotrieve 35 houlston rs tomlinson ipm modifier genes humans strategies identification eur j hum genet 680 1998medline order article via infotrieve 36 martin gm austad sn johnson te genetic analysis ageing role oxidative damage environmental stresses nat genet 1325 1996medline order article via infotrieve 37 li y huang carlson ej melov ursell pc olson jl noble lj yoshimura mp berger c chan ph wallace dc epstein cj dilated cardiomyopathy neonatal lethality mutant mice lacking manganese superoxide dismutase nat genet 11376 1995medline order article via infotrieve 38 brown po hartwell l genomics human diseasevariations variation nat genet 1891 1998medline order article via infotrieve 1998 american society hematology 0006 49719892 00133000
0.30754375.9787187.html.plaintext.txt	58	references abstract introduction methods results discussion references 1 kan yw dozy polymorphism dna sequence adjacent human globin structural gene relationship sickle mutation proc natl acad sci usa 755631 1978abstract 2 boehm cd antonarakis se phillips ja stetten g kazazian hh jr prenatal diagnosis using dna polymorphisms report 95 pregnancies risk sickle cell disease thalassemia n engl j med 3081054 1983abstract 3 pirastu m kan yw cao conner bj teplitz rl wallace rb prenatal diagnosis thalassemia detection single nucleotide mutation dna n engl j med 309284 1983abstract 4 wood wg hemoglobinopathies scriver cr beaudet al sly ws valle d eds metabolic molecular bases inherited disease new york ny mcgraw hill 1995 p 3417 5 sapoznikov d lewis n rachmilewitz ea gotsman ms lewis bs left ventricular filling emptying patterns anemia due beta thalassemia computer assisted echocardiographic study cardiology 69276 1982medline order article via infotrieve 6 lau kc li amc hui pw yeung cy left ventricular function thalassemia major arch dis child 641046 1989abstract 7 olivieri nf nathan dg macmillan jh wayne liu pp mcgee martin m koren g cohen ar survival medically treated patients homozygous thalassemia n engl j med 331574 1994abstractfree full text 8 freeman ap giles rw berdoukas va walsh wf choy d murray pc early left ventricular dysfunction chelation therapy thalassemia major ann intern med 99450 1983medline order article via infotrieve 9 wolfe l olivieri n sallan d colan rose v propper r freedman mh nathan dg prevention cardiac disease subcutaneous deferoxamine patients thalassemia major n engl j med 3121600 1985abstract 10 marcus re davies sc bantock hm underwood sr walton huehns er desferrioxamine improve cardiac function iron overloaded patients thalassaemia major lancet 1392 1984medline order article via infotrieve 11 mahley rw apolipoprotein e cholesterol transport protein expanding role cell biology science 240622 1988medline order article via infotrieve 12 strittmatter wj saunders schmechel d pericak vance m enghild j salvesen gs roses ad apolipoprotein e high avidity binding amyloid increased frequency type 4 allele late onset familial alzheimer disease proc natl acad sci usa 901977 1993abstract 13 zannis vi breslow jl utermann g mahley rw weisgraber kh havel rj goldstein jl brown ms schonfeld g hazzard wr blum c proposed nomenclature apoe isoproteins apoe genotypes phenotypes j lipid res 23911 1982medline order article via infotrieve 14 miyata m smith jd apolipoprotein e allele specific antioxidant activity effects cytotoxicity oxidative insults amyloid peptides nat genet 1455 1996medline order article via infotrieve 15 sahn dj de maria kisslo j weyman committee m mode standardization american society echocardiography results survey echocardiographic measurements circulation 581072 1978abstract 16 schiller nb shah pm crawford m demaria devereux r fligenbaum h gutgesell h reicher n sahn d schnittger silverman nh tajih aj recommendations quantitation left ventricle two dimensional echocardiography american society echocardiography committee standards subcommittee quantitation two dimensional echocardiography j soc echocardiogr 2358 1989medline order article via infotrieve 17 crisaru d rachmilewitz ea mosseri m gotsman m latair js okon e goldfard hasin y cardiopulmonary assessment thalassemia major chest 981138 1990abstract 18 aessopos stamatelos g skoumas v vassilopoulos g mantzourani m loukopoulos d pulmonary hypertension right ventricle failure patients beta thalassemia intermedia chest 10750 1995abstractfree full text 19 miller sa dykes dd polesky hf simple salting procedure extracting dna human nucleated cells nucleic acids res 161215 1988medline order article via infotrieve 20 wenham pr price wh blundell g apolipoprotein e genotyping one stage pcr lancet 3371158 1991medline order article via infotrieve 21 avramopoulos d mikkelsen m vassilopoulos d grigoriadou m petersen mb apolipoprotein e allele distribution parents downs syndrome children lancet 347862 1996medline order article via infotrieve 22 sklavounou e economou petersen e karadima g panas m avramopoulos d varsou vassilopoulos d petersen mb apolipoprotein e polymorphism greek population clin genet 52216 1997medline order article via infotrieve 23 leon mb borer js bacharach sl green mv benz ej jr griffith p nienhuis aw detection early cardiac dysfunction patients severe beta thalassemia chronic iron overload n engl j med 3011143 1979abstract 24 brittenham gm griffith pm nienhuis aw mclaren ce young ns tucker ee allen cj farrell de harris jw efficacy deferoxamine preventing complications iron overload patients thalassemia major n engl j med 331567 1994abstractfree full text 25 halliwell b role oxygen radicals human disease particular reference vascular system haemostasis 23118 1993medline order article via infotrievesuppl 1 26 kukreja rc hess ml oxygen free radical system equations membrane protein interactions cardiovascular injury protection cardiovasc res 26641 1992medline order article via infotrieve 27 kremastinos dth tiniakos g theodorakis gn katritsis dg toutouzas pk myocarditis thalassemia major cause heart failure circulation 9166 1995abstractfree full text 28 hiraoka y kishimoto c takada h kurokawa m ochiai h shiraki k sasayama role oxygen derived free radicals pathogenesis coxsackievirus b3 myocarditis mice cardiovasc res 27957 1993medline order article via infotrieve 29 suzuki h matsumori matoba y kyu bs tanaka fujita j sasayama enhanced expression superoxide dismutase messenger rna viral myocarditis sh dependent reduction expression myocardial injury j clin invest 912727 1993medline order article via infotrieve 30 roses ad apolipoprotein e genotyping differential diagnosis prediction alzheimers disease ann neurol 386 1995medline order article via infotrieve 31 national institute agingalzheimers association working group apolipoprotein e genotyping alzheimers disease lancet 3471091 1996medline order article via infotrieve 32 davignon j gregg re sing cf apolipoprotein e polymorphism atherosclerosis arteriosclerosis 81 1988abstract 33 cariolou ma kakkofitou manoli p christou karagrigoriou middleton l underexpression apolipoprotein e2 e4 alleles greek cypriot population cyprus genet epidemiol 12489 1995medline order article via infotrieve 34 estivill x complexity monogenic disease nat genet 12348 1996medline order article via infotrieve 35 houlston rs tomlinson ipm modifier genes humans strategies identification eur j hum genet 680 1998medline order article via infotrieve 36 martin gm austad sn johnson te genetic analysis ageing role oxidative damage environmental stresses nat genet 1325 1996medline order article via infotrieve 37 li y huang carlson ej melov ursell pc olson jl noble lj yoshimura mp berger c chan ph wallace dc epstein cj dilated cardiomyopathy neonatal lethality mutant mice lacking manganese superoxide dismutase nat genet 11376 1995medline order article via infotrieve 38 brown po hartwell l genomics human diseasevariations variation nat genet 1891 1998medline order article via infotrieve 1998 american society hematology 0006 49719892 00133000
0.30761042.15010453.html.plaintext.txt	0	defective endoplasmic reticulum resident membrane protein cln6 affects lysosomal degradation endocytosed arylsulfatase claudia heine bettina koch stephan storch alfried kohlschutter david n palmer thomas braulke
0.30761042.15010453.html.plaintext.txt	1	department biochemistry childrens hospital university hamburg d 20246 hamburg germany animal food science division lincoln university canterbury 8150 new zealand
0.30761042.15010453.html.plaintext.txt	2	received publication january 20 2004 revised form march 8 2004
0.30761042.15010453.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references variant late infantile neuronal ceroid lipofuscinosis lysosomal storage disorder characterized progressive mental deterioration blindness caused mutations polytopic membrane protein cln6 unknown intracellular localization function study transient transfection bhk21 cells cln6 cdna immunoblot analysis using peptide specific cln6 antibodies demonstrated expression 27 kda protein undergo proteolytic processing cross linking experiments revealed presence cln6 dimers using double immunofluorescence microscopy epitope tagged cln6 shown retained endoplasmic reticulum er colocalization cis golgi lysosomal markers translocation er proper folding confirmed n linked glycosylation mutant cln6 polypeptide pulse chase labeling fibroblasts cln6 patients sheep ocl6 mouse nclf models disease followed immunoprecipitation cathepsin d indicated neither synthesis sorting proteolytic processing lysosomal enzyme affected cln6 defective cells however degradation endocytosed index protein arylsulfatase strongly reduced mutant cln6 cell lines compared controls data suggest defects er resident cln6 protein lead lysosomal dysfunctions may result lysosomal accumulation storage material
0.30761042.15010453.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references variant late infantile neuronal ceroid lipofuscinosis lysosomal storage disorder characterized progressive mental deterioration blindness caused mutations polytopic membrane protein cln6 unknown intracellular localization function study transient transfection bhk21 cells cln6 cdna immunoblot analysis using peptide specific cln6 antibodies demonstrated expression 27 kda protein undergo proteolytic processing cross linking experiments revealed presence cln6 dimers using double immunofluorescence microscopy epitope tagged cln6 shown retained endoplasmic reticulum er colocalization cis golgi lysosomal markers translocation er proper folding confirmed n linked glycosylation mutant cln6 polypeptide pulse chase labeling fibroblasts cln6 patients sheep ocl6 mouse nclf models disease followed immunoprecipitation cathepsin d indicated neither synthesis sorting proteolytic processing lysosomal enzyme affected cln6 defective cells however degradation endocytosed index protein arylsulfatase strongly reduced mutant cln6 cell lines compared controls data suggest defects er resident cln6 protein lead lysosomal dysfunctions may result lysosomal accumulation storage material
0.30761042.15010453.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references neuronal ceroid lipofuscinoses ncls1 also collectively called batten disease group autosomal recessively inherited neurodegenerative diseases affect children adults clinical features include loss vision seizures mental motor deterioration depending affected gene clinical signs become visible various developmental stages 1 currently eight forms human ncls cln1 8 differentiated six underlying genes identified 2 cln1 cln2 encode soluble lysosomal enzymes palmitoyl protein thioesterase 1 tripeptidylpeptidase 1 respectively 3 5 cln3 cln5 cln6 cln8 represent transmembrane proteins still unknown function 6 10 although nature cln genes differs defects lead massive storage autofluorescent material lysosomes identified subunit c mitochondrial atp synthase 2 11 12
0.30761042.15010453.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references neuronal ceroid lipofuscinoses ncls1 also collectively called batten disease group autosomal recessively inherited neurodegenerative diseases affect children adults clinical features include loss vision seizures mental motor deterioration depending affected gene clinical signs become visible various developmental stages 1 currently eight forms human ncls cln1 8 differentiated six underlying genes identified 2 cln1 cln2 encode soluble lysosomal enzymes palmitoyl protein thioesterase 1 tripeptidylpeptidase 1 respectively 3 5 cln3 cln5 cln6 cln8 represent transmembrane proteins still unknown function 6 10 although nature cln genes differs defects lead massive storage autofluorescent material lysosomes identified subunit c mitochondrial atp synthase 2 11 12
0.30761042.15010453.html.plaintext.txt	7	newly synthesized palmitoyl protein thioesterase 1 tripeptidylpeptidase 1 transported lysosome man 6 p dependent manner 3 5 binding man 6 p specific receptors mpr46 mpr300 allows segregation secretory pathway transport trans golgi network endosomal compartment low ph receptor ligand complexes dissociate enzymes delivered lysosome soluble enzymes escape binding mpr trans golgi network secreted partially endocytosed binding mpr localized cell surface transported lysosome 13 cln3 cln5 cln8 localized lysosomes endoplasmic reticulum erer golgi intermediate compartment respectively 14 16 subcellular localization cln6 known transport lysosomal membrane proteins requires tyrosine dileucine based sorting signals 17 recently lysosomal targeting motifs identified cln3 protein 18 whereas localization cln8 er mediated kkxx er retrieval signal 16
0.30761042.15010453.html.plaintext.txt	8	newly synthesized palmitoyl protein thioesterase 1 tripeptidylpeptidase 1 transported lysosome man 6 p dependent manner 3 5 binding man 6 p specific receptors mpr46 mpr300 allows segregation secretory pathway transport trans golgi network endosomal compartment low ph receptor ligand complexes dissociate enzymes delivered lysosome soluble enzymes escape binding mpr trans golgi network secreted partially endocytosed binding mpr localized cell surface transported lysosome 13 cln3 cln5 cln8 localized lysosomes endoplasmic reticulum erer golgi intermediate compartment respectively 14 16 subcellular localization cln6 known transport lysosomal membrane proteins requires tyrosine dileucine based sorting signals 17 recently lysosomal targeting motifs identified cln3 protein 18 whereas localization cln8 er mediated kkxx er retrieval signal 16
0.30761042.15010453.html.plaintext.txt	9	cln6 gene encodes highly conserved 311 amino acid protein six seven predicted membrane spanning domains deduced amino acid sequence contains putative n glycosylation sites classical lysosomal sorting signals furthermore sequence homologies proteins described 9 10
0.30761042.15010453.html.plaintext.txt	10	cln6 gene encodes highly conserved 311 amino acid protein six seven predicted membrane spanning domains deduced amino acid sequence contains putative n glycosylation sites classical lysosomal sorting signals furthermore sequence homologies proteins described 9 10
0.30761042.15010453.html.plaintext.txt	11	various mutations cln6 gene identified leading variant late infantile form ncl 9 10 19 21 naturally occurring ncls south hampshire merino sheep ocl6 nclf mice localized cln6 22 24 severe progressive neurodegeneration cerebral cortex accompanied astrocytosis elevated expression radical scavenger protein mn sod 24 25 furthermore differences fatty acid profiles brain phosphatidylethanolamine observed ocl6 affected sheep 26
0.30761042.15010453.html.plaintext.txt	12	various mutations cln6 gene identified leading variant late infantile form ncl 9 10 19 21 naturally occurring ncls south hampshire merino sheep ocl6 nclf mice localized cln6 22 24 severe progressive neurodegeneration cerebral cortex accompanied astrocytosis elevated expression radical scavenger protein mn sod 24 25 furthermore differences fatty acid profiles brain phosphatidylethanolamine observed ocl6 affected sheep 26
0.30761042.15010453.html.plaintext.txt	13	study expressed human cln6 bhk21 cells investigate subcellular localization furthermore transport lysosomal enzymes via biosynthetic endocytic pathway examined fibroblasts cln6 patients ocl6 nclf mice data indicate cln6 er resident protein
0.30761042.15010453.html.plaintext.txt	14	study expressed human cln6 bhk21 cells investigate subcellular localization furthermore transport lysosomal enzymes via biosynthetic endocytic pathway examined fibroblasts cln6 patients ocl6 nclf mice data indicate cln6 er resident protein
0.30761042.15010453.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references materials sodium 125i 15 cimg iodine 35smethionine 1000 cimmol rainbowtm colored protein molecular mass marker obtained amersham biosciences opti mem lipofectaminetm 2000 antibiotics penicillinstreptomycin purchased invitrogen protease inhibitor mixture p 2714 transferrin protein agarose 2 mercaptoethanesulfonic acid mesna man 6 p obtained sigma bradford reagent trans blot nitrocellulose membrane 02 microm purchased bio rad bissulfosuccinimidylsuberate bs3 disuccinimidylsuberate dss sulfosuccinimidyl 2 biotinamidoethyl 13 dithio propionate iodo gen obtained pierce restriction endonucleases t4 dna ligase molecular biology reagents invitrogen new england biolabs qiagen stratagene la jolla ca recombinant human arylsulfatase asa purified asa overexpressing mouse embryonic fibroblasts deficient mprs 27 kindly provided dr dierks university gottingen gottingen germany
0.30761042.15010453.html.plaintext.txt	16	experimental procedures top abstract introduction experimental procedures results discussion references materials sodium 125i 15 cimg iodine 35smethionine 1000 cimmol rainbowtm colored protein molecular mass marker obtained amersham biosciences opti mem lipofectaminetm 2000 antibiotics penicillinstreptomycin purchased invitrogen protease inhibitor mixture p 2714 transferrin protein agarose 2 mercaptoethanesulfonic acid mesna man 6 p obtained sigma bradford reagent trans blot nitrocellulose membrane 02 microm purchased bio rad bissulfosuccinimidylsuberate bs3 disuccinimidylsuberate dss sulfosuccinimidyl 2 biotinamidoethyl 13 dithio propionate iodo gen obtained pierce restriction endonucleases t4 dna ligase molecular biology reagents invitrogen new england biolabs qiagen stratagene la jolla ca recombinant human arylsulfatase asa purified asa overexpressing mouse embryonic fibroblasts deficient mprs 27 kindly provided dr dierks university gottingen gottingen germany
0.30761042.15010453.html.plaintext.txt	17	cln6 cloning full length cln6 cdna amplified using forward primer 5 cgggatccgcgatggaggcgacgcggagg 3 reverse primer 5 cccaagcttggggtgccgactgctgacgtg 3 image clone imag p998e179643 template vector pcmvsport6 pcr product subcloned frame c terminal myc tag vector pcdna31myc invitrogen bamhihindiii restriction sites untagged cln6 wild type construct amplified reverse primer 5 cccaagcttgggtcagtgccgactgctgac 3
0.30761042.15010453.html.plaintext.txt	18	cln6 cloning full length cln6 cdna amplified using forward primer 5 cgggatccgcgatggaggcgacgcggagg 3 reverse primer 5 cccaagcttggggtgccgactgctgacgtg 3 image clone imag p998e179643 template vector pcmvsport6 pcr product subcloned frame c terminal myc tag vector pcdna31myc invitrogen bamhihindiii restriction sites untagged cln6 wild type construct amplified reverse primer 5 cccaagcttgggtcagtgccgactgctgac 3
0.30761042.15010453.html.plaintext.txt	19	expression glutathione transferase cln6 fusion protein cdnas coding aa 137 181 amplified primers 137 181for 5 ggaattcctgctcttcagtggctac 3 137 181rev 5 ggaattcctcaccacatgcagtgacccag 3 subcloned ecori restriction sites vector pgex 4t 1 amersham biosciences
0.30761042.15010453.html.plaintext.txt	20	mutation pile153ser introduced pcr using quick change site directed mutagenesis kit stratagene primers ile153serfor 5 gagaaccccagcatcaagaat 3 ile153serrev 5 attcttgatgctggggttctc 3 clones sequenced rule pcr introduced mutations verify reading frames fusion proteins
0.30761042.15010453.html.plaintext.txt	21	antibodies polyclonal antibodies mouse ctsd human ctsd purified mouse liver human placenta human mpr300 raised rabbits 28 30 polyclonal anti myc antibody obtained santa cruz biotechnology ors santa cruz ca monoclonal anti myc antibody gift j blanz zmnh hamburg germany produced hybridoma cell lines purchased lgc promochem teddington united kingdom monoclonal antibody protein disulfide isomerase pdi purchased stressgene biotechnologies corp victoria british columbia canada polyclonal anti cln6 antibody raised rabbits peptide sequences 155 168 281 293 eurogentech seraing belgium purified sequential affinity chromatography glutathione transferase glutathione transferase cln6 137 181 fusion protein matrix anti mouse igg cy3 anti rabbit igg fluorescein isothiocyanate conjugates obtained sigma peroxidase conjugated goat anti rabbit igg jackson immunoresearch laboratories west grove pa
0.30761042.15010453.html.plaintext.txt	22	antibodies polyclonal antibodies mouse ctsd human ctsd purified mouse liver human placenta human mpr300 raised rabbits 28 30 polyclonal anti myc antibody obtained santa cruz biotechnology ors santa cruz ca monoclonal anti myc antibody gift j blanz zmnh hamburg germany produced hybridoma cell lines purchased lgc promochem teddington united kingdom monoclonal antibody protein disulfide isomerase pdi purchased stressgene biotechnologies corp victoria british columbia canada polyclonal anti cln6 antibody raised rabbits peptide sequences 155 168 281 293 eurogentech seraing belgium purified sequential affinity chromatography glutathione transferase glutathione transferase cln6 137 181 fusion protein matrix anti mouse igg cy3 anti rabbit igg fluorescein isothiocyanate conjugates obtained sigma peroxidase conjugated goat anti rabbit igg jackson immunoresearch laboratories west grove pa
0.30761042.15010453.html.plaintext.txt	23	isolation culture mouse fibroblasts cln6 defective mice b6cg nclf obtained jackson laboratory bar harbor age matched c57bl6 mice served controls animals maintained killed according institutional guidelines animal facilities university hospital hamburg eppendorf fibroblasts prepared lung biopsies 3 month old mice described previously 31
0.30761042.15010453.html.plaintext.txt	24	isolation culture mouse fibroblasts cln6 defective mice b6cg nclf obtained jackson laboratory bar harbor age matched c57bl6 mice served controls animals maintained killed according institutional guidelines animal facilities university hospital hamburg eppendorf fibroblasts prepared lung biopsies 3 month old mice described previously 31
0.30761042.15010453.html.plaintext.txt	25	cell cultures cell transfection skin fibroblasts affected south hampshire age matched control sheep well cln6 patients described previously 25 cells cultured dulbeccos modified eagles medium invitrogen containing 10 fetal calf serum paa laboratories linz austria 1 penicillinstreptomycin humidified atmosphere containing 5 co2 95 o2 37 degrees c bhk21 cells cultured conditions dmemfetal calf serum transiently transfected described previously 32 control cells transfected pcdna31myc vector alone
0.30761042.15010453.html.plaintext.txt	26	cell cultures cell transfection skin fibroblasts affected south hampshire age matched control sheep well cln6 patients described previously 25 cells cultured dulbeccos modified eagles medium invitrogen containing 10 fetal calf serum paa laboratories linz austria 1 penicillinstreptomycin humidified atmosphere containing 5 co2 95 o2 37 degrees c bhk21 cells cultured conditions dmemfetal calf serum transiently transfected described previously 32 control cells transfected pcdna31myc vector alone
0.30761042.15010453.html.plaintext.txt	27	metabolic labelings immunoprecipitation cells labeled 35smethionine 150 microciml 1 h followed chase indicated time ctsd immunoprecipitated cell extracts media described previously 33 analyzed sds page fluorography
0.30761042.15010453.html.plaintext.txt	28	metabolic labelings immunoprecipitation cells labeled 35smethionine 150 microciml 1 h followed chase indicated time ctsd immunoprecipitated cell extracts media described previously 33 analyzed sds page fluorography
0.30761042.15010453.html.plaintext.txt	29	cell surface biotinylation mpr300 immunoprecipitation cell surface proteins biotinylated sulfo nhs ss biotin 4 degrees c described previously 34 washing cells incubated presence absence 50 mm mesna 50 mm tris buffer ph 86 containing 100 mm nacl 1 mm mgcl2 01 mm cacl2 followed immunoprecipitation mpr300 cell extracts described previously 29
0.30761042.15010453.html.plaintext.txt	30	cell surface biotinylation mpr300 immunoprecipitation cell surface proteins biotinylated sulfo nhs ss biotin 4 degrees c described previously 34 washing cells incubated presence absence 50 mm mesna 50 mm tris buffer ph 86 containing 100 mm nacl 1 mm mgcl2 01 mm cacl2 followed immunoprecipitation mpr300 cell extracts described previously 29
0.30761042.15010453.html.plaintext.txt	31	ligand internalization internalization 125iasa examined described previously 33 internalized 125itransferrin determined 3 h incubation 37 degrees c cells washed cell surface bound 125itransferrin displaced acidic wash 35 cells solubilized analyzed sds page autoradiography
0.30761042.15010453.html.plaintext.txt	32	ligand internalization internalization 125iasa examined described previously 33 internalized 125itransferrin determined 3 h incubation 37 degrees c cells washed cell surface bound 125itransferrin displaced acidic wash 35 cells solubilized analyzed sds page autoradiography
0.30761042.15010453.html.plaintext.txt	33	sds page western blotting solubilized proteins transfected non transfected cells separated sds page transferred nitrocellulose membrane examined cln6 myc immunoreactivity described previously 25
0.30761042.15010453.html.plaintext.txt	34	cross link experiments cln6 overexpressing bhk21 cells permeabilized 025 saponin 50 mm mes buffer ph 65 containing 150 mm nacl 05 bovine serum albumin 40 min 4 degrees c cross linked bs3 dss indicated concentrations proteins analyzed western blotting 36 37
0.30761042.15010453.html.plaintext.txt	35	cross link experiments cln6 overexpressing bhk21 cells permeabilized 025 saponin 50 mm mes buffer ph 65 containing 150 mm nacl 05 bovine serum albumin 40 min 4 degrees c cross linked bs3 dss indicated concentrations proteins analyzed western blotting 36 37
0.30761042.15010453.html.plaintext.txt	36	methods protein concentrations determined using bradford protein assay bovine serum albumin standard proteins 05 1 microg iodinated iodo gen described previously 38 deglycosylation experiments total bhk21 extracts solubilized incubated presence absence 1 milliunit peptide n glycosidase f pngase f 5 milliunits endoglycosidase h endo h roche applied science according manufacturers protocol samples separated sds page followed western blot analysis double immunofluorescence microscopy performed transfected bhk21 cells described previously 25 using anti myc 150 anti pdi 1300 anti mouse ctsd antibodies 150 indicated hexosaminidase asa activities determined described previously 39 40
0.30761042.15010453.html.plaintext.txt	37	results top abstract introduction experimental procedures results discussion references expression wild type myc tagged cln6 wild type c terminally myc tagged cln6 transiently expressed bhk21 cells non transfected pcdna31 vector transfected bhk21 cells used controls western blot analysis using peptide specific anti cln6 antibody revealed single prominent immunoreactive band 27 kda cell extracts wild type cln6 transfected cells fig 1 specific cross reacting material found cells transfected vector immunoreactive band 30 kda observed cells expressing cln6myc construct stripping nitrocellulose membrane reprobing anti myc antibodies 30 kda myc tagged cln6 detectable
0.30761042.15010453.html.plaintext.txt	38	view larger version 23k fig 1 overexpression cln6 bhk21 cells cell extracts vector transfected wild type cln6 wild type cln6mychis tag expressing bhk21 cells separated sds page transferred nitrocellulose membrane analyzed peptide specific cln6 antibody b western blot analysis carried nitrocellulose using antibodies myc tag positions molecular mass markers kda indicated
0.30761042.15010453.html.plaintext.txt	39	cln6 er resident protein deduced amino acid sequence predicted protein structure cln6 revealed neither potential n glycosylation site sequences nxst x amino acid classical lysosomal sorting motifs hand n terminal rrr sequence amino acids residues 5 7 detected er type ii membrane protein glucosidase 41 whereas n terminal segment cln6 encoded exon 1 amino acids residues 1 28 suggested function putative targeting signal mitochondria 10 investigate subcellular localization n glycosylation site introduced predicted second luminal loop ile residue 153 substituted ser pile153ser site directed mutagenesis cln6 cdna changing sequence asn x ile asn x ser pile153ser expressed bhk21 cells western blot analysis revealed additional band 33 kda disappeared deglycosylation pngase f endo h fig 2a data demonstrate nascent cln6 polypeptide translocated lumen er became accessible glycosylation machinery confirmed double immunofluorescence microscopy cln6myc protein colocalized er marker protein pdi lysosomal marker enzyme cathepsin d fig 2b ctsd
0.30761042.15010453.html.plaintext.txt	40	cln6 er resident protein deduced amino acid sequence predicted protein structure cln6 revealed neither potential n glycosylation site sequences nxst x amino acid classical lysosomal sorting motifs hand n terminal rrr sequence amino acids residues 5 7 detected er type ii membrane protein glucosidase 41 whereas n terminal segment cln6 encoded exon 1 amino acids residues 1 28 suggested function putative targeting signal mitochondria 10 investigate subcellular localization n glycosylation site introduced predicted second luminal loop ile residue 153 substituted ser pile153ser site directed mutagenesis cln6 cdna changing sequence asn x ile asn x ser pile153ser expressed bhk21 cells western blot analysis revealed additional band 33 kda disappeared deglycosylation pngase f endo h fig 2a data demonstrate nascent cln6 polypeptide translocated lumen er became accessible glycosylation machinery confirmed double immunofluorescence microscopy cln6myc protein colocalized er marker protein pdi lysosomal marker enzyme cathepsin d fig 2b ctsd
0.30761042.15010453.html.plaintext.txt	41	view larger version 34k fig 2 er localization cln6 extracts bhk21 cells overexpressing either wild type mutant cln6 pile153ser vector transfected cells incubated presence absence pngase f endo h 16 h 37 degrees c samples separated sds page analyzed western blot using anti myc antibodies positions molecular mass marker proteins kda indicated b bhk21 cells transfected cln6 wild type fixed permeabilized 24 h transfection cells double stained myc green pdi b red myc d red ctsd e green red green channels merged adjustment fluorescence signals similar levels c f
0.30761042.15010453.html.plaintext.txt	42	cln6 forms dimers capability cln6 form oligomeric structures membranes examined cross linkage experiments semi intact bhk21 cells overexpressing cln6 cross linked non cleavable reagents bs3 dss immunoblot analysis showed amounts 60 kda immunoreactive band increased cross linkage concentration dependent manner whereas intensity 30 kda cln6 band decreased fig 3 results indicate cln6 partially exists dimer vivo
0.30761042.15010453.html.plaintext.txt	43	cln6 forms dimers capability cln6 form oligomeric structures membranes examined cross linkage experiments semi intact bhk21 cells overexpressing cln6 cross linked non cleavable reagents bs3 dss immunoblot analysis showed amounts 60 kda immunoreactive band increased cross linkage concentration dependent manner whereas intensity 30 kda cln6 band decreased fig 3 results indicate cln6 partially exists dimer vivo
0.30761042.15010453.html.plaintext.txt	44	view larger version 42k fig 3 chemical cross linkage overexpressed cln6 dss bs3 cln6myc fusion protein overexpressing bhk21 cells permeabilized treated indicated concentrations cross linker bs3 dss cell extracts separated sds page followed western blot analysis using anti myc antibodies m monomer d dimer
0.30761042.15010453.html.plaintext.txt	45	defective cln6 mice impair sorting processing newly synthesized cathepsin d examine whether cln6 critical transport processing man 6 p containing lysosomal proteins secretion proteolytic modifications newly synthesized ctsd determined fibroblasts cln6 patients ocl6 sheep nclf mice corresponding control cells human fibroblasts ctsd synthesized 53 kda precursor form 28 small fraction ctsd precursor study border03 total secreted fig 4a majority precursor protein binds mprs trans golgi network transported prelysosomalendosomal compartments processed 47 kda intermediate form within 2 h synthesis 42 intermediate ctsd forms delivered lysosomes processed mature 31 14 kda forms within 6 h synthesis fig 4a south hampshire sheep fibroblasts labeled 1 h 35smethionine 45 kda polypeptide immunoprecipitated anti human ctsd antibody fig 4b chase period 6 h 13 16 total ctsd recovered 30 kda mature form cells 48 kda form media respectively fig 4b metabolic labeling primary mouse fibroblasts followed immunoprecipitation anti mouse ctsd antibody predominant 45 kda polypeptide observed 32 small amounts 9 total synthesized ctsd detected 51 48 kda band media fig 4c suggesting variable extent glycosylation results show sorting processing newly synthesized ctsd affected fibroblasts cln6 patient ocl6 sheep nclf mice additionally specific activities two lysosomal enzymes hexosaminidase asa comparable control human sheep mouse cln6 defective cells
0.30761042.15010453.html.plaintext.txt	46	defective cln6 mice impair sorting processing newly synthesized cathepsin d examine whether cln6 critical transport processing man 6 p containing lysosomal proteins secretion proteolytic modifications newly synthesized ctsd determined fibroblasts cln6 patients ocl6 sheep nclf mice corresponding control cells human fibroblasts ctsd synthesized 53 kda precursor form 28 small fraction ctsd precursor study border03 total secreted fig 4a majority precursor protein binds mprs trans golgi network transported prelysosomalendosomal compartments processed 47 kda intermediate form within 2 h synthesis 42 intermediate ctsd forms delivered lysosomes processed mature 31 14 kda forms within 6 h synthesis fig 4a south hampshire sheep fibroblasts labeled 1 h 35smethionine 45 kda polypeptide immunoprecipitated anti human ctsd antibody fig 4b chase period 6 h 13 16 total ctsd recovered 30 kda mature form cells 48 kda form media respectively fig 4b metabolic labeling primary mouse fibroblasts followed immunoprecipitation anti mouse ctsd antibody predominant 45 kda polypeptide observed 32 small amounts 9 total synthesized ctsd detected 51 48 kda band media fig 4c suggesting variable extent glycosylation results show sorting processing newly synthesized ctsd affected fibroblasts cln6 patient ocl6 sheep nclf mice additionally specific activities two lysosomal enzymes hexosaminidase asa comparable control human sheep mouse cln6 defective cells
0.30761042.15010453.html.plaintext.txt	47	view larger version 31k fig 4 immunoprecipitation ctsd affected fibroblasts fibroblasts control co cln6 patients control ocl6 sheep fibroblasts b control nclf mouse fibroblasts c metabolically labeled 1 h 35smethionine ctsd immunoprecipitated cell extracts medium samples separated sds page visualized fluorography positions molecular mass markers kda precursor p intermediate mature m ctsd forms indicated
0.30761042.15010453.html.plaintext.txt	48	accumulation endocytosed arylsulfatase cln6 defective fibroblasts examine whether defective cln6 affect endocytic pathway lysosome fibroblasts cln6 patients ocl6 sheep nclf mice respective controls incubated 125iasa 16 h mpr46 function endocytosis lysosomal enzymes 43 uptake asa mediated mpr300 asa uptake specific shown complete inhibition presence excess man 6 p fig 5 densitometric evaluation autoradiographs several experiments n 3 4 showed average amount 125iasa detectable human cln6 ocl6 nclf cells 2 51 2 fold higher respectively control cells effect specific mpr300 mediated uptake amounts internalized 125itransferrin comparable control cln6 defective cells fig 5b
0.30761042.15010453.html.plaintext.txt	49	accumulation endocytosed arylsulfatase cln6 defective fibroblasts examine whether defective cln6 affect endocytic pathway lysosome fibroblasts cln6 patients ocl6 sheep nclf mice respective controls incubated 125iasa 16 h mpr46 function endocytosis lysosomal enzymes 43 uptake asa mediated mpr300 asa uptake specific shown complete inhibition presence excess man 6 p fig 5 densitometric evaluation autoradiographs several experiments n 3 4 showed average amount 125iasa detectable human cln6 ocl6 nclf cells 2 51 2 fold higher respectively control cells effect specific mpr300 mediated uptake amounts internalized 125itransferrin comparable control cln6 defective cells fig 5b
0.30761042.15010453.html.plaintext.txt	50	view larger version 41k fig 5 man 6 p m6p dependent uptake 125i labeled proteins fibroblasts affected human cln6 mouse nclf sheep ocl6 fibroblasts corresponding controls co incubated 125iasa 200000 cpmplate 16 h 37 degrees c presence absence 10 mm man 6 p removal medium displacement cell surface bound material man 6 p cells solubilized separated sds page internalized 125iasa visualized autoradiography densitometric evaluation represented autoradiograph revealed 41 human 26 mouse 27 ovine fold increased amounts 125iasa cln6 defective cells b cln6 defective cells controls incubated 125i labeled transferrin 3 h 37 degrees c presence absence excess unlabeled transferrin cell surface bound material removed acidic wash followed solubilization cells sds page autoradiography
0.30761042.15010453.html.plaintext.txt	51	increased intracellular amounts 125iasa cln6 defective cells could result increased rate endocytosis 125iasa caused elevated concentrations mpr300 cell surface rapid mpr300 kinetics cycling decreased degradation endocytosed 125iasa concentration mpr300 cell surface control ocl6 sheep fibroblasts shown determined control affected sheep fibroblasts showing significant difference intracellular 125iasa content endocytosis cell surface biotinylation followed immunoprecipitation mpr300 western blot analysis fig 6 even cells amounts mpr300 cell surface control ocl6 fibroblasts similar indicating increased amounts intracellular 125iasa ocl6 cells result increased concentrations mpr300 cell surface specificity procedure shown effect mesna cleaved biotin label linkage
0.30761042.15010453.html.plaintext.txt	52	increased intracellular amounts 125iasa cln6 defective cells could result increased rate endocytosis 125iasa caused elevated concentrations mpr300 cell surface rapid mpr300 kinetics cycling decreased degradation endocytosed 125iasa concentration mpr300 cell surface control ocl6 sheep fibroblasts shown determined control affected sheep fibroblasts showing significant difference intracellular 125iasa content endocytosis cell surface biotinylation followed immunoprecipitation mpr300 western blot analysis fig 6 even cells amounts mpr300 cell surface control ocl6 fibroblasts similar indicating increased amounts intracellular 125iasa ocl6 cells result increased concentrations mpr300 cell surface specificity procedure shown effect mesna cleaved biotin label linkage
0.30761042.15010453.html.plaintext.txt	53	view larger version 81k fig 6 cell surface biotinylation mpr300 control co ocl6 sheep fibroblasts chilled 4 degrees c cell surface biotinylated followed incubation presence absence reducing agent mesna mpr300 immunoprecipitated cell extracts separated sds page 5 acrylamide transferred nitrocellulose membrane visualized streptavidin hrp enhanced chemiluminescence
0.30761042.15010453.html.plaintext.txt	54	examine whether degradation endocytosed 125iasa inhibited cln6 defective fibroblasts cells incubated 125iasa for3hat37 degrees c removal radioactive media cells either harvested chased 20 h solubilized cells analyzed sds page autoradiography fig 7 densitometry autoradiograph revealed amount intracellular 125iasa detected cells cln6 patients 15 fold control cells 3 h endocytosis following chase period 20 h intracellular 125iasa remaining control cells reduced 32 whereas 96 remained fibroblasts cln6 patients data indicate degradation endocytosed 125iasa strongly inhibited cln6 defective cells
0.30761042.15010453.html.plaintext.txt	55	examine whether degradation endocytosed 125iasa inhibited cln6 defective fibroblasts cells incubated 125iasa for3hat37 degrees c removal radioactive media cells either harvested chased 20 h solubilized cells analyzed sds page autoradiography fig 7 densitometry autoradiograph revealed amount intracellular 125iasa detected cells cln6 patients 15 fold control cells 3 h endocytosis following chase period 20 h intracellular 125iasa remaining control cells reduced 32 whereas 96 remained fibroblasts cln6 patients data indicate degradation endocytosed 125iasa strongly inhibited cln6 defective cells
0.30761042.15010453.html.plaintext.txt	56	view larger version 34k fig 7 degradation endocytosed 125iasa reduced cln6 defective fibroblasts fibroblasts control co affected cln6 patients incubated 125iasa 800000 cpmml 3 h 37 degrees c removal media cells either harvested chased additional 20 h 37 degrees c cells solubilized separated sds page internalized 125iasa visualized autoradiography autoradiograph quantified densitometric scanning expressed percentage total 125iasa detectable control cells experiment repeated twice similar results
0.30761042.15010453.html.plaintext.txt	57	discussion top abstract introduction experimental procedures results discussion references present study examined subcellular localization cln6 protein mutations cln6 gene cause accumulation storage material lysosomes clinical manifestation variant late infantile neuronal ceroid lipofuscinosis report cln6 er resident protein capable forming dimers furthermore neither synthesis sorting transport newly synthesized ctsd lysosomal protease impaired cln6 defective cells whereas degradation exogenous protein asa reduced
0.30761042.15010453.html.plaintext.txt	58	discussion top abstract introduction experimental procedures results discussion references present study examined subcellular localization cln6 protein mutations cln6 gene cause accumulation storage material lysosomes clinical manifestation variant late infantile neuronal ceroid lipofuscinosis report cln6 er resident protein capable forming dimers furthermore neither synthesis sorting transport newly synthesized ctsd lysosomal protease impaired cln6 defective cells whereas degradation exogenous protein asa reduced
0.30761042.15010453.html.plaintext.txt	59	several lines evidence imply translocation localization cln6 protein er first cln6 antigenic sites found colocalize pdi established er marker cis golgi marker gm130 lysosomes stained ctsd secondly cln6 protein undergo proteolytic processing steps thirdly although contains potential n glycosylation sites replacement residue isoleucine 153 serine located second proposed luminal loop amino acid residues 137 179 resulted addition oligosaccharide chain could removed pngase f treatment mutant cln6 also completely sensitive endo h removing high mannose er type oligosaccharide chains complex golgi type oligosaccharides data strongly support concept cln6 residency er
0.30761042.15010453.html.plaintext.txt	60	several lines evidence imply translocation localization cln6 protein er first cln6 antigenic sites found colocalize pdi established er marker cis golgi marker gm130 lysosomes stained ctsd secondly cln6 protein undergo proteolytic processing steps thirdly although contains potential n glycosylation sites replacement residue isoleucine 153 serine located second proposed luminal loop amino acid residues 137 179 resulted addition oligosaccharide chain could removed pngase f treatment mutant cln6 also completely sensitive endo h removing high mannose er type oligosaccharide chains complex golgi type oligosaccharides data strongly support concept cln6 residency er
0.30761042.15010453.html.plaintext.txt	61	er residency membrane proteins achieved retention andor retrieval mechanisms requiring signal structures targeting motifs within proteins thus er resident type transmembrane proteins contain dileucine motif c terminal cytoplasmic domain whereas arginine containing signal structure functions targeting signal type ii membrane proteins 41 44 45 recent studies revealed additional er retention signals rxr r arginine x large neutral positively charged residue 46 48 furthermore oligomerization proteins mediated transmembrane andor luminal domains forming large homodimeric heteromeric protein complexes might prevent package transport vesicles export er 44 49 50 signal structures responsible retention polytopic cln6 er known n c terminal domain harbor potential rrr rkk retention motifs however replacement motifs lysine leucine residues respectively alter er localization mutant cln62 also possible dimerization reported study assembly cln6 oligomeric complexes prevents export er
0.30761042.15010453.html.plaintext.txt	62	er residency membrane proteins achieved retention andor retrieval mechanisms requiring signal structures targeting motifs within proteins thus er resident type transmembrane proteins contain dileucine motif c terminal cytoplasmic domain whereas arginine containing signal structure functions targeting signal type ii membrane proteins 41 44 45 recent studies revealed additional er retention signals rxr r arginine x large neutral positively charged residue 46 48 furthermore oligomerization proteins mediated transmembrane andor luminal domains forming large homodimeric heteromeric protein complexes might prevent package transport vesicles export er 44 49 50 signal structures responsible retention polytopic cln6 er known n c terminal domain harbor potential rrr rkk retention motifs however replacement motifs lysine leucine residues respectively alter er localization mutant cln62 also possible dimerization reported study assembly cln6 oligomeric complexes prevents export er
0.30761042.15010453.html.plaintext.txt	63	function cln6 defined however comparable rates synthesis sorting proteolytic processing ctsd cln6 defective control cells well similar specific activities two lysosomal enzymes hexosaminidase asa suggest cln6 limit transport least three enzymes lysosome hand study shows capability degrade exogenous arylsulfatase strikingly impaired cln6 defective cells whereas half life newly synthesized asa reported 40 days 51 internalized human asa rapidly degraded ref 52 present study probable acidic ph dependent octamerization cannot completed endocytosed asa resulting increased lysosomal instability 53 taking endocytosed asa index delayed degradation cln6 defective cells results indicate either specific lysosomal proteases absent andor inactive lysosomal parameters ph presence cofactors affected interest incubation n1e115 neuroblastoma cells amyloid protein fragments suspected neurotoxic mediator alzheimers disease led increased expression acetylcholinesterase slowed lysosomal degradation data suggest lysosomal acidification impaired 54
0.30761042.15010453.html.plaintext.txt	64	function cln6 defined however comparable rates synthesis sorting proteolytic processing ctsd cln6 defective control cells well similar specific activities two lysosomal enzymes hexosaminidase asa suggest cln6 limit transport least three enzymes lysosome hand study shows capability degrade exogenous arylsulfatase strikingly impaired cln6 defective cells whereas half life newly synthesized asa reported 40 days 51 internalized human asa rapidly degraded ref 52 present study probable acidic ph dependent octamerization cannot completed endocytosed asa resulting increased lysosomal instability 53 taking endocytosed asa index delayed degradation cln6 defective cells results indicate either specific lysosomal proteases absent andor inactive lysosomal parameters ph presence cofactors affected interest incubation n1e115 neuroblastoma cells amyloid protein fragments suspected neurotoxic mediator alzheimers disease led increased expression acetylcholinesterase slowed lysosomal degradation data suggest lysosomal acidification impaired 54
0.30761042.15010453.html.plaintext.txt	65	lysosomal dysfunction attributed defective er resident membrane protein without precedent cln8 another polytopic er membrane protein defective progressive epilepsy mental retardation belonging group ncl disorders 16 remains investigated whether reduced capability lysosomal degradation proteins demonstrated study specific cln6 common cln6 cln8 defective cells
0.30761042.15010453.html.plaintext.txt	66	lysosomal dysfunction attributed defective er resident membrane protein without precedent cln8 another polytopic er membrane protein defective progressive epilepsy mental retardation belonging group ncl disorders 16 remains investigated whether reduced capability lysosomal degradation proteins demonstrated study specific cln6 common cln6 cln8 defective cells
0.30761042.15010453.html.plaintext.txt	67	footnotes work supported deutsche forschungsgemeinschaft grant br 99010 2 werner otto foundation hamburg germany national institutes health grant ns40297 d n p costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.30761042.15010453.html.plaintext.txt	68	correspondence addressed childrens hospital biochemistry university hospital hamburg martinistr 52 bldg w23 d 20246 hamburg germany tel 49 40 42803 4493 fax 49 40 42803 8504 e mail braulkeatukeuni hamburgde u d
0.30761042.15010453.html.plaintext.txt	69	1 abbreviations used ncl neuronal ceroid lipofuscinosis mpr mannose 6 phosphate receptor er endoplasmic reticulum ocl6 ovine ncl mesna 2 mercaptoethanesulfonic acid bs3 bissulfosuccinimidyl suberate dss disuccinimidylsuberate asa arylsulfatase ctsd cathepsin d pdi protein disulfide isomerase endo h endoglycosidase h mes 4 morpholineethanesulfonic acid pngase f peptide n glycosidase f
0.30761042.15010453.html.plaintext.txt	70	references top abstract introduction experimental procedures results discussion references goebel h h schochet jaynes m bruck w kohlschutter hentati f 1999 mol genet metab 66 367 372crossrefmedline order article via infotrieve haltia m 2003 j neuropathol exp neurol 62 1 13medline order article via infotrieve hellsten e vesa j olkkonen v m jalanko peltonen l 1996 embo j 15 5240 5245abstract vines d warburton m j 1999 febs lett 443 131 135crossrefmedline order article via infotrieve lin l sohar lackland h lobel p 2001 j biol chem 276 2249 2255abstractfree full text janes r w munroe p b mitchison h m gardiner r m mole e wallace b 1996 febs lett 399 75 77crossrefmedline order article via infotrieve savukoski m klockars holmberg v santavuori p lander e peltonen l 1998 science 277 1802 1805 ranta zhang y ross b lonka l takkunen e messer sharp j wheeler r kusumi k mole liu w soares m b bonaldo m f hirvasniemi de la chapelle gilliam c lehesjoki e 1999 nat genet 23 233 236crossrefmedline order article via infotrieve wheeler r b sharp j d schultz r joslin j m williams r e mole e 2002 j hum genet 70 537 542crossrefmedline order article via infotrieve gao h boustany r m espinola j cotman l srinidhi l antonellis k gillis qin x liu donahue l r bronson r faust j r stout d haines j l lerner j macdonald m e 2002 j hum genet 70 324 335crossrefmedline order article via infotrieve palmer d n fearnley m walker j e hall n lake b d wolfe l haltia m martinus r d jolly r d 1992 j med genet 42 561 567medline order article via infotrieve palmer d n jolly r d van mil h c tyynela j westlake v j 1997 neuropediatrics 28 45 48medline order article via infotrieve braulke 1996 subcellular biochemistry biology lysosome lloyd j b mason r w eds vol 27 pp 15 49 plenum press new york jarvela lehtovirta m tikknen r kyttala jalanko 1999 hum mol genet 8 1091 1098abstractfree full text isosomppi j vesa j jalanko peltonen l 2002 hum mol genet 11 885 891abstractfree full text lonka l kyttala ranta jalanko lehesjoki e 2000 hum mol genet 9 1691 1697abstractfree full text bonifacino j dellangelica e c 1999 j cell biol 145 923 926free full text kyttala ihrke g vesa j schell m j luzio j p 2004 mol biol cell 15 1313 1323abstractfree full text sharp j d wheeler r b parker k gardiner r m williams r e mole e 2003 hum mutat 22 35 42crossrefmedline order article via infotrieve teixeira c guimaraes bessa c ferreira m j lopes l pinto e pinto r boustany r m sa miranda m c ribeiro m g 2003 j neurol 250 661 667medline order article via infotrieve teixeira c espinola j huo l kohlschutter j persaud sawin d minassian b bessa c j guimaraes stephan d sa miranda m c macdonald m e ribeiro m g boustany r m 2003 hum mutat 21 502 508crossrefmedline order article via infotrieve jolly r d walkley u 1999 mol genet metab 66 376 380crossrefmedline order article via infotrieve bronson r donahue l r johnson k r tanner lane p w faust j r 1998 j med genet 77 289 29733co2 n j cooper j d palmer d n elleder m kohlschutter braulke 2003 biochem j 376 369 376crossrefmedline order article via infotrieve palmer d n husbands d r jolly r d 1985 biochim biophys acta 834 159 163medline order article via infotrieve dierks schmidt b von figura k 1997 proc natl acad sci u 94 11963 11968abstractfree full text hasilik neufeld e f 1980 j biol chem 255 4937 4945free full text korner c nurnberg b uhde m braulke 1995 j biol chem 270 287 295abstractfree full text claussen m kubler b wendland m neifer k schmidt b zapf j braulke 1997 endocrinology 138 3797 3803abstractfree full text zwad o kubler b roth w scharf j g saftig p peters c braulke 2002 febs lett 510 211 215crossrefmedline order article via infotrieve partanen storch loffler h g hasilik tyynela j braulke 2003 biochem j 369 55 62crossrefmedline order article via infotrieve muschol n matzner u tiede gieselmann v ullrich k braulke 2002 biochem j 368 845 853crossrefmedline order article via infotrieve meyer c eskelinen e l guruprasad m r von figura k schu p 2001 j cell sci 114 4469 4476medline order article via infotrieve damke h von figura k braulke 1992 biochem j 281 225 229medline order article via infotrieve rosorius o issinger o g braulke 1993 j biol chem 268 21470 21473abstractfree full text breuer p korner c boker c herzog pohlmann r braulke 1997 mol biol cell 8 567 576abstract parker k c strominger j l 1983 biochemistry 22 1145 1153medline order article via infotrieve porter m fluharty l kihara h 1969 proc natl acad sci u 62 887 891abstract von figura k 1978 exp cell res 111 15 21medline order article via infotrieve hardt b kalz fuller b aparicio r volker c bause e 2003 glycobiology 13 159 168abstractfree full text gieselmann v pohlmann r hasilik von figura k 1983 j cell biol 97 1 5abstract stein m zijderhand bleekemolen j e geuze h hasilik von figura k 1987 embo j 6 2677 2681abstract schutze m p peterson p jackson m r 1994 embo j 13 1696 1705abstract cosson p letourneur f 1997 curr opin cell biol 9 484 487crossrefmedline order article via infotrieve margeta mitrovic m jan y n jan l y 2000 neuron 27 97 106medline order article via infotrieve ren z riley n j garcia e p sanders j m swanson g marshall j 2003 j neurosci 23 6608 6616abstractfree full text scott d b blanpied swanson g zhang c ehlers m d 2001 j neurosci 21 3063 3072abstractfree full text maza j mateescu m sarma j d koval m 2003 cell commun adhesion 10 319 322medline order article via infotrieve ren z riley n j needleman l sanders j m swanson g marshall j 2003 j biol chem 278 52700 52709abstractfree full text steckel f hasilik von figura k 1985 eur j biochem 151 141 145abstract steckel f hasilik von figura k 1985 eur j biochem 151 147 152abstract von bulow r schmidt b dierks schwabauer n schilling k weber e uson von figura k 2002 j biol chem 277 9455 9461abstractfree full text hu w gray n w brimijoin 2003 j neurochem 86 470 478crossrefmedline order article via infotrieve
0.30876386.9218423.html.plaintext.txt	0	targeted replacement mouse apolipoprotein e gene common human apoe3 allele enhances diet induced hypercholesterolemia atherosclerosis
0.30876386.9218423.html.plaintext.txt	1	received publication december 19 1996 revised form april 24 1997
0.30876386.9218423.html.plaintext.txt	2	patrick m sullivan hafid mezdour yasuaki aratani chris knouff jamila najib robert l reddick steven h quarfordt nobuyo maeda
0.30876386.9218423.html.plaintext.txt	3	department pathology laboratory medicine university north carolina chapel hill north carolina 27599 7525 institut pasteur de lille u 235 lille france department medicine durham va hospital duke university medical center durham north carolina 27705 abstract introduction experimental procedures results discussion footnotes acknowledgements references
0.30876386.9218423.html.plaintext.txt	4	apolipoprotein apo e constituent several lipoproteins ligand low density lipoprotein receptor interaction important maintaining cholesterol triglyceride homeostasis used gene replacement strategy generate mice express human apoe3 isoform place mouse protein levels apoe mrna various tissues virtually human apoe3 homozygous 33 mice littermates wild type mouse allele total cholesterol triglyceride levels fasted plasma 33 mice different mice maintained normal low fat chow diet found however notable differences distribution plasma lipoproteins apolipoprotein e two groups migrating lipoproteins plasma apob100 levels decreased 33 mice apoe distribution shifted high density lipoproteins larger lipoprotein particles addition fractional catabolic rate exogenously administered remnant particles without apoe 6 fold slower 33 mice compared mice 33 animals fed high fathigh cholesterol diet 33 animals responded dramatic increase 5 fold total cholesterol compared mice 15 fold 12 weeks diet 33 animals developed significantly least 13 fold larger atherosclerotic plaques aortic sinus area animals thus structural differences human apoe3 mouse apoe proteins sufficient cause increased susceptibility dietary induced hypercholesterolemia atherosclerosis 33 mice
0.30876386.9218423.html.plaintext.txt	5	apolipoprotein apo e constituent several lipoproteins ligand low density lipoprotein receptor interaction important maintaining cholesterol triglyceride homeostasis used gene replacement strategy generate mice express human apoe3 isoform place mouse protein levels apoe mrna various tissues virtually human apoe3 homozygous 33 mice littermates wild type mouse allele total cholesterol triglyceride levels fasted plasma 33 mice different mice maintained normal low fat chow diet found however notable differences distribution plasma lipoproteins apolipoprotein e two groups migrating lipoproteins plasma apob100 levels decreased 33 mice apoe distribution shifted high density lipoproteins larger lipoprotein particles addition fractional catabolic rate exogenously administered remnant particles without apoe 6 fold slower 33 mice compared mice 33 animals fed high fathigh cholesterol diet 33 animals responded dramatic increase 5 fold total cholesterol compared mice 15 fold 12 weeks diet 33 animals developed significantly least 13 fold larger atherosclerotic plaques aortic sinus area animals thus structural differences human apoe3 mouse apoe proteins sufficient cause increased susceptibility dietary induced hypercholesterolemia atherosclerosis 33 mice
0.30876386.9218423.html.plaintext.txt	6	apolipoprotein apo1 e important transport cholesterol triglyceride throughout body amphipathic protein stabilizes structure lipoprotein particles via ability bind lipid functions ligand lipoprotein receptors low density lipoprotein receptor ldlr low density lipoprotein receptor related protein 1 3 apoe major protein component chylomicron remnants low density lipoproteins vldl intermediate density lipoproteins idl present low density lipoproteins ldl apoe also enriched subclass high density lipoproteins hdl functions effective ligand binding ldlr 4
0.30876386.9218423.html.plaintext.txt	7	apolipoprotein apo1 e important transport cholesterol triglyceride throughout body amphipathic protein stabilizes structure lipoprotein particles via ability bind lipid functions ligand lipoprotein receptors low density lipoprotein receptor ldlr low density lipoprotein receptor related protein 1 3 apoe major protein component chylomicron remnants low density lipoproteins vldl intermediate density lipoproteins idl present low density lipoproteins ldl apoe also enriched subclass high density lipoproteins hdl functions effective ligand binding ldlr 4
0.30876386.9218423.html.plaintext.txt	8	human apoe gene located chromosome 19 5 part apolipoprotein cluster also includes genes encoding apoci apocii apociv 6 multiple tissue specific enhancers negative elements identified region proximal gene 7 distal enhancer hepatic control region required liver expression located 15 kb downstream gene 8 9 liver synthesizes approximately 70 apoe found body 20 found brain remainder synthesized several tissues including spleen lung heart ovary testis kidney skin 10 11
0.30876386.9218423.html.plaintext.txt	9	human apoe gene located chromosome 19 5 part apolipoprotein cluster also includes genes encoding apoci apocii apociv 6 multiple tissue specific enhancers negative elements identified region proximal gene 7 distal enhancer hepatic control region required liver expression located 15 kb downstream gene 8 9 liver synthesizes approximately 70 apoe found body 20 found brain remainder synthesized several tissues including spleen lung heart ovary testis kidney skin 10 11
0.30876386.9218423.html.plaintext.txt	10	three major apoe alleles 2 3 4 occur humans frequencies 73 783 143 respectively 12 three alleles distinguished coding differences positions 112 158 13 common isoform apoe3 cysteine position 112 arginine position 158 apoe2 isoform cysteine positions whereas apoe4 isoform arginine positions functionally three isoforms differ affinity ldlr apoe3 e4 exhibiting 100 binding apoe2 displaying 1 normal binding affinity 14 despite lower affinity apoe2 ldlr individuals homozygous 2 typically lower normal plasma cholesterol levels except fraction homozygotes 5 10 develop type iii hyperlipoproteinemia 15 individuals homozygous 4 higher total plasma cholesterol ldl cholesterol compared 3 homozygotes increased risk developing coronary artery disease 16 4 allele also associated development alzheimers disease 17 18
0.30876386.9218423.html.plaintext.txt	11	apoe isoform specific effects important etiology atherosclerosis diseases appropriate animal models rigorously investigate effects currently lacking date transgenic animals made pronuclear injection human dna used study effects method produces mice varying levels transgene expression due differences chromosomal location copy number expression endogenous mouse apoe complicates interpretation data 19 24 47 overcome difficulties used targeted gene replacement generate mice express human apoe3 isoform levels physiological range mice coding sequences mouse apoe replaced sequences coding human apoe3 without disturbing known regulatory sequences replacement results animals expression human apoe mrna identical tissue distribution levels mouse apoe mrna wild type animals
0.30876386.9218423.html.plaintext.txt	12	apoe isoform specific effects important etiology atherosclerosis diseases appropriate animal models rigorously investigate effects currently lacking date transgenic animals made pronuclear injection human dna used study effects method produces mice varying levels transgene expression due differences chromosomal location copy number expression endogenous mouse apoe complicates interpretation data 19 24 47 overcome difficulties used targeted gene replacement generate mice express human apoe3 isoform levels physiological range mice coding sequences mouse apoe replaced sequences coding human apoe3 without disturbing known regulatory sequences replacement results animals expression human apoe mrna identical tissue distribution levels mouse apoe mrna wild type animals
0.30876386.9218423.html.plaintext.txt	13	describe essentially normal cholesterol triglyceride levels mice homozygous human apoe3 33 maintained normal low fat mouse chow diet show markedly susceptible diet induced atherosclerosis wild type littermates
0.30876386.9218423.html.plaintext.txt	14	targeting construct made inserting ppnt vector 25 41 kb saci human genomic fragment isolated plasmid pheg 1 20 kindly provided dr john taylor university california san francisco fragment contains 3 part intron 1 723 base pairs exons 2 4 human apoe3 gene 15 kb 3 flanking dna 53 kb ecori saci strain 129 mouse genomic fragment containing sequences upstream mouse apoe gene including exon 1 5 part intron 1 376 base pairs inserted 5 human apoe3 fragment 14 kb pvui kpni strain 129 mouse genomic fragment containing 3 half exon 4 3 flanking sequence inserted downstream neomycin resistant gene ppnt see fig 1 fig 1 replacement mouse apoe gene human apoe3 gene genomic organization mouse apoe gene containing exons 1 4 black boxes b apoe3 targeting construct containing 5 3 arms mouse homology black line boxes interrupted human apoe3 gene hatched boxes 2 3 4 labeled hue3 neomycin resistant neo thymidine kinase tk genes selection targeted es cells ppnt plasmid vector c resulting chimeric gene encoding human apoe3 mouse exon 4 probe probe used detect targeted allele sizes diagnostic fragments shown dashed lines sites follows e ecori saci h hindiii p pvui k kpni x xbai b bamhi view larger version image 20k gif file
0.30876386.9218423.html.plaintext.txt	15	targeting construct made inserting ppnt vector 25 41 kb saci human genomic fragment isolated plasmid pheg 1 20 kindly provided dr john taylor university california san francisco fragment contains 3 part intron 1 723 base pairs exons 2 4 human apoe3 gene 15 kb 3 flanking dna 53 kb ecori saci strain 129 mouse genomic fragment containing sequences upstream mouse apoe gene including exon 1 5 part intron 1 376 base pairs inserted 5 human apoe3 fragment 14 kb pvui kpni strain 129 mouse genomic fragment containing 3 half exon 4 3 flanking sequence inserted downstream neomycin resistant gene ppnt see fig 1 fig 1 replacement mouse apoe gene human apoe3 gene genomic organization mouse apoe gene containing exons 1 4 black boxes b apoe3 targeting construct containing 5 3 arms mouse homology black line boxes interrupted human apoe3 gene hatched boxes 2 3 4 labeled hue3 neomycin resistant neo thymidine kinase tk genes selection targeted es cells ppnt plasmid vector c resulting chimeric gene encoding human apoe3 mouse exon 4 probe probe used detect targeted allele sizes diagnostic fragments shown dashed lines sites follows e ecori saci h hindiii p pvui k kpni x xbai b bamhi view larger version image 20k gif file
0.30876386.9218423.html.plaintext.txt	16	generation homozygous human apoe3 mice
0.30876386.9218423.html.plaintext.txt	17	subclone bk4 mouse strain 129 embryonic stem es cell line e14tg2a cultured electroporated human apoe3 targeting construct described previously 26 targeted es cell clones identified southern blot analysis chimeras generated mated c57bl6j b6 mice f2 generation mice used experiments described mice kept normal low fat chow diet consisting 5 ww fat 0022 ww cholesterol prolab rmh 3000 number 5p76 st louis mo atherogenic diet contains 158 ww fat 125 ww cholesterol 05 ww sodium cholate tk 88051 teklad premier madison wi
0.30876386.9218423.html.plaintext.txt	18	subclone bk4 mouse strain 129 embryonic stem es cell line e14tg2a cultured electroporated human apoe3 targeting construct described previously 26 targeted es cell clones identified southern blot analysis chimeras generated mated c57bl6j b6 mice f2 generation mice used experiments described mice kept normal low fat chow diet consisting 5 ww fat 0022 ww cholesterol prolab rmh 3000 number 5p76 st louis mo atherogenic diet contains 158 ww fat 125 ww cholesterol 05 ww sodium cholate tk 88051 teklad premier madison wi
0.30876386.9218423.html.plaintext.txt	19	lipid measurements performed mice age 8 20 weeks animals fasted overnight approximately 16 h anesthetized avertin 150 microl blood collected retro orbital sinus tubes containing 8 mm edta 1 microgml aprotinin boehringer mannheim 1 microgml gentamycin stored ice plasma removed centrifugation 8000 x g 10 min 4 degrees c total cholesterol hdl cholesterol measured using diagnostic cii kits wako richmond va according manufacturers instructions triglyceride levels measured using enzymatic kit sigma
0.30876386.9218423.html.plaintext.txt	20	lipid measurements performed mice age 8 20 weeks animals fasted overnight approximately 16 h anesthetized avertin 150 microl blood collected retro orbital sinus tubes containing 8 mm edta 1 microgml aprotinin boehringer mannheim 1 microgml gentamycin stored ice plasma removed centrifugation 8000 x g 10 min 4 degrees c total cholesterol hdl cholesterol measured using diagnostic cii kits wako richmond va according manufacturers instructions triglyceride levels measured using enzymatic kit sigma
0.30876386.9218423.html.plaintext.txt	21	within 1 h blood collection 1 microl plasma electrophoresed precast 1 agarose gels ciba corning diagnostics corp palo alto ca neutral lipids visualized fat red 7b staining sigma one ml pooled plasma 10 mice 100 microl separated sequential density ultracentrifugation seven fractions ranging densities 1006 gml 121 gml using procedure described de silva et al 27 total lipoproteins isolated plasma density 121 gml lipoprotein fractions dialyzed 10 mm tris ph 74 1 mm edta 150 mm nacl electrophoresis 3 20 denaturing sds page gel 27 plasma 100 microl either individual pooled samples separated gel filtration chromatography using superose 6 hr1030 column pharmacia biotech inc immunoblot analysis fplc fractions 2 microl electrophoresed precast 1 agarose gels performed antibodies described
0.30876386.9218423.html.plaintext.txt	22	within 1 h blood collection 1 microl plasma electrophoresed precast 1 agarose gels ciba corning diagnostics corp palo alto ca neutral lipids visualized fat red 7b staining sigma one ml pooled plasma 10 mice 100 microl separated sequential density ultracentrifugation seven fractions ranging densities 1006 gml 121 gml using procedure described de silva et al 27 total lipoproteins isolated plasma density 121 gml lipoprotein fractions dialyzed 10 mm tris ph 74 1 mm edta 150 mm nacl electrophoresis 3 20 denaturing sds page gel 27 plasma 100 microl either individual pooled samples separated gel filtration chromatography using superose 6 hr1030 column pharmacia biotech inc immunoblot analysis fplc fractions 2 microl electrophoresed precast 1 agarose gels performed antibodies described
0.30876386.9218423.html.plaintext.txt	23	total rna extracted several tissues according method chomczynski sacchi 28 using rnazoltm b tel test friendswood tx total rna 20 microg electrophoresed 1 agarose gel denaturation glyoxalme2so mixture 29 rna transferred hybond membrane amersham corp hybridized overnight 42 degrees c 50 formamide 5 x ssc 1 x denhardts solution 100 microg salmon sperm dna 30 mm sodium phosphate ph 65 10 dextran sulfate probe mouse exon 4 dna fragment labeled 32pdctp blot washed 3 x ssc 01 sds 10 min 37 degrees c 01 x ssc 01 sds 10 min 65 degrees c blot exposed preflashed kodak xar film 20 h
0.30876386.9218423.html.plaintext.txt	24	total rna extracted several tissues according method chomczynski sacchi 28 using rnazoltm b tel test friendswood tx total rna 20 microg electrophoresed 1 agarose gel denaturation glyoxalme2so mixture 29 rna transferred hybond membrane amersham corp hybridized overnight 42 degrees c 50 formamide 5 x ssc 1 x denhardts solution 100 microg salmon sperm dna 30 mm sodium phosphate ph 65 10 dextran sulfate probe mouse exon 4 dna fragment labeled 32pdctp blot washed 3 x ssc 01 sds 10 min 37 degrees c 01 x ssc 01 sds 10 min 65 degrees c blot exposed preflashed kodak xar film 20 h
0.30876386.9218423.html.plaintext.txt	25	apoe enzyme linked immunosorbent assay
0.30876386.9218423.html.plaintext.txt	26	human apoe mouse plasma measured sandwich type enzyme linked immunosorbent assay elisa essentially described 30 mouse anti human apoe monoclonal antibody e01 hue m 30 used capture antibody goat anti human apoe antibody hue p calbiochem detecting antibody hue p antibody cross reacts mouse apoe low level hue m antibody shown react human apoe classes lipoprotein particles 30 cross react mouse apoe values determined standard curve made pooled human plasma whose apoe levels determined purified recombinant human apoe3 number 178475 calbiochem validated international calibrator dr n rifai childrens hospital boston ma
0.30876386.9218423.html.plaintext.txt	27	human apoe mouse plasma measured sandwich type enzyme linked immunosorbent assay elisa essentially described 30 mouse anti human apoe monoclonal antibody e01 hue m 30 used capture antibody goat anti human apoe antibody hue p calbiochem detecting antibody hue p antibody cross reacts mouse apoe low level hue m antibody shown react human apoe classes lipoprotein particles 30 cross react mouse apoe values determined standard curve made pooled human plasma whose apoe levels determined purified recombinant human apoe3 number 178475 calbiochem validated international calibrator dr n rifai childrens hospital boston ma
0.30876386.9218423.html.plaintext.txt	28	mouse apoe measured similar manner using purified rabbit anti mouse apoe antibody mue m 10 microgml raised mouse apoe peptide residues 179 241 capture antibody antibody conjugated horseradish peroxidase used detection chromagen mouse peptide residues 179 241 used standard determining concentration mouse apoe
0.30876386.9218423.html.plaintext.txt	29	mouse apoe measured similar manner using purified rabbit anti mouse apoe antibody mue m 10 microgml raised mouse apoe peptide residues 179 241 capture antibody antibody conjugated horseradish peroxidase used detection chromagen mouse peptide residues 179 241 used standard determining concentration mouse apoe
0.30876386.9218423.html.plaintext.txt	30	fasted whole plasma 1 microl electrophoresed 4 20 denaturing sds page gel 1 agarose gel transferred immobilon p membrane millipore corp bedford ma reacted three anti apoe antibodies described immunoreactive proteins visualized horseradish peroxidase conjugate using enhanced chemiluminescence kit amersham corp western blots analysis apob made similarly using 4 sds page rabbit anti mouse apob sera gift dr steven young university california san francisco
0.30876386.9218423.html.plaintext.txt	31	fasted whole plasma 1 microl electrophoresed 4 20 denaturing sds page gel 1 agarose gel transferred immobilon p membrane millipore corp bedford ma reacted three anti apoe antibodies described immunoreactive proteins visualized horseradish peroxidase conjugate using enhanced chemiluminescence kit amersham corp western blots analysis apob made similarly using 4 sds page rabbit anti mouse apob sera gift dr steven young university california san francisco
0.30876386.9218423.html.plaintext.txt	32	four apoe mice injected 20 microg free cholesterol containing 25 microci 4 14c labeled cholesterol dispersed egg lecithinfree cholesterol 11 molar ratio mesophase apoe vldl fraction isolated 36 h later centrifugation 1010 gml 72 tracer cholesterol ester fraction 31 three mice group apoe 33 injected labeled apoe vldl fractional catabolic rates variances determined 4 h described previously 31
0.30876386.9218423.html.plaintext.txt	33	four apoe mice injected 20 microg free cholesterol containing 25 microci 4 14c labeled cholesterol dispersed egg lecithinfree cholesterol 11 molar ratio mesophase apoe vldl fraction isolated 36 h later centrifugation 1010 gml 72 tracer cholesterol ester fraction 31 three mice group apoe 33 injected labeled apoe vldl fractional catabolic rates variances determined 4 h described previously 31
0.30876386.9218423.html.plaintext.txt	34	evaluation atherosclerotic lesions
0.30876386.9218423.html.plaintext.txt	35	female mice fed high fat diet 3 months sacrificed avertin overdose 16 h fast thoracic cavity opened heart vascular system perfused 4 paraformaldehyde phosphate buffered saline ph 74 physiological pressure segments proximal aorta aortic sinus embedded sectioned stained described previously 32 morphometric evaluations lesion size made using nih image version 141 software
0.30876386.9218423.html.plaintext.txt	36	female mice fed high fat diet 3 months sacrificed avertin overdose 16 h fast thoracic cavity opened heart vascular system perfused 4 paraformaldehyde phosphate buffered saline ph 74 physiological pressure segments proximal aorta aortic sinus embedded sectioned stained described previously 32 morphometric evaluations lesion size made using nih image version 141 software
0.30876386.9218423.html.plaintext.txt	37	significance differences means tested using two tailed unpaired student test nonparametric mann whitney u test
0.30876386.9218423.html.plaintext.txt	38	replacement mouse apoe gene human apoe3 allele
0.30876386.9218423.html.plaintext.txt	39	targeting strategy used replace mouse apoe coding exons 2 4 human counterpart illustrated fig 1 homologous recombination targeting construct fig 1b endogenous mouse apoe locus fig 1a results chimeric gene fig 1c mouse coding sequences replaced sequences coding human apoe3 chimeric locus retains normal mouse regulatory sequences addition non coding mouse exon one identification correctly modified embryonic stem es cells southern blot analysis mouse exon 1 exon 4 probe data shown es cell dna digested ecori hybridized mouse exon 1 probe revealed 83 kb endogenous band 78 kb targeted band confirming correct modification 5 region es cell dna digested hindiii hybridized mouse exon 4 probe revealed 75 kb endogenous band 15 kb targeted band confirming correct modification 3 region modified locus transmitted f1 generation chimeras made one targeted cell lines f1 matings produced normal litter sizes normal mendelian segregation pattern modified locus genotypes f2 animals determined using southern blot analysis tail dna digested bamhi fig 2a nucleotide sequence codon 112 tgc codon 158 cgc 33 mouse confirmed using allele specific pcr 33 tail dna fig 2 southern western blot analysis southern analysis mouse exon 4 probe identify f2 mice carrying targeted allele 112 kb hybridizing bamhi fragment indicates presence human apoe3 allele 48 kb hybridizing bamhi fragment indicates presence mouse apoe allele b fasted whole plasma 1 microl electrophoresed 4 20 denaturing sds page gel proteins transferred immobilon p membrane incubated either anti human apoe antisera hue p weakly cross reacts mouse apoe top panel anti mouse apoe antibody mue m middle panel anti human apoe monoclonal antibody hue m bottom panel cross react mouse apoe c fasted whole plasma 1 microl electrophoresed 4 20 sds page gel proteins transferred immobilon p membrane incubated hue p antiserum presence absence mercaptoethanol abbreviations used hu human sample 33 sample homozygous human apoe3 mouse 3 heterozygous sample wild type sample view larger version image 59k gif file
0.30876386.9218423.html.plaintext.txt	40	human apoe3 levels whole plasma
0.30876386.9218423.html.plaintext.txt	41	confirm presence human apoe protein mice plasma 1 microl 33 3 mice human hu electrophoresed 4 20 gradient denaturing sds page gel western blot analysis anti human apoe antisera hue p slightly cross reacts mouse apoe showed human apoe 34 200 da 33 plasma migrates rate apoe human plasma slightly slower mouse apoe 32 600 da plasma fig 2b absence mouse apoe 33 plasma confirmed western blot analysis anti mouse apoe antibody mu m shows mouse apoe present 3 samples 33 plasma contrast anti human apoe monoclonal antibody hue m cross react mouse apoe shows human apoe present 33 3 human plasma plasma fig 2b western blotting plasma two 33 mice 4 20 nonreducing sds page gel showed human apoe3 homodimer present less 5 monomeric e3 fig 2c
0.30876386.9218423.html.plaintext.txt	42	confirm presence human apoe protein mice plasma 1 microl 33 3 mice human hu electrophoresed 4 20 gradient denaturing sds page gel western blot analysis anti human apoe antisera hue p slightly cross reacts mouse apoe showed human apoe 34 200 da 33 plasma migrates rate apoe human plasma slightly slower mouse apoe 32 600 da plasma fig 2b absence mouse apoe 33 plasma confirmed western blot analysis anti mouse apoe antibody mu m shows mouse apoe present 3 samples 33 plasma contrast anti human apoe monoclonal antibody hue m cross react mouse apoe shows human apoe present 33 3 human plasma plasma fig 2b western blotting plasma two 33 mice 4 20 nonreducing sds page gel showed human apoe3 homodimer present less 5 monomeric e3 fig 2c
0.30876386.9218423.html.plaintext.txt	43	concentration apoe 33 plasma 130 plus minus 047 mgdl determined elisa similar levels 113 plus minus 023 mgdl found plasma see table
0.30876386.9218423.html.plaintext.txt	44	table plasma lipid profiles apoe concentration mice fed normal high fat diet
0.30876386.9218423.html.plaintext.txt	45	data means plus minus sd fasted mice receiving chow c high fat hf diet parentheses show number mice tg triglyceride genotype diet tc tg hdl cholesterol human apoe3 mouse apoe mgdl mgdl mgdl mgdl mgdl females 33 c 67 plus minus 18 30 35 plus minus 12 26 46 plus minus 11 26 130 plus minus 047 10 hf 350 plus minus 207 17a 29 plus minus 22 15 22 plus minus 11 14 1080 plus minus 560 8a c 73 plus minus 20 30 43 plus minus 15 26 53 plus minus 15 23 113 plus minus 023 6 hf 111 plus minus 44 17b 21 plus minus 7 14 23 plus minus 15 13 111 plus minus 034 5 males 33 c 104 plus minus 22 15c 39 plus minus 16 13 54 plus minus 19 7 c 95 plus minus 16 15 41 plus minus 17 14 52 plus minus 15 7 p 001 versus 33 females chow b p 0001 versus 33 females high fat c p 0001 versus female 33
0.30876386.9218423.html.plaintext.txt	46	tissue distribution apoe mrna
0.30876386.9218423.html.plaintext.txt	47	total rna extracted several tissues including skin sk spleen sp kidney ki small intestine si stomach st heart testis te muscle mu lung lu liver li submandibular gland su brain br 33 male mouse wild type male mouse northern blot analysis mouse exon 4 probe used compare levels apoe mrna two types animal fig 3 probe hybridizes equally well human gene mouse gene conditions used actin probe hybridized blot removal apoe probe lower panels fig 3 assess amount mrna loaded group agreement previous reports 10 11 apoe mrna expression highest liver second brain lesser amounts tissues apoe mrna detected muscle expression apoe mrna 33 animals essentially indistinguishable tissues analyzed exception small intestine reduced levels apoe mrna 33 animals compared mice northern blot analysis clearly demonstrates modified locus containing human apoe3 coding sequences wild type mouse gene expressed virtually identical levels tissues fig 3 northern blot analysis total rna various tissues total rna 20 microg electrophoresed 1 gel blotted hybridized mouse apoe exon 4 probe indicated filter rehybridized actin probe 3 identifies lanes containing rna human apoe3 mice identifies lanes containing rna wild type mice sk skin sp spleen ki kidney si small intestine st stomach heart te testis mu muscle lu lung li liver su submandibular gland br brain view larger version image 116k gif file
0.30876386.9218423.html.plaintext.txt	48	total rna extracted several tissues including skin sk spleen sp kidney ki small intestine si stomach st heart testis te muscle mu lung lu liver li submandibular gland su brain br 33 male mouse wild type male mouse northern blot analysis mouse exon 4 probe used compare levels apoe mrna two types animal fig 3 probe hybridizes equally well human gene mouse gene conditions used actin probe hybridized blot removal apoe probe lower panels fig 3 assess amount mrna loaded group agreement previous reports 10 11 apoe mrna expression highest liver second brain lesser amounts tissues apoe mrna detected muscle expression apoe mrna 33 animals essentially indistinguishable tissues analyzed exception small intestine reduced levels apoe mrna 33 animals compared mice northern blot analysis clearly demonstrates modified locus containing human apoe3 coding sequences wild type mouse gene expressed virtually identical levels tissues fig 3 northern blot analysis total rna various tissues total rna 20 microg electrophoresed 1 gel blotted hybridized mouse apoe exon 4 probe indicated filter rehybridized actin probe 3 identifies lanes containing rna human apoe3 mice identifies lanes containing rna wild type mice sk skin sp spleen ki kidney si small intestine st stomach heart te testis mu muscle lu lung li liver su submandibular gland br brain view larger version image 116k gif file
0.30876386.9218423.html.plaintext.txt	49	plasma lipids lipoproteins mice fed normal chow
0.30876386.9218423.html.plaintext.txt	50	levels total cholesterol tc triglycerides hdl cholesterol female mice fed normal low fat chow diet determined plasma obtained 16 h fast table difference tc levels 33 mice 67 plus minus 18 mgdl n 30 controls 73 plus minus 20 mgdl n 30 striking contrast total cholesterol levels previously found apoe deficient mice diet 541 plus minus 220 mgdl 32 tc levels males higher females p 00001 differences 33 group triglyceride hdl cholesterol levels 33 mice mice also similar table
0.30876386.9218423.html.plaintext.txt	51	levels total cholesterol tc triglycerides hdl cholesterol female mice fed normal low fat chow diet determined plasma obtained 16 h fast table difference tc levels 33 mice 67 plus minus 18 mgdl n 30 controls 73 plus minus 20 mgdl n 30 striking contrast total cholesterol levels previously found apoe deficient mice diet 541 plus minus 220 mgdl 32 tc levels males higher females p 00001 differences 33 group triglyceride hdl cholesterol levels 33 mice mice also similar table
0.30876386.9218423.html.plaintext.txt	52	fasted wild type plasma lipoproteins migrate three distinct bands designated hdl ldl pre vldl using agarose gel electrophoresis fig 4a plasma fasted 33 mice hand showed increase pre band absence migrating lipoproteins relative samples differences observed plasma male female 33 mice amount migrating particles 33 mice results suggest 33 mice slightly increased amounts vldlidl remnants reduction ldl particles fig 4 analysis plasma lipoproteins fasted plasma 1 microl males females maintained normal low fat chow diet electrophoresed 1 agarose gel stained fat red 7b positions pre lipoproteins indicated b western analysis fasted plasma 1 microl female mice using denaturing 4 sds page gel anti apob antisera positions apob100 48 proteins indicated samples 33 homozygous human apoe3 mice wild type mice c total lipoproteins density 121 gml pooled five female 33 four mice electrophoresed 3 20 sds page gel stained coomassie brilliant blue positions apolipoproteins indicated view larger version image 59k gif file
0.30876386.9218423.html.plaintext.txt	53	determine amount apob100 relative apob48 equal amounts whole plasma 33 female mouse separated 4 sds page gel blotted reacted anti mouse apob sera fig 4b densitometric scan autoradiograph showed 33 sample b100b48 ratio 13 compared b100b48 ratio 108 sample separate experiment total lipoproteins density 121 gml isolated pooled plasma five female 33 mice four mice electrophoresed 3 20 sds page gel coomassie brilliant blue staining gel fig 4c showed plasma apob100 levels 33 mice greatly reduced compared mice apob48 levels higher 33 mice compared mice
0.30876386.9218423.html.plaintext.txt	54	different distribution human mouse apolipoprotein e
0.30876386.9218423.html.plaintext.txt	55	individual plasma samples pooled n 10 plasma samples separated gel filtration chromatography superose 6b column determination cholesterol triglyceride apoe distribution distribution cholesterol solid circles fig 5 b nearly identical 33 mice except small decrease fractions 21 24 33 group decrease ldl cholesterol agrees agarose gel electrophoresis results described triglyceride distribution essentially groups data shown largest percentage triglyceride present fractions 14 16 fig 5 distribution cholesterol apoe mice fed normal chow b pooled plasma 10 mice fractionated gel filtration chromatography superose 6b column 05 ml fractions collected cholesterol measured microgfraction apoe microgfraction measured using elisa antibodies specific human hue m mouse apoe mue m b c d western blot analysis fplc fractions c 33 d electrophoresed 1 agarose gels incubated hue p antiserum cross reacts mouse apoe view larger version image 39k gif file
0.30876386.9218423.html.plaintext.txt	56	individual plasma samples pooled n 10 plasma samples separated gel filtration chromatography superose 6b column determination cholesterol triglyceride apoe distribution distribution cholesterol solid circles fig 5 b nearly identical 33 mice except small decrease fractions 21 24 33 group decrease ldl cholesterol agrees agarose gel electrophoresis results described triglyceride distribution essentially groups data shown largest percentage triglyceride present fractions 14 16 fig 5 distribution cholesterol apoe mice fed normal chow b pooled plasma 10 mice fractionated gel filtration chromatography superose 6b column 05 ml fractions collected cholesterol measured microgfraction apoe microgfraction measured using elisa antibodies specific human hue m mouse apoe mue m b c d western blot analysis fplc fractions c 33 d electrophoresed 1 agarose gels incubated hue p antiserum cross reacts mouse apoe view larger version image 39k gif file
0.30876386.9218423.html.plaintext.txt	57	contrary identical distribution lipids distribution apoe open circles fig 5 b 33 mice markedly different determined elisa mouse human specific antibodies majority apoe mice present hdl region fractions 26 31 minor amount present vldl fractions 14 17 idl ldl regions fractions 18 25 fig 5b western blot analysis fplc fractions electrophoresed agarose gel using hue p antisera support results obtained elisa fig 5d however 33 mice majority apoe present two distinct peaks vldl fractions 14 17 idl species fractions 18 21 typically elute fig 5a western blots agarose gel fplc fraction agreement apoe3 distribution determined elisa fig 5c sds page gel electrophoresis lipoproteins fractionated sequential density ultracentrifugation fig 6a showed apoe3 33 mice found predominantly lower density fractions d 104 gml major differences detectable distributions apolipoproteins ai 33 samples apocs sds page fractions separated sequential density ultracentrifugation fig 6a fig 6 distribution apolipoproteins mice fed either normal high fat diet pooled plasma 10 mice fed normal chow fractionated sequential density ultracentrifugation fraction electrophoresed denaturing sds page 3 20 gradient gel stained coomassie brilliant blue density fractions 1006 1006 gml 102 1006 102 gml 104 102 104 gml 106 104 106 gml 108 106 108 gml 110 108 110 gml 121 110 121 gml b except mice fed high fat diet 3 months view larger version image 75k gif file
0.30876386.9218423.html.plaintext.txt	58	contrary identical distribution lipids distribution apoe open circles fig 5 b 33 mice markedly different determined elisa mouse human specific antibodies majority apoe mice present hdl region fractions 26 31 minor amount present vldl fractions 14 17 idl ldl regions fractions 18 25 fig 5b western blot analysis fplc fractions electrophoresed agarose gel using hue p antisera support results obtained elisa fig 5d however 33 mice majority apoe present two distinct peaks vldl fractions 14 17 idl species fractions 18 21 typically elute fig 5a western blots agarose gel fplc fraction agreement apoe3 distribution determined elisa fig 5c sds page gel electrophoresis lipoproteins fractionated sequential density ultracentrifugation fig 6a showed apoe3 33 mice found predominantly lower density fractions d 104 gml major differences detectable distributions apolipoproteins ai 33 samples apocs sds page fractions separated sequential density ultracentrifugation fig 6a fig 6 distribution apolipoproteins mice fed either normal high fat diet pooled plasma 10 mice fed normal chow fractionated sequential density ultracentrifugation fraction electrophoresed denaturing sds page 3 20 gradient gel stained coomassie brilliant blue density fractions 1006 1006 gml 102 1006 102 gml 104 102 104 gml 106 104 106 gml 108 106 108 gml 110 108 110 gml 121 110 121 gml b except mice fed high fat diet 3 months view larger version image 75k gif file
0.30876386.9218423.html.plaintext.txt	59	idl like peak 33 plasma particularly noteworthy since cholesterol triglyceride fractions low idl like particles enriched apoe3 likely represent vldlchylomicron remnants since agarose gel electrophoresis fplc fractions followed western blotting hue p antisera demonstrated majority apoe3 associated particles migrating pre position association apoe3 large hdl particles position minimal fig 5c fplc analysis plasma immunoprecipitation anti mouse apob antibody confirms idl like particles contain apob data shown interestingly fplc analysis plasma mice heterozygous human apoe3 3 showed shift second apoe3 peak fractions 21 25 suggesting co presence mouse apoe reduces size remnant particles apoe3 accumulates data shown increase mouse apoe associated larger particles also evident heterozygote although approximately half mouse apoe still found associated hdl
0.30876386.9218423.html.plaintext.txt	60	idl like peak 33 plasma particularly noteworthy since cholesterol triglyceride fractions low idl like particles enriched apoe3 likely represent vldlchylomicron remnants since agarose gel electrophoresis fplc fractions followed western blotting hue p antisera demonstrated majority apoe3 associated particles migrating pre position association apoe3 large hdl particles position minimal fig 5c fplc analysis plasma immunoprecipitation anti mouse apob antibody confirms idl like particles contain apob data shown interestingly fplc analysis plasma mice heterozygous human apoe3 3 showed shift second apoe3 peak fractions 21 25 suggesting co presence mouse apoe reduces size remnant particles apoe3 accumulates data shown increase mouse apoe associated larger particles also evident heterozygote although approximately half mouse apoe still found associated hdl
0.30876386.9218423.html.plaintext.txt	61	response atherogenic diet
0.30876386.9218423.html.plaintext.txt	62	33 n 12 n 12 female mice used measure lipid profiles normal chow fed atherogenic diet 8 weeks assess change response diet two groups one animal showed significant weight loss yellow colored plasma diet study excluded 33 mice responded 5 fold increase cholesterol 350 plus minus 207 versus 67 plus minus 18 mgdl whereas cholesterol control mice increased 15 fold 111 plus minus 44 versus 73 plus minus 20 mgdl table triglyceride levels 33 mice reduced 18 50 respectively hdl cholesterol levels reduced groups mice extent approximately 50 agarose gel electrophoresis plasma types animals showed decrease migrating particles increase pre migrating particles consistent total lipid measurements data shown results suggest marked increase remnant particles concurrent reduction hdl response atherogenic diet types mice extent increase 33 mice much larger
0.30876386.9218423.html.plaintext.txt	63	33 n 12 n 12 female mice used measure lipid profiles normal chow fed atherogenic diet 8 weeks assess change response diet two groups one animal showed significant weight loss yellow colored plasma diet study excluded 33 mice responded 5 fold increase cholesterol 350 plus minus 207 versus 67 plus minus 18 mgdl whereas cholesterol control mice increased 15 fold 111 plus minus 44 versus 73 plus minus 20 mgdl table triglyceride levels 33 mice reduced 18 50 respectively hdl cholesterol levels reduced groups mice extent approximately 50 agarose gel electrophoresis plasma types animals showed decrease migrating particles increase pre migrating particles consistent total lipid measurements data shown results suggest marked increase remnant particles concurrent reduction hdl response atherogenic diet types mice extent increase 33 mice much larger
0.30876386.9218423.html.plaintext.txt	64	elution profile superose 6 gel filtration column 33 plasma fig 7a showed majority highly elevated cholesterol vldl idl fractions whereas group modestly increased cholesterol distributed equally vldl hdl fractions fig 7b expected mice distribution apoe followed cholesterol fig 7b apoe distribution pattern 33 animals highly unusual similar seen animals fed normal chow diet two distinct classes lipoproteins vldl idl range associated human apoe fig 7a large increase plasma apoe 33 animals 1080 plus minus 560 versus 130 plus minus 047 mgdl compared increase animals 111 plus minus 034 versus 113 plus minus 023 mgdl two diets table fig 7 distribution cholesterol apoe mice high fat hf diet b plasma 10 mice pooled group lipoproteins fractionated gel filtration chromatography superose 6b column 05 ml fractions collected cholesterol measured microgfraction apoe microgfraction measured using elisa antibodies specific human hue m mouse apoe mue m b view larger version image 17k gif file
0.30876386.9218423.html.plaintext.txt	65	elution profile superose 6 gel filtration column 33 plasma fig 7a showed majority highly elevated cholesterol vldl idl fractions whereas group modestly increased cholesterol distributed equally vldl hdl fractions fig 7b expected mice distribution apoe followed cholesterol fig 7b apoe distribution pattern 33 animals highly unusual similar seen animals fed normal chow diet two distinct classes lipoproteins vldl idl range associated human apoe fig 7a large increase plasma apoe 33 animals 1080 plus minus 560 versus 130 plus minus 047 mgdl compared increase animals 111 plus minus 034 versus 113 plus minus 023 mgdl two diets table fig 7 distribution cholesterol apoe mice high fat hf diet b plasma 10 mice pooled group lipoproteins fractionated gel filtration chromatography superose 6b column 05 ml fractions collected cholesterol measured microgfraction apoe microgfraction measured using elisa antibodies specific human hue m mouse apoe mue m b view larger version image 17k gif file
0.30876386.9218423.html.plaintext.txt	66	distributions several plasma apolipoproteins also different 33 mice fed high fat diet fig 6b comparison apolipoprotein distribution among density fractions sds page fig 6 normal chow b high fat revealed marked increase high fat diet apoe ai aiv mainly 1006 104 gml fractions mice contrast 33 mice showed increases proteins whole density range particular interest increase apoai 1006 d 104 fraction apoaiv 104 d 106 fraction 33 mice amount apob48 increased 33 mice compared mice distribution different
0.30876386.9218423.html.plaintext.txt	67	delayed clearance apoe deficient vldl 33 mice
0.30876386.9218423.html.plaintext.txt	68	marked increase cholesterol rich remnant particles seen 33 animals response atherogenic diet suggests human apoe3 effective murine homologue clearance particles mice test possibility injected 14c radiolabeled remnant particles 72 cholesterol ester vldl flotation range prepared apoe deficient mice mice fed normal chow measured decay label 4 h period decay 14ccholesterol rapid mice virtually complete 15 min fig 8 fractional catabolic rate mice based single compartment system 012 plus minus 0002min clearance lipoproteins apoe mice considerably slower fractional catabolic rate 0005 plus minus 00003min 33 mice rate 002 plus minus 00003min 6 fold slower mice rapid apoe mice note however within 2 h amount label remaining 33 mice decreased levels seen mice fig 8 plasma clearance apoe remnant particles controls 33 mice three mice group apoe deficient mice e 33 injected radiolabeled apoe remnant particles clearance measured 4 h data point shows mean plus minus sd abbreviations 33 homozygous human apoe3 mice wild type mice e apoe deficient mice view larger version image 18k gif file
0.30876386.9218423.html.plaintext.txt	69	marked increase cholesterol rich remnant particles seen 33 animals response atherogenic diet suggests human apoe3 effective murine homologue clearance particles mice test possibility injected 14c radiolabeled remnant particles 72 cholesterol ester vldl flotation range prepared apoe deficient mice mice fed normal chow measured decay label 4 h period decay 14ccholesterol rapid mice virtually complete 15 min fig 8 fractional catabolic rate mice based single compartment system 012 plus minus 0002min clearance lipoproteins apoe mice considerably slower fractional catabolic rate 0005 plus minus 00003min 33 mice rate 002 plus minus 00003min 6 fold slower mice rapid apoe mice note however within 2 h amount label remaining 33 mice decreased levels seen mice fig 8 plasma clearance apoe remnant particles controls 33 mice three mice group apoe deficient mice e 33 injected radiolabeled apoe remnant particles clearance measured 4 h data point shows mean plus minus sd abbreviations 33 homozygous human apoe3 mice wild type mice e apoe deficient mice view larger version image 18k gif file
0.30876386.9218423.html.plaintext.txt	70	morphometric evaluations aortic lesions
0.30876386.9218423.html.plaintext.txt	71	3 months atherogenic diet 33 animals females evaluated atherosclerotic lesions measurements made sections proximal aorta near aortic valve attachment sites six 33 animals developed substantial atherosclerotic lesions logarithmic mean area 64 x 104 microm2 ranging 24 x 104 168 x 104 contrast four five animals developed fatty streak lesions small logarithmic mean area 51 x 103 microm2 ranging 29 x 103 92 x 103 fig 9 one animal lesions observations clearly demonstrate 33 mice much susceptible diet induced atherosclerosis mice fig 9 morphometric evaluation atherosclerotic lesions mice fed atherogenic diet mice f2 females kept atherogenic diet 12 weeks sacrifice measurements animal made single section proximal aorta near aortic valve attachment site logarithmic means lesion areas six 33 mice four five mice indicated p 0006 one mouse lesions view larger version image 17k gif file
0.30876386.9218423.html.plaintext.txt	72	3 months atherogenic diet 33 animals females evaluated atherosclerotic lesions measurements made sections proximal aorta near aortic valve attachment sites six 33 animals developed substantial atherosclerotic lesions logarithmic mean area 64 x 104 microm2 ranging 24 x 104 168 x 104 contrast four five animals developed fatty streak lesions small logarithmic mean area 51 x 103 microm2 ranging 29 x 103 92 x 103 fig 9 one animal lesions observations clearly demonstrate 33 mice much susceptible diet induced atherosclerosis mice fig 9 morphometric evaluation atherosclerotic lesions mice fed atherogenic diet mice f2 females kept atherogenic diet 12 weeks sacrifice measurements animal made single section proximal aorta near aortic valve attachment site logarithmic means lesion areas six 33 mice four five mice indicated p 0006 one mouse lesions view larger version image 17k gif file
0.30876386.9218423.html.plaintext.txt	73	successfully replaced coding sequence mouse apoe gene equivalent human apoe3 coding region without altering known endogenous regulatory sequences expression human apoe mrna liver brain tissues parallels found normally wild type mice thus human apoe3 protein functional expressed physiological levels modified mice thereby providing model studying function human apoe3 vivo
0.30876386.9218423.html.plaintext.txt	74	successfully replaced coding sequence mouse apoe gene equivalent human apoe3 coding region without altering known endogenous regulatory sequences expression human apoe mrna liver brain tissues parallels found normally wild type mice thus human apoe3 protein functional expressed physiological levels modified mice thereby providing model studying function human apoe3 vivo
0.30876386.9218423.html.plaintext.txt	75	date pronuclear injection dna used generate transgenic animals expressing various forms human apoe study role lipid metabolism 19 24 47 three severe limitations approach follows number copies transgene vary wide ranges marked uncontrolled differences expression transgenes different chromosomal locations presence endogenous mouse protein complicates interpretation results importantly rigorous comparisons different isoforms possible variable expression inherent conventional transgenic animals
0.30876386.9218423.html.plaintext.txt	76	date pronuclear injection dna used generate transgenic animals expressing various forms human apoe study role lipid metabolism 19 24 47 three severe limitations approach follows number copies transgene vary wide ranges marked uncontrolled differences expression transgenes different chromosomal locations presence endogenous mouse protein complicates interpretation results importantly rigorous comparisons different isoforms possible variable expression inherent conventional transgenic animals
0.30876386.9218423.html.plaintext.txt	77	mice made replacement endogenous mouse coding region equivalent region human gene retain natural chromosomal context apoe locus thus locus specific sequences enhancers altered except possible intragenic control sequences differ mice humans therefore expected tissue specific expression human replacement apoe3 gene would closely parallel endogenous mouse apoe gene mrna studies show expectation indeed fulfilled exception intestinal apoe mrna slightly reduced 33 mice compared mice significance reduction intestinal expression clear considering intestinal apoe expression low compared tissues chylomicrons originating small intestine known contain little apoe 34 35 differences 33 mice consequently highly informative far function apolipoprotein concerned thus gene replacement demonstrates advantages pronuclear injection generating transgenic animals
0.30876386.9218423.html.plaintext.txt	78	mice made replacement endogenous mouse coding region equivalent region human gene retain natural chromosomal context apoe locus thus locus specific sequences enhancers altered except possible intragenic control sequences differ mice humans therefore expected tissue specific expression human replacement apoe3 gene would closely parallel endogenous mouse apoe gene mrna studies show expectation indeed fulfilled exception intestinal apoe mrna slightly reduced 33 mice compared mice significance reduction intestinal expression clear considering intestinal apoe expression low compared tissues chylomicrons originating small intestine known contain little apoe 34 35 differences 33 mice consequently highly informative far function apolipoprotein concerned thus gene replacement demonstrates advantages pronuclear injection generating transgenic animals
0.30876386.9218423.html.plaintext.txt	79	lipid profiles 33 mice similar mice maintained chow low fat diet fasting levels total cholesterol triglyceride hdl cholesterol essentially identical two animals however mice fed high fat diet 33 animals responded 5 fold increase total cholesterol compared 15 fold increase animals second 3 months high fat diet atherosclerotic plaques seen 33 animals 13 fold larger observed wild type controls third 6 fold slower clearance rate remnant lipoprotein particles 33 animals accumulation cholesterol delayed clearance remnant particles observed 33 animals likely causes increased susceptibility lesion development
0.30876386.9218423.html.plaintext.txt	80	lipid profiles 33 mice similar mice maintained chow low fat diet fasting levels total cholesterol triglyceride hdl cholesterol essentially identical two animals however mice fed high fat diet 33 animals responded 5 fold increase total cholesterol compared 15 fold increase animals second 3 months high fat diet atherosclerotic plaques seen 33 animals 13 fold larger observed wild type controls third 6 fold slower clearance rate remnant lipoprotein particles 33 animals accumulation cholesterol delayed clearance remnant particles observed 33 animals likely causes increased susceptibility lesion development
0.30876386.9218423.html.plaintext.txt	81	dramatic delay clearance remnant particles 33 mice unexpected since previous studies using transgenic mice expressing human apoe revealed normal enhanced clearance kinetics 22 36 one possible explanation observed delay clearance human apoe3 protein lower affinity mouse ldlr andor receptors mouse apoe species differences structures mouse human apoe differ 30 amino acid sequences differences amino carboxyl termini 1 receptor binding domain residues 136 160 highly conserved mouse human apoe since 21 25 residues identical region including seven residues designated critical receptor binding 37 38 residues differ conservative substitutions eg methionine leucine affect net charge hydrophobicity protein would predicted substantial effects protein conformation 39 thus must ascribed differences outside receptor binding domain affinity receptor differs mouse human apoe proteins species differences receptors interact apoe ldlr low density lipoprotein receptor related protein could also contribute lower affinity
0.30876386.9218423.html.plaintext.txt	82	dramatic delay clearance remnant particles 33 mice unexpected since previous studies using transgenic mice expressing human apoe revealed normal enhanced clearance kinetics 22 36 one possible explanation observed delay clearance human apoe3 protein lower affinity mouse ldlr andor receptors mouse apoe species differences structures mouse human apoe differ 30 amino acid sequences differences amino carboxyl termini 1 receptor binding domain residues 136 160 highly conserved mouse human apoe since 21 25 residues identical region including seven residues designated critical receptor binding 37 38 residues differ conservative substitutions eg methionine leucine affect net charge hydrophobicity protein would predicted substantial effects protein conformation 39 thus must ascribed differences outside receptor binding domain affinity receptor differs mouse human apoe proteins species differences receptors interact apoe ldlr low density lipoprotein receptor related protein could also contribute lower affinity
0.30876386.9218423.html.plaintext.txt	83	dysfunctional interaction human apoe3 mouse heparan sulfate proteoglycans hspg may also contribute delay clearance postulated hspgs involved initial sequestration process enhances uptake apoe containing lipoproteins 40 41 interaction apoe hspgs thought occur mainly via electrostatic attraction 42 human apoe3 cysteine position 112 mouse protein arginine equivalent position mouse apoe residue 104 charge difference could significant even though residue 112 outside known heparin binding domain
0.30876386.9218423.html.plaintext.txt	84	dysfunctional interaction human apoe3 mouse heparan sulfate proteoglycans hspg may also contribute delay clearance postulated hspgs involved initial sequestration process enhances uptake apoe containing lipoproteins 40 41 interaction apoe hspgs thought occur mainly via electrostatic attraction 42 human apoe3 cysteine position 112 mouse protein arginine equivalent position mouse apoe residue 104 charge difference could significant even though residue 112 outside known heparin binding domain
0.30876386.9218423.html.plaintext.txt	85	delayed clearance could also due protein protein interactions involving receptors several proteins known interact apoe play role lipid metabolism example interaction apoe hepatic lipoprotein lipases mediatesor enhances catabolism lipoproteins 41 lipoprotein particles containing human apoe3 may less efficient type interaction mouse apoe would important consequences remodeling processing phase lipoprotein catabolism
0.30876386.9218423.html.plaintext.txt	86	delayed clearance could also due protein protein interactions involving receptors several proteins known interact apoe play role lipid metabolism example interaction apoe hepatic lipoprotein lipases mediatesor enhances catabolism lipoproteins 41 lipoprotein particles containing human apoe3 may less efficient type interaction mouse apoe would important consequences remodeling processing phase lipoprotein catabolism
0.30876386.9218423.html.plaintext.txt	87	another consideration clearance experiment exogenously introduced remnant particles acquire apoe prior removal receptors mice plasma apoe associated hdl particles presumably source apoe used clear exogenously added remnants 33 animals however majority plasma apoe3 associated large lipoproteins may transfer easily exogenously added particles support others 27 noted distributions apoe among mouse plasma lipoproteins analyzed fplc ultracentrifugation always agree apoe associated hdl readily lost ultracentrifugation although capacity apoe3 exchange different classes lipoproteins documented decreased ability apoe3 transfer large lipoproteins may important implications
0.30876386.9218423.html.plaintext.txt	88	another consideration clearance experiment exogenously introduced remnant particles acquire apoe prior removal receptors mice plasma apoe associated hdl particles presumably source apoe used clear exogenously added remnants 33 animals however majority plasma apoe3 associated large lipoproteins may transfer easily exogenously added particles support others 27 noted distributions apoe among mouse plasma lipoproteins analyzed fplc ultracentrifugation always agree apoe associated hdl readily lost ultracentrifugation although capacity apoe3 exchange different classes lipoproteins documented decreased ability apoe3 transfer large lipoproteins may important implications
0.30876386.9218423.html.plaintext.txt	89	association apoe3 larger lipoproteins mice fig 5 c different observations made humans demonstrate preference apoe3 hdl 1 43 unlikely difference result mutation unexpectedly introduced apoe3 gene manipulation work2 observed transgenic apoe3 mice endogenous apoe background virtually identical apoe3 distribution pattern seen 33 replacement mice mice made pronuclear injection human cosmid clone isolated different individual one used make mice 24 similar findings also reported taylor et al 44 transgenic apoe3 mice also express mouse apoe showed majority human apoe3 resided larger lipoprotein particles using sds page immunoblot analysis fractions separated sequential density ultracentrifugation work authors also found mouse apoe human apoe co distributed among lipoproteins different results fplc analysis 3 heterozygote plasma shows approximately half mouse apoe minor fraction human apoe3 associated hdl data shown known whether observed differences work taylor et al result different techniques used fractionate plasma lipoproteins result different levels human apoe mouse apoe expression two types mice characterization large apoe3 rich lipoprotein particles required understand observed delay clearance 33 animals
0.30876386.9218423.html.plaintext.txt	90	association apoe3 larger lipoproteins mice fig 5 c different observations made humans demonstrate preference apoe3 hdl 1 43 unlikely difference result mutation unexpectedly introduced apoe3 gene manipulation work2 observed transgenic apoe3 mice endogenous apoe background virtually identical apoe3 distribution pattern seen 33 replacement mice mice made pronuclear injection human cosmid clone isolated different individual one used make mice 24 similar findings also reported taylor et al 44 transgenic apoe3 mice also express mouse apoe showed majority human apoe3 resided larger lipoprotein particles using sds page immunoblot analysis fractions separated sequential density ultracentrifugation work authors also found mouse apoe human apoe co distributed among lipoproteins different results fplc analysis 3 heterozygote plasma shows approximately half mouse apoe minor fraction human apoe3 associated hdl data shown known whether observed differences work taylor et al result different techniques used fractionate plasma lipoproteins result different levels human apoe mouse apoe expression two types mice characterization large apoe3 rich lipoprotein particles required understand observed delay clearance 33 animals
0.30876386.9218423.html.plaintext.txt	91	reduced clearance rate remnant particles 33 mice whatever cause eventually proves sufficient cause alteration fasted plasma cholesterol levels animals relative littermates animals normal chow diet 33 mice however much susceptible diet induced hyperlipidemia atherosclerosis littermates possibly high fat diet postprandial accumulation vldls occurs leads development atherosclerosis suggested zilversmit 45 human apoe2 homozygous individuals type iii hyperlipoproteinemia abnormal accumulation remnant particles suggested cause accelerated coronary peripheral vascular disease 46 even small changes lipid metabolism decrease clearance efficiency lipoproteins likely dramatic effects development atherosclerosis thus 33 animals give us opportunity investigate changes important
0.30876386.9218423.html.plaintext.txt	92	reduced clearance rate remnant particles 33 mice whatever cause eventually proves sufficient cause alteration fasted plasma cholesterol levels animals relative littermates animals normal chow diet 33 mice however much susceptible diet induced hyperlipidemia atherosclerosis littermates possibly high fat diet postprandial accumulation vldls occurs leads development atherosclerosis suggested zilversmit 45 human apoe2 homozygous individuals type iii hyperlipoproteinemia abnormal accumulation remnant particles suggested cause accelerated coronary peripheral vascular disease 46 even small changes lipid metabolism decrease clearance efficiency lipoproteins likely dramatic effects development atherosclerosis thus 33 animals give us opportunity investigate changes important
0.30876386.9218423.html.plaintext.txt	93	conclusion demonstrated use targeted gene replacement generate mice expressing common human isoform apoe3 physiological levels mice allow us document behavior human apoe3 isoform vivo mice without co expression mouse apoe future experiments comparing mice mice expressing human apoe2 e4 isoforms created identical manner prove invaluable studying diseases related different human apoe isoforms
0.30876386.9218423.html.plaintext.txt	94	conclusion demonstrated use targeted gene replacement generate mice expressing common human isoform apoe3 physiological levels mice allow us document behavior human apoe3 isoform vivo mice without co expression mouse apoe future experiments comparing mice mice expressing human apoe2 e4 isoforms created identical manner prove invaluable studying diseases related different human apoe isoforms
0.30876386.9218423.html.plaintext.txt	95	work supported national institute health grant hl42630the costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact supported part fellowships arcol france uehara memorial foundation japan respectively current address yokohama city university kihara institute biological research yokohama 244 japan current address dept pathology university texas san antonio tx 78284 7750 correspondence addressed tel 919 966 6916 fax 919 966 8800 1 abbreviations used apo apolipoprotein ldlr low density lipoprotein receptor vldl low density lipoprotein idl intermediate density lipoprotein ldl low density lipoprotein r receptor hdl high density lipoprotein hspg heparan sulfate proteoglycans 33 mice homozygous human apoe3 allele 3 mice heterozygous human apoe3 mice homozygous wild type mouse apoe allele kb kilobase es cell embryonic stem cell tc total cholesterol elisa enzyme linked immunosorbent assay hu human fplc fast protein liquid chromatography page polyacrylamide gel electrophoresis 2 p m sullivan n maeda unpublished observations acknowledgements
0.30876386.9218423.html.plaintext.txt	96	work supported national institute health grant hl42630the costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact supported part fellowships arcol france uehara memorial foundation japan respectively current address yokohama city university kihara institute biological research yokohama 244 japan current address dept pathology university texas san antonio tx 78284 7750 correspondence addressed tel 919 966 6916 fax 919 966 8800 1 abbreviations used apo apolipoprotein ldlr low density lipoprotein receptor vldl low density lipoprotein idl intermediate density lipoprotein ldl low density lipoprotein r receptor hdl high density lipoprotein hspg heparan sulfate proteoglycans 33 mice homozygous human apoe3 allele 3 mice heterozygous human apoe3 mice homozygous wild type mouse apoe allele kb kilobase es cell embryonic stem cell tc total cholesterol elisa enzyme linked immunosorbent assay hu human fplc fast protein liquid chromatography page polyacrylamide gel electrophoresis 2 p m sullivan n maeda unpublished observations acknowledgements
0.30876386.9218423.html.plaintext.txt	97	thank dr masahiko watanabe help building targeting construct daniel throckmorton brian oswald denise lee kim kluckman technical help also thank dr j taylor apoe3 plasmid dr j c fruchart e01 antibody dr young anti mouse apob sera dr n rifai validation human apoe standard dr o smithies dr h desilva dr kirby reviewing manuscript
0.3103701.9811940.html.plaintext.txt	0	genetic association alpha2 macroglobulin val1000ile polymorphism alzheimers disease
0.3103701.9811940.html.plaintext.txt	1	alzheimer research unit neurology service massachusetts general hospital 149 13th street cny 6405 charlestown ma 02129 usa 1university hamburg hamburg germany 2irccs giovanni de dio fbf brescia italy 3university basel basel switzerland
0.3103701.9811940.html.plaintext.txt	2	alzheimer research unit neurology service massachusetts general hospital 149 13th street cny 6405 charlestown ma 02129 usa 1university hamburg hamburg germany 2irccs giovanni de dio fbf brescia italy 3university basel basel switzerland
0.3103701.9811940.html.plaintext.txt	3	received july 2 1998 revised accepted august 20 1998
0.3103701.9811940.html.plaintext.txt	4	alpha2 macroglobulin a2m proteinase inhibitor found association senile plaques sp alzheimers disease ad a2m implicated biochemically binding degradation amyloid beta abeta protein accumulates sp studied relationship alzheimers disease common a2m polymorphism val1000 gtcile1000 atc occurs near thiolester active site molecule initial exploratory data set 90 controls 171 alzheimers disease noted increased frequency gg genotype 007 012 therefore tested hypothesis gg genotype represented alzheimers disease additional independent data set group 359 controls 566 alzheimers disease patients hypothesis testing cohort gg genotype increased 007 controls 012 alzheimers disease p 005 fishers exact test odds ratio alzheimers disease associated gg genotype 177 116 270 p 001 combination apoe4 968 95 ci 391 240 p 0001 presence g allele associated increase abeta burden small series a2m receptor a2m rlrp multifunctional receptor whose ligands include apolipoprotein e amyloid precursor protein four proteins genetically linked alzheimers disease suggesting may participate common disease pathway
0.3103701.9811940.html.plaintext.txt	5	alpha2 macroglobulin a2m proteinase inhibitor found association senile plaques sp alzheimers disease ad a2m implicated biochemically binding degradation amyloid beta abeta protein accumulates sp studied relationship alzheimers disease common a2m polymorphism val1000 gtcile1000 atc occurs near thiolester active site molecule initial exploratory data set 90 controls 171 alzheimers disease noted increased frequency gg genotype 007 012 therefore tested hypothesis gg genotype represented alzheimers disease additional independent data set group 359 controls 566 alzheimers disease patients hypothesis testing cohort gg genotype increased 007 controls 012 alzheimers disease p 005 fishers exact test odds ratio alzheimers disease associated gg genotype 177 116 270 p 001 combination apoe4 968 95 ci 391 240 p 0001 presence g allele associated increase abeta burden small series a2m receptor a2m rlrp multifunctional receptor whose ligands include apolipoprotein e amyloid precursor protein four proteins genetically linked alzheimers disease suggesting may participate common disease pathway
0.3103701.9811940.html.plaintext.txt	6	alpha2 macroglobulin a2m proteinase inhibitor inhibits proteinases classes steric trapping mechanism tetrameric a2m structure undergoes conformational change upon cleavage peptide bond bait region proteinase conformational change traps proteinase a2m implicated several pathophysiological processes alzheimers disease a2m immunostains senile plaques sp 1 3 binds amyloid beta protein abeta 1 42 high affinity apparent kd 10 nm 4 moreover recent data suggest serine proteinase a2m complex degrade abeta 5 trypsin activated a2m efficiently degrades abeta vitro prevents vitro formation thioflavin positive abeta fibrils well abeta induced toxicity cultured human cortical neuronal cells 6
0.3103701.9811940.html.plaintext.txt	7	alpha2 macroglobulin a2m proteinase inhibitor inhibits proteinases classes steric trapping mechanism tetrameric a2m structure undergoes conformational change upon cleavage peptide bond bait region proteinase conformational change traps proteinase a2m implicated several pathophysiological processes alzheimers disease a2m immunostains senile plaques sp 1 3 binds amyloid beta protein abeta 1 42 high affinity apparent kd 10 nm 4 moreover recent data suggest serine proteinase a2m complex degrade abeta 5 trypsin activated a2m efficiently degrades abeta vitro prevents vitro formation thioflavin positive abeta fibrils well abeta induced toxicity cultured human cortical neuronal cells 6
0.3103701.9811940.html.plaintext.txt	8	activated a2m cleared a2m rlow density lipoprotein receptor related protein a2m rlrp a2m rlrp multifunctional receptor interestingly also primary neuronal apolipoprotein e apoe receptor 78 lrp also binds clears kunitz proteinase inhibitor containing isoforms amyloid precursor protein app 9 thus a2m potentially impacts apoe app metabolism brain
0.3103701.9811940.html.plaintext.txt	9	activated a2m cleared a2m rlow density lipoprotein receptor related protein a2m rlrp a2m rlrp multifunctional receptor interestingly also primary neuronal apolipoprotein e apoe receptor 78 lrp also binds clears kunitz proteinase inhibitor containing isoforms amyloid precursor protein app 9 thus a2m potentially impacts apoe app metabolism brain
0.3103701.9811940.html.plaintext.txt	10	biological links alzheimers disease studied possible association previously reported polymorphism a2m gene alzheimers disease poller et al 10 screened 30 normal 30 pulmonary disease patients a2m polymorphisms near active site reported three a2m polymorphisms common occurred 25 amino acids downstream thiolester site interchanging val1000 gtc ile1000 atc 10 numbering based cdna sequence includes 24 amino acid signal peptide corresponds valile976 mature protein allele frequencies 60 probands 03 gtc 07 atc difference a2m serum levels associated two alleles polymorphism especially interesting potential biologically relevant function a2m proteinase inhibitor occurs near thiolester active site molecule
0.3103701.9811940.html.plaintext.txt	11	initial exploratory experiment tested possibility less common form a2m g allele would associated alzheimers disease potential error due multiple hypothesis testing planned use initial data set exploratory data set intent formulate specific hypotheses would tested formally second independent data set genotyped 90 non alzheimers individuals either undergone screening tests blessed dementia scale 11 whose dna isolated autopsy material demonstrated alzheimers disease 171 individuals either clinical diagnosis alzheimers disease neuropathologically proven alzheimers disease table 1 genotypes determined pcr amplification dna restriction enzyme digestion fig 1 control series g allele frequency 028 six 90 individuals contained gg genotype 0067 alzheimers disease set g allele frequency 032 noticed gg genotype frequency increased alzheimers group 012 table 1 results suggest possible influence a2m polymorphism genetic risk factor alzheimers disease
0.3103701.9811940.html.plaintext.txt	12	initial exploratory experiment tested possibility less common form a2m g allele would associated alzheimers disease potential error due multiple hypothesis testing planned use initial data set exploratory data set intent formulate specific hypotheses would tested formally second independent data set genotyped 90 non alzheimers individuals either undergone screening tests blessed dementia scale 11 whose dna isolated autopsy material demonstrated alzheimers disease 171 individuals either clinical diagnosis alzheimers disease neuropathologically proven alzheimers disease table 1 genotypes determined pcr amplification dna restriction enzyme digestion fig 1 control series g allele frequency 028 six 90 individuals contained gg genotype 0067 alzheimers disease set g allele frequency 032 noticed gg genotype frequency increased alzheimers group 012 table 1 results suggest possible influence a2m polymorphism genetic risk factor alzheimers disease
0.3103701.9811940.html.plaintext.txt	13	figure 1 electrophoresis pattern restriction digest demonstrating bands representing g 532 bp alleles 429 bp
0.3103701.9811940.html.plaintext.txt	14	table 1 representation a2m gg genotype alzheimers disease n g allele gg genotype exploratory data set control 90 028 007 ad 171 032 012 hypothesis testing data set control 359 032 007 ad 566 034 012a combined data set total control 449 032 007 ad 737 034 012b ap 005 bp 001
0.3103701.9811940.html.plaintext.txt	15	formally test hypothesis gg genotype a2m represented alzheimers disease collected genotyped additional independent groups patients controls power analysis showed 500 alzheimers disease control individuals would necessary 80 chance showing difference genotype frequencies 007 012 therefore collected cases controls several sites order approximate number samples second data set consisted individuals met criteria alzheimers disease control hypothesis generating set derived sporadic alzheimers disease patients massachusetts three european centers probands multicenter us study sib pairs small families results second data set supported hypothesis gg genotype frequencies 007 controls 012 alzheimers disease p 005 fishers exact test table 1 g allele represented data set control 032 alzheimers disease 034 difference age onset gg non gg found second data set multivariate analysis showed site collection influence genotype frequencies also compared rate controls subset 387 clinic based alzheimers disease cases gg frequency 114 p 006 subset 179 familial alzheimers disease samples gg frequency 127 p 0056 found essentially equal representation gg data support association gg genotype alzheimers disease
0.3103701.9811940.html.plaintext.txt	16	formally test hypothesis gg genotype a2m represented alzheimers disease collected genotyped additional independent groups patients controls power analysis showed 500 alzheimers disease control individuals would necessary 80 chance showing difference genotype frequencies 007 012 therefore collected cases controls several sites order approximate number samples second data set consisted individuals met criteria alzheimers disease control hypothesis generating set derived sporadic alzheimers disease patients massachusetts three european centers probands multicenter us study sib pairs small families results second data set supported hypothesis gg genotype frequencies 007 controls 012 alzheimers disease p 005 fishers exact test table 1 g allele represented data set control 032 alzheimers disease 034 difference age onset gg non gg found second data set multivariate analysis showed site collection influence genotype frequencies also compared rate controls subset 387 clinic based alzheimers disease cases gg frequency 114 p 006 subset 179 familial alzheimers disease samples gg frequency 127 p 0056 found essentially equal representation gg data support association gg genotype alzheimers disease
0.3103701.9811940.html.plaintext.txt	17	carried series exploratory analyses using pooled data individuals 737 alzheimers disease patients 449 controls gg genotype present 119 alzheimer patients 73 controls p 001 fishers exact test genotype frequency controls consistent hardy weinberg equilibrium age onset different alzheimers disease patients gg 700 plus minus 92 mean plus minus sd non gg carriers 706 plus minus 91 multivariate logistic model controlled presence apoe4 allele gender showed odds ratio 188 95 ci 120 295 p 001 presence a2m gg genotype presence apoe4 model associated odds ratio 421 95 ci 320 555 p 0001 odds ratio combination gg apoe4 968 95 ci 391 240 p 0001 relative neither risk factor explore whether gg mediated risk influenced presence absence apoe4 stratified sample presence absence apoe4 similar representations gg genotype seen strata without apoe4 suggesting effects two risk factors independent multivariate analysis interaction gg genotype either apoe4 gender demonstrated interactions p 05 interaction terms analysis based mantel haenszel estimator suggested heterogeneity odds ratios strata without apoe4 p 05 consistent absence interaction a2m apoe4 logistic regression model
0.3103701.9811940.html.plaintext.txt	18	carried series exploratory analyses using pooled data individuals 737 alzheimers disease patients 449 controls gg genotype present 119 alzheimer patients 73 controls p 001 fishers exact test genotype frequency controls consistent hardy weinberg equilibrium age onset different alzheimers disease patients gg 700 plus minus 92 mean plus minus sd non gg carriers 706 plus minus 91 multivariate logistic model controlled presence apoe4 allele gender showed odds ratio 188 95 ci 120 295 p 001 presence a2m gg genotype presence apoe4 model associated odds ratio 421 95 ci 320 555 p 0001 odds ratio combination gg apoe4 968 95 ci 391 240 p 0001 relative neither risk factor explore whether gg mediated risk influenced presence absence apoe4 stratified sample presence absence apoe4 similar representations gg genotype seen strata without apoe4 suggesting effects two risk factors independent multivariate analysis interaction gg genotype either apoe4 gender demonstrated interactions p 05 interaction terms analysis based mantel haenszel estimator suggested heterogeneity odds ratios strata without apoe4 p 05 consistent absence interaction a2m apoe4 logistic regression model
0.3103701.9811940.html.plaintext.txt	19	next turned attention possible biological effects inheritance a2m gg genotype previous studies a2m immunohistochemistry alzheimer brain suggested sp different cases stained varying intensity 3 explored possibility variability due different genotypes immunostaining eight alzheimers disease cases known gg aa genotype instances a2m immunoreactivity present robustly sp astrocytes neurons qualitative differences observed genotype groups
0.3103701.9811940.html.plaintext.txt	20	next turned attention possible biological effects inheritance a2m gg genotype previous studies a2m immunohistochemistry alzheimer brain suggested sp different cases stained varying intensity 3 explored possibility variability due different genotypes immunostaining eight alzheimers disease cases known gg aa genotype instances a2m immunoreactivity present robustly sp astrocytes neurons qualitative differences observed genotype groups
0.3103701.9811940.html.plaintext.txt	21	also explored effect inheritance a2m gg genotype neuropathological phenotype alzheimers disease table 2 previously used stereological techniques quantitative image analysis measure amount abeta present amyloid burden neocortical association area surrounding superior temporal sulcus number neurofibrillary tangles present region 12 thirty one previously analyzed alzheimers disease cases a2m genotyped selected analysis initial inspection data suggested increase abeta individuals ag gg difference two groups statistically significant increase abeta deposition seen comparing g containing cases non g containing cases 88 plus minus 28 versus 66 plus minus 19 p 003 unpaired test effect appears primarily due presence least one g allele difference ag gg genotypes observed although sample size limits power comparison statistically significant differences neurofibrillary tangle number g alleles suggesting specific effect abeta deposition
0.3103701.9811940.html.plaintext.txt	22	also explored effect inheritance a2m gg genotype neuropathological phenotype alzheimers disease table 2 previously used stereological techniques quantitative image analysis measure amount abeta present amyloid burden neocortical association area surrounding superior temporal sulcus number neurofibrillary tangles present region 12 thirty one previously analyzed alzheimers disease cases a2m genotyped selected analysis initial inspection data suggested increase abeta individuals ag gg difference two groups statistically significant increase abeta deposition seen comparing g containing cases non g containing cases 88 plus minus 28 versus 66 plus minus 19 p 003 unpaired test effect appears primarily due presence least one g allele difference ag gg genotypes observed although sample size limits power comparison statistically significant differences neurofibrillary tangle number g alleles suggesting specific effect abeta deposition
0.3103701.9811940.html.plaintext.txt	23	table 2 neuropathological correlates a2m genotype genotype n amyloid burden neurofibrillary tangles x 103 aa 10 66 plus minus 19a 69 plus minus 42 ag gg 21 88 plus minus 28b 90 plus minus 50c amean plus minus sd bp 003 test cn 17 measurement discussion
0.3103701.9811940.html.plaintext.txt	24	exploratory studies genetic risk factors run risk type errors large number hypotheses either explicitly implicitly tested alternatively type ii errors occur sample size insufficient order overcome difficulties inherent exploratory studies genetic risk factors used independent data sets first generate test hypothesis gg genotype associated alzheimers disease two separate control populations gave identical genotype frequencies hypothesis testing data set made two groups sporadic ad probands multicenter study alzheimers disease sib pairs small families gave essentially identical genotype frequencies representation gg genotype a2m gg effect dependent apoe genotype effect additive substantial odds ratio gg presence apoe4 allele showed almost 10 fold increased risk power analysis using size effect observed combined data set using 500 samples suggests group size 578 controls 578 alzheimers disease patients would necessary alpha 005 beta 80 hypothesis gg genotype increased 007 012 alzheimers disease
0.3103701.9811940.html.plaintext.txt	25	exploratory studies genetic risk factors run risk type errors large number hypotheses either explicitly implicitly tested alternatively type ii errors occur sample size insufficient order overcome difficulties inherent exploratory studies genetic risk factors used independent data sets first generate test hypothesis gg genotype associated alzheimers disease two separate control populations gave identical genotype frequencies hypothesis testing data set made two groups sporadic ad probands multicenter study alzheimers disease sib pairs small families gave essentially identical genotype frequencies representation gg genotype a2m gg effect dependent apoe genotype effect additive substantial odds ratio gg presence apoe4 allele showed almost 10 fold increased risk power analysis using size effect observed combined data set using 500 samples suggests group size 578 controls 578 alzheimers disease patients would necessary alpha 005 beta 80 hypothesis gg genotype increased 007 012 alzheimers disease
0.3103701.9811940.html.plaintext.txt	26	association gg a2m genotype risk factor alzheimers disease leads several interesting mechanistic interpretations previous data shown a2m immunostains sp implicated a2m amyloid precursor protein metabolism 13 well possible interactions binding abeta 4 mediation degradation abeta 56 a2m abeta complexes undergo endocytosis via a2m rlrp receptor 14 a2m associates abeta prevents fibril formation 15 addition a2m viewed subacute phase reactive molecule potent proteinase inhibitor might participate inflammatory response alzheimer brain interestingly a2m also implicated trophic factor possibly result binding transporting number polypeptide growth factors cytokines 16 like apoe a2m may serve binding protein targeting various bioactive molecules site action clearing 3 finally fact apoe app two ligands a2m rlrp receptor clearly involved pathophysiology alzheimers disease support plausibility idea a2m polymorphism might contribute risk alzheimers disease fact polymorphism a2m rlrp recently reported two studies show genetic association alzheimers disease 1718
0.3103701.9811940.html.plaintext.txt	27	association gg a2m genotype risk factor alzheimers disease leads several interesting mechanistic interpretations previous data shown a2m immunostains sp implicated a2m amyloid precursor protein metabolism 13 well possible interactions binding abeta 4 mediation degradation abeta 56 a2m abeta complexes undergo endocytosis via a2m rlrp receptor 14 a2m associates abeta prevents fibril formation 15 addition a2m viewed subacute phase reactive molecule potent proteinase inhibitor might participate inflammatory response alzheimer brain interestingly a2m also implicated trophic factor possibly result binding transporting number polypeptide growth factors cytokines 16 like apoe a2m may serve binding protein targeting various bioactive molecules site action clearing 3 finally fact apoe app two ligands a2m rlrp receptor clearly involved pathophysiology alzheimers disease support plausibility idea a2m polymorphism might contribute risk alzheimers disease fact polymorphism a2m rlrp recently reported two studies show genetic association alzheimers disease 1718
0.3103701.9811940.html.plaintext.txt	28	although strong biological rationale involvement a2m polymorphism alzheimers disease possibility remains genetic association observe reflects linkage another mutation polymorphism either a2m gene nearby gene chromosome 12 a2m gene resides 25 cm distal marker d12s1042 yielded maximal lod score recent linkage study suggesting chromosome 12 contains alzheimer risk factor 19 however likelihood a2m risk factor supported results recent separate study observed association intronic 5prime splice site exon 18 pentanucleotide deletion allele 2 within a2m gene alzheimers disease sibship analysis alzheimers disease sib pairs small alzheimers disease families 20 current results extend observation showing linkage missense mutation case control sample rather family based association currently studying two a2m polymorphisms relate one another preliminary results consistent hypothesis act independent risk factors initial study group evaluated polymorphisms suggests g allele inherited 1 allele 70 g chromosomes examined 35 gg individuals 97 allele 1 3 allele 2 compared allele 2 frequency 15 p 0005 chi2 analysis yates correction
0.3103701.9811940.html.plaintext.txt	29	although strong biological rationale involvement a2m polymorphism alzheimers disease possibility remains genetic association observe reflects linkage another mutation polymorphism either a2m gene nearby gene chromosome 12 a2m gene resides 25 cm distal marker d12s1042 yielded maximal lod score recent linkage study suggesting chromosome 12 contains alzheimer risk factor 19 however likelihood a2m risk factor supported results recent separate study observed association intronic 5prime splice site exon 18 pentanucleotide deletion allele 2 within a2m gene alzheimers disease sibship analysis alzheimers disease sib pairs small alzheimers disease families 20 current results extend observation showing linkage missense mutation case control sample rather family based association currently studying two a2m polymorphisms relate one another preliminary results consistent hypothesis act independent risk factors initial study group evaluated polymorphisms suggests g allele inherited 1 allele 70 g chromosomes examined 35 gg individuals 97 allele 1 3 allele 2 compared allele 2 frequency 15 p 0005 chi2 analysis yates correction
0.3103701.9811940.html.plaintext.txt	30	taken together believe polymorphisms a2m gene may contribute risk alzheimers disease moreover data focus attention mechanisms pathophysiology impact a2m rlrp ligands including clearance mechanisms mediated a2m rlrp 714 suggest a2m rlrp ligands may candidate alzheimers disease genes well
0.3103701.9811940.html.plaintext.txt	31	taken together believe polymorphisms a2m gene may contribute risk alzheimers disease moreover data focus attention mechanisms pathophysiology impact a2m rlrp ligands including clearance mechanisms mediated a2m rlrp 714 suggest a2m rlrp ligands may candidate alzheimers disease genes well
0.3103701.9811940.html.plaintext.txt	32	initial hypothesis generating data set established 171 alzheimers disease patients clinical history probable alzheimers disease 90 age compatible control individuals primarily spouses patients second hypothesis testing data set collected several sources attempt approximate 500 patients controls estimated power analysis adequately test hypothesis gg genotype represented alzheimers disease individuals included additional cases 380 sporadic alzheimer disease 337 controls matched site primarily cognitively tested spouses collected massachusetts general hospital memory disorder unit consortium european centers university hamburg germany university basel switzerland cuore fatebenefratelli hospital brescia italy 179 probands multicenter study alzheimer disease sib pairs small alzheimers disease families 21
0.3103701.9811940.html.plaintext.txt	33	initial hypothesis generating data set established 171 alzheimers disease patients clinical history probable alzheimers disease 90 age compatible control individuals primarily spouses patients second hypothesis testing data set collected several sources attempt approximate 500 patients controls estimated power analysis adequately test hypothesis gg genotype represented alzheimers disease individuals included additional cases 380 sporadic alzheimer disease 337 controls matched site primarily cognitively tested spouses collected massachusetts general hospital memory disorder unit consortium european centers university hamburg germany university basel switzerland cuore fatebenefratelli hospital brescia italy 179 probands multicenter study alzheimer disease sib pairs small alzheimers disease families 21
0.3103701.9811940.html.plaintext.txt	34	genomic dna isolated brain tissue blood amplified pcr presence oligonucleotide sense primer c23 5prime atc cct gaa act gcc acc aa 3prime antisense primer as24 5prime gta act gaa acc tac tgg aa 3prime 10 mm tris hc1 50 mm kc1 ph 83 15 mm mgc12 5 mm dntps 5 pmol primer 125 u taq dna polymerase pcr carried touchdown procedure stepped annealing temperature increase primer specificity follows one cycle 94 degrees c 5 min four cycles 94 degrees c 30 65 degrees c 30 72 degrees c 1 min four cycles 94 degrees c 30 62 degrees c 30 72 degrees c 1 min four cycles 94 degrees c 30 59 degrees c 30 72 degrees c 1 min 20 cycles 94 degrees c 30 56 degrees c 30 72 degrees c 1 min one cycle 72 degrees c 5 min
0.3103701.9811940.html.plaintext.txt	35	reaction mixture mboi added amplified product 615 bp digestion carried 37 degrees c 3 h producing fragments 532 g allele 429 bp allele digested product loaded onto 2 agarose gel treated ethidium bromide 0005 electrophoresed 2 h constant voltage 150 v sufficient separate digested product 532 429 bp bands distinguished electrophoresis dna fragments visualized uv illumination using bio rad gel doc system incomplete digestion monitored continued presence 615 bp product
0.3103701.9811940.html.plaintext.txt	36	reaction mixture mboi added amplified product 615 bp digestion carried 37 degrees c 3 h producing fragments 532 g allele 429 bp allele digested product loaded onto 2 agarose gel treated ethidium bromide 0005 electrophoresed 2 h constant voltage 150 v sufficient separate digested product 532 429 bp bands distinguished electrophoresis dna fragments visualized uv illumination using bio rad gel doc system incomplete digestion monitored continued presence 615 bp product
0.3103701.9811940.html.plaintext.txt	37	immunohistochemical analysis used anti a2m antibody 1500 zymed goat cy3 linked secondary antibody jackson immunoresearch used visualize immunostaining instances double immunofluorescence carried abeta counterstain antibody 10d5 courtesy dr d schenk athena neurosciences using bodipy fluorescein linked secondary antibody molecular probes second fluorochrome quantitative neuropathological techniques measuring abeta burden neurofibrillary tangles number superior temporal sulcus area previously published 12
0.3103701.9811940.html.plaintext.txt	38	immunohistochemical analysis used anti a2m antibody 1500 zymed goat cy3 linked secondary antibody jackson immunoresearch used visualize immunostaining instances double immunofluorescence carried abeta counterstain antibody 10d5 courtesy dr d schenk athena neurosciences using bodipy fluorescein linked secondary antibody molecular probes second fluorochrome quantitative neuropathological techniques measuring abeta burden neurofibrillary tangles number superior temporal sulcus area previously published 12
0.3103701.9811940.html.plaintext.txt	39	comparisons a2m allele frequency proportion chromosomes allele present genotype frequency proportion individuals genotype performed 2 x 2 tables using fishers exact test significance age onset alzheimers disease normally distributed compared test multivariate analysis odds alzheimers disease performed logistic regression apoe genotype coded according presence absence apoe4 similar results obtained group apoe4 coded separately heterozygotes homozygotes allele odds ratios presented 95 confidence intervals cis analyses performed stata software college park tx significance tests two tailed
0.3103701.9811940.html.plaintext.txt	40	comparisons a2m allele frequency proportion chromosomes allele present genotype frequency proportion individuals genotype performed 2 x 2 tables using fishers exact test significance age onset alzheimers disease normally distributed compared test multivariate analysis odds alzheimers disease performed logistic regression apoe genotype coded according presence absence apoe4 similar results obtained group apoe4 coded separately heterozygotes homozygotes allele odds ratios presented 95 confidence intervals cis analyses performed stata software college park tx significance tests two tailed
0.3103701.9811940.html.plaintext.txt	41	thank c maschke technical assistance thank massachusetts alzheimers research center ag05134 brain bank dr et hedley whyte neuropathological specimens additional neurological pathological specimens obtained brain tissue research center mhns 31862 work supported nih grants ag12406 ag08487
0.3103701.9811940.html.plaintext.txt	42	correspondence addressed tel 1 617 726 2299 fax 1 617 726 5677 email bhymanhelixmghharvardedu page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 nov 1998 copyright oxford university press 1998
0.3103701.9811940.html.plaintext.txt	43	correspondence addressed tel 1 617 726 2299 fax 1 617 726 5677 email bhymanhelixmghharvardedu page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 nov 1998 copyright oxford university press 1998
0.31053388.15890642.html.plaintext.txt	0	engineering conformational destabilization mouse apolipoprotein e model unique property human apolipoprotein e4 danny m hatters clare peters libeu karl h weisgraber
0.31053388.15890642.html.plaintext.txt	1	gladstone institute neurological disease san francisco california 94158 cardiovascular research institute department pathology university california san francisco california 94143
0.31053388.15890642.html.plaintext.txt	2	received publication april 11 2005 revised form may 11 2005
0.31053388.15890642.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references apolipoprotein apo e4 major risk factor alzheimer cardiovascular diseases apoe4 differs two common isoforms apoe2 apoe3 lower resistance denaturation greater propensity form partially folded intermediates first step determine importance stability differences vivo reengineered partially humanized variant amino terminal domain mouse apoe t61r mouse apoe acquire destabilized conformation like apoe4 process determined crystal structure wild type mouse apoe like apoe4 forms four helix bundle identified two structural differences turn helices 2 3 middle helix 3 potentially destabilizing sites introducing mutations g83t n113g sites destabilized mouse apoe conformation mutant mouse apoe rapidly remodeled phospholipid t61r mouse apoe supports hypothesis destabilized conformation promotes apoe4 lipid binding
0.31053388.15890642.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references apolipoprotein apo e4 major risk factor alzheimer cardiovascular diseases apoe4 differs two common isoforms apoe2 apoe3 lower resistance denaturation greater propensity form partially folded intermediates first step determine importance stability differences vivo reengineered partially humanized variant amino terminal domain mouse apoe t61r mouse apoe acquire destabilized conformation like apoe4 process determined crystal structure wild type mouse apoe like apoe4 forms four helix bundle identified two structural differences turn helices 2 3 middle helix 3 potentially destabilizing sites introducing mutations g83t n113g sites destabilized mouse apoe conformation mutant mouse apoe rapidly remodeled phospholipid t61r mouse apoe supports hypothesis destabilized conformation promotes apoe4 lipid binding
0.31053388.15890642.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references apolipoprotein apo1 e plays central role transport metabolic fate lipids throughout central nervous cardiovascular systems 1 3 one common human isoforms apoe4 major risk factor cardiovascular alzheimer diseases two common isoforms apoe3 apoe2 correlate lowered risk respectively alzheimer disease 4 8 apoe4 also associated poor outcome recovery neurological injury 9 11 rapid progression multiple sclerosis amyotrophic lateral sclerosis 12 13
0.31053388.15890642.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references apolipoprotein apo1 e plays central role transport metabolic fate lipids throughout central nervous cardiovascular systems 1 3 one common human isoforms apoe4 major risk factor cardiovascular alzheimer diseases two common isoforms apoe3 apoe2 correlate lowered risk respectively alzheimer disease 4 8 apoe4 also associated poor outcome recovery neurological injury 9 11 rapid progression multiple sclerosis amyotrophic lateral sclerosis 12 13
0.31053388.15890642.html.plaintext.txt	7	three isoforms encoded one gene differ one two amino acid sequence positions apoe3 cysteine position 112 arginine 158 apoe2 cysteines apoe4 arginines positions 14 sequence differences result structural biophysical properties alter function hence likely affect disease apoe4 two modular domains interact unique manner known domain interaction 15 17 arg 112 apoe4 causes arg 61 side chain adopt different conformation apoe2 apoe3 allowing form putative salt bridge glu 255 carboxyl terminal domain 16 18
0.31053388.15890642.html.plaintext.txt	8	three isoforms encoded one gene differ one two amino acid sequence positions apoe3 cysteine position 112 arginine 158 apoe2 cysteines apoe4 arginines positions 14 sequence differences result structural biophysical properties alter function hence likely affect disease apoe4 two modular domains interact unique manner known domain interaction 15 17 arg 112 apoe4 causes arg 61 side chain adopt different conformation apoe2 apoe3 allowing form putative salt bridge glu 255 carboxyl terminal domain 16 18
0.31053388.15890642.html.plaintext.txt	9	isoforms also differ conformational stability amino terminal domains unfold independently carboxy terminal domain contain isoform specific sequence differences 19 22 amino terminal domain apoe4 least resistant chemical thermal denaturation apoe2 resistant 20 22 amino terminal domain apoe4 also readily forms partially folded intermediates characteristics molten globule state 21
0.31053388.15890642.html.plaintext.txt	10	isoforms also differ conformational stability amino terminal domains unfold independently carboxy terminal domain contain isoform specific sequence differences 19 22 amino terminal domain apoe4 least resistant chemical thermal denaturation apoe2 resistant 20 22 amino terminal domain apoe4 also readily forms partially folded intermediates characteristics molten globule state 21
0.31053388.15890642.html.plaintext.txt	11	increasing evidence indicates molten globules common mediate wide variety physiological processes including translocation across membranes increased affinity membranes binding liposomes phospholipids protein trafficking extracellular secretion cell cycle regulation 23 one explanation functional differences among isoforms vivo others suggested partially folded intermediates provide apoe greater conformational adaptability bind phospholipids 21 24
0.31053388.15890642.html.plaintext.txt	12	increasing evidence indicates molten globules common mediate wide variety physiological processes including translocation across membranes increased affinity membranes binding liposomes phospholipids protein trafficking extracellular secretion cell cycle regulation 23 one explanation functional differences among isoforms vivo others suggested partially folded intermediates provide apoe greater conformational adaptability bind phospholipids 21 24
0.31053388.15890642.html.plaintext.txt	13	previously laboratory introduced domain interaction mouse apoe gene targeting used replace threonine mouse equivalent position 61 arginine t61r resulted apoe4 like lipoprotein binding preference 25 characteristic domain interaction however unlike apoe4 t61r mouse apoe folds highly cooperatively lacks apparent folding intermediates gain sight differences isoform stability affect phenotype disease sought introduce t61r mouse apoe reduced folding stability characteristic apoe4
0.31053388.15890642.html.plaintext.txt	14	previously laboratory introduced domain interaction mouse apoe gene targeting used replace threonine mouse equivalent position 61 arginine t61r resulted apoe4 like lipoprotein binding preference 25 characteristic domain interaction however unlike apoe4 t61r mouse apoe folds highly cooperatively lacks apparent folding intermediates gain sight differences isoform stability affect phenotype disease sought introduce t61r mouse apoe reduced folding stability characteristic apoe4
0.31053388.15890642.html.plaintext.txt	15	objective humanize mouse apoe replacing residues apoe4 destabilize conformation empirical approach taken change urea denaturation curve t61r mouse apoe resemble apoe4 crystal structure amino terminal domain wild type mouse apoe determined identify potential structural differences apoe4 mouse apoe might result packing differences leading differences urea denaturation curves
0.31053388.15890642.html.plaintext.txt	16	objective humanize mouse apoe replacing residues apoe4 destabilize conformation empirical approach taken change urea denaturation curve t61r mouse apoe resemble apoe4 crystal structure amino terminal domain wild type mouse apoe determined identify potential structural differences apoe4 mouse apoe might result packing differences leading differences urea denaturation curves
0.31053388.15890642.html.plaintext.txt	17	materials methods top abstract introduction materials methods results discussion references protein expression purification cdnas corresponding amino terminal domains human mouse apoe cloned pet32a amino terminal thioredoxin tag fusion mutants generated quikchange mutagenesis kit stratagene dna sequences verified dna sequencing protein expressed escherichia coli described 26 expression 6 liter culture cells resuspended 30 ml 10 mm tris ph 74 150 mm sodium chloride 025 mm edta 00005 sodium azide tbs cells frozen thawed lysed sonication debris removed centrifugation 15000 x g 20 min 4 degrees c dimyristoylphosphatidylcholine dmpc powder 18 g added cell lysate mixture incubated overnight 24 degrees c dialyzed 10 mm tris ph 80 two buffer changes fusion protein cleaved adding 1 mg bovine thrombin mixture incubated overnight room temperature apoe dmpc complexes isolated density gradient centrifugation 03265 gml kbr added lysate overlaid 148 m potassium bromide 10 mm tris ph 74 beckmancoulter quick seal tube centrifugation 55000 rpm 12 h beckman ti60 rotor 15 degrees c floated pellet collected slicing tube dmpc apoe fraction dialyzed exhaustively 01 m ammonium bicarbonate lyophilized delipidated purified gel filtration described 26 crystallization final anion exchange chromatography step involved deae resin linear salt gradient protein concentrations determined lowry assay bovine serum albumin mass standard
0.31053388.15890642.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references protein expression purification cdnas corresponding amino terminal domains human mouse apoe cloned pet32a amino terminal thioredoxin tag fusion mutants generated quikchange mutagenesis kit stratagene dna sequences verified dna sequencing protein expressed escherichia coli described 26 expression 6 liter culture cells resuspended 30 ml 10 mm tris ph 74 150 mm sodium chloride 025 mm edta 00005 sodium azide tbs cells frozen thawed lysed sonication debris removed centrifugation 15000 x g 20 min 4 degrees c dimyristoylphosphatidylcholine dmpc powder 18 g added cell lysate mixture incubated overnight 24 degrees c dialyzed 10 mm tris ph 80 two buffer changes fusion protein cleaved adding 1 mg bovine thrombin mixture incubated overnight room temperature apoe dmpc complexes isolated density gradient centrifugation 03265 gml kbr added lysate overlaid 148 m potassium bromide 10 mm tris ph 74 beckmancoulter quick seal tube centrifugation 55000 rpm 12 h beckman ti60 rotor 15 degrees c floated pellet collected slicing tube dmpc apoe fraction dialyzed exhaustively 01 m ammonium bicarbonate lyophilized delipidated purified gel filtration described 26 crystallization final anion exchange chromatography step involved deae resin linear salt gradient protein concentrations determined lowry assay bovine serum albumin mass standard
0.31053388.15890642.html.plaintext.txt	19	view larger version 19k fig 1 urea denaturation curves amino terminal domains apoe isoforms curves derived fractional change cd ellipticity wavelength 222 nm 0 8 m urea apoe3 apoe4 wild type mouse apoe t61r mouse apoe shown
0.31053388.15890642.html.plaintext.txt	20	crystallization x ray diffraction data collection crystals grown hanging drop technique 19 mgml mouse apoe 425 saturated sodium malonate ph 72 100 mm sodium acetate ph 57 diffraction data collected beam line 7 1 stanford synchrotron radiation laboratory data collection statistics summarized table space group determined p212121 unit cell 29034 b 49233 c 112177 initial phases obtained using molecular replacement program epmr 27 structure amino terminal domain apoe4 starting model decrease model bias resolve 28 used refine initial phases build preliminary model cns 29 refmac 30 used subsequent refinement cycles
0.31053388.15890642.html.plaintext.txt	21	view table table data collection refinement statistics
0.31053388.15890642.html.plaintext.txt	22	urea denaturation curves saturated urea solution freshly deionized filtered urea concentration determined measurement refractive index described 31 circular dichroism spectra collected apoe 22 kda fragment 05 mgml 0 8 m urea 5 mm dithiothreitol 20 mm sodium acetate ph 40 samples preincubated overnight 4 degrees c spectroscopic analysis data collected 24 degrees c using 1 mm path length cuvette applied biophysics 180 jasco j 720 cd spectrometer 1000 ms acquisition time ellipticity 222 nm served indicator secondary structure predominately helical folded state data adjusted fraction unfolded assuming protein 100 unfolded 8 m urea
0.31053388.15890642.html.plaintext.txt	23	urea denaturation curves saturated urea solution freshly deionized filtered urea concentration determined measurement refractive index described 31 circular dichroism spectra collected apoe 22 kda fragment 05 mgml 0 8 m urea 5 mm dithiothreitol 20 mm sodium acetate ph 40 samples preincubated overnight 4 degrees c spectroscopic analysis data collected 24 degrees c using 1 mm path length cuvette applied biophysics 180 jasco j 720 cd spectrometer 1000 ms acquisition time ellipticity 222 nm served indicator secondary structure predominately helical folded state data adjusted fraction unfolded assuming protein 100 unfolded 8 m urea
0.31053388.15890642.html.plaintext.txt	24	dmpc turbidity clearance assays samples apoe 22 kda fragment 1 mgml prepared 1 mm tris carboxyethylphosphine 20 mm sodium acetate ph 40 buffer dmpc prepared 5 mgml buffer incubated 42 degrees c 20 min extruded 100 nm pore filter lipex pressure extruder resulting large unilamellar vesicles diluted 1 mgml buffer vesicles protein samples spectrophotometer cuvette holding block pre equilibrated 26 degrees c overnight samples apoe buffer 200 microl mixed rapidly vesicles 400 microl turbidity monitored absorbance 325 nm 20 min 26 degrees c cuvettes pre equilibrated 26 degrees c 10 min use
0.31053388.15890642.html.plaintext.txt	25	results top abstract introduction materials methods results discussion references differences urea denaturation curves amino terminal domain mouse human apoe urea denaturation studies showed amino terminal domain apoe4 lower apparent conformational stability apoe3 apoe2 greater tendency form partially folded intermediates revealed less cooperative transition folded state unfolded state 21 denaturation curve t61r mouse apoe displayed greater cooperativity apoe3 apoe4 unfolded urea concentrations similar apoe3 unfolds apoe4 fig 1 wild type mouse apoe denaturation curve similar t61r mouse apoe fig 1
0.31053388.15890642.html.plaintext.txt	26	results top abstract introduction materials methods results discussion references differences urea denaturation curves amino terminal domain mouse human apoe urea denaturation studies showed amino terminal domain apoe4 lower apparent conformational stability apoe3 apoe2 greater tendency form partially folded intermediates revealed less cooperative transition folded state unfolded state 21 denaturation curve t61r mouse apoe displayed greater cooperativity apoe3 apoe4 unfolded urea concentrations similar apoe3 unfolds apoe4 fig 1 wild type mouse apoe denaturation curve similar t61r mouse apoe fig 1
0.31053388.15890642.html.plaintext.txt	27	structural comparison amino terminal domain mouse human apoe crystal structure amino terminal domain wild type mouse apoe determined resolution 21 used find clues packing differences apoe4 may influence folding stability x ray diffraction data collection refinement statistics summarized table
0.31053388.15890642.html.plaintext.txt	28	structural comparison amino terminal domain mouse human apoe crystal structure amino terminal domain wild type mouse apoe determined resolution 21 used find clues packing differences apoe4 may influence folding stability x ray diffraction data collection refinement statistics summarized table
0.31053388.15890642.html.plaintext.txt	29	excluding eight additional amino terminal residues human apoe amino terminal domains mouse apoe apoe4 differ 35 sequence positions corresponding 81 sequence identity fig 2 overall fold amino terminal domain wild type mouse apoe similar apoe4 fig 3 32 except residues 9 11 166 172 186 191 residues amino terminal domain mouse apoe clearly visible final electron density map
0.31053388.15890642.html.plaintext.txt	30	although amino terminal domain mouse apoe like apoe4 forms four helix bundle structural differences alignment mouse human structures along helices 1 2 shows relative apoe4 helices 3 4 amino terminal domain mouse apoe shifted direction roughly parallel helical axis helix 3 addition helices 1 2 4 longer mouse apoe apoe4 crystal contact residue 20 mouse apoe likely stabilizes extension helix 1 apoe4 contact occurs crystal contact residue 126 mouse apoe seen apoe4 likely influences structure loop helices 3 4 residues 120 130
0.31053388.15890642.html.plaintext.txt	31	although amino terminal domain mouse apoe like apoe4 forms four helix bundle structural differences alignment mouse human structures along helices 1 2 shows relative apoe4 helices 3 4 amino terminal domain mouse apoe shifted direction roughly parallel helical axis helix 3 addition helices 1 2 4 longer mouse apoe apoe4 crystal contact residue 20 mouse apoe likely stabilizes extension helix 1 apoe4 contact occurs crystal contact residue 126 mouse apoe seen apoe4 likely influences structure loop helices 3 4 residues 120 130
0.31053388.15890642.html.plaintext.txt	32	two structural differences positions 83 113 mediated sequence differences exclusion crystal contact sites two key structural differences result sequence differences loop helices 2 3 residues 81 86 forms tight turn mouse apoe extended relaxed crystal structures human apoe 33 difference reflects cis conformation gly 83 mouse apoe cannot sterically accommodated thr 83 apoe4 fig 4a mouse apoe helix 2 one helical turn apoe4 dipoles helices 2 3 less parallel fig 4b
0.31053388.15890642.html.plaintext.txt	33	two structural differences positions 83 113 mediated sequence differences exclusion crystal contact sites two key structural differences result sequence differences loop helices 2 3 residues 81 86 forms tight turn mouse apoe extended relaxed crystal structures human apoe 33 difference reflects cis conformation gly 83 mouse apoe cannot sterically accommodated thr 83 apoe4 fig 4a mouse apoe helix 2 one helical turn apoe4 dipoles helices 2 3 less parallel fig 4b
0.31053388.15890642.html.plaintext.txt	34	view larger version 64k fig 2 sequence alignment amino terminal domains mouse apoe apoe4 numbering system mouse apoe standardized apoe4 sequence apoe4 eight additional amino terminal residues identical residues highlighted gray major structural elements noted sequence apoe4 black bars mouse apoe gray bars
0.31053388.15890642.html.plaintext.txt	35	major difference residue 113 mouse apoe contains asparagine apoe4 contains glycine fig 4 b c asn 113 mouse apoe lies straight portion helix 3 gly 113 apoe4 lies pronounced kink cannot form hydrogen bond arg 112 formed asn 113 mouse apoe fig 4c result reduced local hydrogen bond network fig 4c table ii addition glycines high configurational entropy localized flexibility middle helix 3 caused gly 113 may account lower stability greater propensity apoe4 form partially folded intermediates net effects sequence differences positions 83 113 greater stabilization helix 3 parallel alignment dipoles helices 2 3 mouse apoe apoe4 fig 4b thus data suggest two sequence differences contribute differences human mouse urea denaturation curves
0.31053388.15890642.html.plaintext.txt	36	view table table ii potential hydrogen bonds mouse apoe human apoe4 near 112
0.31053388.15890642.html.plaintext.txt	37	view larger version 24k fig 3 stereo image overlay crystal structures amino terminal domain mouse apoe apoe4 carbon traces apoe4 blue mouse apoe orange shown backbone deviation helices 2 3 crystal form 05 10
0.31053388.15890642.html.plaintext.txt	38	introducing apoe4 residues positions 83 113 destabilizes t61r mouse apoe thr 83 gly 113 apoe4 introduced t61r mouse apoe prediction would destabilize global conformation urea denaturation curves showed mutants unfolded urea readily t61r mouse apoe mutations additive effects destabilizing conformation fig 5a triple mutant mouse apoe t61r g83t n113g apoe4 displayed similar denaturation curves range 0 45 m urea suggesting mutations position 83 113 account largest effects differences stability t61r mouse e apoe4 fig 5b
0.31053388.15890642.html.plaintext.txt	39	introducing apoe4 residues positions 83 113 destabilizes t61r mouse apoe thr 83 gly 113 apoe4 introduced t61r mouse apoe prediction would destabilize global conformation urea denaturation curves showed mutants unfolded urea readily t61r mouse apoe mutations additive effects destabilizing conformation fig 5a triple mutant mouse apoe t61r g83t n113g apoe4 displayed similar denaturation curves range 0 45 m urea suggesting mutations position 83 113 account largest effects differences stability t61r mouse e apoe4 fig 5b
0.31053388.15890642.html.plaintext.txt	40	seven mutants made probe influence structural differences introduced apoe4 residues q52l andor h123q occur sites crystal contacts apoe4 residues m114l m149l together correlate differences packing core t61r mouse apoe mutations marginal effects urea denaturation curves data shown three mutants made t61r g83t n113g backbone introduced nonconservative sequence differences minimal effects stability introducing apoe4 residues g94s n120g group residues n23g g94s n120g p25r g116v q28l slightly reduced folding cooperativity stability fig 5b introduction apoe4 residues ie apoe4 sequence without first eight amino acids yielded urea denaturation curve similar apoe4 fig 5b suggests additional eight residues apoe4 play minor role stability contrast mutations g83t n113g collection seven group mutations minor effects urea denaturation curve
0.31053388.15890642.html.plaintext.txt	41	seven mutants made probe influence structural differences introduced apoe4 residues q52l andor h123q occur sites crystal contacts apoe4 residues m114l m149l together correlate differences packing core t61r mouse apoe mutations marginal effects urea denaturation curves data shown three mutants made t61r g83t n113g backbone introduced nonconservative sequence differences minimal effects stability introducing apoe4 residues g94s n120g group residues n23g g94s n120g p25r g116v q28l slightly reduced folding cooperativity stability fig 5b introduction apoe4 residues ie apoe4 sequence without first eight amino acids yielded urea denaturation curve similar apoe4 fig 5b suggests additional eight residues apoe4 play minor role stability contrast mutations g83t n113g collection seven group mutations minor effects urea denaturation curve
0.31053388.15890642.html.plaintext.txt	42	destabilizing mutations g83t n113g increase lipid binding t61r mouse apoe stability differences amino terminal domains human apoe isoforms correlate inversely lipid binding 21 34 examined lipid binding destabilized mouse apoe lipid binding assessed standard apolipoprotein lipid binding assay examines ability apoe remodel large unilamellar vesicles dmpc 35 upon binding dmpc vesicles apoe forms smaller apoe dmpc particles thereby decreasing turbidity solution 36 human isoforms apoe4 clears turbidity fastest followed apoe3 apoe2 21 amino terminal domain apoe4 cleared turbidity exponential decay like manner much faster t61r mouse apoe fig 6 destabilizing mutations g83t n113g cleared faster t61r mouse apoe mutations together increased clearance rate fig 6
0.31053388.15890642.html.plaintext.txt	43	destabilizing mutations g83t n113g increase lipid binding t61r mouse apoe stability differences amino terminal domains human apoe isoforms correlate inversely lipid binding 21 34 examined lipid binding destabilized mouse apoe lipid binding assessed standard apolipoprotein lipid binding assay examines ability apoe remodel large unilamellar vesicles dmpc 35 upon binding dmpc vesicles apoe forms smaller apoe dmpc particles thereby decreasing turbidity solution 36 human isoforms apoe4 clears turbidity fastest followed apoe3 apoe2 21 amino terminal domain apoe4 cleared turbidity exponential decay like manner much faster t61r mouse apoe fig 6 destabilizing mutations g83t n113g cleared faster t61r mouse apoe mutations together increased clearance rate fig 6
0.31053388.15890642.html.plaintext.txt	44	view larger version 35k fig 4 key structural differences mouse apoe apoe4 amino terminal domains differences carbon trace overlay mouse apoe yellow apoe4 cyan loop helices 2 3 influenced residue 83 b differences helical dipoles helix 3 mouse apoe yellow apoe4 cyan helices 2 3 shown c differences hydrogen bond network mouse apoe yellow apoe4 cyan influenced residue 113
0.31053388.15890642.html.plaintext.txt	45	discussion top abstract introduction materials methods results discussion references objective study introduce instability mouse apoe mutant t61r displays domain interaction making apoe4 like based comparison x ray crystal structures amino terminal domains human apoe4 wild type mouse apoe identified two potential structural differences loop connecting helices 2 3 position 83 middle helix 3 position 113 likely would affect stability although several differences human mouse apoe found introduction human residues g83t n113g loop helices 2 3 middle helix 3 required mimic unfolding behavior apoe4 fig 7 destabilized t61r mouse apoe increased lipid binding properties demonstrating analogous functional switch apoe3 like apoe4 like interesting stability apoe isoforms apoe4 apoe3 apoe2 parallels relative susceptibility carriers isoforms alzheimer disease
0.31053388.15890642.html.plaintext.txt	46	discussion top abstract introduction materials methods results discussion references objective study introduce instability mouse apoe mutant t61r displays domain interaction making apoe4 like based comparison x ray crystal structures amino terminal domains human apoe4 wild type mouse apoe identified two potential structural differences loop connecting helices 2 3 position 83 middle helix 3 position 113 likely would affect stability although several differences human mouse apoe found introduction human residues g83t n113g loop helices 2 3 middle helix 3 required mimic unfolding behavior apoe4 fig 7 destabilized t61r mouse apoe increased lipid binding properties demonstrating analogous functional switch apoe3 like apoe4 like interesting stability apoe isoforms apoe4 apoe3 apoe2 parallels relative susceptibility carriers isoforms alzheimer disease
0.31053388.15890642.html.plaintext.txt	47	new model apoe4 useful testing exploring cooperative additive effects domain interaction lower stability furthermore t61r introduces domain interaction wild type mouse apoe mouse model specific apoe4 reduced stability without domain interaction made mutation e255a 16
0.31053388.15890642.html.plaintext.txt	48	new model apoe4 useful testing exploring cooperative additive effects domain interaction lower stability furthermore t61r introduces domain interaction wild type mouse apoe mouse model specific apoe4 reduced stability without domain interaction made mutation e255a 16
0.31053388.15890642.html.plaintext.txt	49	several proteins mutations conditions destabilize native conformation also facilitate formation aggregates properties amyloid fibrils consist ordered polymer strands 37 39 thus destabilization compactly folded state apoe although advantageous lipid binding may predispose misfolding amyloid fibrils could provide basis amyloid formation amyloid plaques brains alzheimer patients show apoe immunoreactivity 40 41 apoe isoforms differ ability promote amyloid formation vitro co incubation purified apoe promotes fibrillization fibrils coated apoe 42 apoe4 facilitates formation extensive matrix fibrils apoe3 assessed electron microscopy 42 43
0.31053388.15890642.html.plaintext.txt	50	several proteins mutations conditions destabilize native conformation also facilitate formation aggregates properties amyloid fibrils consist ordered polymer strands 37 39 thus destabilization compactly folded state apoe although advantageous lipid binding may predispose misfolding amyloid fibrils could provide basis amyloid formation amyloid plaques brains alzheimer patients show apoe immunoreactivity 40 41 apoe isoforms differ ability promote amyloid formation vitro co incubation purified apoe promotes fibrillization fibrils coated apoe 42 apoe4 facilitates formation extensive matrix fibrils apoe3 assessed electron microscopy 42 43
0.31053388.15890642.html.plaintext.txt	51	vivo gene dosage apoe4 alzheimer patients correlates deposition amyloid 44 mouse models alzheimer disease ie mice expressing human amyloid precursor protein human apoe isoforms apoe4 effective promoting deposition apoe3 45 49 furthermore apoe knock mice expressing human apoe isoforms apoe4 drives nucleation aggregation immunopositive deposits greater extent apoe3 50 differences co aggregation apoe isoforms may provide mechanism acceleration nucleation polymerization plaque formation
0.31053388.15890642.html.plaintext.txt	52	vivo gene dosage apoe4 alzheimer patients correlates deposition amyloid 44 mouse models alzheimer disease ie mice expressing human amyloid precursor protein human apoe isoforms apoe4 effective promoting deposition apoe3 45 49 furthermore apoe knock mice expressing human apoe isoforms apoe4 drives nucleation aggregation immunopositive deposits greater extent apoe3 50 differences co aggregation apoe isoforms may provide mechanism acceleration nucleation polymerization plaque formation
0.31053388.15890642.html.plaintext.txt	53	view larger version 23k fig 5 effect mutations urea denaturation curves t61r mouse apoe compared apoe4 amino terminal domain t61r mouse apoe t61r g83t mouse apoe t61r n113g mouse apoe triple mutant t61r g83t n113g mouse apoe shown b amino terminal domains completely humanized mouse apoe 1 8 apoe4 apoe4 triple mutant t61rg83tn113g mouse apoe multiple mutant t61rg83tn113gn23gg94sn120gp25rg116vq28l mouse apoe multiple mutant t61rg83tn113gg94sn120g mouse apoe shown
0.31053388.15890642.html.plaintext.txt	54	enhanced lipid remodeling properties destabilized apoe could also influence cellular functioning result pathologic effects apoe4 apoe3 potentiates induced lysosomal leakage cultured neuronal cells suggesting apoe4 destabilizes lysosomal membrane integrity cooperatively 51 results support hypothesis greater phospholipid binding ability destabilized variants apoe accounts greater permeabilization phospholipid membranes
0.31053388.15890642.html.plaintext.txt	55	enhanced lipid remodeling properties destabilized apoe could also influence cellular functioning result pathologic effects apoe4 apoe3 potentiates induced lysosomal leakage cultured neuronal cells suggesting apoe4 destabilizes lysosomal membrane integrity cooperatively 51 results support hypothesis greater phospholipid binding ability destabilized variants apoe accounts greater permeabilization phospholipid membranes
0.31053388.15890642.html.plaintext.txt	56	view larger version 30k fig 6 turbidity clearance assay apoe amino terminal domains change absorbance followed addition apoe dmpc multilamellar vesicles data shown apoe4 single mutant t61r mouse apoe double mutants t61rg83t mouse apoe t61rn113g mouse apoe triple mutant t61rg83tn113g mouse apoe buffer alone dashed line
0.31053388.15890642.html.plaintext.txt	57	mouse model apoe4 conformational stability valuable tool studying potential mechanisms addition system provide unique model exploring role conformational stability protein function pathology directly vivo
0.31053388.15890642.html.plaintext.txt	58	mouse model apoe4 conformational stability valuable tool studying potential mechanisms addition system provide unique model exploring role conformational stability protein function pathology directly vivo
0.31053388.15890642.html.plaintext.txt	59	view larger version 16k fig 7 urea denaturation curves amino terminal domains human partially humanized mouse apoe mutants apoe3 apoe4 shown b t61r mouse apoe t61rg83tn113g mouse apoe shown
0.31053388.15890642.html.plaintext.txt	60	footnotes atomic coordinates structure factors code 1ya9 deposited protein data bank research collaboratory structural bioinformatics rutgers university new brunswick nj httpwwwrcsborg
0.31053388.15890642.html.plaintext.txt	61	work supported grants p01 ag022074 r01 ag020235 national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.31053388.15890642.html.plaintext.txt	62	work supported grants p01 ag022074 r01 ag020235 national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.31053388.15890642.html.plaintext.txt	63	authors contributed equally work
0.31053388.15890642.html.plaintext.txt	64	correspondence addressed gladstone institute neurological disease 1650 owens st san francisco ca 94158 tel 415 734 2000 fax 415 355 0824 e mail kweisgraberatgladstoneucsfedu u d
0.31053388.15890642.html.plaintext.txt	65	1 abbreviations used apo apolipoprotein dmpc dimyristoylphosphatidylcholine amyloid
0.31053388.15890642.html.plaintext.txt	66	acknowledgments thank jon menke maryam tabar yvonne newhouse earl rutenber technical assistance stephen ordway gary howard editorial assistance john carroll jack hull stephen gonzales chris goodfellow graphics assistance karina fantillo manuscript preparation
0.31053388.15890642.html.plaintext.txt	67	references top abstract introduction materials methods results discussion references boyles j k pitas r e wilson e mahley r w taylor j m 1985 j clin investig 76 1501 1513medline order article via infotrieve pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text mahley r w 1988 science 240 622 630medline order article via infotrieve saunders m strittmatter w j schmechel d st george hyslop p h pericak vance m joo h rosi b l gusella j f crapper maclachlan d r alberts m j hulette c crain b goldgaber d roses d 1993 neurology 43 1467 1472abstract corder e h saunders m strittmatter w j schmechel d e gaskell p c small g w roses d haines j l pericak vance m 1993 science 261 921 923medline order article via infotrieve strittmatter w j roses d 1995 proc natl acad sci u 92 4725 4727abstractfree full text saunders m schmader k breitner j c benson m d brown w goldfarb l goldgaber d manwaring m g szymanski m h mccown n dole k c schmechel d e strittmatter w j pericak vance m roses d 1993 lancet 342 710 711crossrefmedline order article via infotrieve nathan b p bellosta sanan d weisgraber k h mahley r w pitas r e 1994 science 264 850 852medline order article via infotrieve mayeux r ottman r maestre g ngai c tang m x ginsberg h chun m tycko b shelanski m 1995 neurology 45 555 557abstract slooter j c tang m x van duijn c m stern y ott bell k breteler m m b van broeckhoven c tatemichi k tycko b hofman mayeux r 1997 j med assoc 277 818 821abstract teasdale g m nicoll j r murray g fiddes m 1997 lancet 350 1069 1071crossrefmedline order article via infotrieve fazekas f strasser fuchs schmidt h enzinger c ropele lechner flooh e schmidt r hartung h p 2000 j neurol neurosurg psychiatry 69 25 28abstractfree full text drory v e birnbaum m korczyn d chapman j 2001 j neurol sci 190 17 20crossrefmedline order article via infotrieve weisgraber k h rall c jr mahley r w 1981 j biol chem 256 9077 9083free full text dong l m wilson c wardell m r simmons mahley r w weisgraber k h agard d 1994 j biol chem 269 22358 22365abstractfree full text dong l m weisgraber k h 1996 j biol chem 271 19053 19057abstractfree full text xu q brecht w j weisgraber k h mahley r w huang y 2004 j biol chem 279 25511 25516abstractfree full text weisgraber k h mahley r w 1996 faseb j 10 1485 1494abstractfree full text wetterau j r aggerbeck l p rall c jr weisgraber k h 1988 j biol chem 263 6240 6248abstractfree full text morrow j segall m l lund katz phillips m c knapp m rupp b weisgraber k h 2000 biochemistry 39 11657 11666crossrefmedline order article via infotrieve morrow j hatters d m lu b hochtl p oberg k rupp b weisgraber k h 2002 j biol chem 277 50380 50385abstractfree full text acharya p segall m l zaiou m morrow j weisgraber k h phillips m c lund katz snow j 2002 biochim biophys acta 1584 9 19medline order article via infotrieve ptitsyn o b 1995 adv protein chem 47 83 229medline order article via infotrieve weers p m m narayanaswami v choy n luty r hicks l kay c m ryan r o 2003 biophys chem 100 481 492crossrefmedline order article via infotrieve raffai r l dong l m farese r v jr weisgraber k h 2001 proc natl acad sci u 98 11587 11591abstractfree full text morrow j arnold k weisgraber k h 1999 protein expression purif 16 224 230crossrefmedline order article via infotrieve kissinger c r gehlhaar d k fogel d b 1999 acta crystallogr sect d 55 484 491crossrefmedline order article via infotrieve terwilliger c berendzen j 1999 acta crystallogr sect d 55 849 861crossrefmedline order article via infotrieve brunger adams p d clore g m delano w l gros p grosse kunstleve r w jiang j kuszewski j nilges m pannu n read r j rice l m simonson warren g l 1998 acta crystallogr sect d 54 905 921crossrefmedline order article via infotrieve murshudov g n vagin dodson e j 1997 acta crystallogr sect d 53 240 255crossrefmedline order article via infotrieve pace c n 1986 methods enzymol 131 266 280medline order article via infotrieve wilson c wardell m r weisgraber k h mahley r w agard d 1991 science 252 1817 1822medline order article via infotrieve segelke b w forstner m knapp m trakhanov d parkin newhouse y m bellamy h d weisgraber k h rupp b 2000 protein sci 9 886 897abstract segall m l dhanasekaran p baldwin f anantharamaiah g m weisgraber k h phillips m c lund katz 2002 j lipid res 43 1688 1700abstractfree full text pownall h j massey j b kusserow k gotto m jr 1978 biochemistry 17 1183 1188crossrefmedline order article via infotrieve saito h dhanasekaran p baldwin f weisgraber k h phillips m c lund katz 2003 j biol chem 278 40723 40729abstractfree full text booth d r sunde m bellotti v robinson c v hutchinson w l fraser p e hawkins p n dobson c m radford e blake c c f pepys m b 1997 nature 385 787 793crossrefmedline order article via infotrieve nettleton e j sunde m lai z kelly j w dobson c m robinson c v 1998 j mol biol 281 553 564crossrefmedline order article via infotrieve fandrich m fletcher m dobson c m 2001 nature 410 165 166crossrefmedline order article via infotrieve namba y tomonaga m kawasaki h otomo e ikeda k 1991 brain res 541 163 166crossrefmedline order article via infotrieve wisniewski lalowski m golabek vogel frangione b 1995 lancet 345 956 958crossrefmedline order article via infotrieve sanan d weisgraber k h russell j mahley r w huang d saunders schmechel d wisniewski frangione b roses d strittmatter w j 1994 j clin investig 94 860 869medline order article via infotrieve ma j yee brewer h b jr das potter h 1994 nature 372 92 94crossrefmedline order article via infotrieve schmechel d e saunders m strittmatter w j crain b j hulette c m joo h pericak vance m goldgaber d roses d 1993 proc natl acad sci u 90 9649 9653abstractfree full text bales k r verina dodel r c du y altstiel l bender m hyslop p johnstone e m little p cummins d j piccardo p ghetti b paul m 1997 nat genet 17 263 264medline order article via infotrieve holtzman d m bales k r wu bhat p parsadanian m fagan m chang l k sun y paul m 1999 j clin investig 103 15 21 holtzman d m bales k r tenkova fagan m parsadanian m sartorius l j mackey b olney j mckeel d wozniak d paul m 2000 proc natl acad sci u 97 2892 2897abstractfree full text brendza r p bales k r paul m holtzman d m 2002 mol psychiatry 7 132 135crossrefmedline order article via infotrieve buttini m yu g q shockley k huang y jones b masliah e mallory m yeo longo f m mucke l 2002 j neurosci 22 10539 10548abstractfree full text dolev michaelson d m 2004 proc natl acad sci u 101 13909 13914abstractfree full text ji z miranda r d newhouse y m weisgraber k h huang y mahley r w 2002 j biol chem 277 21821 21828abstractfree full text
0.3125666.12588864.html.plaintext.txt	0	characterization heparin binding sites human apolipoprotein e hiroyuki saito padmaja dhanasekaran david nguyen faye baldwin karl h weisgraber suzanne wehrli michael c phillips sissel lund katz
0.3125666.12588864.html.plaintext.txt	1	characterization heparin binding sites human apolipoprotein e hiroyuki saito padmaja dhanasekaran david nguyen faye baldwin karl h weisgraber suzanne wehrli michael c phillips sissel lund katz
0.3125666.12588864.html.plaintext.txt	2	joseph stokes jr research institute childrens hospital philadelphia university pennsylvania school medicine philadelphia pennsylvania 19104 4318 gladstone institute cardiovascular disease cardiovascular research institute department pathology university california san francisco california 94141
0.3125666.12588864.html.plaintext.txt	3	received publication december 26 2002 revised form february 14 2003
0.3125666.12588864.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	5	apolipoprotein apo e mediates lipoprotein remnant clearance via interaction cell surface heparan sulfate proteoglycans 22 kda n terminal domain 10 kda c terminal domain apoe contain heparin binding site n terminal site overlaps low density lipoprotein receptor binding region c terminal site undefined understand molecular details apoe heparin interaction defined microenvironments 12 lysine residues intact apoe3 examined relative contributions heparin binding nuclear magnetic resonance measurements showed apoe3 dimyristoyl phosphatidylcholine discs lys 143 146 n terminal domain lys 233 c terminal domain unusually low pka values indicating high positive electrostatic potential around residues binding experiments using heparin sepharose gel demonstrated lipid free 10 kda fragment interacted strongly heparin point mutation k233q largely abolished binding indicating lys 233 involved heparin binding unusually basic lysine microenvironment critical interaction heparin lipidated apoe3 confirmed lys 233 site completely masked n terminal site mediates heparin binding addition mutations two heparin binding sites intact apoe3 demonstrated dominant role n terminal site heparin binding apoe even lipid free state results suggest apoe interacts predominately cell surface heparan sulfate proteoglycans n terminal binding site however lys 233 may involved binding apoe certain cell surface sites protein core biglycan introduction top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	6	apolipoprotein apo e mediates lipoprotein remnant clearance via interaction cell surface heparan sulfate proteoglycans 22 kda n terminal domain 10 kda c terminal domain apoe contain heparin binding site n terminal site overlaps low density lipoprotein receptor binding region c terminal site undefined understand molecular details apoe heparin interaction defined microenvironments 12 lysine residues intact apoe3 examined relative contributions heparin binding nuclear magnetic resonance measurements showed apoe3 dimyristoyl phosphatidylcholine discs lys 143 146 n terminal domain lys 233 c terminal domain unusually low pka values indicating high positive electrostatic potential around residues binding experiments using heparin sepharose gel demonstrated lipid free 10 kda fragment interacted strongly heparin point mutation k233q largely abolished binding indicating lys 233 involved heparin binding unusually basic lysine microenvironment critical interaction heparin lipidated apoe3 confirmed lys 233 site completely masked n terminal site mediates heparin binding addition mutations two heparin binding sites intact apoe3 demonstrated dominant role n terminal site heparin binding apoe even lipid free state results suggest apoe interacts predominately cell surface heparan sulfate proteoglycans n terminal binding site however lys 233 may involved binding apoe certain cell surface sites protein core biglycan introduction top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	7	apolipoprotein e apoe1 critical ligand several hepatic lipoprotein receptors including low density lipoprotein ldl receptor ldl receptor related protein lrp cell surface heparan sulfate proteoglycans hspg 1 3 interaction receptors hspg lrp pathway apoe mediates catabolism remnant lipoproteins 4 5 hspg lrp pathway apoe postulated interact initially cell surface hspg transfer lrp internalization 6 7 therefore interaction apoe hspg initial step clearance apoe containing lipoproteins plasma apoe hspg interaction also involved differential effects apoe isoforms neurite outgrowth 8 9 existence pool newly secreted apoe cell surface 10 12 inhibition platelet derived growth factor stimulated smooth muscle cell proliferation 13 addition several studies suggest binding apoe hspg may involved alzheimers disease 5 14 15
0.3125666.12588864.html.plaintext.txt	8	apolipoprotein e apoe1 critical ligand several hepatic lipoprotein receptors including low density lipoprotein ldl receptor ldl receptor related protein lrp cell surface heparan sulfate proteoglycans hspg 1 3 interaction receptors hspg lrp pathway apoe mediates catabolism remnant lipoproteins 4 5 hspg lrp pathway apoe postulated interact initially cell surface hspg transfer lrp internalization 6 7 therefore interaction apoe hspg initial step clearance apoe containing lipoproteins plasma apoe hspg interaction also involved differential effects apoe isoforms neurite outgrowth 8 9 existence pool newly secreted apoe cell surface 10 12 inhibition platelet derived growth factor stimulated smooth muscle cell proliferation 13 addition several studies suggest binding apoe hspg may involved alzheimers disease 5 14 15
0.3125666.12588864.html.plaintext.txt	9	apoe 299 amino acid single chain protein contains two independently folded functional domains 22 kda n terminal domain residues 1 191 10 kda c terminal domain residues 222 299 2 16 n terminal domain exists lipid free state four helix bundle amphipathic helices contains ldl receptor binding region residues 136 150 helix 4 17 amphipathic nature helix containing residues 136 150 critical normal binding ldl receptor 18 recent studies using nuclear magnetic resonance nmr demonstrated lys 143 lys 146 unusually low pka values local increases positive electrostatic potential associated region surrounding residues 136 150 19 20 c terminal domain also predicted highly helical structure contains major lipid binding region 21 22 detailed molecular features helices c terminal domain poorly understood
0.3125666.12588864.html.plaintext.txt	10	apoe 299 amino acid single chain protein contains two independently folded functional domains 22 kda n terminal domain residues 1 191 10 kda c terminal domain residues 222 299 2 16 n terminal domain exists lipid free state four helix bundle amphipathic helices contains ldl receptor binding region residues 136 150 helix 4 17 amphipathic nature helix containing residues 136 150 critical normal binding ldl receptor 18 recent studies using nuclear magnetic resonance nmr demonstrated lys 143 lys 146 unusually low pka values local increases positive electrostatic potential associated region surrounding residues 136 150 19 20 c terminal domain also predicted highly helical structure contains major lipid binding region 21 22 detailed molecular features helices c terminal domain poorly understood
0.3125666.12588864.html.plaintext.txt	11	n c terminal domains contain heparin binding site 23 24 n terminal domain site located residues 142 147 overlaps receptor binding region 24 fact hspg binding activity apoe variants significantly decreased mutations arg 142 arg 145 lys 146 indicating basic amino acid residues contribute heparin binding 25 recent study interaction heparin derived oligosaccharide n terminal domain apoe4 found arg 142 145 form salt bridges sulfate groups octasaccharide fragment 26 consistent dramatically reduced binding affinity apoe4r142c apoe4r145c mutants hspg 25 study also predicted additional interactions heparin fragment lys 143 lys 146 arg 147 recently site directed mutagenesis study showed arg 142 lys 143 arg 145 lys 146 arg 147 required high affinity binding heparin lys 146 participating ionic interaction heparin fragment lys 143 participating hydrogen bond 27
0.3125666.12588864.html.plaintext.txt	12	n c terminal domains contain heparin binding site 23 24 n terminal domain site located residues 142 147 overlaps receptor binding region 24 fact hspg binding activity apoe variants significantly decreased mutations arg 142 arg 145 lys 146 indicating basic amino acid residues contribute heparin binding 25 recent study interaction heparin derived oligosaccharide n terminal domain apoe4 found arg 142 145 form salt bridges sulfate groups octasaccharide fragment 26 consistent dramatically reduced binding affinity apoe4r142c apoe4r145c mutants hspg 25 study also predicted additional interactions heparin fragment lys 143 lys 146 arg 147 recently site directed mutagenesis study showed arg 142 lys 143 arg 145 lys 146 arg 147 required high affinity binding heparin lys 146 participating ionic interaction heparin fragment lys 143 participating hydrogen bond 27
0.3125666.12588864.html.plaintext.txt	13	goal current study identify heparin binding site c terminal domain apoe characterize contribution apoe heparin interaction lipid free lipidated states demonstrated isolated c terminal domain binds heparin higher affinity n terminal domain lipid free state unusual basic microenvironment around lys 233 involved heparin binding surprisingly c terminal site unavailable heparin binding lipid free lipidated states intact apoe molecule suggesting n terminal site contributes interaction apoe hspg vivo experimental procedures top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	14	goal current study identify heparin binding site c terminal domain apoe characterize contribution apoe heparin interaction lipid free lipidated states demonstrated isolated c terminal domain binds heparin higher affinity n terminal domain lipid free state unusual basic microenvironment around lys 233 involved heparin binding surprisingly c terminal site unavailable heparin binding lipid free lipidated states intact apoe molecule suggesting n terminal site contributes interaction apoe hspg vivo experimental procedures top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	15	materials 12 dimyristoyl phosphatidylcholine dmpc 1 palmitoyl 2 oleoyl phosphatidylcholine popc purchased avanti polar lipids pelham al stock solutions stored chloroformmethanol 21 nitrogen 20 degrees c purity assayed thin layer chromatography silica gel g plates analtech newark de chloroformmethanolwater 65254 lipids visualized spraying developed thin layer plates 50 sulfuric acid solution charring 200 degrees c 15 min 100 microg quantities gave single spot charring heparin sepharose cl 6b lot se 203810 purchased amersham biosciences ligand density determined using enzymatic kit heparin diapharma west chester oh 3 mg heparing dried gel sepharose cl 6b sigma d2o cambridge isotope laboratories andover ma routinely deoxygenated stored nitrogen 13cformaldehyde 99 isotopic enrichment 20 solution water also obtained cambridge isotope laboratories 14cformaldehyde 40 60 cimol distilled water purchased perkinelmer life sciences nacnbh3 aldrich milwaukee wi recrystallized methylene chloride use salts reagents analytical grade
0.3125666.12588864.html.plaintext.txt	16	materials 12 dimyristoyl phosphatidylcholine dmpc 1 palmitoyl 2 oleoyl phosphatidylcholine popc purchased avanti polar lipids pelham al stock solutions stored chloroformmethanol 21 nitrogen 20 degrees c purity assayed thin layer chromatography silica gel g plates analtech newark de chloroformmethanolwater 65254 lipids visualized spraying developed thin layer plates 50 sulfuric acid solution charring 200 degrees c 15 min 100 microg quantities gave single spot charring heparin sepharose cl 6b lot se 203810 purchased amersham biosciences ligand density determined using enzymatic kit heparin diapharma west chester oh 3 mg heparing dried gel sepharose cl 6b sigma d2o cambridge isotope laboratories andover ma routinely deoxygenated stored nitrogen 13cformaldehyde 99 isotopic enrichment 20 solution water also obtained cambridge isotope laboratories 14cformaldehyde 40 60 cimol distilled water purchased perkinelmer life sciences nacnbh3 aldrich milwaukee wi recrystallized methylene chloride use salts reagents analytical grade
0.3125666.12588864.html.plaintext.txt	17	bacteriological media obtained fisher pittsburgh pa prokaryotic expression vector pet32a novagen madison wi competent escherichia coli strain bl21 star de3 invitrogen competent e coli strain dh5 invitrogen pcr supplies qiagen chatsworth ca restriction enzymes purchased promega madison wi isopropyl d galactopyranoside mercaptoethanol aprotinin ampicillin sigma ultrapure guanidine hcl icn pharmaceuticals costa mesa ca oligonucleotides idt coraville ia dna purification kits qiagen
0.3125666.12588864.html.plaintext.txt	18	bacteriological media obtained fisher pittsburgh pa prokaryotic expression vector pet32a novagen madison wi competent escherichia coli strain bl21 star de3 invitrogen competent e coli strain dh5 invitrogen pcr supplies qiagen chatsworth ca restriction enzymes purchased promega madison wi isopropyl d galactopyranoside mercaptoethanol aprotinin ampicillin sigma ultrapure guanidine hcl icn pharmaceuticals costa mesa ca oligonucleotides idt coraville ia dna purification kits qiagen
0.3125666.12588864.html.plaintext.txt	19	expression purification proteins mutations k146q k146e k233q k233e full length apoe3 k233q k242q k262q 10 kda fragment introduced using pcr create dna inserts ligated thioredoxin fusion expression vector pet32a described 18 28 mutation sequence cdna orientation confirmed restriction enzyme analysis double stranded dna sequencing resulting fusion proteins expressed e coli cleaved purified described 28 c terminal truncated apoe3 apoe3 1 260 full length human apoe3 22 10 kda fragments expressed purified described 29 12 kda fragment apoe3 residues 192 299 prepared thrombin digestion full length apoe3 30
0.3125666.12588864.html.plaintext.txt	20	expression purification proteins mutations k146q k146e k233q k233e full length apoe3 k233q k242q k262q 10 kda fragment introduced using pcr create dna inserts ligated thioredoxin fusion expression vector pet32a described 18 28 mutation sequence cdna orientation confirmed restriction enzyme analysis double stranded dna sequencing resulting fusion proteins expressed e coli cleaved purified described 28 c terminal truncated apoe3 apoe3 1 260 full length human apoe3 22 10 kda fragments expressed purified described 29 12 kda fragment apoe3 residues 192 299 prepared thrombin digestion full length apoe3 30
0.3125666.12588864.html.plaintext.txt	21	nmr measurements full length apoe3 complexed dmpc isolated gel filtration chromatography 19 lysine residues apoe3 dmpc complexes labeled 13c reductive methylation 31 1h 13c heteronuclear single quantum coherence hsqc two dimensional nmr spectra 13c labeled full length apoe3 dmpc complexes obtained bruker dm x 600 wide bore spectrometer equipped sgi 02 computer 5 mm inverse broadband probe 19 two dimensional 1h 13c hsqc spectra recorded carbon decoupling acquisition 310 k time proportional phase increment method used obtain phase sensitive spectra chemical shifts line widths lipid protein complexes measured described 19 31 32 chemical shifts 13cdimethyl lysine 13cdimethyl terminal amino residues complexes determined function ph pka values 13cdimethyl lysines obtained nonlinear regression fitting chemical shifts different ph values henderson hasselbalch equation graphpad prism program graphpad software san diego ca 19 20 sigmoidal equation y u w x 10x xc10x xc 1 y chemical shift u lower limit shift w upper limit x ph xc pka
0.3125666.12588864.html.plaintext.txt	22	nmr measurements full length apoe3 complexed dmpc isolated gel filtration chromatography 19 lysine residues apoe3 dmpc complexes labeled 13c reductive methylation 31 1h 13c heteronuclear single quantum coherence hsqc two dimensional nmr spectra 13c labeled full length apoe3 dmpc complexes obtained bruker dm x 600 wide bore spectrometer equipped sgi 02 computer 5 mm inverse broadband probe 19 two dimensional 1h 13c hsqc spectra recorded carbon decoupling acquisition 310 k time proportional phase increment method used obtain phase sensitive spectra chemical shifts line widths lipid protein complexes measured described 19 31 32 chemical shifts 13cdimethyl lysine 13cdimethyl terminal amino residues complexes determined function ph pka values 13cdimethyl lysines obtained nonlinear regression fitting chemical shifts different ph values henderson hasselbalch equation graphpad prism program graphpad software san diego ca 19 20 sigmoidal equation y u w x 10x xc10x xc 1 y chemical shift u lower limit shift w upper limit x ph xc pka
0.3125666.12588864.html.plaintext.txt	23	binding apoe heparin binding apoe heparin assayed using centrifugation method 24 33 apoe samples 14c labeled specific activity 1 microcimg protein reductive methylation lysines 14cformaldehyde described 19 29 31 14c labeled lipid free apoe apoe dmpc complexes incubated heparin sepharose sepharose gel 03 mg gelml 2 h room temperature 300 microl tris buffer 10 mm tris hcl 150 mm nacl 002 nan3 1 mm edta ph 74 mixture centrifuged 10000 rpm 15 min tabletop centrifuge radioactivity 200 microl aliquots top fraction 100 microl aliquots bottom fraction quantitated amount apoe bound gel calculated subtracting background free apoe concentration bottom fraction heparin bound apoe expressed g apoe bound per g dried weight gel dried incubation 24 h room temperature vacuum oven gel corrected binding sepharose subtraction sepharose gel bound radioactivity obtained parallel incubation binding data fitted nonlinear regression one binding site model using graphpad prizm program
0.3125666.12588864.html.plaintext.txt	24	binding apoe heparin binding apoe heparin assayed using centrifugation method 24 33 apoe samples 14c labeled specific activity 1 microcimg protein reductive methylation lysines 14cformaldehyde described 19 29 31 14c labeled lipid free apoe apoe dmpc complexes incubated heparin sepharose sepharose gel 03 mg gelml 2 h room temperature 300 microl tris buffer 10 mm tris hcl 150 mm nacl 002 nan3 1 mm edta ph 74 mixture centrifuged 10000 rpm 15 min tabletop centrifuge radioactivity 200 microl aliquots top fraction 100 microl aliquots bottom fraction quantitated amount apoe bound gel calculated subtracting background free apoe concentration bottom fraction heparin bound apoe expressed g apoe bound per g dried weight gel dried incubation 24 h room temperature vacuum oven gel corrected binding sepharose subtraction sepharose gel bound radioactivity obtained parallel incubation binding data fitted nonlinear regression one binding site model using graphpad prizm program
0.3125666.12588864.html.plaintext.txt	25	analytical procedures protein concentrations determined lowry procedure 34 phospholipid content monitored phosphorus analysis 35 14c radioactivity assessed standard liquid scintillation procedures sds page 8 25 gradient performed pharmacia phast electrophoresis system monitor purity proteins results top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	26	analytical procedures protein concentrations determined lowry procedure 34 phospholipid content monitored phosphorus analysis 35 14c radioactivity assessed standard liquid scintillation procedures sds page 8 25 gradient performed pharmacia phast electrophoresis system monitor purity proteins results top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	27	pka values lysines full length apoe3 previously used two dimensional nmr spectra 13cdimethyl lysines study microenvironments eight lysine residues 22 kda apoe dmpc complexes 19 20 study application higher field 600 mhz nmr spectrometer enabled us evaluate microenvironments 12 lysine residues full length apoe3 enhanced resolution resonances nmr spectrum fig 1 shows nmr spectrum sequence specific assignment 12 13cdimethyl lysine resonances full length apoe3 dmpc discoidal complexes addition eight lysine resonances n terminal domain four lysine resonances c terminal domain lys 233 242 262 282 resolved assigned using selective lysine glutamine mutation technique 19
0.3125666.12588864.html.plaintext.txt	28	pka values lysines full length apoe3 previously used two dimensional nmr spectra 13cdimethyl lysines study microenvironments eight lysine residues 22 kda apoe dmpc complexes 19 20 study application higher field 600 mhz nmr spectrometer enabled us evaluate microenvironments 12 lysine residues full length apoe3 enhanced resolution resonances nmr spectrum fig 1 shows nmr spectrum sequence specific assignment 12 13cdimethyl lysine resonances full length apoe3 dmpc discoidal complexes addition eight lysine resonances n terminal domain four lysine resonances c terminal domain lys 233 242 262 282 resolved assigned using selective lysine glutamine mutation technique 19
0.3125666.12588864.html.plaintext.txt	29	view larger version 22k fig 1 phase sensitive 600 mhz 1h 13c hsqc nmr spectrum full length apoe3 dmpc discoidal complexes 37 degrees c lysine residues converted 13ch32 lysine reductive methylation 251 ww dmpcfull length apoe3 discoidal complexes 32 mg proteinml dissolved borate buffer ph 101 spectra obtained conditions similar used previously 19 assignments 12 lysine resonances indicated
0.3125666.12588864.html.plaintext.txt	30	pka value lysine obtained monitoring chemical shift function ph range ph values 55 125 titration curves fully reversible across ph range studied data shown pka values lysines full length apoe3 listed table expected pka values eight lysines n terminal domain full length apoe3 22 kda fragment apoe3 reported previously 19 lys 233 low pka 94 similar pka values lys 143 146 located ldl receptorheparin binding region n terminal domain apoe3 suggests lys 233 may behave similarly part heparin binding region c terminal domain
0.3125666.12588864.html.plaintext.txt	31	view table table pka values lysine residues full length apoe3 discoidal complex dmpc
0.3125666.12588864.html.plaintext.txt	32	heparin binding 10 kda fragment determine relative heparin binding activities apoe molecules measured binding apoe heparin sepharose gel 24 33 binding 10 kda fragment heparin saturable depended salt concentration fig 2 dissociation constant kd calculated 26 microgml 50 mm nacl 76 microgml 150 mm nacl consistent previous report 24 maximal binding capacities concentrations similar corresponded 140 170 g proteing heparin contrast apoa bind heparin even low salt concentration results indicate interaction 10 kda fragment heparin electrostatic 36 37 amphipathic characteristics common helical apolipoproteins 38 responsible heparin binding
0.3125666.12588864.html.plaintext.txt	33	heparin binding 10 kda fragment determine relative heparin binding activities apoe molecules measured binding apoe heparin sepharose gel 24 33 binding 10 kda fragment heparin saturable depended salt concentration fig 2 dissociation constant kd calculated 26 microgml 50 mm nacl 76 microgml 150 mm nacl consistent previous report 24 maximal binding capacities concentrations similar corresponded 140 170 g proteing heparin contrast apoa bind heparin even low salt concentration results indicate interaction 10 kda fragment heparin electrostatic 36 37 amphipathic characteristics common helical apolipoproteins 38 responsible heparin binding
0.3125666.12588864.html.plaintext.txt	34	view larger version 14k fig 2 effect salt concentration apolipoprotein binding heparin varying concentrations apoe 10 kda fragment tris buffer ph 74 containing 50 mm nacl 150 mm nacl incubated heparin sepharose gel 2 h room temperature binding data apoa 50 mm nacl buffer also shown point represents mean plus minus sd two independent experiments done duplicate binding curves obtained nonlinear regression fitting one binding site model
0.3125666.12588864.html.plaintext.txt	35	basic residues arginine lysine heparin binding region n terminal domain key interaction heparin 26 27 39 compared heparin binding activities three lysine mutants k233q k242q k262q 10 kda fragment identify heparin binding site c terminal domain apoe shown fig 3 large decrease heparin binding observed 10 kda k233q variant maximal binding capacity 31 wild type 10 kda fragment without change binding affinity kd values 76 microgml four lysines c terminal domain lys 233 showed relatively low pka value table suggesting unusually basic microenvironment around lys 233 critical interaction c terminal domain heparin
0.3125666.12588864.html.plaintext.txt	36	basic residues arginine lysine heparin binding region n terminal domain key interaction heparin 26 27 39 compared heparin binding activities three lysine mutants k233q k242q k262q 10 kda fragment identify heparin binding site c terminal domain apoe shown fig 3 large decrease heparin binding observed 10 kda k233q variant maximal binding capacity 31 wild type 10 kda fragment without change binding affinity kd values 76 microgml four lysines c terminal domain lys 233 showed relatively low pka value table suggesting unusually basic microenvironment around lys 233 critical interaction c terminal domain heparin
0.3125666.12588864.html.plaintext.txt	37	view larger version 14k fig 3 binding isotherms apoe 10 kda fragment variants heparin wild type apoe 10 kda fragment 10 kdak233q 10 kdak242q 10 kdak262q
0.3125666.12588864.html.plaintext.txt	38	comparison heparin binding full length apoe3 22 10 kda fragments determine relative contributions n c terminal domains heparin binding apoe next compared heparin binding full length apoe3 22 10 kda fragments lipid free lipidated forms lipid free form full length apoe 10 kda fragment bound heparin similar affinities whereas 22 kda fragment bound heparin much lower affinity fig 4a complexed dmpc heparin binding 10 kda fragment completely abolished indicating c terminal binding site masked lipids fig 4b instead lipidated 22 kda fragment bound heparin high affinity rather better full length apoe similar results obtained popc physiological phospholipid data shown although binding capacity lipidated full length apoe3 much lower lipid free form binding affinity full length apoe3 states similar kd lipid free lipidated forms 157 210 microgml respectively consistent previous observation using surface plasmon resonance analysis 37
0.3125666.12588864.html.plaintext.txt	39	comparison heparin binding full length apoe3 22 10 kda fragments determine relative contributions n c terminal domains heparin binding apoe next compared heparin binding full length apoe3 22 10 kda fragments lipid free lipidated forms lipid free form full length apoe 10 kda fragment bound heparin similar affinities whereas 22 kda fragment bound heparin much lower affinity fig 4a complexed dmpc heparin binding 10 kda fragment completely abolished indicating c terminal binding site masked lipids fig 4b instead lipidated 22 kda fragment bound heparin high affinity rather better full length apoe similar results obtained popc physiological phospholipid data shown although binding capacity lipidated full length apoe3 much lower lipid free form binding affinity full length apoe3 states similar kd lipid free lipidated forms 157 210 microgml respectively consistent previous observation using surface plasmon resonance analysis 37
0.3125666.12588864.html.plaintext.txt	40	view larger version 17k fig 4 binding isotherms full length apoe3 22 10 kda fragments heparin lipid free form complexed dmpc b full length apoe3 apoe3 22 kda fragment apoe 10 kda fragment
0.3125666.12588864.html.plaintext.txt	41	heparin binding apoe mutants observations suggest two apoe domains contribute differently heparin binding c terminal domain playing dominant role lipid free state n terminal domain lipidated state examine hypothesis introduced mutations two lysines full length apoe compared heparin binding activities variants mutated proteins apoek146q apoek146e n terminal domains bind defectively heparin 27 apoe3k233q apoe3k233e thought low heparin binding capacity c terminal site large decreases heparin binding observed apoek146e lipid free fig 5a dmpc complexed forms fig 5b indicating lys 146 contributes greatly heparin binding full length apoe however also shown fig 5 b lipid free apoek146q exhibited much smaller decrease heparin binding wild type apoe3 apoek146q dmpc complexes bound heparin similar manner lipid free form disparity apoek146e apoek146q variants probably ionization state glutamate residue ph 74 responsible difference heparin binding activities 27
0.3125666.12588864.html.plaintext.txt	42	heparin binding apoe mutants observations suggest two apoe domains contribute differently heparin binding c terminal domain playing dominant role lipid free state n terminal domain lipidated state examine hypothesis introduced mutations two lysines full length apoe compared heparin binding activities variants mutated proteins apoek146q apoek146e n terminal domains bind defectively heparin 27 apoe3k233q apoe3k233e thought low heparin binding capacity c terminal site large decreases heparin binding observed apoek146e lipid free fig 5a dmpc complexed forms fig 5b indicating lys 146 contributes greatly heparin binding full length apoe however also shown fig 5 b lipid free apoek146q exhibited much smaller decrease heparin binding wild type apoe3 apoek146q dmpc complexes bound heparin similar manner lipid free form disparity apoek146e apoek146q variants probably ionization state glutamate residue ph 74 responsible difference heparin binding activities 27
0.3125666.12588864.html.plaintext.txt	43	view larger version 17k fig 5 binding isotherms full length apoe variants heparin lipid free form c complexed dmpc b d apoek146q apoek146e apoe3k233q apoek233e data wild type apoe3 dotted line also shown comparison
0.3125666.12588864.html.plaintext.txt	44	contrast k233q mutation effect heparin binding activity either lipid free lipidated form case apoe3k233e variant small decrease heparin binding observed lipid free form complexing dmpc virtually effect heparin binding ability variant fig 5 c d suggesting lys 233 site unavailable heparin binding full length apoe wild type apoe apoek146e apoek233q variants heparin binding free protein differs protein dmpc complexes binding dmpc results opening four helix bundle n terminal domain apoe 40 42 therefore likely apoe variants subtle differences final conformations dmpc disc may modulate heparin binding properties 27 may reason lipidated k146q k223e variants bind somewhat heparin wild type apoe3
0.3125666.12588864.html.plaintext.txt	45	contrast k233q mutation effect heparin binding activity either lipid free lipidated form case apoe3k233e variant small decrease heparin binding observed lipid free form complexing dmpc virtually effect heparin binding ability variant fig 5 c d suggesting lys 233 site unavailable heparin binding full length apoe wild type apoe apoek146e apoek233q variants heparin binding free protein differs protein dmpc complexes binding dmpc results opening four helix bundle n terminal domain apoe 40 42 therefore likely apoe variants subtle differences final conformations dmpc disc may modulate heparin binding properties 27 may reason lipidated k146q k223e variants bind somewhat heparin wild type apoe3
0.3125666.12588864.html.plaintext.txt	46	explore role c terminal domain heparin binding apoe used apoe 1 260 c terminal truncated variant monomeric rather tetrameric aqueous solution 21 although c terminal heparin binding site conserved variant heparin binding apoe 1 260 significantly lower wild type apoe3 close apoe3 22 kda fragment fig 6 indicates tetramerization c terminal domain major influence heparin binding ability lipid free apoe also measured binding 12 kda apoe fragment 2 heparin investigate whether hinge region plays role heparin interaction c terminal domain surprisingly heparin binding ability almost disappeared lipid free 12 kda fragment fig 6 suggesting hinge region may mask heparin binding site c terminal domain
0.3125666.12588864.html.plaintext.txt	47	explore role c terminal domain heparin binding apoe used apoe 1 260 c terminal truncated variant monomeric rather tetrameric aqueous solution 21 although c terminal heparin binding site conserved variant heparin binding apoe 1 260 significantly lower wild type apoe3 close apoe3 22 kda fragment fig 6 indicates tetramerization c terminal domain major influence heparin binding ability lipid free apoe also measured binding 12 kda apoe fragment 2 heparin investigate whether hinge region plays role heparin interaction c terminal domain surprisingly heparin binding ability almost disappeared lipid free 12 kda fragment fig 6 suggesting hinge region may mask heparin binding site c terminal domain
0.3125666.12588864.html.plaintext.txt	48	view larger version 13k fig 6 binding isotherms apoe3 1 260 apoe 12 kda fragment apoe3 1 260 12 kda fragment data wild type apoe3 dotted line apoe3 22 kda fragment dashed line also shown comparison discussion top abstract introduction experimental procedures results discussion references
0.3125666.12588864.html.plaintext.txt	49	interaction apoe hspg important several processes lipoprotein remnant clearance 5 43 neurite outgrowth 3 14 apoe least two heparin binding sites located residues 142 147 n terminal receptor binding region 24 less well defined sites c terminal lipid binding region 23 24 n terminal site recently characterized using apoe4 22 kda fragments enzymatically prepared heparin oligosaccharide arg 142 lys 143 arg 145 lys 146 arg 147 within site involved interaction heparin fragment 27 study using site directed mutagenesis identified lys 233 key lysine residue c terminal site also estimated relative contributions sites heparin binding full length apoe earlier studies using either synthetic apoe peptides blocking monoclonal antibodies suggested residues 211 218 23 243 272 24 contain heparin binding sites former site factor observed binding c terminal 10 kda fragment heparin included domain also functional 12 kda fragment bind heparin fig 6 presumably small peptide containing residues 211 218 23 bind conformation different present part apoe molecule possible lys 233 part heparin binding site identified blocking antibody epitope located residues 243 272 24 presence antibody may interfere functionality lys 233
0.3125666.12588864.html.plaintext.txt	50	interaction apoe hspg important several processes lipoprotein remnant clearance 5 43 neurite outgrowth 3 14 apoe least two heparin binding sites located residues 142 147 n terminal receptor binding region 24 less well defined sites c terminal lipid binding region 23 24 n terminal site recently characterized using apoe4 22 kda fragments enzymatically prepared heparin oligosaccharide arg 142 lys 143 arg 145 lys 146 arg 147 within site involved interaction heparin fragment 27 study using site directed mutagenesis identified lys 233 key lysine residue c terminal site also estimated relative contributions sites heparin binding full length apoe earlier studies using either synthetic apoe peptides blocking monoclonal antibodies suggested residues 211 218 23 243 272 24 contain heparin binding sites former site factor observed binding c terminal 10 kda fragment heparin included domain also functional 12 kda fragment bind heparin fig 6 presumably small peptide containing residues 211 218 23 bind conformation different present part apoe molecule possible lys 233 part heparin binding site identified blocking antibody epitope located residues 243 272 24 presence antibody may interfere functionality lys 233
0.3125666.12588864.html.plaintext.txt	51	nmr results imply among 12 lysines full length apoe3 lys 143 146 n terminal domain lys 233 c terminal domain unusually low pka values indicative high positive electrostatic potential around residues previous studies showed greater positive electrostatic potential around lys 143 146 involved high affinity binding n terminal domain apoe ldl receptor heparin study demonstrated residue lys 233 critical heparin binding c terminal domain fig 3 indicating unusually basic lysine microenvironment c terminal domain also involved heparin interaction amphipathic helix spanning region basic residues arg 226 lys 233 lys 240 aligned two turns apart along one side helix interesting several acidic residues amino acid sequence near lys 233 mostly located opposite side amphipathic helix consequently reduce positive electrostatic potential around side chain lys 233
0.3125666.12588864.html.plaintext.txt	52	nmr results imply among 12 lysines full length apoe3 lys 143 146 n terminal domain lys 233 c terminal domain unusually low pka values indicative high positive electrostatic potential around residues previous studies showed greater positive electrostatic potential around lys 143 146 involved high affinity binding n terminal domain apoe ldl receptor heparin study demonstrated residue lys 233 critical heparin binding c terminal domain fig 3 indicating unusually basic lysine microenvironment c terminal domain also involved heparin interaction amphipathic helix spanning region basic residues arg 226 lys 233 lys 240 aligned two turns apart along one side helix interesting several acidic residues amino acid sequence near lys 233 mostly located opposite side amphipathic helix consequently reduce positive electrostatic potential around side chain lys 233
0.3125666.12588864.html.plaintext.txt	53	comparison heparin binding abilities full length apoe3 22 10 kda fragments yields interesting insights lipid free state 10 kda fragment binds heparin higher affinity 22 kda fragment fig 4a contrast heparin binding 10 kda fragment completely abolished complexed lipid fig 4b consistent previous observations showing c terminal site available interaction lipid free state 24 44 c terminal domain apoe forms stable tetramer responsible self association apoe aqueous solution whereas n terminal domain primarily monomeric 16 therefore stronger interaction c terminal domain heparin appears tetramerization shown fig 6 heparin binding affinity apoe3 1 260 variant monomeric solution much lower wild type apoe3 comparable 22 kda fragment indicating tetramerization c terminal domain crucial heparin binding ability lipid free apoe multiple sequences heparin binding peptide enhance heparin binding cooperativity effects 45 similarly multiple copies receptor binding domain necessary high affinity interaction apoe ldl receptor 46 47 regard different binding affinities full length apoe3 22 kda fragment dmpc discs fig 4b may explained difference cooperativity arising different numbers n terminal domain per particle
0.3125666.12588864.html.plaintext.txt	54	comparison heparin binding abilities full length apoe3 22 10 kda fragments yields interesting insights lipid free state 10 kda fragment binds heparin higher affinity 22 kda fragment fig 4a contrast heparin binding 10 kda fragment completely abolished complexed lipid fig 4b consistent previous observations showing c terminal site available interaction lipid free state 24 44 c terminal domain apoe forms stable tetramer responsible self association apoe aqueous solution whereas n terminal domain primarily monomeric 16 therefore stronger interaction c terminal domain heparin appears tetramerization shown fig 6 heparin binding affinity apoe3 1 260 variant monomeric solution much lower wild type apoe3 comparable 22 kda fragment indicating tetramerization c terminal domain crucial heparin binding ability lipid free apoe multiple sequences heparin binding peptide enhance heparin binding cooperativity effects 45 similarly multiple copies receptor binding domain necessary high affinity interaction apoe ldl receptor 46 47 regard different binding affinities full length apoe3 22 kda fragment dmpc discs fig 4b may explained difference cooperativity arising different numbers n terminal domain per particle
0.3125666.12588864.html.plaintext.txt	55	despite strong heparin binding ability 10 kda fragment c terminal site full length apoe3 appear involved heparin binding lipid free apoe shown fig 5c small differences heparin binding among lipid free wild type apoe3 apoe3k233q apoe3k233e variants suggesting even lipid free state n terminal site involved heparin interaction full length apoe clear c terminal site lipid free apoe unavailable interaction heparin one possible explanation heparin interaction c terminal domain sterically hindered hinge region residues 192 215 acts spacer connecting two domains indeed 12 kda fragment contains 10 kda domain hinge region bound defectively heparin fig 6 thus interaction 10 kda domain hinge region might mask c terminal heparin binding site basic residues around lys 233 preventing interaction heparin recent fluorescence resonance energy transfer study apoe3 indicates spatial proximity n c terminal domains lipid free state hinge region tethering n terminal domain close c terminal domain 48
0.3125666.12588864.html.plaintext.txt	56	apoe containing high density lipoproteins bind proteoglycan biglycan arterial walls apoe thought act bridging molecule traps particles atherosclerotic intima 49 binding interaction apoe biglycan shown recently occur via c terminal domain charged residues especially lysine arginine residues 223 230 involved binding 50 51 results present study suggest unusually basic microenvironment around lys 233 contributes apoe biglycan interaction recent studies demonstrated c terminal fragments apoe complexed amyloid brain 52 53 c terminal truncated forms apoe occur alzheimers disease 54 presence apoe proteolytic fragments vivo raises possibility c terminal fragment may contribute alzheimers disease interaction hspg brain
0.3125666.12588864.html.plaintext.txt	57	apoe containing high density lipoproteins bind proteoglycan biglycan arterial walls apoe thought act bridging molecule traps particles atherosclerotic intima 49 binding interaction apoe biglycan shown recently occur via c terminal domain charged residues especially lysine arginine residues 223 230 involved binding 50 51 results present study suggest unusually basic microenvironment around lys 233 contributes apoe biglycan interaction recent studies demonstrated c terminal fragments apoe complexed amyloid brain 52 53 c terminal truncated forms apoe occur alzheimers disease 54 presence apoe proteolytic fragments vivo raises possibility c terminal fragment may contribute alzheimers disease interaction hspg brain
0.3125666.12588864.html.plaintext.txt	58	conclusion identified heparin binding site c terminal domain apoe data show basic residues around lysine 233 critical heparin binding c terminal domain unavailable heparin binding full length apoe even lipid free state thus seems lipid poor apoe associates cell surface hspg n terminal domain leaving c terminal domain available binding lipoprotein particles footnotes
0.3125666.12588864.html.plaintext.txt	59	conclusion identified heparin binding site c terminal domain apoe data show basic residues around lysine 233 critical heparin binding c terminal domain unavailable heparin binding full length apoe even lipid free state thus seems lipid poor apoe associates cell surface hspg n terminal domain leaving c terminal domain available binding lipoprotein particles footnotes
0.3125666.12588864.html.plaintext.txt	60	work supported national institutes health grants hl56083 l k hl41633 k h wthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3125666.12588864.html.plaintext.txt	61	present address national institute health sciences 1 1 43 hoenzaka chuo ku osaka 540 0006 japan
0.3125666.12588864.html.plaintext.txt	62	correspondence addressed joseph stokes jr research inst childrens hospital philadelphia abramson research bldg suite 302 3615 civic center blvd philadelphia pa 19104 4318 tel 215 590 0588 fax 215 590 0583 e mail katzs emailchopedu
0.3125666.12588864.html.plaintext.txt	63	published jbc papers press february 14 2003 doi 101074jbcm213207200
0.3125666.12588864.html.plaintext.txt	64	abbreviations used apo apolipoprotein hspg heparan sulfate proteoglycan hsqc heteronuclear single quantum coherence ldl low density lipoprotein lrp ldl receptor related protein dmpc 12 dimyristoyl phosphatidylcholine popc 1 palmitoyl 2 oleoyl phosphatidylcholine nmr nuclear magnetic resonance
0.3125666.12588864.html.plaintext.txt	65	references top abstract introduction experimental procedures results discussion references 1 mahley r w 1988 science 240 622 630medline order article via infotrieve 2 weisgraber k h 1994 adv protein chem 45 249 302medline order article via infotrieve 3 mahley r w rall c jr 2000 annu rev genomics hum genet 1 507 537crossrefmedline order article via infotrieve 4 cooper d 1997 j lipid res 38 2173 2192abstract 5 mahley r w ji z 1999 j lipid res 40 1 16abstractfree full text 6 ji z fazio lee y l mahley r w 1994 j biol chem 269 2764 2772abstractfree full text 7 mahley r w 1996 isr j med sci 32 414 429medline order article via infotrieve 8 holtzman d m pitas r e kilbridge j nathan b mahley r w bu g schwartz l 1995 proc natl acad sci u 92 9480 9484abstract 9 ji z pitas r e mahley r w 1998 j biol chem 273 13452 13460abstractfree full text 10 lucas m mazzone 1996 j biol chem 271 13454 13460abstractfree full text 11 burgess j w gould d r marcel y l 1998 j biol chem 273 5645 5654abstractfree full text 12 lin c y huang z h mazzone 2001 j lipid res 42 1125 1133abstractfree full text 13 swertfeger d k hui d y 2001 j biol chem 276 25043 25048abstractfree full text 14 weisgraber k h mahley r w 1996 faseb j 10 1485 1494abstractfree full text 15 shuvaev v v siest g 2000 neurosci lett 280 131 134crossrefmedline order article via infotrieve 16 aggerbeck l p wetterau j r weisgraber k h wu c lindgren f 1988 j biol chem 263 6249 6258abstractfree full text 17 wilson c wardell m r weisgraber k h mahley r w agard d 1991 science 252 1817 1822medline order article via infotrieve 18 zaiou m arnold k newhouse y m innerarity l weisgraber k h segall m l phillips m c lund katz 2000 j lipid res 41 1087 1095abstractfree full text 19 lund katz zaiou m wehrli dhanasekaran p baldwin f weisgraber k h phillips m c 2000 j biol chem 275 34459 34464abstractfree full text 20 lund katz wehrli zaiou m newhouse y weisgraber k h phillips m c 2001 j lipid res 42 894 901abstractfree full text 21 westerlund j weisgraber k h 1993 j biol chem 268 15745 15750abstractfree full text 22 segrest j p garber d w brouillette c g harvey c anantharamaiah g m 1994 adv protein chem 45 303 369medline order article via infotrieve 23 cardin d hirose n blankenship d jackson r l harmony j sparrow d sparrow j 1986 biochem biophys res commun 134 783 789medline order article via infotrieve 24 weisgraber k h rall c jr mahley r w milne r w marcel y l sparrow j 1986 j biol chem 261 2068 2076abstractfree full text 25 ji z fazio mahley r w 1994 j biol chem 269 13421 13428abstractfree full text 26 dong j peters libeu c weisgraber k h segelke b w rupp b capila hernaiz m j lebrun l linhardt r j 2001 biochemistry 40 2826 2834crossrefmedline order article via infotrieve 27 libeu c p lund katz phillips m c wehrli hernaiz m j capila linhardt r j raffai r l newhouse y m zhou f weisgraber k h 2001 j biol chem 276 39138 39144abstractfree full text 28 morrow j arnold k weisgraber k h 1999 protein expr purif 16 224 230crossrefmedline order article via infotrieve 29 saito h dhanasekaran p baldwin f weisgraber k h lund katz phillips m c 2001 j biol chem 276 40949 40954abstractfree full text 30 innerarity l friedlander e j rall c jr weisgraber k h mahley r w 1983 j biol chem 258 12341 12347abstractfree full text 31 lund katz weisgraber k h mahley r w phillips m c 1993 j biol chem 268 23008 23015abstractfree full text 32 lund katz ibdah j letizia j y thomas m phillips m c 1988 j biol chem 263 13831 13838abstractfree full text 33 mann w meyer n weber w meyer greten h beisiegel u 1995 j lipid res 36 517 525abstract 34 lowry o h rosebrough n j farr l randall r j 1951 j biol chem 193 265 275free full text 35 bartlett g r 1959 j biol chem 234 466 468free full text 36 cardin d demeter d weintraub h j jackson r l 1991 methods enzymol 203 556 583medline order article via infotrieve 37 shuvaev v v laffont siest g 1999 febs lett 459 353 357crossrefmedline order article via infotrieve 38 segrest j p jones m k de loof h brouillette c g venkatachalapathi y v anantharamaiah g m 1992 j lipid res 33 141 166abstract 39 cardin d jackson r l 1988 adv exp med biol 243 157 163medline order article via infotrieve 40 fisher c ryan r o 1999 j lipid res 40 93 99abstractfree full text 41 lu b morrow j weisgraber k h 2000 j biol chem 275 20775 20781abstractfree full text 42 fisher c narayanaswami v ryan r o 2000 j biol chem 275 33601 33606abstractfree full text 43 ji z brecht w j miranda r d hussain m m innerarity l mahley r w 1993 j biol chem 268 10160 10167abstractfree full text 44 dong j balestra m e newhouse y m weisgraber k h 2000 j lipid res 41 1783 1789abstractfree full text 45 verrecchio germann m w schick b p kung b twardowski san antonio j d 2000 j biol chem 275 7701 7707abstractfree full text 46 funahashi yokoyama yamamoto 1989 j biochem tokyo 105 582 587abstract 47 dyer c smith r curtiss l k 1991 j biol chem 266 15009 15015abstractfree full text 48 narayanaswami v szeto w ryan r o 2001 j biol chem 276 37853 37860abstractfree full text 49 obrien k d olin k l alpers c e chiu w ferguson m hudkins k wight n chait 1998 circulation 98 519 527abstractfree full text 50 klezovitch o formato m cherchi g m weisgraber k h scanu m 2000 j biol chem 275 18913 18918abstractfree full text 51 olin k l potter perigo barrett p h wight n chait 2001 arterioscler thromb vasc biol 21 129 135abstractfree full text 52 castano e m prelli f pras m frangione b 1995 j biol chem 270 17610 17615abstractfree full text 53 aizawa y fukatsu r takamaru y tsuzuki k chiba h kobayashi k fujii n takahata n 1997 brain res 768 208 214crossrefmedline order article via infotrieve 54 huang y liu x q wyss coray brecht w j sanan d mahley r w 2001 proc natl acad sci u 98 8838 8843abstractfree full text
0.3125666.12588864.html.plaintext.txt	66	copyright 2003 american society biochemistry molecular biology inc
0.31263503.15319409.html.plaintext.txt	0	methodological problems genetic association studies longevity apolipoprotein e gene example sarah j lewis eric j brunner
0.31263503.15319409.html.plaintext.txt	1	international centre health society department epidemiology public health university college london london uk
0.31263503.15319409.html.plaintext.txt	2	correspondence sarah j lewis department social medicine university bristol canynge hall whiteladies road bristol bs8 2pr uk e mail sjlewisatbristolacuk
0.31263503.15319409.html.plaintext.txt	3	abstract top abstract approaches studying methods results discussion conclusion references background cross sectional genetic association studies widely employed look genes confer longevity studies based two assumptions initial relative allele frequencies different age cohorts similar b risk mortality conferred genotypes depend year birth
0.31263503.15319409.html.plaintext.txt	4	methods explored validity assumptions reviewed 15 cross sectional studies common apolipoprotein e apoe polymorphisms longevity
0.31263503.15319409.html.plaintext.txt	5	results higher relative 2 frequencies lower relative 4 allele frequencies observed elderly versus younger populations assumptions b correct estimates 2 4 alleles respectively versus 3 alleles would 134 95 ci 119 135 054 95 ci 046 063 elderly versus younger individuals however association relative 4 allele frequency controls apoe 4 effect ss 045 95 ci 089 000 relation assumption substantial variation relative apoe allele frequencies 4 21 considerable heterogeneity evident within geographically proximate populations population admixture likely resulted changes allele frequency time assumption b apoe related causes death context specific changed considerably last 30 years
0.31263503.15319409.html.plaintext.txt	6	results higher relative 2 frequencies lower relative 4 allele frequencies observed elderly versus younger populations assumptions b correct estimates 2 4 alleles respectively versus 3 alleles would 134 95 ci 119 135 054 95 ci 046 063 elderly versus younger individuals however association relative 4 allele frequency controls apoe 4 effect ss 045 95 ci 089 000 relation assumption substantial variation relative apoe allele frequencies 4 21 considerable heterogeneity evident within geographically proximate populations population admixture likely resulted changes allele frequency time assumption b apoe related causes death context specific changed considerably last 30 years
0.31263503.15319409.html.plaintext.txt	7	conclusion validity case control type studies genetic basis longevity based assumptions questionable especially considerable differences exist allele frequency population genes question interact environmental factors vary time place
0.31263503.15319409.html.plaintext.txt	8	keywords longevity ageing genetic association gene apoe methodology
0.31263503.15319409.html.plaintext.txt	9	twin studies longevity suggest around 25 variation lifespan developed countries may inherited1 understanding heritability consequently biological processes involved ageing longevity one greatest scientific challenges time post genomic era large dna resources becoming available within epidemiological studies better placed ever begin unravel complex problem
0.31263503.15319409.html.plaintext.txt	10	twin studies longevity suggest around 25 variation lifespan developed countries may inherited1 understanding heritability consequently biological processes involved ageing longevity one greatest scientific challenges time post genomic era large dna resources becoming available within epidemiological studies better placed ever begin unravel complex problem
0.31263503.15319409.html.plaintext.txt	11	epidemiological studies widely used look genes conferring risk common multifactorial diseases comparing genotype distributions cases controls2 recently case control designs used identify differences genotypes allele frequencies elderly compared younger populations34 centenarians typically studied represent survivors may lack disease susceptibility genes genes associated premature mortality however specific methodological problems inherent studies comparing populations across time periods although alluded several reviews adequately addressed study designs date argue previous claims resulting studies may flawed based following assumptions initial relative allele frequencies different age groups similar b risk mortality conferred genotype depend year birth
0.31263503.15319409.html.plaintext.txt	12	epidemiological studies widely used look genes conferring risk common multifactorial diseases comparing genotype distributions cases controls2 recently case control designs used identify differences genotypes allele frequencies elderly compared younger populations34 centenarians typically studied represent survivors may lack disease susceptibility genes genes associated premature mortality however specific methodological problems inherent studies comparing populations across time periods although alluded several reviews adequately addressed study designs date argue previous claims resulting studies may flawed based following assumptions initial relative allele frequencies different age groups similar b risk mortality conferred genotype depend year birth
0.31263503.15319409.html.plaintext.txt	13	due secular trends common disease incidence changes patterns exposure environmental risk factors smoking genetic associations found studies unlikely contribute blueprint future longevity unless improvements made methodology used indication type changes needed provided concluding section paper
0.31263503.15319409.html.plaintext.txt	14	due secular trends common disease incidence changes patterns exposure environmental risk factors smoking genetic associations found studies unlikely contribute blueprint future longevity unless improvements made methodology used indication type changes needed provided concluding section paper
0.31263503.15319409.html.plaintext.txt	15	approaches studying genetics ageing top abstract approaches studying methods results discussion conclusion references centenarians quite rare linkage studies require relatively large number long lived sib pairs together dna sibs died early avoid acertainment bias ideally dna would also available one generation genetic association studies therefore feasible becoming widely used look genes important longevity56
0.31263503.15319409.html.plaintext.txt	16	likely many genes contribute longevity candidate genes selected either 1 genes implicated general processes cellular maintenance repair superoxide dismutase 2 sod2 involved scavenging reactive oxygen species apoptosis 2 genes confer increased susceptibility age related diseases apolipoprotein e apoe gene involved lipoprotein metabolism proposed risk factor coronary heart disease chd alzheimers disease78 since genetic studies longevity date second type paper focus studies disease risk genes
0.31263503.15319409.html.plaintext.txt	17	likely many genes contribute longevity candidate genes selected either 1 genes implicated general processes cellular maintenance repair superoxide dismutase 2 sod2 involved scavenging reactive oxygen species apoptosis 2 genes confer increased susceptibility age related diseases apolipoprotein e apoe gene involved lipoprotein metabolism proposed risk factor coronary heart disease chd alzheimers disease78 since genetic studies longevity date second type paper focus studies disease risk genes
0.31263503.15319409.html.plaintext.txt	18	initial gene frequencies age cohorts represented longevity study likely different necessarily represented frequencies youngercontrol population population stratification genetic association studies received large amount negative press recently mainly due lack repeatability results opportunity spurious results29 12 one reason problems population stratification phenomenon pertinent studies longevity whilst genuine differences elderly cohorts younger individuals may exist due role genes longevity artefactual results genetic effects may also arise due variations initial relative allele frequency two comparison groups result population admixture although novel mutations infrequent diffuse slowly interval human generations long gene pool given population change considerably relatively short period result geographical mobility ethnic admixing selective mating10
0.31263503.15319409.html.plaintext.txt	19	initial gene frequencies age cohorts represented longevity study likely different necessarily represented frequencies youngercontrol population population stratification genetic association studies received large amount negative press recently mainly due lack repeatability results opportunity spurious results29 12 one reason problems population stratification phenomenon pertinent studies longevity whilst genuine differences elderly cohorts younger individuals may exist due role genes longevity artefactual results genetic effects may also arise due variations initial relative allele frequency two comparison groups result population admixture although novel mutations infrequent diffuse slowly interval human generations long gene pool given population change considerably relatively short period result geographical mobility ethnic admixing selective mating10
0.31263503.15319409.html.plaintext.txt	20	migration take britain example last 100 years mass emigration usa south africa australia new zealand coupled influx individuals india pakistan bangladesh china caribbean africa recently migration countries europe become common result constitutional rights established within european union scale movement substantial respondents decennial census england 13 population england gave ethnic origin white british 2001 compared 11 1991 increase 18 10 years13 since migration among young adults tends work education net inflows often concentrated cities genetic association studies may based england highest levels flow south east14 central london 253 residents classified white british irish 2001 census13 whilst genetic association studies usually collect data ethnic group rarely distinguish caucasians hence group together individuals different countries regions origin
0.31263503.15319409.html.plaintext.txt	21	migration take britain example last 100 years mass emigration usa south africa australia new zealand coupled influx individuals india pakistan bangladesh china caribbean africa recently migration countries europe become common result constitutional rights established within european union scale movement substantial respondents decennial census england 13 population england gave ethnic origin white british 2001 compared 11 1991 increase 18 10 years13 since migration among young adults tends work education net inflows often concentrated cities genetic association studies may based england highest levels flow south east14 central london 253 residents classified white british irish 2001 census13 whilst genetic association studies usually collect data ethnic group rarely distinguish caucasians hence group together individuals different countries regions origin
0.31263503.15319409.html.plaintext.txt	22	migration within countries individuals better placed work health care may also played role population mixing last century movement regions result changes genetic structure regional populations approximately 20 individuals born england scotland wales 3 9 march 1958 resided different region 1981 birth resulted reduction interregional variability abo blood groups15 migration patterns differ widely countries time periods scale problem depend study population
0.31263503.15319409.html.plaintext.txt	23	migration within countries individuals better placed work health care may also played role population mixing last century movement regions result changes genetic structure regional populations approximately 20 individuals born england scotland wales 3 9 march 1958 resided different region 1981 birth resulted reduction interregional variability abo blood groups15 migration patterns differ widely countries time periods scale problem depend study population
0.31263503.15319409.html.plaintext.txt	24	risk mortality conferred genotypes depend birth year cohort secular trends disease risk migration different gene pools may change genetic risk within given population influence mortality rates time periods order decades addressing first assumption effect also addressing dynamic aside changes population genetic structure environmental risk factors disease changed considerably last 100 years two populations born decades apart likely exposed different pattern stressors reason populations different susceptibilities disease regardless genotype environmental risk factors unlikely change population distribution genetic variants unless offer strong selection particular allele childhood reproductive years therefore secular trends genetic susceptibility diseases elderly confounded environment rather environment acts effect modifier
0.31263503.15319409.html.plaintext.txt	25	risk mortality conferred genotypes depend birth year cohort secular trends disease risk migration different gene pools may change genetic risk within given population influence mortality rates time periods order decades addressing first assumption effect also addressing dynamic aside changes population genetic structure environmental risk factors disease changed considerably last 100 years two populations born decades apart likely exposed different pattern stressors reason populations different susceptibilities disease regardless genotype environmental risk factors unlikely change population distribution genetic variants unless offer strong selection particular allele childhood reproductive years therefore secular trends genetic susceptibility diseases elderly confounded environment rather environment acts effect modifier
0.31263503.15319409.html.plaintext.txt	26	life expectancy doubled first half 20th century largely due reduction malnutrition childhood infection chronic diseases heart disease cancer occur later life became major causes death developed countries16 shift causes mortality epidemiological transition occurred relatively short period suggested rise chd cancer incidence western countries consequence ageing populations however increase rates mortality cancer took place among men britain 1921 1960 largely attributed lung cancer smoking main environmental cause17 levels smoking britain reached peak 1960s followed steady decline although approximately 30 adult population continue smoke figure 116 similarly national chd mortality rates rose fell past century deaths chd reached peak many westernized countries 1970s declining figure 218 hence disease risks changed time levels exposure major environmental causes changed
0.31263503.15319409.html.plaintext.txt	27	life expectancy doubled first half 20th century largely due reduction malnutrition childhood infection chronic diseases heart disease cancer occur later life became major causes death developed countries16 shift causes mortality epidemiological transition occurred relatively short period suggested rise chd cancer incidence western countries consequence ageing populations however increase rates mortality cancer took place among men britain 1921 1960 largely attributed lung cancer smoking main environmental cause17 levels smoking britain reached peak 1960s followed steady decline although approximately 30 adult population continue smoke figure 116 similarly national chd mortality rates rose fell past century deaths chd reached peak many westernized countries 1970s declining figure 218 hence disease risks changed time levels exposure major environmental causes changed
0.31263503.15319409.html.plaintext.txt	28	view larger version 11k figure 1 number cigarettes smoked per person per day britain16
0.31263503.15319409.html.plaintext.txt	29	view larger version 21k figure 2 mortality cardiovascular disease seven different countries18
0.31263503.15319409.html.plaintext.txt	30	smoking nutrition physical activity sexual behaviour poverty occupation stress education social contacts health care pollution war infectious disease factors play part disease risk longevity individual societal level patterns availability exposure many changed enormously secular socio economic cultural trends last 100 years seen case smoking treatment disease may also impact mortality rates depend disease year contracted
0.31263503.15319409.html.plaintext.txt	31	smoking nutrition physical activity sexual behaviour poverty occupation stress education social contacts health care pollution war infectious disease factors play part disease risk longevity individual societal level patterns availability exposure many changed enormously secular socio economic cultural trends last 100 years seen case smoking treatment disease may also impact mortality rates depend disease year contracted
0.31263503.15319409.html.plaintext.txt	32	apoe longevity possibly extensively studied gene relation longevity apoe protein encoded gene ligand low density lipoprotein ldl receptor receptors ldl receptor gene family cell matrix associated heparin sulphate proteoglycans gene plays important role lipoprotein metabolism shown associated chd risk719 three common polymorphic forms apoe known exist 2 3 4 various apoe isoforms produced result polymorphism interact differently specific lipoprotein receptors ultimately altering circulating levels cholesterol high ldl cholesterol levels associated apoe 4 low levels apoe 2 apoe 3 levels intermediate two19 apoe 4 allele also associated increase risk alzheimers disease8 although mechanism entirely clear association could due 1 effects amyloid ss metabolism 2 effects neurons glial cells including neuronal survival neurite extension 3 effects related atherosclerosis cerebral blood flow blood brain barrier19 since chd alzheimers disease common disease old age apoe become candidate gene studies longevity several studies comparing apoe genotypes elderly versus younger populations carried out20 34 overview literature gerdes et al28 found apoe 4 associated premature death
0.31263503.15319409.html.plaintext.txt	33	apoe longevity possibly extensively studied gene relation longevity apoe protein encoded gene ligand low density lipoprotein ldl receptor receptors ldl receptor gene family cell matrix associated heparin sulphate proteoglycans gene plays important role lipoprotein metabolism shown associated chd risk719 three common polymorphic forms apoe known exist 2 3 4 various apoe isoforms produced result polymorphism interact differently specific lipoprotein receptors ultimately altering circulating levels cholesterol high ldl cholesterol levels associated apoe 4 low levels apoe 2 apoe 3 levels intermediate two19 apoe 4 allele also associated increase risk alzheimers disease8 although mechanism entirely clear association could due 1 effects amyloid ss metabolism 2 effects neurons glial cells including neuronal survival neurite extension 3 effects related atherosclerosis cerebral blood flow blood brain barrier19 since chd alzheimers disease common disease old age apoe become candidate gene studies longevity several studies comparing apoe genotypes elderly versus younger populations carried out20 34 overview literature gerdes et al28 found apoe 4 associated premature death
0.31263503.15319409.html.plaintext.txt	34	determine inaccurate assumptions initial apoe allele frequencies among elderly populations may influence outcome gene association studies whether increased risk mortality conferred apoe gene depends year birth determine whether published studies addressed problems carried review studies comparing apoe allele frequencies elderly versus younger populations
0.31263503.15319409.html.plaintext.txt	35	methods top abstract approaches studying methods results discussion conclusion references search strategy selection criteria papers published prior end april 2003 identified search medline wwwncbinlmnihgov using following search terms longevity centenarian aging ageing apolipoprotein e apo e apoe publications also identified review bibliographies retrieved articles studies included control group country elderly group least 80 years old restrictions publications based health participants results study population published recent report used studies published english abstract english included
0.31263503.15319409.html.plaintext.txt	36	statistical methods unadjusted odds ratios based published allele frequencies calculated proportion 2 alleles 4 alleles elderly versus control populations using relative 3 allele frequencies reference effect apoe allele shown dependent upon genotype3536 however expected relative frequency 22 44 homozygotes low around 1 25 respectively stable estimates effect homozygotes longevity possible small studies relative frequencies 22 44 homozygotes available 3 15 studies reviewed here242932 studies compare allele frequencies combine 22 homozygotes 32 heterozygotes combine 44 homozygotes 34 heterozygotes give estimates 2 carriers versus 33 homozygotes 4 carriers versus 33 homozygotes using allele frequencies weighted effect size genotype frequency however analysis genotype instead allele frequency gave similar results shown
0.31263503.15319409.html.plaintext.txt	37	statistical methods unadjusted odds ratios based published allele frequencies calculated proportion 2 alleles 4 alleles elderly versus control populations using relative 3 allele frequencies reference effect apoe allele shown dependent upon genotype3536 however expected relative frequency 22 44 homozygotes low around 1 25 respectively stable estimates effect homozygotes longevity possible small studies relative frequencies 22 44 homozygotes available 3 15 studies reviewed here242932 studies compare allele frequencies combine 22 homozygotes 32 heterozygotes combine 44 homozygotes 34 heterozygotes give estimates 2 carriers versus 33 homozygotes 4 carriers versus 33 homozygotes using allele frequencies weighted effect size genotype frequency however analysis genotype instead allele frequency gave similar results shown
0.31263503.15319409.html.plaintext.txt	38	random effects models used calculate summary standard errors three studies provided genotypeallele frequencies one age group control population222327 data different age groups studies combined give overall estimate age less 80 combined relative risks males females presented forest plots constructed logarithmic scales assess association frequency 2 4 alleles control group log allele frequency elderly populations versus controls used bayesian random effects meta regression model fitted using bugs winbugs 14 wwwmrc bsucamacukbugs37 avoids bias caused association allele frequency arises due sampling error statistical analysis carried stata version 8 stata corporation texas tests funnel plot asymmetry3839 used investigate publication bias studies grouped geographical location north america included studies usa canada asia included studies china japan korea northern europe included finland denmark uk central europe included france southern europe included italy
0.31263503.15319409.html.plaintext.txt	39	random effects models used calculate summary standard errors three studies provided genotypeallele frequencies one age group control population222327 data different age groups studies combined give overall estimate age less 80 combined relative risks males females presented forest plots constructed logarithmic scales assess association frequency 2 4 alleles control group log allele frequency elderly populations versus controls used bayesian random effects meta regression model fitted using bugs winbugs 14 wwwmrc bsucamacukbugs37 avoids bias caused association allele frequency arises due sampling error statistical analysis carried stata version 8 stata corporation texas tests funnel plot asymmetry3839 used investigate publication bias studies grouped geographical location north america included studies usa canada asia included studies china japan korea northern europe included finland denmark uk central europe included france southern europe included italy
0.31263503.15319409.html.plaintext.txt	40	results top abstract approaches studying methods results discussion conclusion references fifteen studies met inclusion criteria characteristics studies summarized table 1 first study carried canada one study carried usa four asia remaining nine europe elderly versus control populations ranged 056 95 ci 023 139 244 95 ci 118 506 presence 2 allele 032 95 ci 010 101 212 95 ci 079 566 presence 4 allele summary effect estimate 134 95 ci 119 135 presence 2 allele 054 95 ci 046 063 presence 4 allele elderly versus younger individuals
0.31263503.15319409.html.plaintext.txt	41	view table table 1 cross sectional studies apolipoprotein e apoe polymorphisms longevity
0.31263503.15319409.html.plaintext.txt	42	large differences relative apoe allele frequencies existed control populations 2 4 10 4 4 21 regional variations apoe allele frequencies high relative apoe 4 northern europe 15 21 intermediate frequencies central europe 11 13 asia 8 13 north america 12 15 low frequencies southern europe 4 6 elderly people 4 allele frequencies converged homogeneous 2 12 despite differences 2 15 studies reportedly matched geographic origin one study matched ethnicity meta analysis including studies gave result closer null rr 074 95 ci 034 156 presence 4 elderly versus younger populations four studies stated controls nationality21232731 although necessarily exclude migrants particularly second generation migrants
0.31263503.15319409.html.plaintext.txt	43	large differences relative apoe allele frequencies existed control populations 2 4 10 4 4 21 regional variations apoe allele frequencies high relative apoe 4 northern europe 15 21 intermediate frequencies central europe 11 13 asia 8 13 north america 12 15 low frequencies southern europe 4 6 elderly people 4 allele frequencies converged homogeneous 2 12 despite differences 2 15 studies reportedly matched geographic origin one study matched ethnicity meta analysis including studies gave result closer null rr 074 95 ci 034 156 presence 4 elderly versus younger populations four studies stated controls nationality21232731 although necessarily exclude migrants particularly second generation migrants
0.31263503.15319409.html.plaintext.txt	44	regression coefficient association log odds 4 control group log 4 allele frequency elderly versus controls 045 95 ci 089 000 providing evidence association two finnish study23 frequency 4 allele 20 037 95 ci 025 054 obtained whereas italian study26 4 frequency 4 212 95 ci 079 566 significant association 2 effect size relative 2 allele frequencies control group ss 044 95 ci 107 017
0.31263503.15319409.html.plaintext.txt	45	meta analysis considering studies centenarians gave point estimate 150 95 ci 127 178 2 049 95 ci 041 058 4 frequency among centenarians versus controls
0.31263503.15319409.html.plaintext.txt	46	whole approaches validating laboratory results stated papers although blanche et al30 reported re genotyping 1994 cohort published schachter 199421 finding discordance rate 58 beggs funnel plot figure 5 eggers test standardized effect versus precision provide evidence publication bias p 040 eggers p 066 beggs3839
0.31263503.15319409.html.plaintext.txt	47	view larger version 8k figure 5 beggs funnel plot cross sectional studies apoe 4 allele longevity
0.31263503.15319409.html.plaintext.txt	48	view larger version 11k figure 3 schematic illustration apoe longevity
0.31263503.15319409.html.plaintext.txt	49	view larger version 21k figure 4 forest plots representing case control studies apoe longevity ordered allele frequency controls
0.31263503.15319409.html.plaintext.txt	50	apoe 2 allele longevitya
0.31263503.15319409.html.plaintext.txt	51	b apoe 4 allele longevitya
0.31263503.15319409.html.plaintext.txt	52	astudies order allele frequency control population low top high bottom
0.31263503.15319409.html.plaintext.txt	53	discussion top abstract approaches studying methods results discussion conclusion references reviewed 15 cross sectional studies apoe polymorphisms longevity determine whether two key methodological assumptions addressed studies provide direct evidence size genetic effect interest sensitive relative allele frequency among controls relative apoe 4 allele frequency exhibits wide variation within proximate populations inference initial allele frequencies likely differ age cohorts compared groups drawn assumption generally invalid biology epidemiology presumed apoe related diseases particular great variation coronary death rates time place provides indirect evidence mortality risk conferred apoe genotype depends interaction environmental behavioural risk factors life course pattern exposures closely related year birth thus assumption b likely invalid gene environment interaction important case apoe
0.31263503.15319409.html.plaintext.txt	54	since genetic studies common polygenic disease recent phenomenon impossible determine directly whether initial allele frequencies elderly individuals represented younger controls similarly whether risk mortality associated common genetic variants depends year birth however case apoe 4 clear allele frequencies differ widely population even among neighbouring countries geographically separated populations within country example lapps finns40 migration patterns differ country substantial internal international migration many countries within last 100 years41 factors likely produced differences apoe allele frequency age group within given geographical area recent decades migration particularly prevalent among younger populations large university cities14 studies carried whilst almost studies showed deficit apoe 4 alleles elderly versus younger populations heterogeneity effect size remained even populations stratified region
0.31263503.15319409.html.plaintext.txt	55	since genetic studies common polygenic disease recent phenomenon impossible determine directly whether initial allele frequencies elderly individuals represented younger controls similarly whether risk mortality associated common genetic variants depends year birth however case apoe 4 clear allele frequencies differ widely population even among neighbouring countries geographically separated populations within country example lapps finns40 migration patterns differ country substantial internal international migration many countries within last 100 years41 factors likely produced differences apoe allele frequency age group within given geographical area recent decades migration particularly prevalent among younger populations large university cities14 studies carried whilst almost studies showed deficit apoe 4 alleles elderly versus younger populations heterogeneity effect size remained even populations stratified region
0.31263503.15319409.html.plaintext.txt	56	able make inferences based biology epidemiology apoe suggests assumption b invalid longevity effect may subject modification periods years decades corresponding age difference elderly control groups apoe plays important role lipoprotein metabolism therefore apoe genotype one influence health effects dietary fat intake apoe associated chd risk one mechanism proposed explain association apoe longevity last 30 years chd mortality decreased substantially many countries figure 2 factors underlying decrease include changes diet smoking treatments chd studies reviewed size apoe 4 effect differed population providing evidence 4 effects context dependant
0.31263503.15319409.html.plaintext.txt	57	able make inferences based biology epidemiology apoe suggests assumption b invalid longevity effect may subject modification periods years decades corresponding age difference elderly control groups apoe plays important role lipoprotein metabolism therefore apoe genotype one influence health effects dietary fat intake apoe associated chd risk one mechanism proposed explain association apoe longevity last 30 years chd mortality decreased substantially many countries figure 2 factors underlying decrease include changes diet smoking treatments chd studies reviewed size apoe 4 effect differed population providing evidence 4 effects context dependant
0.31263503.15319409.html.plaintext.txt	58	appeared association 4 allele frequency controls effect 4 longevity sampling variation important potential explanation chance estimated 4 prevalence true prevalence former tend high within distribution effect size tend extreme due regression mean however relative apoe 4 allele frequency known vary population studies reviewed anomalous respect among europeans relative apoe 4 frequencies exhibit north south cline42 accordingly high relative apoe 4 allele frequencies observed studies northern european participants 15 21 low frequencies southern european studies 4 6 furthermore bayesian approach used calculate association control allele frequency effect size avoids bias arise due sampling error
0.31263503.15319409.html.plaintext.txt	59	appeared association 4 allele frequency controls effect 4 longevity sampling variation important potential explanation chance estimated 4 prevalence true prevalence former tend high within distribution effect size tend extreme due regression mean however relative apoe 4 allele frequency known vary population studies reviewed anomalous respect among europeans relative apoe 4 frequencies exhibit north south cline42 accordingly high relative apoe 4 allele frequencies observed studies northern european participants 15 21 low frequencies southern european studies 4 6 furthermore bayesian approach used calculate association control allele frequency effect size avoids bias arise due sampling error
0.31263503.15319409.html.plaintext.txt	60	remains unclear whether sampling younger control population produces valid estimates initial allele frequencies corresponding elderly population migration population substructure may confound studies relative allele frequencies control populations overestimate initial relative allele frequencies elderly group spurious estimate longevity effect obtained migration likely change relative allele frequencies substantially source recipient populations different allele frequencies changes allele frequency short term function difference frequency migration rate large differences seen one generation43 net immigration regions relatively high allele frequency overestimate decrease 4 elderly relative controls conversely net immigration areas relatively low allele frequency underestimate difference example canadian study20 relative apoe 4 allele frequency control group 152 represents allele frequency elderly population birth 053 95 ci 032 088 good estimate link apoe 4 longevity however 19 current canadian residents born canada41 migrants came countries relatively high allele frequencies 31 reported among lapps44 migration would result overestimation real initial relative allele frequency 115 true 4 effect closer null 076 95 ci 044 130 alternatively migrants came countries areas low apoe 4 frequency frequencies 5 reported sardinians45 real initial frequency would higher around 176 4 effect around 045 95 ci 027 072 simple example international migration occurring within one generation take account second generation migrants born canada internal migration involves somewhat unrealistic assumptions migration patterns example offer insight migration may influence results genetic association studies longevity
0.31263503.15319409.html.plaintext.txt	61	remains unclear whether sampling younger control population produces valid estimates initial allele frequencies corresponding elderly population migration population substructure may confound studies relative allele frequencies control populations overestimate initial relative allele frequencies elderly group spurious estimate longevity effect obtained migration likely change relative allele frequencies substantially source recipient populations different allele frequencies changes allele frequency short term function difference frequency migration rate large differences seen one generation43 net immigration regions relatively high allele frequency overestimate decrease 4 elderly relative controls conversely net immigration areas relatively low allele frequency underestimate difference example canadian study20 relative apoe 4 allele frequency control group 152 represents allele frequency elderly population birth 053 95 ci 032 088 good estimate link apoe 4 longevity however 19 current canadian residents born canada41 migrants came countries relatively high allele frequencies 31 reported among lapps44 migration would result overestimation real initial relative allele frequency 115 true 4 effect closer null 076 95 ci 044 130 alternatively migrants came countries areas low apoe 4 frequency frequencies 5 reported sardinians45 real initial frequency would higher around 176 4 effect around 045 95 ci 027 072 simple example international migration occurring within one generation take account second generation migrants born canada internal migration involves somewhat unrealistic assumptions migration patterns example offer insight migration may influence results genetic association studies longevity
0.31263503.15319409.html.plaintext.txt	62	3 15 studies matched ethnicity andor place birth remaining studies assumed static population identical gene pool elderly younger age groups meta analysis including studies matching origin ethnicity gave result closer null consistent artefactual explanation studies failing take account genetic heterogeneity remaining studies effectively assumed static population identical gene pool elderly younger age groups
0.31263503.15319409.html.plaintext.txt	63	3 15 studies matched ethnicity andor place birth remaining studies assumed static population identical gene pool elderly younger age groups meta analysis including studies matching origin ethnicity gave result closer null consistent artefactual explanation studies failing take account genetic heterogeneity remaining studies effectively assumed static population identical gene pool elderly younger age groups
0.31263503.15319409.html.plaintext.txt	64	explanation apparent association 4 prevalence magnitude 4 effect longevity impact greater populations higher underlying risk chd international comparisons suggest apoe 4 allele frequency may explain geographical variation chd risk46 japan low chd risk population ratio relative 4 frequency elderly versus younger populations 078 95 ci 039 15825 whereas finland high chd risk population ratio found 043 95 ci 026 07322 037 95 ci 025 05423 difference chd risk japan finland could due genetic susceptibility environmental factors likely combination example northern europe high apoe 4 relative allele frequencies historically accompanied high levels saturated fat intake
0.31263503.15319409.html.plaintext.txt	65	explanation apparent association 4 prevalence magnitude 4 effect longevity impact greater populations higher underlying risk chd international comparisons suggest apoe 4 allele frequency may explain geographical variation chd risk46 japan low chd risk population ratio relative 4 frequency elderly versus younger populations 078 95 ci 039 15825 whereas finland high chd risk population ratio found 043 95 ci 026 07322 037 95 ci 025 05423 difference chd risk japan finland could due genetic susceptibility environmental factors likely combination example northern europe high apoe 4 relative allele frequencies historically accompanied high levels saturated fat intake
0.31263503.15319409.html.plaintext.txt	66	influence genetic variation longevity priori important research question proponents genetic epidemiology argue predicting multifactorial disease outcomes without consideration epigenetic networks increasingly seen naive 47 implication methodology genetic dimension included risk factor models chronic disease extension longevity papers reviewed focus single genetic effect main effect apoe longevity represent early attempts develop genetic perspective field dominated environmental explanations example know environment broad sense including behavioural factors essential understanding time trends chd rates figure 2 longevity known whether single common genetic variations apoe polymorphism important factors add explanation provided conventional environmental risk factors studies apoe longevity reviewed consistently showed effect 2 4 alleles longevity suggest apoe may part play however analyses taking simultaneous account genetic environmental factors needed address question
0.31263503.15319409.html.plaintext.txt	67	influence genetic variation longevity priori important research question proponents genetic epidemiology argue predicting multifactorial disease outcomes without consideration epigenetic networks increasingly seen naive 47 implication methodology genetic dimension included risk factor models chronic disease extension longevity papers reviewed focus single genetic effect main effect apoe longevity represent early attempts develop genetic perspective field dominated environmental explanations example know environment broad sense including behavioural factors essential understanding time trends chd rates figure 2 longevity known whether single common genetic variations apoe polymorphism important factors add explanation provided conventional environmental risk factors studies apoe longevity reviewed consistently showed effect 2 4 alleles longevity suggest apoe may part play however analyses taking simultaneous account genetic environmental factors needed address question
0.31263503.15319409.html.plaintext.txt	68	conclusion top abstract approaches studying methods results discussion conclusion references review leads us following conclusions relation validity assumptions b
0.31263503.15319409.html.plaintext.txt	69	assumption initial relative allele frequencies different age groups similar assumption may hold considerable variation allele frequencies population migration resulted changes population substructure
0.31263503.15319409.html.plaintext.txt	70	assumption b risk mortality conferred genotype depend year birth assumption may invalid mortality risk conferred genotype depends interaction environmental behavioural risk factors pattern exposure risk factors closely related year birth
0.31263503.15319409.html.plaintext.txt	71	assumption b risk mortality conferred genotype depend year birth assumption may invalid mortality risk conferred genotype depends interaction environmental behavioural risk factors pattern exposure risk factors closely related year birth
0.31263503.15319409.html.plaintext.txt	72	whilst studies reviewed provide evidence link apoe longevity problem size effect depends population question probably also time period study spans link size apoe effect relative allele frequency seen review likely result population differences underlying disease susceptibility changes population structure time illustrates impact violating assumptions
0.31263503.15319409.html.plaintext.txt	73	whilst studies reviewed provide evidence link apoe longevity problem size effect depends population question probably also time period study spans link size apoe effect relative allele frequency seen review likely result population differences underlying disease susceptibility changes population structure time illustrates impact violating assumptions
0.31263503.15319409.html.plaintext.txt	74	future case control type studies could improved least including comprehensive data birth origins exposure potential confounding factors also possible address concerns population stratification case control studies carrying genome analysis using methods genomic control structured association48
0.31263503.15319409.html.plaintext.txt	75	future case control type studies could improved least including comprehensive data birth origins exposure potential confounding factors also possible address concerns population stratification case control studies carrying genome analysis using methods genomic control structured association48
0.31263503.15319409.html.plaintext.txt	76	cohort studies subject assumptions hence preferable cross sectional design participants selected followed given time period subject age related mortality rate cohort studies carried date looked apoe longevity tend short follow periods typically 5 years49 56 hence provide snapshot overall survival studies reported mixed results documenting null findings apoe 4 longevity5051 others showing negative associations subgroups only54 56 address question adequately cohort studies ideally birth cohorts long follow required
0.31263503.15319409.html.plaintext.txt	77	cohort studies subject assumptions hence preferable cross sectional design participants selected followed given time period subject age related mortality rate cohort studies carried date looked apoe longevity tend short follow periods typically 5 years49 56 hence provide snapshot overall survival studies reported mixed results documenting null findings apoe 4 longevity5051 others showing negative associations subgroups only54 56 address question adequately cohort studies ideally birth cohorts long follow required
0.31263503.15319409.html.plaintext.txt	78	cross sectional studies longevity assume relative allele frequencies different age cohorts b risk mortality conferred genotypes depend year birth population admixture may result considerable population changes allele frequency time allele frequencies differ substantially population migration high mortality risk conferred genotypes may differ gene question interacts environmental factors vary time place studies apolipoprotein e apoe 4 longevity show effect size estimates associated relative allele frequency control populations hence accurately predicting impact apoe longevity depends validity assumption apoe associated coronary heart disease chd risk one mechanism proposed explain association apoe longevity however chd mortality decreased mortaliy last 30 years largely due environmental behavioural factors hence effect apoe longevity context dependent
0.31263503.15319409.html.plaintext.txt	79	cross sectional studies longevity assume relative allele frequencies different age cohorts b risk mortality conferred genotypes depend year birth population admixture may result considerable population changes allele frequency time allele frequencies differ substantially population migration high mortality risk conferred genotypes may differ gene question interacts environmental factors vary time place studies apolipoprotein e apoe 4 longevity show effect size estimates associated relative allele frequency control populations hence accurately predicting impact apoe longevity depends validity assumption apoe associated coronary heart disease chd risk one mechanism proposed explain association apoe longevity however chd mortality decreased mortaliy last 30 years largely due environmental behavioural factors hence effect apoe longevity context dependent
0.31263503.15319409.html.plaintext.txt	80	acknowledgments would like thank dr meena kumari dr mark pearce comments manuscript also drs jonathan sterne nicola welton help statistical analysis using bugs work funded co op research grant medical research council uk
0.31263503.15319409.html.plaintext.txt	81	acknowledgments would like thank dr meena kumari dr mark pearce comments manuscript also drs jonathan sterne nicola welton help statistical analysis using bugs work funded co op research grant medical research council uk
0.31263503.15319409.html.plaintext.txt	82	references top abstract approaches studying methods results discussion conclusion references 1 cournil kirkwood tbl would live long choose parents well trends genet 200117233 35crossrefisimedline
0.31263503.15319409.html.plaintext.txt	83	2 hirschhorn jn lohmueller k byrne e hirschhorn k comprehensive review genetic association studies genet med 2002445 61isimedline
0.31263503.15319409.html.plaintext.txt	84	2 hirschhorn jn lohmueller k byrne e hirschhorn k comprehensive review genetic association studies genet med 2002445 61isimedline
0.31263503.15319409.html.plaintext.txt	85	3 heijmans bt westendorp rgj slagboom pe common gene variants mortality extreme longevity humans exp gerontol 200035865 77crossrefisimedline
0.31263503.15319409.html.plaintext.txt	86	3 heijmans bt westendorp rgj slagboom pe common gene variants mortality extreme longevity humans exp gerontol 200035865 77crossrefisimedline
0.31263503.15319409.html.plaintext.txt	87	4 de benedictis g tan q jeune b et al recent advances human gene longevity association studies mech ageing dev 2001122909 20crossrefisimedline
0.31263503.15319409.html.plaintext.txt	88	4 de benedictis g tan q jeune b et al recent advances human gene longevity association studies mech ageing dev 2001122909 20crossrefisimedline
0.31263503.15319409.html.plaintext.txt	89	5 vijg j van orsouw n searching genetic determinants human aging longevity opportunities challenges mech ageing dev 2002123195 205crossrefisimedline
0.31263503.15319409.html.plaintext.txt	90	6 schachter f cohen d kirkwood prospects genetics human longevity hum genet 199391519 26isimedline
0.31263503.15319409.html.plaintext.txt	91	6 schachter f cohen d kirkwood prospects genetics human longevity hum genet 199391519 26isimedline
0.31263503.15319409.html.plaintext.txt	92	7 wilson pwf schaefer ej larson mg ordovas jm apolipoprotein e alleles risk coronary disease meta analysis arterioscler thromb vasc biol 1996161250 55abstractfree full text
0.31263503.15319409.html.plaintext.txt	93	7 wilson pwf schaefer ej larson mg ordovas jm apolipoprotein e alleles risk coronary disease meta analysis arterioscler thromb vasc biol 1996161250 55abstractfree full text
0.31263503.15319409.html.plaintext.txt	94	8 rubinsztein dc easton df apolipoprotein e genetic variation alzheimers disease meta analysis dement geriatr cogn disord 199910199 209crossrefisimedline
0.31263503.15319409.html.plaintext.txt	95	9 ioannidis jpa ntzani ee trikalinos ta contopoulos ioannidis dg replication validity genetic association studies nat genet 200129306 09crossrefisimedline
0.31263503.15319409.html.plaintext.txt	96	9 ioannidis jpa ntzani ee trikalinos ta contopoulos ioannidis dg replication validity genetic association studies nat genet 200129306 09crossrefisimedline
0.31263503.15319409.html.plaintext.txt	97	10 cardon lr bell ji association study designs complex diseases nat rev genet 2001291 99crossrefisimedline
0.31263503.15319409.html.plaintext.txt	98	11 colhoun hm mckeigue davey smith g problems reporting genetic associations complex outcomes lancet 20033611 8crossrefisimedline
0.31263503.15319409.html.plaintext.txt	99	11 colhoun hm mckeigue davey smith g problems reporting genetic associations complex outcomes lancet 20033611 8crossrefisimedline
0.31263503.15319409.html.plaintext.txt	100	12 cardon lr palmer lj population stratification spurious allelic association lancet 2003361598 604crossrefisimedline
0.31263503.15319409.html.plaintext.txt	101	13 census 2001 stationery office ons london 2001
0.31263503.15319409.html.plaintext.txt	102	14 dobson j mclaughlan g international migration united kingdom 1975 1999 consistency change implications labour market popul trends 200110629 38medline
0.31263503.15319409.html.plaintext.txt	103	15 mascie taylor cg lasker gw effect interregional migration geographic variability biological social trends britain hum biol 199567629 40isimedline
0.31263503.15319409.html.plaintext.txt	104	16 office national statistics health adult britain 1841 1994 stationery office ons london 1998
0.31263503.15319409.html.plaintext.txt	105	16 office national statistics health adult britain 1841 1994 stationery office ons london 1998
0.31263503.15319409.html.plaintext.txt	106	17 davey smith g marmot mg trends mortality britain 1920 1986 ann nutr metab 19913553 63isimedline
0.31263503.15319409.html.plaintext.txt	107	18 levi f lucchini f negri e la vecchia c trends mortality cardiovascular cerebrovascular diseases europe areas world heart 200288119 124abstractfree full text
0.31263503.15319409.html.plaintext.txt	108	18 levi f lucchini f negri e la vecchia c trends mortality cardiovascular cerebrovascular diseases europe areas world heart 200288119 124abstractfree full text
0.31263503.15319409.html.plaintext.txt	109	19 smith jd apolipoproteins aging emerging mechanisms ageing res rev 20021345 65crossrefisimedline
0.31263503.15319409.html.plaintext.txt	110	20 davignon j bouthillier nestruck c sing cf apolipoprotein e polymorphism atherosclerosis insight study octogenarians trans clin climatol assoc 198799100 10medline
0.31263503.15319409.html.plaintext.txt	111	20 davignon j bouthillier nestruck c sing cf apolipoprotein e polymorphism atherosclerosis insight study octogenarians trans clin climatol assoc 198799100 10medline
0.31263503.15319409.html.plaintext.txt	112	21 schachter f faure delanef l guenot f et al genetic associations human longevity apoe ace loci nature genet 1994829 32
0.31263503.15319409.html.plaintext.txt	113	21 schachter f faure delanef l guenot f et al genetic associations human longevity apoe ace loci nature genet 1994829 32
0.31263503.15319409.html.plaintext.txt	114	22 kervinen k savolainen mj salokannel j et al apolipoprotein e b polymorphisms longevity factors assessed nonagenarians atheroscerosis 199412689 95
0.31263503.15319409.html.plaintext.txt	115	22 kervinen k savolainen mj salokannel j et al apolipoprotein e b polymorphisms longevity factors assessed nonagenarians atheroscerosis 199412689 95
0.31263503.15319409.html.plaintext.txt	116	23 louhija j miettinen k kontula k tikkanen mj miettinen ta tivlis rs aging genetic variation plasma apolipoproteins relative loss apolipoprotein e4 phenotype centenarians arterioscler thromb 1994141084 89abstract
0.31263503.15319409.html.plaintext.txt	117	23 louhija j miettinen k kontula k tikkanen mj miettinen ta tivlis rs aging genetic variation plasma apolipoproteins relative loss apolipoprotein e4 phenotype centenarians arterioscler thromb 1994141084 89abstract
0.31263503.15319409.html.plaintext.txt	118	24 galinsky d tysoe c brayne ce et al atherosclerosis analysis apo eapo c angiotensin converting enzyme methylenetetrahydrofolate reductase genes candidates affecting human longevity atherosclerosis 1997129177 83crossrefisimedline
0.31263503.15319409.html.plaintext.txt	119	25 hirose n homma arai y et al tokyo centenarian study 4 apolipoprotein e phenotype japanese centenarians living tokyo metropolitan area nippon ronen igakkai zasshi 19974267 72
0.31263503.15319409.html.plaintext.txt	120	26 bader g zuliani g kostner gm fellin r apolipoprotein e polymorphism associated longevity disability sample italian octo nonagenarians gerontology 199844293 99isimedline
0.31263503.15319409.html.plaintext.txt	121	26 bader g zuliani g kostner gm fellin r apolipoprotein e polymorphism associated longevity disability sample italian octo nonagenarians gerontology 199844293 99isimedline
0.31263503.15319409.html.plaintext.txt	122	27 jian gang z yong xing m chuan fu w et al apolipoprotein e longevity among han chinese population mech ageing dev 1998104159 67crossrefisimedline
0.31263503.15319409.html.plaintext.txt	123	27 jian gang z yong xing m chuan fu w et al apolipoprotein e longevity among han chinese population mech ageing dev 1998104159 67crossrefisimedline
0.31263503.15319409.html.plaintext.txt	124	28 gerdes lu jeune b ranberg ka nybo h vaupel jw estimation apolipoprotein e genotype specific relative mortality risks distribution genotypes centenarians middle aged men apolipoprotein e gene frailty gene longevity gene genet epidemiol 200019202 1030co2 qlinktypedoi crossrefisimedline
0.31263503.15319409.html.plaintext.txt	125	28 gerdes lu jeune b ranberg ka nybo h vaupel jw estimation apolipoprotein e genotype specific relative mortality risks distribution genotypes centenarians middle aged men apolipoprotein e gene frailty gene longevity gene genet epidemiol 200019202 1030co2 qlinktypedoi crossrefisimedline
0.31263503.15319409.html.plaintext.txt	126	29 rea im mcdowell mcmaster d smye m stout r evans apolipoprotein e alleles nonagenarian subjects belfast elderly longitudinal free living ageing study belfast mech ageing dev 20011221367 72crossrefisimedline
0.31263503.15319409.html.plaintext.txt	127	29 rea im mcdowell mcmaster d smye m stout r evans apolipoprotein e alleles nonagenarian subjects belfast elderly longitudinal free living ageing study belfast mech ageing dev 20011221367 72crossrefisimedline
0.31263503.15319409.html.plaintext.txt	128	30 blanche h cabanne l sahbatou m thomas g study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline
0.31263503.15319409.html.plaintext.txt	129	30 blanche h cabanne l sahbatou m thomas g study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline
0.31263503.15319409.html.plaintext.txt	130	31 wang x wang g yang c xuan l apolipoprotein e gene polymorphism association human longevity uygar nationality xinjiang chin med j 2001114817 20isimedline
0.31263503.15319409.html.plaintext.txt	131	31 wang x wang g yang c xuan l apolipoprotein e gene polymorphism association human longevity uygar nationality xinjiang chin med j 2001114817 20isimedline
0.31263503.15319409.html.plaintext.txt	132	32 zubenko gs stiffler hughes hb fatigati mj zubenko wn genome survey loci influence successful aging sample characterization method validation initial results y chromosome j geriatr psychiatry 200210619 30abstractfree full text
0.31263503.15319409.html.plaintext.txt	133	32 zubenko gs stiffler hughes hb fatigati mj zubenko wn genome survey loci influence successful aging sample characterization method validation initial results y chromosome j geriatr psychiatry 200210619 30abstractfree full text
0.31263503.15319409.html.plaintext.txt	134	33 choi yh kim jh kim dk et al distributions ace apoe polymorphisms relations dementia status korean centenarians j gerontol biol sci med sci 200358227 31isimedline
0.31263503.15319409.html.plaintext.txt	135	33 choi yh kim jh kim dk et al distributions ace apoe polymorphisms relations dementia status korean centenarians j gerontol biol sci med sci 200358227 31isimedline
0.31263503.15319409.html.plaintext.txt	136	34 panza f solfrizzi v colacicco et al apolipoprotein e apoe polymorphism influences serum apoe levels alzheimers disease patients centenarians neuroreport 200314605 08crossrefisimedline
0.31263503.15319409.html.plaintext.txt	137	34 panza f solfrizzi v colacicco et al apolipoprotein e apoe polymorphism influences serum apoe levels alzheimers disease patients centenarians neuroreport 200314605 08crossrefisimedline
0.31263503.15319409.html.plaintext.txt	138	35 schiele f de bacquer d vincent viry m et al apolipoprotein e serum concentration polymorphism six european countries apoeurope project atherosclerosis 2000152475 88crossrefisimedline
0.31263503.15319409.html.plaintext.txt	139	35 schiele f de bacquer d vincent viry m et al apolipoprotein e serum concentration polymorphism six european countries apoeurope project atherosclerosis 2000152475 88crossrefisimedline
0.31263503.15319409.html.plaintext.txt	140	36 frikke schmidt r tybjaerg hansen steffensen r jensen g nordestgaard bg apolipoprotein e genotype epsilon 32 women protected epsilon 43 epsilon 44 men susceptible ischemic heart disease copenhagen city heart study j coll cardiol 2000351192 99crossrefisimedline
0.31263503.15319409.html.plaintext.txt	141	36 frikke schmidt r tybjaerg hansen steffensen r jensen g nordestgaard bg apolipoprotein e genotype epsilon 32 women protected epsilon 43 epsilon 44 men susceptible ischemic heart disease copenhagen city heart study j coll cardiol 2000351192 99crossrefisimedline
0.31263503.15319409.html.plaintext.txt	142	37 thomson sg smith tc sharp sj investigating underlying risk source heterogeneity meta analysis statist med 1997162741 5830co2 0linktypedoi crossrefisi
0.31263503.15319409.html.plaintext.txt	143	37 thomson sg smith tc sharp sj investigating underlying risk source heterogeneity meta analysis statist med 1997162741 5830co2 0linktypedoi crossrefisi
0.31263503.15319409.html.plaintext.txt	144	38 begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics 1994501088 101isimedline
0.31263503.15319409.html.plaintext.txt	145	39 egger m davey smith g schneider m minder c bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text
0.31263503.15319409.html.plaintext.txt	146	39 egger m davey smith g schneider m minder c bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text
0.31263503.15319409.html.plaintext.txt	147	40 corbo rm scacchi r apolipoprotein e apoe allele distribution world apoe4 thrifty allele ann hum genet 199963301 10crossrefisimedline
0.31263503.15319409.html.plaintext.txt	148	41 united nations population division department economic social affairs international migration 2002 united nations publication 2002
0.31263503.15319409.html.plaintext.txt	149	42 haddy n de bacquer d chemaly mm et al importance plasma apolipoprotein e concentration addition common polymorphism inter individual variation lipid levels results apo europe eur j hum genet 200210841 50crossrefisimedline
0.31263503.15319409.html.plaintext.txt	150	42 haddy n de bacquer d chemaly mm et al importance plasma apolipoprotein e concentration addition common polymorphism inter individual variation lipid levels results apo europe eur j hum genet 200210841 50crossrefisimedline
0.31263503.15319409.html.plaintext.txt	151	43 wang j whitlock mc estimating effective population size migration rates genetic samples space time genetics 2003163429 46abstractfree full text
0.31263503.15319409.html.plaintext.txt	152	44 lehtinen luoma p lehtimaki nayha hassi j nikkari differences genetic variation apolipoprotein lapps finns atherosclerosis 1994109263
0.31263503.15319409.html.plaintext.txt	153	44 lehtinen luoma p lehtimaki nayha hassi j nikkari differences genetic variation apolipoprotein lapps finns atherosclerosis 1994109263
0.31263503.15319409.html.plaintext.txt	154	45 corbo rm scacchi r mureddu l mulas g alfano g apolipoprotein e polymorphism italy investigated native plasma simple polyacrylamide gel isoelectric focusing technique comparison frequency data european populations ann hum genet 199559197 209isimedline
0.31263503.15319409.html.plaintext.txt	155	45 corbo rm scacchi r mureddu l mulas g alfano g apolipoprotein e polymorphism italy investigated native plasma simple polyacrylamide gel isoelectric focusing technique comparison frequency data european populations ann hum genet 199559197 209isimedline
0.31263503.15319409.html.plaintext.txt	156	46 stengard jh weiss km sing cf ecological study association coronary heart disease mortality rates men relative frequencies common allelic variations gene coding apolipoprotein e hum genet 1998103234 41crossrefisimedline
0.31263503.15319409.html.plaintext.txt	157	46 stengard jh weiss km sing cf ecological study association coronary heart disease mortality rates men relative frequencies common allelic variations gene coding apolipoprotein e hum genet 1998103234 41crossrefisimedline
0.31263503.15319409.html.plaintext.txt	158	47 sing cf stengard jh kardia slr genes environment cardiovascular disease arterioscler thromb vasc biol 2003231190 96abstractfree full text
0.31263503.15319409.html.plaintext.txt	159	47 sing cf stengard jh kardia slr genes environment cardiovascular disease arterioscler thromb vasc biol 2003231190 96abstractfree full text
0.31263503.15319409.html.plaintext.txt	160	48 ewbank dc mortality differences apoe genotype estimated apoe genotype estimated demographic synthesis genet epidemiol 200222146 55crossrefisimedline
0.31263503.15319409.html.plaintext.txt	161	49 tilvis rs strandberg te juva k apolipoprotein e phenotypes dementia mortality prospective population sample j geriatr soc 199846712 15isimedline
0.31263503.15319409.html.plaintext.txt	162	49 tilvis rs strandberg te juva k apolipoprotein e phenotypes dementia mortality prospective population sample j geriatr soc 199846712 15isimedline
0.31263503.15319409.html.plaintext.txt	163	50 slooter ajc apolipoprotein e longevity rotterdam study j geriatr soc 2001491258 59crossrefisimedline
0.31263503.15319409.html.plaintext.txt	164	51 louhija j aguero torres h tilvis r survival finnish centenarians relation apolipoprotein e polymorphism j geriatr soc 2001491007 08crossrefisimedline
0.31263503.15319409.html.plaintext.txt	165	51 louhija j aguero torres h tilvis r survival finnish centenarians relation apolipoprotein e polymorphism j geriatr soc 2001491007 08crossrefisimedline
0.31263503.15319409.html.plaintext.txt	166	52 stengard jh zerba ke pekkanen j ehnholm c nissinen sing cf apolipoprotein e polymorphism predicts death coronary heart disease longitudinal study elderly finnish men circulation 199591265 69abstractfree full text
0.31263503.15319409.html.plaintext.txt	167	52 stengard jh zerba ke pekkanen j ehnholm c nissinen sing cf apolipoprotein e polymorphism predicts death coronary heart disease longitudinal study elderly finnish men circulation 199591265 69abstractfree full text
0.31263503.15319409.html.plaintext.txt	168	53 stengard jh pekkanen j ehnholm c nissinen sing cf genotypes apolipoprotein episilon 4 allele predictors coronary heart disease mortality longitudinal study elderly finnish men hum genet 199697677 84crossrefisimedline
0.31263503.15319409.html.plaintext.txt	169	53 stengard jh pekkanen j ehnholm c nissinen sing cf genotypes apolipoprotein episilon 4 allele predictors coronary heart disease mortality longitudinal study elderly finnish men hum genet 199697677 84crossrefisimedline
0.31263503.15319409.html.plaintext.txt	170	54 corder eh lannfelt l vittanen m et al apolipoprotein e genotype determines survival oldest old 85 years older good cognition arch neurol 199653418 22abstract
0.31263503.15319409.html.plaintext.txt	171	54 corder eh lannfelt l vittanen m et al apolipoprotein e genotype determines survival oldest old 85 years older good cognition arch neurol 199653418 22abstract
0.31263503.15319409.html.plaintext.txt	172	55 lee jh tang mx schupf n et al mortality apolipoprotein e hispanic african american caucasian elders j med genet 2001103121 27crossrefisimedline
0.31263503.15319409.html.plaintext.txt	173	55 lee jh tang mx schupf n et al mortality apolipoprotein e hispanic african american caucasian elders j med genet 2001103121 27crossrefisimedline
0.31263503.15319409.html.plaintext.txt	174	56 vogt mt cauley ja kuller lh apolipoprotein e phenotype arterial disease mortality among older women study osteoporotic fractures genet epidemiol 199714147 5633co2 klinktypedoi crossrefisimedline
0.31263503.15319409.html.plaintext.txt	175	56 vogt mt cauley ja kuller lh apolipoprotein e phenotype arterial disease mortality among older women study osteoporotic fractures genet epidemiol 199714147 5633co2 klinktypedoi crossrefisimedline
0.31481948.7615568.html.plaintext.txt	0	1995 american society biochemistry molecular biology inc apolipoprotein e carboxyl terminal fragments complexed amyloids l implications amyloidogenesis alzheimers disease
0.31481948.7615568.html.plaintext.txt	1	1995 american society biochemistry molecular biology inc apolipoprotein e carboxyl terminal fragments complexed amyloids l implications amyloidogenesis alzheimers disease
0.31481948.7615568.html.plaintext.txt	2	received publication february 21 1995 revised form may 1 1995
0.31481948.7615568.html.plaintext.txt	3	eduardo m castao frances prelli mordechai pras 1 blas frangione
0.31481948.7615568.html.plaintext.txt	4	department pathology new york university medical center new york new york 10016 heller institute medical research sheba medical center tel hashomer israel abstract introduction experimental procedures results discussion footnotes references
0.31481948.7615568.html.plaintext.txt	5	apolipoprotein e apoe immunoreactivity consistently present senile plaques neurofibrillary tangles alzheimers disease ad brain vitro apoe particular apoe4 isoform bind promote fibrillogenesis amyloid peptide main constituent senile plaques findings together strong genetic association late onset ad e4 allele apoe strengthened hypothesis apoe may central role pathogenesis ad modulating cerebral accumulation however apoe immunoreactivity present cerebral systemic amyloidoses tested tryptic apoe fragments identified association amyloid aa order elucidate interaction apoe amyloids purified aa amyloid l al fibrils patients familial mediterranean fever primary amyloidosis respectively studied association apoe aa al proteins case apoe fragments detected western blot co purified amyloid fibrils microsequencing analysis identified cooh terminal fragments apoe similar 10 kda fragment produced thrombin digestion contains purported binding region vitro co incubation aa purified human apoe resulted formation sds resistant aaapoe complex higher degree polymerization aa peptide findings similar results obtained ad senile plaques suggest 1 carboxyl terminal fragment apoe complexed amyloid fibrils resists proteolysis vivo 2 apoe may promote amyloidogenesis conformation dependent interaction regardless primary structure amyloid precursors
0.31481948.7615568.html.plaintext.txt	6	apolipoprotein e apoe immunoreactivity consistently present senile plaques neurofibrillary tangles alzheimers disease ad brain vitro apoe particular apoe4 isoform bind promote fibrillogenesis amyloid peptide main constituent senile plaques findings together strong genetic association late onset ad e4 allele apoe strengthened hypothesis apoe may central role pathogenesis ad modulating cerebral accumulation however apoe immunoreactivity present cerebral systemic amyloidoses tested tryptic apoe fragments identified association amyloid aa order elucidate interaction apoe amyloids purified aa amyloid l al fibrils patients familial mediterranean fever primary amyloidosis respectively studied association apoe aa al proteins case apoe fragments detected western blot co purified amyloid fibrils microsequencing analysis identified cooh terminal fragments apoe similar 10 kda fragment produced thrombin digestion contains purported binding region vitro co incubation aa purified human apoe resulted formation sds resistant aaapoe complex higher degree polymerization aa peptide findings similar results obtained ad senile plaques suggest 1 carboxyl terminal fragment apoe complexed amyloid fibrils resists proteolysis vivo 2 apoe may promote amyloidogenesis conformation dependent interaction regardless primary structure amyloid precursors
0.31481948.7615568.html.plaintext.txt	7	amyloidosis disorder protein conformation low molecular weight proteins soluble physiological conditions become deposited accumulate either intact partially digested diverse tissues organs insoluble amyloid fibrils spite biochemical diversity amyloid proteins adopt common secondary structure pleated sheet form fibrils similar morphology fibrils characteristically long straight filaments 5 12 nm wide share tinctorial properties green birefringence congo red staining specific affinity fluorescent dyes thioflavine addition features shared types amyloids several factors consistently associated pathological condition viewed part biochemical setting amyloid deposition arises develops include elevated concentration amyloid precursors fluids tissues invariable presence certain amyloid associated proteins amyloid p component ap1 2 sulfated proteoglycans 3 4 5 apolipoprotein e apoe 6 7 apolipoprotein j 8 notorious whether amyloid associated proteins play active role promoting inhibiting amyloidogenesis inert bystanders present unknown
0.31481948.7615568.html.plaintext.txt	8	amyloidosis disorder protein conformation low molecular weight proteins soluble physiological conditions become deposited accumulate either intact partially digested diverse tissues organs insoluble amyloid fibrils spite biochemical diversity amyloid proteins adopt common secondary structure pleated sheet form fibrils similar morphology fibrils characteristically long straight filaments 5 12 nm wide share tinctorial properties green birefringence congo red staining specific affinity fluorescent dyes thioflavine addition features shared types amyloids several factors consistently associated pathological condition viewed part biochemical setting amyloid deposition arises develops include elevated concentration amyloid precursors fluids tissues invariable presence certain amyloid associated proteins amyloid p component ap1 2 sulfated proteoglycans 3 4 5 apolipoprotein e apoe 6 7 apolipoprotein j 8 notorious whether amyloid associated proteins play active role promoting inhibiting amyloidogenesis inert bystanders present unknown
0.31481948.7615568.html.plaintext.txt	9	apoe 34 kda exchangeable apolipoprotein present types lipoprotein particles involved cholesterol transport well less defined functions nerve regeneration injury9 10 11 12 recently reported association certain apoe genetic isoforms alzheimers disease ad condition characterized massive deposition brain 39 44 residue amyloid protein a13 14 15 16 17 18 strengthened hypothesis apolipoprotein may directly involved pathogenesis cerebral amyloidosis19 20 moreover vitro binding experiments using human apoe isolated plasma recombinant human apoe synthetic peptides homologous shown two proteins form sds resistant complex promote fibril formation vitro21 22 23 24 lines evidence together immunohistochemical colocalization apoe senile plaques presence intraneuronal amyloid neurofibrillary tangles6 suggest apoe may play active role pathogenesis ad promoting fibrillogenesis however immunohistochemical studies shown apoe tightly associated types cerebral amyloidosis including syndrome related hereditary cerebral amyloid angiopathy icelandic type related cystatin c variant spongiform encephalopathies creutzfeldt jakob kuru gerstmann straussler scheinker disease associated prion amyloid6 7 25 furthermore apoe immunohistochemically identified within amyloid deposits systemic forms disease secondary amyloidosis familial mediterranean fever related amyloid immunoglobulin related primary amyloidosis al familial amyloidotic polyneuropathy due deposition transthyretin genetic variants7 noteworthy apoe rarely detected nonfibrillar monoclonal deposits light chain deposition disease light heavy chain deposition disease may considered preamyloid forms al disease26
0.31481948.7615568.html.plaintext.txt	10	apoe 34 kda exchangeable apolipoprotein present types lipoprotein particles involved cholesterol transport well less defined functions nerve regeneration injury9 10 11 12 recently reported association certain apoe genetic isoforms alzheimers disease ad condition characterized massive deposition brain 39 44 residue amyloid protein a13 14 15 16 17 18 strengthened hypothesis apolipoprotein may directly involved pathogenesis cerebral amyloidosis19 20 moreover vitro binding experiments using human apoe isolated plasma recombinant human apoe synthetic peptides homologous shown two proteins form sds resistant complex promote fibril formation vitro21 22 23 24 lines evidence together immunohistochemical colocalization apoe senile plaques presence intraneuronal amyloid neurofibrillary tangles6 suggest apoe may play active role pathogenesis ad promoting fibrillogenesis however immunohistochemical studies shown apoe tightly associated types cerebral amyloidosis including syndrome related hereditary cerebral amyloid angiopathy icelandic type related cystatin c variant spongiform encephalopathies creutzfeldt jakob kuru gerstmann straussler scheinker disease associated prion amyloid6 7 25 furthermore apoe immunohistochemically identified within amyloid deposits systemic forms disease secondary amyloidosis familial mediterranean fever related amyloid immunoglobulin related primary amyloidosis al familial amyloidotic polyneuropathy due deposition transthyretin genetic variants7 noteworthy apoe rarely detected nonfibrillar monoclonal deposits light chain deposition disease light heavy chain deposition disease may considered preamyloid forms al disease26
0.31481948.7615568.html.plaintext.txt	11	widespread association apoe biochemically clinically diverse types amyloidoses suggests apoe may participate general manner process amyloid formation order gain insight biochemistry association apoe amyloid proteins characterized western blot amino terminal sequence analysis apoe fragments co purified amyloid subunits cases systemic amyloidosis aa al also studied vitro binding human apoe isolated plasma amyloid proteins
0.31481948.7615568.html.plaintext.txt	12	widespread association apoe biochemically clinically diverse types amyloidoses suggests apoe may participate general manner process amyloid formation order gain insight biochemistry association apoe amyloid proteins characterized western blot amino terminal sequence analysis apoe fragments co purified amyloid subunits cases systemic amyloidosis aa al also studied vitro binding human apoe isolated plasma amyloid proteins
0.31481948.7615568.html.plaintext.txt	13	protein purificationamyloid al fibrils isolated method pras et al27 spleen tissue patients familial mediterranean fever coh primary amyloidosis ram briefly 20 g spleen tissue homogenized 015 m sodium chloride centrifuged 8000 g 30 min 4 degrees c supernatant discarded procedure repeated supernatant absorbance less 0075 280 nm insoluble residue homogenized distilled water centrifuged 8000 g 4 degrees c 1 h amyloid fibrils appear mucoid mass upper layer dialyzed water lyophilized lyophilization aa protein purified high performance liquid chromatography hplc see al fibrils solubilized 3 ml 6 m guanidine hydrochloride 01 m tris 017 m dithiothreitol ph 102 stirred 48 h room temperature 1 ml 2 m guanidine hydrochloride 4 m acetic acid added solution applied column 25 180 cm consisting 11 wt sephadex g 75 sephadex g 100 pharmacia biotech inc equilibrated 5 m guanidine hydrochloride 1 m acetic acid al amyloid fragments isolated size exclusion chromatography aa fibrils subjected reverse phase chromatography deltapak c column 078 30 cm waters gradient 30 80 acetonitrile 01 vv trifluoroacetic acid ph 25 column eluents monitored 214 nm protein peaks pooled lyophilized
0.31481948.7615568.html.plaintext.txt	14	protein purificationamyloid al fibrils isolated method pras et al27 spleen tissue patients familial mediterranean fever coh primary amyloidosis ram briefly 20 g spleen tissue homogenized 015 m sodium chloride centrifuged 8000 g 30 min 4 degrees c supernatant discarded procedure repeated supernatant absorbance less 0075 280 nm insoluble residue homogenized distilled water centrifuged 8000 g 4 degrees c 1 h amyloid fibrils appear mucoid mass upper layer dialyzed water lyophilized lyophilization aa protein purified high performance liquid chromatography hplc see al fibrils solubilized 3 ml 6 m guanidine hydrochloride 01 m tris 017 m dithiothreitol ph 102 stirred 48 h room temperature 1 ml 2 m guanidine hydrochloride 4 m acetic acid added solution applied column 25 180 cm consisting 11 wt sephadex g 75 sephadex g 100 pharmacia biotech inc equilibrated 5 m guanidine hydrochloride 1 m acetic acid al amyloid fragments isolated size exclusion chromatography aa fibrils subjected reverse phase chromatography deltapak c column 078 30 cm waters gradient 30 80 acetonitrile 01 vv trifluoroacetic acid ph 25 column eluents monitored 214 nm protein peaks pooled lyophilized
0.31481948.7615568.html.plaintext.txt	15	crude amyloid fibrils fractions obtained gel filtration hplc subjected 125 tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page28 proteins electrophoretically transferred 1 h 400 ma 4 degrees c polyvinylidene difluoride membranes immobilon millipore using 10 mm caps buffer ph 11 containing 10 methanol membranes blocked 5 nonfat dry milk 10 mm tris hcl 150 mm sodium chloride 01 tween 20 ph 76 2 h room temperature incubated overnight 4 degrees c following antibodies rabbit polyclonal antibodies amyloid a29 light chain dako corp goat anti human apolipoprotein e fitzgerald monoclonal antibodies id7 6c5 raised residues 142 158 1 15 apoe respectively generous gift dr y marcel horseradish peroxidase conjugated sheep anti mouse amersham corp goat anti rabbit rabbit anti goat igg biosource international used second antibody dilution 15000 immunoblots visualized ecl chemiluminescence kit amersham corp according manufacturers specifications anti apoe antiserum adsorbed incubating 15 microg purified human apoe anti apoe diluted 1100 03 bovine serum albumin bsa tris buffered saline ph 74 3 h room temperature
0.31481948.7615568.html.plaintext.txt	16	crude amyloid fibrils fractions obtained gel filtration hplc subjected 125 tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page28 proteins electrophoretically transferred 1 h 400 ma 4 degrees c polyvinylidene difluoride membranes immobilon millipore using 10 mm caps buffer ph 11 containing 10 methanol membranes blocked 5 nonfat dry milk 10 mm tris hcl 150 mm sodium chloride 01 tween 20 ph 76 2 h room temperature incubated overnight 4 degrees c following antibodies rabbit polyclonal antibodies amyloid a29 light chain dako corp goat anti human apolipoprotein e fitzgerald monoclonal antibodies id7 6c5 raised residues 142 158 1 15 apoe respectively generous gift dr y marcel horseradish peroxidase conjugated sheep anti mouse amersham corp goat anti rabbit rabbit anti goat igg biosource international used second antibody dilution 15000 immunoblots visualized ecl chemiluminescence kit amersham corp according manufacturers specifications anti apoe antiserum adsorbed incubating 15 microg purified human apoe anti apoe diluted 1100 03 bovine serum albumin bsa tris buffered saline ph 74 3 h room temperature
0.31481948.7615568.html.plaintext.txt	17	protein sequence analysisautomated edman degradation sequence analysis carried 477a proteinpeptide sequenator resulting phenylthiohydantoin amino acid derivatives identified using line 120a pth analyzer applied biosystems foster city ca
0.31481948.7615568.html.plaintext.txt	18	vitro incubation apoe amyloid peptideshuman apoe purchased cortex biochem bovine ubiquitin bsa purchased sigma purity 95 proteins assessed sds page nh terminal sequence analysis since human pooled apoe used seems likely major isoform apoe3 according statistical distribution normal population stock solutions amyloid peptides prepared 01 trifluoroacetic acid 50 acetonitrile quantitated amino acid analysis using pico tag analyzer waters using microbicinchoninic acid assay kit pierce apoe stock solution made 07 mgml 01 m tris ph 74 aliquots stored 20 degrees c aliquots stock solutions lyophilized used co incubation experiments described21 brief 05 microg apoe incubated 10 microg aa 15 microg al 12 microl 01 m tris ph 74 indicated time room temperature incubation 15 microl 4 sds sample buffer added mixture run 125 sds tricine gels nondenaturing 75 polyacrylamide gels without sds proteins transferred immobilon p detected using polyclonal anti apoe anti aa anti al antibodies described control co incubation experiments ubiquitin molecular mass 8 kda bsa used instead amyloid peptides apoe respectively
0.31481948.7615568.html.plaintext.txt	19	vitro incubation apoe amyloid peptideshuman apoe purchased cortex biochem bovine ubiquitin bsa purchased sigma purity 95 proteins assessed sds page nh terminal sequence analysis since human pooled apoe used seems likely major isoform apoe3 according statistical distribution normal population stock solutions amyloid peptides prepared 01 trifluoroacetic acid 50 acetonitrile quantitated amino acid analysis using pico tag analyzer waters using microbicinchoninic acid assay kit pierce apoe stock solution made 07 mgml 01 m tris ph 74 aliquots stored 20 degrees c aliquots stock solutions lyophilized used co incubation experiments described21 brief 05 microg apoe incubated 10 microg aa 15 microg al 12 microl 01 m tris ph 74 indicated time room temperature incubation 15 microl 4 sds sample buffer added mixture run 125 sds tricine gels nondenaturing 75 polyacrylamide gels without sds proteins transferred immobilon p detected using polyclonal anti apoe anti aa anti al antibodies described control co incubation experiments ubiquitin molecular mass 8 kda bsa used instead amyloid peptides apoe respectively
0.31481948.7615568.html.plaintext.txt	20	immunohistochemistrysections spleen tissue cases amyloid coh al ram deparaffinized xylene rehydrated ethanol tris buffered saline rehydration endogenous peroxidase quenched incubation 03 hydrogen peroxide methanol 30 min blocking 3 bsa tris buffered saline sections incubated goat anti human apoe fitzgerald 1100 dilution overnight 4 degrees c rabbit anti goat labeled horseradish peroxidase biosource international 11000 1 h reaction detected using 003 33 diaminobenzidine tetrachloride 001 hydrogen peroxide 50 mm tris ph 74 anti apoe antiserum adsorbed purified human apoe described
0.31481948.7615568.html.plaintext.txt	21	immunohistochemistrysections spleen tissue cases amyloid coh al ram deparaffinized xylene rehydrated ethanol tris buffered saline rehydration endogenous peroxidase quenched incubation 03 hydrogen peroxide methanol 30 min blocking 3 bsa tris buffered saline sections incubated goat anti human apoe fitzgerald 1100 dilution overnight 4 degrees c rabbit anti goat labeled horseradish peroxidase biosource international 11000 1 h reaction detected using 003 33 diaminobenzidine tetrachloride 001 hydrogen peroxide 50 mm tris ph 74 anti apoe antiserum adsorbed purified human apoe described
0.31481948.7615568.html.plaintext.txt	22	immunohistochemistry spleen sections patients coh ram showed polyclonal anti human apoe labeled amyloid deposits described previously7 immunoreactivity completely abolished adsorption purified human apoe indicating specificity fig 1
0.31481948.7615568.html.plaintext.txt	23	immunohistochemistry spleen sections patients coh ram showed polyclonal anti human apoe labeled amyloid deposits described previously7 immunoreactivity completely abolished adsorption purified human apoe indicating specificity fig 1
0.31481948.7615568.html.plaintext.txt	24	figure 1 immunohistochemistry spleen sections patient coh amyloid anti apoe antibody labels amyloid laden vessels bar represents 20 microm b adjacent section adsorption anti apoe human purified apoe
0.31481948.7615568.html.plaintext.txt	25	figure 1 immunohistochemistry spleen sections patient coh amyloid anti apoe antibody labels amyloid laden vessels bar represents 20 microm b adjacent section adsorption anti apoe human purified apoe
0.31481948.7615568.html.plaintext.txt	26	amyloid l patient ram purified procedure saline water extraction gel chromatography sephadex g 100 equilibrated 5 m guanidine sds page fractions revealed main amyloid subunit molecular mass 12 13 kda amino terminal sequence analysis showed homology iii iv ig light chain fig 3 hplc separation ram al yielded broad peak 45 73 solvent b peak divided four fractions b c d rechromatographed fig 2a
0.31481948.7615568.html.plaintext.txt	27	amyloid l patient ram purified procedure saline water extraction gel chromatography sephadex g 100 equilibrated 5 m guanidine sds page fractions revealed main amyloid subunit molecular mass 12 13 kda amino terminal sequence analysis showed homology iii iv ig light chain fig 3 hplc separation ram al yielded broad peak 45 73 solvent b peak divided four fractions b c d rechromatographed fig 2a
0.31481948.7615568.html.plaintext.txt	28	figure 3 microsequence analysis amino terminal sequence amyloid l amyloid proteins apoe peptides co purified
0.31481948.7615568.html.plaintext.txt	29	figure 3 microsequence analysis amino terminal sequence amyloid l amyloid proteins apoe peptides co purified
0.31481948.7615568.html.plaintext.txt	30	figure 2 purification ram amyloid l reverse phase hplc ram amyloid l deltapak c column 078 30 cm using 30 80 linear gradient acetonitrile 01 vv trifluoroacetic acid ram amyloid l eluted broad peak 45 73 solvent b b coomassie blue stain 125 tricine sds page ram al fibrils f hplc fractions b c d ram amyloid l subunit mass 12 13 kda k present fractions together minor dimeric component 26 kda 8 9 kda band present fraction c carboxyl terminal truncated fragment al c western blot analysis hplc fractions b c d using antibody human apoe developed chemoluminescence showed major 8 9 kda band minor 18 kda band fraction d approximate yield apoe fragment obtained ram amyloid estimated follows ratio amyloid apoe fraction d determined densitometry coomassie blue stained 12 13 kda 26 kda al bands 8 9 kda apoe band pdi optical densitometer ratio applied area fraction d hplc profile proportional area fraction d total area hplc profile determined
0.31481948.7615568.html.plaintext.txt	31	figure 2 purification ram amyloid l reverse phase hplc ram amyloid l deltapak c column 078 30 cm using 30 80 linear gradient acetonitrile 01 vv trifluoroacetic acid ram amyloid l eluted broad peak 45 73 solvent b b coomassie blue stain 125 tricine sds page ram al fibrils f hplc fractions b c d ram amyloid l subunit mass 12 13 kda k present fractions together minor dimeric component 26 kda 8 9 kda band present fraction c carboxyl terminal truncated fragment al c western blot analysis hplc fractions b c d using antibody human apoe developed chemoluminescence showed major 8 9 kda band minor 18 kda band fraction d approximate yield apoe fragment obtained ram amyloid estimated follows ratio amyloid apoe fraction d determined densitometry coomassie blue stained 12 13 kda 26 kda al bands 8 9 kda apoe band pdi optical densitometer ratio applied area fraction d hplc profile proportional area fraction d total area hplc profile determined
0.31481948.7615568.html.plaintext.txt	32	sds page analysis fractions revealed addition major al subunit 12 13 kda 26 kda component seen fractions latter probably corresponded dimer al subunit since recognized anti chain antibody shown addition minor bands approximately 8 9 kda present fractions c d fig 2b western blot analysis fractions using anti apoe antibody visualized chemiluminescence detection revealed major band 8 9 kda minor 24 kda component fraction d fig 2c failure detect apoe direct amino terminal sequence analysis ram fraction d despite positive apoe immunoreactivity fraction indicated present low concentration therefore hplc fractions b c d run sds tricine gels transferred immobilon membrane bands excised subjected amino terminal sequence analysis amino terminal sequence 8 9 kda component fraction c revealed fragment al starting position 1 shown 8 9 kda band hplc fraction d yielded two major fragments apoe starting positions 225 227 minor one starting position 216 addition amyloid protein fig 3 estimated relative yield apoe carboxyl fragment extracted amyloid deposits approximately 150 molar ratio apoeamyloid
0.31481948.7615568.html.plaintext.txt	33	sds page analysis fractions revealed addition major al subunit 12 13 kda 26 kda component seen fractions latter probably corresponded dimer al subunit since recognized anti chain antibody shown addition minor bands approximately 8 9 kda present fractions c d fig 2b western blot analysis fractions using anti apoe antibody visualized chemiluminescence detection revealed major band 8 9 kda minor 24 kda component fraction d fig 2c failure detect apoe direct amino terminal sequence analysis ram fraction d despite positive apoe immunoreactivity fraction indicated present low concentration therefore hplc fractions b c d run sds tricine gels transferred immobilon membrane bands excised subjected amino terminal sequence analysis amino terminal sequence 8 9 kda component fraction c revealed fragment al starting position 1 shown 8 9 kda band hplc fraction d yielded two major fragments apoe starting positions 225 227 minor one starting position 216 addition amyloid protein fig 3 estimated relative yield apoe carboxyl fragment extracted amyloid deposits approximately 150 molar ratio apoeamyloid
0.31481948.7615568.html.plaintext.txt	34	purification amyloid subunits coh performed saline water extraction followed separation hplc fig 4a procedure yielded broad ill defined peaks eluted 60 78 solvent b pooled four fractions b c d rechromatographed analyzed sds page major protein band 6 8 kda present fractions minor 16 kda component may polymer 6 8 kda peptide detected fractions b c fig 4b amino terminal sequence analysis hplc fractions revealed one residue per cycle sequence identical serum amyloid protein fig 3 additional sequences identified fractions subjected western blot using anti apoe antibody fluorogram revealed broad band 8 9 kda fraction d fig 4c immunoreactivity band completely suppressed adsorption antiserum purified human apoe reflecting specificity reaction band corresponding intact apoe 34 kda suggesting small fragments apoe associated amyloid subunit
0.31481948.7615568.html.plaintext.txt	35	figure 4 purification coh amyloid proteins reverse phase hplc coh amyloid deltapak c column 078 30 cm using 30 80 linear gradient acetonitrile 01 vv trifluoroacetic acid coh amyloid eluted broad peak 60 78 solvent b b 125 tricine sds page hplc fractions b c d major coh amyloid subunit 6 8 kda k present fractions minor 16 kda component possibly polymer former detected fractions b c c western blot analysis hplc fractions b c d using antibody human apoe developed chemiluminescence revealed broad 8 9 kda component fraction d
0.31481948.7615568.html.plaintext.txt	36	figure 4 purification coh amyloid proteins reverse phase hplc coh amyloid deltapak c column 078 30 cm using 30 80 linear gradient acetonitrile 01 vv trifluoroacetic acid coh amyloid eluted broad peak 60 78 solvent b b 125 tricine sds page hplc fractions b c d major coh amyloid subunit 6 8 kda k present fractions minor 16 kda component possibly polymer former detected fractions b c c western blot analysis hplc fractions b c d using antibody human apoe developed chemiluminescence revealed broad 8 9 kda component fraction d
0.31481948.7615568.html.plaintext.txt	37	failure detect apoe direct amino terminal sequence analysis coh fraction d despite positive apoe immunoreactivity indicated present low concentration therefore similar approach ram al used proteins separated sds tricine gels transferred immobilon membrane upper portion 6 8 kda band hplc fraction d yielded two sequences corresponding n terminus amyloid apoe fragment starting position 199 respectively fig 3 order investigate whether intact apoe present crude l amyloid fibril fraction hplc separation performed western blots using monoclonal antibodies id7 6c5 specific amino terminal domain apoe band corresponding 34 kda intact apoe observed association coh fibrils
0.31481948.7615568.html.plaintext.txt	38	failure detect apoe direct amino terminal sequence analysis coh fraction d despite positive apoe immunoreactivity indicated present low concentration therefore similar approach ram al used proteins separated sds tricine gels transferred immobilon membrane upper portion 6 8 kda band hplc fraction d yielded two sequences corresponding n terminus amyloid apoe fragment starting position 199 respectively fig 3 order investigate whether intact apoe present crude l amyloid fibril fraction hplc separation performed western blots using monoclonal antibodies id7 6c5 specific amino terminal domain apoe band corresponding 34 kda intact apoe observed association coh fibrils
0.31481948.7615568.html.plaintext.txt	39	05 micrograms purified human apoe incubated 10 microg purified coh amyloid 6 h room temperature 01 m tris ph 74 novel component approximately 44 kda detected western immunoblot analysis using anti apoe fig 5a anti aa antibodies shown indicating apoe amyloid complex partially resistant sds formed nondenaturing conditions 75 polyacrylamide gels complex resulted shift electrophoretic mobility apoe fig 5b complex formation detected apoe incubated 20 microg ubiquitin influence apoe upon aa polymerization evaluated detection apoe aa incubation mixture anti aa antibody western blots aa alone incubated 6 h room temperature 01 m tris ph 74 showed mainly monomeric forms minor polymeric components sds page contrast aa co incubated apoe 185 molar ratio apoeamyloid conditions resulted appearance gel higher amount aa dimers trimers tetramers higher molecular weight components fig 5c aa co incubated bsa showed increment polymerization compared aa alone shown experiment done using ram al additional bands present however amyloid apoe incubation mixture remained top stacking running gels high molecular weight components shown result consistent higher degree aggregation amyloid al subunits presence apoe resisted denaturation sds treatment
0.31481948.7615568.html.plaintext.txt	40	figure 5 vitro co incubation amyloid apoe apoe 05 microg amyloid 10 microg incubated 01 m tris ph 74 6 h room temperature incubation stopped addition 2 laemmli sample buffer samples run 125 tricine sds page transferring immobilon p proteins detected anti apoe antibody lane1 apoe alone lane2 apoe incubated amyloid leftmargin indicates molecular mass kilodaltons kd e apoe ea apoe amyloid complex b apoe amyloid incubated described run nondenaturing 75 polyacrylamide gels proteins detected western blots anti apoe antibody shift electrophoretic mobility apoe reflects formation amyloid apoe complex lane1 apoe alone lane2 apoe incubated amyloid c amyloid incubated alone apoe described samples run 125 sds tricine page transferred immobilon p membranes proteins detected anti aa antibody higher degree polymerization amyloid peptide present upon incubation apoe lane1 amyloid alone lane2 amyloid incubated apoe leftmargin indicates molecular mass kda
0.31481948.7615568.html.plaintext.txt	41	apo e two domain protein modeled two major fragments thrombin digestion 22 kda amino terminal domain residues 1 191 stable globular structure containing sequence mediates low density lipoprotein receptor binding9 30 contrast 10 kda carboxyl terminal fragment less stable binds lipoproteins mediates lipid free apoe tetramerization aqueous solutions31 previously published finding tryptic fragment apolipoprotein e corresponding residues 270 278 association two amyloid proteins29 present data extend observation three fragments apoe located within thrombolytic carboxyl fragment apoe co purified ram amyloid l slightly larger fragment apoe starting region connecting thrombolytic amino terminal carboxyl terminal domains apoe co purified coh amyloid fig 6 similar apoe fragments recently obtained ad senile plaques 32
0.31481948.7615568.html.plaintext.txt	42	apo e two domain protein modeled two major fragments thrombin digestion 22 kda amino terminal domain residues 1 191 stable globular structure containing sequence mediates low density lipoprotein receptor binding9 30 contrast 10 kda carboxyl terminal fragment less stable binds lipoproteins mediates lipid free apoe tetramerization aqueous solutions31 previously published finding tryptic fragment apolipoprotein e corresponding residues 270 278 association two amyloid proteins29 present data extend observation three fragments apoe located within thrombolytic carboxyl fragment apoe co purified ram amyloid l slightly larger fragment apoe starting region connecting thrombolytic amino terminal carboxyl terminal domains apoe co purified coh amyloid fig 6 similar apoe fragments recently obtained ad senile plaques 32
0.31481948.7615568.html.plaintext.txt	43	figure 6 schematic representation structural domains apolipoprotein e modeled thrombin proteolytic cleavage31 alignment apoe carboxyl terminal peptides associated al aa proteins shown well representation purported apoe binding domain b20
0.31481948.7615568.html.plaintext.txt	44	figure 6 schematic representation structural domains apolipoprotein e modeled thrombin proteolytic cleavage31 alignment apoe carboxyl terminal peptides associated al aa proteins shown well representation purported apoe binding domain b20
0.31481948.7615568.html.plaintext.txt	45	propose apoe fragments co purify aa al bound amyloid proteins vivo remainder apoe molecule cleaved thrombin andor serine proteases situ either amyloid apoe complex formed alternatively cannot rule apoe partially degraded purification intact apoe apoe fragments determined western blot analysis present crude aa al fibril fractions hplc however purification carboxyl terminal apoe fragment co purifies aa al amyloids question whether apoe amyloid association precedes tissue deposition remains addressed
0.31481948.7615568.html.plaintext.txt	46	propose apoe fragments co purify aa al bound amyloid proteins vivo remainder apoe molecule cleaved thrombin andor serine proteases situ either amyloid apoe complex formed alternatively cannot rule apoe partially degraded purification intact apoe apoe fragments determined western blot analysis present crude aa al fibril fractions hplc however purification carboxyl terminal apoe fragment co purifies aa al amyloids question whether apoe amyloid association precedes tissue deposition remains addressed
0.31481948.7615568.html.plaintext.txt	47	likely initial formation stable apoe amyloid complexes requires interaction amino carboxyl terminal domains apoe binding low density lipoprotein receptor amino terminal domain apoe requires lipid association largely mediated carboxyl end molecule31 interdependence domains apoe reflected effect amino acid substitutions within amino terminal region association apoe diverse lipoprotein classes association known mediated carboxyl terminus apoe 9 apoe3 isoform cys position 112 preferentially binds high density lipoproteins whereas presence arg position favors binding low density intermediate density lipoproteins33 34 cooperation domains unique apoe isoform postulated explain selective lipoprotein distribution35 whether similar mechanism account higher avidity apoe4 isoform ad remains tested
0.31481948.7615568.html.plaintext.txt	48	likely initial formation stable apoe amyloid complexes requires interaction amino carboxyl terminal domains apoe binding low density lipoprotein receptor amino terminal domain apoe requires lipid association largely mediated carboxyl end molecule31 interdependence domains apoe reflected effect amino acid substitutions within amino terminal region association apoe diverse lipoprotein classes association known mediated carboxyl terminus apoe 9 apoe3 isoform cys position 112 preferentially binds high density lipoproteins whereas presence arg position favors binding low density intermediate density lipoproteins33 34 cooperation domains unique apoe isoform postulated explain selective lipoprotein distribution35 whether similar mechanism account higher avidity apoe4 isoform ad remains tested
0.31481948.7615568.html.plaintext.txt	49	apoe capable binding synthetic strong interaction resistant sds21 similar interaction apoe dutch variant cerebral amyloid angiopathy rare form familial ad also documented 36 details apoe binding published elsewhere using set truncated recombinants purported binding region located within carboxyl end apoe amino acids 244 272 21 findings suggest binding region specific peptide rather reflects hydrophobic interaction apoe carboxyl end common conformation shared different amyloids secondary structure predictions indicate putative amphipathic helix high affinity lipids 37 located within region co purifies amyloid peptides possibly exchangeable apolipoproteins sharing similar amphipathic helices also amyloid apolipoprotein interactions noteworthy genetic variants apoai form amyloid certain hereditary forms human amyloidosis 38 39 saa precursor aa apolipoprotein associated high density lipoprotein40 recently found apoai bind promote fibrillogenesis vitropresumably way large number amyloidogenic precursor proteins end insoluble amyloid fibrils also group amyloidogenic apolipoproteins acute phase reactants actively participate process either constituents fibrils modulators fibrillogenesis
0.31481948.7615568.html.plaintext.txt	50	apoe capable binding synthetic strong interaction resistant sds21 similar interaction apoe dutch variant cerebral amyloid angiopathy rare form familial ad also documented 36 details apoe binding published elsewhere using set truncated recombinants purported binding region located within carboxyl end apoe amino acids 244 272 21 findings suggest binding region specific peptide rather reflects hydrophobic interaction apoe carboxyl end common conformation shared different amyloids secondary structure predictions indicate putative amphipathic helix high affinity lipids 37 located within region co purifies amyloid peptides possibly exchangeable apolipoproteins sharing similar amphipathic helices also amyloid apolipoprotein interactions noteworthy genetic variants apoai form amyloid certain hereditary forms human amyloidosis 38 39 saa precursor aa apolipoprotein associated high density lipoprotein40 recently found apoai bind promote fibrillogenesis vitropresumably way large number amyloidogenic precursor proteins end insoluble amyloid fibrils also group amyloidogenic apolipoproteins acute phase reactants actively participate process either constituents fibrils modulators fibrillogenesis
0.31481948.7615568.html.plaintext.txt	51	finding higher degree polymerization aa al native peptides upon incubation apoe together previous work using synthetic 22 23 24 36 points general role apoe amyloidogenesis molar ratios apoe aa used vitro experiments opposite found plasma normal conditions apoe saa however saa acute phase reactant concentration plasma capable rising 1000 fold tissue injury inflammation41 al turn derived monoclonal light chains known high levels circulation cases therefore believe concentrations used vitro resemble closely pathological conditions amyloidosis develops physiological levels apoe amyloid precursors
0.31481948.7615568.html.plaintext.txt	52	finding higher degree polymerization aa al native peptides upon incubation apoe together previous work using synthetic 22 23 24 36 points general role apoe amyloidogenesis molar ratios apoe aa used vitro experiments opposite found plasma normal conditions apoe saa however saa acute phase reactant concentration plasma capable rising 1000 fold tissue injury inflammation41 al turn derived monoclonal light chains known high levels circulation cases therefore believe concentrations used vitro resemble closely pathological conditions amyloidosis develops physiological levels apoe amyloid precursors
0.31481948.7615568.html.plaintext.txt	53	apoe may act one group pathological chaperones promote aggregation amyloidogenic precursors diverse primary structure pleated sheet conformation amyloid fibrils absence apoe ap nonfibrillar congo red negative monoclonal deposits light chain deposition disease light heavy chain deposition disease considered preamyloid forms al disease26 suggests apoe ap may essential catalysts modulation amyloid generation process interaction apoe amyloids may also influenced local acute phase reactants proteoglycans amyloid precursors apoe known bind42 43 spite putative widespread role apoe amyloid formation seems likely certain specificity exists amyloid precursors apoe genetic isoforms thus far preferential associations systemic amyloidoses apoe isoforms reported however genetic association ad apoe4 vitro higher avidity isoform may reflect specificity19 21 alternatively apoe4 isoform may participate pathogenesis ad different pathway unrelated formation deposition
0.31481948.7615568.html.plaintext.txt	54	apoe may act one group pathological chaperones promote aggregation amyloidogenic precursors diverse primary structure pleated sheet conformation amyloid fibrils absence apoe ap nonfibrillar congo red negative monoclonal deposits light chain deposition disease light heavy chain deposition disease considered preamyloid forms al disease26 suggests apoe ap may essential catalysts modulation amyloid generation process interaction apoe amyloids may also influenced local acute phase reactants proteoglycans amyloid precursors apoe known bind42 43 spite putative widespread role apoe amyloid formation seems likely certain specificity exists amyloid precursors apoe genetic isoforms thus far preferential associations systemic amyloidoses apoe isoforms reported however genetic association ad apoe4 vitro higher avidity isoform may reflect specificity19 21 alternatively apoe4 isoform may participate pathogenesis ad different pathway unrelated formation deposition
0.31481948.7615568.html.plaintext.txt	55	recently reported apoe inhibit aggregation vitro concentrations similar found normally biological fluids44 apparent discrepancy previous studies could due different experimental conditions22 23 24 36 however raises intriguing possibility apoe may dual effect upon fibrillogenesis vivo depending local concentrations apoe amyloid precursors sites amyloid formation within physiological levels apoe may protective role amyloid formation sequestering soluble amyloid precursors postulated a44 however appears associated apolipoproteins ie apolipoprotein j biological fluids vivo45 yet tissues local membrane repair lipid turnover increased cell injury apoe overexpressed reach higher concentrations found normally circulation10 11 12 46 circumstances apoe may substantially different effect upon association amyloid precursors pathological setting several factors may affect apoe behavior state oxidation lipid association presence amyloidapoe binding proteins stage amyloid process47
0.31481948.7615568.html.plaintext.txt	56	recently reported apoe inhibit aggregation vitro concentrations similar found normally biological fluids44 apparent discrepancy previous studies could due different experimental conditions22 23 24 36 however raises intriguing possibility apoe may dual effect upon fibrillogenesis vivo depending local concentrations apoe amyloid precursors sites amyloid formation within physiological levels apoe may protective role amyloid formation sequestering soluble amyloid precursors postulated a44 however appears associated apolipoproteins ie apolipoprotein j biological fluids vivo45 yet tissues local membrane repair lipid turnover increased cell injury apoe overexpressed reach higher concentrations found normally circulation10 11 12 46 circumstances apoe may substantially different effect upon association amyloid precursors pathological setting several factors may affect apoe behavior state oxidation lipid association presence amyloidapoe binding proteins stage amyloid process47
0.31481948.7615568.html.plaintext.txt	57	abnormal amyloid response individual determined finally complex process involving critical concentrations amyloid precursors set amyloid associated proteins apoe apolipoproteins ap antichymotrypsin 22 proteoglycans may act conjunction yet undefined tissue specific factors modulate conformational transition soluble protein insoluble fibril better understanding complex interactions amyloids factors modulate formation may open novel strategies treatment systemic cerebral amyloid related diseases
0.31481948.7615568.html.plaintext.txt	58	abnormal amyloid response individual determined finally complex process involving critical concentrations amyloid precursors set amyloid associated proteins apoe apolipoproteins ap antichymotrypsin 22 proteoglycans may act conjunction yet undefined tissue specific factors modulate conformational transition soluble protein insoluble fibril better understanding complex interactions amyloids factors modulate formation may open novel strategies treatment systemic cerebral amyloid related diseases
0.31481948.7615568.html.plaintext.txt	59	work supported national institutes health grants ar02594 merit ag10953 lead ag05891 metropolitan life foundation award medical research 1993 part work presented 1994 annual meeting society neuroscience miami beach florida costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.31481948.7615568.html.plaintext.txt	60	work supported national institutes health grants ar02594 merit ag10953 lead ag05891 metropolitan life foundation award medical research 1993 part work presented 1994 annual meeting society neuroscience miami beach florida costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.31481948.7615568.html.plaintext.txt	61	correspondence addressed dept pathology new york university medical center 550 first ave th427 new york ny 10016 tel 212 263 5775 fax 212 263 6751
0.31481948.7615568.html.plaintext.txt	62	correspondence addressed dept pathology new york university medical center 550 first ave th427 new york ny 10016 tel 212 263 5775 fax 212 263 6751
0.31481948.7615568.html.plaintext.txt	63	abbreviations used ap amyloid p component hplc high performance liquid chromatography al amyloid l saa serum amyloid precursor aa amyloid ad alzheimers disease caps 3 cyclohexylaminopropanesulfonic acid bsa bovine serum albumin page polyacrylamide gel electrophoresis
0.31518275.8817335.html.plaintext.txt	0	alzheimers disease associated mutations presenilin 2 rare variably penetrant alzheimers disease associated mutations presenilin 2 rare variably penetrant r sherrington1 froelich2 sorbi3 d campion4 h chi1 e rogaeva1 g levesque1 e rogaev1 c lin1 y liang1 m ikeda1 l mar5 brice6 y agid6 m e percy7 f clerget darpoux8 piacentini3 g marcon9 b nacmias3 l amaducci3 frebourg4 l lannfelt2 j m rommens5 p h st george hyslop1
0.31518275.8817335.html.plaintext.txt	1	1centre research neurodegenerative diseases department medicine university toronto department medicine division neurology toronto hospital toronto ontario m5s 1a8 canada 2karolinska institute department clinical neurosciences geriatric medicine novum kfc 141 86 huddinge sweden 3department neurology psychiatry university florence viale morgagni 65 florence italy 4laboratoire de genetique moleculaire chu rouen 76031 rouen france 5department medical molecular genetics university toronto research institute hospital sick children 555 university avenue toronto ontario canada 6department neurology hopital de la salpetriere inserm u289 75013 paris france 7surrey place centre department obstetrics gynaecology dept physiology university toronto toronto ontario m5s 1a8 canada 8inserm u155 chateau de longchamp 75016 paris france 9department neurology university udine udine italy
0.31518275.8817335.html.plaintext.txt	2	1centre research neurodegenerative diseases department medicine university toronto department medicine division neurology toronto hospital toronto ontario m5s 1a8 canada 2karolinska institute department clinical neurosciences geriatric medicine novum kfc 141 86 huddinge sweden 3department neurology psychiatry university florence viale morgagni 65 florence italy 4laboratoire de genetique moleculaire chu rouen 76031 rouen france 5department medical molecular genetics university toronto research institute hospital sick children 555 university avenue toronto ontario canada 6department neurology hopital de la salpetriere inserm u289 75013 paris france 7surrey place centre department obstetrics gynaecology dept physiology university toronto toronto ontario m5s 1a8 canada 8inserm u155 chateau de longchamp 75016 paris france 9department neurology university udine udine italy
0.31518275.8817335.html.plaintext.txt	3	received february 20 1996 revised accepted april 17 1996
0.31518275.8817335.html.plaintext.txt	4	missense mutations presenilin 2 ps 2 gene chromosome 1 sought direct nucleotide sequence analysis open reading frame 60 pedigrees familial alzheimers disease fad majority pedigrees ps 1 beta amyloid precursor protein betaapp gene mutations excluded additional ps 2 pathogenic mutations detected four silent nucleotide substitutions alternative splicing nucleotides 1338 1340 glu325 observed analysis additional members pedigree known segregate met239val mutation ps 2 revealed age onset symptoms highly variable range 45 88 years variability attributable differences apoe genotypes results suggest contrast mutations ps 1 mutations ps 2 relatively rare cause fad ii genetic environmental factors modify ad phenotype associated ps 2 mutations iii still fad susceptibility genes remain identified introduction
0.31518275.8817335.html.plaintext.txt	5	missense mutations presenilin 2 ps 2 gene chromosome 1 sought direct nucleotide sequence analysis open reading frame 60 pedigrees familial alzheimers disease fad majority pedigrees ps 1 beta amyloid precursor protein betaapp gene mutations excluded additional ps 2 pathogenic mutations detected four silent nucleotide substitutions alternative splicing nucleotides 1338 1340 glu325 observed analysis additional members pedigree known segregate met239val mutation ps 2 revealed age onset symptoms highly variable range 45 88 years variability attributable differences apoe genotypes results suggest contrast mutations ps 1 mutations ps 2 relatively rare cause fad ii genetic environmental factors modify ad phenotype associated ps 2 mutations iii still fad susceptibility genes remain identified introduction
0.31518275.8817335.html.plaintext.txt	6	missense mutations associated early onsetalzheimers disease ad discovered two related genes termed presenilin chromosome 14 1 presenilin ii chromosome 1 2 3 analysis number large data sets revealed missense mutations presenilin ps 1 gene frequent cause early onset familial alzheimers disease fad accounting perhaps much 50 cases early onset fad 1 2 4 6 order determine frequency mutations presenilin ii ps 2 gene undertook survey mutations open reading frame orf ps 2 gene 60 pedigrees fad disease families characterized occurrence ad consistent ninds adrda criteria least three closely related subjects often one generation pedigrees age onset range 35 82 years 36 mean age onset 64 years 14 mean age onset 65 years 10 insufficient reliable data age onset overlapped observed pedigrees known ps 2 mutations onset 45 72 years determine penetrance ps 2 mutations also examined several additional members flo10 pedigree previously described met239val missense mutation ps 2 gene 2 data suggest missense mutations ps 2 gene rare cause ad missense mutations may subject modifying action genes environmental influences results
0.31518275.8817335.html.plaintext.txt	7	missense mutations associated early onsetalzheimers disease ad discovered two related genes termed presenilin chromosome 14 1 presenilin ii chromosome 1 2 3 analysis number large data sets revealed missense mutations presenilin ps 1 gene frequent cause early onset familial alzheimers disease fad accounting perhaps much 50 cases early onset fad 1 2 4 6 order determine frequency mutations presenilin ii ps 2 gene undertook survey mutations open reading frame orf ps 2 gene 60 pedigrees fad disease families characterized occurrence ad consistent ninds adrda criteria least three closely related subjects often one generation pedigrees age onset range 35 82 years 36 mean age onset 64 years 14 mean age onset 65 years 10 insufficient reliable data age onset overlapped observed pedigrees known ps 2 mutations onset 45 72 years determine penetrance ps 2 mutations also examined several additional members flo10 pedigree previously described met239val missense mutation ps 2 gene 2 data suggest missense mutations ps 2 gene rare cause ad missense mutations may subject modifying action genes environmental influences results
0.31518275.8817335.html.plaintext.txt	8	fibroblasts transformed lymphoblasts peripheral blood samples obtained least one affected member 60 kindreds multiple 3 family members affected fad ascertained familial alzheimers disease registry university toronto clinics university florence massachusetts alzheimers disease research centre karolinska institute stockholm sweden french university hospitals national inserm network france indiana university alzheimers disease dna bank nia sponsored repository coriell institute diagnosis ad affected members used ninds adrda criteria similar cerad criteria mutations ps 1 beta amyloid precursor protein betaapp genes previously excluded majority pedigrees sequencing reverse transcriptase polymerase chain reaction rt pcr products corresponding ps 1 gene genomic pcr products corresponding exons 16 17 betaapp
0.31518275.8817335.html.plaintext.txt	9	fibroblasts transformed lymphoblasts peripheral blood samples obtained least one affected member 60 kindreds multiple 3 family members affected fad ascertained familial alzheimers disease registry university toronto clinics university florence massachusetts alzheimers disease research centre karolinska institute stockholm sweden french university hospitals national inserm network france indiana university alzheimers disease dna bank nia sponsored repository coriell institute diagnosis ad affected members used ninds adrda criteria similar cerad criteria mutations ps 1 beta amyloid precursor protein betaapp genes previously excluded majority pedigrees sequencing reverse transcriptase polymerase chain reaction rt pcr products corresponding ps 1 gene genomic pcr products corresponding exons 16 17 betaapp
0.31518275.8817335.html.plaintext.txt	10	analysis nucleotide sequence rt pcr products corresponding orf ps 2 60 fad pedigrees failed uncover additional mutations beyond two initial mutations asn141ile mutation three related kindreds volga german origin met239val mutation flo10 pedigree italian origin previously reported data set 2 specific screening asn141ile met239val mutations supplemental set genomic dna samples affected probands 81 swedish fad pedigrees also failed identify instances either mutation however although pathogenic nucleotide sequence differences observed four silent nucleotide substitutions detected c 626 bpcodon 23 c 806 bpcodon 147 c 1571 bpcodon 402 g 1670 bpcodon 435 sequence numbering accession l44577 substitutions occurred third nucleotide position codon would therefore predicted cause change amino acid sequence fifth sequence variant variable presence nucleotides 1338 1340 encoding glu325 residuewas found transcripts tissues transcripts without nucleotides 1338 1340 reflects use alternate splice donor sequence approximately equal abundance brain fibroblasts leukocytes
0.31518275.8817335.html.plaintext.txt	11	analysis nucleotide sequence rt pcr products corresponding orf ps 2 60 fad pedigrees failed uncover additional mutations beyond two initial mutations asn141ile mutation three related kindreds volga german origin met239val mutation flo10 pedigree italian origin previously reported data set 2 specific screening asn141ile met239val mutations supplemental set genomic dna samples affected probands 81 swedish fad pedigrees also failed identify instances either mutation however although pathogenic nucleotide sequence differences observed four silent nucleotide substitutions detected c 626 bpcodon 23 c 806 bpcodon 147 c 1571 bpcodon 402 g 1670 bpcodon 435 sequence numbering accession l44577 substitutions occurred third nucleotide position codon would therefore predicted cause change amino acid sequence fifth sequence variant variable presence nucleotides 1338 1340 encoding glu325 residuewas found transcripts tissues transcripts without nucleotides 1338 1340 reflects use alternate splice donor sequence approximately equal abundance brain fibroblasts leukocytes
0.31518275.8817335.html.plaintext.txt	12	investigation ps 2 gene several newly ascertained members flo10 pedigree segregating met239val mutation ps 2 identified additional carrier mutation subject iii 20 table 1 surprisingly subject aged 87 years evidence cognitive memory impairment serial follow several years age 84 years noted become mildly demented profoundly demented mini mental status examination score 430 clinical features sustain diagnosis probable ad ninds adrda criteria review clinical data additional members extended pedigree also uncovered two subjects direct lineage family either historical evidence late onset ad subject 2 affected grandfather iii 20 died 75 years dementia currently clinical features consistent probable ad using ninds adrda criteria subject iii 39 onset 88 years others previously reported genotype apolipoprotein e gene modulate age onset alzheimers disease subjects val717ile mutation betaapp 7 8 however flo10 family met239val mutation ps 2 apoe genotypes correlate age onset table 1 thus elderly symptomatic subject iii 20 onset 84 years apoe genotype epsilon3epsilon3 three affected carriers met239val mutation developed symptoms younger age onset 45 72 years moreover affected carrier iv 21 apoe genotype epsilon3epsilon4 developed symptoms age 48 years similar affected sibling iv 18 apoe genotype epsilon3epsilon3 onset 45 years table 1 fig 1 sample size small draw reliable conclusions presence absence interactions apoe genotype asn141ile mutation table 1
0.31518275.8817335.html.plaintext.txt	13	investigation ps 2 gene several newly ascertained members flo10 pedigree segregating met239val mutation ps 2 identified additional carrier mutation subject iii 20 table 1 surprisingly subject aged 87 years evidence cognitive memory impairment serial follow several years age 84 years noted become mildly demented profoundly demented mini mental status examination score 430 clinical features sustain diagnosis probable ad ninds adrda criteria review clinical data additional members extended pedigree also uncovered two subjects direct lineage family either historical evidence late onset ad subject 2 affected grandfather iii 20 died 75 years dementia currently clinical features consistent probable ad using ninds adrda criteria subject iii 39 onset 88 years others previously reported genotype apolipoprotein e gene modulate age onset alzheimers disease subjects val717ile mutation betaapp 7 8 however flo10 family met239val mutation ps 2 apoe genotypes correlate age onset table 1 thus elderly symptomatic subject iii 20 onset 84 years apoe genotype epsilon3epsilon3 three affected carriers met239val mutation developed symptoms younger age onset 45 72 years moreover affected carrier iv 21 apoe genotype epsilon3epsilon4 developed symptoms age 48 years similar affected sibling iv 18 apoe genotype epsilon3epsilon3 onset 45 years table 1 fig 1 sample size small draw reliable conclusions presence absence interactions apoe genotype asn141ile mutation table 1
0.31518275.8817335.html.plaintext.txt	14	figure 1abbreviated pedigree diagram flo10 small type face roman numerals pedigree locations subject solid symbols ad affected subjects hatched symbols risk subjects open symbols risk known age onset age death denoted arabic numerals apoe genotypes depicted exception subject iii 39 whose genotypes ps 2 apoe unknown biological samples available affected subjects carried ps 2 met239val mutation discussion
0.31518275.8817335.html.plaintext.txt	15	although large cadre fad pedigrees reported represent unbiased survey paucity missense mutations ps 2 gene amongst fad pedigrees data set suggests contrast mutations orf ps 1 mutations orf gene rare cause fad least caucasian populations confidently exclude mutations intronic sequences associated rna splice sites indeed one mutation affects splicing exon 10 ps 1 found fad affected subjects miki et al preparation however 5 utr 3 utr sequences searched pathogenic mutations cannot exclude formal possibility mutations might exist sequences pedigrees nevertheless two corollaries conclusion ps 2 orf mutations rare first unless phenotype uniquely associated least enriched subjects ps 2 mutants found screening programs mutations orf ps 2 likely low yield second importantly yet unidentified fad susceptibility loci must exist
0.31518275.8817335.html.plaintext.txt	16	although large cadre fad pedigrees reported represent unbiased survey paucity missense mutations ps 2 gene amongst fad pedigrees data set suggests contrast mutations orf ps 1 mutations orf gene rare cause fad least caucasian populations confidently exclude mutations intronic sequences associated rna splice sites indeed one mutation affects splicing exon 10 ps 1 found fad affected subjects miki et al preparation however 5 utr 3 utr sequences searched pathogenic mutations cannot exclude formal possibility mutations might exist sequences pedigrees nevertheless two corollaries conclusion ps 2 orf mutations rare first unless phenotype uniquely associated least enriched subjects ps 2 mutants found screening programs mutations orf ps 2 likely low yield second importantly yet unidentified fad susceptibility loci must exist
0.31518275.8817335.html.plaintext.txt	17	table 1 age onset relative genotypes apoe ps 2 genes subject
0.31518275.8817335.html.plaintext.txt	18	age symptom onset current age ps 2 mutation carriers displayed along subjects apoe genotype
0.31518275.8817335.html.plaintext.txt	19	conclusion drawn data age symptom onset subjects ps 2 mutations generally older 45 88 years observed ps 1 mutations 25 65 years highly variable even amongst affected members pedigree contrasts sharply experience ps 1 mutations age onset generally quite similar amongst affected members family often amongst members different families mutation 1 2 4 6 date subjects ad flo10 pedigree inherited met239val mutation unlikely late onset cases represent phenocopies andor represents polymorphism linkage disequilibrium nearby pathogenic mutation consequently parsimonious explanation single cause disease met239val mutation phenotype modified genetic environmental factors limited number subjects asn141ile mutation data set prevents rigorous conclusions interactions apoe genotype mutation however analysis larger data set bird g schellenberg also reveals obvious interaction genotypes apoe ps 2 asn141ile manuscript preparation absence close correlation apoe genotype age symptom onset subjects ps 2 mutation two implications first view parallel observations showing apparent interaction apoe genotype mutations ps 1 7 9 10 together structural amino acid sequence similarities ps 1 ps 2 proteins 1 3 likely functional effect ps 1 ps 2 mutations similar either remote functional effect apoe epsilon4 allele affect biochemical pathway leading ad different influenced apoe epsilon4 second variation age onset ps 2 mutation carriers argues modifying environmental genetic factors eg polymorphisms within presenilin genes differences genes must exist nature factors remains determined however modifying factors identified might exploitable therapeutic tool materials methods
0.31518275.8817335.html.plaintext.txt	20	conclusion drawn data age symptom onset subjects ps 2 mutations generally older 45 88 years observed ps 1 mutations 25 65 years highly variable even amongst affected members pedigree contrasts sharply experience ps 1 mutations age onset generally quite similar amongst affected members family often amongst members different families mutation 1 2 4 6 date subjects ad flo10 pedigree inherited met239val mutation unlikely late onset cases represent phenocopies andor represents polymorphism linkage disequilibrium nearby pathogenic mutation consequently parsimonious explanation single cause disease met239val mutation phenotype modified genetic environmental factors limited number subjects asn141ile mutation data set prevents rigorous conclusions interactions apoe genotype mutation however analysis larger data set bird g schellenberg also reveals obvious interaction genotypes apoe ps 2 asn141ile manuscript preparation absence close correlation apoe genotype age symptom onset subjects ps 2 mutation two implications first view parallel observations showing apparent interaction apoe genotype mutations ps 1 7 9 10 together structural amino acid sequence similarities ps 1 ps 2 proteins 1 3 likely functional effect ps 1 ps 2 mutations similar either remote functional effect apoe epsilon4 allele affect biochemical pathway leading ad different influenced apoe epsilon4 second variation age onset ps 2 mutation carriers argues modifying environmental genetic factors eg polymorphisms within presenilin genes differences genes must exist nature factors remains determined however modifying factors identified might exploitable therapeutic tool materials methods
0.31518275.8817335.html.plaintext.txt	21	subjects familially clustered alzheimers disease defined occurrence least three first second degree relatives ad recruited patients referred investigation dementia university toronto university florence massachusetts alzheimers disease research centre huddinge hospital karolinska institute french university hospitals subjects provided informed consent using institutionally approved protocols diagnosis ad made affected pedigree members direct clinical examination standard laboratory procedures met exceeded stringency nincds adrda criteria 11 12 evidence ad deceased family members ascertained investigation medical family records previously described 13 additional fad pedigree samples obtained cornell institute camden nj n 4 indiana university alzheimers disease dna bank indianapolis n 6
0.31518275.8817335.html.plaintext.txt	22	subjects familially clustered alzheimers disease defined occurrence least three first second degree relatives ad recruited patients referred investigation dementia university toronto university florence massachusetts alzheimers disease research centre huddinge hospital karolinska institute french university hospitals subjects provided informed consent using institutionally approved protocols diagnosis ad made affected pedigree members direct clinical examination standard laboratory procedures met exceeded stringency nincds adrda criteria 11 12 evidence ad deceased family members ascertained investigation medical family records previously described 13 additional fad pedigree samples obtained cornell institute camden nj n 4 indiana university alzheimers disease dna bank indianapolis n 6
0.31518275.8817335.html.plaintext.txt	23	mutations sought orf ps 1 gene 4760 pedigrees exon 16 17 betaapp gene 5160 pedigrees using methods previously described 1 14 15 ps 2 gene orf investigated north american italian pedigrees isolating complimentary dna fragments amplification using rt pcr oligonucleotide primer sequences reaction conditions previously described 2 french families rt pcr performed using primers f1 5 caggaaacagctatgaccgagctgaccctcaaatacgg f2 5 tgtaaaacgacggccagtgagatcatacacagagatgg recover codons 85 257 primers f3 5 caggaaacagctatgacctcaagtacctcccagagtgg f4 5 tgtaaaacgacggccagtagcctgtggcacaccatgtc recover codons 251 448 nucleotide sequence rt pcr products affected pedigree member determined using fluorescent dye terminator dye primer cycle sequencing mutations detected analysis resultant chromatograms heterozygous nucleotidesubstitutions using direct inspection factura ver 120 sequence navigator ver 101b15 software packages abi foster city ca
0.31518275.8817335.html.plaintext.txt	24	mutations sought orf ps 1 gene 4760 pedigrees exon 16 17 betaapp gene 5160 pedigrees using methods previously described 1 14 15 ps 2 gene orf investigated north american italian pedigrees isolating complimentary dna fragments amplification using rt pcr oligonucleotide primer sequences reaction conditions previously described 2 french families rt pcr performed using primers f1 5 caggaaacagctatgaccgagctgaccctcaaatacgg f2 5 tgtaaaacgacggccagtgagatcatacacagagatgg recover codons 85 257 primers f3 5 caggaaacagctatgacctcaagtacctcccagagtgg f4 5 tgtaaaacgacggccagtagcctgtggcacaccatgtc recover codons 251 448 nucleotide sequence rt pcr products affected pedigree member determined using fluorescent dye terminator dye primer cycle sequencing mutations detected analysis resultant chromatograms heterozygous nucleotidesubstitutions using direct inspection factura ver 120 sequence navigator ver 101b15 software packages abi foster city ca
0.31518275.8817335.html.plaintext.txt	25	presence c substitution base pair 1624 ps 2 cdna sequence gives rise met239val mutation assessed genomic dna previously described 2
0.31518275.8817335.html.plaintext.txt	26	genotypes apoe determined pcr amplification hhai digestion previously described 16 17 acknowledgements
0.31518275.8817335.html.plaintext.txt	27	work supported alzheimer association ontario canadian genetic diseases network medical research council canada american health assistance foundation national institute health scottish rite charitable foundation eva gordon memorial trust lifebeat swedish medical research council project 10819ll inserm network 492002 consiglio nazionale delle richerche pf aging 952631 ss telethon italy e304 bn glaxo canada rs helen b hunter foundation gl hc peterborough burgess fellowship ear ontario mental health foundation mep pstgh jmr scholars medical research council canada cell lines obtained indiana university alzheimers disease dna bank p30 ag10133 references 1 sherrington r rogaev e liang y et al 1995 cloning gene bearing missense mutations early onset familial alzheimers disease nature 375 754 760 medline abstract
0.31518275.8817335.html.plaintext.txt	28	work supported alzheimer association ontario canadian genetic diseases network medical research council canada american health assistance foundation national institute health scottish rite charitable foundation eva gordon memorial trust lifebeat swedish medical research council project 10819ll inserm network 492002 consiglio nazionale delle richerche pf aging 952631 ss telethon italy e304 bn glaxo canada rs helen b hunter foundation gl hc peterborough burgess fellowship ear ontario mental health foundation mep pstgh jmr scholars medical research council canada cell lines obtained indiana university alzheimers disease dna bank p30 ag10133 references 1 sherrington r rogaev e liang y et al 1995 cloning gene bearing missense mutations early onset familial alzheimers disease nature 375 754 760 medline abstract
0.31518275.8817335.html.plaintext.txt	29	6 alzheimers disease collaborative group 1995 structure presenilin gene identification six mutations early onset ad pedigrees nature genet 11 219 222
0.31518275.8817335.html.plaintext.txt	30	10 french alzheimers disease collaborative study group 1996 apolipoprotein e genotype affect age onset patients chromosome 14 encoded alzheimers disease j med genet press
0.31518275.8817335.html.plaintext.txt	31	correspondence addressed page maintained oup admin last updated thu oct 31 152515 gmt 1996 part oup journals world wide web servicecopyright oxford university press 1996
0.31518275.8817335.html.plaintext.txt	32	correspondence addressed page maintained oup admin last updated thu oct 31 152515 gmt 1996 part oup journals world wide web servicecopyright oxford university press 1996
0.31636134.15033916.html.plaintext.txt	0	estrogen facilitates neurite extension via apolipoprotein e cultured adult mouse cortical neurons britto p nathan anna g barsukova fei shen mary mcasey robert g struble
0.31636134.15033916.html.plaintext.txt	1	department biological sciences bpn agb fs eastern illinois university charleston illinois 61920 department obstetrics gynecology mm center alzheimer disease rgs southern illinois university school medicine springfield illinois 62794
0.31636134.15033916.html.plaintext.txt	2	address correspondence requests reprints robert g struble phd po box 19628 center alzheimer disease related disorders southern illinois university school medicine springfield illinois 62794 9628 e mail rstrubleatsiumededu u d
0.31636134.15033916.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references literature review suggests close relationship estrogen apolipoprotein e apoe central nervous system epidemiology studies show estrogen replacement therapy ert decreases morbidity several chronic neurological diseases alleles apoe modify risk progression diseases apoe levels rodent brain vary estrous cycle increase 17ss estradiol administration estradiol apoe3 common isoform human apoe increase extent neurite outgrowth culture combined observations suggest common mechanism whereby estrogen may increase apoe levels facilitate neurite growth tested hypothesis characterizing effects estradiol apoe isoforms neurite outgrowth cultured adult mouse cortical neurons estradiol increased apoe levels neurite outgrowth apoe2 increased neurite length apoe3 presence estradiol estradiol effect neurite outgrowth mice lacking apoe gene apoe4 isoform apoe associated increased risk neurological disease exogenously supplied cultures mice transgenic human apoe3 apoe4 showed isoform specific effect neuronal internalization recombinant human apoe3 greater apoe4 apoe3 effective apoe4 facilitating neuronal uptake fatty acid conclude estradiol facilitates neurite growth apoe dependent mechanism effects ert chronic neurological diseases may vary apoe genotype clinical use ert may require apoe genotyping optimal efficacy
0.31636134.15033916.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references literature review suggests close relationship estrogen apolipoprotein e apoe central nervous system epidemiology studies show estrogen replacement therapy ert decreases morbidity several chronic neurological diseases alleles apoe modify risk progression diseases apoe levels rodent brain vary estrous cycle increase 17ss estradiol administration estradiol apoe3 common isoform human apoe increase extent neurite outgrowth culture combined observations suggest common mechanism whereby estrogen may increase apoe levels facilitate neurite growth tested hypothesis characterizing effects estradiol apoe isoforms neurite outgrowth cultured adult mouse cortical neurons estradiol increased apoe levels neurite outgrowth apoe2 increased neurite length apoe3 presence estradiol estradiol effect neurite outgrowth mice lacking apoe gene apoe4 isoform apoe associated increased risk neurological disease exogenously supplied cultures mice transgenic human apoe3 apoe4 showed isoform specific effect neuronal internalization recombinant human apoe3 greater apoe4 apoe3 effective apoe4 facilitating neuronal uptake fatty acid conclude estradiol facilitates neurite growth apoe dependent mechanism effects ert chronic neurological diseases may vary apoe genotype clinical use ert may require apoe genotyping optimal efficacy
0.31636134.15033916.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references epidemiological studies suggest estrogen replacement therapy ert decreases risk rate progression several chronic neurological diseases majority epidemiological studies suggest history ert decreases likelihood developing late life dementia 1 2 3 4 5 6 however women health initiative trial continuous estrogen plus progestin arm discontinued early found protection dementia perhaps slight increase risk 7 8 history ert also may delay either onset progression parkinson disease pd 9 10 11 12 studies also mixed reporting change risk 9 finally rate clinical progression multiple sclerosis attenuated estrogen 13 14 disagreement studies emphasizes lack clear understanding mechanism whereby steroid replacement may decrease risk neurological diseases
0.31636134.15033916.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references epidemiological studies suggest estrogen replacement therapy ert decreases risk rate progression several chronic neurological diseases majority epidemiological studies suggest history ert decreases likelihood developing late life dementia 1 2 3 4 5 6 however women health initiative trial continuous estrogen plus progestin arm discontinued early found protection dementia perhaps slight increase risk 7 8 history ert also may delay either onset progression parkinson disease pd 9 10 11 12 studies also mixed reporting change risk 9 finally rate clinical progression multiple sclerosis attenuated estrogen 13 14 disagreement studies emphasizes lack clear understanding mechanism whereby steroid replacement may decrease risk neurological diseases
0.31636134.15033916.html.plaintext.txt	7	apolipoprotein e apoe modifies risks several chronic neurological diseases humans three major isoforms apoe apoe2 apoe3 apoe4 produced three alleles 2 3 4 single gene locus chromosome 19 15 16 inheritance 4 increases risk rate progression late onset alzheimer disease 17 18 19 individuals 4 alleles also appear earlier age onset pd greater risk developing dementia pd 20 21 additionally 4 inheritance increases risk developing dementia head trauma 22 23 24 increases severity relapsing remitting multiple sclerosis 25 26
0.31636134.15033916.html.plaintext.txt	8	apolipoprotein e apoe modifies risks several chronic neurological diseases humans three major isoforms apoe apoe2 apoe3 apoe4 produced three alleles 2 3 4 single gene locus chromosome 19 15 16 inheritance 4 increases risk rate progression late onset alzheimer disease 17 18 19 individuals 4 alleles also appear earlier age onset pd greater risk developing dementia pd 20 21 additionally 4 inheritance increases risk developing dementia head trauma 22 23 24 increases severity relapsing remitting multiple sclerosis 25 26
0.31636134.15033916.html.plaintext.txt	9	neuronal repair may common factor diseases estradiol apoe independently facilitate neuriteprocess outgrowth vivo vitro estradiol increases complexity neuritic growth axonal elongation vitro 27 28 29 neuronal repair brain lesion rapid presence estradiol 30 31 apoe similar estrogen dramatic effects neurite outgrowth variety cultured neurons apoe3 increases neurite outgrowth whereas absence apoe treatment apoe4 either decreases effect neurite outgrowth 32 33 34 neuropathological studies documented deficits dendritic growth plasticity brains apoe4 individuals 35 apoe appears critical element neuronal growth repair
0.31636134.15033916.html.plaintext.txt	10	neuronal repair may common factor diseases estradiol apoe independently facilitate neuriteprocess outgrowth vivo vitro estradiol increases complexity neuritic growth axonal elongation vitro 27 28 29 neuronal repair brain lesion rapid presence estradiol 30 31 apoe similar estrogen dramatic effects neurite outgrowth variety cultured neurons apoe3 increases neurite outgrowth whereas absence apoe treatment apoe4 either decreases effect neurite outgrowth 32 33 34 neuropathological studies documented deficits dendritic growth plasticity brains apoe4 individuals 35 apoe appears critical element neuronal growth repair
0.31636134.15033916.html.plaintext.txt	11	apoe levels cns vary estrous cycle 36 several studies show estradiol increase apoe vivo 36 37 vitro 38 39 sum observations suggest generalized mechanism whereby estrogen could increase apoe levels apoe levels could facilitate process regrowth injury tested hypothesis cultured neurons adult mice found presence apoe2 apoe3 necessary obtain effect estrogen neurite outgrowth addition data suggest apoe isoforms differential rates internalizaton lipid transport neurons
0.31636134.15033916.html.plaintext.txt	12	apoe levels cns vary estrous cycle 36 several studies show estradiol increase apoe vivo 36 37 vitro 38 39 sum observations suggest generalized mechanism whereby estrogen could increase apoe levels apoe levels could facilitate process regrowth injury tested hypothesis cultured neurons adult mice found presence apoe2 apoe3 necessary obtain effect estrogen neurite outgrowth addition data suggest apoe isoforms differential rates internalizaton lipid transport neurons
0.31636134.15033916.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references subjects vitro culture paradigm adult cortical neurons 40 used examine effect 17ss estradiol estradiol apoe levels neurite extension adult cortical culture procedure previously described 33 40 procedures approved eastern illinois university animal care committee
0.31636134.15033916.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references subjects vitro culture paradigm adult cortical neurons 40 used examine effect 17ss estradiol estradiol apoe levels neurite extension adult cortical culture procedure previously described 33 40 procedures approved eastern illinois university animal care committee
0.31636134.15033916.html.plaintext.txt	15	control mice c57bl6 homozygous apoe knockout ko mice bred 10 generations onto c57bl6 background c57bl6 apoe tmiunc obtained jackson laboratory bar harbor transgenic tg human apoe3 tg human apoe4 mice gift dr david holtzman washington university st louis mo apoe3 apoe4 transgene inserted glial fibrillary acidic protein gfap promoter region 34
0.31636134.15033916.html.plaintext.txt	16	control mice c57bl6 homozygous apoe knockout ko mice bred 10 generations onto c57bl6 background c57bl6 apoe tmiunc obtained jackson laboratory bar harbor transgenic tg human apoe3 tg human apoe4 mice gift dr david holtzman washington university st louis mo apoe3 apoe4 transgene inserted glial fibrillary acidic protein gfap promoter region 34
0.31636134.15033916.html.plaintext.txt	17	culture preparation experiment 4 month old female mouse euthanized sodium pentobarbital 80 mgkg entire cerebral cortex dissected brain placed 2 ml b27hibernate medium b27ha invitrogen life technologies carlsbad ca 05 mm glutamine sigma st louis mo 4 c cortex sliced 05 mm thickness transferred 50 ml tube containing 5 ml b27ha warming 8 min 30 c slices digested 6 ml 2 mgml papain sigma solution b27ha 30 min 30 c gyrating water bath slices transferred 2 ml b27ha 2 min room temperature slices triturated 10 times siliconized 9 inch pasteur pipette allowed settle 1 min approximately 2 ml supernatant transferred another tube sediment resuspended 2 ml b27ha step repeated twice total 6 ml collected resultant supernatant subjected density gradient centrifugation 800 x g 15 min density gradient prepared four 1 ml layers 35 25 20 15 optiprep invitrogen life technologies b27ha medium volvol debris 7 ml discarded rest fractions excluding bottom pellet collected diluted 5 ml b27ha centrifuging twice 200 x g 2 min cell pellets resuspended 3 ml b27neurobasal medium invitrogen life technologies 05 mm glutamine 001 mgml gentamicin sigma total 4 x 104 cells plated 50 microl aliquots glass cover slips 12 mm diameter coated overnight poly d lysine 50 mgml sigma 1 h incubation humidified incubator 37 c 5 co2 cover slip rinsed twice b27ha transferred 24 well plate containing 04 ml b27neurobasal medium 5 ngml fibroblast growth factor 2 invitrogen life technologies
0.31636134.15033916.html.plaintext.txt	18	culture preparation experiment 4 month old female mouse euthanized sodium pentobarbital 80 mgkg entire cerebral cortex dissected brain placed 2 ml b27hibernate medium b27ha invitrogen life technologies carlsbad ca 05 mm glutamine sigma st louis mo 4 c cortex sliced 05 mm thickness transferred 50 ml tube containing 5 ml b27ha warming 8 min 30 c slices digested 6 ml 2 mgml papain sigma solution b27ha 30 min 30 c gyrating water bath slices transferred 2 ml b27ha 2 min room temperature slices triturated 10 times siliconized 9 inch pasteur pipette allowed settle 1 min approximately 2 ml supernatant transferred another tube sediment resuspended 2 ml b27ha step repeated twice total 6 ml collected resultant supernatant subjected density gradient centrifugation 800 x g 15 min density gradient prepared four 1 ml layers 35 25 20 15 optiprep invitrogen life technologies b27ha medium volvol debris 7 ml discarded rest fractions excluding bottom pellet collected diluted 5 ml b27ha centrifuging twice 200 x g 2 min cell pellets resuspended 3 ml b27neurobasal medium invitrogen life technologies 05 mm glutamine 001 mgml gentamicin sigma total 4 x 104 cells plated 50 microl aliquots glass cover slips 12 mm diameter coated overnight poly d lysine 50 mgml sigma 1 h incubation humidified incubator 37 c 5 co2 cover slip rinsed twice b27ha transferred 24 well plate containing 04 ml b27neurobasal medium 5 ngml fibroblast growth factor 2 invitrogen life technologies
0.31636134.15033916.html.plaintext.txt	19	estradiol 17ss sigma dissolved 95 ethanol 40 microm added culture medium 1 d vitro 1 div incubation continued 4 div human recombinant apoe3 apoe4 panvera madison wi dialyzed overnight 01 m ammonium bicarbonate final concentrations estrogen apoe test reagents culture medium varied based experiments quantification performed cells 4 div experiment performed three times
0.31636134.15033916.html.plaintext.txt	20	estradiol 17ss sigma dissolved 95 ethanol 40 microm added culture medium 1 d vitro 1 div incubation continued 4 div human recombinant apoe3 apoe4 panvera madison wi dialyzed overnight 01 m ammonium bicarbonate final concentrations estrogen apoe test reagents culture medium varied based experiments quantification performed cells 4 div experiment performed three times
0.31636134.15033916.html.plaintext.txt	21	apoe quantification media 4 div cultures collected centrifuged 5 min apoe immunoprecipitated incubating medium monoclonal anti apoe 3h1 heart institute university ottawa ottawa canada 11000 dilution media ice 1 h incubation 10 protein sepharose cl 4b sigma added 1100 medium incubated ice 1 h shaker medium centrifuged 11000 x g 15 min 4 c supernatant discarded pellet boiled 5 min 2x lammeli sample buffer electrophoresed 4 20 sodium dodecyl sulfate polyacrylamide gradient gel ec120 mini gel vertical system samples run 80 v separation began 140 v dye front neared bottom gel
0.31636134.15033916.html.plaintext.txt	22	apoe quantification media 4 div cultures collected centrifuged 5 min apoe immunoprecipitated incubating medium monoclonal anti apoe 3h1 heart institute university ottawa ottawa canada 11000 dilution media ice 1 h incubation 10 protein sepharose cl 4b sigma added 1100 medium incubated ice 1 h shaker medium centrifuged 11000 x g 15 min 4 c supernatant discarded pellet boiled 5 min 2x lammeli sample buffer electrophoresed 4 20 sodium dodecyl sulfate polyacrylamide gradient gel ec120 mini gel vertical system samples run 80 v separation began 140 v dye front neared bottom gel
0.31636134.15033916.html.plaintext.txt	23	electrophoresis gel placed transfer buffer 303 g tris base 144 g glycine 200 ml methanol 800 ml distilled h2o shaker 10 min transfer membrane immobilon p transfer membrane millipore bedford ma first soaked methanol 5 sec washed distilled h2o 5 min remove excess methanol proteins gel transferred membrane using bio rad hercules ca trans blot transfer cell following manufacturer protocol membranes blocked tbs buffer 20 mm tris hcl 150 mm nacl ph 75 1 bsa 4 c overnight room temperature 1 h blocking membranes washed twice 5 min tbs buffer tbs buffer 005 tween 20 incubated goat antihuman apoe calbiochem san diego ca 15000 dilution tbs buffer 1 h shaker room temperature membranes washed four times 10 min tbs buffer incubated horseradish peroxidase conjugated rabbit antigoat igg chemicon temecula ca 110000 dilution tbs buffer 1 h shaker room temperature washing five times 10 min tbs buffer membranes incubated supersignal west pico chemiluminescent substrate pierce rockford il exposed kodak biomax light 2 film fisher scientific chicago il 34 kda band visualized consistent published molecular mass apoe bands quantified densitometry scion image frederick md compared band recombinant human apoe
0.31636134.15033916.html.plaintext.txt	24	neurite extension cells prepared described treated varying concentrations estradiol ethanol 01 nm vehicle estradiol included additional control single neurite extension length longest neurite neuron combined neurite length total length neurites neuron measured described previously 33 first technique employed ocular micrometer measure longest neurite second technique measured total length neurites minimum ten cells per coverslip quantified values coverslip averaged yield mean longest length mean total length experiment performed three times following experiments performed culture system
0.31636134.15033916.html.plaintext.txt	25	experimental studies time course apoe levels estradiol treatment time course apoe levels response exogenous estradiol examined apoe secretion adult mouse cultures evaluated incubating cells 01 nm estradiol 0 01 05 10 40 160 360 480 h incubation medium collected secreted apoe quantified immunoblotting immunoprecipitation
0.31636134.15033916.html.plaintext.txt	26	experimental studies time course apoe levels estradiol treatment time course apoe levels response exogenous estradiol examined apoe secretion adult mouse cultures evaluated incubating cells 01 nm estradiol 0 01 05 10 40 160 360 480 h incubation medium collected secreted apoe quantified immunoblotting immunoprecipitation
0.31636134.15033916.html.plaintext.txt	27	dose response apoe estradiol treatment obtained dose response curve apoe levels estradiol addition wild type mice 3 d estradiol treatment dosages estradiol ranging 01 pm 10 nm cortical cells wild type mice treated varying concentrations estradiol 01 pm 10 nm 3 d amount secreted apoe measured described
0.31636134.15033916.html.plaintext.txt	28	dose response apoe estradiol treatment obtained dose response curve apoe levels estradiol addition wild type mice 3 d estradiol treatment dosages estradiol ranging 01 pm 10 nm cortical cells wild type mice treated varying concentrations estradiol 01 pm 10 nm 3 d amount secreted apoe measured described
0.31636134.15033916.html.plaintext.txt	29	dose response estradiol neurite extension second dose response study estradiol performed neurite outgrowth 4 div cultures prepared varying concentrations estradiol added cells 1 div 4 div cells evaluated neurite extension described
0.31636134.15033916.html.plaintext.txt	30	dose response estradiol neurite extension second dose response study estradiol performed neurite outgrowth 4 div cultures prepared varying concentrations estradiol added cells 1 div 4 div cells evaluated neurite extension described
0.31636134.15033916.html.plaintext.txt	31	apoe replacement neurite extension performed apoe replacement studies estradiol treated cell cultures derived mice lacking apoe gene apoe ko jackson laboratory cells incubated without 100 pm estradiol ethanol starting 1 div purified recombinant human apoe isoforms added 3 microgml panvera concentration comparable found human cerebrospinal fluid 41 4 div combined length neuritic trees obtained described
0.31636134.15033916.html.plaintext.txt	32	apoe replacement neurite extension performed apoe replacement studies estradiol treated cell cultures derived mice lacking apoe gene apoe ko jackson laboratory cells incubated without 100 pm estradiol ethanol starting 1 div purified recombinant human apoe isoforms added 3 microgml panvera concentration comparable found human cerebrospinal fluid 41 4 div combined length neuritic trees obtained described
0.31636134.15033916.html.plaintext.txt	33	estradiol effects neurite outgrowth tg mice tg mice expressing human apoe3 apoe4 control glial fibrillary acidic protein promoter 34 used evaluate effects endogenous apoe estradiol stimulated neurite extension culture vivo mice show apoe protein expression astrocytes ref 34 struble r g b p nathan personal observations cultures prepared evaluation 4 div
0.31636134.15033916.html.plaintext.txt	34	estradiol effects neurite outgrowth tg mice tg mice expressing human apoe3 apoe4 control glial fibrillary acidic protein promoter 34 used evaluate effects endogenous apoe estradiol stimulated neurite extension culture vivo mice show apoe protein expression astrocytes ref 34 struble r g b p nathan personal observations cultures prepared evaluation 4 div
0.31636134.15033916.html.plaintext.txt	35	apoelipid uptake studies apoe transfers lipids neurons endocytosis tested rate uptake exogenous apoe lipid neurons cultures derived apoe ko mice examined rate apoe uptake rate fatty acid transported cultured neurons cultures 4 div apoe ko mice incubated 1 h recombinant human apoe3 human apoe4 prepared immunocytochemical localization apoe coverslips fixed 80 ethanol 1 h rt rinsed three times tbs 02 tween 20 mm tbs ph 75 permeabilized 025 triton pbs 01 m ph 72 30 min coverslips rinsed three times tbs nonspecific binding blocked 1 bsa 15 apoe ko mouse serum tbs 1 h rt incubated 2 h room temperature goat anti apoe antibody chemicon 1200 dilution washing six times tbs coverslips incubated fluorescently labeled antigoat antisera pierce 30 min 1200 dilution washed five times tbs 5 min control coverslips incubated 4 c coverslips mounted anti photobleach medium vectashield vector laboratories burlingame ca stored dark digital images 30 fields per coverslip x40 objective containing neurons obtained using fluorescence microscope excitation frequency 520 nm emission 492 nm digital camera pixera penguin 150cl maintaining identical exposure settings images apoe immunofluorescence measured quantifying mean optical fluorescence field using scion image software upper lower 20 bits cut eliminate nonspecific fluorescence mean density pixelsfield within range obtained data transformed scale 0 100 statistical analysis
0.31636134.15033916.html.plaintext.txt	36	lipid uptake neurons quantified fluorescently labeled dodecanoic acid 44 difluoro 5 methyl 4 bora 3a4a diaza indacene 3 dodecanoic acid accumulation adult cortical neurons fluorescence absorption emission 500 510 nm respectively cells grown coverslips 4 d incubated 1 h 3 microgml either apoe 3 apoe 4 together 10 microgml fluorescently labeled lipid 44 difluoro 5 methyl 4 bora 3a4a diaza indacene 3 dodecanoic acid molecular probes eugene incubation coverslips rinsed three times warm 37 c pbs fluorescent images digitized objective magnification x100 described od measured using scion image software described
0.31636134.15033916.html.plaintext.txt	37	lipid uptake neurons quantified fluorescently labeled dodecanoic acid 44 difluoro 5 methyl 4 bora 3a4a diaza indacene 3 dodecanoic acid accumulation adult cortical neurons fluorescence absorption emission 500 510 nm respectively cells grown coverslips 4 d incubated 1 h 3 microgml either apoe 3 apoe 4 together 10 microgml fluorescently labeled lipid 44 difluoro 5 methyl 4 bora 3a4a diaza indacene 3 dodecanoic acid molecular probes eugene incubation coverslips rinsed three times warm 37 c pbs fluorescent images digitized objective magnification x100 described od measured using scion image software described
0.31636134.15033916.html.plaintext.txt	38	receptor inhibition apoe uptake determine type lipoprotein receptors underlying effects apoe isoforms neuronal internalization lipoproteins three different lipoprotein receptor inhibitors used 1 receptor associated protein rap 5 microgml gift dr dudley strickland american red cross rockville md 2 lactoferrin lac 10 microgml sigma 3 heparinase 10 uml sigma heparinase depletes cell surface heparan sulfate proteoglycans hspgs bind apoe enriched lipoproteins internalization via lrp whereas rap lac inhibits binding lipoproteins lrp cells 3 div apoe ko mice preincubated 1 h medium alone medium containing one three inhibitors cultures subsequently treated 1 h recombinant apoe3 apoe4 prepared immunofluorescent localization apoe images 10 neurons per coverslip digitized analyzed experimental condition
0.31636134.15033916.html.plaintext.txt	39	receptor inhibition apoe uptake determine type lipoprotein receptors underlying effects apoe isoforms neuronal internalization lipoproteins three different lipoprotein receptor inhibitors used 1 receptor associated protein rap 5 microgml gift dr dudley strickland american red cross rockville md 2 lactoferrin lac 10 microgml sigma 3 heparinase 10 uml sigma heparinase depletes cell surface heparan sulfate proteoglycans hspgs bind apoe enriched lipoproteins internalization via lrp whereas rap lac inhibits binding lipoproteins lrp cells 3 div apoe ko mice preincubated 1 h medium alone medium containing one three inhibitors cultures subsequently treated 1 h recombinant apoe3 apoe4 prepared immunofluorescent localization apoe images 10 neurons per coverslip digitized analyzed experimental condition
0.31636134.15033916.html.plaintext.txt	40	statistical analysis data experiment analyzed anova per cell n 3 cases representing three replications experiment appropriate noted significant effect found anova pair wise post hoc testing performed bonferroni corrected tests maintain overall type error rate p 005 presence significant interaction data decomposed treated one way analysis bonferroni corrected tests
0.31636134.15033916.html.plaintext.txt	41	statistical analysis data experiment analyzed anova per cell n 3 cases representing three replications experiment appropriate noted significant effect found anova pair wise post hoc testing performed bonferroni corrected tests maintain overall type error rate p 005 presence significant interaction data decomposed treated one way analysis bonferroni corrected tests
0.31636134.15033916.html.plaintext.txt	42	results top abstract introduction materials methods results discussion references time course apoe levels estradiol treatment experiment showed apoe rapidly produced introduction estradiol anova time independent factor identified significant effect f716 81939 p 0001 post hoc testing disclosed 4 h estradiol exposure resulted significant increase apoe levels compared earlier time periods fig 1 apoe levels 4 48 h differ western blots apoe showed expected band 34 kda fig 2
0.31636134.15033916.html.plaintext.txt	43	results top abstract introduction materials methods results discussion references time course apoe levels estradiol treatment experiment showed apoe rapidly produced introduction estradiol anova time independent factor identified significant effect f716 81939 p 0001 post hoc testing disclosed 4 h estradiol exposure resulted significant increase apoe levels compared earlier time periods fig 1 apoe levels 4 48 h differ western blots apoe showed expected band 34 kda fig 2
0.31636134.15033916.html.plaintext.txt	44	view larger version 15k fig 1 time course apoe levels cultures response 100 pm 17ss estradiol added one div sampled 6 min 96 h apoe levels significantly increased 4 h addition estradiol remain elevated data presented mean plus minus sem show variability point 4 h variability among cultures apoe levels extremely small
0.31636134.15033916.html.plaintext.txt	45	view larger version 21k fig 2 western blotting apoe mixed cell cultures treatment estradiol little apoe produced 4 h exposure estradiol
0.31636134.15033916.html.plaintext.txt	46	dose response apoe levels estradiol treatment next examined effects increasing concentrations estradiol apoe levels culture fig 3a anova found overall significance estradiol concentration apoe levels f512 260546 p 0001 post hoc testing bonferroni corrected test showed higher dose estradiol significantly increased apoe levels lower dose except 100 pm different 1 pm estradiol dose 1 nm estrogen exhibited highest response apoe levels 10 nm concentration estrogen significantly smaller effect apoe levels 1 pm 1 nm estradiol normal female mouse estradiol concentrations 10 80 pm throughout estrous cycle 42 hence data suggest physiological concentration estradiol greatest effect supraphysiologic concentration less effective
0.31636134.15033916.html.plaintext.txt	47	view larger version 18k fig 3 increasing concentrations estradiol significantly increase apoe levels culture post hoc testing bonferroni corrected test showed higher dose significant lower dose except 100 pm different 1 pm response 1 nm estrogen significantly higher doses 10 nm concentration estrogen significantly smaller effect apoe levels than1 pm 1 nm estradiol b estradiol stimulates combined neuritic length one way anova showed significance p 0001 post hoc testing bonferroni corrected tests showed 100 pm 1 nm estrogen significantly increased neuritic outgrowth compared control conditions estradiol ethanol alone note peak responses estrogen apoe production neuritic outgrowth occurred identical estrogen concentrations
0.31636134.15033916.html.plaintext.txt	48	dose response estradiol neurite extension experiment examined effect increasing doses estradiol neurite outgrowth fig 3b neurons easily identifiable culture differential interference contrast microscopy fig 4 previously confirmed immunocytochemistry 33 longest neurite combined length correlated highly r 098 combined length reported one way anova showed significance estrogen treatment neurite extension f612 8012 p 0001 post hoc testing indicated 100 pm 1 nm estrogen significantly increased neuritic outgrowth compared control conditions estradiol ethanol alone whereas response 10 nm estrogen differ control conditions therefore neuritic extension showed peak dosage effect estradiol apoe levels
0.31636134.15033916.html.plaintext.txt	49	view larger version 123k fig 4 differential interference contrast digital image two adjacent neurons culture 4 div typical appearance neurons adult mouse cultures previous study 33 used antineurofilament antibody confirm conclusion note microglia lower left figure
0.31636134.15033916.html.plaintext.txt	50	apoe replacement neurite extension previous studies shown apoe isoforms differential effects neurite outgrowth 32 33 34 43 experiment determined combined effects 100 pm estradiol apoe neurite growth cultures apoe ko mice fig 5 anova showed significant main effect estradiol neuritic length f116 125344 p 0001 apoe isoform f 256 f316 p 0001 interaction estradiol treatment apoe isoform f316 45315 p 0001 decomposition interaction term post hoc one way anova post hoc tests showed apoe2 apoe3 alone increased combined neurite length 30 compared cultures without apoe apoe4 f38 27649 p 0001 apoe2 differ apoe3 post hoc testing data replicate previous results 32 33 analysis estradiol group also showed isoform specific effect f38 700702 p 0001 bonferroni corrected post hoc testing showed combined neurite length ko group equivalent apoe4 replacement group less apoe2 p 0001 apoe3 p 0002 replacement group estradiol increased neuritic length combined apoe2 95 apoe3 79 absence apoe treatment apoe4 post hoc testing found difference apoe2 apoe3 significant p 0003 sum estradiol increased neurite outgrowth presence apoe2 apoe3 estradiol greater effect neurite growth presence apoe2 compared apoe3
0.31636134.15033916.html.plaintext.txt	51	apoe replacement neurite extension previous studies shown apoe isoforms differential effects neurite outgrowth 32 33 34 43 experiment determined combined effects 100 pm estradiol apoe neurite growth cultures apoe ko mice fig 5 anova showed significant main effect estradiol neuritic length f116 125344 p 0001 apoe isoform f 256 f316 p 0001 interaction estradiol treatment apoe isoform f316 45315 p 0001 decomposition interaction term post hoc one way anova post hoc tests showed apoe2 apoe3 alone increased combined neurite length 30 compared cultures without apoe apoe4 f38 27649 p 0001 apoe2 differ apoe3 post hoc testing data replicate previous results 32 33 analysis estradiol group also showed isoform specific effect f38 700702 p 0001 bonferroni corrected post hoc testing showed combined neurite length ko group equivalent apoe4 replacement group less apoe2 p 0001 apoe3 p 0002 replacement group estradiol increased neuritic length combined apoe2 95 apoe3 79 absence apoe treatment apoe4 post hoc testing found difference apoe2 apoe3 significant p 0003 sum estradiol increased neurite outgrowth presence apoe2 apoe3 estradiol greater effect neurite growth presence apoe2 compared apoe3
0.31636134.15033916.html.plaintext.txt	52	view larger version 22k fig 5 estradiol apoe isoform specific effect neuritic outgrowth cultures derived apoe ko mice anova showed overall significant interaction apoe replacement estradiol treatment p 0001 post hoc testing found estradiol effect cultures lacking apoe supplemented apoe4 inclusion apoe2 apoe3 absence estrogen significantly increased neuritic extent compared apoe apoe4 estradiol increased neurite outgrowth beyond apoe alone apoe2 apoe3 conditions addition neuritic extent significantly greater p 0003 apoe2 apoe3 group line
0.31636134.15033916.html.plaintext.txt	53	estradiol effects neurite outgrowth tg mice determine whether endogenously produced apoe isoforms differentially modulate estradiol induced neurite outgrowth added estradiol neuronal cultures derived tg mice expressing either apoe3 apoe4 treatment neuronal cultures estradiol secreted apoe levels fig 6a comparable genotypes f18 0162 p 0698 estradiol 100 pm significantly increased apoe levels 30 cultures genotypes f18 81619 p 0001 interaction estradiol treatment apoe levels two genotypes f18 0030 p 0867
0.31636134.15033916.html.plaintext.txt	54	estradiol effects neurite outgrowth tg mice determine whether endogenously produced apoe isoforms differentially modulate estradiol induced neurite outgrowth added estradiol neuronal cultures derived tg mice expressing either apoe3 apoe4 treatment neuronal cultures estradiol secreted apoe levels fig 6a comparable genotypes f18 0162 p 0698 estradiol 100 pm significantly increased apoe levels 30 cultures genotypes f18 81619 p 0001 interaction estradiol treatment apoe levels two genotypes f18 0030 p 0867
0.31636134.15033916.html.plaintext.txt	55	view larger version 19k fig 6 amounts apoe produced estradiol stimulation apoe tg mice treatment 100 pm 17ss estradiol increased apoe levels apoe tg mice cultures 30 compared vehicle treated cultures effect genotype specific b neuritic extent apoe tg mice apoe3 tg mice cultures greater combined neurite outgrowth apoe4 tg mice estradiol increased difference estradiol effect neuritic extent apoe4 tg cultures although increased apoe levels equal estradiol treated apoe3 tg cultures
0.31636134.15033916.html.plaintext.txt	56	combined length neurites fig 6b significantly greater apoe3 tg apoe4 tg mouse cultures f18 390543 p 0001 estradiol treatment increased total length f18 58292 p 0001 significant interaction genotype estradiol treatment effect combined neuritic length apoe4 tg mouse cultures whereas neuritic extent increased apoe3 tg mouse cultures f18 53937 p 0001 essence neurites longer cultures apoe3 tg mice estradiol increased differential cultures apoe3 tg mice
0.31636134.15033916.html.plaintext.txt	57	combined length neurites fig 6b significantly greater apoe3 tg apoe4 tg mouse cultures f18 390543 p 0001 estradiol treatment increased total length f18 58292 p 0001 significant interaction genotype estradiol treatment effect combined neuritic length apoe4 tg mouse cultures whereas neuritic extent increased apoe3 tg mouse cultures f18 53937 p 0001 essence neurites longer cultures apoe3 tg mice estradiol increased differential cultures apoe3 tg mice
0.31636134.15033916.html.plaintext.txt	58	apoelipid uptake studies experiment evaluated rate internalization two apoe isoforms apoe3 apoe4 adult culture model replicate previous results higher concentrations apoe neuroblastoma cells 32 also evaluated rate uptake fluorescently labeled fatty acid function apoe isoform less intracellular accumulation apoe4 apoe3 fig 7a apoe like immunoreactivity within neurons incubated apoe3 significantly greater f120 6420 p 002 apoe4 previously reported 32 anova showed neither significant effect time post addition apoe f420 2032 p 0128 interaction time type apoe f420 0697 p 0603 apoe like immunoreactivity intense cell body extended processes vesicular like accumulations fig 8
0.31636134.15033916.html.plaintext.txt	59	apoelipid uptake studies experiment evaluated rate internalization two apoe isoforms apoe3 apoe4 adult culture model replicate previous results higher concentrations apoe neuroblastoma cells 32 also evaluated rate uptake fluorescently labeled fatty acid function apoe isoform less intracellular accumulation apoe4 apoe3 fig 7a apoe like immunoreactivity within neurons incubated apoe3 significantly greater f120 6420 p 002 apoe4 previously reported 32 anova showed neither significant effect time post addition apoe f420 2032 p 0128 interaction time type apoe f420 0697 p 0603 apoe like immunoreactivity intense cell body extended processes vesicular like accumulations fig 8
0.31636134.15033916.html.plaintext.txt	60	view larger version 20k fig 7 accumulation apoe isoforms neurons anova showed significant effect apoe type p 002 apoe3 immunoreactivity found within neurons apoe4 factor reached statistical significance b lipid accumulation 1 h incubation apoe isoforms absence apoe ko recombinant apoe3 facilitated fluorescently labeled dodecanoic acid accumulation neurons compared recombinant apoe4 post hoc testing showed apoe3 apoe4 apoe ko total lipid uptake
0.31636134.15033916.html.plaintext.txt	61	view larger version 31k fig 8 immunofluoresence localization apoe3 apoe4 neurons neuronal internalization apoe4 less efficient apoe3 time zero b intensity intracellular immunoreactivity apoe3 apoe4 roughly comparable greater uptake apoe 3 e4 seen 1 h c d apoe also present vesicular like structures neurites bar d 20 microm
0.31636134.15033916.html.plaintext.txt	62	comparable apoe isoform specific effect fatty acid accumulation neurons present f26142173 p 0001 accumulation fluorescent lipid cells cultured apoe3 approximately twice p 0001 post hoc test cells treated apoe4 displayed vesicular appearance processes neurons apoe fig 9 apoe4 roughly doubled p 0001 post hoc test amount lipid internalized compared absence apoe fig 7b apoe4 much less effective apoe3 intracellular transport lipids although effective apoe treatment
0.31636134.15033916.html.plaintext.txt	63	view larger version 24k fig 9 uptake fluorescently labeled dodecanoic acid uptake absence apoe less apoe3 b apoe4 c present perikaryal size equivalent condition appears greater apoe3 fluorescent lipid cell body note fluorescence vesicular like neurites bar c 20 microm
0.31636134.15033916.html.plaintext.txt	64	receptor inhibition apoe uptake experiment performed determine receptor specificity apoe uptake adult neuronal cultures neither apoe3 apoe4 like immunoreactivity found neurons treated heparinase therefore statistical analysis performed repeated measures anova apoe accumulation neurons rap lac compared inhibitor inhibition condition repeated measure showed significant main effect apoe isoform f14 383123 p 0001 fig 10a overall less apoe4 entered neurons apoe3 significant effect inhibitor compared inhibitor found f28 2381714 p 0001 addition significant interaction isoform inhibitor f24 372474 p 0001 calculating percent inhibition fig 10b untreated condition showed lac inhibited apoe3 uptake 91 apoe4 uptake 97 contrast rap inhibited apoe3 uptake 76 apoe4 99
0.31636134.15033916.html.plaintext.txt	65	receptor inhibition apoe uptake experiment performed determine receptor specificity apoe uptake adult neuronal cultures neither apoe3 apoe4 like immunoreactivity found neurons treated heparinase therefore statistical analysis performed repeated measures anova apoe accumulation neurons rap lac compared inhibitor inhibition condition repeated measure showed significant main effect apoe isoform f14 383123 p 0001 fig 10a overall less apoe4 entered neurons apoe3 significant effect inhibitor compared inhibitor found f28 2381714 p 0001 addition significant interaction isoform inhibitor f24 372474 p 0001 calculating percent inhibition fig 10b untreated condition showed lac inhibited apoe3 uptake 91 apoe4 uptake 97 contrast rap inhibited apoe3 uptake 76 apoe4 99
0.31636134.15033916.html.plaintext.txt	66	view larger version 19k fig 10 inhibition apoe immunoreactivity cells lac rap note rap greater effect apoe4 apoe3 roughly equivalent inhibitory effects apoe isoforms shown lac b plotting inhibition b emphasizes differential effect rap apoe3 vs apoe4
0.31636134.15033916.html.plaintext.txt	67	discussion top abstract introduction materials methods results discussion references numerous studies shown estradiol modifies neuronal growth culture see ref 44 generally effects increase survival process extension general assumption studies direct effect estradiol neuronal activation growth assumption may simplistic data suggest apoe plays important role neuronal activation growth stimulated estradiol
0.31636134.15033916.html.plaintext.txt	68	previous data suggest glia primary source apoe 45 46 47 studies apoe tg mice support therefore selected mixed culture derived adult mouse brain evaluate estradiol effects apoe levels neuronal process growth adult cortical neuronal cultures contain microglia astroglia early culture previous study showed neurons comprise 70 total cells astroglia 15 microglia 15 4 div 33 glial derived factors important synaptogenesis see ref 48 inclusion glia culture may required see broader spectrum effects estrogen neurons vitro example previous report shown microglia astroglia must present obtain estrogen induced increase apoe mrna 38 hence monotypic cell culture may give biased interpretation critical estradiol effects interactions exist glia neurons
0.31636134.15033916.html.plaintext.txt	69	previous data suggest glia primary source apoe 45 46 47 studies apoe tg mice support therefore selected mixed culture derived adult mouse brain evaluate estradiol effects apoe levels neuronal process growth adult cortical neuronal cultures contain microglia astroglia early culture previous study showed neurons comprise 70 total cells astroglia 15 microglia 15 4 div 33 glial derived factors important synaptogenesis see ref 48 inclusion glia culture may required see broader spectrum effects estrogen neurons vitro example previous report shown microglia astroglia must present obtain estrogen induced increase apoe mrna 38 hence monotypic cell culture may give biased interpretation critical estradiol effects interactions exist glia neurons
0.31636134.15033916.html.plaintext.txt	70	data previous studies suggest direct relationship apoe neurite outgrowth 32 33 34 49 50 found physiological concentration estradiol maximal effect apoe levels neurite outgrowth data also suggest synergistic effect estradiol apoe estradiol effects neurite outgrowth facilitated apoe3 apoe4 apoe3 alone increased neurite extent 30 combined estradiol neuritic growth increased 70 80 addition apoe2 significantly effective apoe3 facilitating neurite outgrowth presence estradiol effect corresponds studies suggest protective effect apoe2 dementia see ref 51 addition differential effects apoe3 vs apoe4 confirmed using tg mice expressing apoe3 apoe4 estrogen increased levels apoe3 apoe4 similar extent adult cultures derived apoe3 apoe4 tg mice however apoe3 isoform effective facilitating neurite outgrowth presence estradiol
0.31636134.15033916.html.plaintext.txt	71	data previous studies suggest direct relationship apoe neurite outgrowth 32 33 34 49 50 found physiological concentration estradiol maximal effect apoe levels neurite outgrowth data also suggest synergistic effect estradiol apoe estradiol effects neurite outgrowth facilitated apoe3 apoe4 apoe3 alone increased neurite extent 30 combined estradiol neuritic growth increased 70 80 addition apoe2 significantly effective apoe3 facilitating neurite outgrowth presence estradiol effect corresponds studies suggest protective effect apoe2 dementia see ref 51 addition differential effects apoe3 vs apoe4 confirmed using tg mice expressing apoe3 apoe4 estrogen increased levels apoe3 apoe4 similar extent adult cultures derived apoe3 apoe4 tg mice however apoe3 isoform effective facilitating neurite outgrowth presence estradiol
0.31636134.15033916.html.plaintext.txt	72	partial mechanism differential effects apoe3 apoe4 suggested uptake studies procedure used preparing adult cultures strips cell processes next 4 d extensive neurite sprouting occurs estradiol may stimulate neurons extend processes concurrently stimulate astroglia perhaps microglia produce apoe glial derived apoe supplies lipids neuronal membrane synthesis function receptor inhibition studies suggest apoe3 apoe4 using low density lipoprotein receptor related protein hspg neurite outgrowth 33 49 however neuronal growth slowed disrupted absence apoe presence apoe4 worth noting apoe4 reported show toxic effects culture 52 disrupt microtubule polymerization although 10 fold higher concentrations used study 32 hence less complex neuritic field seen cells incubated apoe4 may represent deficiency lipid combination toxic effects apoe4
0.31636134.15033916.html.plaintext.txt	73	partial mechanism differential effects apoe3 apoe4 suggested uptake studies procedure used preparing adult cultures strips cell processes next 4 d extensive neurite sprouting occurs estradiol may stimulate neurons extend processes concurrently stimulate astroglia perhaps microglia produce apoe glial derived apoe supplies lipids neuronal membrane synthesis function receptor inhibition studies suggest apoe3 apoe4 using low density lipoprotein receptor related protein hspg neurite outgrowth 33 49 however neuronal growth slowed disrupted absence apoe presence apoe4 worth noting apoe4 reported show toxic effects culture 52 disrupt microtubule polymerization although 10 fold higher concentrations used study 32 hence less complex neuritic field seen cells incubated apoe4 may represent deficiency lipid combination toxic effects apoe4
0.31636134.15033916.html.plaintext.txt	74	process extension neuronal repair vivo may critical factor rate progression chronic neurological diseases dementia trauma degeneration repair may dynamic balance dementia cognitive decline may occur degenerative processes exceed regenerative responses apoe4 may tip scales slower incomplete regeneration accelerate cognitive decline rapidly apoe2 apoe3 interest apoe4 shown dominant negative factor mice expressing apoe3 apoe4 49 53 ert may less protective 4 allele previously noted 54 full benefit ert protection chronic neurological diseases may compromised presence apoe4 clinical studies evaluate protective effects ert estradiol like compounds may need consider apoe genotype obtain optimal efficacy
0.31636134.15033916.html.plaintext.txt	75	process extension neuronal repair vivo may critical factor rate progression chronic neurological diseases dementia trauma degeneration repair may dynamic balance dementia cognitive decline may occur degenerative processes exceed regenerative responses apoe4 may tip scales slower incomplete regeneration accelerate cognitive decline rapidly apoe2 apoe3 interest apoe4 shown dominant negative factor mice expressing apoe3 apoe4 49 53 ert may less protective 4 allele previously noted 54 full benefit ert protection chronic neurological diseases may compromised presence apoe4 clinical studies evaluate protective effects ert estradiol like compounds may need consider apoe genotype obtain optimal efficacy
0.31636134.15033916.html.plaintext.txt	76	acknowledgments gfap apoe3 gfap apoe4 tg mice generously provided dr david m holtzman washington university st louis mo rap generous gift dr dudley strickland american red cross rockville md
0.31636134.15033916.html.plaintext.txt	77	footnotes research funded illinois department public health alzheimer fund bpn rgs national institutes health academic research enhancement award bpn eastern illinois university council faculty research grants bpn southern illinois university school medicine central research committee rgs
0.31636134.15033916.html.plaintext.txt	78	abbreviations apoe apolipoprotein e div days vitro ert estrogen replacement therapy gfap glial fibrillary acidic protein ha hibernate hspg heparan sulfate proteoglycan ko knockout lac lactoferrin pd parkinson disease rap receptor associated protein tg transgenic
0.31636134.15033916.html.plaintext.txt	79	accepted publication march 11 2004
0.31636134.15033916.html.plaintext.txt	80	references top abstract introduction materials methods results discussion references paganini hill henderson v 1994 estrogen deficiency risk alzheimer disease women j epidemiol 140256 261abstract brenner de kukull wa stergachis van belle g bowen jd mccormick wc teri l larson eb 1994 postmenopausal estrogen replacement therapy risk alzheimer disease population based case control study j epidemiol 140262 267abstract tang mx jacobs d stern y marder k schofield p gurland b andrews h mayeux r 1996 effect oestrogen menopause risk age onset alzheimer disease lancet 348429 432crossrefmedline kawas c resnick morrison brookmeyer r corrada m zonderman bacal c lingle dd metter e 1997 prospective study estrogen replacement therapy risk developing alzheimer disease baltimore longitudinal study aging neurology 481517 1521abstract leblanc es janowsky j chan bk nelson hd 2001 hormone replacement therapy cognition systematic review meta analysis jama 2851489 1499abstractfree full text zandi pp carlson mc plassman bl welsh bohmer ka mayer ls steffens dc breitner jc 2002 hormone replacement therapy incidence alzheimer disease older women cache county study jama 2882123 2129abstractfree full text rapp sr espeland ma shumaker sa henderson vw brunner rl manson je gass ml stefanick ml lane ds hays j johnson kc coker lh dailey m bowen d whims investigators 2003 effect estrogen plus progestin global cognitive function postmenopausal women women health initiative memory study randomized controlled trial jama 2892663 2672abstractfree full text shumaker sa legault c rapp sr thal l wallace rb ockene jk hendrix sl jones 3rd bn assaf ar jackson rd kotchen jm wassertheil smoller wactawski wende j whims investigators 2003 estrogen plus progestin incidence dementia mild cognitive impairment postmenopausal women women health initiative memory study randomized controlled trial jama 2892651 2662abstractfree full text mayeux r marder k cote lj denaro j hemenegildo n mejia h tang mx lantigua r wilder d gurland b 1995 frequency idiopathic parkinson disease age ethnic group sex northern manhattan 1988 1993 j epidemiol 142820 827abstract kuopio marttila rj helenius h rinne uk 1999 changing epidemiology parkinson disease southwestern finland neurology 52302 308abstractfree full text saunders pullman r gordon elliott j parides m fahn saunders hr bressman 1999 effect estrogen replacement early parkinson disease neurology 521417 1421abstractfree full text marder k tang mx alfaro b mejia h cote l jacobs d stern y sano m mayeux r 1998 postmenopausal estrogen use parkinson disease without dementia neurology 501141 1143abstract smith r studd jw 1992 pilot study effect upon multiple sclerosis menopause hormone replacement therapy menstrual cycle j r soc med 85612 613abstract sicotte nl liva sm klutch r pfeiffer p bouvier odesa wu tc voskuhl rr 2002 treatment multiple sclerosis pregnancy hormone estriol ann neurol 52421 428crossrefmedline mahley rw 1988 apolipoprotein e cholesterol transport protein expanding role cell biology science 240622 630medline weisgraber kh 1994 apolipoprotein e structure function relationships adv protein chem 45249 302medline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma 1993 gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science 261921 923medline roses ad 1997 apolipoprotein e gene complex biological interactions aging brain neurobiol dis 4170 185crossrefmedline strittmatter wj roses ad 1996 apolipoprotein e alzheimer annu rev neurosci 1953 77crossrefmedline tang g xie h xu l hao y lin d ren d 2002 genetic study apolipoprotein e gene 1 antichymotrypsin gene sporadic parkinson disease j med genet 114446 449crossrefmedline zareparsi camicioli r sexton g bird swanson p kaye j nutt j payami h 2002 age onset parkinson disease apolipoprotein e genotypes j med genet 107156 161crossrefmedline mayeux r ottman r maestre g ngai c tang mx ginsberg h chun m tycko b shelanski m 1995 synergistic effects traumatic head injury apolipoprotein 4 patients alzheimer disease neurology 45555 557abstract teasdale gm nicoll ja murray g fiddes m 1997 association apolipoprotein e polymorphism outcome head injury lancet 3501069 1071crossrefmedline jordan bd relkin nr ravdin ld jacobs ar bennett gandy 1997 apolipoprotein e 4 associated chronic traumatic brain injury jama 278136 140abstract fazekas f strasser fuchs kollegger h berger kristoferitsch w schmidt h enzinger c schiefermeier m schwarz c kornek b reindl m huber k grass r wimmer g vass k pfeiffer kh hartung hp schmidt r 2001 apolipoprotein e epsilon 4 associated rapid progression multiple sclerosis neurology 57853 857abstractfree full text masterman zhang z hellgren d salter h anvret m lilius l lannfelt l hillert j 2002 apoe genotypes disease severity multiple sclerosis mult scler 898 103crossrefmedline ferreira caceres 1991 estrogen enhanced neurite growth evidence selective induction stable microtubules j neurosci 11392 401abstract diaz h lorenzo carrer hf caceres 1992 time lapse study neurite growth hypothalamic dissociated neurons culture sex differences estrogen j neurosci res 33266 281medline brinton rd tran j proffitt p montoya m 1997 17beta estradiol enhances outgrowth survival neocortical neurons culture neurochem res 221339 1351crossrefmedline morse jk dekosky st scheff sw 1992 neurotrophic effects steroids lesion induced growth thehippocampus ii hormone replacement exp neurol 11847 52medline stone dj rozovsky morgante anderson cp finch ce 1998 increased synaptic sprouting response estrogen via apolipoprotein e dependent mechanism implications alzheimer disease j neurosci 183180 3185abstractfree full text nathan bp chang kc bellosta brisch e ge n mahley rw pitas re 1995 inhibitory effect apolipoprotein e4 neurite outgrowth associated microtubule depolymerization j biol chem 27019791 19799abstractfree full text nathan bp jiang y wong gk shen f brewer gj struble rg 2002 apolipoprotein e4 inhibits apolipoprotein e3 promotes neurite outgrowth cultured adult mouse cortical neurons low density lipoprotein receptor related protein brain res 92896 105crossrefmedline sun y wu bu g onifade mk patel sn ladu mj fagan holtzman dm 1998 glial fibrillary acidic protein apolipoprotein e apoe transgenic mice astrocyte specific expression differing biological effects astrocyte secreted apoe3 apoe4 lipoproteins j neurosci 183261 3272abstractfree full text arendt schindler c bruckner mk eschrich k bigl v zedlick d marcova l 1997 plastic neuronal remodeling impaired patients alzheimer disease carrying apolipoprotein 4 allele j neurosci 17516 529abstractfree full text struble rg rosario er kircher ml ludwig sm mcadamis pj watabe k mcasey cady c nathan bp 2003 regionally specific modulation brain apolipoprotein e mouse estrous cycle exogenous 17ss estradiol exp neurol 183638 644crossrefmedline levin allerhand j mcewen bs lominska ce lubahn db korach ks smith jd 2001 brain region specific regulation mouse apoliporotein e pharmacological estrogen treatments j neurochem 79796 803crossrefmedline stone dj rozovsky morgan te anderson cp hajian h finch ce 1997 astrocytes microglia respond estrogen increased apoe mrna vivo vitro exp neurol 143313 318crossrefmedline rozovsky hoving anderson cp o callaghan j finch ce 2002 equine estrogens induce apolipoprotein e glial fibrillary acidic protein mixed cultures neurosci lett 323191 194crossrefmedline brewer gj 1997 isolation culture adult rat hippocampal neurons j neurosci methods 71143 155crossrefmedline demeester n castro g desrumaux c de geitere c fruchart jc santens p mulleners e engelborghs de deyn pp vandekerckhove j rosseneu m labeur c 2000 characterization functional studies lipoproteins lipid transfer proteins lecithincholesterol acyltransferase csf normal individuals patients alzheimer disease j lipid res 41963 974abstractfree full text walmer dk wrona ma hughes cl nelson kg 1992 lactoferrin expression mouse reproductive tract natural estrous cycle correlation circulating estradiol progesterone endocrinology 1311458 1466abstract teter b xu pt gilbert jr roses ad galasko d cole gm 2002 defective neuronal sprouting human apolipoprotein e4 gain negative function j neurosci res 68331 336crossrefmedline brinton rd 2001 cellular molecular mechanisms estrogen regulation memory function neuroprotection alzheimer disease recent insights remaining challenges learn mem 8121 133abstractfree full text boyles jk pitas re wilson e mahley rw taylor jm 1985 apolipoprotein e associated astrocytic glia central nervous system nonmyelinating glia peripheral nervous system j clin invest 761501 1513medline pitas re boyles jk lee sh foss d mahley rw 1987 astrocytes synthesize apolipoprotein e metabolize apolipoprotein e containing lipoproteins biochim biophys acta 91748 61medline nathan bp nisar r randall short j sherrow m wong gk struble rg 2001 time course apolipoprotein e levels following olfactory nerve lesioning mice exp neurol 172128 136crossrefmedline slezak m pfrieger fw 2003 new roles astrocytes regulation cns synaptogenesis trends neurosci 26531 535crossrefmedline holtzman dm pitas re kilbridge j nathan b mahley rw bu g schwartz al 1995 low density lipoprotein receptor related protein mediates apolipoprotein e dependent neurite outgrowth central nervous system derived neuronal cell line proc natl acad sci usa 929480 9484abstract bellosta nathan bp orth m dong lm mahley rw pitas re 1995 stable expression secretion apolipoproteins e3 e4 mouse neuroblastoma cells produces differential effects neurite outgrowth j biol chem 27027063 27071abstractfree full text saunders 2000 apolipoprotein e alzheimer disease update genetic functional analyses j neuropathol exp neurol 59751 758medline qiu z crutcher ka hyman bt rebeck gw 2003 apoe isoforms affect neuronal n methyl d aspartate calcium responses toxicity via receptor mediated processes neuroscience 122291 303crossrefmedline buttini m akeefe h lin c mahley rw pitas re wyss coray mucke l 2000 dominant negative effects apolipoprotein e4 revealed transgenic models neurodegenerative disease neuroscience 97207 210crossrefmedline yaffe k haan m byers tangen c kuller l 2000 estrogen use apoe cognitive decline evidence gene environment interaction neurology 541949 1954abstractfree full text
0.31636134.15033916.html.plaintext.txt	81	references top abstract introduction materials methods results discussion references paganini hill henderson v 1994 estrogen deficiency risk alzheimer disease women j epidemiol 140256 261abstract brenner de kukull wa stergachis van belle g bowen jd mccormick wc teri l larson eb 1994 postmenopausal estrogen replacement therapy risk alzheimer disease population based case control study j epidemiol 140262 267abstract tang mx jacobs d stern y marder k schofield p gurland b andrews h mayeux r 1996 effect oestrogen menopause risk age onset alzheimer disease lancet 348429 432crossrefmedline kawas c resnick morrison brookmeyer r corrada m zonderman bacal c lingle dd metter e 1997 prospective study estrogen replacement therapy risk developing alzheimer disease baltimore longitudinal study aging neurology 481517 1521abstract leblanc es janowsky j chan bk nelson hd 2001 hormone replacement therapy cognition systematic review meta analysis jama 2851489 1499abstractfree full text zandi pp carlson mc plassman bl welsh bohmer ka mayer ls steffens dc breitner jc 2002 hormone replacement therapy incidence alzheimer disease older women cache county study jama 2882123 2129abstractfree full text rapp sr espeland ma shumaker sa henderson vw brunner rl manson je gass ml stefanick ml lane ds hays j johnson kc coker lh dailey m bowen d whims investigators 2003 effect estrogen plus progestin global cognitive function postmenopausal women women health initiative memory study randomized controlled trial jama 2892663 2672abstractfree full text shumaker sa legault c rapp sr thal l wallace rb ockene jk hendrix sl jones 3rd bn assaf ar jackson rd kotchen jm wassertheil smoller wactawski wende j whims investigators 2003 estrogen plus progestin incidence dementia mild cognitive impairment postmenopausal women women health initiative memory study randomized controlled trial jama 2892651 2662abstractfree full text mayeux r marder k cote lj denaro j hemenegildo n mejia h tang mx lantigua r wilder d gurland b 1995 frequency idiopathic parkinson disease age ethnic group sex northern manhattan 1988 1993 j epidemiol 142820 827abstract kuopio marttila rj helenius h rinne uk 1999 changing epidemiology parkinson disease southwestern finland neurology 52302 308abstractfree full text saunders pullman r gordon elliott j parides m fahn saunders hr bressman 1999 effect estrogen replacement early parkinson disease neurology 521417 1421abstractfree full text marder k tang mx alfaro b mejia h cote l jacobs d stern y sano m mayeux r 1998 postmenopausal estrogen use parkinson disease without dementia neurology 501141 1143abstract smith r studd jw 1992 pilot study effect upon multiple sclerosis menopause hormone replacement therapy menstrual cycle j r soc med 85612 613abstract sicotte nl liva sm klutch r pfeiffer p bouvier odesa wu tc voskuhl rr 2002 treatment multiple sclerosis pregnancy hormone estriol ann neurol 52421 428crossrefmedline mahley rw 1988 apolipoprotein e cholesterol transport protein expanding role cell biology science 240622 630medline weisgraber kh 1994 apolipoprotein e structure function relationships adv protein chem 45249 302medline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma 1993 gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science 261921 923medline roses ad 1997 apolipoprotein e gene complex biological interactions aging brain neurobiol dis 4170 185crossrefmedline strittmatter wj roses ad 1996 apolipoprotein e alzheimer annu rev neurosci 1953 77crossrefmedline tang g xie h xu l hao y lin d ren d 2002 genetic study apolipoprotein e gene 1 antichymotrypsin gene sporadic parkinson disease j med genet 114446 449crossrefmedline zareparsi camicioli r sexton g bird swanson p kaye j nutt j payami h 2002 age onset parkinson disease apolipoprotein e genotypes j med genet 107156 161crossrefmedline mayeux r ottman r maestre g ngai c tang mx ginsberg h chun m tycko b shelanski m 1995 synergistic effects traumatic head injury apolipoprotein 4 patients alzheimer disease neurology 45555 557abstract teasdale gm nicoll ja murray g fiddes m 1997 association apolipoprotein e polymorphism outcome head injury lancet 3501069 1071crossrefmedline jordan bd relkin nr ravdin ld jacobs ar bennett gandy 1997 apolipoprotein e 4 associated chronic traumatic brain injury jama 278136 140abstract fazekas f strasser fuchs kollegger h berger kristoferitsch w schmidt h enzinger c schiefermeier m schwarz c kornek b reindl m huber k grass r wimmer g vass k pfeiffer kh hartung hp schmidt r 2001 apolipoprotein e epsilon 4 associated rapid progression multiple sclerosis neurology 57853 857abstractfree full text masterman zhang z hellgren d salter h anvret m lilius l lannfelt l hillert j 2002 apoe genotypes disease severity multiple sclerosis mult scler 898 103crossrefmedline ferreira caceres 1991 estrogen enhanced neurite growth evidence selective induction stable microtubules j neurosci 11392 401abstract diaz h lorenzo carrer hf caceres 1992 time lapse study neurite growth hypothalamic dissociated neurons culture sex differences estrogen j neurosci res 33266 281medline brinton rd tran j proffitt p montoya m 1997 17beta estradiol enhances outgrowth survival neocortical neurons culture neurochem res 221339 1351crossrefmedline morse jk dekosky st scheff sw 1992 neurotrophic effects steroids lesion induced growth thehippocampus ii hormone replacement exp neurol 11847 52medline stone dj rozovsky morgante anderson cp finch ce 1998 increased synaptic sprouting response estrogen via apolipoprotein e dependent mechanism implications alzheimer disease j neurosci 183180 3185abstractfree full text nathan bp chang kc bellosta brisch e ge n mahley rw pitas re 1995 inhibitory effect apolipoprotein e4 neurite outgrowth associated microtubule depolymerization j biol chem 27019791 19799abstractfree full text nathan bp jiang y wong gk shen f brewer gj struble rg 2002 apolipoprotein e4 inhibits apolipoprotein e3 promotes neurite outgrowth cultured adult mouse cortical neurons low density lipoprotein receptor related protein brain res 92896 105crossrefmedline sun y wu bu g onifade mk patel sn ladu mj fagan holtzman dm 1998 glial fibrillary acidic protein apolipoprotein e apoe transgenic mice astrocyte specific expression differing biological effects astrocyte secreted apoe3 apoe4 lipoproteins j neurosci 183261 3272abstractfree full text arendt schindler c bruckner mk eschrich k bigl v zedlick d marcova l 1997 plastic neuronal remodeling impaired patients alzheimer disease carrying apolipoprotein 4 allele j neurosci 17516 529abstractfree full text struble rg rosario er kircher ml ludwig sm mcadamis pj watabe k mcasey cady c nathan bp 2003 regionally specific modulation brain apolipoprotein e mouse estrous cycle exogenous 17ss estradiol exp neurol 183638 644crossrefmedline levin allerhand j mcewen bs lominska ce lubahn db korach ks smith jd 2001 brain region specific regulation mouse apoliporotein e pharmacological estrogen treatments j neurochem 79796 803crossrefmedline stone dj rozovsky morgan te anderson cp hajian h finch ce 1997 astrocytes microglia respond estrogen increased apoe mrna vivo vitro exp neurol 143313 318crossrefmedline rozovsky hoving anderson cp o callaghan j finch ce 2002 equine estrogens induce apolipoprotein e glial fibrillary acidic protein mixed cultures neurosci lett 323191 194crossrefmedline brewer gj 1997 isolation culture adult rat hippocampal neurons j neurosci methods 71143 155crossrefmedline demeester n castro g desrumaux c de geitere c fruchart jc santens p mulleners e engelborghs de deyn pp vandekerckhove j rosseneu m labeur c 2000 characterization functional studies lipoproteins lipid transfer proteins lecithincholesterol acyltransferase csf normal individuals patients alzheimer disease j lipid res 41963 974abstractfree full text walmer dk wrona ma hughes cl nelson kg 1992 lactoferrin expression mouse reproductive tract natural estrous cycle correlation circulating estradiol progesterone endocrinology 1311458 1466abstract teter b xu pt gilbert jr roses ad galasko d cole gm 2002 defective neuronal sprouting human apolipoprotein e4 gain negative function j neurosci res 68331 336crossrefmedline brinton rd 2001 cellular molecular mechanisms estrogen regulation memory function neuroprotection alzheimer disease recent insights remaining challenges learn mem 8121 133abstractfree full text boyles jk pitas re wilson e mahley rw taylor jm 1985 apolipoprotein e associated astrocytic glia central nervous system nonmyelinating glia peripheral nervous system j clin invest 761501 1513medline pitas re boyles jk lee sh foss d mahley rw 1987 astrocytes synthesize apolipoprotein e metabolize apolipoprotein e containing lipoproteins biochim biophys acta 91748 61medline nathan bp nisar r randall short j sherrow m wong gk struble rg 2001 time course apolipoprotein e levels following olfactory nerve lesioning mice exp neurol 172128 136crossrefmedline slezak m pfrieger fw 2003 new roles astrocytes regulation cns synaptogenesis trends neurosci 26531 535crossrefmedline holtzman dm pitas re kilbridge j nathan b mahley rw bu g schwartz al 1995 low density lipoprotein receptor related protein mediates apolipoprotein e dependent neurite outgrowth central nervous system derived neuronal cell line proc natl acad sci usa 929480 9484abstract bellosta nathan bp orth m dong lm mahley rw pitas re 1995 stable expression secretion apolipoproteins e3 e4 mouse neuroblastoma cells produces differential effects neurite outgrowth j biol chem 27027063 27071abstractfree full text saunders 2000 apolipoprotein e alzheimer disease update genetic functional analyses j neuropathol exp neurol 59751 758medline qiu z crutcher ka hyman bt rebeck gw 2003 apoe isoforms affect neuronal n methyl d aspartate calcium responses toxicity via receptor mediated processes neuroscience 122291 303crossrefmedline buttini m akeefe h lin c mahley rw pitas re wyss coray mucke l 2000 dominant negative effects apolipoprotein e4 revealed transgenic models neurodegenerative disease neuroscience 97207 210crossrefmedline yaffe k haan m byers tangen c kuller l 2000 estrogen use apoe cognitive decline evidence gene environment interaction neurology 541949 1954abstractfree full text
0.3207539.15509658.html.plaintext.txt	0	apoe mediated cholesterol efflux macrophages separation autocrine paracrine effects dwayne e dove1 macrae f linton23 sergio fazio12
0.3207539.15509658.html.plaintext.txt	1	1department pathology 2division cardiovascular medicine department medicine 3department pharmacology vanderbilt university medical center nashville tennessee
0.3207539.15509658.html.plaintext.txt	2	submitted 28 april 2004 accepted final form 19 october 2004
0.3207539.15509658.html.plaintext.txt	3	abstract top abstract glossary materials methods results discussion grants references macrophages vessel wall secrete high levels apolipoprotein e apoe cholesterol efflux macrophages apoe shown decrease foam cell formation prevent atherosclerosis apoe molecule mediate cholesterol efflux macrophage originally secreted autocrine effect surrounding macrophages paracrine effect traditional methodologies able separate serial effects novel methodology presented developed separate autocrine paracrine effects using simple mathematical model interpret effects dilution apoe mediated cholesterol efflux results show dilute concentrations paracrine effect apoe evident autocrine effect becomes dominant mediator efflux however saturating concentrations paracrine apoe causes 80 90 apoe mediated cholesterol efflux whereas autocrine apoe responsible remaining 10 20 results suggest relative importance autocrine paracrine apoe depends size local distribution volume factor considered previous vitro studies apoe function furthermore autocrine effects apoe could critical prevention foam cell formation vivo novel methodology may applicable types mixed autocrineparacrine systems signal transduction systems
0.3207539.15509658.html.plaintext.txt	4	abstract top abstract glossary materials methods results discussion grants references macrophages vessel wall secrete high levels apolipoprotein e apoe cholesterol efflux macrophages apoe shown decrease foam cell formation prevent atherosclerosis apoe molecule mediate cholesterol efflux macrophage originally secreted autocrine effect surrounding macrophages paracrine effect traditional methodologies able separate serial effects novel methodology presented developed separate autocrine paracrine effects using simple mathematical model interpret effects dilution apoe mediated cholesterol efflux results show dilute concentrations paracrine effect apoe evident autocrine effect becomes dominant mediator efflux however saturating concentrations paracrine apoe causes 80 90 apoe mediated cholesterol efflux whereas autocrine apoe responsible remaining 10 20 results suggest relative importance autocrine paracrine apoe depends size local distribution volume factor considered previous vitro studies apoe function furthermore autocrine effects apoe could critical prevention foam cell formation vivo novel methodology may applicable types mixed autocrineparacrine systems signal transduction systems
0.3207539.15509658.html.plaintext.txt	5	autocrineparacrine system cholesterol acceptor extracellular space distribution volume
0.3207539.15509658.html.plaintext.txt	6	important challenge atherosclerosis research characterization effects locally synthesized apolipoprotein e apoe within vessel wall endogenous synthesis secretion apoe macrophages vessel wall shown protect atherosclerosis 22 arterial macrophages participate inflammation tissue remodeling lipid metabolism apoe synthesized hepatocytes adipocytes macrophages mediates lipoprotein metabolism affects cellular cholesterol homeostasis apoe macrophages accepts cholesterol cells vessel wall transports back liver cholesterol excreted bile 3 9 pathway called reverse cholesterol transport rct system effect apoe due cellular extracellular positioning therefore apoe molecule mediate cholesterol efflux macrophage originally secreted autocrine effect surrounding macrophages paracrine effect terms autocrine paracrine traditionally applied signaling peptides hormones also used describe actions mediators broad range functions besides signal transduction 1 7 25 assumed sake cholesterol efflux individual macrophage cannot distinguish apoe secretes apoe derived neighboring cells however endogenous synthesis apoe causes high spatial proximity autocrine apoe advantage compared paracrine apoe spatial proximity advantage endogenous apoe results temporal sequence autocrine effects occurring paracrine effects concentration gradient autocrine compartment high concentration paracrine compartment low concentration
0.3207539.15509658.html.plaintext.txt	7	important challenge atherosclerosis research characterization effects locally synthesized apolipoprotein e apoe within vessel wall endogenous synthesis secretion apoe macrophages vessel wall shown protect atherosclerosis 22 arterial macrophages participate inflammation tissue remodeling lipid metabolism apoe synthesized hepatocytes adipocytes macrophages mediates lipoprotein metabolism affects cellular cholesterol homeostasis apoe macrophages accepts cholesterol cells vessel wall transports back liver cholesterol excreted bile 3 9 pathway called reverse cholesterol transport rct system effect apoe due cellular extracellular positioning therefore apoe molecule mediate cholesterol efflux macrophage originally secreted autocrine effect surrounding macrophages paracrine effect terms autocrine paracrine traditionally applied signaling peptides hormones also used describe actions mediators broad range functions besides signal transduction 1 7 25 assumed sake cholesterol efflux individual macrophage cannot distinguish apoe secretes apoe derived neighboring cells however endogenous synthesis apoe causes high spatial proximity autocrine apoe advantage compared paracrine apoe spatial proximity advantage endogenous apoe results temporal sequence autocrine effects occurring paracrine effects concentration gradient autocrine compartment high concentration paracrine compartment low concentration
0.3207539.15509658.html.plaintext.txt	8	making comparisons autocrine paracrine effects apoe synthesized macrophages proven difficult vitro experiments cultured macrophages exogenously applied apoe used approximate paracrine endocrine apoe 14 19 endogenously synthesized apoe used approximate autocrine apoe 16 19 21 approximations consider single molecule endogenously synthesized mediator series interactions employ combination autocrine paracrine mechanisms 4
0.3207539.15509658.html.plaintext.txt	9	making comparisons autocrine paracrine effects apoe synthesized macrophages proven difficult vitro experiments cultured macrophages exogenously applied apoe used approximate paracrine endocrine apoe 14 19 endogenously synthesized apoe used approximate autocrine apoe 16 19 21 approximations consider single molecule endogenously synthesized mediator series interactions employ combination autocrine paracrine mechanisms 4
0.3207539.15509658.html.plaintext.txt	10	novel methodology discussed developed separate autocrine paracrine mechanisms using simple mathematical model interpret mediator induced biological effects study shows whereas macrophage apoe autocrine paracrine effects cholesterol efflux autocrine apoe smaller consistent effects paracrine apoe whereas macrophage apoe used demonstrate novel methodology concepts applications separating autocrine paracrine effects many secreted biological mediators including growth factors cytokines carrier proteins
0.3207539.15509658.html.plaintext.txt	11	novel methodology discussed developed separate autocrine paracrine mechanisms using simple mathematical model interpret mediator induced biological effects study shows whereas macrophage apoe autocrine paracrine effects cholesterol efflux autocrine apoe smaller consistent effects paracrine apoe whereas macrophage apoe used demonstrate novel methodology concepts applications separating autocrine paracrine effects many secreted biological mediators including growth factors cytokines carrier proteins
0.3207539.15509658.html.plaintext.txt	12	glossary top abstract glossary materials methods results discussion grants references ttime h
0.3207539.15509658.html.plaintext.txt	13	ewtcholesterol efflux efflux apoe macrophages
0.3207539.15509658.html.plaintext.txt	14	ekocholesterol efflux efflux apoe macrophages
0.3207539.15509658.html.plaintext.txt	15	eapoe mediated cholesterol efflux efflux
0.3207539.15509658.html.plaintext.txt	16	vvolume extracellular space ml
0.3207539.15509658.html.plaintext.txt	17	v 1relative concentration ml 1 apoe extracellular space
0.3207539.15509658.html.plaintext.txt	18	mslope effluxml 1 linear e vs v 1 curve
0.3207539.15509658.html.plaintext.txt	19	intercept efflux linear e vs v 1 curve
0.3207539.15509658.html.plaintext.txt	20	ceffective concentration ml 1 apoe juxtacellular space
0.3207539.15509658.html.plaintext.txt	21	nslope ml 124 h bt vs m curve
0.3207539.15509658.html.plaintext.txt	22	fy intercept efflux24 h bt vs m curve
0.3207539.15509658.html.plaintext.txt	23	kecoefficient ml 1 apoe mediated cholesterol efflux
0.3207539.15509658.html.plaintext.txt	24	kicoefficient ml 1 apoe mediated cholesterol influx
0.3207539.15509658.html.plaintext.txt	25	materials methods top abstract glossary materials methods results discussion grants references primary culture peritoneal macrophages murine peritoneal macrophages elicited intraperitoneal injection 3 thioglycollate macrophages harvested 3 4 days injection peritoneal lavage ice cold dmem washed counted plated dmem 10 fbs 37 degrees c macrophages plated 4 x 105 macrophageswell 24 well plates treated 100 microgml acetyl ldl acldl dmem 2 fbs 48 h load cholesterol stimulate apoe secretion 24
0.3207539.15509658.html.plaintext.txt	26	materials methods top abstract glossary materials methods results discussion grants references primary culture peritoneal macrophages murine peritoneal macrophages elicited intraperitoneal injection 3 thioglycollate macrophages harvested 3 4 days injection peritoneal lavage ice cold dmem washed counted plated dmem 10 fbs 37 degrees c macrophages plated 4 x 105 macrophageswell 24 well plates treated 100 microgml acetyl ldl acldl dmem 2 fbs 48 h load cholesterol stimulate apoe secretion 24
0.3207539.15509658.html.plaintext.txt	27	lipoprotein preparation chemical modification lipoproteins isolated human blood plasma sequential ultracentrifugation density 1019 1063 gml ldl ldl dialyzed 4 degrees c lipoprotein buffer 015 m nacl 03 mm edta acldl prepared repeated addition acetic anhydride ldl 2 modification reaction acldl dialyzed lipoprotein buffer lipoprotein species modifications confirmed electrophoretic mobility agarose gels protein concentrations determined modified lowry assay 23 modified lipoproteins filtered 045 microm syringe filters immediately applied cultured cells
0.3207539.15509658.html.plaintext.txt	28	lipoprotein preparation chemical modification lipoproteins isolated human blood plasma sequential ultracentrifugation density 1019 1063 gml ldl ldl dialyzed 4 degrees c lipoprotein buffer 015 m nacl 03 mm edta acldl prepared repeated addition acetic anhydride ldl 2 modification reaction acldl dialyzed lipoprotein buffer lipoprotein species modifications confirmed electrophoretic mobility agarose gels protein concentrations determined modified lowry assay 23 modified lipoproteins filtered 045 microm syringe filters immediately applied cultured cells
0.3207539.15509658.html.plaintext.txt	29	efflux cellular cholesterol macrophages labeled 2 microciml 12 3hncholesterol perkin elmer life sciences boston ma dmem 12 h 19 26 apoe apoe macrophages 641 plus minus 50 980 plus minus 123 microg total cholesterolmg cell protein respectively apoe apoe macrophages 78666 plus minus 13336 7828 plus minus 9893 cpmmg cell protein respectively labeled macrophages rinsed three times dmem 02 bsa efflux period initiated addition dmem acceptors 03 05 075 10 15 20 ml efflux medium removed efflux period 8 24 48 72 h cell debris removed centrifugation remaining cellular 3hcholesterol harvested rinsing cells pbs lysing cells 10 ml 01 n naoh counts cpm medium lysate detected beckman ls 6000ic scintillation counter ecolite scintillation fluid icn costa mesa ca cholesterol efflux calculated counts medium percentage total counts medium lysate difference cholesterol efflux e apoe ko apoe wt macrophages considered cholesterol efflux specifically mediated apoe e calculated
0.3207539.15509658.html.plaintext.txt	30	western blot analysis secreted apoe macrophages incubated dmem acceptors 03 05 075 10 15 20 ml 18 h cell debris removed centrifugation apoe extracted total volume culture medium liposorb gel calbiochem san diego ca western blot analysis secreted apoe extracted apoe separated 4 12 nupage bis tris gels invitrogen carlsbad ca transferred nitrocellulose membranes apoe detected anti murine apoe rabbit antiserum visualized chemiluminescent ecl plus amersham biosciences piscataway nj
0.3207539.15509658.html.plaintext.txt	31	western blot analysis secreted apoe macrophages incubated dmem acceptors 03 05 075 10 15 20 ml 18 h cell debris removed centrifugation apoe extracted total volume culture medium liposorb gel calbiochem san diego ca western blot analysis secreted apoe extracted apoe separated 4 12 nupage bis tris gels invitrogen carlsbad ca transferred nitrocellulose membranes apoe detected anti murine apoe rabbit antiserum visualized chemiluminescent ecl plus amersham biosciences piscataway nj
0.3207539.15509658.html.plaintext.txt	32	14c labeled adenine release assay cellular toxicity cytotoxicity cultured macrophages assayed measuring release 14c labeled adenine 34 cells labeled 3 h dmem 04 microciml u 14cadenine amersham biosciences cells rinsed three times dmem release period initiated addition dmem medium removed release period 24 h cell debris removed centrifugation cellular 14cadenine harvested rinsing cells pbs lysing cells 10 ml 01 n naoh sample aliquots loaded ecolite scintillation fluid 14cadenine counts detected beckman ls 6000ic scintillation counter adenine release calculated medium 14cadenine counts expressed percentage total counts lysate medium
0.3207539.15509658.html.plaintext.txt	33	14c labeled adenine release assay cellular toxicity cytotoxicity cultured macrophages assayed measuring release 14c labeled adenine 34 cells labeled 3 h dmem 04 microciml u 14cadenine amersham biosciences cells rinsed three times dmem release period initiated addition dmem medium removed release period 24 h cell debris removed centrifugation cellular 14cadenine harvested rinsing cells pbs lysing cells 10 ml 01 n naoh sample aliquots loaded ecolite scintillation fluid 14cadenine counts detected beckman ls 6000ic scintillation counter adenine release calculated medium 14cadenine counts expressed percentage total counts lysate medium
0.3207539.15509658.html.plaintext.txt	34	volume dependence theory manipulate extracellular concentration endogenously synthesized biological mediator volume dependence theory takes advantage implicit relationship concentration distribution volume concentration secreted mediator apoe proportional reciprocal extracellular distribution volume increasing distribution volume v causes decrease relative concentration v 1 secreted mediator varying extracellular volume given number cells fig 1a allows juxtacellular extracellular mechanisms synthesized mediator mathematically separated characterized theory illustrated graphically follows plot biological effect e vs extracellular volume v extracellular volume increased effect decreases asymptotically plateau represents portion total effect independent extracellular volume fig 1b value plateau y intercept b plot biological effect e vs reciprocal volume v 1 fig 1c dose response curve linear low relative concentrations v 1 fits linear equation
0.3207539.15509658.html.plaintext.txt	35	view larger version 28k fig 1 theoretical basis separation autocrine paracrine effects apolipoprotein e apoe cholesterol efflux experimental design changes relative concentrations apoe increasing extracellular distribution volume b dependence effect apoe distribution volume c dependence effect apoe reciprocal volume effects apoe depend relative concentration extracellular distribution volume paracrine effects occur solely juxtacellular space independent extracellular distribution volume autocrine
0.3207539.15509658.html.plaintext.txt	36	data analysis data expressed means plus minus sd means compared students test curves analyzed linear regression
0.3207539.15509658.html.plaintext.txt	37	results top abstract glossary materials methods results discussion grants references volume dependence apoe mediated cholesterol efflux apoe macrophages efflux decreased distribution volume increased fig 2a apoe mediated efflux appeared saturated smaller distribution volumes fell plateau b volume increased 48 h dependence apoe mediated efflux reciprocal volume initially linear m 295 plus minus 063 effluxml 1 b 085 plus minus 058 efflux r2 092 determined linear regression analysis fig 2 b c similar trends seen 8 24 72 h least 10 20 b expressed maximum efflux apoe mediated cholesterol efflux independent reciprocal volume table 1 remaining 80 90 apoe mediated cholesterol efflux linearly dependent reciprocal volume table 1 volume independent contributions efflux become dominant extracellular apoe became dilute descriptive equation apoe mediated cholesterol efflux generated data
0.3207539.15509658.html.plaintext.txt	38	results top abstract glossary materials methods results discussion grants references volume dependence apoe mediated cholesterol efflux apoe macrophages efflux decreased distribution volume increased fig 2a apoe mediated efflux appeared saturated smaller distribution volumes fell plateau b volume increased 48 h dependence apoe mediated efflux reciprocal volume initially linear m 295 plus minus 063 effluxml 1 b 085 plus minus 058 efflux r2 092 determined linear regression analysis fig 2 b c similar trends seen 8 24 72 h least 10 20 b expressed maximum efflux apoe mediated cholesterol efflux independent reciprocal volume table 1 remaining 80 90 apoe mediated cholesterol efflux linearly dependent reciprocal volume table 1 volume independent contributions efflux become dominant extracellular apoe became dilute descriptive equation apoe mediated cholesterol efflux generated data
0.3207539.15509658.html.plaintext.txt	39	view larger version 28k fig 2 volume dependence apoe mediated cholesterol efflux b volume v dependence relative concentration v 1 dependence b cholesterol efflux apoe apoe macrophages apoe mediated efflux values expressed means plus minus sd 4 samples efflux apoe apoe macrophages statistically significant difference p 005 students test c linear fit apoe mediated efflux e vs reciprocal volume 8 24 48 72 h b y intercept
0.3207539.15509658.html.plaintext.txt	40	view table table 1 volume independent volume dependent apoe effects contribute cholesterol efflux
0.3207539.15509658.html.plaintext.txt	41	volume dependence apoe secretion western blot analysis performed determine whether changes apoe secretion related trends efflux determine whether macrophages secreted equal masses apoe apoe extracted culture medium densitometric analysis macrophages cultured higher medium volumes 075 10 15 20 ml secreted similar amounts apoe per cell culture suggesting size distribution volume effect apoe secretion fig 3a however macrophages cultured smaller volumes 03 05 ml secreted apoe per cell culture
0.3207539.15509658.html.plaintext.txt	42	volume dependence apoe secretion western blot analysis performed determine whether changes apoe secretion related trends efflux determine whether macrophages secreted equal masses apoe apoe extracted culture medium densitometric analysis macrophages cultured higher medium volumes 075 10 15 20 ml secreted similar amounts apoe per cell culture suggesting size distribution volume effect apoe secretion fig 3a however macrophages cultured smaller volumes 03 05 ml secreted apoe per cell culture
0.3207539.15509658.html.plaintext.txt	43	view larger version 13k fig 3 volume dependence apoe secretion macrophage viability secretion apoe per cell culture viability apoe macrophages varying volumes b reciprocal volumes c shown values expressed means plus minus sd 4 samples adenine release apoe macrophages
0.3207539.15509658.html.plaintext.txt	44	volume dependence cellular viability 14cadenine release studies performed determine whether changes viability related trends efflux apoe secretion viability increased smaller distribution volumes indicated higher amounts 14cadenine remaining fig 3b viability increased log linear fashion r2 099 increasing reciprocal volume fig 3c log linear trend viability different linear trend efflux
0.3207539.15509658.html.plaintext.txt	45	volume dependence cellular viability 14cadenine release studies performed determine whether changes viability related trends efflux apoe secretion viability increased smaller distribution volumes indicated higher amounts 14cadenine remaining fig 3b viability increased log linear fashion r2 099 increasing reciprocal volume fig 3c log linear trend viability different linear trend efflux
0.3207539.15509658.html.plaintext.txt	46	model apoe mediated cholesterol efflux limited number assumptions mathematical model generated suggests physical model autocrine paracrine effects apoe cholesterol efflux calculation e eq 1 assumes difference primary effect apoe secondary effect changes cellular cholesterol homeostasis ie changes viability changes membrane fluidity data fig 2 table 1 fig 3 assume evaporation extracellular distribution volume negligible however evaporation determined 003 ml24 h system evaporation rate affects calculation e calculation v 1 factoring evaporation rate change trends data however evaporation corrections necessary estimate parameters mathematical model data shown
0.3207539.15509658.html.plaintext.txt	47	model apoe mediated cholesterol efflux limited number assumptions mathematical model generated suggests physical model autocrine paracrine effects apoe cholesterol efflux calculation e eq 1 assumes difference primary effect apoe secondary effect changes cellular cholesterol homeostasis ie changes viability changes membrane fluidity data fig 2 table 1 fig 3 assume evaporation extracellular distribution volume negligible however evaporation determined 003 ml24 h system evaporation rate affects calculation e calculation v 1 factoring evaporation rate change trends data however evaporation corrections necessary estimate parameters mathematical model data shown
0.3207539.15509658.html.plaintext.txt	48	extrapolation concentration dependence lines common x intercept observed assigned value negative c 0270 plus minus 0047 ml 1 fig 4a common x intercept c 0 lines fit eq 2 yields following equation
0.3207539.15509658.html.plaintext.txt	49	3 reveals concentration dependence lines combined one equation function time rather contained within four unrelated equations would expected secretion apoe function time therefore apoe mediated effects would also function time y intercept represents autocrine effect results constant rate secretion apoe normalizing y intercept time would reveal constant f
0.3207539.15509658.html.plaintext.txt	50	3 reveals concentration dependence lines combined one equation function time rather contained within four unrelated equations would expected secretion apoe function time therefore apoe mediated effects would also function time y intercept represents autocrine effect results constant rate secretion apoe normalizing y intercept time would reveal constant f
0.3207539.15509658.html.plaintext.txt	51	4 normalized y intercepts bt however constant time point 066 043 039 033 efflux24 h plot normalized y intercepts bt vs corresponding slope m reveals unexpected relationship linear n 00411 plus minus 00009 ml 124 h f 0305 plus minus 0004 efflux24 h r2 100 determined linear regression analysis expressed
0.3207539.15509658.html.plaintext.txt	52	5 equations 2 3 5 combined generate function describe effects apoe cholesterol efflux interpreted mechanistically compartmentalized manner
0.3207539.15509658.html.plaintext.txt	53	6 equation 6 fits experimental data fig 4 b c form eq 6 expresses apoe mediated cholesterol efflux product capacity ft system ratio two coefficients efflux coefficient ke v 1 c influx coefficient ki c nt basis mathematical model biological model proposed fig 5
0.3207539.15509658.html.plaintext.txt	54	view larger version 23k fig 4 mathematical trends apoe mediated cholesterol efflux data common x intercept c 0 arrow lines apoe mediated efflux vs reciprocal volume plots b kinetics apoe mediated efflux distribution volumes 10 15 20 ml experimental data fit eq 6 experimentally estimated values parameters effective apoe concentration c slope n y intercept f c correlation experimental theoretical values proposed model apoe mediated efflux eq 6
0.3207539.15509658.html.plaintext.txt	55	view larger version 17k fig 5 proposed model apoe mediated cholesterol efflux autocrine paracrine effects 2 compartments secreted apoe distributed juxtacellular space extracellular space endogenously synthesized apoe initially distributed juxtacellular space accepts cholesterol autocrine fashion apoe eventually distributed extracellular space accepts cholesterol paracrine fashion sensitive volume cells cultured determining volume independent effects cholesterol efflux distinguish autocrine actions apoe paracrine actions ke coefficient apoe mediated efflux ki coefficient apoe mediated influx
0.3207539.15509658.html.plaintext.txt	56	discussion top abstract glossary materials methods results discussion grants references determine whether autocrine paracrine actions apoe separated quantified measured cholesterol efflux macrophages cultured varying distribution volumes found volume independent effects apoe identified using simple mathematical model eq 2 theorize volume independent effects correspond autocrine actions apoe basis theory range autocrine signals approximates width secretion layer separates cell bulk medium studies oehrtman et al 27 shvartsman et al 30 suggest two phenomena occur mediator goes beyond autocrine range 1 mediator longer autocrine 2 mediator becomes diluted bulk medium data suggest relative importance autocrine paracrine effects apoe depends size local distribution volume autocrine effects remaining constant even paracrine effects diminished apoe dilution descriptive equation generated data eq 6 suggests autocrine paracrine apoe work parallel mediate cholesterol efflux macrophages
0.3207539.15509658.html.plaintext.txt	57	discussion top abstract glossary materials methods results discussion grants references determine whether autocrine paracrine actions apoe separated quantified measured cholesterol efflux macrophages cultured varying distribution volumes found volume independent effects apoe identified using simple mathematical model eq 2 theorize volume independent effects correspond autocrine actions apoe basis theory range autocrine signals approximates width secretion layer separates cell bulk medium studies oehrtman et al 27 shvartsman et al 30 suggest two phenomena occur mediator goes beyond autocrine range 1 mediator longer autocrine 2 mediator becomes diluted bulk medium data suggest relative importance autocrine paracrine effects apoe depends size local distribution volume autocrine effects remaining constant even paracrine effects diminished apoe dilution descriptive equation generated data eq 6 suggests autocrine paracrine apoe work parallel mediate cholesterol efflux macrophages
0.3207539.15509658.html.plaintext.txt	58	study suggests autocrine apoe advantages biologically relevant even extracellular space saturated apoe least 10 20 apoe mediated cholesterol efflux result volume independent interactions endogenous apoe table 1 lin et al 19 found apoe deficient cells exogenous application apoe 10 times concentration normal endogenous apoe secretion increase cholesterol efflux much normal endogenous apoe secretion apoe producing cells fundamental importance media transfer studies show exogenous apoe paracrine equivalent endogenous apoe autocrine paracrine macrophage endogenously synthesized apoe advantage autocrine apoe may become critical homeostasis challenged cholesterol loading conditioned space large making apoe diluted turnover conditioned space high interstitial flow macrophage isolated macrophages interstitial concentration distribution volume turnover macrophage apoe vessel wall known factors critical interpretation data vitro cell culture systems generalization data biology macrophages vivo example trend viability may related changes apoe secretion observed low volumes fig 3a log linear trend viability fig 3c may due relative concentrations confounding mediators like growth factors culture gases eg co2 varying distribution volumes apoe mediator secreted system necessary subtract effects confounding mediators apoe macrophages compared apoe macrophages specific apoe effect calculated apoe mediated cholesterol efflux e effects confounding mediators cholesterol efflux minimal fig 2 b although major role apoe extracellular cholesterol acceptor also possible portion effect apoe cholesterol efflux consequence actions apoe receptor proteoglycan binding 17 intracellular cholesterol routing 8 even stabilization cytoskeleton 6 irrespective ultimate mechanisms combination effects may responsible modulation cholesterol efflux apoe occur either autocrine paracrine events therefore addressed whole study
0.3207539.15509658.html.plaintext.txt	59	study suggests autocrine apoe advantages biologically relevant even extracellular space saturated apoe least 10 20 apoe mediated cholesterol efflux result volume independent interactions endogenous apoe table 1 lin et al 19 found apoe deficient cells exogenous application apoe 10 times concentration normal endogenous apoe secretion increase cholesterol efflux much normal endogenous apoe secretion apoe producing cells fundamental importance media transfer studies show exogenous apoe paracrine equivalent endogenous apoe autocrine paracrine macrophage endogenously synthesized apoe advantage autocrine apoe may become critical homeostasis challenged cholesterol loading conditioned space large making apoe diluted turnover conditioned space high interstitial flow macrophage isolated macrophages interstitial concentration distribution volume turnover macrophage apoe vessel wall known factors critical interpretation data vitro cell culture systems generalization data biology macrophages vivo example trend viability may related changes apoe secretion observed low volumes fig 3a log linear trend viability fig 3c may due relative concentrations confounding mediators like growth factors culture gases eg co2 varying distribution volumes apoe mediator secreted system necessary subtract effects confounding mediators apoe macrophages compared apoe macrophages specific apoe effect calculated apoe mediated cholesterol efflux e effects confounding mediators cholesterol efflux minimal fig 2 b although major role apoe extracellular cholesterol acceptor also possible portion effect apoe cholesterol efflux consequence actions apoe receptor proteoglycan binding 17 intracellular cholesterol routing 8 even stabilization cytoskeleton 6 irrespective ultimate mechanisms combination effects may responsible modulation cholesterol efflux apoe occur either autocrine paracrine events therefore addressed whole study
0.3207539.15509658.html.plaintext.txt	60	although volume dependence apoe secretion viability could explain volume dependent trends apoe mediated efflux fig 2c data definitely underscore sensitivity biological processes vitro culture volumes higher order characteristics macrophage tissue could overlooked vitro studies macrophages example aggregate macrophages may become tissue works autocrine efficiency instead sum autocrineparacrine cellular units spatial range autocrine effect 30 important another cell within range possibility autocrine cooperation possibility could explored vitro vivo studies effects geometry density cell aggregates apoe mediated cholesterol efflux compared exogenous lipoprotein bound apoe hepatic origin local secretion lipid free apoe macrophages results decreased atherosclerosis due small amount apoe critical location 12 22 study fazio et al 12 wt mice transplanted apoe bone marrow chimeric mice normal plasma apoe macrophage apoe production vessel walls although immunocytochemical staining lesions wt macrophages reveals high apoe levels chimeric mice plasma apoe little apoe lesions lack staining plasma derived apoe within artery wall suggests penetration clusters macrophages limited macrophage plasma derived apoe primary source apoe rct 5 12 22 along lines paracrine apoe may able fulfill critical actions small amount autocrine apoe juxtacellular space possibly even intracellular space apoe recycling internalization resecretion apoe 10 13 33 reported mediate cholesterol efflux hepatocytes macrophages 13 methodology study unable resolve internal autocrine 31 intracrine 28 29 mechanism could mediated intracellular apoe
0.3207539.15509658.html.plaintext.txt	61	although volume dependence apoe secretion viability could explain volume dependent trends apoe mediated efflux fig 2c data definitely underscore sensitivity biological processes vitro culture volumes higher order characteristics macrophage tissue could overlooked vitro studies macrophages example aggregate macrophages may become tissue works autocrine efficiency instead sum autocrineparacrine cellular units spatial range autocrine effect 30 important another cell within range possibility autocrine cooperation possibility could explored vitro vivo studies effects geometry density cell aggregates apoe mediated cholesterol efflux compared exogenous lipoprotein bound apoe hepatic origin local secretion lipid free apoe macrophages results decreased atherosclerosis due small amount apoe critical location 12 22 study fazio et al 12 wt mice transplanted apoe bone marrow chimeric mice normal plasma apoe macrophage apoe production vessel walls although immunocytochemical staining lesions wt macrophages reveals high apoe levels chimeric mice plasma apoe little apoe lesions lack staining plasma derived apoe within artery wall suggests penetration clusters macrophages limited macrophage plasma derived apoe primary source apoe rct 5 12 22 along lines paracrine apoe may able fulfill critical actions small amount autocrine apoe juxtacellular space possibly even intracellular space apoe recycling internalization resecretion apoe 10 13 33 reported mediate cholesterol efflux hepatocytes macrophages 13 methodology study unable resolve internal autocrine 31 intracrine 28 29 mechanism could mediated intracellular apoe
0.3207539.15509658.html.plaintext.txt	62	autocrineparacrine systems many documents found literature search term autocrine terms autocrine andor paracrine describe proposed mechanism action difficult quantitatively separate two mechanisms experimentally traditional approaches problem limitations rely simple qualitative assessments traditional methodologies used study macrophage apoe include characterizing tissue distribution apoe 11 measuring effects endogenous synthesis apoe vs complete absence 11 measuring effects endogenous synthesis vs exogenous application apoe 15 19 methods useful comparative assessments unable simultaneously quantify serial effects mediated apoe secreted biological mediators
0.3207539.15509658.html.plaintext.txt	63	present study performed experiments based theory portion endogenous acceptor mediates autocrine effects cannot diluted previous studies utilized experimental strategies similar one used study steck et al 32 performed volume dependence experiments study whether efflux exogenous acceptors proceeded aqueous diffusion cholesterol acceptor membrane collisions found certain types acceptors efflux approached volume insensitive plateau proposed types acceptors may sites efficient collisional transfer 32 studies endogenously synthesized acceptors suggest sites may combination binding sites membrane enriched aqueous layer around membrane ie juxtacellular space oehrtman et al 27 used theoretical model study escape autocrine signaling ligands extracellular space found model ligand receptor signaling system varying volume heights shows little effect ligand concentrations remains seen whether dilution methodology discussed change mediator concentrations large dynamic range many orders magnitude log linear dose response curve seen ligand receptor signaling pathways
0.3207539.15509658.html.plaintext.txt	64	present study performed experiments based theory portion endogenous acceptor mediates autocrine effects cannot diluted previous studies utilized experimental strategies similar one used study steck et al 32 performed volume dependence experiments study whether efflux exogenous acceptors proceeded aqueous diffusion cholesterol acceptor membrane collisions found certain types acceptors efflux approached volume insensitive plateau proposed types acceptors may sites efficient collisional transfer 32 studies endogenously synthesized acceptors suggest sites may combination binding sites membrane enriched aqueous layer around membrane ie juxtacellular space oehrtman et al 27 used theoretical model study escape autocrine signaling ligands extracellular space found model ligand receptor signaling system varying volume heights shows little effect ligand concentrations remains seen whether dilution methodology discussed change mediator concentrations large dynamic range many orders magnitude log linear dose response curve seen ligand receptor signaling pathways
0.3207539.15509658.html.plaintext.txt	65	summary study separates quantifies autocrine paracrine effects apoe cholesterol efflux macrophages data suggest relative importance autocrine paracrine apoe depends size local distribution volume autocrine effects remaining constant even paracrine effects diminished dilution apoe
0.3207539.15509658.html.plaintext.txt	66	summary study separates quantifies autocrine paracrine effects apoe cholesterol efflux macrophages data suggest relative importance autocrine paracrine apoe depends size local distribution volume autocrine effects remaining constant even paracrine effects diminished dilution apoe
0.3207539.15509658.html.plaintext.txt	67	grants top abstract glossary materials methods results discussion grants references m f linton fazio supported national heart lung blood institute nhlbi grants hl 53989 hl 65709 hl 57986 hl 65405 d e dove supported nhlbi training grant hl 07751 08
0.3207539.15509658.html.plaintext.txt	68	footnotes address reprint requests correspondence fazio vanderbilt univ medical center div cardiovascular medicine 383 preston research bldg nashville tn 37232 6300 e mail sergiofazioatvanderbiltedu u d
0.3207539.15509658.html.plaintext.txt	69	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3207539.15509658.html.plaintext.txt	70	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3207539.15509658.html.plaintext.txt	71	references top abstract glossary materials methods results discussion grants references 1 balboa ma perez r balsinde j amplification mechanisms inflammation paracrine stimulation arachidonic acid mobilization secreted phospholipase a2 regulated cytosolic phospholipase a2 derived hydroperoxyeicosatetraenoic acid j immunol 171 989 994 2003abstractfree full text
0.3207539.15509658.html.plaintext.txt	72	references top abstract glossary materials methods results discussion grants references 1 balboa ma perez r balsinde j amplification mechanisms inflammation paracrine stimulation arachidonic acid mobilization secreted phospholipase a2 regulated cytosolic phospholipase a2 derived hydroperoxyeicosatetraenoic acid j immunol 171 989 994 2003abstractfree full text
0.3207539.15509658.html.plaintext.txt	73	2 basu sk goldstein jl anderson gw brown ms degradation cationized low density lipoprotein regulation cholesterol metabolism homozygous familial hypercholesterolemia fibroblasts proc natl acad sci usa 73 3178 3182 1976abstract
0.3207539.15509658.html.plaintext.txt	74	3 basu sk goldstein jl brown ms independent pathways secretion cholesterol apolipoprotein e macrophages science 219 871 873 1983isimedline
0.3207539.15509658.html.plaintext.txt	75	4 batsilas l berezhkovskii shvartsman sy stochastic model autocrine paracrine signals cell culture assays biophys j 85 3659 3665 2003abstractfree full text
0.3207539.15509658.html.plaintext.txt	76	5 blum cb aron l sciacca r radioimmunoassay studies human apolipoprotein e j clin invest 66 1240 1250 1980isimedline
0.3207539.15509658.html.plaintext.txt	77	6 brecht wj harris fm chang tesseur yu gq xu q dee fish j wyss coray buttini m mucke l mahley rw huang y neuron specific apolipoprotein e4 proteolysis associated increased tau phosphorylation brains transgenic mice j neurosci 24 2527 2534 2004abstractfree full text
0.3207539.15509658.html.plaintext.txt	78	7 coussens lm tinkle cl hanahan d werb z mmp 9 supplied bone marrow derived cells contributes skin carcinogenesis cell 103 481 490 2000crossrefisimedline
0.3207539.15509658.html.plaintext.txt	79	10 farkas mh swift ll hasty ah linton mf fazio recycling apolipoprotein e primary cultures mouse hepatocytes evidence physiologic connection high density lipoprotein metabolism j biol chem 278 9412 9417 2003abstractfree full text
0.3207539.15509658.html.plaintext.txt	80	11 fazio babaev vr burleigh major hasty ah linton mf physiological expression macrophage apoe artery wall reduces atherosclerosis severely hyperlipidemic mice j lipid res 43 1602 1609 2002abstractfree full text
0.3207539.15509658.html.plaintext.txt	81	12 fazio babaev vr murray ab hasty ah carter kj gleaves la atkinson jb linton mf increased atherosclerosis mice reconstituted apolipoprotein e null macrophages proc natl acad sci usa 94 4647 4652 1997abstractfree full text
0.3207539.15509658.html.plaintext.txt	82	13 heeren j grewal laatsch rottke d rinninger f enrich c beisiegel u recycling apoprotein e associated cholesterol efflux high density lipoprotein internalization j biol chem 278 14370 14378 2003abstractfree full text
0.3207539.15509658.html.plaintext.txt	83	14 ho yy al haideri m mazzone vogel presley jf sturley sl deckelbaum rj endogenously expressed apolipoprotein e different effects cell lipid metabolism compared exogenous apolipoprotein e carried triglyceride rich particles biochemistry 39 4746 4754 2000crossrefisimedline
0.3207539.15509658.html.plaintext.txt	84	15 ho yy deckelbaum rj chen y vogel talmage da apolipoprotein e inhibits serum stimulated cell proliferation enhances serum independent cell proliferation j biol chem 276 43455 43462 2001abstractfree full text
0.3207539.15509658.html.plaintext.txt	85	16 huang zh lin cy oram jf mazzone sterol efflux mediated endogenous macrophage apoe expression independent abca1 arterioscler thromb vasc biol 21 2019 2025 2001abstractfree full text
0.3207539.15509658.html.plaintext.txt	86	17 ji zs pitas re mahley rw differential cellular accumulationretention apolipoprotein e mediated cell surface heparan sulfate proteoglycans apolipoproteins e3 e2 greater e4 j biol chem 273 13452 13460 1998abstractfree full text
0.3207539.15509658.html.plaintext.txt	87	18 lauffenburger da oehrtman gt walker l wiley hs real time quantitative measurement autocrine ligand binding indicates autocrine loops spatially localized proc natl acad sci usa 95 15368 15373 1998abstractfree full text
0.3207539.15509658.html.plaintext.txt	88	20 lin cy huang zh mazzone interaction proteoglycans enhances sterol efflux produced endogenous expression macrophage apoe j lipid res 42 1125 1133 2001abstractfree full text
0.3207539.15509658.html.plaintext.txt	89	21 lin cy lucas m mazzone endogenous apoe expression modulates hdl3 binding macrophages j lipid res 39 293 301 1998abstractfree full text
0.3207539.15509658.html.plaintext.txt	90	22 linton mf atkinson jb fazio prevention atherosclerosis apolipoprotein e deficient mice bone marrow transplantation science 267 1034 1037 1995isimedline
0.3207539.15509658.html.plaintext.txt	91	23 lowry oh rosebrough nj farr al randall rj protein measurement folin phenol reagent j biol chem 193 265 275 1951free full text
0.3207539.15509658.html.plaintext.txt	92	24 mazzone gump h diller p getz gs macrophage free cholesterol content regulates apolipoprotein e synthesis j biol chem 262 11657 11662 1987abstractfree full text
0.3207539.15509658.html.plaintext.txt	93	25 moran ec kamiguti cawley jc pettitt ar cytoprotective antioxidant activity serum albumin autocrine catalase chronic lymphocytic leukaemia br j haematol 116 316 328 2002crossrefisimedline
0.3207539.15509658.html.plaintext.txt	94	26 mukherjee zha x tabas maxfield fr cholesterol distribution living cells fluorescence imaging using dehydroergosterol fluorescent cholesterol analog biophys j 75 1915 1925 1998abstractfree full text
0.3207539.15509658.html.plaintext.txt	95	27 oehrtman gt wiley hs lauffenburger da escape autocrine ligands extracellular medium experimental test theoretical model predictions biotechnol bioeng 57 571 582 199830co2 dlinktypedoi crossrefisimedline
0.3207539.15509658.html.plaintext.txt	96	30 shvartsman sy wiley hs deen wm lauffenburger da spatial range autocrine signaling modeling computational analysis biophys j 81 1854 1867 2001abstractfree full text
0.3207539.15509658.html.plaintext.txt	97	32 steck tl kezdy fj lange y activation collision mechanism cholesterol transfer membranes j biol chem 263 13023 13031 1988abstractfree full text
0.3207539.15509658.html.plaintext.txt	98	33 swift ll farkas mh major valyi nagy k linton mf fazio recycling pathway resecretion internalized apolipoprotein e liver cells j biol chem 276 22965 22970 2001abstractfree full text
0.3207539.15509658.html.plaintext.txt	99	34 warner gj stoudt g bamberger m johnson wj rothblat gh cell toxicity induced inhibition acyl coenzyme acholesterol acyltransferase accumulation unesterified cholesterol j biol chem 270 5772 5778 1995abstractfree full text
0.32282493.12501252.html.plaintext.txt	0	novel role apolipoprotein e central nervous system modulation sulfatide content xianlin han hua cheng john d fryer anne m fagan david m holtzman
0.32282493.12501252.html.plaintext.txt	1	division bioorganic chemistry molecular pharmacology department internal medicine department neurology department molecular biology pharmacology center study nervous system injury washington university school medicine st louis missouri 63110
0.32282493.12501252.html.plaintext.txt	2	received publication december 4 2002 revised form december 20 2002
0.32282493.12501252.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	4	long postulated apolipoprotein e apoe may play role lipid metabolism brain however direct evidence apoe plays role lacking investigated whether apoe isoforms influence lipid content brain compared brains wild type mice apoe knockout human apoe3 apoe4 transgenic mice compared cerebrospinal fluid csf humans different apoe isoforms found effect apoe content multiple phospholipids sphingolipids cholesterol however marked effect apoe sulfatide st content brain csf sulfatide mass hippocampus cortex apoe knockout mice found 61 114 mol higher wild type mice counterparts 12 months age contrast sulfatide content brain tissues human apoe4 expressing mice 60 less found wild type mice age st mass human csf significantly dependent apoe genotypes subjects examination potential sulfatide carriers human csf demonstrated sulfatides specifically associated apoe containing high density lipoproteins suggesting sulfatide levels central nervous system cns likely directly modulated metabolic pathways regulate levels apoe containing cns lipoproteins novel role apoe cns may provide new insights connection apoe alzheimers disease poor recovery brain injury introduction top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	5	long postulated apolipoprotein e apoe may play role lipid metabolism brain however direct evidence apoe plays role lacking investigated whether apoe isoforms influence lipid content brain compared brains wild type mice apoe knockout human apoe3 apoe4 transgenic mice compared cerebrospinal fluid csf humans different apoe isoforms found effect apoe content multiple phospholipids sphingolipids cholesterol however marked effect apoe sulfatide st content brain csf sulfatide mass hippocampus cortex apoe knockout mice found 61 114 mol higher wild type mice counterparts 12 months age contrast sulfatide content brain tissues human apoe4 expressing mice 60 less found wild type mice age st mass human csf significantly dependent apoe genotypes subjects examination potential sulfatide carriers human csf demonstrated sulfatides specifically associated apoe containing high density lipoproteins suggesting sulfatide levels central nervous system cns likely directly modulated metabolic pathways regulate levels apoe containing cns lipoproteins novel role apoe cns may provide new insights connection apoe alzheimers disease poor recovery brain injury introduction top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	6	human apolipoprotein e apoe protein apoe gene1 34 kda protein coded gene chromosome 19 plays prominent role transport metabolism plasma cholesterol triacylglycerides ability interact low density lipoprotein ldl receptor ldl receptor related protein 1 2 postulated apoe may also play important role redistribution cholesterol phospholipids within central nervous system cns 3 apoe expressed mainly astrocytes 4 5 vitro vivo data suggest apoe play role neurite outgrowth sprouting 4 6 9 however whether due effects cholesterol lipid metabolism unclear addition role plasma lipid transport protein apoe participates pathobiological processes including alzheimers disease ad 10 effect apoe ad likely occur least part via interactions amyloid peptide see ref 11 review date mechanisms apoe involved biological processes completely clarified
0.32282493.12501252.html.plaintext.txt	7	human apolipoprotein e apoe protein apoe gene1 34 kda protein coded gene chromosome 19 plays prominent role transport metabolism plasma cholesterol triacylglycerides ability interact low density lipoprotein ldl receptor ldl receptor related protein 1 2 postulated apoe may also play important role redistribution cholesterol phospholipids within central nervous system cns 3 apoe expressed mainly astrocytes 4 5 vitro vivo data suggest apoe play role neurite outgrowth sprouting 4 6 9 however whether due effects cholesterol lipid metabolism unclear addition role plasma lipid transport protein apoe participates pathobiological processes including alzheimers disease ad 10 effect apoe ad likely occur least part via interactions amyloid peptide see ref 11 review date mechanisms apoe involved biological processes completely clarified
0.32282493.12501252.html.plaintext.txt	8	three common isoforms human apoe differ amino acids positions 112 158 1 common isoform apoe3 cysteine position 112 arginine 158 whereas apoe2 cysteine positions apoe4 contains arginine positions isoforms encoded three alleles gene locus apoe4 shown risk factor ad cerebral amyloid angiopathy 10 although role apoe pathogenesis ad entirely clear studies suggest apoe influences deposition toxicity brain 12 15
0.32282493.12501252.html.plaintext.txt	9	three common isoforms human apoe differ amino acids positions 112 158 1 common isoform apoe3 cysteine position 112 arginine 158 whereas apoe2 cysteine positions apoe4 contains arginine positions isoforms encoded three alleles gene locus apoe4 shown risk factor ad cerebral amyloid angiopathy 10 although role apoe pathogenesis ad entirely clear studies suggest apoe influences deposition toxicity brain 12 15
0.32282493.12501252.html.plaintext.txt	10	sulfatides st represent class sulfated galactocerebrosides differ composition fatty acid residue acylates amino group sphingosine sulfatides mediate diverse biological processes including regulation cell growth protein trafficking signal transduction cell adhesion neuronal plasticity cell morphogenesis see refs 16 18 reviews sulfatides almost exclusively synthesized oligodendrocytes cns present predominantly myelin sheath surrounding axons thus present white matter gray matter 16 altered levels st human brain tissues involved pathogenesis various human diseases accumulation st due sulfatidase deficiency responsible metachromatic leukodystrophy encephalopathy long tract signs degeneration myelin cns 19 contrast recent study demonstrated substantial st deficiency occurs earliest stages ad although one causes deficiency remain unclear 20 mice deficient st galactocerebrosides galc generated knocking ceramide galactosyltransferase generally die 3 months age demonstrate several abnormalities including abnormal axonal function dysmyelinosis loss axonal conduction velocity 21 24
0.32282493.12501252.html.plaintext.txt	11	sulfatides st represent class sulfated galactocerebrosides differ composition fatty acid residue acylates amino group sphingosine sulfatides mediate diverse biological processes including regulation cell growth protein trafficking signal transduction cell adhesion neuronal plasticity cell morphogenesis see refs 16 18 reviews sulfatides almost exclusively synthesized oligodendrocytes cns present predominantly myelin sheath surrounding axons thus present white matter gray matter 16 altered levels st human brain tissues involved pathogenesis various human diseases accumulation st due sulfatidase deficiency responsible metachromatic leukodystrophy encephalopathy long tract signs degeneration myelin cns 19 contrast recent study demonstrated substantial st deficiency occurs earliest stages ad although one causes deficiency remain unclear 20 mice deficient st galactocerebrosides galc generated knocking ceramide galactosyltransferase generally die 3 months age demonstrate several abnormalities including abnormal axonal function dysmyelinosis loss axonal conduction velocity 21 24
0.32282493.12501252.html.plaintext.txt	12	numerous studies demonstrated role apoe normal variation plasma lipids isoform dependent manner see refs 1 25 reviews therefore long postulated apoe may also play role lipid metabolism brain however direct evidence apoe plays role lacking study investigated whether apoe apoe isoforms influence lipid content cns found significant effects apoe content multiple phospholipids sphingolipids cholesterol contrast apoe dramatic effect sulfatide content cns furthermore potential mechanisms relationship apoe st including st assembly nascent apoe particles st transport presence within cerebrospinal fluid csf lipoproteins st hydrolysis mediated apoe also investigated study collectively uncovered novel role apoe modulation st content cns finding may provide new insights roles apoe biological pathological processes cns ad following brain injury experimental procedures top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	13	materials synthetic heptadecanoyl ceramide n170 cer phospholipids including 12 dimyristoleoyl 3 phosphatidylcholine 141 141 ptdcho 12 dipentadecanoyl 3 phosphatidylethanolamine 150 150 ptdetn 1 myristoyl 2 palmitoyl 3 phosphadylglycerol 140 160 ptdgro purchased avanti polar lipids inc alabaster al semisynthetic n palmitoyl sulfatide n160 st perdeuterated n stearoyl galactocerebroside d35 n180 galc obtained matreya inc pleasant gap pa amplex red cholesterol assay kit obtained molecular probes inc eugene human recombinant apoe rhapoe isoforms rhapoe2 rhapoe3 rhapoe4 purchased calbiochem novabiochem corp san diego ca rhapoe isoforms determined st free electrospray ionization mass spectrometry esims cell culture supplies invitrogen new york ny unless specified goat anti apoe anti apoj antibodies purchased biodesign saco goat igg control antibody purchased sigma st louis mo protein g sepharose obtained pierce rockford il
0.32282493.12501252.html.plaintext.txt	14	mouse brain tissues wild type ie apoe apoe transgenic mice studies c57bl6 background transgenic mice hemizygous gfap apoe3 gfap apoe4 transgene mouse apoe background produced described previously 26 gfap refers glial fibrillary acidic protein promoter gfap apoe3 apoe4 mice express apoe level indicated age mice anesthetized intraperitoneal pentobarbital 150 mgkg perfused transcardially 01 m phosphate buffered saline ph 74 4 degrees c brain regions immediately dissected frozen powdered dry ice analysis
0.32282493.12501252.html.plaintext.txt	15	human cerebrospinal fluid astrocyte secreted lipoproteins human lumbar csf samples collected previously described 27 freshly frozen csf samples 80 degrees c 05 1 ml subject used study st content lumbar csf samples obtained cognitively normal subjects clinical dementia rating score 0 non demented 28 clinical dementia rating score assigned subjects experienced clinicians based extensive clinical neuropsychological evaluation described 28 subjects genotypes apoe kindly provided laboratory dr goate washington university school medicine total 16 subjects participated study apoe3e3 n 8 apoe3e4 n 6 apoe4e4 n 2 overall average age 708 plus minus 49 mean plus minus se 711 plus minus 57 712 plus minus 42 685 plus minus 05 respectively
0.32282493.12501252.html.plaintext.txt	16	human cerebrospinal fluid astrocyte secreted lipoproteins human lumbar csf samples collected previously described 27 freshly frozen csf samples 80 degrees c 05 1 ml subject used study st content lumbar csf samples obtained cognitively normal subjects clinical dementia rating score 0 non demented 28 clinical dementia rating score assigned subjects experienced clinicians based extensive clinical neuropsychological evaluation described 28 subjects genotypes apoe kindly provided laboratory dr goate washington university school medicine total 16 subjects participated study apoe3e3 n 8 apoe3e4 n 6 apoe4e4 n 2 overall average age 708 plus minus 49 mean plus minus se 711 plus minus 57 712 plus minus 42 685 plus minus 05 respectively
0.32282493.12501252.html.plaintext.txt	17	astrocyte secreted apoe3 apoe4 lipoproteins purified using immunoaffinity columns described 29 briefly primary cultures forebrain astrocytes 95 pure prepared neonatal 1 2 day old wild type c57bl6 apoe gfap apoe3 transgenic gfap apoe4 transgenic mice grown confluence 10 14 days t75 flasks cultures incubated 5 ml serum free dulbeccos modified eagles mediumhams f 12 11 medium containing n2 supplement invitrogen additional 72 h conditioned media collected apoe3 apoe4 lipoproteins purified corresponding conditioned media anti apoe immunoaffinity column
0.32282493.12501252.html.plaintext.txt	18	astrocyte secreted apoe3 apoe4 lipoproteins purified using immunoaffinity columns described 29 briefly primary cultures forebrain astrocytes 95 pure prepared neonatal 1 2 day old wild type c57bl6 apoe gfap apoe3 transgenic gfap apoe4 transgenic mice grown confluence 10 14 days t75 flasks cultures incubated 5 ml serum free dulbeccos modified eagles mediumhams f 12 11 medium containing n2 supplement invitrogen additional 72 h conditioned media collected apoe3 apoe4 lipoproteins purified corresponding conditioned media anti apoe immunoaffinity column
0.32282493.12501252.html.plaintext.txt	19	preparation quantitation lipids mouse brain tissues human csf astrocyte secreted lipoproteins lipids individual mouse brain tissue prepared presence 141 141 ptdcho 20 nmolmg protein 150 150 ptdetn 18 nmolmg protein 140 160 ptdgro 30 nmolmg protein d35 n180 galc 35 nmolmg protein n170 cer 5 nmolmg protein used internal standards quantification choline containing phospholipids ethanolamine containing phospholipids anionic lipids including ptdgro phosphatidylinositol ptdins phosphatidylserine ptdser st galc cer respectively similarly prepared described previously 20 30 31 lipids similarly extracted human csf astrocyte secreted lipoproteins presence n160 st 270 pmolmg csf protein 2 nmolmg apoe respectively used internal standard quantification st
0.32282493.12501252.html.plaintext.txt	20	preparation quantitation lipids mouse brain tissues human csf astrocyte secreted lipoproteins lipids individual mouse brain tissue prepared presence 141 141 ptdcho 20 nmolmg protein 150 150 ptdetn 18 nmolmg protein 140 160 ptdgro 30 nmolmg protein d35 n180 galc 35 nmolmg protein n170 cer 5 nmolmg protein used internal standards quantification choline containing phospholipids ethanolamine containing phospholipids anionic lipids including ptdgro phosphatidylinositol ptdins phosphatidylserine ptdser st galc cer respectively similarly prepared described previously 20 30 31 lipids similarly extracted human csf astrocyte secreted lipoproteins presence n160 st 270 pmolmg csf protein 2 nmolmg apoe respectively used internal standard quantification st
0.32282493.12501252.html.plaintext.txt	21	esims analyses lipids performed utilizing finnigan tsq 7000 spectrometer equipped electrospray ion source described 20 30 32 molecular species directly quantitated comparisons individual ion peak intensities properly selected internal standard eg 140 160 ptdgro anionic lipids including ptdins ptdser correction 13c isotope effects 33 quantification cholesterol brain tissue samples tissue 10 mg homogenized 02 ml phosphate buffered saline cholesterol mass homogenates quantitated using enzymatic methodology amplex red cholesterol assay kit molecular probe inc eugene
0.32282493.12501252.html.plaintext.txt	22	esims analyses lipids performed utilizing finnigan tsq 7000 spectrometer equipped electrospray ion source described 20 30 32 molecular species directly quantitated comparisons individual ion peak intensities properly selected internal standard eg 140 160 ptdgro anionic lipids including ptdins ptdser correction 13c isotope effects 33 quantification cholesterol brain tissue samples tissue 10 mg homogenized 02 ml phosphate buffered saline cholesterol mass homogenates quantitated using enzymatic methodology amplex red cholesterol assay kit molecular probe inc eugene
0.32282493.12501252.html.plaintext.txt	23	hydrolysis assay sulfatide mediated human recombinant apoe isoforms hydrolysis st mediated rhapoes performed modification n sulfatidase assay described previously 34 briefly rhapoe isoforms 50 microg incubated 1 ml final assay buffer 100 mm imidazole ph 72 containing 25 mm mgcl2 n160 st 05 micromol dissolved 50 microl me2so injected assay solution incubation 05 1 2 4 h 37 degrees c aliquots 100 microl assay mixture pipetted lipids mixture immediately extracted modified bligh dyer technique 35 presence n170 cer 5 nmol d35 n180 galc 5 nmol internal standards used quantitation cer galc two products st hydrolysis mass cer galc quantitated esims described previously 20 31
0.32282493.12501252.html.plaintext.txt	24	hydrolysis assay sulfatide mediated human recombinant apoe isoforms hydrolysis st mediated rhapoes performed modification n sulfatidase assay described previously 34 briefly rhapoe isoforms 50 microg incubated 1 ml final assay buffer 100 mm imidazole ph 72 containing 25 mm mgcl2 n160 st 05 micromol dissolved 50 microl me2so injected assay solution incubation 05 1 2 4 h 37 degrees c aliquots 100 microl assay mixture pipetted lipids mixture immediately extracted modified bligh dyer technique 35 presence n170 cer 5 nmol d35 n180 galc 5 nmol internal standards used quantitation cer galc two products st hydrolysis mass cer galc quantitated esims described previously 20 31
0.32282493.12501252.html.plaintext.txt	25	fractionation immunoprecipitation assays human csf human csf obtained fasted healthy subject via lumbar puncture l4l5 trained neurologist dmh immediately put ice blood contamination csf centrifuged 5 min 800 x g 4 degrees c pellet cellular elements twenty milliliters csf concentrated 1 ml 4 degrees c using centriplus 10 concentrators 10 kda molecular mass millipore bedford ma prior fractionation via gel filtration chromatography biologic system bio rad hercules ca using tandem superose 6 hr 1030 columns amersham biosciences piscataway nj conditions physiological ph ph 74 ionic strength 015 m nacl 1 mm edta seventy fractions 400 microl collected lipids individual fractions extracted presence n160 st 70 pmolfraction used internal standard st quantitation using modified method bligh dyer 35 st content fraction analyzed esims described
0.32282493.12501252.html.plaintext.txt	26	immunoprecipitation initiated incubating 17 ml pooled human csf individual antibody final concentration 100 microgml 100 microl 50 protein g sepharose slurry 3 h room temperature immunoprecipitation complexes pelleted briefly rinsed three times gently ice cooled phosphate buffered saline lipids extracted final immunoprecipitation pellets supernatants using modified bligh dyer method st content lipid extracts analyzed esims described
0.32282493.12501252.html.plaintext.txt	27	immunoprecipitation initiated incubating 17 ml pooled human csf individual antibody final concentration 100 microgml 100 microl 50 protein g sepharose slurry 3 h room temperature immunoprecipitation complexes pelleted briefly rinsed three times gently ice cooled phosphate buffered saline lipids extracted final immunoprecipitation pellets supernatants using modified bligh dyer method st content lipid extracts analyzed esims described
0.32282493.12501252.html.plaintext.txt	28	miscellaneous protein concentration determined utilizing bicinchoninic acid protein assay kit pierce rockford il using bovine serum albumin standard quantitative data mouse brain samples normalized protein content tissues data presented means plus minus se least three separate animals differences mean values determined anova analysis followed dunns test p 001 considered significant results top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	29	miscellaneous protein concentration determined utilizing bicinchoninic acid protein assay kit pierce rockford il using bovine serum albumin standard quantitative data mouse brain samples normalized protein content tissues data presented means plus minus se least three separate animals differences mean values determined anova analysis followed dunns test p 001 considered significant results top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	30	altered mass sulfatides examined lipids brain apoe mice examine effects apoe mouse brain lipid homeostasis molecular species mass lipids including choline glycerophospholipids pc ethanolamine glycerophospholipids pe phosphatidylglycerol ptdgro phosphatidylinositol ptdins phosphatidylserine ptdser sphingomyelin sm galactocerebroside galc st cholesterol apoe apoe mouse brain regions analyzed either esims fluorometric assay negative ion esims analyses chloroform extracts wild type c57bl6 mice apoe mouse hippocampus 12 months age demonstrated multiple abundant ion peaks corresponding pe molecular species indicated fig 1a pe molecular species account total mass 3200 plus minus 146 nmolmg protein including 1527 plus minus 75 nmolmg protein ethanolamine plasmalogen fig 1b illustrates positive ion esims spectrum identical lipid extract apoe mouse hippocampus 12 months age pc sm galc molecular species identified quantitated total masses 2770 plus minus 36 395 plus minus 34 1067 plus minus 97 nmolmg protein pc sm galc respectively obtained table negative ion esims analyses identical chloroform extracts apoe mouse hippocampus without addition lioh demonstrated multiple abundant ion peaks corresponding ptdins ptdser st anionic lipid molecular species indicated fig 2a total mass species tabulated table total mass 3814 plus minus 223 nmolmg protein cholesterol hippocampus obtained using enzymatic methodology amplex red cholesterol assay kit esims analyses fluorometric assays lipids apoe mouse cortex cerebellum also performed results tabulated table
0.32282493.12501252.html.plaintext.txt	31	altered mass sulfatides examined lipids brain apoe mice examine effects apoe mouse brain lipid homeostasis molecular species mass lipids including choline glycerophospholipids pc ethanolamine glycerophospholipids pe phosphatidylglycerol ptdgro phosphatidylinositol ptdins phosphatidylserine ptdser sphingomyelin sm galactocerebroside galc st cholesterol apoe apoe mouse brain regions analyzed either esims fluorometric assay negative ion esims analyses chloroform extracts wild type c57bl6 mice apoe mouse hippocampus 12 months age demonstrated multiple abundant ion peaks corresponding pe molecular species indicated fig 1a pe molecular species account total mass 3200 plus minus 146 nmolmg protein including 1527 plus minus 75 nmolmg protein ethanolamine plasmalogen fig 1b illustrates positive ion esims spectrum identical lipid extract apoe mouse hippocampus 12 months age pc sm galc molecular species identified quantitated total masses 2770 plus minus 36 395 plus minus 34 1067 plus minus 97 nmolmg protein pc sm galc respectively obtained table negative ion esims analyses identical chloroform extracts apoe mouse hippocampus without addition lioh demonstrated multiple abundant ion peaks corresponding ptdins ptdser st anionic lipid molecular species indicated fig 2a total mass species tabulated table total mass 3814 plus minus 223 nmolmg protein cholesterol hippocampus obtained using enzymatic methodology amplex red cholesterol assay kit esims analyses fluorometric assays lipids apoe mouse cortex cerebellum also performed results tabulated table
0.32282493.12501252.html.plaintext.txt	32	view larger version 29k fig 1 representative esi mass spectra lipid extracts wild type mouse hippocampus lipids wild type ie apoe mouse hippocampus 12 months age extracted modified method bligh dyer described experimental procedures negative ion positive ion b esims lipid extracts performed presence trace amount lioh experimental procedures major individual molecular species indicated identified using tandem mass spectrometry internal standard
0.32282493.12501252.html.plaintext.txt	33	view table table lipid content brain regions wild type apoe human apoe3 transgenic mice 12 months age mouse brain tissue lipids extracted bligh dyer method 35 phospholipids sphingolipids analyzed directly esims described experimental procedures lipid molecular species identified esi tandem mass spectrometry quantitated comparisons individual ion peak intensities properly selected internal standards corrections 13c isotope effects cholesterol contents determined flurometric technique results expressed nmolmg protein represent means plus minus se least three separate animals
0.32282493.12501252.html.plaintext.txt	34	view table table lipid content brain regions wild type apoe human apoe3 transgenic mice 12 months age mouse brain tissue lipids extracted bligh dyer method 35 phospholipids sphingolipids analyzed directly esims described experimental procedures lipid molecular species identified esi tandem mass spectrometry quantitated comparisons individual ion peak intensities properly selected internal standards corrections 13c isotope effects cholesterol contents determined flurometric technique results expressed nmolmg protein represent means plus minus se least three separate animals
0.32282493.12501252.html.plaintext.txt	35	view larger version 26k fig 2 representative negative ion esi mass spectra lipid extracts wild type apoe knockout mouse hippocampi lipids wild type ie apoe panel apoe knockout ie apoe panel b mouse hippocampi 12 months age extracted modified method bligh dyer negative ion esims lipid extracts without presence lioh performed experimental procedures major individual molecular species indicated identified using tandem mass spectrometry asterisks indicate lower abundant ion peaks sulfatide molecular species present lipid extracts 2oh n241 st represents 2 hydroxy n241 st molecular species note differences st
0.32282493.12501252.html.plaintext.txt	36	examination mass various lipid molecular species hippocampus cortex cerebellum apoe mice esims analyses fluorometric assays demonstrated significant differences pc pe ptdins ptdser sm galc cholesterol comparison obtained corresponding regions apoe mice fig 2b table interestingly mass content st hippocampus cortex cerebellum apoe mice increased 61 114 7 mol respectively relative found apoe mice age 12 months figs 2b 3 table results indicate apoe way regulates st content cns
0.32282493.12501252.html.plaintext.txt	37	alterations sulfatide content mediated apoe dependence apoe isoform age examine effects human apoe isoforms modulation st content mouse brain st molecular species mass lipid extracts different brain regions transgenic mice expressing human apoe3 apoe4 specifically brain astrocytes compared apoe mice esims analysis fig 3 importantly levels apoe3 apoe4 expression hemizygous transgenic mice indistinguishable 70 levels mouse apoe wild type mice 26 36 levels st mass hippocampus cortex apoe3 transgenic mice 12 months age 53 40 mol respectively found apoe mice statistically lower found apoe mice fig 3 levels st mass cortex hippocampus apoe4 transgenic mice 28 37 mol respectively counterparts apoe mouse tissues 59 60 mol respectively found corresponding apoe mouse tissues 12 months age fig 3 st mass levels brain regions apoe4 transgenic mice significantly lower found corresponding apoe3 transgenic mouse tissues p 001 fig 3 demonstrating isoform specific regulation st mass levels apoe apoe mice significantly higher st content thalamus striatum septum compared present apoe mice even 6 months age fig 4 contrast significantly lower st content brain regions demonstrated apoe3 transgenic mice relative wild type apoe mice fig 4 fact human apoe transgenic mice express apoe brain lower levels sulfatide wild type mice demonstrates regulation brain sulfatide levels via apoe produced brain
0.32282493.12501252.html.plaintext.txt	38	view larger version 16k fig 3 comparison sulfatide mass levels hippocampi cortices wild type apoe human apoe3 apoe4 transgenic mice 12 months age sulfatide mass lipid extracts hippocampus cortex b wild type apoe apoe3 apoe4 transgenic mice 12 months age determined using negative ion esims described experimental procedures data represent means plus minus se least three separate animals p 001 p 0001 relative apoe mice also significant difference human apoe3 apoe4 transgenic mice p 001 hippocampus cortex
0.32282493.12501252.html.plaintext.txt	39	view larger version 42k fig 4 absence apoe results increase sulfatide mass levels several brain regions 6 months age total mass sulfatides lipid extracts thalamus striatum septum apoe unfilled apoe dot filled human apoe3 transgenic black filled mice 6 months age determined using negative ion esims described experimental procedures p 001 p 0001 relative apoe mice
0.32282493.12501252.html.plaintext.txt	40	experiments performed examine effects age alterations st content mediated mouse human apoe overall st content brain regions wild type apoe mice relatively unchanged 6 months age fig 5 however levels st mass apoe mice 6 12 months age substantially increased relative apoe mice advanced age fig 5 contrast st content examined regions apoe3 transgenic mice substantially lower compared found apoe mice ages 12 months older although st content two types mice almost identical 6 months age fig 5 also found alterations st mass mediated apoe smaller cerebellum found cortex hippocampus early ages fig 5
0.32282493.12501252.html.plaintext.txt	41	experiments performed examine effects age alterations st content mediated mouse human apoe overall st content brain regions wild type apoe mice relatively unchanged 6 months age fig 5 however levels st mass apoe mice 6 12 months age substantially increased relative apoe mice advanced age fig 5 contrast st content examined regions apoe3 transgenic mice substantially lower compared found apoe mice ages 12 months older although st content two types mice almost identical 6 months age fig 5 also found alterations st mass mediated apoe smaller cerebellum found cortex hippocampus early ages fig 5
0.32282493.12501252.html.plaintext.txt	42	view larger version 14k fig 5 age dependent regulation sulfatide mass levels hippocampus cortex cerebellum wild type apoe human apoe3 transgenic mice sulfatide mass levels lipid extracts hippocampus cortex b cerebellum c apoe apoe human apoe3 transgenic mice determined using negative ion esims described experimental procedures error bars within symbols
0.32282493.12501252.html.plaintext.txt	43	sulfatide content cultured astrocyte secreted apoe particles human csf investigate possible mechanisms apoe mediated alterations st content cns two experiments performed first purified astrocyte secreted lipoproteins containing either apoe3 apoe4 prepared cultured astrocytes described experimental procedures st content particles quantitated esims found st content particles negligible although apoe4 particles contained st mass found apoe3 particles 731 plus minus 45 versus 562 plus minus 22 pmolmg apoe respectively second csf contains cns produced apoe containing lipoprotein particles samples collected age matched cognitively normal human subjects st content csf samples analyzed esims st mass nmolmg apoe apoe3e3 homozygous subjects 464 plus minus 33 whereas level significantly higher subjects one two alleles apoe4 537 plus minus 46 p 001 fig 6 noted st content csf samples subjects either heterozygous homozygous apoe4 34 44 indistinguishable study therefore concluded human csf contains significant amount st mass level st human csf apoe isoform dependent
0.32282493.12501252.html.plaintext.txt	44	sulfatide content cultured astrocyte secreted apoe particles human csf investigate possible mechanisms apoe mediated alterations st content cns two experiments performed first purified astrocyte secreted lipoproteins containing either apoe3 apoe4 prepared cultured astrocytes described experimental procedures st content particles quantitated esims found st content particles negligible although apoe4 particles contained st mass found apoe3 particles 731 plus minus 45 versus 562 plus minus 22 pmolmg apoe respectively second csf contains cns produced apoe containing lipoprotein particles samples collected age matched cognitively normal human subjects st content csf samples analyzed esims st mass nmolmg apoe apoe3e3 homozygous subjects 464 plus minus 33 whereas level significantly higher subjects one two alleles apoe4 537 plus minus 46 p 001 fig 6 noted st content csf samples subjects either heterozygous homozygous apoe4 34 44 indistinguishable study therefore concluded human csf contains significant amount st mass level st human csf apoe isoform dependent
0.32282493.12501252.html.plaintext.txt	45	view larger version 10k fig 6 relationship sulfatide mass human cerebrospinal fluid apoe genotypes subjects cerebrospinal fluid samples collected age matched 708 plus minus 49 years cognitively normal human subjects lipids extracted modified method bligh dyer described experimental procedures mass st lipid extracts human cerebrospinal fluid subjects homozygous apoe3 denotes average level sulfatide mass homozygous heterozygous apoe4 denotes average level sulfatide mass determined using negative ion esims described experimental procedures p 001
0.32282493.12501252.html.plaintext.txt	46	identification st carriers human csf examination mass levels st cultured astrocyte secreted apoe particles human csf see last subsection suggests two possibilities first st molecules acquired directly associate apoe particles cns apoe particles secreted astrocytes alternatively st molecules may influenced apoe indirect fashion directly associate interact apoe containing lipoproteins therefore understand one mechanisms apoe mediated alterations st content cns necessary identify carrier carriers st molecules location st molecules first investigated analyzing st content human csf fractions gel filtration chromatography found sulfatides co localized exactly hdl like lipoproteins present human csf fig 7a two abundant apolipoproteins produced cns apoe apoj well several apolipoproteins present human csf therefore experiments performed identify specific carriers st human csf immunoprecipitation see inset fig 7b western blots followed esims quantitation st content supernatants pellets found 80 mol st molecules immunoprecipitated anti apoe antibodies whereas st molecules specifically immunoprecipitated anti apoj antibodies fig 7 b c results clearly demonstrated st molecules specifically associated apoe containing hdl like lipoproteins csf suggested apoe particles mainly acquired st cns secretion astrocytes
0.32282493.12501252.html.plaintext.txt	47	identification st carriers human csf examination mass levels st cultured astrocyte secreted apoe particles human csf see last subsection suggests two possibilities first st molecules acquired directly associate apoe particles cns apoe particles secreted astrocytes alternatively st molecules may influenced apoe indirect fashion directly associate interact apoe containing lipoproteins therefore understand one mechanisms apoe mediated alterations st content cns necessary identify carrier carriers st molecules location st molecules first investigated analyzing st content human csf fractions gel filtration chromatography found sulfatides co localized exactly hdl like lipoproteins present human csf fig 7a two abundant apolipoproteins produced cns apoe apoj well several apolipoproteins present human csf therefore experiments performed identify specific carriers st human csf immunoprecipitation see inset fig 7b western blots followed esims quantitation st content supernatants pellets found 80 mol st molecules immunoprecipitated anti apoe antibodies whereas st molecules specifically immunoprecipitated anti apoj antibodies fig 7 b c results clearly demonstrated st molecules specifically associated apoe containing hdl like lipoproteins csf suggested apoe particles mainly acquired st cns secretion astrocytes
0.32282493.12501252.html.plaintext.txt	48	view larger version 22k fig 7 identification sulfatide carrier human cerebrospinal fluid quantitation sulfatide content human cerebrospinal fluid fractions gel filtration chromatography human cerebrospinal fluid fractionated employing tandem superose 6 columns described experimental procedures seventy fractions 400 microl collected lipids individual fraction extracted presence n palmitoyl sulfatide 70 pmolfraction used internal standard sulfatide quantitation using modified bligh dyer method sulfatide content fraction quantitated esims described experimental procedures x axis indicates fraction number known elution profile csf lipoproteins reported previously 27 quantitation sulfatide content immunoprecipitated lipoprotein particles b supernatants immunoprecipitation c initiated incubating 17 ml pooled human cerebrospinal fluids individual antibodies indicated described experimental procedures lipids immunoprecipitation pellet extracted presence n palmitoyl sulfatide 70 pmol sulfatide content lipid extracts quantitated esims described experimental procedures data represent means plus minus se least three separate experiments inset b shows typical western blot using anti apoe anti apoj antibodies analyze apoe apoj content csf samples prior pre ip immunoprecipitation following post ip following immunoprecipitation csf pellet also analyzed apoe apoj
0.32282493.12501252.html.plaintext.txt	49	examination hydrolysis sulfatide mediated apoes demonstrated human csf apoe containing lipoproteins contain st likely effects apoe st via association apoe containing cns lipoproteins subsequent apoe regulated metabolism however possible one determinant apoe mediated st content differences cns might occur apoe catalyzed hydrolysis accordingly hydrolytic products st ie galc cer brain tissue samples wild type apoe human apoe transgenic mice determined esims significant differences galc content table cer content data shown mice additionally neither galc cer detected lipid extracts sulfatide vesicles incubation type rhapoe isoforms vesicles 4 h results suggest differences st content different apoe mice caused apoe mediated st hydrolysis discussion top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	50	examination hydrolysis sulfatide mediated apoes demonstrated human csf apoe containing lipoproteins contain st likely effects apoe st via association apoe containing cns lipoproteins subsequent apoe regulated metabolism however possible one determinant apoe mediated st content differences cns might occur apoe catalyzed hydrolysis accordingly hydrolytic products st ie galc cer brain tissue samples wild type apoe human apoe transgenic mice determined esims significant differences galc content table cer content data shown mice additionally neither galc cer detected lipid extracts sulfatide vesicles incubation type rhapoe isoforms vesicles 4 h results suggest differences st content different apoe mice caused apoe mediated st hydrolysis discussion top abstract introduction experimental procedures results discussion references
0.32282493.12501252.html.plaintext.txt	51	involvement apoe metabolism phospholipids cholesterol plasma well known 1 25 investigate whether apoe influences mass distribution brain lipids systematically quantified distribution lipids including multiple phospholipids sphingolipids cholesterol different brain regions wild type apoe human apoe transgenic mice found significant effects apoe content examined lipids exception st levels dramatically altered apoe knockout human apoe transgenic mice furthermore apoe mediated alteration st content cns regulated aging well apoe produced brain human apoe transgenic mice express apoe brain still markedly elevated plasma cholesterol 26 results examination st content astrocyte secreted apoe particles indicate apoe acquire small amount st directly cells secrete apoe however brain st produced oligodendrocytes located myelin cns likely majority st apoe particles cns acquired myelin apoe secretion expressed cells major effect mouse human apoe appears keeping st levels brain lower level present absence apoe effect probably due apoe containing lipoproteins facilitating cellular clearance st although hydrolysis st directly catalyzed apoe observed study apoe associated st hydrolysis vivo completely excluded showed st directly associates apoe containing lipoproteins csf likely transport st apoe particles brain interstitial fluid csf endocytotic recycling apoe particles ldl receptor ldl receptor family members ldl receptor related proteins 37 major pathways apoe mediates st metabolism cns
0.32282493.12501252.html.plaintext.txt	52	involvement apoe metabolism phospholipids cholesterol plasma well known 1 25 investigate whether apoe influences mass distribution brain lipids systematically quantified distribution lipids including multiple phospholipids sphingolipids cholesterol different brain regions wild type apoe human apoe transgenic mice found significant effects apoe content examined lipids exception st levels dramatically altered apoe knockout human apoe transgenic mice furthermore apoe mediated alteration st content cns regulated aging well apoe produced brain human apoe transgenic mice express apoe brain still markedly elevated plasma cholesterol 26 results examination st content astrocyte secreted apoe particles indicate apoe acquire small amount st directly cells secrete apoe however brain st produced oligodendrocytes located myelin cns likely majority st apoe particles cns acquired myelin apoe secretion expressed cells major effect mouse human apoe appears keeping st levels brain lower level present absence apoe effect probably due apoe containing lipoproteins facilitating cellular clearance st although hydrolysis st directly catalyzed apoe observed study apoe associated st hydrolysis vivo completely excluded showed st directly associates apoe containing lipoproteins csf likely transport st apoe particles brain interstitial fluid csf endocytotic recycling apoe particles ldl receptor ldl receptor family members ldl receptor related proteins 37 major pathways apoe mediates st metabolism cns
0.32282493.12501252.html.plaintext.txt	53	4 allele apoe strong genetic risk factor ad cerebral amyloid angiopathy whereas 2 allele protective although several possible mechanisms associations exist strong evidence suggest interaction apoe play important role effect apoe ad see refs 11 38 reviews example transgenic animal models develop ad like amyloidosis neuritic plaques lack apoe results little fibrillar amyloid formation neuritic dystrophy 14 39 expression human apoe results isoform specific deposition amyloid within neuritic plaques effect order apoe4 e3 e2 15 40 effects apoe likely mediated interactions apoe containing hdl form apoe brain given issues way sulfatide association apoe containing lipoproteins may involved apoe interactions
0.32282493.12501252.html.plaintext.txt	54	4 allele apoe strong genetic risk factor ad cerebral amyloid angiopathy whereas 2 allele protective although several possible mechanisms associations exist strong evidence suggest interaction apoe play important role effect apoe ad see refs 11 38 reviews example transgenic animal models develop ad like amyloidosis neuritic plaques lack apoe results little fibrillar amyloid formation neuritic dystrophy 14 39 expression human apoe results isoform specific deposition amyloid within neuritic plaques effect order apoe4 e3 e2 15 40 effects apoe likely mediated interactions apoe containing hdl form apoe brain given issues way sulfatide association apoe containing lipoproteins may involved apoe interactions
0.32282493.12501252.html.plaintext.txt	55	shown apoe interaction markedly influenced presence lipids 41 43 however previous work 27 data presented shown quantitative difference amount phospholipids cholesterol present brain csf lipoproteins presence absence apoe apoe isoforms contrast observed significant isoform specific difference st levels e4 e3 human csf lipoproteins although yet explored whether sulfatide levels apoe particles influence interactions shown portion co elutes apoe containing hdl particles shown also contain st human csf 27
0.32282493.12501252.html.plaintext.txt	56	shown apoe interaction markedly influenced presence lipids 41 43 however previous work 27 data presented shown quantitative difference amount phospholipids cholesterol present brain csf lipoproteins presence absence apoe apoe isoforms contrast observed significant isoform specific difference st levels e4 e3 human csf lipoproteins although yet explored whether sulfatide levels apoe particles influence interactions shown portion co elutes apoe containing hdl particles shown also contain st human csf 27
0.32282493.12501252.html.plaintext.txt	57	addition effect apoe apoe isoform risk ad substantial evidence apoe4 also risk factor poor outcome following certain cns injuries head trauma multiple sclerosis possibly stroke see ref 9 recent review apoe plays role processes remains unclear possible effect via isoform specific difference regeneration shown vitro vivo models see ref 9 recent review also possible particularly case multiple sclerosis possibly stroke apoe somehow regulating cns inflammatory processes cytokine production seen models eg ref 44
0.32282493.12501252.html.plaintext.txt	58	interestingly numerous studies shown sulfatides ligands family receptor proteins called selectins located activated vascular endothelial cells leukocytes activated platelets 45 51 although relationship role apoe immunoregulation sulfatide ligand selectins unclear shown sulfatides potent anti inflammatory agents 52 potential relationship likely indicates possible role st apoe particles anti inflammatory immunomodulatory molecule
0.32282493.12501252.html.plaintext.txt	59	interestingly numerous studies shown sulfatides ligands family receptor proteins called selectins located activated vascular endothelial cells leukocytes activated platelets 45 51 although relationship role apoe immunoregulation sulfatide ligand selectins unclear shown sulfatides potent anti inflammatory agents 52 potential relationship likely indicates possible role st apoe particles anti inflammatory immunomodulatory molecule
0.32282493.12501252.html.plaintext.txt	60	sum although apoe brain play major role regulating brain phospholipid cholesterol levels data show apoe plays important role regulating brain sulfatide levels via apoe containing cns lipoproteins serving extracellular st carrier regulates metabolism work understanding relationship apoe st may provide important clues pathogenesis effects apoe ad following different cns injuries acknowledgements
0.32282493.12501252.html.plaintext.txt	61	sum although apoe brain play major role regulating brain phospholipid cholesterol levels data show apoe plays important role regulating brain sulfatide levels via apoe containing cns lipoproteins serving extracellular st carrier regulates metabolism work understanding relationship apoe st may provide important clues pathogenesis effects apoe ad following different cns injuries acknowledgements
0.32282493.12501252.html.plaintext.txt	62	grateful washington university mass spectrometer facility center use electrospray ionization mass spectrometer thank clinical core washington university alzheimers disease research center providing subject evaluations clinical dementia ratings washington university general clinical research center providing lumbar csf samples also give special thanks maia parsadanian skillful assistance mouse brain dissection
0.32282493.12501252.html.plaintext.txt	63	grateful washington university mass spectrometer facility center use electrospray ionization mass spectrometer thank clinical core washington university alzheimers disease research center providing subject evaluations clinical dementia ratings washington university general clinical research center providing lumbar csf samples also give special thanks maia parsadanian skillful assistance mouse brain dissection
0.32282493.12501252.html.plaintext.txt	64	work supported nia national institutes health nih grant p50 ag05681 nih grant ag 13956 nih grant m01 rr00036 alzheimers disease related disorders program university missouri systemthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.32282493.12501252.html.plaintext.txt	65	work supported nia national institutes health nih grant p50 ag05681 nih grant ag 13956 nih grant m01 rr00036 alzheimers disease related disorders program university missouri systemthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.32282493.12501252.html.plaintext.txt	66	correspondence addressed division bioorganic chemistry molecular pharmacology dept internal medicine washington university school medicine box 8020 660 euclid ave st louis mo 63110 tel 314 362 2690 fax 314 362 1402 e mail xianlinpcgwustledu
0.32282493.12501252.html.plaintext.txt	67	correspondence addressed division bioorganic chemistry molecular pharmacology dept internal medicine washington university school medicine box 8020 660 euclid ave st louis mo 63110 tel 314 362 2690 fax 314 362 1402 e mail xianlinpcgwustledu
0.32282493.12501252.html.plaintext.txt	68	published jbc papers press december 24 2002 doi 101074jbcm212340200
0.32282493.12501252.html.plaintext.txt	69	abbreviations used apoe apolipoprotein e apoe3 apoe4 human apoe isoforms apoj apolipoprotein j ad alzheimers disease cer ceramides cns central nervous system csf cerebrospinal fluid esims electrospray ionization mass spectrometry galc galactocerebrosides hdl high density lipoprotein ldl low density lipoprotein mn acyl chain containing m carbons n double bonds nmn acyl amide m carbons n double bonds pc choline glycerophospholipids pe ethanolamine glycerophospholipids ptdcho phosphatidylcholine ptdetn phosphatidylethanolamine ptdgro phosphatidylglycerols ptdins phosphatidylinositols ptdser phosphatidylserines rhapoe human recombinant apoe sm sphingomyelins st sulfatides amyloid peptide gfap glial fibrillary acidic protein
0.32282493.12501252.html.plaintext.txt	70	references top abstract introduction experimental procedures results discussion references 1 mahley r w 1988 science 240 622 630medline order article via infotrieve 2 weisgraber k h 1994 adv protein chem 45 249 302medline order article via infotrieve 3 pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text 4 elshourbagy n liao w mahley r w taylor j m 1985 proc natl acad sci u 82 203 207abstract 5 pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917 148 161medline order article via infotrieve 6 ignatius m j shooter e m pitas r e mahley r w 1987 science 236 959 962medline order article via infotrieve 7 holtzman d m pitas r e kilbridge j nathan b mahley r w bu g schwartz l 1995 proc natl acad sci u 92 9480 9484abstract 8 buttini m orth m bellosta akeefe h pitas r e wyss coray mucke l mahley r w 1999 j neurosci 19 4867 4880abstractfree full text 9 teter b 2000 alzheimers rep 3 199 212 10 strittmatter w j roses d 1996 annu rev neurosci 19 53 77crossrefmedline order article via infotrieve 11 holtzman d m 2001 j mol neurosci 17 147 155crossrefmedline order article via infotrieve 12 wisniewski frangione b 1992 neurosci lett 135 235 238crossrefmedline order article via infotrieve 13 strittmatter w j weisgraber k h huang d y dong l salvesen g pericak vance m schmechel d saunders m goldgaber d roses d 1993 proc natl acad sci u 90 8098 8102abstractfree full text 14 bales k r verina dodel r c du y altstiel l bender m hyslop p johnstone e m little p cummins d j piccardo p ghetti b paul m 1997 nat genet 17 263 264medline order article via infotrieve 15 holtzman d m bales k r tenkova fagan m parsadanian m sartorius l j mackey b olney j mckeel d wozniak d paul m 2000a proc natl acad sci u 97 2892 2897abstractfree full text 16 vos j p lopes cardozo m gadella b m 1994 biochim biophys acta 1211 125 149medline order article via infotrieve 17 merrill h jr schmelz e m dillehay d l spiegel shayman j schroeder j j riley r voss k wang e 1997 toxicol appl pharmacol 142 208 225crossrefmedline order article via infotrieve 18 ishizuka 1997 prog lipid res 36 245 319crossrefmedline order article via infotrieve 19 kolodny e h fluharty l 1995 metabolic basis inherited disease scriver c r beaudet l sly w valle d eds pp 2693 2739 mcgraw hill new york 20 han x holtzman d m mckeel d w jr kelley j morris j c 2002 j neurochem 82 809 818crossrefmedline order article via infotrieve 21 bosio binczek e stoffel w 1996 proc natl acad sci u 93 13280 13285abstractfree full text 22 coetzee dupree j l popko b 1998 j neurosci res 54 613 62230co2 v ssow h adam j stoffel w 1998 cell tissue res 292 199 210crossrefmedline order article via infotrieve 24 coetzee fujita n dupree j shi r blight suzuki k popko b 1996 cell 86 209 219medline order article via infotrieve 25 plump breslow j l 1995 annu rev nutr 15 495 518crossrefmedline order article via infotrieve 26 sun y wu bu g onifade m k patel n ladu m j fagan m holtzman d m 1998 j neurosci 18 3261 3272abstractfree full text 27 fagan m younkin l h morris j c fryer j d cole g younkin g holtzman d m 2000 ann neurol 48 201 21030co2 x 2 8linktypedoi crossrefmedline order article via infotrieve 40 fagan m watson m parsadanian m bales k r paul m holtzman d m 2002 neurobiol dis 9 305 318crossrefmedline order article via infotrieve 41 ladu m j falduto m manelli m reardon c getz g frail d e 1994 j biol chem 269 23403 23406abstractfree full text 42 ladu m j pederson m frail d e reardon c getz g falduto m 1995 j biol chem 270 9039 9042abstractfree full text 43 tokuda calero m matsubara e vidal r kumar permanne b zlokovic b smith j d ladu m j rostagno frangione b ghiso j 2000 biochem j 348 359 365crossrefmedline order article via infotrieve 44 laskowitz d goel bennett e r matthew w d 1997 j neuroimmunol 76 70 74crossrefmedline order article via infotrieve 45 todderud g alford j millsap k aruffo tramposch k m 1992 j leukocyte biol 52 85 88abstract 46 suzuki y toda y tamatani watanabe suzuki nakao murase k kiso m hasegawa tadano aritomi k ishizuka miyasaka m 1993 biochem biophys res commun 190 426 434crossrefmedline order article via infotrieve 47 bajorath j hollenbaugh d king g harte w jr eustice d c darveau r p aruffo 1994 biochemistry 33 1332 1339medline order article via infotrieve 48 kajihara j ye g kato k suzuki y 1995 biosci biotechnol biochem 59 155 157medline order article via infotrieve 49 mulligan m miyasaka m suzuki m kawashima h lizuka m hasegawa kiso m warner r l ward p 1995 int immunol 7 1107 1113abstract 50 bowman k g cook b n de graffenried c l bertozzi c r 2001 biochemistry 40 5382 5391crossrefmedline order article via infotrieve 51 merten m thiagarajan p 2001 circulation 104 2955 2960abstractfree full text 52 marinier martel banville j bachand c remillard r lapointe p turmel b menard m harte w e jr wright j j k todderud g tramposch k m bajorath j hollenbaugh d aruffo 1997 j med chem 40 3234 3247crossrefmedline order article via infotrieve
0.32282493.12501252.html.plaintext.txt	71	copyright 2003 american society biochemistry molecular biology inc
0.3345159.16033878.html.plaintext.txt	0	large meta analysis establishes ace insertion deletion polymorphism marker alzheimers disease donald j lehmann1 mario cortina borja2 donald r warden1 david smith1 kristel sleegers3 jonathan prince4 cornelia m van duijn3 patrick g kehoe5
0.3345159.16033878.html.plaintext.txt	1	large meta analysis establishes ace insertion deletion polymorphism marker alzheimers disease donald j lehmann1 mario cortina borja2 donald r warden1 david smith1 kristel sleegers3 jonathan prince4 cornelia m van duijn3 patrick g kehoe5
0.3345159.16033878.html.plaintext.txt	2	1 oxford project investigate memory ageing optima department pharmacology university oxford oxford united kingdom 2 centre paediatric epidemiology biostatistics institute child health university college london london united kingdom 3 department epidemiology biostatistics erasmus mc rotterdam netherlands 4 center genomics bioinformatics karolinska institute stockholm sweden 5 care elderly department clinical science north bristol university bristol frenchay hospital bristol united kingdom
0.3345159.16033878.html.plaintext.txt	3	received publication january 5 2005 accepted publication march 22 2005
0.3345159.16033878.html.plaintext.txt	4	received publication january 5 2005 accepted publication march 22 2005
0.3345159.16033878.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references apolipoprotein e 4 apoe4 fully established susceptibility allele alzheimers disease one studied candidates insertion ideletion d polymorphism indel gene angiotensin converting enzyme ace study aimed clarify association alzheimers disease meta analysis included 39 samples comprising 6037 cases alzheimers disease 12099 controls using mainly primary data potential interactions gender age ethnic group carrier status apolipoprotein e 4 allele examined d homozygotes reduced risk alzheimers disease odds ratio 081 95 confidence interval 072 090 corrected p 00004 homozygotes showed association alzheimers disease heterozygotes increased risk although clear differences among three ethnic groups examined north europeans south caucasians east asians groups d homozygotes reduced risk results confirm association angiotensin converting enzyme indel alzheimers disease across diverse populations although probably due linkage disequilibrium true risk factor north europeans association hardy weinberg analysis suggested partial heterosis increased risk heterozygotes due hidden interaction another yet unknown risk factor interaction warrants investigation
0.3345159.16033878.html.plaintext.txt	6	abstract top abstract introduction materials methods results discussion references apolipoprotein e 4 apoe4 fully established susceptibility allele alzheimers disease one studied candidates insertion ideletion d polymorphism indel gene angiotensin converting enzyme ace study aimed clarify association alzheimers disease meta analysis included 39 samples comprising 6037 cases alzheimers disease 12099 controls using mainly primary data potential interactions gender age ethnic group carrier status apolipoprotein e 4 allele examined d homozygotes reduced risk alzheimers disease odds ratio 081 95 confidence interval 072 090 corrected p 00004 homozygotes showed association alzheimers disease heterozygotes increased risk although clear differences among three ethnic groups examined north europeans south caucasians east asians groups d homozygotes reduced risk results confirm association angiotensin converting enzyme indel alzheimers disease across diverse populations although probably due linkage disequilibrium true risk factor north europeans association hardy weinberg analysis suggested partial heterosis increased risk heterozygotes due hidden interaction another yet unknown risk factor interaction warrants investigation
0.3345159.16033878.html.plaintext.txt	7	alzheimer disease heterogeneity meta analysis
0.3345159.16033878.html.plaintext.txt	8	abbreviations ace angiotensin converting enzyme protein ace angiotensin converting enzyme gene apoe4 apolipoprotein e 4 allele
0.3345159.16033878.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references 1999 kehoe et al 1 first proposed association alzheimers disease insertion ideletion d polymorphism indel intron 16 gene angiotensin converting enzyme ace chromosome 17q23 enzyme converts angiotensin angiotensin ii potently hypertensive d allele associated raised plasma levels enzyme 2 3 kehoe et al 1 found positives di ii increased risk alzheimers disease study comprised three samples cardiff london britain belfast northern ireland strikingly similar results
0.3345159.16033878.html.plaintext.txt	10	introduction top abstract introduction materials methods results discussion references 1999 kehoe et al 1 first proposed association alzheimers disease insertion ideletion d polymorphism indel intron 16 gene angiotensin converting enzyme ace chromosome 17q23 enzyme converts angiotensin angiotensin ii potently hypertensive d allele associated raised plasma levels enzyme 2 3 kehoe et al 1 found positives di ii increased risk alzheimers disease study comprised three samples cardiff london britain belfast northern ireland strikingly similar results
0.3345159.16033878.html.plaintext.txt	11	since potential association examined 40 samples 4 5 table 1 around world several studies replicated report increased risk positives contradicted many found association alzheimers disease one study suggested effect age association 6 another proposed influence gender 7 association onset age alzheimers disease also proposed 8
0.3345159.16033878.html.plaintext.txt	12	since potential association examined 40 samples 4 5 table 1 around world several studies replicated report increased risk positives contradicted many found association alzheimers disease one study suggested effect age association 6 another proposed influence gender 7 association onset age alzheimers disease also proposed 8
0.3345159.16033878.html.plaintext.txt	13	view table table 1 cohorts used meta analysis ace insertion deletion polymorphism alzheimers disease
0.3345159.16033878.html.plaintext.txt	14	association recently studied longitudinal observational cohorts oxford project investigate memory ageing optima rotterdam study 9 groups found suggestion gender difference results consistent previous report 7 therefore undertook meta analysis studies association ace indel alzheimers disease stratified gender age ethnic group apolipoprotein e 4 allele apoe4 carrier status using mainly primary data supplied authors
0.3345159.16033878.html.plaintext.txt	15	association recently studied longitudinal observational cohorts oxford project investigate memory ageing optima rotterdam study 9 groups found suggestion gender difference results consistent previous report 7 therefore undertook meta analysis studies association ace indel alzheimers disease stratified gender age ethnic group apolipoprotein e 4 allele apoe4 carrier status using mainly primary data supplied authors
0.3345159.16033878.html.plaintext.txt	16	although three previous meta analyses ace studies reported 10 12 subsequent studies made data available compared even latest meta analysis 12 10 samples eight studies available us 9 13 18 study oxford project investigate memory ageing addition previous meta analyses based published data largely unstratified thus limited interpretations allowed using primary data able explore deeply searching sources heterogeneity two previous stratified meta analyses alzheimers disease genes 19 20 based primary data deepened understanding
0.3345159.16033878.html.plaintext.txt	17	although three previous meta analyses ace studies reported 10 12 subsequent studies made data available compared even latest meta analysis 12 10 samples eight studies available us 9 13 18 study oxford project investigate memory ageing addition previous meta analyses based published data largely unstratified thus limited interpretations allowed using primary data able explore deeply searching sources heterogeneity two previous stratified meta analyses alzheimers disease genes 19 20 based primary data deepened understanding
0.3345159.16033878.html.plaintext.txt	18	egger et al 21 stressed need examine sources heterogeneity meta analyses case control studies therefore divided analysis two phases first broad overall analysis second detailed examination sources heterogeneity aimed discover whether ace indel associated alzheimers disease nature association
0.3345159.16033878.html.plaintext.txt	19	materials methods top abstract introduction materials methods results discussion references phase 1 broad analysis april 2003 following pubmed searches study references abstracts communication experts wrote authors association studies ace indel alzheimers disease known us 33 studies involving 41 samples 4 5 table 1 including seven samples unpublished studies searches updated november 2004 without data arising stratified analyses used raw data stratified summaries received authors 26 samples overall analyses also used published data making 39 samples altogether table 1 early onset cases 50 years young controls 50 years excluded identifiable subjects incomplete data distinct populations treated separately possible large number controls cohort sleegers et al 9 fully assessed 22 samples genotyped ace indel except two prince et al 23 24 used ace rs4343 marker 85 90 percent linkage disequilibrium indel north europeans
0.3345159.16033878.html.plaintext.txt	20	materials methods top abstract introduction materials methods results discussion references phase 1 broad analysis april 2003 following pubmed searches study references abstracts communication experts wrote authors association studies ace indel alzheimers disease known us 33 studies involving 41 samples 4 5 table 1 including seven samples unpublished studies searches updated november 2004 without data arising stratified analyses used raw data stratified summaries received authors 26 samples overall analyses also used published data making 39 samples altogether table 1 early onset cases 50 years young controls 50 years excluded identifiable subjects incomplete data distinct populations treated separately possible large number controls cohort sleegers et al 9 fully assessed 22 samples genotyped ace indel except two prince et al 23 24 used ace rs4343 marker 85 90 percent linkage disequilibrium indel north europeans
0.3345159.16033878.html.plaintext.txt	21	phase 2 examination heterogeneity examined six possible sources heterogeneity performed analyses stratified age gender apoe4 status age stratifications 65 years 65 75 years 75 years divided samples two groups according ages cases defined example onset first group examination death second group also conducted analyses restricted controls diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease cerad 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda 26 26 full samples two part samples separate analyses excluded eight samples hardy weinberg analysis genotyping methods compatible mistyping underreporting heterozygotes may occur unless either 5 percent dimethyl sulfoxide included polymerase chain reaction 27 dd genotype confirmed insertion specific second amplification 28 analyses samples placed possible 34 39 samples one three ethnic groups north european 19 samples south caucasian 11 samples defined mediterranean middle east east asian four samples china japan
0.3345159.16033878.html.plaintext.txt	22	phase 2 examination heterogeneity examined six possible sources heterogeneity performed analyses stratified age gender apoe4 status age stratifications 65 years 65 75 years 75 years divided samples two groups according ages cases defined example onset first group examination death second group also conducted analyses restricted controls diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease cerad 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association nincds adrda 26 26 full samples two part samples separate analyses excluded eight samples hardy weinberg analysis genotyping methods compatible mistyping underreporting heterozygotes may occur unless either 5 percent dimethyl sulfoxide included polymerase chain reaction 27 dd genotype confirmed insertion specific second amplification 28 analyses samples placed possible 34 39 samples one three ethnic groups north european 19 samples south caucasian 11 samples defined mediterranean middle east east asian four samples china japan
0.3345159.16033878.html.plaintext.txt	23	data analysis statistical methods three methods commonly used produce odds ratios genetic association studies method 1 allelic ie d vs case method 2 comparing genotype one turn eg dd vs di method 3 comparing genotype turn two combined three methods subject bias degree bias depending imperfectly model fits reality instance method 1 best suited testing codominant model allelic dose effect eg dd di ii method 3 hand may used test either dominantd recessive d dominanti recessive model chose follow hypothesis generating study 1 using method 3 partly preliminary examination subsequent studies shown evidence codominance also used methods 2 3 examine heterosis heterozygotes greater lesser risk either homozygote main approach method 3 gives estimate risk associated genotype compared rest population
0.3345159.16033878.html.plaintext.txt	24	pooled odds ratios calculated three times fixed effects method mantel haenszel 29 random effects method dersimonian laird 30 bayesian random effects method warn et al 31 however results three methods similar first two shown table 2 methods meta analysis permit accumulation results across independent studies even number subjects ratio cases controls varies considerably cohort sleegers et al 9 example heterogeneity test method armitage 32 logistic regression analysis used compare odds ratios among ethnic groups funnel plots 33 cumulative meta analysis 34 used investigate bias analyses performed using r 35 package rmeta thomas lumley httpwwwcranr projectorgsrccontribdescriptionsrmetahtml tests significance two sided bonferroni correction factor 3 applied p values genotype
0.3345159.16033878.html.plaintext.txt	25	view table table 2 odds ratios alzheimers disease ace genotype versus two meta analysis
0.3345159.16033878.html.plaintext.txt	26	results top abstract introduction materials methods results discussion references phase 1 broad analysis examination bias found evidence publication bias funnel plots comparisons commonly made d homozygotes versus positives ie di ii homozygotes versus d positives shown figure 1 plots gave p 019 p 021 respectively figure 2 shows cumulative meta analysis study july 1998 november 2004 d homozygotes versus positives comparison made hypothesis generating study kehoe et al 1 four 39 cohorts studied odds ratio dersimonian laird 30 became significantly less 1 remained thereafter changed little around 08 2001
0.3345159.16033878.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references phase 1 broad analysis examination bias found evidence publication bias funnel plots comparisons commonly made d homozygotes versus positives ie di ii homozygotes versus d positives shown figure 1 plots gave p 019 p 021 respectively figure 2 shows cumulative meta analysis study july 1998 november 2004 d homozygotes versus positives comparison made hypothesis generating study kehoe et al 1 four 39 cohorts studied odds ratio dersimonian laird 30 became significantly less 1 remained thereafter changed little around 08 2001
0.3345159.16033878.html.plaintext.txt	28	view larger version 18k figure 1 funnel plots angiotensin converting enzyme gene ace studies d homozygotes versus di ii p 021 b homozygotes versus di dd p 019 d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals dashed vertical lines summary log odds ratios
0.3345159.16033878.html.plaintext.txt	29	view larger version 18k figure 1 funnel plots angiotensin converting enzyme gene ace studies d homozygotes versus di ii p 021 b homozygotes versus di dd p 019 d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals dashed vertical lines summary log odds ratios
0.3345159.16033878.html.plaintext.txt	30	view larger version 45k figure 2 cumulative meta analysis odds ratio alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals vertical dotted line summary odds ratio optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	31	view larger version 45k figure 2 cumulative meta analysis odds ratio alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals vertical dotted line summary odds ratio optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	32	risk alzheimers disease genotype odds ratios genotype versus two shown figures 3 4 5 summarized table 2 d homozygotes reduced risk alzheimers disease overall odds ratio 081 95 percent confidence interval 072 090 corrected p 00004 method dersimonian laird 30 heterozygotes increased risk alzheimers disease overall odds ratio 112 95 percent confidence interval 104 122 corrected p 0006 odds ratio alzheimers disease homozygotes versus d positives differ significantly 1 two three results heterogeneous
0.3345159.16033878.html.plaintext.txt	33	risk alzheimers disease genotype odds ratios genotype versus two shown figures 3 4 5 summarized table 2 d homozygotes reduced risk alzheimers disease overall odds ratio 081 95 percent confidence interval 072 090 corrected p 00004 method dersimonian laird 30 heterozygotes increased risk alzheimers disease overall odds ratio 112 95 percent confidence interval 104 122 corrected p 0006 odds ratio alzheimers disease homozygotes versus d positives differ significantly 1 two three results heterogeneous
0.3345159.16033878.html.plaintext.txt	34	view larger version 45k figure 3 odds ratios alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	35	view larger version 45k figure 3 odds ratios alzheimers disease aced homozygotes versus positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	36	view larger version 48k figure 4 odds ratios alzheimers disease ace heterozygotes versus homozygotes horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	37	view larger version 48k figure 4 odds ratios alzheimers disease ace heterozygotes versus homozygotes horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	38	view larger version 46k figure 5 odds ratios alzheimers disease acei homozygotes versus d positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	39	view larger version 46k figure 5 odds ratios alzheimers disease acei homozygotes versus d positives d represents deletion allele represents insertion allele horizontal lines 95 confidence intervals optima oxford project investigate memory ageing ace angiotensin converting enzyme gene additional study information given table 1
0.3345159.16033878.html.plaintext.txt	40	onset age alzheimers disease onset age data available 13 samples comprising 2309 cases alzheimers disease stratified analyses linear regression analysis performed data also subset 10 north european samples comprising 1822 cases alzheimers disease effect acei carrier status onset age alzheimers disease surprisingly modest effect apoe4 carrier status onset age seen data shown
0.3345159.16033878.html.plaintext.txt	41	onset age alzheimers disease onset age data available 13 samples comprising 2309 cases alzheimers disease stratified analyses linear regression analysis performed data also subset 10 north european samples comprising 1822 cases alzheimers disease effect acei carrier status onset age alzheimers disease surprisingly modest effect apoe4 carrier status onset age seen data shown
0.3345159.16033878.html.plaintext.txt	42	phase 2 examination heterogeneity examined six potential sources heterogeneity age gender race apoe4 status misdiagnosis mistyping
0.3345159.16033878.html.plaintext.txt	43	stratification gender apoe4 status significant effects seen gender apoe4 status associations alzheimers disease stratification either two factors remove heterogeneity data shown
0.3345159.16033878.html.plaintext.txt	44	stratification gender apoe4 status significant effects seen gender apoe4 status associations alzheimers disease stratification either two factors remove heterogeneity data shown
0.3345159.16033878.html.plaintext.txt	45	stratification age calculated odds ratios alzheimers disease aced homozygotes versus positives stratified age 65 years 65 75 years 75 years rather little effect age seen association d homozygotes alzheimers disease data shown reduction heterogeneity stratification age
0.3345159.16033878.html.plaintext.txt	46	examination diagnosis repeated overall analyses three genotypes restricting data 28 samples could limited rigorous diagnoses probable definite alzheimers disease according criteria consortium establish registry alzheimers disease 25 national institute neurological communicative disorders stroke alzheimers disease related disorders association 26 odds ratios similar shown table 2 significant odds ratios method dersimonian laird 30 077 d homozygotes 115 heterozygotes nonsignificant odds ratio 110 homozygotes heterogeneity remained d homozygotes p 0005 longer significant p 016 homozygotes
0.3345159.16033878.html.plaintext.txt	47	examination genotyping 12 instances hardy weinberg disequilibrium individual studies four six groups pooled cases controls analyzed race table 3 therefore excluded eight samples mistyping considered possible underreporting heterozygotes taking account genotyping methods hardy weinberg analysis repeated overall analyses remaining 31 samples odds ratios similar table 2 significant odds ratios 081 d homozygotes 112 heterozygotes nonsignificant odds ratio 109 homozygotes heterogeneity remained homozygotes p 002 longer significant d homozygotes p 019
0.3345159.16033878.html.plaintext.txt	48	view table table 3 odds ratios alzheimers disease ace genotype meta analysis ethnic group
0.3345159.16033878.html.plaintext.txt	49	ethnic stratification samples divided three ethnic groups possible north european 19 samples south caucasian mediterranean middle eastern 11 samples east asian chinese japanese four samples removed nearly heterogeneity table 3 table 3 shows clear differences among three ethnic groups overlap whatsoever allelic frequencies among three groups north europeans east asians differed odds ratios d homozygotes versus positives p 00008 homozygotes versus d positives p 00005 south caucasians also differed east asians odds ratio d homozygotes versus positives p 00003 d homozygotes reduced risk groups particularly east asians heterozygotes increased risk north europeans homozygotes higher risk east asians except bayesian analysis examined heterosis heterozygotes greater risk north europeans comparing di dd ii turn found heterozygotes higher risk d homozygotes odds ratio 125 95 percent confidence interval 108 145 significantly higher homozygotes odds ratio 108 95 percent confidence interval 095 122
0.3345159.16033878.html.plaintext.txt	50	discussion top abstract introduction materials methods results discussion references large meta analysis standards alzheimers disease genetics 39 samples comprising 6037 cases alzheimers disease 12099 elderly controls table 1 found evidence publication bias
0.3345159.16033878.html.plaintext.txt	51	discussion top abstract introduction materials methods results discussion references large meta analysis standards alzheimers disease genetics 39 samples comprising 6037 cases alzheimers disease 12099 elderly controls table 1 found evidence publication bias
0.3345159.16033878.html.plaintext.txt	52	aced homozygotes reduced risk alzheimers disease table 2 three main ethnic groups examined table 3 homozygotes neutral regards alzheimers disease risk table 2 except east asians homozygotes may higher risk table 3 heterozygotes increased risk alzheimers disease overall table 2 mainly north europeans table 3 example heterosis discussed similar results achieved three methods fixed effects random effects bayesian random effects refer materials methods table 2 genotypic comparisons made refer materials methods showed allelic dose effect except east asians table 3 thus allelic comparisons would proved less informative
0.3345159.16033878.html.plaintext.txt	53	aced homozygotes reduced risk alzheimers disease table 2 three main ethnic groups examined table 3 homozygotes neutral regards alzheimers disease risk table 2 except east asians homozygotes may higher risk table 3 heterozygotes increased risk alzheimers disease overall table 2 mainly north europeans table 3 example heterosis discussed similar results achieved three methods fixed effects random effects bayesian random effects refer materials methods table 2 genotypic comparisons made refer materials methods showed allelic dose effect except east asians table 3 thus allelic comparisons would proved less informative
0.3345159.16033878.html.plaintext.txt	54	findings odds ratios close 1 even though significantly different 1 tables 2 3 suggest either linkage disequilibrium true risk factor confounding hidden interaction second possibility discussed regarding former kehoe et al 1 study ace haplotypes gave evidence indel may actual risk factor rather linkage disequilibrium nearby functional polymorphism true risk factor ace haplotype analysis also proved value phenotypes enzyme levels 36 insulin levels myocardial infarction obesity 37 future alzheimers disease studies may better examine polymorphisms regulatory regions rather indel
0.3345159.16033878.html.plaintext.txt	55	findings odds ratios close 1 even though significantly different 1 tables 2 3 suggest either linkage disequilibrium true risk factor confounding hidden interaction second possibility discussed regarding former kehoe et al 1 study ace haplotypes gave evidence indel may actual risk factor rather linkage disequilibrium nearby functional polymorphism true risk factor ace haplotype analysis also proved value phenotypes enzyme levels 36 insulin levels myocardial infarction obesity 37 future alzheimers disease studies may better examine polymorphisms regulatory regions rather indel
0.3345159.16033878.html.plaintext.txt	56	overall results consistent kehoe et al 1 1999 also recent meta analyses kehoe et al 11 2003 elkins et al 12 2004 latter report 12 also suggested age difference however although actual ages available mean cohort ages take account different ways defining case ages refer materials methods strongly confounding factor latter problem cannot exclude possibility association might stronger younger cases example aged less 65 years onset less 75 years death
0.3345159.16033878.html.plaintext.txt	57	overall results consistent kehoe et al 1 1999 also recent meta analyses kehoe et al 11 2003 elkins et al 12 2004 latter report 12 also suggested age difference however although actual ages available mean cohort ages take account different ways defining case ages refer materials methods strongly confounding factor latter problem cannot exclude possibility association might stronger younger cases example aged less 65 years onset less 75 years death
0.3345159.16033878.html.plaintext.txt	58	heterogeneity overall results showed heterogeneity table 2 heterogeneity may due differences sample selection eg age gender diagnosis methods eg genotyping may due real differences populations eg race interactions risk factors eg apoe4 examined potential sources heterogeneity found little effect age gender apoe4 status thus confounding initial hypothesis diagnostic genotyping differences contributed heterogeneity former mainly due diagnosis possible alzheimers disease reported poor record confirmation autopsy 38 latter largely due certain genotyping methods may lead underreporting heterozygotes 27 28 shown hardy weinberg analysis
0.3345159.16033878.html.plaintext.txt	59	heterogeneity overall results showed heterogeneity table 2 heterogeneity may due differences sample selection eg age gender diagnosis methods eg genotyping may due real differences populations eg race interactions risk factors eg apoe4 examined potential sources heterogeneity found little effect age gender apoe4 status thus confounding initial hypothesis diagnostic genotyping differences contributed heterogeneity former mainly due diagnosis possible alzheimers disease reported poor record confirmation autopsy 38 latter largely due certain genotyping methods may lead underreporting heterozygotes 27 28 shown hardy weinberg analysis
0.3345159.16033878.html.plaintext.txt	60	however greatest source heterogeneity ethnic differences ethnic stratification removed nearly heterogeneity table 3 clear contrasts among three ethnic groups examined north europeans south caucasians east asians allelic frequencies odds ratios table 3 latter might due differences linkage disequilibrium true risk polymorphism see ethnic differences previously pointed panza et al 17 39 buss et al 40 elkins et al 12 contrasts highlight dangers combining ethnic groups within single cohort even north south europeans indicated panza et al 17 39 unfortunately one cohort african origin united states 41 thus conclusions could drawn africans
0.3345159.16033878.html.plaintext.txt	61	however greatest source heterogeneity ethnic differences ethnic stratification removed nearly heterogeneity table 3 clear contrasts among three ethnic groups examined north europeans south caucasians east asians allelic frequencies odds ratios table 3 latter might due differences linkage disequilibrium true risk polymorphism see ethnic differences previously pointed panza et al 17 39 buss et al 40 elkins et al 12 contrasts highlight dangers combining ethnic groups within single cohort even north south europeans indicated panza et al 17 39 unfortunately one cohort african origin united states 41 thus conclusions could drawn africans
0.3345159.16033878.html.plaintext.txt	62	heterosis deviations hardy weinberg equilibrium common studies ace indel previously pointed buss et al 40 may due either mistyping heterosis several cases disequilibrium indeed compatible mistyping examples disequilibrium north europeans however excess heterozygotes alzheimers disease requires another explanation believe explanation heterosis heterosis occurs heterozygotes show either greater lesser association given trait either group homozygotes case north europeans excess heterozygotes alzheimers disease association heterozygotes alzheimers disease found comings macmurray 42 suggested three explanations heterosis second applied proposes heterosis may follow inadvertent combination two unlike subsets due hidden interaction another unknown risk factor test proposal constructed mathematical model two equal subsets based median split unknown factor x table 4 model illustrates although heterozygotes may intermediate odds ratios subset emerge highest odds ratio subsets combined ie heterosis overall results illustrative model table 4 close present meta analysis table 2 stress however heterosis found north europeans moreover although heterozygotes greater risk d homozygotes odds ratio 125 95 percent confidence interval 108 145 significantly higher risk homozygotes odds ratio 108 95 percent confidence interval 095 122 thus partial heterosis better describes case
0.3345159.16033878.html.plaintext.txt	63	view table table 4 model show heterosis may follow combination two unlike subsets
0.3345159.16033878.html.plaintext.txt	64	hidden interaction partial heterosis north europeans suggests interaction another risk factor alzheimers disease another potential source heterogeneity candidates include cardiovascular risk factors since many also contribute alzheimers disease risk since ace indel associated cardiovascular risk 43 47
0.3345159.16033878.html.plaintext.txt	65	hidden interaction partial heterosis north europeans suggests interaction another risk factor alzheimers disease another potential source heterogeneity candidates include cardiovascular risk factors since many also contribute alzheimers disease risk since ace indel associated cardiovascular risk 43 47
0.3345159.16033878.html.plaintext.txt	66	biologic background full discussion biologic basis associations outside scope mainly analytical study however note associations ace indel nearby polymorphisms various phenotypes including cardiovascular risk 37 43 47 addition ace protein levels raised certain brain regions alzheimers disease 48 50 enzyme reported modify ss amyloid aggregation 51 ace inhibitors reported maintain memory aged rats 52 human patients 53 brain penetrating ace inhibitors associated reduced incidence alzheimers disease elderly hypertensive patients 54 less cognitive decline cases mild moderate alzheimers disease 55 sleegers et al 9 recently provided evidence magnetic resonance imaging increased atrophy hippocampus amygdala nondemented women homozygous acei allele together modest significant increase risk alzheimers disease independent vascular factors d allele associated raised plasma levels ace 2 association thought due linkage disequilibrium nearby polymorphisms 3 36 apparent conflict benefits ace inhibitor therapy associations indel alzheimers disease risk pathology plasma levels ace however influence ace polymorphisms brain levels enzyme yet known cannot assumed reflect levels plasma subject warrants fuller discussion possible detailed discussion given kehoe 56 although need reconsidered perhaps revised light interacting factor factors may emerge future studies
0.3345159.16033878.html.plaintext.txt	67	biologic background full discussion biologic basis associations outside scope mainly analytical study however note associations ace indel nearby polymorphisms various phenotypes including cardiovascular risk 37 43 47 addition ace protein levels raised certain brain regions alzheimers disease 48 50 enzyme reported modify ss amyloid aggregation 51 ace inhibitors reported maintain memory aged rats 52 human patients 53 brain penetrating ace inhibitors associated reduced incidence alzheimers disease elderly hypertensive patients 54 less cognitive decline cases mild moderate alzheimers disease 55 sleegers et al 9 recently provided evidence magnetic resonance imaging increased atrophy hippocampus amygdala nondemented women homozygous acei allele together modest significant increase risk alzheimers disease independent vascular factors d allele associated raised plasma levels ace 2 association thought due linkage disequilibrium nearby polymorphisms 3 36 apparent conflict benefits ace inhibitor therapy associations indel alzheimers disease risk pathology plasma levels ace however influence ace polymorphisms brain levels enzyme yet known cannot assumed reflect levels plasma subject warrants fuller discussion possible detailed discussion given kehoe 56 although need reconsidered perhaps revised light interacting factor factors may emerge future studies
0.3345159.16033878.html.plaintext.txt	68	limitations meta analysis lack information authors limitation obtained full data 84 percent subjects quality diagnosis genotyping varied among studies overall results changed questions taken account considerable heterogeneity initial results however found main sources heterogeneity able remove since cardiovascular factors strong candidates potential interaction ace variants lack data available us factors limitation hope overcome future studies cardiovascular factors might also influenced results selective mortality however d homozygotes slightly increased risk cardiovascular complications 43 47 57 little evidence association reduced life span 57 62 thus influence selective mortality likely small enough provide alternative explanation findings
0.3345159.16033878.html.plaintext.txt	69	limitations meta analysis lack information authors limitation obtained full data 84 percent subjects quality diagnosis genotyping varied among studies overall results changed questions taken account considerable heterogeneity initial results however found main sources heterogeneity able remove since cardiovascular factors strong candidates potential interaction ace variants lack data available us factors limitation hope overcome future studies cardiovascular factors might also influenced results selective mortality however d homozygotes slightly increased risk cardiovascular complications 43 47 57 little evidence association reduced life span 57 62 thus influence selective mortality likely small enough provide alternative explanation findings
0.3345159.16033878.html.plaintext.txt	70	conclusions suggest large study established ace indel marker alzheimers disease risk since found evidence bias found removed main sources heterogeneity excluded various potential interactions significant results remained three ethnic groups examined indel however probably linkage disequilibrium true risk polymorphism 11 marked contrasts among three ethnic groups studied table 3 also found evidence interaction another risk factor north europeans potential interactions factors age gender apoe4 status examined particularly interactions cardiovascular risk factors
0.3345159.16033878.html.plaintext.txt	71	conclusions suggest large study established ace indel marker alzheimers disease risk since found evidence bias found removed main sources heterogeneity excluded various potential interactions significant results remained three ethnic groups examined indel however probably linkage disequilibrium true risk polymorphism 11 marked contrasts among three ethnic groups studied table 3 also found evidence interaction another risk factor north europeans potential interactions factors age gender apoe4 status examined particularly interactions cardiovascular risk factors
0.3345159.16033878.html.plaintext.txt	72	acknowledgments financial support received bristol myers squibb phytopharm plc medical research council norman collisson foundation takayama foundation dr p g kehoe supported gestetner foundation fellowship
0.3345159.16033878.html.plaintext.txt	73	authors thank groups undertaken acealzheimers disease association studies thereby providing data analyses especially thank authors generously responded requests primary data dr v alvarez dr h arboleda dr capurso dr l cook dr m m esiri dr r fellin dr l fernandez novoa dr u finkh dr r c p go dr h gurling dr n helbecque dr m r keikhaee dr c l lendon dr lovestone dr d m mann dr k m mattila dr p mcilroy dr l myllykangas dr f panza dr r perry dr d c rubinsztein dr r scacchi dr d seripa dr h weiner dr c wu dr g zuliani authors particularly grateful dr u finkh colleagues highlighting issue hardy weinberg disequilibrium ace studies 40 dr capurso colleagues 17 39 pointing ethnic differences ace indel frequencies authors also warmly thank dr m pembrey advice genetics dr j marchini advice statistics c aldridge administrative support m g lehmann help mathematical calculations dr j wu chinese translations
0.3345159.16033878.html.plaintext.txt	74	authors thank groups undertaken acealzheimers disease association studies thereby providing data analyses especially thank authors generously responded requests primary data dr v alvarez dr h arboleda dr capurso dr l cook dr m m esiri dr r fellin dr l fernandez novoa dr u finkh dr r c p go dr h gurling dr n helbecque dr m r keikhaee dr c l lendon dr lovestone dr d m mann dr k m mattila dr p mcilroy dr l myllykangas dr f panza dr r perry dr d c rubinsztein dr r scacchi dr d seripa dr h weiner dr c wu dr g zuliani authors particularly grateful dr u finkh colleagues highlighting issue hardy weinberg disequilibrium ace studies 40 dr capurso colleagues 17 39 pointing ethnic differences ace indel frequencies authors also warmly thank dr m pembrey advice genetics dr j marchini advice statistics c aldridge administrative support m g lehmann help mathematical calculations dr j wu chinese translations
0.3345159.16033878.html.plaintext.txt	75	conflict interest none declared
0.3345159.16033878.html.plaintext.txt	76	note added proof two association studies published since submission article kolsch et al neurosci lett 200537737 9 zhang et al dement geriatr cogn disord 20052052 6
0.3345159.16033878.html.plaintext.txt	77	note added proof two association studies published since submission article kolsch et al neurosci lett 200537737 9 zhang et al dement geriatr cogn disord 20052052 6
0.3345159.16033878.html.plaintext.txt	78	references top abstract introduction materials methods results discussion references kehoe pg russ c mcilroy et al variation dcp1 encoding ace associated susceptibility alzheimer disease nat genet 19992171 2crossrefisimedline rigat b hubert c alhenc gelas f et al insertiondeletion polymorphism angiotensin converting enzyme gene accounting half variance serum enzyme levels j clin invest 1990861343 6isimedline tiret l rigat b visvikis et al evidence combined segregation linkage analysis variant angiotensin converting enzyme ace gene controls plasma ace levels j hum genet 199251197 205isimedline nacmias b tedde forleo p et al angiotensin converting enzyme polymorphism sporadic presenilin linked alzheimers disease families abstract neurology 199952 suppl 2a323 wakutani y kowa h kusumi m et al genetic analysis vascular factors alzheimers disease ann n y acad sci 2002977232 8abstractfree full text farrer la sherbatich keryanov sa et al association angiotensin converting enzyme alzheimer disease arch neurol 200057210 14abstractfree full text crawford f abdullah l schinka j et al gender specific association angiotensin converting enzyme gene alzheimers disease neurosci lett 2000280215 19crossrefisimedline kehoe pg katzov h andreasen n et al common variants ace contribute variable age onset alzheimers disease hum genet 2004114478 83crossrefisimedline sleegers k den heijer van dijk ej et al ace gene associated alzheimers disease atrophy hippocampus amygdala neurobiol aging 2005261153 9crossrefisimedline narain y yip murphy et al ace gene alzheimers disease susceptibility j med genet 200037695 7abstractfree full text kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimers disease hum mol genet 200312859 67abstractfree full text elkins js douglas vc johnston sc alzheimer disease risk genetic variation ace meta analysis neurology 200462363 8abstractfree full text camelo d arboleda g yunis jj et al angiotensin converting enzyme alpha 2 macroglobulin gene polymorphisms associated alzheimers disease colombian patients j neurol sci 200421847 51crossrefisimedline fernandez novoa l lombardi vrm seoane et al ace gene alzheimers disease hanin fisher cacabelos r eds new trends alzheimer parkinson related disorders bologna italy monduzzi editore 2004123 6 keikhaee mr najmabadi h pasalar p angiotensin converting enzyme apolipoprotein e genotype alzheimers disease iranian population abstract neurobiol aging 200223suppls404 lendon cl thaker u harris jm et al angiotensin 1 converting enzyme insertion ideletion d polymorphism influence extent amyloid tau pathology patients sporadic alzheimers disease neurosci lett 2002328314 18crossrefisimedline panza f solfrizzi v dintrono et al lack association ace polymorphism alzheimers disease southern italy arch gerontol geriatr suppl 20028239 45crossrefmedline seripa d dal forno g matera mg et al methylenetetrahydrofolate reductase angiotensin converting enzyme gene polymorphisms two genetically diagnostically distinct cohorts alzheimer patients neurobiol aging 200324933 9crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis jama 19972781349 56abstract lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimers disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline egger m davey smith g altman dge systematic reviews health care meta analysis context london united kingdom bmj books 2001 ott breteler mm van harskamp f et al incidence risk dementia rotterdam study j epidemiol 1998147574 80abstract prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimers disease eur j hum genet 20019437 44crossrefisimedline prince j feuk l brookes et al genetic variation ace influences severity alzheimers disease abstract neurobiol aging 200223suppls319crossref mirra ss heyman mckeel d et al consortium establish registry alzheimers disease cerad part ii standardization neuropathologic assessment alzheimers disease neurology 199141479 86abstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology 198434939 44abstract fogarty dg maxwell ap doherty cc et al ace gene typing letter lancet 1994343851isimedline shanmugam v sell kw saha bk mistyping ace heterozygotes pcr methods appl 19933120 1isimedline mantel n haenszel w statistical aspects analysis data retrospective studies disease j natl cancer inst 195922719 48isimedline dersimonian r laird n meta analysis clinical trials control clin trials 19867177 88crossrefisimedline warn de thompson sg spiegelhalter dj bayesian random effects meta analysis trials binary outcomes methods absolute risk difference relative risk scales stat med 2002211601 23crossrefisimedline armitage p statistical methods medical research oxford united kingdom blackwell scientific publications 1983 egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n eng j med 1992327248 54abstract ihaka r gentleman r r language data analysis graphics j comput graph stat 19965299 314 cox r bouzekri n martin et al angiotensin 1 converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol genet 2002112969 77abstractfree full text katzov h bennet kehoe p et al cladistic model ace sequence variation implications myocardial infarction alzheimer disease obesity hum mol genet 2004132647 57abstractfree full text nagy z esiri mm hindley nj et al accuracy clinical operational diagnostic criteria alzheimers disease relation different pathological diagnostic protocols dement geriatr cogn disord 19989219 26crossrefisimedline panza f solfrizzi v dintrono et al shifts angiotensin 1 converting enzyme insertion allele frequency across europe implications alzheimers disease risk j neurol neurosurg psychiatry 2003741159 61free full text buss muller thomsen hock c et al association dcp1 genotype late onset alzheimer disease j med genet 2002114440 5crossrefisimedline perry rt collins js harrell le et al investigation association 13 polymorphisms eight genes southeastern african american alzheimer disease patients compared age matched controls j med genet 2001105332 42crossrefisimedline comings de macmurray jp molecular heterosis review mol genet metab 20007119 31crossrefisimedline samani nj thompson jr otoole l et al meta analysis association deletion allele angiotensin converting enzyme gene myocardial infarction circulation 199694708 12abstractfree full text staessen ja wang jg ginocchio g et al deletioninsertion polymorphism angiotensin converting enzyme gene cardiovascular renal risk j hypertens 1997151579 92crossrefisimedline sharma p meta analysis ace gene ischaemic stroke j neurol neurosurg psychiatry 199864227 30abstractfree full text keavney b mckenzie c parish et al large scale test hypothesised associations angiotensin converting enzyme insertiondeletion polymorphism myocardial infarction 5000 cases 6000 controls lancet 2000355434 42isimedline sayed tabatabaei fa houwing duistermaat jj van duijn cm et al angiotensin converting enzyme gene polymorphism carotid artery wall thickness meta analysis stroke 2003341634 9abstractfree full text arregui perry ek rossor m et al angiotensin converting enzyme alzheimers disease increased activity caudate nucleus cortical areas j neurochem 1982381490 2isimedline barnes nm cheng ch costall b et al angiotensin converting enzyme density increased temporal cortex patients alzheimers disease eur j pharmacol 1991200289 92crossrefisimedline savaskan e hock c olivieri g et al cortical alterations angiotensin converting enzyme angiotensin ii at1 receptor alzheimers dementia neurobiol aging 200122541 6crossrefisimedline hu j igarashi kamata m et al angiotensin converting enzyme degrades alzheimer amyloid beta peptide ab retards ab aggregation deposition fibril formation inhibits cytotoxicity j biol chem 200127647863 8abstractfree full text hirawa n uehara y kawabata y et al long term inhibition renin angiotensin system sustains memory function aged dahl rats hypertension 199934496 502abstractfree full text sudilovsky turnbull b croog sh et al angiotensin converting enzyme memory preclinical clinical data int j neurol 1987 8821 22145 62 ohrui matsui yamaya m et al angiotensin converting enzyme inhibitors incidence alzheimers disease japan j geriatr soc 200452649 50crossrefisimedline ohrui tomita n sato nakagawa et al effects brain penetrating ace inhibitors alzheimer disease progression neurology 2004631324 5free full text kehoe pg renin angiotensin aldosterone system alzheimers disease j renin angiotensin aldosterone syst 2003480 93isimedline agerholm larsen b nordestgaard bg steffensen r et al ace gene polymorphism ischemic heart disease longevity 10150 individuals case referent retrospective cohort study based copenhagen city heart study circulation 1997952358 67abstractfree full text galinsky d tysoe c brayne ce et al analysis apoe eapo c angiotensin converting enzyme methylenetetrahydrofolate reductase genes candidates affecting human longevity atherosclerosis 1997129177 83crossrefisimedline shimokata h yamada y nakagawa m et al distribution geriatric disease related genotypes national institute longevity sciences longitudinal study aging nils lsa j epidemiol 200010suppls46 55medline blanche h cabanne l sahbatou m et al study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline panza f solfrizzi v dintrono et al angiotensin converting enzyme ace gene polymorphism centenarians different allele frequencies north south europe exp gerontol 2003381015 20crossrefisimedline da cruz ib oliveira g taufer m et al angiotensin converting enzyme gene polymorphism two ethnic groups living brazils southern region association age j gerontol biol sci med sci 200358m851 6abstractfree full text alvarez r alvarez v lahoz ch et al angiotensin converting enzyme endothelial nitric oxide synthase dna polymorphisms late onset alzheimers disease j neurol neurosurg psychiatry 199967733 6abstractfree full text carbonell j allen r kalsi g et al variation dcp1 gene encoding angiotensin converting enzyme ace associated increased susceptibility alzheimers disease psychiatr genet 20031347 50crossrefisimedline chapman j wang n treves ta et al ace mthfr factor v leiden apoe polymorphisms patients vascular alzheimers dementia stroke 1998291401 4abstractfree full text cheng cy hong cj liu hc et al study association alzheimers disease angiotensin converting enzyme gene polymorphism using dna lymphocytes eur neurol 20024726 9crossrefisimedline hu j miyatake f aizu y et al angiotensin converting enzyme genotype associated alzheimer disease japanese population neurosci lett 199927765 7crossrefisimedline isbir agachan b yilmaz h et al angiotensin converting enzyme gene polymorphism alzheimers disease cell biochem funct 200018141 233co2 ytta m et al dipeptidyl carboxypeptidase 1 dcp1 butyrylcholinesterase bche gene interactions apolipoprotein e 4 allele risk factors alzheimers disease parkinsons disease coexisting alzheimer pathology j med genet 200037766 70abstractfree full text monastero r caldarella r mannino m et al lack association angiotensin converting enzyme polymorphism sporadic alzheimers disease neurosci lett 2002335147 9crossrefisimedline myllykangas l polvikoski sulkava r et al cardiovascular risk factors alzheimers disease genetic association study population aged 85 neurosci lett 2000292195 8crossrefisimedline palumbo b cadini d nocentini g et al angiotensin converting enzyme deletion allele different kinds dementia disorders neurosci lett 199926797 100crossrefisimedline richard f fromentin david ricolfi f et al angiotensin converting enzyme gene susceptibility factor dementia neurology 2001561593 5abstractfree full text scacchi r de bernardini l mantuano e et al dna polymorphisms apolipoprotein b angiotensin 1 converting enzyme genes relationships lipid levels italian patients vascular dementia alzheimers disease dement geriatr cogn disord 19989186 90crossrefisimedline wu c zhou d guan z et al association angiotensin converting enzyme gene polymorphism chinese late onset alzheimer disease chinese zhonghua yi xue yi chuan xue za zhi 200219401 4medline yang jd feng g zhang j et al association angiotensin converting enzyme gene late onset alzheimers disease han chinese neurosci lett 200029541 4crossrefisimedline zuliani g ble zanca r et al genetic polymorphisms older subjects vascular alzheimers dementia acta neurol scand 2001103304 8crossrefisimedline american psychiatric association diagnostic statistical manual mental disorders dsm iv 4th ed washington dc american psychiatric association 1994 khachaturian zs diagnosis alzheimers disease arch neurol 1985421097 105crossrefisimedline
0.3345159.16033878.html.plaintext.txt	79	references top abstract introduction materials methods results discussion references kehoe pg russ c mcilroy et al variation dcp1 encoding ace associated susceptibility alzheimer disease nat genet 19992171 2crossrefisimedline rigat b hubert c alhenc gelas f et al insertiondeletion polymorphism angiotensin converting enzyme gene accounting half variance serum enzyme levels j clin invest 1990861343 6isimedline tiret l rigat b visvikis et al evidence combined segregation linkage analysis variant angiotensin converting enzyme ace gene controls plasma ace levels j hum genet 199251197 205isimedline nacmias b tedde forleo p et al angiotensin converting enzyme polymorphism sporadic presenilin linked alzheimers disease families abstract neurology 199952 suppl 2a323 wakutani y kowa h kusumi m et al genetic analysis vascular factors alzheimers disease ann n y acad sci 2002977232 8abstractfree full text farrer la sherbatich keryanov sa et al association angiotensin converting enzyme alzheimer disease arch neurol 200057210 14abstractfree full text crawford f abdullah l schinka j et al gender specific association angiotensin converting enzyme gene alzheimers disease neurosci lett 2000280215 19crossrefisimedline kehoe pg katzov h andreasen n et al common variants ace contribute variable age onset alzheimers disease hum genet 2004114478 83crossrefisimedline sleegers k den heijer van dijk ej et al ace gene associated alzheimers disease atrophy hippocampus amygdala neurobiol aging 2005261153 9crossrefisimedline narain y yip murphy et al ace gene alzheimers disease susceptibility j med genet 200037695 7abstractfree full text kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimers disease hum mol genet 200312859 67abstractfree full text elkins js douglas vc johnston sc alzheimer disease risk genetic variation ace meta analysis neurology 200462363 8abstractfree full text camelo d arboleda g yunis jj et al angiotensin converting enzyme alpha 2 macroglobulin gene polymorphisms associated alzheimers disease colombian patients j neurol sci 200421847 51crossrefisimedline fernandez novoa l lombardi vrm seoane et al ace gene alzheimers disease hanin fisher cacabelos r eds new trends alzheimer parkinson related disorders bologna italy monduzzi editore 2004123 6 keikhaee mr najmabadi h pasalar p angiotensin converting enzyme apolipoprotein e genotype alzheimers disease iranian population abstract neurobiol aging 200223suppls404 lendon cl thaker u harris jm et al angiotensin 1 converting enzyme insertion ideletion d polymorphism influence extent amyloid tau pathology patients sporadic alzheimers disease neurosci lett 2002328314 18crossrefisimedline panza f solfrizzi v dintrono et al lack association ace polymorphism alzheimers disease southern italy arch gerontol geriatr suppl 20028239 45crossrefmedline seripa d dal forno g matera mg et al methylenetetrahydrofolate reductase angiotensin converting enzyme gene polymorphisms two genetically diagnostically distinct cohorts alzheimer patients neurobiol aging 200324933 9crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis jama 19972781349 56abstract lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimers disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline egger m davey smith g altman dge systematic reviews health care meta analysis context london united kingdom bmj books 2001 ott breteler mm van harskamp f et al incidence risk dementia rotterdam study j epidemiol 1998147574 80abstract prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimers disease eur j hum genet 20019437 44crossrefisimedline prince j feuk l brookes et al genetic variation ace influences severity alzheimers disease abstract neurobiol aging 200223suppls319crossref mirra ss heyman mckeel d et al consortium establish registry alzheimers disease cerad part ii standardization neuropathologic assessment alzheimers disease neurology 199141479 86abstract mckhann g drachman d folstein m et al clinical diagnosis alzheimers disease report nincds adrda work group auspices department health human services task force alzheimers disease neurology 198434939 44abstract fogarty dg maxwell ap doherty cc et al ace gene typing letter lancet 1994343851isimedline shanmugam v sell kw saha bk mistyping ace heterozygotes pcr methods appl 19933120 1isimedline mantel n haenszel w statistical aspects analysis data retrospective studies disease j natl cancer inst 195922719 48isimedline dersimonian r laird n meta analysis clinical trials control clin trials 19867177 88crossrefisimedline warn de thompson sg spiegelhalter dj bayesian random effects meta analysis trials binary outcomes methods absolute risk difference relative risk scales stat med 2002211601 23crossrefisimedline armitage p statistical methods medical research oxford united kingdom blackwell scientific publications 1983 egger m davey smith g schneider m et al bias meta analysis detected simple graphical test bmj 1997315629 34abstractfree full text lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n eng j med 1992327248 54abstract ihaka r gentleman r r language data analysis graphics j comput graph stat 19965299 314 cox r bouzekri n martin et al angiotensin 1 converting enzyme ace plasma concentration influenced multiple ace linked quantitative trait nucleotides hum mol genet 2002112969 77abstractfree full text katzov h bennet kehoe p et al cladistic model ace sequence variation implications myocardial infarction alzheimer disease obesity hum mol genet 2004132647 57abstractfree full text nagy z esiri mm hindley nj et al accuracy clinical operational diagnostic criteria alzheimers disease relation different pathological diagnostic protocols dement geriatr cogn disord 19989219 26crossrefisimedline panza f solfrizzi v dintrono et al shifts angiotensin 1 converting enzyme insertion allele frequency across europe implications alzheimers disease risk j neurol neurosurg psychiatry 2003741159 61free full text buss muller thomsen hock c et al association dcp1 genotype late onset alzheimer disease j med genet 2002114440 5crossrefisimedline perry rt collins js harrell le et al investigation association 13 polymorphisms eight genes southeastern african american alzheimer disease patients compared age matched controls j med genet 2001105332 42crossrefisimedline comings de macmurray jp molecular heterosis review mol genet metab 20007119 31crossrefisimedline samani nj thompson jr otoole l et al meta analysis association deletion allele angiotensin converting enzyme gene myocardial infarction circulation 199694708 12abstractfree full text staessen ja wang jg ginocchio g et al deletioninsertion polymorphism angiotensin converting enzyme gene cardiovascular renal risk j hypertens 1997151579 92crossrefisimedline sharma p meta analysis ace gene ischaemic stroke j neurol neurosurg psychiatry 199864227 30abstractfree full text keavney b mckenzie c parish et al large scale test hypothesised associations angiotensin converting enzyme insertiondeletion polymorphism myocardial infarction 5000 cases 6000 controls lancet 2000355434 42isimedline sayed tabatabaei fa houwing duistermaat jj van duijn cm et al angiotensin converting enzyme gene polymorphism carotid artery wall thickness meta analysis stroke 2003341634 9abstractfree full text arregui perry ek rossor m et al angiotensin converting enzyme alzheimers disease increased activity caudate nucleus cortical areas j neurochem 1982381490 2isimedline barnes nm cheng ch costall b et al angiotensin converting enzyme density increased temporal cortex patients alzheimers disease eur j pharmacol 1991200289 92crossrefisimedline savaskan e hock c olivieri g et al cortical alterations angiotensin converting enzyme angiotensin ii at1 receptor alzheimers dementia neurobiol aging 200122541 6crossrefisimedline hu j igarashi kamata m et al angiotensin converting enzyme degrades alzheimer amyloid beta peptide ab retards ab aggregation deposition fibril formation inhibits cytotoxicity j biol chem 200127647863 8abstractfree full text hirawa n uehara y kawabata y et al long term inhibition renin angiotensin system sustains memory function aged dahl rats hypertension 199934496 502abstractfree full text sudilovsky turnbull b croog sh et al angiotensin converting enzyme memory preclinical clinical data int j neurol 1987 8821 22145 62 ohrui matsui yamaya m et al angiotensin converting enzyme inhibitors incidence alzheimers disease japan j geriatr soc 200452649 50crossrefisimedline ohrui tomita n sato nakagawa et al effects brain penetrating ace inhibitors alzheimer disease progression neurology 2004631324 5free full text kehoe pg renin angiotensin aldosterone system alzheimers disease j renin angiotensin aldosterone syst 2003480 93isimedline agerholm larsen b nordestgaard bg steffensen r et al ace gene polymorphism ischemic heart disease longevity 10150 individuals case referent retrospective cohort study based copenhagen city heart study circulation 1997952358 67abstractfree full text galinsky d tysoe c brayne ce et al analysis apoe eapo c angiotensin converting enzyme methylenetetrahydrofolate reductase genes candidates affecting human longevity atherosclerosis 1997129177 83crossrefisimedline shimokata h yamada y nakagawa m et al distribution geriatric disease related genotypes national institute longevity sciences longitudinal study aging nils lsa j epidemiol 200010suppls46 55medline blanche h cabanne l sahbatou m et al study french centenarians ace apoe associated longevity c r acad sci iii 2001324129 35isimedline panza f solfrizzi v dintrono et al angiotensin converting enzyme ace gene polymorphism centenarians different allele frequencies north south europe exp gerontol 2003381015 20crossrefisimedline da cruz ib oliveira g taufer m et al angiotensin converting enzyme gene polymorphism two ethnic groups living brazils southern region association age j gerontol biol sci med sci 200358m851 6abstractfree full text alvarez r alvarez v lahoz ch et al angiotensin converting enzyme endothelial nitric oxide synthase dna polymorphisms late onset alzheimers disease j neurol neurosurg psychiatry 199967733 6abstractfree full text carbonell j allen r kalsi g et al variation dcp1 gene encoding angiotensin converting enzyme ace associated increased susceptibility alzheimers disease psychiatr genet 20031347 50crossrefisimedline chapman j wang n treves ta et al ace mthfr factor v leiden apoe polymorphisms patients vascular alzheimers dementia stroke 1998291401 4abstractfree full text cheng cy hong cj liu hc et al study association alzheimers disease angiotensin converting enzyme gene polymorphism using dna lymphocytes eur neurol 20024726 9crossrefisimedline hu j miyatake f aizu y et al angiotensin converting enzyme genotype associated alzheimer disease japanese population neurosci lett 199927765 7crossrefisimedline isbir agachan b yilmaz h et al angiotensin converting enzyme gene polymorphism alzheimers disease cell biochem funct 200018141 233co2 ytta m et al dipeptidyl carboxypeptidase 1 dcp1 butyrylcholinesterase bche gene interactions apolipoprotein e 4 allele risk factors alzheimers disease parkinsons disease coexisting alzheimer pathology j med genet 200037766 70abstractfree full text monastero r caldarella r mannino m et al lack association angiotensin converting enzyme polymorphism sporadic alzheimers disease neurosci lett 2002335147 9crossrefisimedline myllykangas l polvikoski sulkava r et al cardiovascular risk factors alzheimers disease genetic association study population aged 85 neurosci lett 2000292195 8crossrefisimedline palumbo b cadini d nocentini g et al angiotensin converting enzyme deletion allele different kinds dementia disorders neurosci lett 199926797 100crossrefisimedline richard f fromentin david ricolfi f et al angiotensin converting enzyme gene susceptibility factor dementia neurology 2001561593 5abstractfree full text scacchi r de bernardini l mantuano e et al dna polymorphisms apolipoprotein b angiotensin 1 converting enzyme genes relationships lipid levels italian patients vascular dementia alzheimers disease dement geriatr cogn disord 19989186 90crossrefisimedline wu c zhou d guan z et al association angiotensin converting enzyme gene polymorphism chinese late onset alzheimer disease chinese zhonghua yi xue yi chuan xue za zhi 200219401 4medline yang jd feng g zhang j et al association angiotensin converting enzyme gene late onset alzheimers disease han chinese neurosci lett 200029541 4crossrefisimedline zuliani g ble zanca r et al genetic polymorphisms older subjects vascular alzheimers dementia acta neurol scand 2001103304 8crossrefisimedline american psychiatric association diagnostic statistical manual mental disorders dsm iv 4th ed washington dc american psychiatric association 1994 khachaturian zs diagnosis alzheimers disease arch neurol 1985421097 105crossrefisimedline
0.3375625.15328426.html.plaintext.txt	0	presence apolipoprotein e 4 allele predisposes early onset primary sjogrens syndrome m pertovaara lehtimaki1 r rontu1 j antonen1 pasternack1 m hurme1
0.3375625.15328426.html.plaintext.txt	1	tampere university hospital 1 university tampere medical school tampere university hospital tampere finland
0.3375625.15328426.html.plaintext.txt	2	correspondence m pertovaara department internal medicine section rheumatology tampere university hospital po box 2000 fin 33521 tampere finland e mail marjapertovaaraatpshpfi
0.3375625.15328426.html.plaintext.txt	3	abstract top abstract introduction subjects methods results references background apolipoprotein e apoe polymorphism plays central role lipid metabolism recently also suggested regulate inflammation judged levels serum c reactive protein crp
0.3375625.15328426.html.plaintext.txt	4	abstract top abstract introduction subjects methods results references background apolipoprotein e apoe polymorphism plays central role lipid metabolism recently also suggested regulate inflammation judged levels serum c reactive protein crp
0.3375625.15328426.html.plaintext.txt	5	objective establish whether polymorphism apoe genes affects susceptibility primary sjogrens syndrome pss degree inflammation age onset pss
0.3375625.15328426.html.plaintext.txt	6	methods apoe genotype distribution allelic frequencies analysed using pcr taqman system 63 finnish caucasian patients pss 64 healthy controls matched sex ethnic origin area residence clinical immunological data pss patients analysed relation apoe genotypes
0.3375625.15328426.html.plaintext.txt	7	results difference pss patients controls apoe genotype allelic frequencies apoe 4 allele significantly associated early onset pss entire population female patients kaplan meier log rank test p 00407 p 00168 respectively average age plus minus sd onset pss apoe 4 allele carriers 46 plus minus 12 genotypes 53 plus minus 10 yr p 0031 test apoe polymorphism associated signs inflammation evaluated markers concentration plasma crp plasma interleukin 6 plasma tnf immunoglobulin g haemoglobin leucocyte count esr
0.3375625.15328426.html.plaintext.txt	8	conclusions apoe polymorphism affect susceptibility pss levels plasma inflammatory indices patients pss however clear association prevails apoe 4 early onset pss
0.3375625.15328426.html.plaintext.txt	9	key words apolipoprotein e gene polymorphism primary sjogrens syndrome age disease onset
0.3375625.15328426.html.plaintext.txt	10	introduction top abstract introduction subjects methods results references primary sjogrens syndrome pss chronic inflammatory autoimmune disease characterized symptoms dry eyes mouth various extraglandular symptoms hypergammaglobulinaemia abundant autoantibody production plasma levels interleukin 6 il 6 proinflammatory cytokine increased patients pss 1
0.3375625.15328426.html.plaintext.txt	11	introduction top abstract introduction subjects methods results references primary sjogrens syndrome pss chronic inflammatory autoimmune disease characterized symptoms dry eyes mouth various extraglandular symptoms hypergammaglobulinaemia abundant autoantibody production plasma levels interleukin 6 il 6 proinflammatory cytokine increased patients pss 1
0.3375625.15328426.html.plaintext.txt	12	apolipoprotein e apoe gene polymorphism plays significant role lipid metabolism addition recently also suggested regulate inflammation measured levels c reactive protein 2 gene apoe polymorphic presenting three common alleles 2 3 4 single gene locus chromosome 19 alleles form six genotypes e22 e32 e42 e33 e43 e44 e33 commonest e43 second commonest populations presence apoe 4 allele associated increased risk coronary heart disease alzheimers disease reviewed 3
0.3375625.15328426.html.plaintext.txt	13	apolipoprotein e apoe gene polymorphism plays significant role lipid metabolism addition recently also suggested regulate inflammation measured levels c reactive protein 2 gene apoe polymorphic presenting three common alleles 2 3 4 single gene locus chromosome 19 alleles form six genotypes e22 e32 e42 e33 e43 e44 e33 commonest e43 second commonest populations presence apoe 4 allele associated increased risk coronary heart disease alzheimers disease reviewed 3
0.3375625.15328426.html.plaintext.txt	14	circulating testosterone dehydroepiandrosterone dhea levels recently found associated apoe genotype women carrying apoe 4 allele thus susceptible development diseases associated menopause 4 sjogrens syndrome presents characteristically middle aged women hypothesized apoe could candidate gene susceptibility pss genetic polymorphism apoe could exert effect markers inflammation patients pss hence aims present study investigate well characterized group finnish caucasian patients pss effect polymorphism apoe gene susceptibility severity pss particularly markers inflammation age onset pss
0.3375625.15328426.html.plaintext.txt	15	circulating testosterone dehydroepiandrosterone dhea levels recently found associated apoe genotype women carrying apoe 4 allele thus susceptible development diseases associated menopause 4 sjogrens syndrome presents characteristically middle aged women hypothesized apoe could candidate gene susceptibility pss genetic polymorphism apoe could exert effect markers inflammation patients pss hence aims present study investigate well characterized group finnish caucasian patients pss effect polymorphism apoe gene susceptibility severity pss particularly markers inflammation age onset pss
0.3375625.15328426.html.plaintext.txt	16	subjects methods top abstract introduction subjects methods results references subjects patients fulfilling three modified californian criteria pss 5 salivary flow determinations performed histological findings graded chisholm mason 6 scale grades 3 4 regarded diagnostic selected records patients sicca symptoms examined department internal medicine section rheumatology tampere university hospital finland years 1977 1992 n 111 alive invited letter attend gene polymorphism determinations samples genotyping obtained informed consent 63 pss patients 61 female two male mean age 60 plus minus 12 yr mean disease duration 9 plus minus 4 yr sixty one also fulfilled revised american european consensus group criteria pss 7
0.3375625.15328426.html.plaintext.txt	17	subjects methods top abstract introduction subjects methods results references subjects patients fulfilling three modified californian criteria pss 5 salivary flow determinations performed histological findings graded chisholm mason 6 scale grades 3 4 regarded diagnostic selected records patients sicca symptoms examined department internal medicine section rheumatology tampere university hospital finland years 1977 1992 n 111 alive invited letter attend gene polymorphism determinations samples genotyping obtained informed consent 63 pss patients 61 female two male mean age 60 plus minus 12 yr mean disease duration 9 plus minus 4 yr sixty one also fulfilled revised american european consensus group criteria pss 7
0.3375625.15328426.html.plaintext.txt	18	clinical methods careful clinical examination together depth interview patients covering previous diseases duration sicca symptoms existence recurrent salivary gland swellings recently conducted patients 8 special emphasis laid possible extraglandular symptoms pss dermatological endocrine gastrointestinal lymphoproliferative musculoskeletal neurological renal respiratory vascular symptoms
0.3375625.15328426.html.plaintext.txt	19	clinical methods careful clinical examination together depth interview patients covering previous diseases duration sicca symptoms existence recurrent salivary gland swellings recently conducted patients 8 special emphasis laid possible extraglandular symptoms pss dermatological endocrine gastrointestinal lymphoproliferative musculoskeletal neurological renal respiratory vascular symptoms
0.3375625.15328426.html.plaintext.txt	20	standard laboratory tests standard laboratory tests included blood cell count erythrocyte sedimentation rate esr plasma c reactive protein crp anti ss anti ss b antibodies determined enzyme immunoassay serum concentrations immunoglobulin g igg measured laser nephelometry serum ss2 microglobulin radioimmunoassay pharmacia beta 2 micro ria kit pharmacia diagnostics uppsala sweden plasma il 6 tnf concentrations determined using commercially available elisas pelikine human il 6 elisa kit pelikine compact human tnf elisa kit clb amsterdam netherlands optical density individual wells determined multiscan biochromatic 348 spectrophotometer thermo labsystems helsinki finland detection limit il 6 assay 06 pgml tnf assay 14 pgml
0.3375625.15328426.html.plaintext.txt	21	standard laboratory tests standard laboratory tests included blood cell count erythrocyte sedimentation rate esr plasma c reactive protein crp anti ss anti ss b antibodies determined enzyme immunoassay serum concentrations immunoglobulin g igg measured laser nephelometry serum ss2 microglobulin radioimmunoassay pharmacia beta 2 micro ria kit pharmacia diagnostics uppsala sweden plasma il 6 tnf concentrations determined using commercially available elisas pelikine human il 6 elisa kit pelikine compact human tnf elisa kit clb amsterdam netherlands optical density individual wells determined multiscan biochromatic 348 spectrophotometer thermo labsystems helsinki finland detection limit il 6 assay 06 pgml tnf assay 14 pgml
0.3375625.15328426.html.plaintext.txt	22	normal controls sixty four healthy finnish red cross transfusion service blood donors matched sex 62 female two male ethnic origin finnish caucasian area residence tampere finland served control group dna studies pss patients mean age control subjects 53 plus minus 7 yr
0.3375625.15328426.html.plaintext.txt	23	normal controls sixty four healthy finnish red cross transfusion service blood donors matched sex 62 female two male ethnic origin finnish caucasian area residence tampere finland served control group dna studies pss patients mean age control subjects 53 plus minus 7 yr
0.3375625.15328426.html.plaintext.txt	24	apolipoprotein e genotyping genomic dna extracted peripheral blood leucocytes using commercially available kit qiagen hilden germany apoe 112 genotyping fluorogenic allele specific taqman probes primers used previously described 9 apoe 158 genotypes determined using allele specific fluorogenic probes conjugated minor groove binder mgb group nucleotide sequences apoe 158 primers probes used pcr deduced published sequences deposited genbank database chosen synthesized conjunction applied biosystems foster city ca usa using assay design tool dna samples genotyped means 5 nuclease assay allelic discrimination using abi prism 7000 sequence detection system applied biosystems polymerase chain reaction pcr reaction containing genomic dna 1 x universal pcr master mix 900 nm primer 200 nm probe performed 96 well plates using standard protocol total volume 25 microl water controls known control samples previously typed restriction fragment length polymorphism pcr analysis run parallel unknown dna samples cycling end point fluorescence measured genotype calling carried using allelic discrimination analysis module
0.3375625.15328426.html.plaintext.txt	25	apolipoprotein e genotyping genomic dna extracted peripheral blood leucocytes using commercially available kit qiagen hilden germany apoe 112 genotyping fluorogenic allele specific taqman probes primers used previously described 9 apoe 158 genotypes determined using allele specific fluorogenic probes conjugated minor groove binder mgb group nucleotide sequences apoe 158 primers probes used pcr deduced published sequences deposited genbank database chosen synthesized conjunction applied biosystems foster city ca usa using assay design tool dna samples genotyped means 5 nuclease assay allelic discrimination using abi prism 7000 sequence detection system applied biosystems polymerase chain reaction pcr reaction containing genomic dna 1 x universal pcr master mix 900 nm primer 200 nm probe performed 96 well plates using standard protocol total volume 25 microl water controls known control samples previously typed restriction fragment length polymorphism pcr analysis run parallel unknown dna samples cycling end point fluorescence measured genotype calling carried using allelic discrimination analysis module
0.3375625.15328426.html.plaintext.txt	26	statistical analysis unpaired students test 2 test used comparisons continuous dichotomous variables respectively association 4 allele age onset pss analysed kaplan meier log rank tests findings considered statistically significant p 005 statistical analyses performed spss 101 windows spss chicago il usa
0.3375625.15328426.html.plaintext.txt	27	statistical analysis unpaired students test 2 test used comparisons continuous dichotomous variables respectively association 4 allele age onset pss analysed kaplan meier log rank tests findings considered statistically significant p 005 statistical analyses performed spss 101 windows spss chicago il usa
0.3375625.15328426.html.plaintext.txt	28	ethical approval study protocol approved ethical committee tampere university hospital
0.3375625.15328426.html.plaintext.txt	29	results top abstract introduction subjects methods results references apoe genotypes allelic frequencies age onset pss apoe genotype allele frequencies pss patients control subjects differ table 1 however pss patients carrying apoe 4 allele significantly younger mean plus minus sd 55 plus minus 11 vs 62 plus minus 11 yr p 0028 non carriers moreover apoe 4 allele associated earlier onset pss entire population female patients kaplan meier log rank test p 00407 00168 respectively fig 1 average age disease onset apoe 4 allele carriers 46 plus minus 12 yr genotypes 53 plus minus 10 yr p 0031 test p 0039 patients fulfilling american european consensus group criteria test mean age female patients pss carrying apoe 4 allele 54 plus minus 11 yr compared 62 plus minus 11 yr non carriers p 0023 age disease onset 45 plus minus 12 vs 53 plus minus 10 yr p 0019 respectively
0.3375625.15328426.html.plaintext.txt	30	results top abstract introduction subjects methods results references apoe genotypes allelic frequencies age onset pss apoe genotype allele frequencies pss patients control subjects differ table 1 however pss patients carrying apoe 4 allele significantly younger mean plus minus sd 55 plus minus 11 vs 62 plus minus 11 yr p 0028 non carriers moreover apoe 4 allele associated earlier onset pss entire population female patients kaplan meier log rank test p 00407 00168 respectively fig 1 average age disease onset apoe 4 allele carriers 46 plus minus 12 yr genotypes 53 plus minus 10 yr p 0031 test p 0039 patients fulfilling american european consensus group criteria test mean age female patients pss carrying apoe 4 allele 54 plus minus 11 yr compared 62 plus minus 11 yr non carriers p 0023 age disease onset 45 plus minus 12 vs 53 plus minus 10 yr p 0019 respectively
0.3375625.15328426.html.plaintext.txt	31	view table table 1 apolipoprotein e apoe genotype allelic frequencies patients primary sjogrens syndrome pss healthy subjects
0.3375625.15328426.html.plaintext.txt	32	view larger version 12k fig 1 kaplan meier plots showing earlier age onset female male patients primary sjogrens syndrome pss carrying 4 allele apolipoprotein e gene p 00407 log rank test b female patients pss carrying 4 allele apolipoprotein e gene p 00168 log rank test
0.3375625.15328426.html.plaintext.txt	33	apoe polymorphism markers inflammation mean concentration plasma crp pss patients 58 plus minus 32 mgl plasma il 6 40 plus minus 26 pgml plasma tnf 71 plus minus 134 pgml statistically significant differences markers inflammation plasma crp levels 65 plus minus 42 vs 55 plus minus 28 mgl plasma il 6 32 plus minus 26 vs 41 plus minus 26 pgml plasma tnf concentrations 74 plus minus 131 vs 70 plus minus 140 pgml pss patients carrying apoe 4 allele carrying allele haemoglobin concentration 128 plus minus 7 vs 128 plus minus 13 gl leukocyte count 509 plus minus 258 x 109l vs 512 plus minus 156 x 109l esr 35 plus minus 20 vs 30 plus minus 20 mmh serum igg 206 plus minus 77 vs 180 plus minus 68 gl serum ss2 microglobulin concentrations 290 plus minus 103 vs 290 plus minus 106 mgl differ patient groups neither anti ssa 78 plus minus 45 vs 64 plus minus 55 iul anti ssb antibody titres 56 plus minus 70 vs 67 plus minus 76 iul differ apoe 4 carriers non carriers
0.3375625.15328426.html.plaintext.txt	34	apoe polymorphism clinical features pss differences observed frequencies extraglandular manifestations pss history arthralgia arthritis salivary gland swelling raynauds symptom purpura lymphadenopathy pleuritis alveolitis pulmonary fibrosis peripheral central nervous system symptoms patients without apoe 4 allele number diagnostic criteria pss differ patient groups data shown histological grade labial salivary gland biopsies lower apoe 4 carriers non carriers grade 3 4 56 vs 80 p 0048 respectively
0.3375625.15328426.html.plaintext.txt	35	apoe polymorphism clinical features pss differences observed frequencies extraglandular manifestations pss history arthralgia arthritis salivary gland swelling raynauds symptom purpura lymphadenopathy pleuritis alveolitis pulmonary fibrosis peripheral central nervous system symptoms patients without apoe 4 allele number diagnostic criteria pss differ patient groups data shown histological grade labial salivary gland biopsies lower apoe 4 carriers non carriers grade 3 4 56 vs 80 p 0048 respectively
0.3375625.15328426.html.plaintext.txt	36	discussion genetic variation apoe gene influences susceptibility coronary heart disease sporadic alzheimers disease apoe 4 allele strong association recently genetic variation apoe gene also found affect degree inflammation influencing serum crp levels dyslipidaemic middle aged men 2 surprisingly however patients carrying apoe 4 allele known associated inflammation found lower crp levels others 2
0.3375625.15328426.html.plaintext.txt	37	discussion genetic variation apoe gene influences susceptibility coronary heart disease sporadic alzheimers disease apoe 4 allele strong association recently genetic variation apoe gene also found affect degree inflammation influencing serum crp levels dyslipidaemic middle aged men 2 surprisingly however patients carrying apoe 4 allele known associated inflammation found lower crp levels others 2
0.3375625.15328426.html.plaintext.txt	38	patients pss chronic inflammation present shown markedly elevated esr levels pronounced hypergammaglobulinaemia elevated il 6 levels therefore hypothesized genetic polymorphism apoe could effect markers inflammation patients pss however proved case first differences found apoe genotype allele frequencies pss patients healthy controls moreover apoe 4 allele influence levels crp patients pss finding might explained fact pss known belong group autoimmune diseases modest even absent crp reaction 10 however addition lack differences crp levels differences emerged well established markers inflammatory activity including plasma il 6 tnf igg apoe 4 carriers non carriers apoe 4 carrier state also associated clinical features disease labial salivary gland histology marker severity inflammation pss even milder apoe 4 allele carriers compared non carriers
0.3375625.15328426.html.plaintext.txt	39	patients pss chronic inflammation present shown markedly elevated esr levels pronounced hypergammaglobulinaemia elevated il 6 levels therefore hypothesized genetic polymorphism apoe could effect markers inflammation patients pss however proved case first differences found apoe genotype allele frequencies pss patients healthy controls moreover apoe 4 allele influence levels crp patients pss finding might explained fact pss known belong group autoimmune diseases modest even absent crp reaction 10 however addition lack differences crp levels differences emerged well established markers inflammatory activity including plasma il 6 tnf igg apoe 4 carriers non carriers apoe 4 carrier state also associated clinical features disease labial salivary gland histology marker severity inflammation pss even milder apoe 4 allele carriers compared non carriers
0.3375625.15328426.html.plaintext.txt	40	found age disease onset significantly lower pss patients apoe 4 allele without allele similarly noted effect apoe 4 allele coronary atherosclerosis 11 alzheimers disease 12 age dependent moreover recent studies apoe polymorphism also found affect age onset infectious diseases 13 14 apoe polymorphism found affect age becoming infected plasmodium falciparum children ghana 13 possible role protection early stages malaria 14 viral infections eg epstein barr cytomegalovirus retrovirus infections proposed act triggering agents development pss genetically susceptible subjects 15 data apoe polymorphism susceptibility age disease onset related infections know background significant association apoe 4 earlier disease onset pss one might speculate however association could mediated example possible effect time point triggering viral infection
0.3375625.15328426.html.plaintext.txt	41	found age disease onset significantly lower pss patients apoe 4 allele without allele similarly noted effect apoe 4 allele coronary atherosclerosis 11 alzheimers disease 12 age dependent moreover recent studies apoe polymorphism also found affect age onset infectious diseases 13 14 apoe polymorphism found affect age becoming infected plasmodium falciparum children ghana 13 possible role protection early stages malaria 14 viral infections eg epstein barr cytomegalovirus retrovirus infections proposed act triggering agents development pss genetically susceptible subjects 15 data apoe polymorphism susceptibility age disease onset related infections know background significant association apoe 4 earlier disease onset pss one might speculate however association could mediated example possible effect time point triggering viral infection
0.3375625.15328426.html.plaintext.txt	42	speculative explanation earlier age onset pss particularly female subjects carrying apoe 4 allele might relation hormonal factors view strong female predominance among patients pss also believed involved pathogenesis pss 15 gender bias concomitant characteristic late age disease onset pss difficult interpret oestrogens considered favour autoimmunity androgens protect carriers apoe 4 held susceptible development diseases associated menopause found higher serum dhea testosterone levels women carrying allele 4 furthermore interaction oestrogen apoe alzheimers disease process observed recent study apoe polymorphism influenced binding oestrogen receptor altered transcriptional activity response oestrogen 16
0.3375625.15328426.html.plaintext.txt	43	speculative explanation earlier age onset pss particularly female subjects carrying apoe 4 allele might relation hormonal factors view strong female predominance among patients pss also believed involved pathogenesis pss 15 gender bias concomitant characteristic late age disease onset pss difficult interpret oestrogens considered favour autoimmunity androgens protect carriers apoe 4 held susceptible development diseases associated menopause found higher serum dhea testosterone levels women carrying allele 4 furthermore interaction oestrogen apoe alzheimers disease process observed recent study apoe polymorphism influenced binding oestrogen receptor altered transcriptional activity response oestrogen 16
0.3375625.15328426.html.plaintext.txt	44	demonstrated apoe polymorphism affect susceptibility pss plasma inflammatory indices patients pss clear association apoe 4 allele early onset pss
0.3375625.15328426.html.plaintext.txt	45	acknowledgments study supported medical research fund tampere university hospital tampere finland maud kuistilas foundation
0.3375625.15328426.html.plaintext.txt	46	authors declared conflicts interest
0.3375625.15328426.html.plaintext.txt	47	references top abstract introduction subjects methods results references hulkkonen j pertovaara m antonen j pasternack hurme m elevated interleukin 6 plasma levels regulated promoter region polymorphism il 6 gene primary sjogrens syndrome pss correlate clinical manifestations disease rheumatology 200140656 61abstractfree full text manttari m manninen v palosuo ehnholm c apolipoprotein e polymorphism c reactive protein dyslipidemic middle aged men atherosclerosis 2001156237 8crossrefisimedline mahley rw rall sc jr apolipoprotein e far lipid transport protein annu rev genomics hum genet 20001507 37crossrefisimedline zofkova zajickova k hill m horinek apolipoprotein e gene determines serum testosterone dehydroepiandrosterone levels postmenopausal women eur j endocrinol 2002147503 6 erratum eur j endocrinol 2003148587isi fox ri robinson ca curd jg kozin f howell f sjogrens syndrome proposed criteria classification arthritis rheum 198629577 85isimedline chishom dm mason dk labial salivary gland biopsy sjogrens disease j clin pathol 196821656 60isimedline vitali c bombardieri jonsson r et al classification criteria sjogrens syndrome revised version european criteria proposed american european consensus group ann rheum dis 200261554 9abstractfree full text pertovaara m korpela m kouri pasternack occurrence renal involvement primary sjogrens syndrome study 78 patients rheumatology 1999381113 20abstractfree full text koch w ehrenhaft griesser k et al taqman systems genotyping disease related polymorphisms present gene encoding apolipoprotein e clin chem lab med 2002401123 31medline moutsopoulos hm elkon kb mavridis ak acritidis nc hughes grv pepys mb serum c reactive protein primary sjogrens syndrome clin exp rheumatol 1983157 8isimedline ilveskoski e perola m lehtimaki et al age dependent association apolipoprotein e genotype coronary aortic atherosclerosis middle aged men autopsy study circulation 1999100608 13abstractfree full text poirier j davignon j bouthillier d kogan bertrand b gauthier apolipoprotein e polymorphism alzheimers disease lancet 19938873697 9 wozniak ma faragher eb todd ja koram ka riley em itzhaki rf apolipoprotein e polymorphism influence susceptibility malaria j med genet 200340348 51abstractfree full text aucan c walley aj hill avs common apolipoprotein e polymorphisms risk clinical malaria gambia j med genet 20044121 4free full text jonsson r gordon tp konttinen yt recent advances understanding molecular mechanisms pathogenesis antibody profile sjogrens syndrome curr rheumatol rep 20035311 6medline lambert jc coyle n lendon c allelic modulation apolipoprotein e expression estrogen potential relevance alzheimers disease j med genet 200441104 12abstractfree full text submitted 2 june 2004 revised version accepted 23 july 2004 article abstract full text pdf versions article 43121484 recent keh383v1 alert article cited alert correction posted services email article friend similar articles journal similar articles pubmed alert new issues journal add personal archive download citation manager disclaimer request permissions google scholar articles pertovaara m articles hurme m pubmed pubmed citation articles pertovaara m articles hurme m related collections rheumatology online issn 1462 0332 print issn 1462 0324 copyright 2006 british society rheumatology oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.3375625.15328426.html.plaintext.txt	48	references top abstract introduction subjects methods results references hulkkonen j pertovaara m antonen j pasternack hurme m elevated interleukin 6 plasma levels regulated promoter region polymorphism il 6 gene primary sjogrens syndrome pss correlate clinical manifestations disease rheumatology 200140656 61abstractfree full text manttari m manninen v palosuo ehnholm c apolipoprotein e polymorphism c reactive protein dyslipidemic middle aged men atherosclerosis 2001156237 8crossrefisimedline mahley rw rall sc jr apolipoprotein e far lipid transport protein annu rev genomics hum genet 20001507 37crossrefisimedline zofkova zajickova k hill m horinek apolipoprotein e gene determines serum testosterone dehydroepiandrosterone levels postmenopausal women eur j endocrinol 2002147503 6 erratum eur j endocrinol 2003148587isi fox ri robinson ca curd jg kozin f howell f sjogrens syndrome proposed criteria classification arthritis rheum 198629577 85isimedline chishom dm mason dk labial salivary gland biopsy sjogrens disease j clin pathol 196821656 60isimedline vitali c bombardieri jonsson r et al classification criteria sjogrens syndrome revised version european criteria proposed american european consensus group ann rheum dis 200261554 9abstractfree full text pertovaara m korpela m kouri pasternack occurrence renal involvement primary sjogrens syndrome study 78 patients rheumatology 1999381113 20abstractfree full text koch w ehrenhaft griesser k et al taqman systems genotyping disease related polymorphisms present gene encoding apolipoprotein e clin chem lab med 2002401123 31medline moutsopoulos hm elkon kb mavridis ak acritidis nc hughes grv pepys mb serum c reactive protein primary sjogrens syndrome clin exp rheumatol 1983157 8isimedline ilveskoski e perola m lehtimaki et al age dependent association apolipoprotein e genotype coronary aortic atherosclerosis middle aged men autopsy study circulation 1999100608 13abstractfree full text poirier j davignon j bouthillier d kogan bertrand b gauthier apolipoprotein e polymorphism alzheimers disease lancet 19938873697 9 wozniak ma faragher eb todd ja koram ka riley em itzhaki rf apolipoprotein e polymorphism influence susceptibility malaria j med genet 200340348 51abstractfree full text aucan c walley aj hill avs common apolipoprotein e polymorphisms risk clinical malaria gambia j med genet 20044121 4free full text jonsson r gordon tp konttinen yt recent advances understanding molecular mechanisms pathogenesis antibody profile sjogrens syndrome curr rheumatol rep 20035311 6medline lambert jc coyle n lendon c allelic modulation apolipoprotein e expression estrogen potential relevance alzheimers disease j med genet 200441104 12abstractfree full text submitted 2 june 2004 revised version accepted 23 july 2004 article abstract full text pdf versions article 43121484 recent keh383v1 alert article cited alert correction posted services email article friend similar articles journal similar articles pubmed alert new issues journal add personal archive download citation manager disclaimer request permissions google scholar articles pertovaara m articles hurme m pubmed pubmed citation articles pertovaara m articles hurme m related collections rheumatology online issn 1462 0332 print issn 1462 0324 copyright 2006 british society rheumatology oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.33803913.15066991.html.plaintext.txt	0	apolipoprotein stimulated apolipoprotein e secretion human macrophages independent cholesterol efflux maaike kockxa kerry anne ryeb katharina gausa carmel m quinna janelle wrighta timothy sloanea dimitri sviridovc ying fuc david sullivand john r burnette stephan rustf gerd assmannf g m anantharamaiahg mayakonda n palgunacharig sissel lund katzh michael c phillipsh roger deani wendy jessupa leonard kritharidesabjk
0.33803913.15066991.html.plaintext.txt	1	apolipoprotein stimulated apolipoprotein e secretion human macrophages independent cholesterol efflux maaike kockxa kerry anne ryeb katharina gausa carmel m quinna janelle wrighta timothy sloanea dimitri sviridovc ying fuc david sullivand john r burnette stephan rustf gerd assmannf g m anantharamaiahg mayakonda n palgunacharig sissel lund katzh michael c phillipsh roger deani wendy jessupa leonard kritharidesabjk
0.33803913.15066991.html.plaintext.txt	2	macrophage biology group centre vascular research university new south wales sydney 2052 australia b heart research institute sydney 2050 australia c baker heart research institute melbourne 8008 australia d department clinical biochemistry royal prince alfred hospital university sydney sydney 2050 australia e department core clinical pathology biochemistry royal perth hospital school medicine pharmacology university western australia perth 6847 australia f institut fur arterioskleroseforschung der westfalischen wilhelms universitat munster munster 48149 germany g university alabama birmingham medical center birmingham alabama 35294 hchildrens hospital philadelphia stokes research institute philadelphia pennsylvania 19104 4318 university canberra australian capital territory 2601 australia j department cardiology concord hospital university sydney sydney 2139 australia
0.33803913.15066991.html.plaintext.txt	3	received publication february 3 2004 revised form march 29 2004
0.33803913.15066991.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references apolipoprotein apoa mediated cholesterol efflux involves binding apoa plasma membrane via c terminus requires cellular atp binding cassette transporter abca1 activity apoa also stimulates secretion apolipoprotein e apoe macrophage foam cells although mechanism process understood study demonstrate apoa stimulates secretion apoe independently abca1 mediated cholesterol efflux lipid binding c terminus pulse chase experiments using 35s labeled cellular apoe demonstrate macrophage apoe exists relatively mobile em stable es pools apoa diverts apoe degradation secretion small proportion apoa mobilized apoe derived cell surface structural requirements induction apoe secretion cholesterol efflux clearly dissociated c terminal deletions recombinant apoa reduce cholesterol efflux increase apoe secretion deletion central helices 5 6 decreases apoe secretion without perturbing cholesterol efflux moreover range 11 22 mer helical peptides representing amphipathic helical segments apoa stimulate apoe secretion whereas c terminal helix domains 220 241 stimulates cholesterol efflux helix containing apolipoproteins apoa ii apoa iv apoe2 apoe3 apoe4 also stimulate apoe secretion implying positive feedback autocrine loop apoe secretion although apoe4 less effective finally apoa stimulates apoe secretion normally macrophages two unrelated subjects genetically confirmed tangier disease mutations c733r c5220 5222deltct mutations a1046d c4629 4630insa despite severely inhibited cholesterol efflux conclude apoa stimulates secretion apoe independently cholesterol efflux represents novel abca 1 independent positive feedback pathway stimulation potentially anti atherogenic apoe secretion helix containing molecules including apoa apoe
0.33803913.15066991.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references apolipoprotein apoa mediated cholesterol efflux involves binding apoa plasma membrane via c terminus requires cellular atp binding cassette transporter abca1 activity apoa also stimulates secretion apolipoprotein e apoe macrophage foam cells although mechanism process understood study demonstrate apoa stimulates secretion apoe independently abca1 mediated cholesterol efflux lipid binding c terminus pulse chase experiments using 35s labeled cellular apoe demonstrate macrophage apoe exists relatively mobile em stable es pools apoa diverts apoe degradation secretion small proportion apoa mobilized apoe derived cell surface structural requirements induction apoe secretion cholesterol efflux clearly dissociated c terminal deletions recombinant apoa reduce cholesterol efflux increase apoe secretion deletion central helices 5 6 decreases apoe secretion without perturbing cholesterol efflux moreover range 11 22 mer helical peptides representing amphipathic helical segments apoa stimulate apoe secretion whereas c terminal helix domains 220 241 stimulates cholesterol efflux helix containing apolipoproteins apoa ii apoa iv apoe2 apoe3 apoe4 also stimulate apoe secretion implying positive feedback autocrine loop apoe secretion although apoe4 less effective finally apoa stimulates apoe secretion normally macrophages two unrelated subjects genetically confirmed tangier disease mutations c733r c5220 5222deltct mutations a1046d c4629 4630insa despite severely inhibited cholesterol efflux conclude apoa stimulates secretion apoe independently cholesterol efflux represents novel abca 1 independent positive feedback pathway stimulation potentially anti atherogenic apoe secretion helix containing molecules including apoa apoe
0.33803913.15066991.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references anti atherogenic effects high density lipoprotein hdl1 1 least part attributed ability hdl stimulate cholesterol phospholipid efflux lipid loaded macrophages providing initial step reverse cholesterol transport rct apolipoprotein apoa major protein component hdl understood play important role process 1
0.33803913.15066991.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references anti atherogenic effects high density lipoprotein hdl1 1 least part attributed ability hdl stimulate cholesterol phospholipid efflux lipid loaded macrophages providing initial step reverse cholesterol transport rct apolipoprotein apoa major protein component hdl understood play important role process 1
0.33803913.15066991.html.plaintext.txt	8	lipid removal apoa involves camp inducible active transport pathway 2 known mediated atp binding cassette transporter 1 abca1abc 1 3 transporters membrane proteins utilize atp hydrolysis transport substrates across membranes 4 mutations abca1abc 1 cause tangier disease td severe hdl deficiency syndrome characterized low plasma levels hdl apoa accumulation cholesterol tissue macrophages predisposition atherosclerosis 5 7 fibroblasts subjects tangier disease show impaired cholesterol phospholipid release lipid free apolipoproteins 8 addition inhibition abca1 expression activity inhibits lipid efflux apoa normal fibroblasts 3 6
0.33803913.15066991.html.plaintext.txt	9	lipid removal apoa involves camp inducible active transport pathway 2 known mediated atp binding cassette transporter 1 abca1abc 1 3 transporters membrane proteins utilize atp hydrolysis transport substrates across membranes 4 mutations abca1abc 1 cause tangier disease td severe hdl deficiency syndrome characterized low plasma levels hdl apoa accumulation cholesterol tissue macrophages predisposition atherosclerosis 5 7 fibroblasts subjects tangier disease show impaired cholesterol phospholipid release lipid free apolipoproteins 8 addition inhibition abca1 expression activity inhibits lipid efflux apoa normal fibroblasts 3 6
0.33803913.15066991.html.plaintext.txt	10	properties additional induction cholesterol efflux may contribute anti atherogenic effect apoa 1 human atherosclerotic lesions contain apoe protein mrna especially association macrophage foam cells 9 secretion apoe macrophages may protect atherosclerosis indicated effects transplantation apoe expressing bone marrow apoe null mice 10 11 may depend upon enhanced local clearance cellular lipids andor inhibition local inflammatory responses addition lowering plasma concentrations atherogenic plasma lipoproteins recent studies demonstrated apoa stimulates apoe secretion cholesterol efflux human mouse foam cell macrophages 12 13 stimulation apoe secretion apoa hdl likely post transcriptionally regulated observed endogenous apoe macrophages recycled apoe hepatocytes 12 15 recent studies indicate abca1 may involved basal apoe secretion 16 however requirement abca1 activity apoa induced apoe secretion never reported
0.33803913.15066991.html.plaintext.txt	11	properties additional induction cholesterol efflux may contribute anti atherogenic effect apoa 1 human atherosclerotic lesions contain apoe protein mrna especially association macrophage foam cells 9 secretion apoe macrophages may protect atherosclerosis indicated effects transplantation apoe expressing bone marrow apoe null mice 10 11 may depend upon enhanced local clearance cellular lipids andor inhibition local inflammatory responses addition lowering plasma concentrations atherogenic plasma lipoproteins recent studies demonstrated apoa stimulates apoe secretion cholesterol efflux human mouse foam cell macrophages 12 13 stimulation apoe secretion apoa hdl likely post transcriptionally regulated observed endogenous apoe macrophages recycled apoe hepatocytes 12 15 recent studies indicate abca1 may involved basal apoe secretion 16 however requirement abca1 activity apoa induced apoe secretion never reported
0.33803913.15066991.html.plaintext.txt	12	study provide evidence apoa stimulated apoe secretion mechanistically distinct stimulation abca1 mediated cholesterol efflux demonstrate apoa promotes secretion mobile pool apoe otherwise destined intracellular degradation process require interactions c terminus apoa plasma membrane occurs normally macrophages patients tangier disease implying independence abca1 activity
0.33803913.15066991.html.plaintext.txt	13	study provide evidence apoa stimulated apoe secretion mechanistically distinct stimulation abca1 mediated cholesterol efflux demonstrate apoa promotes secretion mobile pool apoe otherwise destined intracellular degradation process require interactions c terminus apoa plasma membrane occurs normally macrophages patients tangier disease implying independence abca1 activity
0.33803913.15066991.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references reagents solvents high performance liquid chromatography hplc grade mallinckrodt polyclonal goat anti human antibodies human apoe obtained chemicon international inc immunoblotting nitrocellulose membranes non denaturing gel electrophoresis polyclonal goat antibodies human apoa polyclonal sheep antibodies human apoa ii roche applied science used secondary rabbit polyclonal anti goat anti sheep horseradish peroxidase linked antibodies nitrocellulose membranes 045 microm enhanced chemiluminescence ecl reagents hyperfilm obtained amersham biosciences human apoe standard biodesign 12n 3hcholesterol methyl 3hcholine chloride supplied amersham biosciences specific activity 44 cimmol 79 cimmol respectively ldl acetylated ldl acldl 3hcholesterol labeled acldl prepared described 17 18 1 palmitoyl 2 oleoyl phosphatidylcholine popc egg yolk sphingomyelin spm sodium cholate purchased sigma bicinchoninic acid bca reagent protein determination also supplied sigma aldrich pulse chase studies methionine free medium supplied invitrogen 35stran label 1175 cimmol icn
0.33803913.15066991.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references reagents solvents high performance liquid chromatography hplc grade mallinckrodt polyclonal goat anti human antibodies human apoe obtained chemicon international inc immunoblotting nitrocellulose membranes non denaturing gel electrophoresis polyclonal goat antibodies human apoa polyclonal sheep antibodies human apoa ii roche applied science used secondary rabbit polyclonal anti goat anti sheep horseradish peroxidase linked antibodies nitrocellulose membranes 045 microm enhanced chemiluminescence ecl reagents hyperfilm obtained amersham biosciences human apoe standard biodesign 12n 3hcholesterol methyl 3hcholine chloride supplied amersham biosciences specific activity 44 cimmol 79 cimmol respectively ldl acetylated ldl acldl 3hcholesterol labeled acldl prepared described 17 18 1 palmitoyl 2 oleoyl phosphatidylcholine popc egg yolk sphingomyelin spm sodium cholate purchased sigma bicinchoninic acid bca reagent protein determination also supplied sigma aldrich pulse chase studies methionine free medium supplied invitrogen 35stran label 1175 cimmol icn
0.33803913.15066991.html.plaintext.txt	16	apolipoproteins human apoa apoa ii isolated hdl ultracentrifugation anion exchange chromatography 17 19 human apoa iv isolated density 125 gml fraction plasma adsorption onto synthetic triglyceride rich microemulsions microemulsions delipidated apoa iv purified anion exchange chromatography q sepharose fast flow column 20 21 human apoe2 apoe3 apoe4 expressed bl21 escherichia coli provided dr karl weisgraber gladstone institute purified gel filtration chromatography
0.33803913.15066991.html.plaintext.txt	17	apolipoproteins human apoa apoa ii isolated hdl ultracentrifugation anion exchange chromatography 17 19 human apoa iv isolated density 125 gml fraction plasma adsorption onto synthetic triglyceride rich microemulsions microemulsions delipidated apoa iv purified anion exchange chromatography q sepharose fast flow column 20 21 human apoe2 apoe3 apoe4 expressed bl21 escherichia coli provided dr karl weisgraber gladstone institute purified gel filtration chromatography
0.33803913.15066991.html.plaintext.txt	18	apoa peptides recombinant proteins pure peptides representing peptides apoa synthesized using automated solid phase peptide synthesizer described previously 22 24 promote helical stability peptide molecules n c termini acetylated amidated except peptide 1 33 respectively 25 truncated apoa propeptide mutants expressed e colipgex expression system 26 cholesterol efflux proteins previously published 27 apoa deletion mutants constructed described previously 28 29 wild type apoa engineered variants apoa expressed expression host e coli strain bl21 de3 isolated gel filtration anion exchange chromatography 29 identical stimulation apoe secretion human macrophage foam cells observed control experiments using recombinant wild type apoa human apoa prepared human plasma previous studies established 5 10 microgml apoa saturating cholesterol efflux apoe secretion human murine macrophages 13 present studies peptides proteins added cells final concentration 25 microgml culture medium first establishing excess saturating concentrations induction apoe secretion molecules
0.33803913.15066991.html.plaintext.txt	19	apoa peptides recombinant proteins pure peptides representing peptides apoa synthesized using automated solid phase peptide synthesizer described previously 22 24 promote helical stability peptide molecules n c termini acetylated amidated except peptide 1 33 respectively 25 truncated apoa propeptide mutants expressed e colipgex expression system 26 cholesterol efflux proteins previously published 27 apoa deletion mutants constructed described previously 28 29 wild type apoa engineered variants apoa expressed expression host e coli strain bl21 de3 isolated gel filtration anion exchange chromatography 29 identical stimulation apoe secretion human macrophage foam cells observed control experiments using recombinant wild type apoa human apoa prepared human plasma previous studies established 5 10 microgml apoa saturating cholesterol efflux apoe secretion human murine macrophages 13 present studies peptides proteins added cells final concentration 25 microgml culture medium first establishing excess saturating concentrations induction apoe secretion molecules
0.33803913.15066991.html.plaintext.txt	20	preparation phospholipid apoa phospholipid apoa ii discs discs prepared described previously 19 using cholate dialysis method 30 preparation discs dialyzed extensively 001 m tris buffered saline containing 015 m nacl 0005 wv edta na2 0006 wv nan3 stored argon lipid free apoa apoa ii present preparations judged electrophoresis non denaturing 3 40 gradient gels phospholipid composition varied altering proportions phospholipids added time preparation chemical analyses reconstituted particles carried rochehitachi 902 analyzer roche diagnostics zurich switzerland phospholipid concentrations determined enzymatically 31 32 stokes diameter surface charge particles measured non denaturing page agarose gel electrophoresis 19 33 experiments cell efflux incubations media containing apoa phospholipid apoa ii phospholipid discs underwent non denaturing polyacrylamide gel electrophoresis followed electrophoretic transfer nitrocellulose membranes immunoblotting apoe apoa apoa ii investigate possible association apoe phospholipid containing particles
0.33803913.15066991.html.plaintext.txt	21	preparation phospholipid apoa phospholipid apoa ii discs discs prepared described previously 19 using cholate dialysis method 30 preparation discs dialyzed extensively 001 m tris buffered saline containing 015 m nacl 0005 wv edta na2 0006 wv nan3 stored argon lipid free apoa apoa ii present preparations judged electrophoresis non denaturing 3 40 gradient gels phospholipid composition varied altering proportions phospholipids added time preparation chemical analyses reconstituted particles carried rochehitachi 902 analyzer roche diagnostics zurich switzerland phospholipid concentrations determined enzymatically 31 32 stokes diameter surface charge particles measured non denaturing page agarose gel electrophoresis 19 33 experiments cell efflux incubations media containing apoa phospholipid apoa ii phospholipid discs underwent non denaturing polyacrylamide gel electrophoresis followed electrophoretic transfer nitrocellulose membranes immunoblotting apoe apoa apoa ii investigate possible association apoe phospholipid containing particles
0.33803913.15066991.html.plaintext.txt	22	isolation culture human monocyte derived macrophages hmdm human monocytes apoe3e3 phenotype isolated white cell concentrates healthy donors using centrifugal elutriation described 13 genotyping completed taq polymerase chain reaction amplification 232 base pair fragment apoe gene followed cutting restriction endonuclease cfo1 department biochemistry royal prince alfred hospital white cell buffy coat concentrates 24 h ex vivo human serum provided new south wales red cross blood transfusion service sydney australia purified monocytes 95 purity nonspecific esterase staining differentiated plating 15 x 106 cells per 22 mm diameter culture dish costar rpmi 1640 containing penicillin g streptomycin 50 unitsml 50 microgml respectively l glutamine 2 mm 10 vv heat inactivated whole human serum 6 days following differentiation cells washed enriched unesterified cholesterol fc cholesteryl ester ce incubation rpmi 1640 containing 10 lpds vv acldl 50 microg proteinml 4 days 13
0.33803913.15066991.html.plaintext.txt	23	isolation culture human monocyte derived macrophages hmdm human monocytes apoe3e3 phenotype isolated white cell concentrates healthy donors using centrifugal elutriation described 13 genotyping completed taq polymerase chain reaction amplification 232 base pair fragment apoe gene followed cutting restriction endonuclease cfo1 department biochemistry royal prince alfred hospital white cell buffy coat concentrates 24 h ex vivo human serum provided new south wales red cross blood transfusion service sydney australia purified monocytes 95 purity nonspecific esterase staining differentiated plating 15 x 106 cells per 22 mm diameter culture dish costar rpmi 1640 containing penicillin g streptomycin 50 unitsml 50 microgml respectively l glutamine 2 mm 10 vv heat inactivated whole human serum 6 days following differentiation cells washed enriched unesterified cholesterol fc cholesteryl ester ce incubation rpmi 1640 containing 10 lpds vv acldl 50 microg proteinml 4 days 13
0.33803913.15066991.html.plaintext.txt	24	mononuclear cells individual donors tangier disease subjects controls isolated minor modification previously described density separation method 34 35 using optipreptm solution density 1068 gml solution density 1063 gml remove platelets lymphocytes respectively total cells plated density 2 x 106 cells22 mm diameter culture well falcon cells differentiated macrophages rpmi 1640 containing antibiotics glutamine 50 ngml m csf 36 heat inactivated whole human serum 13 37 6 days time cells washed prior cholesterol enrichment see direct comparisons hmdm isolated normal donors density centrifugation centrifugal elutriation confirmed identical cholesterol efflux apoe secretion either method
0.33803913.15066991.html.plaintext.txt	25	mononuclear cells individual donors tangier disease subjects controls isolated minor modification previously described density separation method 34 35 using optipreptm solution density 1068 gml solution density 1063 gml remove platelets lymphocytes respectively total cells plated density 2 x 106 cells22 mm diameter culture well falcon cells differentiated macrophages rpmi 1640 containing antibiotics glutamine 50 ngml m csf 36 heat inactivated whole human serum 13 37 6 days time cells washed prior cholesterol enrichment see direct comparisons hmdm isolated normal donors density centrifugation centrifugal elutriation confirmed identical cholesterol efflux apoe secretion either method
0.33803913.15066991.html.plaintext.txt	26	lipid efflux apoe secretion achieve cholesterol loading macrophages 2 microciml 3hcholesterol ethanol incorporated acldl incubating cells 4 days described 18 triplicate cultures harvested loading confirm efficient enrichment fc ce hplc cells subsequently washed equilibrated overnight rpmi 1640 containing 01 wv bovine serum albumin allow equilibration 3hcholesterol fc ce pools experiments cells loaded acldl without 3hcholesterol phospholipids labeled end 4 day cholesterol loading period incubating cells rpmi 1640 containing 3 microciml 3hcholine chloride ethanol final 2 vv 01 bovine serum albumin wv 22 h followed equilibration 1 h rpmi 1640 containing 01 bovine serum albumin
0.33803913.15066991.html.plaintext.txt	27	lipid efflux apoe secretion achieve cholesterol loading macrophages 2 microciml 3hcholesterol ethanol incorporated acldl incubating cells 4 days described 18 triplicate cultures harvested loading confirm efficient enrichment fc ce hplc cells subsequently washed equilibrated overnight rpmi 1640 containing 01 wv bovine serum albumin allow equilibration 3hcholesterol fc ce pools experiments cells loaded acldl without 3hcholesterol phospholipids labeled end 4 day cholesterol loading period incubating cells rpmi 1640 containing 3 microciml 3hcholine chloride ethanol final 2 vv 01 bovine serum albumin wv 22 h followed equilibration 1 h rpmi 1640 containing 01 bovine serum albumin
0.33803913.15066991.html.plaintext.txt	28	equilibrated cholesterol enriched cells washed warm pbs incubated 10 ml efflux medium comprising rpmi 1640 without 25 microgml apoa appropriate additions 1 8 h media removed mixed complete protease inhibitor roche applied science 002 tiu aprotinin sigma spun 2 min 16000 x g remove detached cells cultures washed twice ice cold pbs scraped 08 ml cold pbs containing complete protease inhibitor aprotinin
0.33803913.15066991.html.plaintext.txt	29	equilibrated cholesterol enriched cells washed warm pbs incubated 10 ml efflux medium comprising rpmi 1640 without 25 microgml apoa appropriate additions 1 8 h media removed mixed complete protease inhibitor roche applied science 002 tiu aprotinin sigma spun 2 min 16000 x g remove detached cells cultures washed twice ice cold pbs scraped 08 ml cold pbs containing complete protease inhibitor aprotinin
0.33803913.15066991.html.plaintext.txt	30	quantitation cholesterol cholesteryl ester cells media 40 microl media aliquots 5 microl cell aliquots analyzed scintillation counting quantify efflux 3hcholesterol proportions label cell 3hfc 3hce determined separation tlc heptaneethyl acetate 11 vv standards fc ce identified charring 100 degrees c 10 cuso4 85h3po4 masses fc ce cells media determined reverse phase hplc extraction methanolhexane 17 38 radiochemical equilibrium determined calculating specific activity free esterified cholesterol dpm per nmol 18 reproducibly achieved 4 days cholesterol enrichment overnight equilibration
0.33803913.15066991.html.plaintext.txt	31	quantitation cholesterol cholesteryl ester cells media 40 microl media aliquots 5 microl cell aliquots analyzed scintillation counting quantify efflux 3hcholesterol proportions label cell 3hfc 3hce determined separation tlc heptaneethyl acetate 11 vv standards fc ce identified charring 100 degrees c 10 cuso4 85h3po4 masses fc ce cells media determined reverse phase hplc extraction methanolhexane 17 38 radiochemical equilibrium determined calculating specific activity free esterified cholesterol dpm per nmol 18 reproducibly achieved 4 days cholesterol enrichment overnight equilibration
0.33803913.15066991.html.plaintext.txt	32	quantitation phospholipids cells media phospholipids extracted 150 microl aliquots cell lysates media samples using method bligh dyer including two backwashes methanolwater 109 vv described previously 39 evaporation chloroform phase lipids dissolved 200 microl chloroformmethanol 21 vv 50 microl aliquots counted scintillation counting determine phospholipid efflux total phospholipid mass determined using modification bartlett assay described 40 used determine specific activity dpm per nmol phospholipid
0.33803913.15066991.html.plaintext.txt	33	quantitation phospholipids cells media phospholipids extracted 150 microl aliquots cell lysates media samples using method bligh dyer including two backwashes methanolwater 109 vv described previously 39 evaporation chloroform phase lipids dissolved 200 microl chloroformmethanol 21 vv 50 microl aliquots counted scintillation counting determine phospholipid efflux total phospholipid mass determined using modification bartlett assay described 40 used determine specific activity dpm per nmol phospholipid
0.33803913.15066991.html.plaintext.txt	34	quantitation apoe cell lysates efflux media western blot elisa aliquots 55 microl cell culture medium mixed sample buffer 275 microl containing 10 mm dithiothreitol heated 100 degrees c 5 min separated sds page using 4 stacking gel 125 polyacrylamide resolving gel reducing conditions tris glycine buffer described 13 electrophoretic western blot transfer onto 045 microm nitrocellulose membranes performed trisglycine buffer 1 h 25 30 v blocked incubating primary antibody apoe goat anti human polyclonal 15000 dilution washing incubating 15000 dilution secondary antibody rabbit anti goat igg conjugated horseradish peroxidase 13 membrane chemiluminescence signal quantified using kodak digital science 1d expressed arbitrary units au per mg cell protein experiments serial dilution authentic human apoe standard sample buffer separated blotted parallel allow calculation secreted apoe mass microgram per culture microg per mg cell protein linear response range chemiluminescence signal mass authentic human apoe standard defined western blot experiment
0.33803913.15066991.html.plaintext.txt	35	quantitation apoe cell lysates efflux media western blot elisa aliquots 55 microl cell culture medium mixed sample buffer 275 microl containing 10 mm dithiothreitol heated 100 degrees c 5 min separated sds page using 4 stacking gel 125 polyacrylamide resolving gel reducing conditions tris glycine buffer described 13 electrophoretic western blot transfer onto 045 microm nitrocellulose membranes performed trisglycine buffer 1 h 25 30 v blocked incubating primary antibody apoe goat anti human polyclonal 15000 dilution washing incubating 15000 dilution secondary antibody rabbit anti goat igg conjugated horseradish peroxidase 13 membrane chemiluminescence signal quantified using kodak digital science 1d expressed arbitrary units au per mg cell protein experiments serial dilution authentic human apoe standard sample buffer separated blotted parallel allow calculation secreted apoe mass microgram per culture microg per mg cell protein linear response range chemiluminescence signal mass authentic human apoe standard defined western blot experiment
0.33803913.15066991.html.plaintext.txt	36	addition apoe secretion measured experiments using elisa nunc 96 well immunoplates coated 15 microgml mouse monoclonal anti human apoe antibody biodesign 02 m na2co3nahco3 buffer standards prepared purified human apoe biodesign whereas antibodies used western analysis used tagging antibodies goat anti human polyclonal 13750 rabbit antigoat horseradish peroxidase 12500
0.33803913.15066991.html.plaintext.txt	37	addition apoe secretion measured experiments using elisa nunc 96 well immunoplates coated 15 microgml mouse monoclonal anti human apoe antibody biodesign 02 m na2co3nahco3 buffer standards prepared purified human apoe biodesign whereas antibodies used western analysis used tagging antibodies goat anti human polyclonal 13750 rabbit antigoat horseradish peroxidase 12500
0.33803913.15066991.html.plaintext.txt	38	metabolic labeling cell proteins 35smethioninecysteine study fate newly synthesized apoe cholesterol enriched hmdm labeled methionine free medium invitrogen containing 250 microciml 35stran label 1175 cimmol icn 3 h washed chased rpmi 1640 media containing 2 mm methionine sigma cysteine sigma 35s labeled apoe cell lysates culture medium determined immunoprecipitation using 110000 dilution polyclonal goat antibody human apoe protein sepharose amersham biosciences separation sds page quantified phosphorimaging photostimulated luminescence fujix bas 1000 expressed au apoemg cell protein 13 indicated experiments detecting small amounts secreted apoe requiring increased sensitivity immunoprecipitated 35s labeled apoe directly quantified radiometric detection confirming single band sds page phosphorimaging 35smethioninecysteine labeling also used discriminate cell derived secreted exogenous apoe experiments investigating secretion apoe recombinant apoe2 e3 e4
0.33803913.15066991.html.plaintext.txt	39	metabolic labeling cell proteins 35smethioninecysteine study fate newly synthesized apoe cholesterol enriched hmdm labeled methionine free medium invitrogen containing 250 microciml 35stran label 1175 cimmol icn 3 h washed chased rpmi 1640 media containing 2 mm methionine sigma cysteine sigma 35s labeled apoe cell lysates culture medium determined immunoprecipitation using 110000 dilution polyclonal goat antibody human apoe protein sepharose amersham biosciences separation sds page quantified phosphorimaging photostimulated luminescence fujix bas 1000 expressed au apoemg cell protein 13 indicated experiments detecting small amounts secreted apoe requiring increased sensitivity immunoprecipitated 35s labeled apoe directly quantified radiometric detection confirming single band sds page phosphorimaging 35smethioninecysteine labeling also used discriminate cell derived secreted exogenous apoe experiments investigating secretion apoe recombinant apoe2 e3 e4
0.33803913.15066991.html.plaintext.txt	40	biotinylation isolation biotinylated apoe cholesterol enriched hmdm incubated 200 microciml 35stran label methionine free dulbeccos modified eagles medium dmem containing 10 dmem 16 h surface proteins biotinylated placing cells ice 5 min followed incubation 1 mgml sulfo nhs ss biotin pierce pbs 4 degrees c 45 min cells washed twice ice cold pbs subsequently incubated without 25 microgml apoa 30 min 37 degrees c apoe immunoprecipitated described biotinylated apoe separated total immunoprecipitated apoe described 41 short total apoe released protein sepharose beads boiling 100 microl hepes buffered saline containing 1 sds 90 degrees c 3 min biotinylated apoe separated unbiotinylated apoe using immunopure immobilized streptavidin pierce quantified using scintillation counting sds pagephosphorimaging biotinylated apoe quantified au apoemg cell protein percent total immunoprecipitated secreted apoe experiments 35 plus minus 05 total cellular apoe biotinylated 340 plus minus 97 cellular apoe protein plasma membrane fractions isolated sucrose density gradient 42 cell surface proteins biotinylated 4 degrees c 41 estimated 112 plus minus 32 plasma membrane pool apoe biotinylated experiments
0.33803913.15066991.html.plaintext.txt	41	biotinylation isolation biotinylated apoe cholesterol enriched hmdm incubated 200 microciml 35stran label methionine free dulbeccos modified eagles medium dmem containing 10 dmem 16 h surface proteins biotinylated placing cells ice 5 min followed incubation 1 mgml sulfo nhs ss biotin pierce pbs 4 degrees c 45 min cells washed twice ice cold pbs subsequently incubated without 25 microgml apoa 30 min 37 degrees c apoe immunoprecipitated described biotinylated apoe separated total immunoprecipitated apoe described 41 short total apoe released protein sepharose beads boiling 100 microl hepes buffered saline containing 1 sds 90 degrees c 3 min biotinylated apoe separated unbiotinylated apoe using immunopure immobilized streptavidin pierce quantified using scintillation counting sds pagephosphorimaging biotinylated apoe quantified au apoemg cell protein percent total immunoprecipitated secreted apoe experiments 35 plus minus 05 total cellular apoe biotinylated 340 plus minus 97 cellular apoe protein plasma membrane fractions isolated sucrose density gradient 42 cell surface proteins biotinylated 4 degrees c 41 estimated 112 plus minus 32 plasma membrane pool apoe biotinylated experiments
0.33803913.15066991.html.plaintext.txt	42	analysis apoe mrna real time pcr cells harvested total rna using tri reagent sigma according manufacturers instructions exception 1 bromo 3 chloropropane sigma substituted chloroform reverse transcription reaction 1 microg total rna reverse transcribed using oligodt primers invitrogen superscript ii reverse transcriptase invitrogen relative real time rt pcr performed using iq sybr green supermix bio rad abi 7700 sequence detector pe biosystems analyzed using abi prism sequence detector software v163 pe biosystems gene specific primers used follows apoe 5 ctgctcagctcccaggtcacccagg 3forward 5 cttctgcaggtcatcggcatcgcgg 3reverse annealing 60 degrees c 30 cycles product size 321 base pairs abca1 5 gcactgaggaagatgctgaaa 3forward 5 agttcctggaaggtcttgttcac 3 reverse annealing 60 degrees c 28 cycles product size 205 base pairs results normalized housekeeping gene pbgd 5 gagtgattcgcgtgggtacc 3 forward 5 ggctccgatggtgaagcc 3 reverse annealing 55 60 degrees c melting curve analysis performed confirm production single product reactions results exposure apoa related without apoa rpmi 1640 medium control experiment results three experiments averaged
0.33803913.15066991.html.plaintext.txt	43	analysis apoe mrna real time pcr cells harvested total rna using tri reagent sigma according manufacturers instructions exception 1 bromo 3 chloropropane sigma substituted chloroform reverse transcription reaction 1 microg total rna reverse transcribed using oligodt primers invitrogen superscript ii reverse transcriptase invitrogen relative real time rt pcr performed using iq sybr green supermix bio rad abi 7700 sequence detector pe biosystems analyzed using abi prism sequence detector software v163 pe biosystems gene specific primers used follows apoe 5 ctgctcagctcccaggtcacccagg 3forward 5 cttctgcaggtcatcggcatcgcgg 3reverse annealing 60 degrees c 30 cycles product size 321 base pairs abca1 5 gcactgaggaagatgctgaaa 3forward 5 agttcctggaaggtcttgttcac 3 reverse annealing 60 degrees c 28 cycles product size 205 base pairs results normalized housekeeping gene pbgd 5 gagtgattcgcgtgggtacc 3 forward 5 ggctccgatggtgaagcc 3 reverse annealing 55 60 degrees c melting curve analysis performed confirm production single product reactions results exposure apoa related without apoa rpmi 1640 medium control experiment results three experiments averaged
0.33803913.15066991.html.plaintext.txt	44	sucrose density ultracentrifugation determine buoyant density secreted apoe media samples subjected sucrose density ultracentrifugation using minor modification published protocol 43 following efflux 625 microl aliquots media centrifuged 16000 x g 2 min remove cellular debris supernatant underlayed underlay completed using 2 ml 133 sucrose solution 123 ml 35 sucrose solution 123 ml 65 sucrose solution 51 ml beckman quick seal tubes samples centrifuged 100000 rpm 543000 x g 20 h 16 degrees c using tl1004 rotor beckman tlx ultracentrifuge 15 x 250 microl aliquots taken analyzed 3hcholesterol apoe western blot
0.33803913.15066991.html.plaintext.txt	45	sucrose density ultracentrifugation determine buoyant density secreted apoe media samples subjected sucrose density ultracentrifugation using minor modification published protocol 43 following efflux 625 microl aliquots media centrifuged 16000 x g 2 min remove cellular debris supernatant underlayed underlay completed using 2 ml 133 sucrose solution 123 ml 35 sucrose solution 123 ml 65 sucrose solution 51 ml beckman quick seal tubes samples centrifuged 100000 rpm 543000 x g 20 h 16 degrees c using tl1004 rotor beckman tlx ultracentrifuge 15 x 250 microl aliquots taken analyzed 3hcholesterol apoe western blot
0.33803913.15066991.html.plaintext.txt	46	tangier disease patients td1 td2 previously unreported 56 year old male clinical features consistent tangier disease td1 identified patient premature coronary artery disease low plasma hdl cholesterol 31 77 mgdl normal range 30 70 mgdl apoa concentrations 0002 0006 mgdl normal 110 140 mgdl low total cholesterol 619 1044 mgdl normal range 116 225 mgdl ldl cholesterol 193 mgdl normal range 50 190 mgdl level also elevated plasma triglycerides 1771 3366 mgdl normal 200 mgdl bilateral cataracts hepatomegaly splenomegaly tonsils removed childhood patient genotyped rust g assmann institut fur arterioskleroseforschung der westfalischen wilhelms universitat munster germany two novel amino acid mutations within abca1 gene found c733r exon 16 c2197c deletion three nucleotides exon 38 c5220 5222deltct different alleles shown segregation analysis numbering follows recommendations international nomenclature working group mutations affect amino acids conserved human mice neither mutations previously described healthy subject normal lipoprotein profile history vascular disease used source control macrophages hc1 since completion study td1 died
0.33803913.15066991.html.plaintext.txt	47	tangier disease patients td1 td2 previously unreported 56 year old male clinical features consistent tangier disease td1 identified patient premature coronary artery disease low plasma hdl cholesterol 31 77 mgdl normal range 30 70 mgdl apoa concentrations 0002 0006 mgdl normal 110 140 mgdl low total cholesterol 619 1044 mgdl normal range 116 225 mgdl ldl cholesterol 193 mgdl normal range 50 190 mgdl level also elevated plasma triglycerides 1771 3366 mgdl normal 200 mgdl bilateral cataracts hepatomegaly splenomegaly tonsils removed childhood patient genotyped rust g assmann institut fur arterioskleroseforschung der westfalischen wilhelms universitat munster germany two novel amino acid mutations within abca1 gene found c733r exon 16 c2197c deletion three nucleotides exon 38 c5220 5222deltct different alleles shown segregation analysis numbering follows recommendations international nomenclature working group mutations affect amino acids conserved human mice neither mutations previously described healthy subject normal lipoprotein profile history vascular disease used source control macrophages hc1 since completion study td1 died
0.33803913.15066991.html.plaintext.txt	48	second td patient td2 healthy normal brother hc2 heterozygous parents hz2a mother hz2b father previously described 44 45 abca1 mutations td patient published missense mutation exon 21 a986d frameshift mutation exon 33 4570insa a1484 x1492 45 using current nomenclature respectively equivalent missense mutation exon 22 c3137c a1046d frameshift mutation exon 34 c4629 4630insa a1544 fs x1552 hc2 neither abca1 mutation hz2a hz2b contain 4629insa a1046d mutations respectively plasma hdl cholesterol concentrations hc2 td2 hz2a hz2b respectively 430 27 258 386 mgdl apoa levels respectively 129 45 957 1158 mgdl plasma triglyceride concentrations elevated subjects 5077 mgdl hc2 2463 mgdl td2 3376 mgdl hz2a 3969 mgdl hz2b
0.33803913.15066991.html.plaintext.txt	49	second td patient td2 healthy normal brother hc2 heterozygous parents hz2a mother hz2b father previously described 44 45 abca1 mutations td patient published missense mutation exon 21 a986d frameshift mutation exon 33 4570insa a1484 x1492 45 using current nomenclature respectively equivalent missense mutation exon 22 c3137c a1046d frameshift mutation exon 34 c4629 4630insa a1544 fs x1552 hc2 neither abca1 mutation hz2a hz2b contain 4629insa a1046d mutations respectively plasma hdl cholesterol concentrations hc2 td2 hz2a hz2b respectively 430 27 258 386 mgdl apoa levels respectively 129 45 957 1158 mgdl plasma triglyceride concentrations elevated subjects 5077 mgdl hc2 2463 mgdl td2 3376 mgdl hz2a 3969 mgdl hz2b
0.33803913.15066991.html.plaintext.txt	50	protein estimation protein contents ldl samples cell lysates determined duplicate triplicate sample measured using bca method bovine serum albumin standard 17
0.33803913.15066991.html.plaintext.txt	51	cell viability cell viability following various treatments routinely assessed light microscopic morphology estimation cell protein measuring leakage lactate dehydrogenase medium 46 cell viability routinely 85 100 incubation efflux media
0.33803913.15066991.html.plaintext.txt	52	cell viability cell viability following various treatments routinely assessed light microscopic morphology estimation cell protein measuring leakage lactate dehydrogenase medium 46 cell viability routinely 85 100 incubation efflux media
0.33803913.15066991.html.plaintext.txt	53	data analysis degradation secretion cellular apoe pulse chase experiments simultaneously fitted first order rate equation k1 k2 describing rate constants secretion degradation respectively first order rate equation shown equation 1
0.33803913.15066991.html.plaintext.txt	54	data analysis degradation secretion cellular apoe pulse chase experiments simultaneously fitted first order rate equation k1 k2 describing rate constants secretion degradation respectively first order rate equation shown equation 1
0.33803913.15066991.html.plaintext.txt	55	eq 1 fitted experimental secretion degradation data using non linear least squares fitting program solver microsoft excel quality fit evaluated error function previously described 42
0.33803913.15066991.html.plaintext.txt	56	efflux calculated 3hlipids eg cholesterol phospholipid released medium expressed percentage total 3h cellular lipids t0 17 18 unless otherwise stated data presented mean plus minus sd triplicate cultures single experiments representative least 2 3 independent experiments significance results assessed unpaired students test simple comparisons two groups one way analysis variance using tukeys test post hoc correction multiple comparisons differences considered significant p 005
0.33803913.15066991.html.plaintext.txt	57	results top abstract introduction experimental procedures results discussion references apoa stimulates secretion apoe previously shown apoa stimulates secretion murine macrophage apoe time concentration dependent manner inhibited transcription inhibitor actinomycin d 13 confirm apoa stimulates apoe secretion primary human macrophages time dependent manner without affecting net cell associated apoe protein cellular apoe mrna levels fig 1 secreted apoe always 34 kda consistent known extensive glycosylation secreted apoe whereas cell associated apoe multiple masses consistent variable degrees glycosylation apoe processing within cells
0.33803913.15066991.html.plaintext.txt	58	results top abstract introduction experimental procedures results discussion references apoa stimulates secretion apoe previously shown apoa stimulates secretion murine macrophage apoe time concentration dependent manner inhibited transcription inhibitor actinomycin d 13 confirm apoa stimulates apoe secretion primary human macrophages time dependent manner without affecting net cell associated apoe protein cellular apoe mrna levels fig 1 secreted apoe always 34 kda consistent known extensive glycosylation secreted apoe whereas cell associated apoe multiple masses consistent variable degrees glycosylation apoe processing within cells
0.33803913.15066991.html.plaintext.txt	59	view larger version 21k fig 1 post transcriptional stimulation apoe secretion apoa hmdm incubated 4 days 50 microgml acldl washed incubated times indicated rpmi 1640 apoa without control 25 microgml apoa apoe protein determined western blotting 8 h three independent cell cultures media cell lysates elisa variable times b apoe mrna levels c determined 8 h real time rt pcr relative housekeeping gene pbgd described experimental procedures p 001 relative control
0.33803913.15066991.html.plaintext.txt	60	determine effect apoa secretion degradation preformed apoe absence ongoing de novo synthesis pulse chase experiments performed pulse incubations first incorporated 35smethionine cellular apoe chased without apoa absence label fig 2 apoa rapidly stimulated secretion 35sapoe differences apoa containing control media apparent within 30 min incubation analysis residual cell 35s labeled apoe chase incubations demonstrated rapid nearly identical decline cell associated apoe without apoa net degradation apoe cells plus media lower apoa containing cultures relative control conditions matched increased secretion apoe apoa containing media identical rate decline cell associated apoe control apoa exposed conditions suggests apoa diverts apoe secretion cellular pool apoe otherwise degraded
0.33803913.15066991.html.plaintext.txt	61	determine effect apoa secretion degradation preformed apoe absence ongoing de novo synthesis pulse chase experiments performed pulse incubations first incorporated 35smethionine cellular apoe chased without apoa absence label fig 2 apoa rapidly stimulated secretion 35sapoe differences apoa containing control media apparent within 30 min incubation analysis residual cell 35s labeled apoe chase incubations demonstrated rapid nearly identical decline cell associated apoe without apoa net degradation apoe cells plus media lower apoa containing cultures relative control conditions matched increased secretion apoe apoa containing media identical rate decline cell associated apoe control apoa exposed conditions suggests apoa diverts apoe secretion cellular pool apoe otherwise degraded
0.33803913.15066991.html.plaintext.txt	62	view larger version 15k fig 2 apoa stimulates secretion preformed apoe decreases net apoe degradation hmdm incubated 4 days 50 microgml acldl washed incubated methionine free dulbeccos modified eagles medium 200 microciml 35smethioninecysteine 3 h cells washed chased without 25 microgml apoa indicated times 35s labeled apoe immunoprecipitated media cell lysates separated detected sds page phosphorimaging single 34 kda band measured scintillation counting excised band described experimental procedures start chase t0 total apoe 278 plus minus 021 x 106 cpmmg cell protein secreted apoe b cell associated apoe c net degradation apoe calculated subtracting residual apoe cells media apoe cells t0 data expressed percent total apoe t0
0.33803913.15066991.html.plaintext.txt	63	investigate pool apoe mobilized apoa degradation secretion cellular apoe simultaneously fitted first order rate equation k1 describing rate constant secretion k2 degradation previously described boundary conditions accepting modeling experimental data error function erf 001 erf 005 42 initial model assumed de novo synthesized apoe equally susceptible degradation secretion net degradation secretion proceeded constant rates independent however comparison experimental calculated data using model identified erf excessive fulfill boundary conditions erf control 0081 apoa 0069 respectively second model simultaneously fitted degradation secretion 35s labeled cellular apoe first order rate equation described experimental procedures cellular labeled apoe start chase divided two pools larger mobile pool apoe em 75 smaller stable pool es 25 neither degraded secreted duration experiment presence es apparent residual pool undegraded cell associated apoe presence stable pool previously identified surface hepg2 cells 47 using model secretion degradation apoe mutually dependent boundary conditions goodness fit fulfilled fig 3 apoa increased rate constant secretion k1 decreased rate constant degradation k2 relative control conditions substantially alter size es em thus apoa stimulated secretion mobile pool apoe otherwise fated intracellular degradation
0.33803913.15066991.html.plaintext.txt	64	investigate pool apoe mobilized apoa degradation secretion cellular apoe simultaneously fitted first order rate equation k1 describing rate constant secretion k2 degradation previously described boundary conditions accepting modeling experimental data error function erf 001 erf 005 42 initial model assumed de novo synthesized apoe equally susceptible degradation secretion net degradation secretion proceeded constant rates independent however comparison experimental calculated data using model identified erf excessive fulfill boundary conditions erf control 0081 apoa 0069 respectively second model simultaneously fitted degradation secretion 35s labeled cellular apoe first order rate equation described experimental procedures cellular labeled apoe start chase divided two pools larger mobile pool apoe em 75 smaller stable pool es 25 neither degraded secreted duration experiment presence es apparent residual pool undegraded cell associated apoe presence stable pool previously identified surface hepg2 cells 47 using model secretion degradation apoe mutually dependent boundary conditions goodness fit fulfilled fig 3 apoa increased rate constant secretion k1 decreased rate constant degradation k2 relative control conditions substantially alter size es em thus apoa stimulated secretion mobile pool apoe otherwise fated intracellular degradation
0.33803913.15066991.html.plaintext.txt	65	view larger version 16k fig 3 apoa diverts apoe degradation secretion degradation secretion 35s labeled cellular apoe pulse chase experiments simultaneously fitted first order rate equation described experimental procedures model apoe turnover es em representing stable mobile cellular apoe pools respectively k1 k2 respectively describing rate constants secretion degradation b experimental open symbols dashed line calculated closed symbols solid line kinetic data secreted cellular degraded apoe presence apoa c summary modeling parameters es representing percent cellular apoe stable pool erf representing error function modeling parameters
0.33803913.15066991.html.plaintext.txt	66	considered cell surface apoe might contribute mobile pool apoe secreted apoa apoe mobilized surface cells 48 investigate 35smethionine labeled hmdm incubated 4 degrees c biotin label cell surface proteins cells exposed control media apoa 30 min 37 degrees c allow apoe secretion fig 4a cell medium samples sequentially immunoprecipitated first using antibodies apoe biotin apoa stimulated secretion biotin labeled apoe 2 fold relative control medium indicating cell surface apoe contribute secreted apoe however biotin labeled apoe represented 2 secreted apoe control 06 plus minus 03 apoa containing 16 plus minus 03 conditions 30 min much less estimated proportion plasma membrane apoe biotinylated 112 plus minus 32 see experimental procedures data indicated net contribution cell surface pool overall apoe secretion minor
0.33803913.15066991.html.plaintext.txt	67	considered cell surface apoe might contribute mobile pool apoe secreted apoa apoe mobilized surface cells 48 investigate 35smethionine labeled hmdm incubated 4 degrees c biotin label cell surface proteins cells exposed control media apoa 30 min 37 degrees c allow apoe secretion fig 4a cell medium samples sequentially immunoprecipitated first using antibodies apoe biotin apoa stimulated secretion biotin labeled apoe 2 fold relative control medium indicating cell surface apoe contribute secreted apoe however biotin labeled apoe represented 2 secreted apoe control 06 plus minus 03 apoa containing 16 plus minus 03 conditions 30 min much less estimated proportion plasma membrane apoe biotinylated 112 plus minus 32 see experimental procedures data indicated net contribution cell surface pool overall apoe secretion minor
0.33803913.15066991.html.plaintext.txt	68	view larger version 11k fig 4 apoa stimulates release cell surface pools apoe hmdm cholesterol enriched acldl radiolabeled 35s methioninecysteine 16 h 35smethionine labeled hmdm placed ice 4 degrees c cell surface proteins biotinylated described experimental procedures cells incubated medium without control 25 microgml apoa apoa 30 min 37 degrees c total 35s labeled apoe immunoprecipitated biotinylated pool immunoprecipitated pool quantified total 35s labeled apoe immunoprecipitated cell cultures t0 838768 plus minus 33266 dpmmg cell protein b 35smethionine labeled hmdm placed ice incubated without apoa 30 min 4 degrees c 35s labeled apoe released medium immunoprecipitated quantified represented 32 plus minus 04 61 plus minus 15 total cellular apoe t0 control apoa respectively significantly different versus control p 005
0.33803913.15066991.html.plaintext.txt	69	cell surface apoe re endocytosed 41 pool biotin labeled apoe secreted apoa could represent apoe directly mobilized cell surface apoe re internalized re secreted although little recycling would expected 30 min confirm apoa directly mobilizes cell surface apoe 35smethionine labeled hmdm precooled 4 degrees c incubated control medium apoa 4 degrees c 30 min fig 4b apoa approximately doubled release cell surface apoe 4 degrees c 32 plus minus 04 61 plus minus 15 total cell apoe present t0 indicating cell surface apoe contribute directly mobile pool apoe released apoa although overall remains minor proportion total apoe released
0.33803913.15066991.html.plaintext.txt	70	cell surface apoe re endocytosed 41 pool biotin labeled apoe secreted apoa could represent apoe directly mobilized cell surface apoe re internalized re secreted although little recycling would expected 30 min confirm apoa directly mobilizes cell surface apoe 35smethionine labeled hmdm precooled 4 degrees c incubated control medium apoa 4 degrees c 30 min fig 4b apoa approximately doubled release cell surface apoe 4 degrees c 32 plus minus 04 61 plus minus 15 total cell apoe present t0 indicating cell surface apoe contribute directly mobile pool apoe released apoa although overall remains minor proportion total apoe released
0.33803913.15066991.html.plaintext.txt	71	c terminal truncations pro apoa differentially affect cholesterol efflux apoe secretion previous studies indicated c terminus apoa particularly important stimulation cholesterol efflux binding apoa cell surface 49 related lipid binding ability c terminus 27 50 investigated role c terminus inducing apoe secretion primary human foam cell macrophages using recombinant pro apoa 6 243 truncations c terminus 6 150 6 222 fig 5 initial studies confirmed pro apoa native human apoa induced similar cholesterol efflux apoe secretion data shown consistent previous studies hepg2 cells 27 deletion c terminal 21 amino acids 6 222 decreased cholesterol efflux relative whole apoa 6 243 whereas deletion c terminal 93 amino acids 6 150 effect correlated relative abilities proteins stimulate phospholipid efflux fig 5b contrast c terminal deletions increased apoe secretion relative full length pro apoa discrepant effects c terminal deletion lipid efflux apoe secretion suggest induction apoe secretion linked apoa lipid affinity stimulation cholesterol efflux via abca1
0.33803913.15066991.html.plaintext.txt	72	c terminal truncations pro apoa differentially affect cholesterol efflux apoe secretion previous studies indicated c terminus apoa particularly important stimulation cholesterol efflux binding apoa cell surface 49 related lipid binding ability c terminus 27 50 investigated role c terminus inducing apoe secretion primary human foam cell macrophages using recombinant pro apoa 6 243 truncations c terminus 6 150 6 222 fig 5 initial studies confirmed pro apoa native human apoa induced similar cholesterol efflux apoe secretion data shown consistent previous studies hepg2 cells 27 deletion c terminal 21 amino acids 6 222 decreased cholesterol efflux relative whole apoa 6 243 whereas deletion c terminal 93 amino acids 6 150 effect correlated relative abilities proteins stimulate phospholipid efflux fig 5b contrast c terminal deletions increased apoe secretion relative full length pro apoa discrepant effects c terminal deletion lipid efflux apoe secretion suggest induction apoe secretion linked apoa lipid affinity stimulation cholesterol efflux via abca1
0.33803913.15066991.html.plaintext.txt	73	view larger version 18k fig 5 truncation c terminal domain recombinant pro apoa increases apoe secretion human macrophages monocytes differentiated incubated 4 days 50 microgml acldl 3hcholesterol acldl 3hcholine b described experimental procedures cells washed equilibrated incubated rpmi 1640 control 25 microgml indicated recombinant whole pro apoa 6 243 pro apoa varying c terminal truncations 6 222 6 150 aliquots media removed 8 h cholesterol efflux phospholipid efflux b apoe secretion c western blot inset measured described experimental procedures lipid composition loading t0 fc 386 plus minus 107 nmolmg cell protein ce 549 plus minus 55 nmolmg cell protein specific activity fc 17856 plus minus 3188 dpmnmol specific activity ce 22771 plus minus 6928 dpmnmol b specific activity pl 45817 plus minus 6110 dpmnmol significantly different versus control values p 005 significantly different versus 6 243 pro apoa p 005
0.33803913.15066991.html.plaintext.txt	74	selected deletions point mutations recombinant modulate stimulation apoe secretion 6 amino acid residue n terminal prosegment pro apoa interfere cholesterol efflux apoa 27 however structural requirements apoe secretion cholesterol efflux appeared dissociated studied second series recombinant apoa molecules lacking propeptide roles c terminus n terminus central protein lcat activation domains d123 166 mediating apoa stimulated apoe secretion cholesterol efflux determined fig 6
0.33803913.15066991.html.plaintext.txt	75	selected deletions point mutations recombinant modulate stimulation apoe secretion 6 amino acid residue n terminal prosegment pro apoa interfere cholesterol efflux apoa 27 however structural requirements apoe secretion cholesterol efflux appeared dissociated studied second series recombinant apoa molecules lacking propeptide roles c terminus n terminus central protein lcat activation domains d123 166 mediating apoa stimulated apoe secretion cholesterol efflux determined fig 6
0.33803913.15066991.html.plaintext.txt	76	view larger version 22k fig 6 recombinant apoa selected deletions differentially promote apoe secretion human macrophages monocytes differentiated cholesterol enriched incubated rpmi 1640 control 25 microgml whole apoa 25 microgml recombinant apoa proteins deletions c terminal d190 243 n terminal d44 126 central d123 166 domains aliquots media removed 8 h cholesterol efflux apoe secretion b measured described experimental procedures lipid composition loading 0 fc 794 plus minus 21 nmolmg cell protein ce 260 plus minus 73 nmolmg cell protein specific activity fc 63622 plus minus 3234 dpmnmol specific activity ce 74321 plus minus 15523 dpmnmol recombinant whole apoa isolated human apoa induced identical apoe secretion cholesterol efflux data shown significantly different versus apoa p 005
0.33803913.15066991.html.plaintext.txt	77	deletion major domains within n terminal segment d44 126 central protein segment d123 166 stimulated equivalent cholesterol efflux whole apoa whereas recombinant apoa c terminal deletion d190 243 significantly less effective intact apoa fig 6a consistent previous reports 29 although d190 243 caused much less cholesterol efflux induced significantly apoe secretion native intact apoa significantly deletion central region apoa domain d123 166 important stimulation apoe secretion absence domain halved apoe secretion relative whole apoa effect cholesterol efflux consistent important role apoa flexibility recently described 29 contributing apoe secretion data also support findings experiments using pro apoa indicating c terminal membrane binding lipid efflux rate limiting apoa mediated apoe secretion
0.33803913.15066991.html.plaintext.txt	78	deletion major domains within n terminal segment d44 126 central protein segment d123 166 stimulated equivalent cholesterol efflux whole apoa whereas recombinant apoa c terminal deletion d190 243 significantly less effective intact apoa fig 6a consistent previous reports 29 although d190 243 caused much less cholesterol efflux induced significantly apoe secretion native intact apoa significantly deletion central region apoa domain d123 166 important stimulation apoe secretion absence domain halved apoe secretion relative whole apoa effect cholesterol efflux consistent important role apoa flexibility recently described 29 contributing apoe secretion data also support findings experiments using pro apoa indicating c terminal membrane binding lipid efflux rate limiting apoa mediated apoe secretion
0.33803913.15066991.html.plaintext.txt	79	synthetic peptides representing helical segments apoa induce apoe secretion apoa contains 10 helical segments 11 22 amino acids length 24 peptides representing segments induce cholesterol efflux approximately proportion lipid bilayer binding lipid affinity segment 50 investigate whether apparent differences recombinant apoa molecules stimulation apoe secretion attributable specific helical domains within apoa particularly n terminal central domains compared apoe secretion 11 22 mer helical peptides representing specific amphipathic helical segments apoa table c terminal peptide 220 241 stimulated cholesterol efflux significantly basal control medium level although significant cholesterol efflux peptide 220 241 less intact apoa 62 versus 81 p 005 consistent previous literature 50 contrast cholesterol efflux helical peptides stimulated apoe secretion ranged 20 60 fold control medium many peptides achieved stimulation apoe secretion equivalent achieved apoa eg peptides 1 33 44 87 88 120 143 186 220 241 correlation known helical content peptides 24 stimulation apoe secretion r2 0002 p 087 data shown peptides studied represent segments n terminus central region c terminus apoa many display low lipid affinity 50 indicates stimulation apoe secretion whole apoa recombinant apoa molecules attributable individual helical segments isolated domains within apoa
0.33803913.15066991.html.plaintext.txt	80	synthetic peptides representing helical segments apoa induce apoe secretion apoa contains 10 helical segments 11 22 amino acids length 24 peptides representing segments induce cholesterol efflux approximately proportion lipid bilayer binding lipid affinity segment 50 investigate whether apparent differences recombinant apoa molecules stimulation apoe secretion attributable specific helical domains within apoa particularly n terminal central domains compared apoe secretion 11 22 mer helical peptides representing specific amphipathic helical segments apoa table c terminal peptide 220 241 stimulated cholesterol efflux significantly basal control medium level although significant cholesterol efflux peptide 220 241 less intact apoa 62 versus 81 p 005 consistent previous literature 50 contrast cholesterol efflux helical peptides stimulated apoe secretion ranged 20 60 fold control medium many peptides achieved stimulation apoe secretion equivalent achieved apoa eg peptides 1 33 44 87 88 120 143 186 220 241 correlation known helical content peptides 24 stimulation apoe secretion r2 0002 p 087 data shown peptides studied represent segments n terminus central region c terminus apoa many display low lipid affinity 50 indicates stimulation apoe secretion whole apoa recombinant apoa molecules attributable individual helical segments isolated domains within apoa
0.33803913.15066991.html.plaintext.txt	81	view table table cholesterol efflux apoe secretion helical segments apoa
0.33803913.15066991.html.plaintext.txt	82	hmdm incubated 8 h rpmi 1640 medium alone control control medium containing 25 microgml apoa control medium containing 25 microgml helical peptides representing segments apoa values mean plus minus sd triplicate cultures one experiment representative three experiments percent cholesterol efflux calculated dividing 3hcholesterol released medium total 3hcholesterol cells equilibration t0 apoe determined western blotting
0.33803913.15066991.html.plaintext.txt	83	hmdm incubated 8 h rpmi 1640 medium alone control control medium containing 25 microgml apoa control medium containing 25 microgml helical peptides representing segments apoa values mean plus minus sd triplicate cultures one experiment representative three experiments percent cholesterol efflux calculated dividing 3hcholesterol released medium total 3hcholesterol cells equilibration t0 apoe determined western blotting
0.33803913.15066991.html.plaintext.txt	84	buoyant density apoe secreted response apoa previous studies shown secreted apoe predominantly lipidated density 121 gml 12 51 proportion secreted apoe cell surface apoe lipid poor 48 52 apoa mediated apoe secretion appeared independent apoa lipid affinity apoa mediated lipid efflux investigated whether apoa induced secretion non lipidated non buoyant apoe fig 7 basal conditions without apoa secreted apoe found buoyant density range 107 122 gml predominant density 108 11 gml addition apoa stimulated increase apoe across density range 107 122 gml although proportion present less buoyant fractions density 118 120 gml much greater controls density distribution cell derived cholesterol media basal stimulated conditions 107 117 gml corresponding buoyant apoe fractions thus apoe secreted control stimulated conditions buoyant however presence apoa significant proportion dense cholesterol containing particles medium observations consistent independent regulation apoe secretion cholesterol efflux apoa exposure suggest apoa induces pathway apoe secretion distinct involved basal apoe secretion
0.33803913.15066991.html.plaintext.txt	85	buoyant density apoe secreted response apoa previous studies shown secreted apoe predominantly lipidated density 121 gml 12 51 proportion secreted apoe cell surface apoe lipid poor 48 52 apoa mediated apoe secretion appeared independent apoa lipid affinity apoa mediated lipid efflux investigated whether apoa induced secretion non lipidated non buoyant apoe fig 7 basal conditions without apoa secreted apoe found buoyant density range 107 122 gml predominant density 108 11 gml addition apoa stimulated increase apoe across density range 107 122 gml although proportion present less buoyant fractions density 118 120 gml much greater controls density distribution cell derived cholesterol media basal stimulated conditions 107 117 gml corresponding buoyant apoe fractions thus apoe secreted control stimulated conditions buoyant however presence apoa significant proportion dense cholesterol containing particles medium observations consistent independent regulation apoe secretion cholesterol efflux apoa exposure suggest apoa induces pathway apoe secretion distinct involved basal apoe secretion
0.33803913.15066991.html.plaintext.txt	86	view larger version 32k fig 7 density secreted apoe without stimulation apoa monocytes differentiated loaded 4 days 50 microgml acldl 3hcholesterol washed equilibrated incubated control medium plus minus 25 microgml apoa aliquots media subjected ultracentrifugation 133 65 sucrose gradients analyzed 3hcholesterol apoe described experimental procedures cholesterol efflux without open circles apoa closed circles b apoe secretion without open circles apoa closed circles density fractions indicated open diamonds total cholesterol efflux control apoa 36 plus minus 04 89 plus minus 20 respectively total apoe secretion control apoa 04 plus minus 01 31 plus minus 03 microgml respectively c fractions analyzed western blot diluting media cultures exposed apoa 40 fold facilitate comparison relative distribution apoe among fractions data representative three independent experiments
0.33803913.15066991.html.plaintext.txt	87	stimulation apoe secretion induced helix containing apolipoproteins broad specificity stimulation apoe secretion helical peptides apoa suggested amphiphathic containing apolipoproteins might induce apoe secretion apolipoproteins specifically apoa ii apoa iv 53 also stimulate cholesterol phospholipid efflux cells 50 vary markedly total helical content hydrophobicity 54 incubated apolipoproteins hmdm saturating conditions 25 microgml found human apoa apoa ii apoa iv stimulated apoe secretion equally effectively fig 8 also induced similar modest cholesterol efflux primary human macrophages ranging 8 15 8 h 2 3 fold control medium significant difference apolipoproteins induction cholesterol efflux multiple independent experiments
0.33803913.15066991.html.plaintext.txt	88	stimulation apoe secretion induced helix containing apolipoproteins broad specificity stimulation apoe secretion helical peptides apoa suggested amphiphathic containing apolipoproteins might induce apoe secretion apolipoproteins specifically apoa ii apoa iv 53 also stimulate cholesterol phospholipid efflux cells 50 vary markedly total helical content hydrophobicity 54 incubated apolipoproteins hmdm saturating conditions 25 microgml found human apoa apoa ii apoa iv stimulated apoe secretion equally effectively fig 8 also induced similar modest cholesterol efflux primary human macrophages ranging 8 15 8 h 2 3 fold control medium significant difference apolipoproteins induction cholesterol efflux multiple independent experiments
0.33803913.15066991.html.plaintext.txt	89	view larger version 19k fig 8 apoe secretion stimulated apolipoproteins apoa monocytes differentiated cholesterol enriched acldl radiolabeled 35smethionine incubation 25 microgml indicated apolipoprotein aliquots media removed 8 h apoe immunoprecipitated secretion media containing apoa apoa ii apoa iv apoe3 determined au 35sapoe per mg cell protein phosphorimaging 34 kda band described experimental procedures apoe secretion apoa ii iv confirmed western blot well phosphorimaging b data expressed au 35smethionine labeled apoe secretedmg cell protein cholesterol efflux apolipoproteins 2 3 fold control differ apolipoproteins data shown significantly different versus apoe3 p 005
0.33803913.15066991.html.plaintext.txt	90	apoe also hdl associated contains helixes extracellular apoe stimulate secretion apoe macrophages may mediate potentially anti atherogenic autocrine loop artery wall apoe stimulate secretion de novo synthesized 35s labeled apoe comparable efficiency apoa apoa ii apoa iv
0.33803913.15066991.html.plaintext.txt	91	apoe also hdl associated contains helixes extracellular apoe stimulate secretion apoe macrophages may mediate potentially anti atherogenic autocrine loop artery wall apoe stimulate secretion de novo synthesized 35s labeled apoe comparable efficiency apoa apoa ii apoa iv
0.33803913.15066991.html.plaintext.txt	92	apoa maintains ability stimulate apoe secretion lipid bound conformation complexed phospholipids eg nascent hdl discs apoa undergoes conformational change increases helicity molecule 54 57 potentially increases exposure polar residues cell surface changes may affect efficacy apoa mediated apoe secretion lipidated particles apoe secretion may thus diminished critical domains apoa obscured lipidation may enhanced greater exposure polar domains enhances apoe secretion also potential synergy phospholipid apoa previous studies identified lipid soluble pool apoe associated extracellular matrix hepg2 cells macrophages 13 41 48 58
0.33803913.15066991.html.plaintext.txt	93	apoa phospholipid discs containing popc popc popcspm popcspm compared popc liposomes lipid free apoa ability induce cholesterol efflux apoe secretion table ii acceptors added concentrations matched apoa content allow accurate comparisons efficiency stimulating apoe secretion lipidation apoa popc significantly increased apoe secretion 2 3 fold relative apoa alone whereas popc alone significantly stimulate apoe secretion data suggest lipidation apoa promotes apoe secretion might caused secondary conformational changes increased exposure polar residues apoa cell surface
0.33803913.15066991.html.plaintext.txt	94	apoa phospholipid discs containing popc popc popcspm popcspm compared popc liposomes lipid free apoa ability induce cholesterol efflux apoe secretion table ii acceptors added concentrations matched apoa content allow accurate comparisons efficiency stimulating apoe secretion lipidation apoa popc significantly increased apoe secretion 2 3 fold relative apoa alone whereas popc alone significantly stimulate apoe secretion data suggest lipidation apoa promotes apoe secretion might caused secondary conformational changes increased exposure polar residues apoa cell surface
0.33803913.15066991.html.plaintext.txt	95	view table table ii lipidation enhances apoe secretion apoa apoa ii
0.33803913.15066991.html.plaintext.txt	96	pre hdl important initial acceptors cell cholesterol 59 represent dynamic pool apoa may play role stimulating apoe secretion artery wall pre hdl contain increased concentrations spm relative mature hdl 59 investigated whether spm modulated ability apoa stimulate apoe secretion whether cholesterol efflux modulated parallel table ii popcspm particles containing 25 spm 75 popc achieved 14 fold p 005 cholesterol efflux achieved popc increase apoe secretion relative popc indicates synergistic interaction apoa phospholipids inducing apoe secretion independent variations phospholipid subtype
0.33803913.15066991.html.plaintext.txt	97	pre hdl important initial acceptors cell cholesterol 59 represent dynamic pool apoa may play role stimulating apoe secretion artery wall pre hdl contain increased concentrations spm relative mature hdl 59 investigated whether spm modulated ability apoa stimulate apoe secretion whether cholesterol efflux modulated parallel table ii popcspm particles containing 25 spm 75 popc achieved 14 fold p 005 cholesterol efflux achieved popc increase apoe secretion relative popc indicates synergistic interaction apoa phospholipids inducing apoe secretion independent variations phospholipid subtype
0.33803913.15066991.html.plaintext.txt	98	apoa ii higher average residue hydrophobicity apoa 54 consequently conformation popc disc may differ apoa unlike secretion apoa apoa ii stimulated apoe secretion increased significantly lipidation popc even though cholesterol efflux enhanced table ii part b suggests relatively specific conformation change apoa seen apoa ii important enhanced stimulation apoe secretion apoa following lipidation
0.33803913.15066991.html.plaintext.txt	99	apoa ii higher average residue hydrophobicity apoa 54 consequently conformation popc disc may differ apoa unlike secretion apoa apoa ii stimulated apoe secretion increased significantly lipidation popc even though cholesterol efflux enhanced table ii part b suggests relatively specific conformation change apoa seen apoa ii important enhanced stimulation apoe secretion apoa following lipidation
0.33803913.15066991.html.plaintext.txt	100	investigate whether secreted apoe associated apoa popc particles density gradient analysis non denaturing gel electrophoresis performed efflux media apoe shared buoyant density effluxed cholesterol apoa media containing apoa popc discs density range 1042 1141 differed media containing lipid free apoa effluxed cholesterol buoyant density secreted apoe consistent possibility apoe associated apoa popc discs directly investigated non denaturing gel electrophoresis media containing apoa popc apoa ii popc discs followed electrophoretic transfer nitrocellulose membranes immunoblotting apoa apoa ii apoe 33 efflux apoa apoa ii migrated popc discs 95 108 nm diameter 95 106 nm diameter respectively without evidence displacement lipid free apoa apoa ii discs data shown secreted apoe migrated large diameter 171 nm particles small proportion migrated particles diameter apoa apoa ii popc containing discs 95 108 nm diameter association apoe apoa popc apoa ii popc discs would expected increase size particles size apoa popc apoa ii popc particles unaltered secretion apoe data suggest secreted apoe significantly associate apoa apoa ii popc discs displace apoa apoa ii particles results also imply amount apoe secreted apoa popc apoa ii popc particles explained differential displacement apoa apoa ii popc particles
0.33803913.15066991.html.plaintext.txt	101	investigate whether secreted apoe associated apoa popc particles density gradient analysis non denaturing gel electrophoresis performed efflux media apoe shared buoyant density effluxed cholesterol apoa media containing apoa popc discs density range 1042 1141 differed media containing lipid free apoa effluxed cholesterol buoyant density secreted apoe consistent possibility apoe associated apoa popc discs directly investigated non denaturing gel electrophoresis media containing apoa popc apoa ii popc discs followed electrophoretic transfer nitrocellulose membranes immunoblotting apoa apoa ii apoe 33 efflux apoa apoa ii migrated popc discs 95 108 nm diameter 95 106 nm diameter respectively without evidence displacement lipid free apoa apoa ii discs data shown secreted apoe migrated large diameter 171 nm particles small proportion migrated particles diameter apoa apoa ii popc containing discs 95 108 nm diameter association apoe apoa popc apoa ii popc discs would expected increase size particles size apoa popc apoa ii popc particles unaltered secretion apoe data suggest secreted apoe significantly associate apoa apoa ii popc discs displace apoa apoa ii particles results also imply amount apoe secreted apoa popc apoa ii popc particles explained differential displacement apoa apoa ii popc particles
0.33803913.15066991.html.plaintext.txt	102	apoa mediated apoe secretion independent abca1 activity apoa mediated cholesterol efflux known critically dependent upon abca1 activity data dissociating structural requirements apoa stimulated apoe secretion cholesterol efflux imply apoa mediated apoe secretion may independent abca1 patients tangier disease impaired abca1 activity although previous study indicated basal apoe secretion impaired td macrophages 16 apoa stimulated apoe secretion investigated directly investigate role abca1 apoe secretion human macrophages studied macrophages two unrelated patients molecular clinical cellular phenotypes td
0.33803913.15066991.html.plaintext.txt	103	apoa mediated apoe secretion independent abca1 activity apoa mediated cholesterol efflux known critically dependent upon abca1 activity data dissociating structural requirements apoa stimulated apoe secretion cholesterol efflux imply apoa mediated apoe secretion may independent abca1 patients tangier disease impaired abca1 activity although previous study indicated basal apoe secretion impaired td macrophages 16 apoa stimulated apoe secretion investigated directly investigate role abca1 apoe secretion human macrophages studied macrophages two unrelated patients molecular clinical cellular phenotypes td
0.33803913.15066991.html.plaintext.txt	104	first subject td td1 see experimental procedures compound heterozygote novel abca1 mutations c733r exon 16 deletion three nucleotides c5220 5222 deltct exon 38 td1 hmdm apoa mediated cholesterol efflux td1 hmdm severely impaired relative unrelated healthy control hc1 hmdm confirming cellular td phenotype table iii basal apoe secretion lower td1 hmdm hc1 macrophages consistent earlier study 16 however apoa strongly stimulated apoe secretion td1 hmdm 11 fold increase p 001 relative control media control hmdm 34 fold increase p 001 relative control media achieving total apoe secretion td1 hmdm hc1 hmdm thus despite severely impaired abca 1 mediated cholesterol efflux apoa stimulated apoe secretion normally td macrophages
0.33803913.15066991.html.plaintext.txt	105	first subject td td1 see experimental procedures compound heterozygote novel abca1 mutations c733r exon 16 deletion three nucleotides c5220 5222 deltct exon 38 td1 hmdm apoa mediated cholesterol efflux td1 hmdm severely impaired relative unrelated healthy control hc1 hmdm confirming cellular td phenotype table iii basal apoe secretion lower td1 hmdm hc1 macrophages consistent earlier study 16 however apoa strongly stimulated apoe secretion td1 hmdm 11 fold increase p 001 relative control media control hmdm 34 fold increase p 001 relative control media achieving total apoe secretion td1 hmdm hc1 hmdm thus despite severely impaired abca 1 mediated cholesterol efflux apoa stimulated apoe secretion normally td macrophages
0.33803913.15066991.html.plaintext.txt	106	view table table iii apoa induced apoe secretion normal hmdm subjects tangier disease
0.33803913.15066991.html.plaintext.txt	107	note apoa stimulated apoe secretion significantly differ subjects panels b cellular data mean plus minus sd three cell cultures subject
0.33803913.15066991.html.plaintext.txt	108	note apoa stimulated apoe secretion significantly differ subjects panels b cellular data mean plus minus sd three cell cultures subject
0.33803913.15066991.html.plaintext.txt	109	exclude mutation specific effect macrophages second unrelated tangier patient td2 hmdm see experimental procedures studied cells td2 compound heterozygote mutations a1046d c4629 4630insa compared healthy brother known free abca1 mutations hc2 hmdm heterozygous parents mutations 4629insa hz2a hmdm a1046d hz2b hmdm 44 45 table iii b basal cholesterol efflux similar four subjects 09 plus minus 02 hc2 hmdm 13 plus minus 05 td2 hmdm 09 plus minus 02 hz2a hmdm 08 plus minus 03 hz2b hmdm apoa mediated cholesterol efflux td2 cells severely impaired relative family members confirming dysfunctional abca1 despite apoa strongly equally increased apoe secretion macrophages including td2 hmdm findings support structural studies clearly dissociate apoa induced cholesterol efflux via abca1 apoa induced apoe secretion
0.33803913.15066991.html.plaintext.txt	110	exclude mutation specific effect macrophages second unrelated tangier patient td2 hmdm see experimental procedures studied cells td2 compound heterozygote mutations a1046d c4629 4630insa compared healthy brother known free abca1 mutations hc2 hmdm heterozygous parents mutations 4629insa hz2a hmdm a1046d hz2b hmdm 44 45 table iii b basal cholesterol efflux similar four subjects 09 plus minus 02 hc2 hmdm 13 plus minus 05 td2 hmdm 09 plus minus 02 hz2a hmdm 08 plus minus 03 hz2b hmdm apoa mediated cholesterol efflux td2 cells severely impaired relative family members confirming dysfunctional abca1 despite apoa strongly equally increased apoe secretion macrophages including td2 hmdm findings support structural studies clearly dissociate apoa induced cholesterol efflux via abca1 apoa induced apoe secretion
0.33803913.15066991.html.plaintext.txt	111	discussion top abstract introduction experimental procedures results discussion references secretion apoe macrophages shown anti atherogenic 11 factors enhance secretion may important targets treatment prevention atherosclerosis demonstrated apoa stimulates secretion mobile pool apoe part derived cell surface otherwise destined intracellular degradation also identified first time biological activity apoa independent lipid binding properties demonstrating apoa stimulated apoe secretion enhanced c terminal deletions independent abca 1 mediated cholesterol efflux data establish non abca1 mediated processes contribute prosecretory roles potentially anti atherogenic effects apoa
0.33803913.15066991.html.plaintext.txt	112	discussion top abstract introduction experimental procedures results discussion references secretion apoe macrophages shown anti atherogenic 11 factors enhance secretion may important targets treatment prevention atherosclerosis demonstrated apoa stimulates secretion mobile pool apoe part derived cell surface otherwise destined intracellular degradation also identified first time biological activity apoa independent lipid binding properties demonstrating apoa stimulated apoe secretion enhanced c terminal deletions independent abca 1 mediated cholesterol efflux data establish non abca1 mediated processes contribute prosecretory roles potentially anti atherogenic effects apoa
0.33803913.15066991.html.plaintext.txt	113	previous studies including secretion apoe exposure cells hdl apoa concurrent efflux cholesterol 12 1560 however cyclodextrin stimulated cholesterol efflux induce apoe secretion acute inhibition apoe synthesis secretion cycloheximide inhibit cholesterol efflux apoa 13 latter observations dissociate stimulation apoa mediated cholesterol efflux apoe secretion similar dissociation earlier reported hdl mediated cholesterol efflux apoe secretion 61 investigated detail structural functional requirements apoa induced apoe secretion identify quite distinct required apoa induced cholesterol efflux
0.33803913.15066991.html.plaintext.txt	114	previous studies including secretion apoe exposure cells hdl apoa concurrent efflux cholesterol 12 1560 however cyclodextrin stimulated cholesterol efflux induce apoe secretion acute inhibition apoe synthesis secretion cycloheximide inhibit cholesterol efflux apoa 13 latter observations dissociate stimulation apoa mediated cholesterol efflux apoe secretion similar dissociation earlier reported hdl mediated cholesterol efflux apoe secretion 61 investigated detail structural functional requirements apoa induced apoe secretion identify quite distinct required apoa induced cholesterol efflux
0.33803913.15066991.html.plaintext.txt	115	apoa increase macrophage apoe mrna levels pulse chase experiments demonstrate apoa stimulates secretion newly synthesized apoe confirming apoa stimulates apoe secretion post transcriptionally modeling pulse chase data indicated human macrophages contain larger mobile pool apoe em lesser stable pool apoe es previous studies indicate heterogeneous pools apoe may include apoe cell surface 47 pronase treatment human macrophages experimental conditions indicates small proportion es cell surface2 em basis biotin labeling 4 degrees c displacement studies part derived cell surface pool apoe apoa increases secretion concurrently diminishes degradation apoe pool however biotin labeled pool represents minor proportion total apoe secreted 2 quantitative significance unclear data consistent either continual displacement apoe cell surface recycling ongoing replenishment intracellular pools 41 consistent two sources secreted apoe smaller cell surface pool larger intracellular pool mobilized apoa
0.33803913.15066991.html.plaintext.txt	116	apoa increase macrophage apoe mrna levels pulse chase experiments demonstrate apoa stimulates secretion newly synthesized apoe confirming apoa stimulates apoe secretion post transcriptionally modeling pulse chase data indicated human macrophages contain larger mobile pool apoe em lesser stable pool apoe es previous studies indicate heterogeneous pools apoe may include apoe cell surface 47 pronase treatment human macrophages experimental conditions indicates small proportion es cell surface2 em basis biotin labeling 4 degrees c displacement studies part derived cell surface pool apoe apoa increases secretion concurrently diminishes degradation apoe pool however biotin labeled pool represents minor proportion total apoe secreted 2 quantitative significance unclear data consistent either continual displacement apoe cell surface recycling ongoing replenishment intracellular pools 41 consistent two sources secreted apoe smaller cell surface pool larger intracellular pool mobilized apoa
0.33803913.15066991.html.plaintext.txt	117	clear structural requirements apoa mediated apoe secretion distinct required cholesterol efflux studies recombinant pro apoa molecules demonstrate deletion c terminus apoa enhances apoe secretion whereas impairs cholesterol efflux phospholipid efflux remarkable previous studies apoa function emphasized importance lipid binding c terminal domain functional integrity binding extracellular matrix cell surface 62 c terminal deletion enhances apoe secretion suggests apoa bind extracellular matrix achieve 62 consistent previous studies indicating heparinase pretreatment inhibit apoa mediated apoe secretion primary macrophages 13
0.33803913.15066991.html.plaintext.txt	118	clear structural requirements apoa mediated apoe secretion distinct required cholesterol efflux studies recombinant pro apoa molecules demonstrate deletion c terminus apoa enhances apoe secretion whereas impairs cholesterol efflux phospholipid efflux remarkable previous studies apoa function emphasized importance lipid binding c terminal domain functional integrity binding extracellular matrix cell surface 62 c terminal deletion enhances apoe secretion suggests apoa bind extracellular matrix achieve 62 consistent previous studies indicating heparinase pretreatment inhibit apoa mediated apoe secretion primary macrophages 13
0.33803913.15066991.html.plaintext.txt	119	central domain apoa regulates lcat activity 63 hdl mediated inhibition macrophage homing atherosclerotic plaque 64 deletion central region apoa d123 166 modification decreased stimulation apoe secretion apoa domain affects apoa flexibility 29 suggests whole apoa flexibility important lipid affinity inducing apoe secretion unlikely contain epitope specific apoa induced apoe secretion given helical peptides away domain apolipoproteins also induced apoe secretion whether apolipoprotein flexibility also important apolipoproteins eg apoa ii apoa iv apoes unknown
0.33803913.15066991.html.plaintext.txt	120	central domain apoa regulates lcat activity 63 hdl mediated inhibition macrophage homing atherosclerotic plaque 64 deletion central region apoa d123 166 modification decreased stimulation apoe secretion apoa domain affects apoa flexibility 29 suggests whole apoa flexibility important lipid affinity inducing apoe secretion unlikely contain epitope specific apoa induced apoe secretion given helical peptides away domain apolipoproteins also induced apoe secretion whether apolipoprotein flexibility also important apolipoproteins eg apoa ii apoa iv apoes unknown
0.33803913.15066991.html.plaintext.txt	121	systematic comparison individual helical peptides apoa identified c terminal helical peptide capable independently inducing cholesterol efflux primary human macrophages consistent earlier studies 50 contrast helical peptides stimulated apoe secretion cholesterol efflux peptides related lipid affinity 50 property appear determine induction apoe secretion stimulation apoe secretion appears general structural property helical proteins peptides case whole apoa enhanced overall protein flexibility inhibited lipid binding plasma membrane
0.33803913.15066991.html.plaintext.txt	122	systematic comparison individual helical peptides apoa identified c terminal helical peptide capable independently inducing cholesterol efflux primary human macrophages consistent earlier studies 50 contrast helical peptides stimulated apoe secretion cholesterol efflux peptides related lipid affinity 50 property appear determine induction apoe secretion stimulation apoe secretion appears general structural property helical proteins peptides case whole apoa enhanced overall protein flexibility inhibited lipid binding plasma membrane
0.33803913.15066991.html.plaintext.txt	123	one striking observations enhanced secretion apoe apoa popc discs relative apoa observed apoa ii stimulated apoe secretion extent free lipid bound state difference response lipidation apoa apoa ii interesting given cholesterol efflux apolipoproteins increased lipidation apolipoprotein mediated apoe secretion may allow subsequent binding secreted apoe exogenous phospholipids could explain apparent synergy apoa popc however association apoe apoa apoa ii popc discs would expected require displacement apoa apoa ii andor increase apparent size popc containing particles neither found non denaturing gel electrophoresis absence synergy apoa ii popc therefore suggests conformational changes unique apoa occur lipidation suggest apoa exposes polar non lipid bound residues popc disc apoa ii enhances interaction exposed residues apoe cell surface undefined plasma membrane sites critical stimulating vesicular trafficking apoe cell surface
0.33803913.15066991.html.plaintext.txt	124	one striking observations enhanced secretion apoe apoa popc discs relative apoa observed apoa ii stimulated apoe secretion extent free lipid bound state difference response lipidation apoa apoa ii interesting given cholesterol efflux apolipoproteins increased lipidation apolipoprotein mediated apoe secretion may allow subsequent binding secreted apoe exogenous phospholipids could explain apparent synergy apoa popc however association apoe apoa apoa ii popc discs would expected require displacement apoa apoa ii andor increase apparent size popc containing particles neither found non denaturing gel electrophoresis absence synergy apoa ii popc therefore suggests conformational changes unique apoa occur lipidation suggest apoa exposes polar non lipid bound residues popc disc apoa ii enhances interaction exposed residues apoe cell surface undefined plasma membrane sites critical stimulating vesicular trafficking apoe cell surface
0.33803913.15066991.html.plaintext.txt	125	apoa ii iv e3 apolipoprotein phospholipid discs stimulated apoe secretion efficiently indicating stimulation apoe secretion broad relevance vivo ability apoe stimulate apoe secretion highly significant local autocrine secretion apoe artery wall could mediate apoe secretion neighboring cells independently requirement plasma derived hdl species apoe4 increases risk atherosclerosis alzheimers disease relative apoe3 65 reduced local stimulation apoe secretion apoe4 artery cns might contribute disease states associated apoe4 phenotype apoe4 differs apoe3 single amino acid substitution arginine instead cysteine position 112 confers positive apoe charge causes conformational change n terminal helix apoe4 salt bridge forms arg112 glu109 alters conformation arg61 interacts glu255 55 e4 also differs e3 e2 lacking potential disulfide formation self association previous study smith et al 2 identified binding e2 e3 e4 raw macrophages cholesterol efflux induced isoforms studies confirmed similar efflux various apoe isoforms supporting differences inducible apoe secretion cannot explained altered efflux binding recent study indicates apoe4 higher lipid affinity apoe isoforms 56 respect data support observations c terminal deletions apoa diminish lipid affinity enhance ability induce apoe secretion
0.33803913.15066991.html.plaintext.txt	126	apoa ii iv e3 apolipoprotein phospholipid discs stimulated apoe secretion efficiently indicating stimulation apoe secretion broad relevance vivo ability apoe stimulate apoe secretion highly significant local autocrine secretion apoe artery wall could mediate apoe secretion neighboring cells independently requirement plasma derived hdl species apoe4 increases risk atherosclerosis alzheimers disease relative apoe3 65 reduced local stimulation apoe secretion apoe4 artery cns might contribute disease states associated apoe4 phenotype apoe4 differs apoe3 single amino acid substitution arginine instead cysteine position 112 confers positive apoe charge causes conformational change n terminal helix apoe4 salt bridge forms arg112 glu109 alters conformation arg61 interacts glu255 55 e4 also differs e3 e2 lacking potential disulfide formation self association previous study smith et al 2 identified binding e2 e3 e4 raw macrophages cholesterol efflux induced isoforms studies confirmed similar efflux various apoe isoforms supporting differences inducible apoe secretion cannot explained altered efflux binding recent study indicates apoe4 higher lipid affinity apoe isoforms 56 respect data support observations c terminal deletions apoa diminish lipid affinity enhance ability induce apoe secretion
0.33803913.15066991.html.plaintext.txt	127	apoa mediated cholesterol efflux apoe secretion independently regulated directly confirmed apoa stimulated apoe secretion two unrelated subjects clinical molecular cellular phenotype tangier disease despite impaired abca1 mediated cholesterol efflux severely reduced basal apoe secretion apoa stimulated apoe secretion normally recent studies shown apoa mediated cholesterol efflux via abca1 linked accelerated secretory vesicular transport golgi plasma membrane absent tangier disease fibroblasts 66 apoa stimulated apoe secretion normally tangier disease macrophages conclude apoa must stimulate distinct pathway apoe secretion unrelated interactions abca1 stimulation cholesterol efflux apoe secretion induced apoa severalfold greater basal apoe secretion abca1 independent secretion likely quantitatively important related abca1 activity knowledge findings represent first reported non abca1 mediated cellular process mediated apoa
0.33803913.15066991.html.plaintext.txt	128	apoa mediated cholesterol efflux apoe secretion independently regulated directly confirmed apoa stimulated apoe secretion two unrelated subjects clinical molecular cellular phenotype tangier disease despite impaired abca1 mediated cholesterol efflux severely reduced basal apoe secretion apoa stimulated apoe secretion normally recent studies shown apoa mediated cholesterol efflux via abca1 linked accelerated secretory vesicular transport golgi plasma membrane absent tangier disease fibroblasts 66 apoa stimulated apoe secretion normally tangier disease macrophages conclude apoa must stimulate distinct pathway apoe secretion unrelated interactions abca1 stimulation cholesterol efflux apoe secretion induced apoa severalfold greater basal apoe secretion abca1 independent secretion likely quantitatively important related abca1 activity knowledge findings represent first reported non abca1 mediated cellular process mediated apoa
0.33803913.15066991.html.plaintext.txt	129	unlikely apoa stimulates apoe secretion directly inhibiting lysosomal proteasomal degradation apoe apoe degraded lysosomal proteasomal compartments 67 68 although direct inhibition lysosomal cysteine proteases inhibit apoe degradation increase apoe secretion 58 possibility apoa exchanges cellular apoe apoa degraded place apoe also seems unlikely mass apoa degraded corresponds 30 mass apoe secreted human macrophages time course experiments3 likely apoa promotes apoe secretion inhibiting trafficking degradatory compartments lysosome proteasome stimulating vesicular traffic plasma membrane analogous effects described fibroblasts 66 although hdl stimulates range protein kinase c dependent independent signaling pathways necessarily activated apoa 69 mechanisms apoa regulates vesicle traffic general protein secretion particular require investigation
0.33803913.15066991.html.plaintext.txt	130	unlikely apoa stimulates apoe secretion directly inhibiting lysosomal proteasomal degradation apoe apoe degraded lysosomal proteasomal compartments 67 68 although direct inhibition lysosomal cysteine proteases inhibit apoe degradation increase apoe secretion 58 possibility apoa exchanges cellular apoe apoa degraded place apoe also seems unlikely mass apoa degraded corresponds 30 mass apoe secreted human macrophages time course experiments3 likely apoa promotes apoe secretion inhibiting trafficking degradatory compartments lysosome proteasome stimulating vesicular traffic plasma membrane analogous effects described fibroblasts 66 although hdl stimulates range protein kinase c dependent independent signaling pathways necessarily activated apoa 69 mechanisms apoa regulates vesicle traffic general protein secretion particular require investigation
0.33803913.15066991.html.plaintext.txt	131	conclude apoa mediated apoe secretion structural requirements distinct regulating stimulation cholesterol efflux facilitated central hinge region apoa inhibited c terminal domain independent macrophage abca1 activity represents novel abca 1 independent positive feedback process secretion anti atherogenic cholesterol efflux inducing apoe helix containing molecules
0.33803913.15066991.html.plaintext.txt	132	conclude apoa mediated apoe secretion structural requirements distinct regulating stimulation cholesterol efflux facilitated central hinge region apoa inhibited c terminal domain independent macrophage abca1 activity represents novel abca 1 independent positive feedback process secretion anti atherogenic cholesterol efflux inducing apoe helix containing molecules
0.33803913.15066991.html.plaintext.txt	133	footnotes work supported grants aid w j l k fellowship w j national health medical research council australia national institutes health grants hl22633 hl34343 national heart foundation australia australian research council k g costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.33803913.15066991.html.plaintext.txt	134	k correspondence addressed macrophage biology group centre vascular research 4th floor wallace wurth bldg university new south wales unsw sydney nsw 2052 australia tel 61 2 93851179 fax 61 2 93851389 e mail lkritharidesatunsweduau u d
0.33803913.15066991.html.plaintext.txt	135	k correspondence addressed macrophage biology group centre vascular research 4th floor wallace wurth bldg university new south wales unsw sydney nsw 2052 australia tel 61 2 93851179 fax 61 2 93851389 e mail lkritharidesatunsweduau u d
0.33803913.15066991.html.plaintext.txt	136	1 abbreviations used hdl high density lipoprotein plv phospholipid vesicles apoa apolipoprotein abca1 atp binding cassette transporter spm sphingomyelin pc phosphatidylcholine td tangier disease ldl low density lipoprotein apo apolipoprotein abca1 atp binding cassette transporter a1 rct reverse cholesterol transport acldl acetylated ldl hmdm human primary monocyte derived macrophages popc 1 palmitoyl 2 oleoyl phosphatidylcholine spm egg yolk sphingomyelin bca bicinchoninic acid pbs phosphate buffered saline au arbitrary units rt pcr reverse transcriptase pcr
0.33803913.15066991.html.plaintext.txt	137	references top abstract introduction experimental procedures results discussion references asztalos b f roheim p 1995 arterioscler thromb vasc biol 15 1419 1423abstractfree full text smith j d miyata m ginsberg m grigaux c shmookler e plump 1996 j biol chem 271 30647 30655abstractfree full text lawn r m wade d p garvin m r wang x schwartz k porter j g seilhamer j j vaughan m oram j f 1999 j clin invest 104 r25 31medline order article via infotrieve higgins c f 1992 annu rev cell biol 8 67 113crossrefmedline order article via infotrieve bodzioch m orso e klucken j langmann bottcher diederich w drobnik w barlage buchler c porsch ozcurumez m kaminski w e hahmann h w oette k rothe g aslanidis c lackner k j schmitz g 1999 nat genet 22 347 351crossrefmedline order article via infotrieve brooks wilson marcil m clee m zhang l h roomp k van dam m yu l brewer c collins j molhuizen h o loubser o ouelette b f fichter k ashbourne excoffon k j sensen c w scherer mott denis m martindale d frohlich j morgan k koop b pimstone kastelein j j hayden m r 1999 nat genet 22 336 345crossrefmedline order article via infotrieve rust rosier m funke h real j amoura z piette j c deleuze j f brewer h b duverger n denefle p assmann g 1999 nat genet 22 352 355crossrefmedline order article via infotrieve remaley schumacher u k stonik j farsi b d nazih h brewer h b 1997 arterioscler thromb vasc biol 17 1813 1821abstractfree full text obrien k d deeb ferguson m mcdonald o allen m d alpers c e chait 1994 j pathol 144 538 548abstract linton m f atkinson j b fazio 1995 science 267 1034 1037medline order article via infotrieve bellosta mahley r w sanan d murata j newland d l taylor j m pitas r e 1995 j clin investig 96 2170 2179medline order article via infotrieve bielicki j k mccall m r forte m 1999 j lipid res 40 85 92abstractfree full text rees d sloane jessup w dean r kritharides l 1999 j biol chem 274 27925 27933abstractfree full text dory l 1989 j lipid res 30 809 816abstract heeren j grewal laatsch rottke d rinninger f enrich c beisiegel u 2003 j biol chem 278 14370 14378abstractfree full text von eckardstein langer c engel schaukal cignarella reinhardt j lorkowski li z zhou x cullen p assmann g 2001 faseb j 15 1555 1561abstractfree full text kritharides l jessup w mander e l dean r 1995 arterioscler thromb vasc biol 15 276 289abstractfree full text kritharides l christian stoudt g morel d rothblat g h 1998 arterioscler thromb vasc biol 18 1589 1599abstractfree full text rye k barter p j 1994 j biol chem 269 10298 10303abstractfree full text steinmetz clavey v vu dac n kaffarnik h fruchart j c 1989 j chromatogr 487 154 160medline order article via infotrieve weinberg r b hopkins r jones j b 1996 methods enzymol 263 282 296medline order article via infotrieve anantharamaiah g m 1986 methods enzymol 128 627 647medline order article via infotrieve palgunachari m n mishra v k lund katz phillips m c adeyeye o alluri anantharamaiah g m segrest j p 1996 arterioscler thromb vasc biol 16 328 338abstractfree full text mishra v k palgunachari m n datta g phillips m c lund katz adeyeye o segrest j p anantharamaiah g m 1998 biochemistry 37 10313 10324crossrefmedline order article via infotrieve venkatachalapathi y v phillips m c epand r m epand r f tytler e m segrest j p anantharamaiah g m 1993 proteins 15 349 359medline order article via infotrieve pyle l e barton p fujiwara y mitchell fidge n 1995 j lipid res 36 2355 2361abstract sviridov d pyle l e fidge n 1996 j biol chem 271 33277 33283abstractfree full text holvoet p zhao z vanloo b vos r deridder e dhoest taveirne j brouwers e demarsin e engelborghs y 1995 biochemistry 34 13334 13342medline order article via infotrieve saito h dhanasekaran p nguyen d holvoet p lund katz phillips m c 2003 j biol chem 278 23227 23232abstractfree full text matz c e jonas 1982 j biol chem 257 4535 4540abstractfree full text trinder p 1969 ann clin biochem 6 24 27 takayama m itoh nagasaki tanimizu 1977 clin chim acta 79 93 98crossrefmedline order article via infotrieve liang h q rye k barter p j 1994 j lipid res 35 1187 1199abstract boyum 1984 methods enzymol 108 88 102medline order article via infotrieve becq f hamon y bajetto gola m verrier b chimini g 1997 j biol chem 272 2695 2699abstractfree full text langmann klucken j reil m liebisch g luciani m f chimini g kaminski w e schmitz g 1999 biochem biophys res commun 257 29 33crossrefmedline order article via infotrieve garner b baoutina dean r jessup w 1997 atherosclerosis 128 47 58crossrefmedline order article via infotrieve kritharides l jessup w gifford j dean r 1993 anal biochem 213 79 89crossrefmedline order article via infotrieve gelissen c rye k brown j dean r jessup w 1999 j lipid res 40 1636 1646abstractfree full text sokoloff l rothblat g h 1974 proc soc exp biol med 146 1166 1172 zhao y mazzone 2000 j biol chem 275 4759 4765abstractfree full text gaus k gooding j j dean r kritharides l jessup w 2001 biochemistry 40 9363 9373crossrefmedline order article via infotrieve arakawa r abe dohmae asai m ito j yokoyama 2000 j lipid res 41 1952 1962abstractfree full text burnett j r law j yeong m l crooke m j sharma k 1994 j cardiol 73 923 925medline order article via infotrieve wang j burnett j r near young k zinman b hanley j connelly p w harris b hegele r 2000 arterioscler thromb vasc biol 20 1983 1989abstractfree full text dean r hylton w allison c 1979 exp cell biol 47 454 462medline order article via infotrieve burgess j w marcel y l 2001 j lipid res 42 1413 1420abstractfree full text burgess j w gould d r marcel y l 1998 j biol chem 273 5645 5654abstractfree full text burgess j w frank p g franklin v liang p mcmanus d c desforges m rassart e marcel y l 1999 biochemistry 38 14524 14533crossrefmedline order article via infotrieve gillotte k l zaiou m lund katz anantharamaiah g m holvoet p dhoest palgunachari m n segrest j p weisgraber k h rothblat g h phillips m c 1999 j biol chem 274 2021 2028abstractfree full text basu k goldstein j l brown m 1983 science 219 871 873medline order article via infotrieve herscovitz h gantz d tercyak m zannis v small d m 1992 j lipid res 33 791 803abstract segrest j p jones m k de loof h brouillette c g venkatachalapathi y v anantharamaiah g m 1992 j lipid res 33 141 166abstract jonas 1992 structure function apolipoproteins von rosseneu m ed pp 218 245 crc press boca raton fl dong l m wilson c wardell m r simmons mahley r w weisgraber k h agard d 1994 j biol chem 269 22358 22365abstractfree full text saito h dhanasekaran p baldwin f weisgraber k h phillips m c lund katz 2003 j biol chem 278 40723 40729abstractfree full text jonas kezdy k e wald j h 1989 j biol chem 264 4818 4824abstractfree full text lucas m mazzone 1996 j biol chem 271 13454 13460abstractfree full text fielding c j fielding p e 1995 j lipid res 36 211 228abstract mazzone gump h diller p getz g 1987 j biol chem 262 11657 11662abstractfree full text dory l 1991 j lipid res 32 783 792abstract burgess j w kiss r zheng h zachariah marcel y l 2002 j biol chem 277 31318 31326abstractfree full text sorci thomas m kearns m w lee j p 1993 j biol chem 268 21403 21409abstractfree full text holvoet p peeters k lund katz mertens verhamme p quarck r stengel d lox m deridder e bernar h nickel m theilmeier g ninio e phillips m c 2001 arterioscler thromb vasc biol 21 1977 1983abstractfree full text nathan b p bellosta sanan d weisgraber k h mahley r w pitas r e 1994 science 264 850 852medline order article via infotrieve zha x gauthier genest j mcpherson r 2003 j biol chem 278 10002 10005abstractfree full text deng j rudick v dory l 1995 j lipid res 36 2129 2140abstract duan h lin c y mazzone 1997 j biol chem 272 31156 31162abstractfree full text grewal de diego kirchhoff m f tebar f heeren j rinninger f enrich c 2003 j biol chem 278 16478 16481abstractfree full text
0.3392243.12502505.html.plaintext.txt	0	apolipoprotein e influences aspects intellectual ability type 1 diabetes stewart c ferguson1 ian j deary2 julie c evans3 sian ellard3 andrew hattersley3 brian m frier1
0.3392243.12502505.html.plaintext.txt	1	1 department diabetes royal infirmary edinburgh edinburgh scotland uk 2 department psychology university edinburgh edinburgh scotland uk 3 centre molecular genetics exeter university exeter england uk
0.3392243.12502505.html.plaintext.txt	2	abstract top abstract research design methods results discussion references 4 allele apolipoprotein e apoe gene associated poor outcome following various cerebral insults relationship apoe genotype cognitive function patients type 1 diabetes unknown cross sectional study 96 people type 1 diabetes subjects apoe genotyped previous exposure severe hypoglycemia estimated questionnaire cognition assessed neuropsychological testing cognitive abilities compared using multivariate general linear modeling multiple analysis covariance mancova n 21 without n 75 apoe 4 allele apoe 4 selectively influenced cognitive ability sex specific manner f 23 p 0044 eta2 015 women apoe 4 performed less well tests current nonverbal intellectual ability wechsler adult intelligence scale revised performance test score p 0001 eta2 026 frontal lobe executive function borkowski verbal fluency p 0016 eta2 015 previous exposure severe hypoglycemia interact apoe 4 produce cognitive disadvantage apoe 4 genotype associated specific cognitive disadvantage young women type 1 diabetes apoe 4 unlikely mediate susceptibility hypoglycemia induced cognitive disadvantage
0.3392243.12502505.html.plaintext.txt	3	abstract top abstract research design methods results discussion references 4 allele apolipoprotein e apoe gene associated poor outcome following various cerebral insults relationship apoe genotype cognitive function patients type 1 diabetes unknown cross sectional study 96 people type 1 diabetes subjects apoe genotyped previous exposure severe hypoglycemia estimated questionnaire cognition assessed neuropsychological testing cognitive abilities compared using multivariate general linear modeling multiple analysis covariance mancova n 21 without n 75 apoe 4 allele apoe 4 selectively influenced cognitive ability sex specific manner f 23 p 0044 eta2 015 women apoe 4 performed less well tests current nonverbal intellectual ability wechsler adult intelligence scale revised performance test score p 0001 eta2 026 frontal lobe executive function borkowski verbal fluency p 0016 eta2 015 previous exposure severe hypoglycemia interact apoe 4 produce cognitive disadvantage apoe 4 genotype associated specific cognitive disadvantage young women type 1 diabetes apoe 4 unlikely mediate susceptibility hypoglycemia induced cognitive disadvantage
0.3392243.12502505.html.plaintext.txt	4	permanent cognitive impairment rare consequence insulin induced hypoglycemia insulin treated diabetes severe hypoglycemia common annual prevalence 30 type 1 diabetes higher incidence people impaired awareness hypoglycemia strict glycemic control 1 whether recurrent exposure severe hypoglycemia promotes long term cognitive sequelae unresolved retrospective cross sectional studies indicated people type 1 diabetes suffer modest cognitive decrement 2 finding replicated prospective observations 10 years 34 cross sectional studies reported individual differences cognitive decrements exposed severe hypoglycemia 2 suggesting factors neuroglycopenia may influence risk developing subsequent cognitive impairment chronological age diabetes duration coexistent microvascular macrovascular complications proposed potential mediators susceptibility hypoglycemia induced cognitive impairment 2 whereas genetic susceptibility examined
0.3392243.12502505.html.plaintext.txt	5	permanent cognitive impairment rare consequence insulin induced hypoglycemia insulin treated diabetes severe hypoglycemia common annual prevalence 30 type 1 diabetes higher incidence people impaired awareness hypoglycemia strict glycemic control 1 whether recurrent exposure severe hypoglycemia promotes long term cognitive sequelae unresolved retrospective cross sectional studies indicated people type 1 diabetes suffer modest cognitive decrement 2 finding replicated prospective observations 10 years 34 cross sectional studies reported individual differences cognitive decrements exposed severe hypoglycemia 2 suggesting factors neuroglycopenia may influence risk developing subsequent cognitive impairment chronological age diabetes duration coexistent microvascular macrovascular complications proposed potential mediators susceptibility hypoglycemia induced cognitive impairment 2 whereas genetic susceptibility examined
0.3392243.12502505.html.plaintext.txt	6	genetic factors influence cognitive aging polymorphism gene apolipoprotein e apoe important genetic determinant late onset alzheimer disease 5 apoe gene three common alleles 2 3 4 coding three protein isoforms designated e2 e3 e4 apolipoprotein e apoe mediates central nervous system cholesterol transport isoform specific manner 6 apoe activity important neuronal repair maintenance least active e4 isoform confers survival disadvantage injured neurons 6 apoe polymorphism influences cognitive ability health disease apparently healthy middle aged adults possessing 4 allele average relatively low learning memory ability 7 4 allele associated poorer cognitive neurological outcome head injury demyelinating disease intracerebral hemorrhage cardiopulmonary bypass surgery 8
0.3392243.12502505.html.plaintext.txt	7	genetic factors influence cognitive aging polymorphism gene apolipoprotein e apoe important genetic determinant late onset alzheimer disease 5 apoe gene three common alleles 2 3 4 coding three protein isoforms designated e2 e3 e4 apolipoprotein e apoe mediates central nervous system cholesterol transport isoform specific manner 6 apoe activity important neuronal repair maintenance least active e4 isoform confers survival disadvantage injured neurons 6 apoe polymorphism influences cognitive ability health disease apparently healthy middle aged adults possessing 4 allele average relatively low learning memory ability 7 4 allele associated poorer cognitive neurological outcome head injury demyelinating disease intracerebral hemorrhage cardiopulmonary bypass surgery 8
0.3392243.12502505.html.plaintext.txt	8	aim present study examine whether possession apoe 4 allele associated cognitive disadvantage people type 1 diabetes secondly determine whether magnitude difference cognitive ability modified preceding exposure recurrent severe hypoglycemia
0.3392243.12502505.html.plaintext.txt	9	research design methods top abstract research design methods results discussion references total 96 people type 1 diabetes recruited completed cross sectional study protocol participants selected two preexisting cohorts 63 patients 9 33 patients 10 completed identical neuropsychological assessments minimize influences confounding neuropsychological performance following exclusion criteria applied hypertension defined blood pressure 14090 mmhg previous central nervous system pathology psychiatric disease alcoholism drug misuse multisystem disease known affect central nervous system
0.3392243.12502505.html.plaintext.txt	10	research design methods top abstract research design methods results discussion references total 96 people type 1 diabetes recruited completed cross sectional study protocol participants selected two preexisting cohorts 63 patients 9 33 patients 10 completed identical neuropsychological assessments minimize influences confounding neuropsychological performance following exclusion criteria applied hypertension defined blood pressure 14090 mmhg previous central nervous system pathology psychiatric disease alcoholism drug misuse multisystem disease known affect central nervous system
0.3392243.12502505.html.plaintext.txt	11	assessment neuropsychological function neuropsychological test battery chosen sensitive cognitive decrements across diverse cognitive abilities assessors blinded diabetes characteristics apoe genotype participants administered neuropsychological tests fixed order incipient hypoglycemia hypoglycemia within preceding 24 h excluded neuropsychological assessment evidence biochemical blood glucose 35 mmoll symptomatic hypoglycemia resulted rescheduling neuropsychological session psychometric instruments used follows
0.3392243.12502505.html.plaintext.txt	12	assessment neuropsychological function neuropsychological test battery chosen sensitive cognitive decrements across diverse cognitive abilities assessors blinded diabetes characteristics apoe genotype participants administered neuropsychological tests fixed order incipient hypoglycemia hypoglycemia within preceding 24 h excluded neuropsychological assessment evidence biochemical blood glucose 35 mmoll symptomatic hypoglycemia resulted rescheduling neuropsychological session psychometric instruments used follows
0.3392243.12502505.html.plaintext.txt	13	hospital anxiety depression scale 11 evaluated potential confounding effects low mood anxiety
0.3392243.12502505.html.plaintext.txt	14	wechsler adult intelligence scale revised wais r 12 uses performance subtests measure current intellectual performance fluid nonverbal intelligence sensitive disruption organic brain disease four performance subtests utilized picture completion object assembly block design digit symbol tests
0.3392243.12502505.html.plaintext.txt	15	wechsler adult intelligence scale revised wais r 12 uses performance subtests measure current intellectual performance fluid nonverbal intelligence sensitive disruption organic brain disease four performance subtests utilized picture completion object assembly block design digit symbol tests
0.3392243.12502505.html.plaintext.txt	16	national adult reading test nart 13 relatively resistant effect age types organic brain disease nart performance correlates closely premorbid iq demographic variables used control confounding effects prior intellectual ability premorbid iq crystallized intelligence present study
0.3392243.12502505.html.plaintext.txt	17	national adult reading test nart 13 relatively resistant effect age types organic brain disease nart performance correlates closely premorbid iq demographic variables used control confounding effects prior intellectual ability premorbid iq crystallized intelligence present study
0.3392243.12502505.html.plaintext.txt	18	inspection time 14 used assess visual perceptual speed component information processing ability participants discriminated spatial position left right longer two briefly presented vertical lines stimuli backward masked presentation duration varied duration time required reliably distinguish stimulus 85 correct termed inspection time
0.3392243.12502505.html.plaintext.txt	19	inspection time 14 used assess visual perceptual speed component information processing ability participants discriminated spatial position left right longer two briefly presented vertical lines stimuli backward masked presentation duration varied duration time required reliably distinguish stimulus 85 correct termed inspection time
0.3392243.12502505.html.plaintext.txt	20	choice reaction time 15 used assess psychomotor speed completed tests information processing ability 1248 8421 choice reaction times examined
0.3392243.12502505.html.plaintext.txt	21	borkowski verbal fluency test controlled association 16 thought assess frontal lobe executive function participants 60 state many words possible beginning letters alphabet specified assessor
0.3392243.12502505.html.plaintext.txt	22	borkowski verbal fluency test controlled association 16 thought assess frontal lobe executive function participants 60 state many words possible beginning letters alphabet specified assessor
0.3392243.12502505.html.plaintext.txt	23	paced auditory serial addition task 17 used assess ability sustain attention concentration participants listened number list required add together according given rule practice two consecutive 61 number trials performed 4 2 successive digits respectively
0.3392243.12502505.html.plaintext.txt	24	paced auditory serial addition task 17 used assess ability sustain attention concentration participants listened number list required add together according given rule practice two consecutive 61 number trials performed 4 2 successive digits respectively
0.3392243.12502505.html.plaintext.txt	25	assessment severe hypoglycemia exposure severe hypoglycemia defined episode requiring external assistance facilitate recovery 18 exposure assessed retrospectively using validated formatted hypoglycemia questionnaire 9 participants asked discuss history severe hypoglycemia family partners friends completing questionnaires improve accuracy estimates total number lifetime episodes frequency episodes total numbers hypoglycemic seizures coma episodes requiring medical intervention recorded
0.3392243.12502505.html.plaintext.txt	26	assessment severe hypoglycemia exposure severe hypoglycemia defined episode requiring external assistance facilitate recovery 18 exposure assessed retrospectively using validated formatted hypoglycemia questionnaire 9 participants asked discuss history severe hypoglycemia family partners friends completing questionnaires improve accuracy estimates total number lifetime episodes frequency episodes total numbers hypoglycemic seizures coma episodes requiring medical intervention recorded
0.3392243.12502505.html.plaintext.txt	27	determination apoe genotype dna extracted venous blood subjects using standard methods apoe genotyping performed using pcr restriction fragment length polymorphism assay described wenham et al 19
0.3392243.12502505.html.plaintext.txt	28	subjects clinical characteristics participants shown table 1 data glycemic control included laboratory reference ranges methodology estimating glycated hemoglobin changed across two time frames data participants collated
0.3392243.12502505.html.plaintext.txt	29	view table table 1 characteristics participants subdivided presence apoe 4 allele
0.3392243.12502505.html.plaintext.txt	30	subdivision participants apoe 4 produced two groups 4 n 21 4 n 75 clinical characteristics shown table 1 subgroups similar premorbid intellectual ability nart similar exposure severe hypoglycemia possessing 4 slightly older p 0033 test tended diabetes longer duration p 0059 test
0.3392243.12502505.html.plaintext.txt	31	subdivision participants apoe 4 produced two groups 4 n 21 4 n 75 clinical characteristics shown table 1 subgroups similar premorbid intellectual ability nart similar exposure severe hypoglycemia possessing 4 slightly older p 0033 test tended diabetes longer duration p 0059 test
0.3392243.12502505.html.plaintext.txt	32	results top abstract research design methods results discussion references severe hypoglycemia neuropsychological performance range exposure severe hypoglycemia wide naive severe hypoglycemia 30 experienced 10 episodes 29 table 1 significant difference cognitive ability observed previously exposed severe hypoglycemia naive severe hypoglycemia estimated marginal mean differences without history severe hypoglycemia shown table 2
0.3392243.12502505.html.plaintext.txt	33	results top abstract research design methods results discussion references severe hypoglycemia neuropsychological performance range exposure severe hypoglycemia wide naive severe hypoglycemia 30 experienced 10 episodes 29 table 1 significant difference cognitive ability observed previously exposed severe hypoglycemia naive severe hypoglycemia estimated marginal mean differences without history severe hypoglycemia shown table 2
0.3392243.12502505.html.plaintext.txt	34	view table table 2 effect severe hypoglycemia cognitive ability interaction apoe
0.3392243.12502505.html.plaintext.txt	35	apoe 4 neuropsychological performance apoe 4 allele associated disadvantage current intellectual performance wais r performance test score p 0037 eta2 0072 trend toward poorer frontal lobe executive functions borkowski verbal fluency p 0063 eta2 0057 consideration age sex duration diabetes preceding severe hypoglycemia premorbid intellectual ability table 3 relative disadvantage associated apoe 4 appeared sex specific apoe x sex interaction f 228 p 004 eta2 015 sex specificity mancova thereafter performed separately men women using similar model excluding sex subjects factor apoe genotype significantly influenced cognitive ability women men table 4 women apoe 4 exhibited significant cognitive disadvantage affecting current intellectual performance wais r performance test score p 0001 eta2 026 frontal lobe executive function borkowski verbal fluency p 0016 eta2 015 difference ability associated possession apoe 4 women moderate large eta2
0.3392243.12502505.html.plaintext.txt	36	apoe 4 neuropsychological performance apoe 4 allele associated disadvantage current intellectual performance wais r performance test score p 0037 eta2 0072 trend toward poorer frontal lobe executive functions borkowski verbal fluency p 0063 eta2 0057 consideration age sex duration diabetes preceding severe hypoglycemia premorbid intellectual ability table 3 relative disadvantage associated apoe 4 appeared sex specific apoe x sex interaction f 228 p 004 eta2 015 sex specificity mancova thereafter performed separately men women using similar model excluding sex subjects factor apoe genotype significantly influenced cognitive ability women men table 4 women apoe 4 exhibited significant cognitive disadvantage affecting current intellectual performance wais r performance test score p 0001 eta2 026 frontal lobe executive function borkowski verbal fluency p 0016 eta2 015 difference ability associated possession apoe 4 women moderate large eta2
0.3392243.12502505.html.plaintext.txt	37	view table table 3 effect apoe 4 4 age premorbid intellectual ability nart cognitive performance
0.3392243.12502505.html.plaintext.txt	38	view table table 4 apoe alleles cognition sex
0.3392243.12502505.html.plaintext.txt	39	apolipoprotein e genotype severe hypoglycemia statistical evidence detrimental interaction apoe genotype previous exposure severe hypoglycemia cognitive ability apoe x severe hypoglycemia interaction f 066 p 068 eta2 005 cognitive ability subjects apoe 4 allele subdivided exposed previously severe hypoglycemia n 15 naive severe hypoglycemia n 6 shown table 2 significant difference cognitive ability demonstrated subgroups although numbers subjects analysis small confident nonsignificant difference table 4
0.3392243.12502505.html.plaintext.txt	40	apolipoprotein e genotype severe hypoglycemia statistical evidence detrimental interaction apoe genotype previous exposure severe hypoglycemia cognitive ability apoe x severe hypoglycemia interaction f 066 p 068 eta2 005 cognitive ability subjects apoe 4 allele subdivided exposed previously severe hypoglycemia n 15 naive severe hypoglycemia n 6 shown table 2 significant difference cognitive ability demonstrated subgroups although numbers subjects analysis small confident nonsignificant difference table 4
0.3392243.12502505.html.plaintext.txt	41	discussion top abstract research design methods results discussion references presence apoe 4 allele associated significant disadvantage current intellectual performance wais r performance test score frontal lobe executive functions borkowski verbal fluency women type 1 diabetes deficits encompass aspects cognitive ability present women evident younger age 39 years reported people diabetes 7 female susceptibility apoe 4 associated cognitive disadvantage described wais r performance test ability healthy elderly women 20 although pathogenesis possible sex difference remains unclear age influences effect apoe 4 cognitive ability neuropsychological performance healthy children 21 healthy young adults 22 affected 4 allele middle aged otherwise healthy adults mean age 46 years observed impaired learning memory ability 7 younger age median age 39 years 4 associated cognitive disadvantage observed adults type 1 diabetes present study implies premature susceptibility compared nondiabetic individuals
0.3392243.12502505.html.plaintext.txt	42	discussion top abstract research design methods results discussion references presence apoe 4 allele associated significant disadvantage current intellectual performance wais r performance test score frontal lobe executive functions borkowski verbal fluency women type 1 diabetes deficits encompass aspects cognitive ability present women evident younger age 39 years reported people diabetes 7 female susceptibility apoe 4 associated cognitive disadvantage described wais r performance test ability healthy elderly women 20 although pathogenesis possible sex difference remains unclear age influences effect apoe 4 cognitive ability neuropsychological performance healthy children 21 healthy young adults 22 affected 4 allele middle aged otherwise healthy adults mean age 46 years observed impaired learning memory ability 7 younger age median age 39 years 4 associated cognitive disadvantage observed adults type 1 diabetes present study implies premature susceptibility compared nondiabetic individuals
0.3392243.12502505.html.plaintext.txt	43	laboratory clinical evidence supports concept 4 associated premature cognitive aging diabetes elderly people type 2 diabetes 4 allele exhibit greater cognitive decrement 23 accelerated cognitive decline 24 compared age matched 4 healthy control subjects apoe people diabetes irreversibly glycated exhibits less vitro bioactivity 25 compared nondiabetic control subjects apoe bioactivity appears clinical relevance outcomes variety cerebral pathologies poorer individuals possessing least biologically active e4 isoform 8 present study include healthy comparator group notion apoe 4 associated premature cognitive aging type 1 diabetes speculative present whereas demonstrated type 2 diabetes 2324
0.3392243.12502505.html.plaintext.txt	44	laboratory clinical evidence supports concept 4 associated premature cognitive aging diabetes elderly people type 2 diabetes 4 allele exhibit greater cognitive decrement 23 accelerated cognitive decline 24 compared age matched 4 healthy control subjects apoe people diabetes irreversibly glycated exhibits less vitro bioactivity 25 compared nondiabetic control subjects apoe bioactivity appears clinical relevance outcomes variety cerebral pathologies poorer individuals possessing least biologically active e4 isoform 8 present study include healthy comparator group notion apoe 4 associated premature cognitive aging type 1 diabetes speculative present whereas demonstrated type 2 diabetes 2324
0.3392243.12502505.html.plaintext.txt	45	present study support hypothesis polymorphism apoe gene may contribute susceptibility hypoglycemia induced cognitive decrement people type 1 diabetes number subjects 4 subgroup n 15 previous severe hypoglycemia vs n 6 hypoglycemia naive give sufficient power allow definitive conclusions appropriately powered investigation required evaluate hypothesis irrespective influence apoe alleles cognitive performance unaffected severe hypoglycemia per se consistent conclusions diabetes control complications trial 3 stockholm diabetes intervention study 4 many participants type 1 diabetes relatively short duration conflicting retrospective cross sectional studies 2 examined older subjects diabetes long duration
0.3392243.12502505.html.plaintext.txt	46	present study support hypothesis polymorphism apoe gene may contribute susceptibility hypoglycemia induced cognitive decrement people type 1 diabetes number subjects 4 subgroup n 15 previous severe hypoglycemia vs n 6 hypoglycemia naive give sufficient power allow definitive conclusions appropriately powered investigation required evaluate hypothesis irrespective influence apoe alleles cognitive performance unaffected severe hypoglycemia per se consistent conclusions diabetes control complications trial 3 stockholm diabetes intervention study 4 many participants type 1 diabetes relatively short duration conflicting retrospective cross sectional studies 2 examined older subjects diabetes long duration
0.3392243.12502505.html.plaintext.txt	47	conclusion data modestly powered study suggest apoe 4 confers cognitive disadvantage young women type 1 diabetes investigation required verify findings determine whether apoe 4 allele associated premature accelerated cognitive aging people type 1 diabetes diabetes specific factors may mediating disadvantage possible interaction sex
0.3392243.12502505.html.plaintext.txt	48	conclusion data modestly powered study suggest apoe 4 confers cognitive disadvantage young women type 1 diabetes investigation required verify findings determine whether apoe 4 allele associated premature accelerated cognitive aging people type 1 diabetes diabetes specific factors may mediating disadvantage possible interaction sex
0.3392243.12502505.html.plaintext.txt	49	footnotes address correspondence reprint requests prof ian j deary department psychology university edinburgh 7 george square edinburgh eh8 9jz scotland e mail idearyatedacuk u d
0.3392243.12502505.html.plaintext.txt	50	received publication 13 may 2002 accepted revised form 7 october 2002
0.3392243.12502505.html.plaintext.txt	51	apoe apolipoprotein e mancova multiple analysis covariance nart national adult reading test wais r wechsler adult intelligence scale revised
0.3392243.12502505.html.plaintext.txt	52	references top abstract research design methods results discussion references tattersall rb frequency causes treatment hypoglycaemia hypoglycaemia clinical diabetes frier bm fisher bm eds chichester john wiley sons ltd1999 p55 88 perros p deary ij long term effect hypoglycaemia cognitive function brain diabetes hypoglycaemia clinical diabetes frier bm fisher bm eds chichester john wiley sons ltd1999 p187 210 diabetes control complications trial research group effects intensive diabetes therapy neuropsychological function adults diabetes control complications trial ann intern med124 379 3881996abstractfree full text reichard p pihl m rosenqvist u sule j complications iddm caused elevated blood glucose level stockholm diabetes intervention study sdis 10 year follow diabetologia39 1483 14881996medline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science261 921 9231993medline maclullich amj seckl jr starr jm deary ij biology intelligence association mechanism intelligence26 63 731998 flory jd manuck sb ferrell re ryan cm muldoon mf memory performance apolipoprotein e polymorphism community sample middle aged adults j med genet96 707 7112000medline smith jd apolipoprotein e4 allele associated many diseases ann med32 118 1272000medline deary ij crawford jr hepburn da langan sj blackmore lm frier bm severe hypoglycemia intelligence adult patients insulin treated diabetes diabetes42 341 3441993abstract ferguson sc blane perros p mccrimmon rj best jjk wardlaw j dreary ij frier bm cognitive ability brain structure type 1 diabetes relation microangiopathy preceding severe hypoglycemia diabetes52 149 1562003abstractfree full text zigmond snaith rp hospital anxiety depression scale acta psychiatr scand67 361 3701983medline wechsler d manual wechsler adult intelligence scale revised new york psychological corporation1981 nelson willison jr national adult reading test nart test manual 2nd ed windsor nfer nelson1991 mccrimmon rj deary ij huntly bjh macleod kjm frier bm visual information processing controlled hypoglycaemia humans brain119 1277 12871996abstract jensen ar individual differences hick paradigm speed information processing intelligence vernon pa ed norwood nj ablex1987 p101 175 borkowski jg benton al word fluency brain damage neuropsychologia5 135 1401967 deary ij langan sj hepburn da frier bm abilities pasat test pers indiv diff12 983 9871991 diabetes control complications trial research group hypoglycemia diabetes control complications trial diabetes46 271 2861997abstract wenham pr price wh blandell g apolipoprotein e genotyping one stage pcr lancet337 1158 11591991medline mortensen el hogh p gender difference association apoe genotype age related cognitive decline neurology57 89 952001abstractfree full text turic d fisher pj plomin r owen mj association apolipoprotein e polymorphisms general cognitive ability children neurosci lett299 97 1002001medline yu yw lin ch chen sp hong cj tsai sj intelligence event related potentials young female human volunteer apolipoprotein e epsilon4 non epsilon4 carriers neurosci lett294 179 1812000medline kalmijn feskens ej launer lj kromhout d cerebrovascular disease apolipoprotein e4 allele cognitive decline community based study elderly men stroke27 2230 22351996abstractfree full text haan mn shemanski l jagust wj manolio ta kuller l role apoe epsilon4 modulating effects risk factors cognitive decline elderly persons jama282 40 461999abstractfree full text shuvaev vv fujii j kawasaki y itoh h hamaoka r barbier ziegler o siest g taniguchi n glycation apolipoprotein e impairs binding heparin identification major glycation site biochim biophys acta1454 296 3081999medline
0.3392243.12502505.html.plaintext.txt	53	references top abstract research design methods results discussion references tattersall rb frequency causes treatment hypoglycaemia hypoglycaemia clinical diabetes frier bm fisher bm eds chichester john wiley sons ltd1999 p55 88 perros p deary ij long term effect hypoglycaemia cognitive function brain diabetes hypoglycaemia clinical diabetes frier bm fisher bm eds chichester john wiley sons ltd1999 p187 210 diabetes control complications trial research group effects intensive diabetes therapy neuropsychological function adults diabetes control complications trial ann intern med124 379 3881996abstractfree full text reichard p pihl m rosenqvist u sule j complications iddm caused elevated blood glucose level stockholm diabetes intervention study sdis 10 year follow diabetologia39 1483 14881996medline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science261 921 9231993medline maclullich amj seckl jr starr jm deary ij biology intelligence association mechanism intelligence26 63 731998 flory jd manuck sb ferrell re ryan cm muldoon mf memory performance apolipoprotein e polymorphism community sample middle aged adults j med genet96 707 7112000medline smith jd apolipoprotein e4 allele associated many diseases ann med32 118 1272000medline deary ij crawford jr hepburn da langan sj blackmore lm frier bm severe hypoglycemia intelligence adult patients insulin treated diabetes diabetes42 341 3441993abstract ferguson sc blane perros p mccrimmon rj best jjk wardlaw j dreary ij frier bm cognitive ability brain structure type 1 diabetes relation microangiopathy preceding severe hypoglycemia diabetes52 149 1562003abstractfree full text zigmond snaith rp hospital anxiety depression scale acta psychiatr scand67 361 3701983medline wechsler d manual wechsler adult intelligence scale revised new york psychological corporation1981 nelson willison jr national adult reading test nart test manual 2nd ed windsor nfer nelson1991 mccrimmon rj deary ij huntly bjh macleod kjm frier bm visual information processing controlled hypoglycaemia humans brain119 1277 12871996abstract jensen ar individual differences hick paradigm speed information processing intelligence vernon pa ed norwood nj ablex1987 p101 175 borkowski jg benton al word fluency brain damage neuropsychologia5 135 1401967 deary ij langan sj hepburn da frier bm abilities pasat test pers indiv diff12 983 9871991 diabetes control complications trial research group hypoglycemia diabetes control complications trial diabetes46 271 2861997abstract wenham pr price wh blandell g apolipoprotein e genotyping one stage pcr lancet337 1158 11591991medline mortensen el hogh p gender difference association apoe genotype age related cognitive decline neurology57 89 952001abstractfree full text turic d fisher pj plomin r owen mj association apolipoprotein e polymorphisms general cognitive ability children neurosci lett299 97 1002001medline yu yw lin ch chen sp hong cj tsai sj intelligence event related potentials young female human volunteer apolipoprotein e epsilon4 non epsilon4 carriers neurosci lett294 179 1812000medline kalmijn feskens ej launer lj kromhout d cerebrovascular disease apolipoprotein e4 allele cognitive decline community based study elderly men stroke27 2230 22351996abstractfree full text haan mn shemanski l jagust wj manolio ta kuller l role apoe epsilon4 modulating effects risk factors cognitive decline elderly persons jama282 40 461999abstractfree full text shuvaev vv fujii j kawasaki y itoh h hamaoka r barbier ziegler o siest g taniguchi n glycation apolipoprotein e impairs binding heparin identification major glycation site biochim biophys acta1454 296 3081999medline
0.3398514.15583000.html.plaintext.txt	0	two step mechanism binding apolipoprotein e heparin implications kinetics apolipoprotein e heparan sulfate proteoglycan complex formation cell surfaces miho futamura padmaja dhanasekaran tetsurou handa michael c phillips sissel lund katz hiroyuki saito
0.3398514.15583000.html.plaintext.txt	1	two step mechanism binding apolipoprotein e heparin implications kinetics apolipoprotein e heparan sulfate proteoglycan complex formation cell surfaces miho futamura padmaja dhanasekaran tetsurou handa michael c phillips sissel lund katz hiroyuki saito
0.3398514.15583000.html.plaintext.txt	2	lipid research group childrens hospital philadelphia university pennsylvania school medicine philadelphia pennsylvania 19104 4318 graduate school pharmaceutical sciences kyoto university kyoto 606 8501 japan
0.3398514.15583000.html.plaintext.txt	3	received publication october 14 2004
0.3398514.15583000.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references interaction apolipoprotein e apoe cell surface heparan sulfate proteoglycans important step uptake lipoprotein remnants liver apoe interacts predominantly heparin n terminal binding site spanning residues around 136 150 work surface plasmon resonance analysis employed investigate amphipathic helix properties basic residue organization region modulate binding apoe heparin apoeheparin interaction involves two step process apoe initially binds heparin fast association dissociation rates followed step exhibiting much slower kinetics circular dichroism surface plasmon resonance experiments using disulfide linked mutant opening n terminal helix bundle prevented demonstrated major secondary tertiary structural change apoe upon heparin binding mutations lys 146 key residue heparin interaction greatly reduced favorable free energy binding first step without affecting second step suggesting electrostatic interaction involved first binding step although lipid free apoe2 tended bind less apoe3 apoe4 significant differences rate equilibrium constants binding among apoe isoforms lipidated state discoidal apoe3 phospholipid complexes using substitution mutant k143rk146r showed similar binding affinity wild type apoe3 indicating basic residue specificity required effective binding apoe heparin unlike binding low density lipoprotein receptor addition disruption helix structure apoe heparin binding region led increased favorable free energy binding second step suggesting hydrophobic interactions contribute second binding step based results seems cell surface heparan sulfate proteoglycan localizes apoe enriched remnant lipoproteins vicinity receptors fast association dissociation
0.3398514.15583000.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references interaction apolipoprotein e apoe cell surface heparan sulfate proteoglycans important step uptake lipoprotein remnants liver apoe interacts predominantly heparin n terminal binding site spanning residues around 136 150 work surface plasmon resonance analysis employed investigate amphipathic helix properties basic residue organization region modulate binding apoe heparin apoeheparin interaction involves two step process apoe initially binds heparin fast association dissociation rates followed step exhibiting much slower kinetics circular dichroism surface plasmon resonance experiments using disulfide linked mutant opening n terminal helix bundle prevented demonstrated major secondary tertiary structural change apoe upon heparin binding mutations lys 146 key residue heparin interaction greatly reduced favorable free energy binding first step without affecting second step suggesting electrostatic interaction involved first binding step although lipid free apoe2 tended bind less apoe3 apoe4 significant differences rate equilibrium constants binding among apoe isoforms lipidated state discoidal apoe3 phospholipid complexes using substitution mutant k143rk146r showed similar binding affinity wild type apoe3 indicating basic residue specificity required effective binding apoe heparin unlike binding low density lipoprotein receptor addition disruption helix structure apoe heparin binding region led increased favorable free energy binding second step suggesting hydrophobic interactions contribute second binding step based results seems cell surface heparan sulfate proteoglycan localizes apoe enriched remnant lipoproteins vicinity receptors fast association dissociation
0.3398514.15583000.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references apolipoprotein e apoe1 key protein regulating lipid transport human plasma brain 1 4 mediates hepatic clearance remnant lipoproteins high affinity ligand low density lipoprotein receptor ldlr family including ldlr ldlr related protein lrp cell surface heparan sulfate proteoglycans hspgs 5 liver hspgs act concert lrp complete interaction remnant particles lrp process known hspg lrp pathway apoe initially interacts hspg cell surface transferred lrp internalization 6 ability apoe interact members ldlr family hspg also significant cell signaling events 7 binding apoe lrp activates camp dependent protein kinase inhibits platelet derived growth factor stimulated migration smooth muscle cells 8 inhibition smooth muscle cell proliferation apoe hand mediated binding hspg 9 addition interaction apoe hspg implicated neuronal growth repair consequently involved progression late onset familial alzheimers disease 10 12
0.3398514.15583000.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references apolipoprotein e apoe1 key protein regulating lipid transport human plasma brain 1 4 mediates hepatic clearance remnant lipoproteins high affinity ligand low density lipoprotein receptor ldlr family including ldlr ldlr related protein lrp cell surface heparan sulfate proteoglycans hspgs 5 liver hspgs act concert lrp complete interaction remnant particles lrp process known hspg lrp pathway apoe initially interacts hspg cell surface transferred lrp internalization 6 ability apoe interact members ldlr family hspg also significant cell signaling events 7 binding apoe lrp activates camp dependent protein kinase inhibits platelet derived growth factor stimulated migration smooth muscle cells 8 inhibition smooth muscle cell proliferation apoe hand mediated binding hspg 9 addition interaction apoe hspg implicated neuronal growth repair consequently involved progression late onset familial alzheimers disease 10 12
0.3398514.15583000.html.plaintext.txt	8	apoe comprises single polypeptide chain 299 amino acid residues contains two independently folded functional domains 22 kda n terminal domain residues 1 191 10 kda c terminal domain residues 222 299 2 13 n terminal domain folded four helix bundle amphipathic helices contains ldlr binding region around residues 136 150 helix 4 14 15 c terminal domain also contains amphipathic helices involved binding lipoprotein particles 2 16 17 n c terminal domains contain heparin binding site 18 19 n terminal domain site located residues 136 147 overlapping ldlr binding region 20 21 whereas c terminal site involves basic residues around lysine 233 22 although sites functional separated fragments n terminal site available interaction lipid free lipidated states intact apoe molecule 22
0.3398514.15583000.html.plaintext.txt	9	apoe comprises single polypeptide chain 299 amino acid residues contains two independently folded functional domains 22 kda n terminal domain residues 1 191 10 kda c terminal domain residues 222 299 2 13 n terminal domain folded four helix bundle amphipathic helices contains ldlr binding region around residues 136 150 helix 4 14 15 c terminal domain also contains amphipathic helices involved binding lipoprotein particles 2 16 17 n c terminal domains contain heparin binding site 18 19 n terminal domain site located residues 136 147 overlapping ldlr binding region 20 21 whereas c terminal site involves basic residues around lysine 233 22 although sites functional separated fragments n terminal site available interaction lipid free lipidated states intact apoe molecule 22
0.3398514.15583000.html.plaintext.txt	10	humans apoe polymorphic protein three major isoforms apoe2 apoe3 apoe4 differing cysteine arginine positions 112 158 11 apoe3 common form contains cysteine arginine positions respectively whereas apoe2 contains cysteine apoe4 contains arginine sites apoe3 apoe4 bind equally high affinity ldlr apoe2 defective binding ldlr associated type iii hyperlipoproteinemia 23 apoe4 associated increased risk coronary artery disease major risk factor alzheimers disease 3 24 25
0.3398514.15583000.html.plaintext.txt	11	humans apoe polymorphic protein three major isoforms apoe2 apoe3 apoe4 differing cysteine arginine positions 112 158 11 apoe3 common form contains cysteine arginine positions respectively whereas apoe2 contains cysteine apoe4 contains arginine sites apoe3 apoe4 bind equally high affinity ldlr apoe2 defective binding ldlr associated type iii hyperlipoproteinemia 23 apoe4 associated increased risk coronary artery disease major risk factor alzheimers disease 3 24 25
0.3398514.15583000.html.plaintext.txt	12	cluster arginine lysine residues located polar face fourth amphipathic helix n terminal bundle represents binding site cell surface receptors 2 despite apparent accessibility basic residues interaction apoe lipid necessary high affinity binding ldlr 26 recent studies indicate lipid binding induces opening helix bundle n terminal domain 27 28 increases exposure lysines 143 146 aqueous phase thereby enhances interaction acidic elements ldlr 29 disruption amphipathic helix spanning residues 140 150 abolishes ldlr binding indicating structural motif apoe critical function 30 contrast binding ldlr stringency binding apoe lrp hspg appears less severe lipid association apoe required binding lrp 31 hspg 22 32 although apoe domain spanning residues 136 150 involved binding 21 33 apoe2 highly defective ldlr binding activity 2 normal apoe3 activity significant binding activity lrp 40 50 apoe3 23 hspg 50 90 apoe3 6 detailed molecular features control high affinity binding apoe lrp hspg yet defined fully
0.3398514.15583000.html.plaintext.txt	13	cluster arginine lysine residues located polar face fourth amphipathic helix n terminal bundle represents binding site cell surface receptors 2 despite apparent accessibility basic residues interaction apoe lipid necessary high affinity binding ldlr 26 recent studies indicate lipid binding induces opening helix bundle n terminal domain 27 28 increases exposure lysines 143 146 aqueous phase thereby enhances interaction acidic elements ldlr 29 disruption amphipathic helix spanning residues 140 150 abolishes ldlr binding indicating structural motif apoe critical function 30 contrast binding ldlr stringency binding apoe lrp hspg appears less severe lipid association apoe required binding lrp 31 hspg 22 32 although apoe domain spanning residues 136 150 involved binding 21 33 apoe2 highly defective ldlr binding activity 2 normal apoe3 activity significant binding activity lrp 40 50 apoe3 23 hspg 50 90 apoe3 6 detailed molecular features control high affinity binding apoe lrp hspg yet defined fully
0.3398514.15583000.html.plaintext.txt	14	previously characterized effect point mutations basic residues present heparin binding sites equilibrium parameters defining interaction apoe heparin 22 predict distribution apoe different receptors ldlr lrp hspg however also important establish kinetics apoe receptor association dissociation receptorligand interactions cell surface occur equilibrium study surface plasmon resonance spr measurements employed determine affinity kinetics interaction engineered apoe molecules lipid free lipidated states heparin using approach provide novel insights mechanism apoeheparin interaction
0.3398514.15583000.html.plaintext.txt	15	previously characterized effect point mutations basic residues present heparin binding sites equilibrium parameters defining interaction apoe heparin 22 predict distribution apoe different receptors ldlr lrp hspg however also important establish kinetics apoe receptor association dissociation receptorligand interactions cell surface occur equilibrium study surface plasmon resonance spr measurements employed determine affinity kinetics interaction engineered apoe molecules lipid free lipidated states heparin using approach provide novel insights mechanism apoeheparin interaction
0.3398514.15583000.html.plaintext.txt	16	experimental procedures top abstract introduction experimental procedures results discussion references materials 12 dimyristoyl phosphatidylcholine dmpc purchased avanti20polar20lipidsavanti polar lipids pelham al stock solutions stored chloroformmethanol 21 nitrogen 20 degrees c brain natriuretic peptide mercaptoethanol sigma ultrapure guanidine hcl icn pharmaceuticals costa mesa ca porcine intestinal mucosa heparin average molecular weight 13500 15000 biotin conjugate purchased calbiochem biotinylated heparin dissolved water extensively dialyzed remove contaminating free biotin use
0.3398514.15583000.html.plaintext.txt	17	experimental procedures top abstract introduction experimental procedures results discussion references materials 12 dimyristoyl phosphatidylcholine dmpc purchased avanti20polar20lipidsavanti polar lipids pelham al stock solutions stored chloroformmethanol 21 nitrogen 20 degrees c brain natriuretic peptide mercaptoethanol sigma ultrapure guanidine hcl icn pharmaceuticals costa mesa ca porcine intestinal mucosa heparin average molecular weight 13500 15000 biotin conjugate purchased calbiochem biotinylated heparin dissolved water extensively dialyzed remove contaminating free biotin use
0.3398514.15583000.html.plaintext.txt	18	expression purification proteins full length human apoe2 apoe3 apoe4 22 kda 12 kda 10 kda fragments expressed purified described previously 34 mutants apoe made using quikchange site directed mutagenesis kit stratagene la jolla ca cdna ligated thioredoxin fusion expression vector pet32a novagen madison wi transformed escherichia coli strain bl21 star de3 invitrogen resulting thioredoxin apoe fusion proteins expressed purified described previously 28 apoe3 22 kda l141kk143lk146ll148k mutant expressed insoluble protein proteins solubilized cell pellet using 6 m urea 30 apoe preparations least 95 pure assessed sds page experiments apoe sample freshly dialyzed 1 mercaptoethanol 6 m guanidine hcl solution tris buffer 10 mm tris hcl 150 mm nacl 002 nan3 1 mm edta ph 74 use disulfide linked apoe4 22 kda mutant dialyzed 6 m guanidine hcl solution maintain interhelical disulfide bonding 27 dmpc complexes apoe3 22 kda variants prepared described previously 29
0.3398514.15583000.html.plaintext.txt	19	expression purification proteins full length human apoe2 apoe3 apoe4 22 kda 12 kda 10 kda fragments expressed purified described previously 34 mutants apoe made using quikchange site directed mutagenesis kit stratagene la jolla ca cdna ligated thioredoxin fusion expression vector pet32a novagen madison wi transformed escherichia coli strain bl21 star de3 invitrogen resulting thioredoxin apoe fusion proteins expressed purified described previously 28 apoe3 22 kda l141kk143lk146ll148k mutant expressed insoluble protein proteins solubilized cell pellet using 6 m urea 30 apoe preparations least 95 pure assessed sds page experiments apoe sample freshly dialyzed 1 mercaptoethanol 6 m guanidine hcl solution tris buffer 10 mm tris hcl 150 mm nacl 002 nan3 1 mm edta ph 74 use disulfide linked apoe4 22 kda mutant dialyzed 6 m guanidine hcl solution maintain interhelical disulfide bonding 27 dmpc complexes apoe3 22 kda variants prepared described previously 29
0.3398514.15583000.html.plaintext.txt	20	spr measurements experiments performed biacore x 2000 spr instruments biacore inc uppsala sweden streptavidin sa sensor chip pretreated three consecutive 5 microl injections 50 mm naoh 1 m nacl remove nonspecifically bound contaminants immobilization heparin sa chip injection biotinylated heparin 10 microgml tris buffer made flow rate 5 microlmin followed 10 microl injection 2 m nacl typically 30 200 resonance units heparin immobilized effects mass transport significant low surface density ligand 35 untreated flow cell used control kinetic measurement apoe interaction heparin 30 microl injection apoe sample passed sensor surface flow rate 10 microlmin end sample plug buffer passed sensor surface facilitate dissociation 3 min dissociation time sensor surface regenerated next sample using 10 microl pulse 2 m nacl resultant sensorgrams analyzed using biaevaluation software version 41 response curves various analyte concentrations globally fitted either 11 langmuir model two state binding model described following equation 3637
0.3398514.15583000.html.plaintext.txt	21	eq 1 equilibrium constants binding step k1 ka1kd1 k2 ka2kd2 overall equilibrium binding constant calculated ka k11 k2 kd 1ka model analyte binds ligand b form initial complex ab undergoes subsequent binding conformational change form stable complex abx apoe 10 12 kda fragments binding responses steady state region sensorgrams req also plotted analyte concentration c determine overall equilibrium binding affinity data subjected nonlinear regression fitting according following equation
0.3398514.15583000.html.plaintext.txt	22	eq 2 rmax maximum binding response kd dissociation constant
0.3398514.15583000.html.plaintext.txt	23	circular dichroism cd spectroscopy far uv cd spectra recorded 195 250 nm 25 degrees c using jasco j 820 spectropolarimeter dialyzing 1 mercaptoethanol 6 m guanidine hcl solution apoe sample diluted 25 microgml tris buffer ph 74 obtain cd spectrum apoeheparin mixture sample apoe mixed heparin apoeheparin ratios 05 2 ww prior measurement results corrected subtracting buffer base line blank sample containing identical concentration heparin helix content calculated molar ellipticity 222 nm 222 according following equation 3839
0.3398514.15583000.html.plaintext.txt	24	circular dichroism cd spectroscopy far uv cd spectra recorded 195 250 nm 25 degrees c using jasco j 820 spectropolarimeter dialyzing 1 mercaptoethanol 6 m guanidine hcl solution apoe sample diluted 25 microgml tris buffer ph 74 obtain cd spectrum apoeheparin mixture sample apoe mixed heparin apoeheparin ratios 05 2 ww prior measurement results corrected subtracting buffer base line blank sample containing identical concentration heparin helix content calculated molar ellipticity 222 nm 222 according following equation 3839
0.3398514.15583000.html.plaintext.txt	25	analytical procedures protein concentrations determined either lowry procedure 40 absorbance coefficient 280 nm phospholipid concentrations determined enzymatic assay kit wako chemicals richmond va
0.3398514.15583000.html.plaintext.txt	26	analytical procedures protein concentrations determined either lowry procedure 40 absorbance coefficient 280 nm phospholipid concentrations determined enzymatic assay kit wako chemicals richmond va
0.3398514.15583000.html.plaintext.txt	27	results top abstract introduction experimental procedures results discussion references comparison apoe binding immobilized heparin heparin sepharose gel previously characterized effects point mutations lysines n c terminal heparin binding sites equilibrium binding heparin using heparin sepharose gel 22 study made spr measurements apoeheparin interaction examine real time binding kinetics fig 1a shows sensorgrams binding apoe c terminal fragments immobilized heparin sensor chip binding equilibrium achieved injection 10 12 kda fragments apoe determined binding isotherms relationship equilibrium binding response req protein concentration fig 1b isotherms similar obtained using heparin sepharose gel fig 1c calculated kd values methods comparable example kd apoe 10 kda fragmentheparin interaction 29 76 microgml fig 1 b c respectively results validate spr method studies apoeheparin interaction 41
0.3398514.15583000.html.plaintext.txt	28	results top abstract introduction experimental procedures results discussion references comparison apoe binding immobilized heparin heparin sepharose gel previously characterized effects point mutations lysines n c terminal heparin binding sites equilibrium binding heparin using heparin sepharose gel 22 study made spr measurements apoeheparin interaction examine real time binding kinetics fig 1a shows sensorgrams binding apoe c terminal fragments immobilized heparin sensor chip binding equilibrium achieved injection 10 12 kda fragments apoe determined binding isotherms relationship equilibrium binding response req protein concentration fig 1b isotherms similar obtained using heparin sepharose gel fig 1c calculated kd values methods comparable example kd apoe 10 kda fragmentheparin interaction 29 76 microgml fig 1 b c respectively results validate spr method studies apoeheparin interaction 41
0.3398514.15583000.html.plaintext.txt	29	view larger version 24k fig 1 comparison use spr sensor chips heparin sepharose gel determine apoeheparin interactions spr sensorgrams interaction apoe 10 kda 10 kda k233q mutant b 12 kda fragment c 30 microgml heparin immobilized sa sensor chip b steady state affinity analysis spr data c binding isotherms apoe 10 kda fragment 10 kda k233q mutant b 12 kda fragment c heparin sepharose gel replotted ref 22 ru resonance unit
0.3398514.15583000.html.plaintext.txt	30	kinetic analysis heparin binding full length apoe3 22 10 kda fragments fig 2 shows typical sensorgram binding full length apoe heparin kinetic data fitted well 11 langmuir binding model indicated large value goodness fit 2 100 fig 2 inset however significantly improved fit 2 74 obtained using two state binding model indicating binding apoe heparin involves either sequential two step process conformational change 36 37 response curve heparin binding apoe3 22 kda fragment also showed two state binding kinetics fig 3a changing injection time revealed dissociation rate progressively decreased longer injection contact time fig 3a inset indicating stability initial apoe heparin complex increases time 36 37 effect contact time dissociation rate seen apoe 10 kda binding heparin contribution second binding step overall process small fig 3b table summarizes kinetic rate constants derived affinity constants full length apoe3 22 10 kda fragments obtained using two state binding model good agreement kd values full length apoe3 data previous report 32 discrepancy apoe3 22 kda fragment 21 previous studies applied 11 langmuir binding model kinetic data addition kd value 10 kda fragment table 15 microgml similar obtained steady state analysis 29 microgml fig 1b validating two state binding model
0.3398514.15583000.html.plaintext.txt	31	kinetic analysis heparin binding full length apoe3 22 10 kda fragments fig 2 shows typical sensorgram binding full length apoe heparin kinetic data fitted well 11 langmuir binding model indicated large value goodness fit 2 100 fig 2 inset however significantly improved fit 2 74 obtained using two state binding model indicating binding apoe heparin involves either sequential two step process conformational change 36 37 response curve heparin binding apoe3 22 kda fragment also showed two state binding kinetics fig 3a changing injection time revealed dissociation rate progressively decreased longer injection contact time fig 3a inset indicating stability initial apoe heparin complex increases time 36 37 effect contact time dissociation rate seen apoe 10 kda binding heparin contribution second binding step overall process small fig 3b table summarizes kinetic rate constants derived affinity constants full length apoe3 22 10 kda fragments obtained using two state binding model good agreement kd values full length apoe3 data previous report 32 discrepancy apoe3 22 kda fragment 21 previous studies applied 11 langmuir binding model kinetic data addition kd value 10 kda fragment table 15 microgml similar obtained steady state analysis 29 microgml fig 1b validating two state binding model
0.3398514.15583000.html.plaintext.txt	32	view larger version 17k fig 2 two state binding apoe heparin detected spr measurements kinetics association dissociation sensorgram binding full length apoe3 30 microgml immobilized heparin experimental data fitted two state binding model b ab abx see experimental procedures simulated curves displaying initial binding ab subsequent binding conformational change abx additive components fitted curve inset shows result fitting 11 langmuir binding model dashed line ru resonance units
0.3398514.15583000.html.plaintext.txt	33	view larger version 25k fig 3 spr sensorgrams binding apoe3 22 kda 10 kda b fragments 30 microgml heparin experimental binding data fitted two state binding model component shown initial complex ab transferred complex ab insets show effect increased injection time stability apoe heparin complex a30s b60s c 120 d 180 ru resonance xunits
0.3398514.15583000.html.plaintext.txt	34	view table table kinetic parameters binding lipid free apoe3 fragments heparin
0.3398514.15583000.html.plaintext.txt	35	effects heparin binding secondary tertiary structure apoe examine possibility conformational change apoe occurs binding heparin far uv cd measurements employed evaluate secondary structure apoe shown fig 4 change spectra apoe 22 kda fragment observed absence presence heparin helix contents derived molar ellipticity 222 nm range 47 49 heparin apoe weight ratio 2 fig 4 inset indicating change secondary structure apoe upon heparin binding four helix bundle apoe 22 kda fragment known open upon lipid binding 27 28 confirm conformational change apoe involved two state binding heparin tested heparin binding triple interhelical disulfide linked apoe4 22 kda mutant opening four helix bundle completely restricted 27 spr sensorgrams heparin binding mutant still exhibited two state binding kinetics data shown indicating conformational change opening helix bundle involved two state binding apoeheparin interaction
0.3398514.15583000.html.plaintext.txt	36	view larger version 21k fig 4 far uv cd spectra apoe3 22 kda alone incubated heparin broken line protein heparin concentrations 25 microgml inset shows change helix content apoe3 22 kda function weight ratio heparin protein protein concentration 25 microgml
0.3398514.15583000.html.plaintext.txt	37	effects lysine mutations heparin binding sites apoe binding kinetics explore molecular mechanism two state heparin binding apoe used mutants substitutions lysines 146 233 residues located n c terminal heparin binding sites respectively contribute ionic interaction heparin 21 22 shown fig 5 large decreases binding responses observed apoe3 k146e mutant whereas apoe3 k233e mutant exhibited responses similar wild type wt consistent previous observations using heparin sepharose gel lys 146 plays dominant role heparin binding full length apoe 22 fig 6a summarizes relative changes rate constants mutant well mutants k146q k233q replacement lysines significantly affected first association rate effect rate constants second step relative contributions step overall free energy binding estimated affinity constants two individual steps fig 6b 42 although first binding step contributes largest part free energy binding proteins significant decreases favorable free energy binding first step observed k146q k146e mutants without changes second step
0.3398514.15583000.html.plaintext.txt	38	view larger version 23k fig 5 spr sensorgrams binding wt k146e b k233e c mutants full length apoe3 heparin experimental binding data fitted two state binding model dashed line ru resonance units
0.3398514.15583000.html.plaintext.txt	39	view larger version 39k fig 6 spr rate constants free energy binding interaction apoe3 mutants heparin relative change spr rate constants binding step apoe mutants heparin b free energy binding step apoe mutants heparin free energy calculated according g rt ln k using binding constants step k1 k2 p 005 p 001 compared wt apoe3
0.3398514.15583000.html.plaintext.txt	40	effects apoe isoform binding kinetics heparin compared association dissociation rate constants equilibrium dissociation constants binding apoe isoforms heparin previous spr study indicated three full length apoe isoforms similar affinities heparin 32 however shown fig 7a full length apoe2 exhibited somewhat slower first association rate higher kd value full length apoe3 regarding 22 kda fragments although apoe2 displayed slower rate apoe4 faster rate first association phase compared apoe3 kd values similar among three isoforms fig 7b overall results indicate apoe2 tends bind heparin somewhat less affinity apoe3 apoe4 slower first binding step
0.3398514.15583000.html.plaintext.txt	41	effects apoe isoform binding kinetics heparin compared association dissociation rate constants equilibrium dissociation constants binding apoe isoforms heparin previous spr study indicated three full length apoe isoforms similar affinities heparin 32 however shown fig 7a full length apoe2 exhibited somewhat slower first association rate higher kd value full length apoe3 regarding 22 kda fragments although apoe2 displayed slower rate apoe4 faster rate first association phase compared apoe3 kd values similar among three isoforms fig 7b overall results indicate apoe2 tends bind heparin somewhat less affinity apoe3 apoe4 slower first binding step
0.3398514.15583000.html.plaintext.txt	42	view larger version 29k fig 7 comparison spr rate constants interaction apoe isoforms heparin full length apoe apoe 22 kda fragments b p 005 compared apoe3
0.3398514.15583000.html.plaintext.txt	43	effects substitution basic residues disruption helical structure n terminal heparin binding site binding kinetics lipidated apoe previously determined structural requirements apoe receptor binding domain effective binding ldlr substituting basic residues disrupting helical structure region 30 examine possibility similar requirements necessary heparin binding used two apoe3 22 kda mutants spr measurements first k143rk146r mutant conservative substitution two lysines arginines decreases affinity ldlr 30 wt value second l141kk143lk146ll148k mutant exchange lysines leucines disrupts helical structure spanning residues 140 150 without altering net charge eliminates binding ldlr 30 lipid association required high affinity binding apoe ldlr 26 used discoidal complexes apoe 22 kda fragments spr measurements compare ldlr binding abilities apoe3 22 kda fragment dmpc discoidal complex displayed second order higher first association rate constant lipid free protein resulting much higher affinity binding heparin cf tables ii 22 among apoe isoforms complexed dmpc significant difference association dissociation rate constants equilibrium affinity table ii mutation k143rk146r effect kinetics affinity binding heparin indicating charge specificity basic residues required effective binding heparin contrast l141kk143lk146ll148k mutant exhibited much lower responses heparin binding wt apoe3 22 kda fragment lipidated state fig 8 suggesting amphipathic nature helix spanning residues 140 150 critical heparin binding apoe interestingly mutation led increased favorable free energy binding second step well decrease free energy first step fig 9 overall kd value significantly different wt table ii
0.3398514.15583000.html.plaintext.txt	44	effects substitution basic residues disruption helical structure n terminal heparin binding site binding kinetics lipidated apoe previously determined structural requirements apoe receptor binding domain effective binding ldlr substituting basic residues disrupting helical structure region 30 examine possibility similar requirements necessary heparin binding used two apoe3 22 kda mutants spr measurements first k143rk146r mutant conservative substitution two lysines arginines decreases affinity ldlr 30 wt value second l141kk143lk146ll148k mutant exchange lysines leucines disrupts helical structure spanning residues 140 150 without altering net charge eliminates binding ldlr 30 lipid association required high affinity binding apoe ldlr 26 used discoidal complexes apoe 22 kda fragments spr measurements compare ldlr binding abilities apoe3 22 kda fragment dmpc discoidal complex displayed second order higher first association rate constant lipid free protein resulting much higher affinity binding heparin cf tables ii 22 among apoe isoforms complexed dmpc significant difference association dissociation rate constants equilibrium affinity table ii mutation k143rk146r effect kinetics affinity binding heparin indicating charge specificity basic residues required effective binding heparin contrast l141kk143lk146ll148k mutant exhibited much lower responses heparin binding wt apoe3 22 kda fragment lipidated state fig 8 suggesting amphipathic nature helix spanning residues 140 150 critical heparin binding apoe interestingly mutation led increased favorable free energy binding second step well decrease free energy first step fig 9 overall kd value significantly different wt table ii
0.3398514.15583000.html.plaintext.txt	45	view table table ii kinetic parameters binding apoe 22 kda dmpc discs heparin
0.3398514.15583000.html.plaintext.txt	46	view larger version 24k fig 8 spr sensorgrams binding dmpc discoidal complexes apoe3 22 kda fragments l141kk143lk146ll148k mutant b heparin experimental binding data fitted two state binding model dashed line
0.3398514.15583000.html.plaintext.txt	47	view larger version 32k fig 9 comparison free energy heparin binding dmpc discoidal complexes apoe3 mutants free energy calculated according g rt ln k using binding constants step p 001 compared apoe3 22 kda fragment dmpc complexes
0.3398514.15583000.html.plaintext.txt	48	discussion top abstract introduction experimental procedures results discussion references ability apoe bind cell surface glycosaminoglycans including hspg heparin important lipoprotein remnant metabolism binding apoe heparin studied extensively 18 21 recently defined dominant role n terminal site residues 136 150 heparin binding lipid free lipid associated apoe 22 however structural requirements region basic residue organization amphipathic nature helix high affinity interaction apoe heparin opposed ldlr defined yet present study characterized kinetics interaction heparin apoe isoforms various mutants lacking effective ldlr binding affinity knowledge association dissociation rate constants obtained relevant understanding events cell surface many receptorligand interactions occur equilibrium
0.3398514.15583000.html.plaintext.txt	49	discussion top abstract introduction experimental procedures results discussion references ability apoe bind cell surface glycosaminoglycans including hspg heparin important lipoprotein remnant metabolism binding apoe heparin studied extensively 18 21 recently defined dominant role n terminal site residues 136 150 heparin binding lipid free lipid associated apoe 22 however structural requirements region basic residue organization amphipathic nature helix high affinity interaction apoe heparin opposed ldlr defined yet present study characterized kinetics interaction heparin apoe isoforms various mutants lacking effective ldlr binding affinity knowledge association dissociation rate constants obtained relevant understanding events cell surface many receptorligand interactions occur equilibrium
0.3398514.15583000.html.plaintext.txt	50	two step mechanism binding apoe heparin spr data indicate binding apoe heparin two state process involving sequential binding andor conformational change known protein binds heparin induce change conformation within heparin andor protein 43 interaction antithrombin heparin initial interaction induces conformational change antithrombin enables additional interactions antithrombin heparin resulting stronger binding 44 also evidence relatively flexible 2 sulfoiduronic acid residue heparin change conformation upon protein binding resulting better fit enhanced binding 43 however cd measurements apoeheparin mixture demonstrated heparin binding induce change secondary structure apoe fig 4 taken together spr data triple interhelical disulfide linked apoe4 22 kda mutant showing two state binding heparin appears two state apoeheparin interaction observed spr measurements due major conformational change apoe upon heparin binding
0.3398514.15583000.html.plaintext.txt	51	two step mechanism binding apoe heparin spr data indicate binding apoe heparin two state process involving sequential binding andor conformational change known protein binds heparin induce change conformation within heparin andor protein 43 interaction antithrombin heparin initial interaction induces conformational change antithrombin enables additional interactions antithrombin heparin resulting stronger binding 44 also evidence relatively flexible 2 sulfoiduronic acid residue heparin change conformation upon protein binding resulting better fit enhanced binding 43 however cd measurements apoeheparin mixture demonstrated heparin binding induce change secondary structure apoe fig 4 taken together spr data triple interhelical disulfide linked apoe4 22 kda mutant showing two state binding heparin appears two state apoeheparin interaction observed spr measurements due major conformational change apoe upon heparin binding
0.3398514.15583000.html.plaintext.txt	52	dominant type interaction heparin proteins ionic clusters basic residues proteins form ion pairs spatially defined acidic groups heparin 45 fact molecular modeling interaction heparin binding site apoe heparin fragment suggested eight polar residues including lys 146 directly contact sulfate carboxyl groups heparin chain 21 thus large reductions association rate favorable free energy first binding step lys 146 mutants fig 6 consistent first step involving fast electrostatic interaction basic residues apoe acidic groups heparin addition analysis dependence kd values sodium chloride concentration data shown using proteinpolyelectrolyte interaction theory 46 indicated 33 27 charged residues respectively involved electrostatic component overall first binding process apoeheparin interaction similarity two values also supports idea electrostatic interaction involved first binding step
0.3398514.15583000.html.plaintext.txt	53	dominant type interaction heparin proteins ionic clusters basic residues proteins form ion pairs spatially defined acidic groups heparin 45 fact molecular modeling interaction heparin binding site apoe heparin fragment suggested eight polar residues including lys 146 directly contact sulfate carboxyl groups heparin chain 21 thus large reductions association rate favorable free energy first binding step lys 146 mutants fig 6 consistent first step involving fast electrostatic interaction basic residues apoe acidic groups heparin addition analysis dependence kd values sodium chloride concentration data shown using proteinpolyelectrolyte interaction theory 46 indicated 33 27 charged residues respectively involved electrostatic component overall first binding process apoeheparin interaction similarity two values also supports idea electrostatic interaction involved first binding step
0.3398514.15583000.html.plaintext.txt	54	besides ionic interaction known significant contribution binding heparin nonionic interactions hydrogen bonding hydrophobic interactions cases 45 fact molecular modeling apoeheparin interaction predicts formation hydrogen bonding residues lys 143 apoe heparin also hydrophobic interaction shallow groove helix apoe saccharide chains heparin 21 regard significant increase contribution second step free energy binding observed l141kk143lk146ll148k mutant fig 9 disruption amphipathic helix heparin binding region destabilizes n terminal helix bundle exposes hydrophobic surface 30 implies hydrophobic interaction apoe heparin contributes second binding step addition found spr data interaction brain natriuretic peptide heparin major contribution free energy binding comes hydrogen bonding interaction 47 displayed two state binding first binding step contributed overall free energy binding data shown suggests hydrogen bonding may involved mostly first binding step
0.3398514.15583000.html.plaintext.txt	55	besides ionic interaction known significant contribution binding heparin nonionic interactions hydrogen bonding hydrophobic interactions cases 45 fact molecular modeling apoeheparin interaction predicts formation hydrogen bonding residues lys 143 apoe heparin also hydrophobic interaction shallow groove helix apoe saccharide chains heparin 21 regard significant increase contribution second step free energy binding observed l141kk143lk146ll148k mutant fig 9 disruption amphipathic helix heparin binding region destabilizes n terminal helix bundle exposes hydrophobic surface 30 implies hydrophobic interaction apoe heparin contributes second binding step addition found spr data interaction brain natriuretic peptide heparin major contribution free energy binding comes hydrogen bonding interaction 47 displayed two state binding first binding step contributed overall free energy binding data shown suggests hydrogen bonding may involved mostly first binding step
0.3398514.15583000.html.plaintext.txt	56	structural requirements receptor binding region apoe heparin interaction although lipid association required high affinity binding apoe ldlr 26 lipid free apoe bind effectively heparin table addition apoe2 highly defective ldlr binding 23 exhibited similar heparin binding activity apoe3 lipid free lipidated states fig 7 table ii results consistent previous observations requirements high affinity binding apoe hspgheparin less stringent binding ldlr 6 suggested multiple basic residues receptor binding region residues 136 150 apoe required particular orientation optimal binding ldlr 48 indeed comparison structure residues 135 151 lipid free lipid associated apoe showed significantly different curvature basic residues less scattered forming better aligned elongated hydrophilic surface lipidated form 49 50 addition nuclear magnetic resonance studies 29 51 demonstrated lipid interaction increases positive electrostatic potential around lysines 143 146 effects much less apoe2 taken together appears enhanced electrostatic potential around residues 136 150 apoe required interaction ldlr necessary high affinity binding heparin
0.3398514.15583000.html.plaintext.txt	57	structural requirements receptor binding region apoe heparin interaction although lipid association required high affinity binding apoe ldlr 26 lipid free apoe bind effectively heparin table addition apoe2 highly defective ldlr binding 23 exhibited similar heparin binding activity apoe3 lipid free lipidated states fig 7 table ii results consistent previous observations requirements high affinity binding apoe hspgheparin less stringent binding ldlr 6 suggested multiple basic residues receptor binding region residues 136 150 apoe required particular orientation optimal binding ldlr 48 indeed comparison structure residues 135 151 lipid free lipid associated apoe showed significantly different curvature basic residues less scattered forming better aligned elongated hydrophilic surface lipidated form 49 50 addition nuclear magnetic resonance studies 29 51 demonstrated lipid interaction increases positive electrostatic potential around lysines 143 146 effects much less apoe2 taken together appears enhanced electrostatic potential around residues 136 150 apoe required interaction ldlr necessary high affinity binding heparin
0.3398514.15583000.html.plaintext.txt	58	previous studies relative strengths heparin binding arginine lysine demonstrated former binds 25 times tightly 52 indeed found spr measurements lipid free substitution mutant k143rk146r displayed 26 times higher affinity heparin wt data shown however shown table ii double substitution lysines arginines effect kinetics affinity binding lipidated apoe heparin although mutant exhibits much reduced binding affinity ldlr 30 follows preference lysine arginine positions heparin binding lipid associated apoe disruption helical structure region 140 150 mutation l141kk143lk146ll148k greatly affected kinetics binding heparin fig 8 table ii mutant still displayed overall heparin binding affinity similar wt table ii suggests amphipathic helical structural motif receptor binding region apoe critical effective binding heparin contrast situation ldlr binding somewhat surprising results may arise appropriate arrangement basic residues required interaction heparin still maintained discoidal complex mutant presumably cooperative binding multiple copies heparin binding sites apoe molecules important determining heparin binding ability apoe bound lipid particles 22
0.3398514.15583000.html.plaintext.txt	59	implications sequestration role hspg remnant lipoprotein metabolism spr kinetic data apoeheparin interaction provide novel insights mechanism hspg lrp pathway remnant lipoprotein uptake cells fig 10 pathway apoe postulated interact initially cell surface hspg transfer lrp internalization 6 limited kinetic parameters apoelrp interaction available 33 compare kinetic parameters binding lipidated apoe heparin related ldlr 53 54 fast association lipidated apoe first binding step heparin long range nondirectional ionic interactions table ii follows apoe enriched remnant particles captured rapidly abundant hspg cell surface fast dissociation step likely allow rapid transfer remnant particles lrp associated closely hspg 55 lrp could retain remnant particles cell surface endocytosis occurs slow dissociation rate apoe receptor complex 10 5 1 53 process would efficient direct binding remnant particles solution lrp remnant particles concentrated cell surface could diffuse two dimensions rapidly exchanging hspg binding sites collide lrp form lrp remnant particle complex lateral diffusion cell surface reminiscent scooting mode proposed interfacial reaction phospholipases 56 also possible initial complexes hspg remnant particle would undergo second binding step forming stable complex internalization without lrp involvement
0.3398514.15583000.html.plaintext.txt	60	view larger version 9k fig 10 model two step kinetics remnant lipoprotein uptake hspg lrp pathway apoe enriched remnant lipoproteins first captured fast association apoe cell surface hspg fast dissociation rate interaction remnant lipoproteins rapidly transferred lrp form stable complex characterized slow dissociation endocytosis initial complexes hspg remnant particle would undergo second binding step forming stable complex internalization
0.3398514.15583000.html.plaintext.txt	61	summary characterized kinetics affinity interaction apoe heparin using spr data show binding apoe heparin two step process fast initial binding involving polar interaction followed relatively slow nonpolar interaction propose fast association dissociation process apoehspg interaction plays role hspg lrp pathway remnant lipoproteins rapidly captured hspg transferred lrp form stable complex internalization
0.3398514.15583000.html.plaintext.txt	62	summary characterized kinetics affinity interaction apoe heparin using spr data show binding apoe heparin two step process fast initial binding involving polar interaction followed relatively slow nonpolar interaction propose fast association dissociation process apoehspg interaction plays role hspg lrp pathway remnant lipoproteins rapidly captured hspg transferred lrp form stable complex internalization
0.3398514.15583000.html.plaintext.txt	63	footnotes work supported national institutes health grant hl56083 grants aid 12470489 14572045 scientific research japan society promotion science costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3398514.15583000.html.plaintext.txt	64	footnotes work supported national institutes health grant hl56083 grants aid 12470489 14572045 scientific research japan society promotion science costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.3398514.15583000.html.plaintext.txt	65	correspondence addressed childrens hospital philadelphia abramson research bldg suite 1102 3615 civic center blvd philadelphia pa 19104 4318 tel 215 590 0588 fax 215 590 0583 e mail katzatemailchopedu u d
0.3398514.15583000.html.plaintext.txt	66	correspondence addressed childrens hospital philadelphia abramson research bldg suite 1102 3615 civic center blvd philadelphia pa 19104 4318 tel 215 590 0588 fax 215 590 0583 e mail katzatemailchopedu u d
0.3398514.15583000.html.plaintext.txt	67	1 abbreviations used apoe apolipoprotein e dmpc 12 dimyristoyl phosphatidylcholine hspg heparan sulfate proteoglycan ldlr low density lipoprotein receptor lrp ldlr related protein spr surface plasmon resonance wt wild type cd circular dichroism
0.3398514.15583000.html.plaintext.txt	68	acknowledgments thank dr masashi hyuga national institute health sciences tokyo japan kaori morimoto biacore kk tokyo japan valuable suggestions spr measurements
0.3398514.15583000.html.plaintext.txt	69	acknowledgments thank dr masashi hyuga national institute health sciences tokyo japan kaori morimoto biacore kk tokyo japan valuable suggestions spr measurements
0.3398514.15583000.html.plaintext.txt	70	references top abstract introduction experimental procedures results discussion references mahley r w 1988 science 240 622 630medline order article via infotrieve weisgraber k h 1994 adv protein chem 45 249 302medline order article via infotrieve weisgraber k h mahley r w 1996 faseb j 10 1485 1494abstractfree full text strittmatter w j bova hill c 2002 curr opin lipidol 13 119 123crossrefmedline order article via infotrieve cooper d 1997 j lipid res 38 2173 2192abstract mahley r w ji z 1999 j lipid res 40 1 16abstractfree full text swertfeger d k hui d y 2001 front biosci 6 d526 d535medline order article via infotrieve zhu y hui d y 2003 j biol chem 278 36257 36263abstractfree full text swertfeger d k hui d y 2001 j biol chem 276 25043 25048abstractfree full text ji z pitas r e mahley r w 1998 j biol chem 273 13452 13460abstractfree full text mahley r w rall c jr 2000 annu rev genomics hum genet 1 507 537crossrefmedline order article via infotrieve bazin h g marques m owens p iii linhardt r j crutcher k 2002 biochemistry 41 8203 8211crossrefmedline order article via infotrieve saito h lund katz phillips m c 2004 prog lipid res 43 350 380crossrefmedline order article via infotrieve wilson c wardell m r weisgraber k h mahley r w agard d 1991 science 252 1817 1822medline order article via infotrieve narayanaswami v ryan r o 2000 biochim biophys acta 1483 15 36medline order article via infotrieve westerlund j weisgraber k h 1993 j biol chem 268 15745 15750abstractfree full text segrest j p garber d w brouillette c g harvey c anantharamaiah g m 1994 adv protein chem 45 303 369medline order article via infotrieve cardin d hirose n blankenship d jackson r l harmony j sparrow d sparrow j 1986 biochem biophys res commun 134 783 789medline order article via infotrieve weisgraber k h rall c jr mahley r w milne r w marcel y l sparrow j 1986 j biol chem 261 2068 2076abstractfree full text dong j peters libeu c weisgraber k h segelke b w rupp b capila hernaiz m j lebrun l linhardt r j 2001 biochemistry 40 2826 2834crossrefmedline order article via infotrieve libeu c p lund katz phillips m c wehrli hernaiz m j capila linhardt r j raffai r l newhouse y m zhou f weisgraber k h 2001 j biol chem 276 39138 39144abstractfree full text saito h dhanasekaran p nguyen d baldwin f weisgraber k h wehrli phillips m c lund katz 2003 j biol chem 278 14782 14787abstractfree full text mahley r w huang y rall c jr 1999 j lipid res 40 1933 1949abstractfree full text davignon j gregg r e sing c f 1988 arteriosclerosis 8 1 21abstract strittmatter w j roses d 1995 proc natl acad sci u 92 4725 4727abstractfree full text innerarity l pitas r e mahley r w 1979 j biol chem 254 4186 4190medline order article via infotrieve lu b morrow j weisgraber k h 2000 j biol chem 275 20775 20781abstractfree full text saito h dhanasekaran p baldwin f weisgraber k h lund katz phillips m c 2001 j biol chem 276 40949 40954abstractfree full text lund katz zaiou m wehrli dhanasekaran p baldwin f weisgraber k h phillips m c 2000 j biol chem 275 34459 34464abstractfree full text zaiou m arnold k newhouse y m innerarity l weisgraber k h segall m l phillips m c lund katz 2000 j lipid res 41 1087 1095abstractfree full text narita m holtzman d m fagan m ladu m j yu l han x gross r w bu g schwartz l 2002 j biochem tokyo 132 743 749abstract shuvaev v v laffont siest g 1999 febs lett 459 353 357crossrefmedline order article via infotrieve croy j e brandon komives e 2004 biochemistry 43 7328 7335crossrefmedline order article via infotrieve saito h dhanasekaran p baldwin f weisgraber k h phillips m c lund katz 2003 j biol chem 278 40723 40729abstractfree full text myszka d g 1997 curr opin biotechnol 8 50 57crossrefmedline order article via infotrieve karlsson r falt 1997 j immunol methods 200 121 133crossrefmedline order article via infotrieve lipschultz c li y smith gill 2000 methods 20 310 318crossrefmedline order article via infotrieve morrisett j d david j pownall h j gotto m jr 1973 biochemistry 12 1290 1299medline order article via infotrieve acharya p segall m l zaiou m morrow j weisgraber k h phillips m c lund katz snow j 2002 biochim biophys acta 1584 9 19medline order article via infotrieve lowry o h rosebrough n j farr l randall r j 1951 j biol chem 193 265 275free full text osmond r kett w c skett e coombe d r 2002 anal biochem 310 199 207medline order article via infotrieve papo n shai y 2004 biochemistry 43 6393 6403crossrefmedline order article via infotrieve munoz e m linhardt r j 2004 arterioscler thromb vasc biol 24 1549 1557abstractfree full text schedin weiss desai u r bock c olson bjork 2004 biochemistry 43 675 683crossrefmedline order article via infotrieve capila linhardt r j 2002 angew chem int ed engl 41 391 412medline order article via infotrieve olson halvorson h r bjork 1991 j biol chem 266 6342 6352abstractfree full text hileman r e jennings r n linhardt r j 1998 biochemistry 37 15231 15237crossrefmedline order article via infotrieve lalazar weisgraber k h rall c jr giladi h innerarity l levanon z boyles j k amit b gorecki m mahley r w 1988 j biol chem 263 3542 3545abstractfree full text raussens v slupsky c m ryan r o sykes b d 2002 j biol chem 277 29172 29180abstractfree full text prevost m raussens v 2004 proteins 55 874 884crossrefmedline order article via infotrieve lund katz wehrli zaiou m newhouse y weisgraber k h phillips m c 2001 j lipid res 42 894 901abstractfree full text fromm j r hileman r e caldwell e e weiler j m linhardt r j 1995 arch biochem biophys 323 279 287crossrefmedline order article via infotrieve pitas r e innerarity l arnold k mahley r w 1979 proc natl acad sci u 76 2311 2315abstract pitas r e innerarity l mahley r w 1980 j biol chem 255 5454 5460free full text wilsie l c orlando r 2003 j biol chem 278 15758 15764abstractfree full text berg o g yu b z rogers j jain m k 1991 biochemistry 30 7283 7297medline order article via infotrieve article abstract full text pdf versions article 28075414 recent m411719200v1 purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles futamura m articles saito h articles citing article pubmed pubmed citation articles futamura m articles saito h
0.3398514.15583000.html.plaintext.txt	71	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright 2005 american society biochemistry molecular biology
0.34268814.15576362.html.plaintext.txt	0	generation recombinant apolipoprotein e variant improved biological functions hydrophobic residues leu 261 trp 264 phe 265 leu 268 val 269 apoe account apoe induced hypertriglyceridemia kyriakos e kypreos ko w van dijk louis m havekes vassilis zannis
0.34268814.15576362.html.plaintext.txt	1	molecular genetics department medicine boston university school medicine boston massachusetts 02118 department human genetics leiden university medical center 2333al leiden netherlands department general internal medicine leiden university medical center 2333al leiden netherlands tno preventie en gezondheid prevention health gaubius laboratory leiden 2333ck netherlands department cardiology leiden university medical center 2333al leiden netherlands department biochemistry institute molecular biology biotechnology university crete medical school heraklion crete 71110 greece
0.34268814.15576362.html.plaintext.txt	2	received publication november 30 2004
0.34268814.15576362.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references identify residues carboxyl terminal region 260 299 human apolipoprotein e apoe contribute hypertriglyceridemia two sets conserved hydrophobic amino acids residues 261 283 mutated alanines recombinant adenoviruses expressing apoe mutants generated adenovirus mediated gene transfer apoe4 mut1 apoe4 l261a w264a f265a l268a v269a apoe deficient mice apoe corrected plasma cholesterol levels cause hypertriglyceridemia contrast gene transfer apoe4 mut2 apoe4 w276a l279a v280a v283a correct hypercholesterolemia induced mild hypertriglyceridemia apoe induced hyperlipidemia corrected co infection recombinant adenovirus expressing human lipoprotein lipase apoe4 mutants caused small increase hepatic low density lipoprotein triglyceride secretion density gradient ultracentrifugation analysis plasma electron microscopy showed wild type apoe4 apoe4 mut2 displaced apoa high density lipoprotein hdl region promoted formation discoidal hdl whereas apoe4 mut1 displace apoa hdl promoted formation spherical hdl findings indicate residues leu 261 trp 264 phe 265 leu 268 val 269 apoe responsible hypertriglyceridemia also interfere formation hdl substitutions residues alanine provide recombinant apoe form improved biological functions
0.34268814.15576362.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references identify residues carboxyl terminal region 260 299 human apolipoprotein e apoe contribute hypertriglyceridemia two sets conserved hydrophobic amino acids residues 261 283 mutated alanines recombinant adenoviruses expressing apoe mutants generated adenovirus mediated gene transfer apoe4 mut1 apoe4 l261a w264a f265a l268a v269a apoe deficient mice apoe corrected plasma cholesterol levels cause hypertriglyceridemia contrast gene transfer apoe4 mut2 apoe4 w276a l279a v280a v283a correct hypercholesterolemia induced mild hypertriglyceridemia apoe induced hyperlipidemia corrected co infection recombinant adenovirus expressing human lipoprotein lipase apoe4 mutants caused small increase hepatic low density lipoprotein triglyceride secretion density gradient ultracentrifugation analysis plasma electron microscopy showed wild type apoe4 apoe4 mut2 displaced apoa high density lipoprotein hdl region promoted formation discoidal hdl whereas apoe4 mut1 displace apoa hdl promoted formation spherical hdl findings indicate residues leu 261 trp 264 phe 265 leu 268 val 269 apoe responsible hypertriglyceridemia also interfere formation hdl substitutions residues alanine provide recombinant apoe form improved biological functions
0.34268814.15576362.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references apoe1 polymorphic protein humans 1 vitro vivo studies shown apoe mutants prevent binding apoe containing lipoproteins ldl receptor associated high plasma cholesterol levels cause premature atherosclerosis humans experimental animals 2 4 apoe promotes cholesterol efflux 5 6 thus may contribute cell tissue cholesterol homeostasis protection atherosclerosis 7 8 apoe also risk factor alzheimers disease 9 10 may contribute lipid homeostasis brain 11
0.34268814.15576362.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references apoe1 polymorphic protein humans 1 vitro vivo studies shown apoe mutants prevent binding apoe containing lipoproteins ldl receptor associated high plasma cholesterol levels cause premature atherosclerosis humans experimental animals 2 4 apoe promotes cholesterol efflux 5 6 thus may contribute cell tissue cholesterol homeostasis protection atherosclerosis 7 8 apoe also risk factor alzheimers disease 9 10 may contribute lipid homeostasis brain 11
0.34268814.15576362.html.plaintext.txt	7	series recent studies used adenoviruses expressing full length truncated genomic apoe sequences correct high cholesterol profile apoe deficient apoe mice shown overexpression full length apoe infection mice 1 2 x 109 pfu correct high cholesterol levels apoe mice contrast increased vldl triglyceride secretion induced hypertriglyceridemia 12 16 overexpression apoe3 apoe4 also aggravated hypercholesterolemia apoe2 knock mice 17 however high cholesterol profile apoe mice apoe2 knock mice corrected infection truncated apoe forms lacking different segments carboxyl terminal domain 12 17 hypertriglyceridemia induced full length apoe independent apoe phenotype mouse strain could corrected overexpression lipoprotein lipase 15 normal c57bl6 mice overexpression full length apoe induced combined hyperlipidemia characterized high cholesterol high triglycerides levels whereas truncated apoe forms change plasma lipid lipoprotein levels mice 13 finally truncated apoe forms could correct high cholesterol profiles apoe x ldlr double deficient mice induce hypertriglyceridemia indicating carboxyl terminal region apoe responsible hypertriglyceridemia 15 16 use series apoe deletion mutants extending amino acid 1 amino acids 185 202 229 259 mapped region responsible hypertriglyceridemia amino acids 260 299 apoe 12 17 region contains two hydrophobic stretches amino acids residues 261 269 276 283
0.34268814.15576362.html.plaintext.txt	8	series recent studies used adenoviruses expressing full length truncated genomic apoe sequences correct high cholesterol profile apoe deficient apoe mice shown overexpression full length apoe infection mice 1 2 x 109 pfu correct high cholesterol levels apoe mice contrast increased vldl triglyceride secretion induced hypertriglyceridemia 12 16 overexpression apoe3 apoe4 also aggravated hypercholesterolemia apoe2 knock mice 17 however high cholesterol profile apoe mice apoe2 knock mice corrected infection truncated apoe forms lacking different segments carboxyl terminal domain 12 17 hypertriglyceridemia induced full length apoe independent apoe phenotype mouse strain could corrected overexpression lipoprotein lipase 15 normal c57bl6 mice overexpression full length apoe induced combined hyperlipidemia characterized high cholesterol high triglycerides levels whereas truncated apoe forms change plasma lipid lipoprotein levels mice 13 finally truncated apoe forms could correct high cholesterol profiles apoe x ldlr double deficient mice induce hypertriglyceridemia indicating carboxyl terminal region apoe responsible hypertriglyceridemia 15 16 use series apoe deletion mutants extending amino acid 1 amino acids 185 202 229 259 mapped region responsible hypertriglyceridemia amino acids 260 299 apoe 12 17 region contains two hydrophobic stretches amino acids residues 261 269 276 283
0.34268814.15576362.html.plaintext.txt	9	present study hydrophobic residues regions mutated alanines functions mutant apoe forms studied vivo using adenovirus mediated gene transfer analysis showed residues leu 261 trp 264 phe 265 leu 268 ala 269 account apoe induced hypertriglyceridemia furthermore 261 269 apoe sequence responsible displacing apoa hdl region leading reduction plasma apoa hdl levels
0.34268814.15576362.html.plaintext.txt	10	present study hydrophobic residues regions mutated alanines functions mutant apoe forms studied vivo using adenovirus mediated gene transfer analysis showed residues leu 261 trp 264 phe 265 leu 268 ala 269 account apoe induced hypertriglyceridemia furthermore 261 269 apoe sequence responsible displacing apoa hdl region leading reduction plasma apoa hdl levels
0.34268814.15576362.html.plaintext.txt	11	experimental procedures top abstract introduction experimental procedures results discussion references construction recombinant adenoviruses expressing wild type mutant forms apoe4 two apoe4 mutants generated apoe4 mut1 apoe4 l261a w264a f265a l268a v269a apoe4 mut2 apoe4 w276a l279a v280a v283a using mutagenesis kit quikchange xl stratagene mutagenic primers used apoe4 mut1 5 gcc ttc cag gcc cgc gcc aag agc gcg gcc gag ccc gcg gcg gaa gac atg cag cgc 3 apoe4 mut1 5 gcg ctg cat gtc ttc cgc cgc ggg ctc ggc cgc gct ctt ggc gcg ggc ctg gaa ggc 3 apoe4 mut2 5 gac atg cag cgc cag gcg gcc ggg gcg gcg gag aag gcg cag gct gcc gt 3 apoe4 mut2 5 gcc cac ggc agc ctg cgc ctt ctc cgc cgc ccc ggc cgc ctg gcg ctg ca 3 nucleotides mutated various codons shown bold mutagenic reactions vector pgem7 apoe4 14 containing exons ii iii iv human apoe used template following 18 cycles pcr amplification template dna pcr product treated dpni digest plasmids containing methylated dna one strands reaction product consisting plasmids containing newly synthesized dna carrying mutations interest used transform competent xl 10 blue bacteria cells stratagene ampicillin resistant clones selected plasmid dna isolated clones subjected sequencing confirm presence point mutations
0.34268814.15576362.html.plaintext.txt	12	experimental procedures top abstract introduction experimental procedures results discussion references construction recombinant adenoviruses expressing wild type mutant forms apoe4 two apoe4 mutants generated apoe4 mut1 apoe4 l261a w264a f265a l268a v269a apoe4 mut2 apoe4 w276a l279a v280a v283a using mutagenesis kit quikchange xl stratagene mutagenic primers used apoe4 mut1 5 gcc ttc cag gcc cgc gcc aag agc gcg gcc gag ccc gcg gcg gaa gac atg cag cgc 3 apoe4 mut1 5 gcg ctg cat gtc ttc cgc cgc ggg ctc ggc cgc gct ctt ggc gcg ggc ctg gaa ggc 3 apoe4 mut2 5 gac atg cag cgc cag gcg gcc ggg gcg gcg gag aag gcg cag gct gcc gt 3 apoe4 mut2 5 gcc cac ggc agc ctg cgc ctt ctc cgc cgc ccc ggc cgc ctg gcg ctg ca 3 nucleotides mutated various codons shown bold mutagenic reactions vector pgem7 apoe4 14 containing exons ii iii iv human apoe used template following 18 cycles pcr amplification template dna pcr product treated dpni digest plasmids containing methylated dna one strands reaction product consisting plasmids containing newly synthesized dna carrying mutations interest used transform competent xl 10 blue bacteria cells stratagene ampicillin resistant clones selected plasmid dna isolated clones subjected sequencing confirm presence point mutations
0.34268814.15576362.html.plaintext.txt	13	recombinant adenoviruses constructed described 14 using ad easy 1 system adenovirus construct generated bacteria bj 5183 cells 18 correct clones propagated reca dh5 cells recombinant adenoviral vectors linearized paci used infect 911 cells 19 following large scale infection human embryonic kidney 293 cell cultures recombinant adenoviruses purified two consecutive cscl ultracentrifugation steps dialyzed titrated 14 usually titers 2 5 x 1010 pfuml obtained
0.34268814.15576362.html.plaintext.txt	14	recombinant adenoviruses constructed described 14 using ad easy 1 system adenovirus construct generated bacteria bj 5183 cells 18 correct clones propagated reca dh5 cells recombinant adenoviral vectors linearized paci used infect 911 cells 19 following large scale infection human embryonic kidney 293 cell cultures recombinant adenoviruses purified two consecutive cscl ultracentrifugation steps dialyzed titrated 14 usually titers 2 5 x 1010 pfuml obtained
0.34268814.15576362.html.plaintext.txt	15	cell culture studies human htb13 cells sw1783 human astrocytoma grown confluence medium containing 10 fetal calf serum infected adgfp e4 adenoviruses expressing mutant apoe forms adgfp e4 mut1 adgfp e4 mut2 multiplicity infection 5 twenty four hours postinfection cell washed twice phosphate buffered saline fresh serum free medium added 24 h incubation medium collected analyzed enzyme linked immunosorbent assay elisa sds page apoe expression
0.34268814.15576362.html.plaintext.txt	16	cell culture studies human htb13 cells sw1783 human astrocytoma grown confluence medium containing 10 fetal calf serum infected adgfp e4 adenoviruses expressing mutant apoe forms adgfp e4 mut1 adgfp e4 mut2 multiplicity infection 5 twenty four hours postinfection cell washed twice phosphate buffered saline fresh serum free medium added 24 h incubation medium collected analyzed enzyme linked immunosorbent assay elisa sds page apoe expression
0.34268814.15576362.html.plaintext.txt	17	animal studies female apoe deficient mice 4 6 weeks old used studies groups 8 10 female mice injected intravenously tail vein dose 2 x 109 pfu blood obtained tail vein 4 h fast preceding adenoviral injection 2 3 4 5 6 days postinfection aliquots plasma stored 4 20 degrees c
0.34268814.15576362.html.plaintext.txt	18	animal studies female apoe deficient mice 4 6 weeks old used studies groups 8 10 female mice injected intravenously tail vein dose 2 x 109 pfu blood obtained tail vein 4 h fast preceding adenoviral injection 2 3 4 5 6 days postinfection aliquots plasma stored 4 20 degrees c
0.34268814.15576362.html.plaintext.txt	19	rna analysis assess expression apoe4 apoe4 mut1 apoe4 mut2 infected mice least 3 mice group sacrificed 5 days postinfection livers collected individual animals frozen liquid nitrogen stored 80 degrees c total rna isolated livers analyzed apoe mrna expression northern blotting quantitated phosphorimaging 13
0.34268814.15576362.html.plaintext.txt	20	rna analysis assess expression apoe4 apoe4 mut1 apoe4 mut2 infected mice least 3 mice group sacrificed 5 days postinfection livers collected individual animals frozen liquid nitrogen stored 80 degrees c total rna isolated livers analyzed apoe mrna expression northern blotting quantitated phosphorimaging 13
0.34268814.15576362.html.plaintext.txt	21	fplc analysis lipid determination fplc analysis serum samples 12 microl serum diluted 15 phosphate buffered saline loaded onto superose 6 column smart micro fplc system amersham biosciences eluted phosphate buffered saline total 25 fractions 50 microl volume collected analysis triglycerides cholesterol determined using gpo trinder kit sigma chol mpr3 kit roche applied science according manufacturers instructions triglyceride cholesterol concentrations serum fplc fractions determined spectrophotometrically 540 492 nm respectively described previously 14
0.34268814.15576362.html.plaintext.txt	22	fplc analysis lipid determination fplc analysis serum samples 12 microl serum diluted 15 phosphate buffered saline loaded onto superose 6 column smart micro fplc system amersham biosciences eluted phosphate buffered saline total 25 fractions 50 microl volume collected analysis triglycerides cholesterol determined using gpo trinder kit sigma chol mpr3 kit roche applied science according manufacturers instructions triglyceride cholesterol concentrations serum fplc fractions determined spectrophotometrically 540 492 nm respectively described previously 14
0.34268814.15576362.html.plaintext.txt	23	quantification human apoe human apoe concentrations measured using sandwich elisa 12 15
0.34268814.15576362.html.plaintext.txt	24	rate vldl triglyceride production c57bl6 mice infected different apoe forms vldl triglyceride secretion determined following infection c57bl6 mice 2 x 109 pfu adenoviruses expressing either wt apoe4 apoe4 mut1 control adgfp adenovirus four days postinfection mice fasted 4 h injected triton wr 1339 dose 500 mgkg body weight using 15 solution wv 09 nacl triton wr 1339 shown completely inhibit vldl catabolism 20 serum samples isolated 20 40 60 90 min injection triton wr 1339 serum triglycerides measured rate vldl triglyceride secretion expressed mgdlmin determined described 14
0.34268814.15576362.html.plaintext.txt	25	rate vldl triglyceride production c57bl6 mice infected different apoe forms vldl triglyceride secretion determined following infection c57bl6 mice 2 x 109 pfu adenoviruses expressing either wt apoe4 apoe4 mut1 control adgfp adenovirus four days postinfection mice fasted 4 h injected triton wr 1339 dose 500 mgkg body weight using 15 solution wv 09 nacl triton wr 1339 shown completely inhibit vldl catabolism 20 serum samples isolated 20 40 60 90 min injection triton wr 1339 serum triglycerides measured rate vldl triglyceride secretion expressed mgdlmin determined described 14
0.34268814.15576362.html.plaintext.txt	26	statistical analysis comparison data two groups mice performed using students test
0.34268814.15576362.html.plaintext.txt	27	density gradient ultracentrifugation assess ability wt mutant apoe forms associate different lipoproteins 03 ml serum mice infected either control adenovirus adgfp adenoviruses expressing wt apoe4 apoe4 mut1 apoe4 mut2 brought volume 05 ml phosphate buffered saline adjusted density 123 gml kbr solution overlaid 1 ml 121 gml kbr 25 ml 1063 gml kbr 05 1019 gml kbr 05 ml saline mixture centrifuged 22 h sw 41 rotor 30000 rpm following ultracentrifugation 10 fractions 05 ml collected analyzed sds page
0.34268814.15576362.html.plaintext.txt	28	density gradient ultracentrifugation assess ability wt mutant apoe forms associate different lipoproteins 03 ml serum mice infected either control adenovirus adgfp adenoviruses expressing wt apoe4 apoe4 mut1 apoe4 mut2 brought volume 05 ml phosphate buffered saline adjusted density 123 gml kbr solution overlaid 1 ml 121 gml kbr 25 ml 1063 gml kbr 05 1019 gml kbr 05 ml saline mixture centrifuged 22 h sw 41 rotor 30000 rpm following ultracentrifugation 10 fractions 05 ml collected analyzed sds page
0.34268814.15576362.html.plaintext.txt	29	electron microscopy aliquots fractions equilibrium density gradient centrifugation dialysis ammonium acetate carbonate buffer stained sodium phosphotungstate visualized phillips cm 120 electron microscopy phillips electron optics eindhoven netherlands photographed described previously 11 photomicrographs taken x75000 magnification enlarged three times
0.34268814.15576362.html.plaintext.txt	30	electron microscopy aliquots fractions equilibrium density gradient centrifugation dialysis ammonium acetate carbonate buffer stained sodium phosphotungstate visualized phillips cm 120 electron microscopy phillips electron optics eindhoven netherlands photographed described previously 11 photomicrographs taken x75000 magnification enlarged three times
0.34268814.15576362.html.plaintext.txt	31	results top abstract introduction experimental procedures results discussion references full length apoe4 mutant apoe forms apoe4 mut1 apoe4 mut2 secreted efficiently htb 13 cells test expression relative levels secretion mutant apoe4 forms apoe4 mut1 apoe4 mut2 comparison wild type apoe4 htb 13 cells synthesize endogenous apoe infected recombinant adenoviruses expressing apoe4 apoe4 mut1 apoe4 mut2 control adenovirus adgfp multiplicity infection 5 analysis culture medium sds page fig 1 sandwich elisa showed apoe4 apoe4 mut1 apoe4 mut2 secreted efficiently comparable levels ranges 130 170 microg apoeml respectively 24 h postinfection
0.34268814.15576362.html.plaintext.txt	32	results top abstract introduction experimental procedures results discussion references full length apoe4 mutant apoe forms apoe4 mut1 apoe4 mut2 secreted efficiently htb 13 cells test expression relative levels secretion mutant apoe4 forms apoe4 mut1 apoe4 mut2 comparison wild type apoe4 htb 13 cells synthesize endogenous apoe infected recombinant adenoviruses expressing apoe4 apoe4 mut1 apoe4 mut2 control adenovirus adgfp multiplicity infection 5 analysis culture medium sds page fig 1 sandwich elisa showed apoe4 apoe4 mut1 apoe4 mut2 secreted efficiently comparable levels ranges 130 170 microg apoeml respectively 24 h postinfection
0.34268814.15576362.html.plaintext.txt	33	view larger version 55k fig 1 sds page analysis culture medium htb 13 cells infected control adenoviruses adenoviruses expressing wt apoe4 apoe4 mut1 apoe4 mut2 m indicates protein markers different molecular mass new england biolabs apoe levels assessed comparison intensity bands samples containing 05 5 microg bovine serum albumin
0.34268814.15576362.html.plaintext.txt	34	residues leu 261 trp 264 phe 265 leu 268 val 269 responsible apoe induced hypertriglyceridemia used adenovirus mediated gene transfer apoe mice assess effects wild type apoe4 two mutants apoe4 mut1 apoe4 mut2 forms induction hyperlipidemia vivo apoe mice infected either control adenovirus adgfp recombinant adenoviruses expressing wild type apoe4 mutant forms apoe4 mut1 contains point mutations l261a w264a f265a l268a v269a apoe4 mut2 contains point mutations w276a l279a v280a v283a blood samples collected 4 5 days postinfection analyzed plasma lipids levels analysis showed infection mice 2 x 109 pfu recombinant adenovirus expressing apoe4 apoe4 mut2 alter significantly plasma cholesterol levels 4 5 days postinfection induced hypertriglyceridemia compared mice infected control virus fig 2 non infected mice data shown apoe4 mut2 overexpression resulted mild hypertriglyceridemia compared wild type apoe4 fig 2 contrast infection mice recombinant adenovirus expressing apoe4 mut1 dose 2 x 109 greatly reduced plasma cholesterol levels 4 5 days postinfection cause hypertriglyceridemia fig 2
0.34268814.15576362.html.plaintext.txt	35	residues leu 261 trp 264 phe 265 leu 268 val 269 responsible apoe induced hypertriglyceridemia used adenovirus mediated gene transfer apoe mice assess effects wild type apoe4 two mutants apoe4 mut1 apoe4 mut2 forms induction hyperlipidemia vivo apoe mice infected either control adenovirus adgfp recombinant adenoviruses expressing wild type apoe4 mutant forms apoe4 mut1 contains point mutations l261a w264a f265a l268a v269a apoe4 mut2 contains point mutations w276a l279a v280a v283a blood samples collected 4 5 days postinfection analyzed plasma lipids levels analysis showed infection mice 2 x 109 pfu recombinant adenovirus expressing apoe4 apoe4 mut2 alter significantly plasma cholesterol levels 4 5 days postinfection induced hypertriglyceridemia compared mice infected control virus fig 2 non infected mice data shown apoe4 mut2 overexpression resulted mild hypertriglyceridemia compared wild type apoe4 fig 2 contrast infection mice recombinant adenovirus expressing apoe4 mut1 dose 2 x 109 greatly reduced plasma cholesterol levels 4 5 days postinfection cause hypertriglyceridemia fig 2
0.34268814.15576362.html.plaintext.txt	36	view larger version 22k fig 2 plasma cholesterol triglyceride apoe levels apoe mice infected recombinant adenoviruses expressing apoe4 apoe4 mut1 apoe4 mut2 control adgfp virus mice infected least triplicate indicated doses recombinant virus serum samples isolated analyzed cholesterol triglyceride levels b indicated days postinfection described experimental procedures apoe levels determined day 5 postinfection
0.34268814.15576362.html.plaintext.txt	37	expression apoe4 apoe4 mut1 apoe4 mut2 assessed mice group 5 days postinfection northern blotting apoe mrna quantitated phosphorimaging analysis showed apoe mrna levels three groups similar fig 3 however apoe4 mut1 cleared efficiently cholesterol apoe deficient mice without induction hypertriglyceridemia whereas full length apoe4 apoe4 mut2 correct cholesterol levels apoe mice induced hypertriglyceridemia fig 2
0.34268814.15576362.html.plaintext.txt	38	expression apoe4 apoe4 mut1 apoe4 mut2 assessed mice group 5 days postinfection northern blotting apoe mrna quantitated phosphorimaging analysis showed apoe mrna levels three groups similar fig 3 however apoe4 mut1 cleared efficiently cholesterol apoe deficient mice without induction hypertriglyceridemia whereas full length apoe4 apoe4 mut2 correct cholesterol levels apoe mice induced hypertriglyceridemia fig 2
0.34268814.15576362.html.plaintext.txt	39	view larger version 20k fig 3 steady state hepatic apoe mrna levels livers individual mice infected adenoviruses expressing apoe4 apoe4 mut2 apoe4 mut1 total rna isolated livers infected mice 5 days postinfection analyzed northern blotting phosphorimaging expression apoe glyceraldehyde 3 phosphate dehydrogenase gapdh mrna representative autoradiograms northern blot analysis total rna isolated livers individual mice infected indicated dose recombinant adenoviruses expressing apoe4 2 apoe4 mut1 wt apoe4 b apoe mrna levels quantified phosphorimager using imagequant program version 42a normalized glyceraldehyde 3 phosphate dehydrogenase mrna levels reported format bar graph mouse
0.34268814.15576362.html.plaintext.txt	40	apoe4 apoe4 mut2 overexpression results accumulation triglyceride rich vldl particles whereas overexpression apoe4 mut1 clears vldl fplc analysis plasma adenovirus infected mice showed mice expressing apoe4 apoe4 mut1 5 days postinfection cholesterol triglyceride levels high distributed predominantly vldl region fig 4 c d f contrast mice infected adgfp e4 mut1 cholesterol triglycerides low distributed lipoprotein fractions fig 4 b e additional control infection mice 2 x 109 pfu control virus adgfp result change cholesterol triglyceride profiles apoe mice data shown
0.34268814.15576362.html.plaintext.txt	41	view larger version 21k fig 4 fplc profiles serum cholesterol c triglycerides d f adenovirus infected mice serum samples obtained uninfected apoe deficient mice mice infected 2 x 109 pfu recombinant adenoviruses expressing wt apo e4 d apoe4 mut1 b e apoe4 mut2 c f 5 days postinfection fractionated fplc cholesterol levels c triglyceride levels d f fplc fraction determined described experimental procedures
0.34268814.15576362.html.plaintext.txt	42	apoe4 mut1 apoe4 mut2 modest effect rate hepatic vldl triglyceride secretion rate hepatic vldl triglyceride secretion plasma determined following injection triton wr 1339 5 days infection recombinant adenoviruses found consistent previous findings 12 16 rate triglyceride secretion increased 65 fold mice infected adenoviruses expressing wt apoe4 compared mice infected adgfp control mice infected adenoviruses expressing either apoe mut1 apoe4 mut2 rate vldl triglyceride secretion increased 19 fold compared mice infected control adenoviruses 27 rate vldl secretion observed mice infected apoe4 expressing adenovirus fig 5 findings suggest residues leu 261 trp 264 phe 265 leu 268 val 269 residues trp 276 leu 279 val 280 val 283 human apoe major effect secretion hepatic triglycerides altered less hydrophobic alanines rate triglyceride secretion diminished
0.34268814.15576362.html.plaintext.txt	43	apoe4 mut1 apoe4 mut2 modest effect rate hepatic vldl triglyceride secretion rate hepatic vldl triglyceride secretion plasma determined following injection triton wr 1339 5 days infection recombinant adenoviruses found consistent previous findings 12 16 rate triglyceride secretion increased 65 fold mice infected adenoviruses expressing wt apoe4 compared mice infected adgfp control mice infected adenoviruses expressing either apoe mut1 apoe4 mut2 rate vldl triglyceride secretion increased 19 fold compared mice infected control adenoviruses 27 rate vldl secretion observed mice infected apoe4 expressing adenovirus fig 5 findings suggest residues leu 261 trp 264 phe 265 leu 268 val 269 residues trp 276 leu 279 val 280 val 283 human apoe major effect secretion hepatic triglycerides altered less hydrophobic alanines rate triglyceride secretion diminished
0.34268814.15576362.html.plaintext.txt	44	view larger version 13k fig 5 hepatic vldl triglyceride tg secretion analysis mice infected either control adgfp adenovirus recombinant adenoviruses expressing wt apoe4 apoe4 mut1 apoe4 mut2 triton wr 1339 500 mgkg body weight injected 3 fasted micevirus group serum samples collected 20 40 60 90 min injection detergent control serum samples isolated 1 min immediately injection detergent serum triglyceride levels determined linear graph serum triglyceride concentration versus time generated rate vldl triglyceride secretion expressed mgdlmin calculated slope linear graph individual mouse mean plus minus sd individual rates vldl triglyceride secretionvirus group presented form bar graphs
0.34268814.15576362.html.plaintext.txt	45	co expression full length apoe4 apoe4 mut2 lipoprotein lipase normalizes lipid levels apoe mice test potential insufficiency activity lipoprotein lipase induction hypertriglyceridemia apoe mice co infected 2 x 109 pfu adenovirus expressing apoe4 apoe4 mut1 apoe4 mut2 5 x 108 pfu adenovirus expressing human lipoprotein lipase treatment corrected hypertriglyceridemia hypercholesterolemia occurs mice treated apoe4 apoe4 mut2 alone fig 6 b g h co infection apoe4 mut1 adenovirus expressing human lipoprotein lipase decreased slightly plasma cholesterol levels significant effect plasma triglyceride levels fig 6 d e findings indicated conditions overexpression apoe4 apoe4 mut2 endogenous lipoprotein lipase activity rate limiting lipolysis clearance vldl combined findings fig 2 b fig 4 b e fig 5 fig 6 d e suggest apoe4 mut1 reduces plasma lipid levels apoe mice affect significantly hepatic vldl triglyceride secretion negative effect activity lipoprotein lipase
0.34268814.15576362.html.plaintext.txt	46	co expression full length apoe4 apoe4 mut2 lipoprotein lipase normalizes lipid levels apoe mice test potential insufficiency activity lipoprotein lipase induction hypertriglyceridemia apoe mice co infected 2 x 109 pfu adenovirus expressing apoe4 apoe4 mut1 apoe4 mut2 5 x 108 pfu adenovirus expressing human lipoprotein lipase treatment corrected hypertriglyceridemia hypercholesterolemia occurs mice treated apoe4 apoe4 mut2 alone fig 6 b g h co infection apoe4 mut1 adenovirus expressing human lipoprotein lipase decreased slightly plasma cholesterol levels significant effect plasma triglyceride levels fig 6 d e findings indicated conditions overexpression apoe4 apoe4 mut2 endogenous lipoprotein lipase activity rate limiting lipolysis clearance vldl combined findings fig 2 b fig 4 b e fig 5 fig 6 d e suggest apoe4 mut1 reduces plasma lipid levels apoe mice affect significantly hepatic vldl triglyceride secretion negative effect activity lipoprotein lipase
0.34268814.15576362.html.plaintext.txt	47	view larger version 18k fig 6 plasma cholesterol triglyceride apoe levels apoe mice infected recombinant adenoviruses expressing either full length apoe4 apoe4 mut2 apoe4 mut1 alone mixture apoe4 apoe4 mut2 apoe4 mut1 human lipoprotein lipase determined 2 6 days postinfection mice infected indicated doses recombinant adenoviruses serum samples isolated analyzed plasma cholesterol d g triglyceride b e h apoe levels c f days 0 2 3 4 5 6 postinfection described experimental procedures
0.34268814.15576362.html.plaintext.txt	48	effects overexpression lipoprotein lipase plasma apoe levels mice infected adenoviruses expressing apoe4 apoe4 mut2 apoe4 mut1 lipoprotein lipase treatment different effect plasma apoe levels mice treated apoe4 compared mice treated either apoe4 mut2 apoe4 mut1 fig 6 thus apoe levels reduced average value 125 mgdl mice infected apoe4 expressing adenovirus 2 6 days postinfection average value 10 mgdl mice infected apoe4 lipoprotein lipase expressing adenoviruses fig 6c lipoprotein lipase treatment reduced apoe levels average value 150 mgdl mice treated apoe4 mut2 alone average value 40 mgdl mice treated apoe4 mut2 lipoprotein lipase fig 6i interesting greatest levels apoe days 2 3 postinfection apoe4 mut2 expressing adenovirus associated mild hypertriglyceridemia fig 6 h contrast apoe levels apoe4 mut1 remained high average value 170 mgdl without treatment lpl expressing adenovirus fig 6f
0.34268814.15576362.html.plaintext.txt	49	apoe4 apoe4 mut2 apoe4 mut1 displace apoa hdl region promote formation discoidal hdl particles establish ability apoe4 apoe4 mut1 apoe4 mut2 associate different lipoproteins 300 microl serum mice infected either recombinant adenoviruses expressing apoe4 apoe4 mut1 apoe4 mut2 fractionated density gradient ultracentrifugation fractions different densities isolated analyzed sds page followed either staining coomassie brilliant blue stain western blotting using anti apoe antibodies found full length apoe4 apoe4 mut1 apoe4 mut2 mutants associate lipoproteins float hdl region lesser extent particles ldl idl vldl regions remarkably however overexpression wt apoe4 apoe4 mut2 resulted displacement apoa hdl whereas overexpression apoe4 mut1 displace apoa hdl density region fig 7 estimated based sds page analysis apoa levels mice infected apoe4 mut1 appear similar apoe mice 90 apoa found hdl following density gradient ultracentrifugation fig 7 compare e
0.34268814.15576362.html.plaintext.txt	50	apoe4 apoe4 mut2 apoe4 mut1 displace apoa hdl region promote formation discoidal hdl particles establish ability apoe4 apoe4 mut1 apoe4 mut2 associate different lipoproteins 300 microl serum mice infected either recombinant adenoviruses expressing apoe4 apoe4 mut1 apoe4 mut2 fractionated density gradient ultracentrifugation fractions different densities isolated analyzed sds page followed either staining coomassie brilliant blue stain western blotting using anti apoe antibodies found full length apoe4 apoe4 mut1 apoe4 mut2 mutants associate lipoproteins float hdl region lesser extent particles ldl idl vldl regions remarkably however overexpression wt apoe4 apoe4 mut2 resulted displacement apoa hdl whereas overexpression apoe4 mut1 displace apoa hdl density region fig 7 estimated based sds page analysis apoa levels mice infected apoe4 mut1 appear similar apoe mice 90 apoa found hdl following density gradient ultracentrifugation fig 7 compare e
0.34268814.15576362.html.plaintext.txt	51	view larger version 26k fig 7 distribution apoe different lipoprotein fractions following density gradient ultracentrifugation plasma obtained apoe mice expressing wt apoe4 apoe4 mut1 apoe4 mut2 mice infected control adenoviruses fractionated density gradient ultracentrifugation analyzed sds page described experimental procedures analysis plasma obtained mice infected control adenovirus adgfp b c analyses plasma obtained apoe mice infected wt apoe4 concentrations plasma apoe e mice analyzed b c 60 233 mgdl respectively fraction numbers density fraction positions apoa apoe shown panel m indicates protein markers different mrs note depending levels apoe expression apoa ai either drastically reduced b totally displaced c hdl d e analyses apoe mice infected apoe4 mut2 apoe4 mut1 respectively
0.34268814.15576362.html.plaintext.txt	52	electron microscopy analysis fraction 6 8 containing apoa showed overexpression wt apoe4 apoe4 mut2 associated formation discoidal hdl particles whereas expression apoe4 mut1 similar levels associated formation spherical hdl particles fig 8 b d differences biogenesis catabolism vldl hdl apoe mice overexpress apoe4 apoe4 mut2 apoe4mut1 summarized fig 9
0.34268814.15576362.html.plaintext.txt	53	view larger version 153k fig 8 electron microscopy analysis hdl fractions obtained plasma mice infected control adenovirus adgfp adenoviruses expressing wt apoe4 b apoe4 mut2 c apoe4 mut1 d pooled hdl fractions 6 8 shown fig 7 c d e used electron microscopy analyses
0.34268814.15576362.html.plaintext.txt	54	view larger version 26k fig 9 schematic representation summarizing differences biosynthesis catabolism vldl hdl apoe mice overexpressing wt apoe4 two mutants apoe4 mut2 b apoe4 mut1 c
0.34268814.15576362.html.plaintext.txt	55	discussion top abstract introduction experimental procedures results discussion references previous vitro experiments shown residues 260 269 apoe important binding apoe lipids lipoproteins 11 deletion residues diminished greatly ability truncated apoe solubilize multilamellar dimyristoyl l phosphatidylcholine vesicles deletion residues 230 299 203 299 166 299 eliminated completely ability apoe solubilize multilamellar dimyristoyl l phosphatidylcholine vesicles 11 thus possible carboxyl terminal 260 299 amino acids apoe may involved initial association apoe phospholipid process may required formation apoe containing lipoproteins whether association apoe phospholipids vivo requires participation abca1 remains established apoe lipoprotein bound may taken ldl receptor
0.34268814.15576362.html.plaintext.txt	56	discussion top abstract introduction experimental procedures results discussion references previous vitro experiments shown residues 260 269 apoe important binding apoe lipids lipoproteins 11 deletion residues diminished greatly ability truncated apoe solubilize multilamellar dimyristoyl l phosphatidylcholine vesicles deletion residues 230 299 203 299 166 299 eliminated completely ability apoe solubilize multilamellar dimyristoyl l phosphatidylcholine vesicles 11 thus possible carboxyl terminal 260 299 amino acids apoe may involved initial association apoe phospholipid process may required formation apoe containing lipoproteins whether association apoe phospholipids vivo requires participation abca1 remains established apoe lipoprotein bound may taken ldl receptor
0.34268814.15576362.html.plaintext.txt	57	apoe ldl receptor interactions control plasma cholesterol levels confer protection atherosclerosis 2 contribution receptors ldl receptor clearance apoe containing lipoprotein remnants previously assessed studies apoe x ldlr double deficient mice 15 studies shown neither full length apoe2 apoe4 truncated apoe2 202 apoe4 202 corrected high cholesterol profiles apoe x ldlr double deficient mice 15 data observations full length apoe2 suggest strongly apoe mediated lipoprotein clearance mice carried mainly ldl receptor 15 absence receptor lipoprotein receptor related protein apoe recognizing lipoprotein receptors heparan sulfate proteoglycans 22 23 sufficient clear lipoprotein remnants accumulate plasma double deficient mice 15 addition role apoe cholesterol homeostasis circulation plasma apoe levels correlate plasma triglyceride levels humans 24
0.34268814.15576362.html.plaintext.txt	58	apoe ldl receptor interactions control plasma cholesterol levels confer protection atherosclerosis 2 contribution receptors ldl receptor clearance apoe containing lipoprotein remnants previously assessed studies apoe x ldlr double deficient mice 15 studies shown neither full length apoe2 apoe4 truncated apoe2 202 apoe4 202 corrected high cholesterol profiles apoe x ldlr double deficient mice 15 data observations full length apoe2 suggest strongly apoe mediated lipoprotein clearance mice carried mainly ldl receptor 15 absence receptor lipoprotein receptor related protein apoe recognizing lipoprotein receptors heparan sulfate proteoglycans 22 23 sufficient clear lipoprotein remnants accumulate plasma double deficient mice 15 addition role apoe cholesterol homeostasis circulation plasma apoe levels correlate plasma triglyceride levels humans 24
0.34268814.15576362.html.plaintext.txt	59	hypertriglyceridemia also induced mice overexpression human apoe 12 15 25 however recent studies shown hypertriglyceridemia occur mice infected adenoviruses expressing truncated apoe forms lacking 260 299 carboxyl terminal domain 12 16 set experiments also showed truncated apoe forms co expressed full length apoe forms dominant effect normalized cholesterol levels apoe mice 15
0.34268814.15576362.html.plaintext.txt	60	hypertriglyceridemia also induced mice overexpression human apoe 12 15 25 however recent studies shown hypertriglyceridemia occur mice infected adenoviruses expressing truncated apoe forms lacking 260 299 carboxyl terminal domain 12 16 set experiments also showed truncated apoe forms co expressed full length apoe forms dominant effect normalized cholesterol levels apoe mice 15
0.34268814.15576362.html.plaintext.txt	61	findings suggested full length apoe bound triglyceride rich vldl particles receptor binding domain may masked thus preventing direct apoe mediated clearance vldl particles prior lipolysis contrast truncated apoe bound triglyceride rich vldl particles receptor binding domain may exposed may allow direct clearance vldl particle 15
0.34268814.15576362.html.plaintext.txt	62	findings suggested full length apoe bound triglyceride rich vldl particles receptor binding domain may masked thus preventing direct apoe mediated clearance vldl particles prior lipolysis contrast truncated apoe bound triglyceride rich vldl particles receptor binding domain may exposed may allow direct clearance vldl particle 15
0.34268814.15576362.html.plaintext.txt	63	current study designed map residues carboxyl terminal region apoe responsible hypertriglyceridemia rationale identification residues may lead generation recombinant apoe form improved biological functions focused two regions apoe residues 260 299 contain hydrophobic amino acids first region includes amino acids leu 261 trp 264 phe 265 leu 268 val 269 second region includes amino acids trp 276 leu 279 val 280 val 283 blast search ncbi data base wwwncbierlmnihgov showed regions highly conserved among mammalian species vivo adenovirus mediated gene transfer two apoe mutants established unequivocally hydrophobic residues apoe amino acids 261 269 account large extent induction hypertriglyceridemia hypertriglyceridemia occur mice infected adenovirus expressing apoe4 mut1 residues changed alanines contrast infection mice adenovirus expressing apoe4 mut2 hydrophobic residues amino acids 276 283 substituted alanines resulted milder hypertriglyceridemia compared mice infected apoe4 expressing adenovirus
0.34268814.15576362.html.plaintext.txt	64	current study designed map residues carboxyl terminal region apoe responsible hypertriglyceridemia rationale identification residues may lead generation recombinant apoe form improved biological functions focused two regions apoe residues 260 299 contain hydrophobic amino acids first region includes amino acids leu 261 trp 264 phe 265 leu 268 val 269 second region includes amino acids trp 276 leu 279 val 280 val 283 blast search ncbi data base wwwncbierlmnihgov showed regions highly conserved among mammalian species vivo adenovirus mediated gene transfer two apoe mutants established unequivocally hydrophobic residues apoe amino acids 261 269 account large extent induction hypertriglyceridemia hypertriglyceridemia occur mice infected adenovirus expressing apoe4 mut1 residues changed alanines contrast infection mice adenovirus expressing apoe4 mut2 hydrophobic residues amino acids 276 283 substituted alanines resulted milder hypertriglyceridemia compared mice infected apoe4 expressing adenovirus
0.34268814.15576362.html.plaintext.txt	65	appears hydrophobic residues within 261 269 well 276 283 regions affect secretion vldl triglycerides mutations residues alanines reduced rate hepatic vldl triglyceride secretion 27 caused wild type apoe4
0.34268814.15576362.html.plaintext.txt	66	appears hydrophobic residues within 261 269 well 276 283 regions affect secretion vldl triglycerides mutations residues alanines reduced rate hepatic vldl triglyceride secretion 27 caused wild type apoe4
0.34268814.15576362.html.plaintext.txt	67	data also showed increase levels plasma lipoprotein lipase co infection recombinant adenoviruses expressing human lipoprotein lipase corrected apoe induced dyslipidemia apoe mice overexpress full length apoe4 finding suggests condition apoe overexpression activity lipoprotein lipase becomes rate limiting clearance hypertriglyceridemic vldl substantial less severe hypertriglyceridemia also observed overexpression apoe4 mut2 also corrected co infection lipoprotein lipase expressing adenovirus difference severity hypertriglyceridemia wt apoe4 apoe4 mut2 may related increased vldl triglyceride secretion caused wt apoe4
0.34268814.15576362.html.plaintext.txt	68	data also showed increase levels plasma lipoprotein lipase co infection recombinant adenoviruses expressing human lipoprotein lipase corrected apoe induced dyslipidemia apoe mice overexpress full length apoe4 finding suggests condition apoe overexpression activity lipoprotein lipase becomes rate limiting clearance hypertriglyceridemic vldl substantial less severe hypertriglyceridemia also observed overexpression apoe4 mut2 also corrected co infection lipoprotein lipase expressing adenovirus difference severity hypertriglyceridemia wt apoe4 apoe4 mut2 may related increased vldl triglyceride secretion caused wt apoe4
0.34268814.15576362.html.plaintext.txt	69	important clue nature hypertriglyceridemic lipoprotein particles accumulate plasma mice provided clearance apoe mice co infected wild type mutant forms apoe lpl expressing adenoviruses apoe cleared mice treated apoe4 lpl partially cleared mice treated apoe4 mut2 lpl unaffected mice treated apoe4 mut1 lpl average apoe levels without treatment lipoprotein lipase 2 6 days postinfection changed 125 mgdl 10 mgdl apoe4 150 mgdl 40 mgdl apoe4 mut2 remained 170 mgdl apoe4 mut1 findings indicate wild type apoe4 resides triglyceride rich lipoprotein particles following hydrolysis triglycerides particles lpl apoe4 recognized cleared component remnant particles ldl receptor appears majority mutant apoe4 mut1 may reside another population triglyceride poor particles cleared ldl receptor finally apoe4 mut2 may partitioned triglyceride rich particles processed lpl cleared ldl receptor triglyceride poor particles cleared ldl receptor possible mutations introduced apoe4 mut1 lesser extent apoe4 mut2 may promoted formation triglyceride poor apoe containing lipoprotein particles accumulate hdl region mice
0.34268814.15576362.html.plaintext.txt	70	important clue nature hypertriglyceridemic lipoprotein particles accumulate plasma mice provided clearance apoe mice co infected wild type mutant forms apoe lpl expressing adenoviruses apoe cleared mice treated apoe4 lpl partially cleared mice treated apoe4 mut2 lpl unaffected mice treated apoe4 mut1 lpl average apoe levels without treatment lipoprotein lipase 2 6 days postinfection changed 125 mgdl 10 mgdl apoe4 150 mgdl 40 mgdl apoe4 mut2 remained 170 mgdl apoe4 mut1 findings indicate wild type apoe4 resides triglyceride rich lipoprotein particles following hydrolysis triglycerides particles lpl apoe4 recognized cleared component remnant particles ldl receptor appears majority mutant apoe4 mut1 may reside another population triglyceride poor particles cleared ldl receptor finally apoe4 mut2 may partitioned triglyceride rich particles processed lpl cleared ldl receptor triglyceride poor particles cleared ldl receptor possible mutations introduced apoe4 mut1 lesser extent apoe4 mut2 may promoted formation triglyceride poor apoe containing lipoprotein particles accumulate hdl region mice
0.34268814.15576362.html.plaintext.txt	71	significant finding study apoe4 apoe4 mut2 w276a l279a v280a v283a displaced apoa hdl promoted formation discoidal hdl contrast apoe mut1 l261a w264a f265a l268a v269a displace apoa hdl region affect formation spherical hdl particles findings suggest wt apoe4 apoe4 mut2 overexpressed may influence formation stability hdl effect apoe mutations biosynthesis catabolism vldl hdl summarized fig 9 c
0.34268814.15576362.html.plaintext.txt	72	significant finding study apoe4 apoe4 mut2 w276a l279a v280a v283a displaced apoa hdl promoted formation discoidal hdl contrast apoe mut1 l261a w264a f265a l268a v269a displace apoa hdl region affect formation spherical hdl particles findings suggest wt apoe4 apoe4 mut2 overexpressed may influence formation stability hdl effect apoe mutations biosynthesis catabolism vldl hdl summarized fig 9 c
0.34268814.15576362.html.plaintext.txt	73	present time clear whether apoe overexpression interferes biogenesis hdl pathway involves abca1 transporter whether affects stability displacing apoa surface hdl processes expected reduce levels hdl undesirable property wt apoe reduce plasma hdl levels overcome recombinant apoe4 mut1 hydrophobic residues 261 269 region mutated alanines
0.34268814.15576362.html.plaintext.txt	74	present time clear whether apoe overexpression interferes biogenesis hdl pathway involves abca1 transporter whether affects stability displacing apoa surface hdl processes expected reduce levels hdl undesirable property wt apoe reduce plasma hdl levels overcome recombinant apoe4 mut1 hydrophobic residues 261 269 region mutated alanines
0.34268814.15576362.html.plaintext.txt	75	ability recombinant apoe forms apoe4 mut1 clear cholesterol without inducing hypertriglyceridemia interfering formation spherical hdl makes attractive therapeutic agents correct remnant removal disorders therapeutic forms apoe may involve pure recombinant protein associated liposomes potential gene therapy future
0.34268814.15576362.html.plaintext.txt	76	ability recombinant apoe forms apoe4 mut1 clear cholesterol without inducing hypertriglyceridemia interfering formation spherical hdl makes attractive therapeutic agents correct remnant removal disorders therapeutic forms apoe may involve pure recombinant protein associated liposomes potential gene therapy future
0.34268814.15576362.html.plaintext.txt	77	footnotes work supported grant hl68216 national institutes health kos pharmaceuticals grant lstclg978402 nato v z grant mcif 2000 02051 european union fifth framework program k e k costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.34268814.15576362.html.plaintext.txt	78	correspondence addressed section molecular genetics whitaker cardiovascular institute dept medicine boston university school medicine 700 albany st w 509 boston massachusetts 02118 tel 617 638 5085 fax 617 638 5141 e mail vzannisatbuedu u d
0.34268814.15576362.html.plaintext.txt	79	correspondence addressed section molecular genetics whitaker cardiovascular institute dept medicine boston university school medicine 700 albany st w 509 boston massachusetts 02118 tel 617 638 5085 fax 617 638 5141 e mail vzannisatbuedu u d
0.34268814.15576362.html.plaintext.txt	80	1 abbreviations used apoe apolipoprotein e apoa apolipoprotein ad adenovirus elisa enzyme linked immunosorbent assay fplc fast pressure liquid chromatography gfp green fluorescence protein hdl high density lipoprotein vldl low density lipoprotein lpl lipoprotein lipase pfu plaque forming unit wt wild type idl intermediate density lipoprotein apoe apoe deficient ldlr ldl receptor deficient
0.34268814.15576362.html.plaintext.txt	81	acknowledgments thank anne plunkett manuscript preparation adelina shkodrani gayle forbes andre van der zee technical assistance course experiments
0.34268814.15576362.html.plaintext.txt	82	references top abstract introduction experimental procedures results discussion references zannis v p w breslow j l 1981 j hum genet 33 11 24medline order article via infotrieve plump smith j d hayek aalto setala k walsh verstuyft j g rubin e m breslow j l 1992 cell 71 343 353medline order article via infotrieve schaefer e j gregg r e ghiselli g forte m ordovas j m zech l brewer h b jr 1986 j clin investig 78 1206 1219medline order article via infotrieve reddick r l zhang h maeda n 1994 arterioscler thromb 14 141 147abstract huang y von eckardstein wu maeda n assmann g 1994 proc natl acad sci u 91 1834 1838abstractfree full text huang y zhu y langer c raabe m wu wiesenhutter b seedorf u maeda n assmann g von eckardstein 1997 arterioscler thromb vasc biol 17 2010 2019abstractfree full text linton m f atkinson j b fazio 1995 science 267 1034 1037medline order article via infotrieve shimano h ohsuga j shimada m namba y gotoda harada k katsuki m yazaki y yamada n 1995 j clin investig 95 469 476medline order article via infotrieve myers r h schaefer e j wilson p w dagostino r ordovas j m espino au r white r f knoefel j e cobb j l mcnulty k beiser wolf p 1996 neurology 46 673 677abstract zannis v zanni e e makrides c kardassis d aleshkov 1998 nato asi series life sciences catravas j d ed pp 179 209 plenum press new york li x kypreos k zanni e e zannis v 2003 biochemistry 42 10406 10417crossrefmedline order article via infotrieve kypreos k e teusink b van dijk k w havekes l m zannis v 2001 faseb j 15 1598 1600abstractfree full text kypreos k e morani p van dijk k w havekes l m zannis v 2001 biochemistry 40 6027 6035crossrefmedline order article via infotrieve kypreos k e van dijk k w van der z havekes l m zannis v 2001 j biol chem 276 19778 19786abstractfree full text kypreos k e li x van dijk k w havekes l m zannis v 2003 biochemistry 42 9841 9853crossrefmedline order article via infotrieve zannis v chroni kypreos k e kan h y cesar b zanni e e kardassis d 2004 curr opin lipidol 15 151 166crossrefmedline order article via infotrieve gerritsen g kypreos k e van der z teusink b zannis v havekes l m van dijk k w 2003 j lipid res 44 408 414abstractfree full text c zhou da costa l yu j kinzler k w vogelstein b 1998 proc natl acad sci u 95 2509 2514abstractfree full text fallaux f j kranenburg o cramer j houweling van ormondt h hoeben r c van der eb j 1996 hum gene ther 7 215 222medline order article via infotrieve aalto setala k fisher e chen x chajek shaul hayek zechner r walsh ramakrishnan r ginsberg h n breslow j l 1992 j clin investig 90 1889 1900medline order article via infotrieve nolte r atkinson d 1992 biophys j 63 1221 1239abstract saito h dhanasekaran p nguyen d baldwin f weisgraber k h wehrli phillips m c lund katz 2003 j biol chem 278 14782 14787abstractfree full text ji z fazio lee y l mahley r w 1994 j biol chem 269 2764 2772abstractfree full text havel r j kotite l vigne j l kane j p tun p phillips n chen g c 1980 j clin investig 66 1351 1362medline order article via infotrieve huang y liu x q rall c jr taylor j m von eckardstein assmann g mahley r w 1998 j biol chem 273 26388 26393abstractfree full text
0.34592706.9302273.html.plaintext.txt	0	synergy genes butyrylcholinesterase k variant apolipoprotein e4 late onset confirmed alzheimers disease synergy genes butyrylcholinesterase k variant apolipoprotein e4 late onset confirmed alzheimers disease d j lehmann c johnston d smith
0.34592706.9302273.html.plaintext.txt	1	oxford project investigate memory ageing optima university department pharmacology mansfield rd oxford ox1 3qt uk radcliffe infirmary woodstock rd oxford ox2 6he uk
0.34592706.9302273.html.plaintext.txt	2	received july 3 1997 revised accepted july 31 1997
0.34592706.9302273.html.plaintext.txt	3	allelic frequency gene k variant butyrylcholinesterase bche k 017 74 subjects late onset age 65 years histopathologically diagnosed alzheimers disease ad higher frequencies 104 elderly control subjects 009 14 early onset cases confirmed ad 007 29 confirmed cases dementia 010 association bche k late onset ad limited carriers epsilon4 allele apolipoprotein e gene apoe among presence bche k gave odds ratio confirmed late onset ad 69 95 ci 165 29 subjects 65 years 128 19 86 subjects 75 years apoeepsilon4 carriers 75 years 122 controls compared 1024 confirmed late onset ad cases bche k suggest bche k nearby gene chromosome 3 acts synergy apoeepsilon4 susceptibility gene late onset ad introduction
0.34592706.9302273.html.plaintext.txt	4	allelic frequency gene k variant butyrylcholinesterase bche k 017 74 subjects late onset age 65 years histopathologically diagnosed alzheimers disease ad higher frequencies 104 elderly control subjects 009 14 early onset cases confirmed ad 007 29 confirmed cases dementia 010 association bche k late onset ad limited carriers epsilon4 allele apolipoprotein e gene apoe among presence bche k gave odds ratio confirmed late onset ad 69 95 ci 165 29 subjects 65 years 128 19 86 subjects 75 years apoeepsilon4 carriers 75 years 122 controls compared 1024 confirmed late onset ad cases bche k suggest bche k nearby gene chromosome 3 acts synergy apoeepsilon4 susceptibility gene late onset ad introduction
0.34592706.9302273.html.plaintext.txt	5	butyrylcholinesterase bche expressed human tissues 1 yet function unknown bche activity brain increases age 60 years elevated alzheimers disease ad 2 3 histochemically reactive bche associated amyloid plaques neurofibrillary tangles amyloid angiopathy ad 4 8 looked possible associations ad two common human variants gene bche bche atypical allele k variant bche k latter point mutation nucleotide 1615 gca aca changes ala539 threonine catalytic activity reduced third 9 bche k thought allelic frequency 012 caucasians 9 11 results
0.34592706.9302273.html.plaintext.txt	6	butyrylcholinesterase bche expressed human tissues 1 yet function unknown bche activity brain increases age 60 years elevated alzheimers disease ad 2 3 histochemically reactive bche associated amyloid plaques neurofibrillary tangles amyloid angiopathy ad 4 8 looked possible associations ad two common human variants gene bche bche atypical allele k variant bche k latter point mutation nucleotide 1615 gca aca changes ala539 threonine catalytic activity reduced third 9 bche k thought allelic frequency 012 caucasians 9 11 results
0.34592706.9302273.html.plaintext.txt	7	178 subjects genotyped three control subjects 104 three ad cases 74 identified heterozygotes atypical bche allele thus association found histopathologically confirmed ad atypical allele bche two six atypical bche heterozygotes carriers bche k
0.34592706.9302273.html.plaintext.txt	8	178 subjects genotyped three control subjects 104 three ad cases 74 identified heterozygotes atypical bche allele thus association found histopathologically confirmed ad atypical allele bche two six atypical bche heterozygotes carriers bche k
0.34592706.9302273.html.plaintext.txt	9	altogether 282 caucasian subjects genotyped bche k apoe alleles bche k common late onset ad cases early onset ad cases dementias controls table 1 subjects aged 65 allelic frequency bche k 009 104 controls 017 74 confirmed ad cases giving odds ratio ad 215 table 2 association appeared due subjects 75 years old frequency bche k 008 68 controls 019 36 confirmed ad cases chi2 yates correction 47 p 003 giving odds ratio ad 27 table 2 insufficient cases trend age reach significance nevertheless thought helpful show data 75 years subgroup well subjects 65 years table 2
0.34592706.9302273.html.plaintext.txt	10	altogether 282 caucasian subjects genotyped bche k apoe alleles bche k common late onset ad cases early onset ad cases dementias controls table 1 subjects aged 65 allelic frequency bche k 009 104 controls 017 74 confirmed ad cases giving odds ratio ad 215 table 2 association appeared due subjects 75 years old frequency bche k 008 68 controls 019 36 confirmed ad cases chi2 yates correction 47 p 003 giving odds ratio ad 27 table 2 insufficient cases trend age reach significance nevertheless thought helpful show data 75 years subgroup well subjects 65 years table 2
0.34592706.9302273.html.plaintext.txt	11	taking account individuals carrier status apoe epsilon4 produced striking results subjects 65 years without apoe epsilon4 allelic frequency bche k 014 22 confirmed ad cases 011 72 controls thus association bche k late onset ad subjects lacking apoe epsilon4 allele apoe epsilon4 carriers however bche k allelic frequencies subjects aged 65 years 018 52 confirmed ad cases 003 32 controls subjects aged 75 years frequencies 023 24 confirmed ad cases 002 22 controls results gave odds ratios confirmed ad 69 128 bche k apoe epsilon4 carriers aged 65 years 75 years respectively table 2 comparison give table 3 odds ratios confirmed ad apoe epsilon4 bche k carriers seen individuals bche k status markedly influences strength effect apoe epsilon4 table 4 shows striking differences cases controls proportions subjects carry bche k apoe epsilon4 alleles
0.34592706.9302273.html.plaintext.txt	12	taking account individuals carrier status apoe epsilon4 produced striking results subjects 65 years without apoe epsilon4 allelic frequency bche k 014 22 confirmed ad cases 011 72 controls thus association bche k late onset ad subjects lacking apoe epsilon4 allele apoe epsilon4 carriers however bche k allelic frequencies subjects aged 65 years 018 52 confirmed ad cases 003 32 controls subjects aged 75 years frequencies 023 24 confirmed ad cases 002 22 controls results gave odds ratios confirmed ad 69 128 bche k apoe epsilon4 carriers aged 65 years 75 years respectively table 2 comparison give table 3 odds ratios confirmed ad apoe epsilon4 bche k carriers seen individuals bche k status markedly influences strength effect apoe epsilon4 table 4 shows striking differences cases controls proportions subjects carry bche k apoe epsilon4 alleles
0.34592706.9302273.html.plaintext.txt	13	findings indicated interaction bche k apoe epsilon4 confirmed logistic regression analysis fitted several logistic regression models data found parsimonious model apoe epsilon4 bche k interaction gave adequate fit residual deviance 55 4 degrees freedom model apoe epsilon4 interaction bche k significantly associated ad bche k
0.34592706.9302273.html.plaintext.txt	14	findings indicated interaction bche k apoe epsilon4 confirmed logistic regression analysis fitted several logistic regression models data found parsimonious model apoe epsilon4 bche k interaction gave adequate fit residual deviance 55 4 degrees freedom model apoe epsilon4 interaction bche k significantly associated ad bche k
0.34592706.9302273.html.plaintext.txt	15	table 1 allelic frequencies bche k apoe epsilon4 subjects fm ratio
0.34592706.9302273.html.plaintext.txt	16	bche k allele frequency apoe epsilon4 allelefrequency controls 65 years 104 126 781 009 016 load cases 105 150 809 016 040 eoad cases 44 110 659 009 042 confirmed load 74 139 814 017 041 confirmed eoad 14 250 678 007 054 confirmed dementia 29 081 768 010 019 load eoad respectively late onset 65 years early onsetalzheimers disease bche k groups exact hardy weinberg equilibrium p 003 p 00001 chi2 yates correction versus controls aages death status confirmed last clinical assessment living subjects
0.34592706.9302273.html.plaintext.txt	17	table 2 odds ratios confirmed late onset alzheimers disease bche k alleles subjects controls cases odds ratioa 95 ci 65 years 104 74 215 11 425 75 years 68 36 27 11 68 apoe epsilon4 carriers 65 years 32 52 69 165 29 apoe epsilon4 carriers 75 years 22 24 128 19 86 ages tables 2 5 onset late onset ad cases controls death confirmed last clinical assessment living athese odds ratios based alleles equivalent odds ratios bche k based carriers 23 26 79 150
0.34592706.9302273.html.plaintext.txt	18	table 3 odds ratios confirmed late onset alzheimers disease apoe epsilon4 alleles subjects controls cases odds ratio 95 ci 65 years 104 74 36 22 59 75 years 68 36 28 14 55 bche k carriers 65 years 17 23 123 26 58 bche k carriers 75 years 11 12 150 195 115
0.34592706.9302273.html.plaintext.txt	19	table 4 proportions controls confirmed late onset ad cases bche k apoe epsilon4 alleles subjects proportions alleles controls cases p 65 years 2104 2 1874 24 00001 75 years 168 1 1036 28 00001 apoe epsilon4 carriers 65 years 232 6 1852 35 0007 apoe epsilon4 carriers 75 years 122 5 1024 42 0009 chi2 yates correction
0.34592706.9302273.html.plaintext.txt	20	table 4 proportions controls confirmed late onset ad cases bche k apoe epsilon4 alleles subjects proportions alleles controls cases p 65 years 2104 2 1874 24 00001 75 years 168 1 1036 28 00001 apoe epsilon4 carriers 65 years 232 6 1852 35 0007 apoe epsilon4 carriers 75 years 122 5 1024 42 0009 chi2 yates correction
0.34592706.9302273.html.plaintext.txt	21	table 5 odds ratios confirmed late onset ad taking subjects neither apoe epsilon4 bche k reference apoe epsilon4 bche k controls cases odds ratio 95 ci age 65 years 57 17 reference 15 5 11 ns 30 34 38 18 81 2 18 302 84 108 age 75 years 36 10 reference 10 2 07 ns 21 14 24 08 73 ns 1 10 360 61 211
0.34592706.9302273.html.plaintext.txt	22	order examine strength interaction bche k apoe epsilon4 give table 5 odds ratios confirmed ad subjects different combinations two genes taking subjects neither gene reference subjects 65 years odds ratio carry bche k 11 apoe epsilon4 38 gave predicted odds ratio 42 subjects genes assumption independent effects two genes compared observed value 302 subjects 75 years predicted odds ratio 17 observed odds ratio 36 therefore suggest strong synergy two alleles late onset ad discussion
0.34592706.9302273.html.plaintext.txt	23	order examine strength interaction bche k apoe epsilon4 give table 5 odds ratios confirmed ad subjects different combinations two genes taking subjects neither gene reference subjects 65 years odds ratio carry bche k 11 apoe epsilon4 38 gave predicted odds ratio 42 subjects genes assumption independent effects two genes compared observed value 302 subjects 75 years predicted odds ratio 17 observed odds ratio 36 therefore suggest strong synergy two alleles late onset ad discussion
0.34592706.9302273.html.plaintext.txt	24	apoe epsilon4 risk factor ad well established 12 13 results consistent hypothesis bche k associated increase risk late onset ad apoe epsilon4 carriers effect could due linkage disequilibrium another gene chromosome 3 conceivably transferrin whose c2 variant reported common 20 clinically diagnosed ad cases general population 14 bche 3q261 q262 15 gene transferrin 3q21 q25 16 hand effect late onset ad might mediated bche k biological plausibility
0.34592706.9302273.html.plaintext.txt	25	apoe epsilon4 risk factor ad well established 12 13 results consistent hypothesis bche k associated increase risk late onset ad apoe epsilon4 carriers effect could due linkage disequilibrium another gene chromosome 3 conceivably transferrin whose c2 variant reported common 20 clinically diagnosed ad cases general population 14 bche 3q261 q262 15 gene transferrin 3q21 q25 16 hand effect late onset ad might mediated bche k biological plausibility
0.34592706.9302273.html.plaintext.txt	26	various potential interactions bche apolipoprotein e apoe proteins produced quantity liver secreted circulation 1 17 apoe probably also bche interact lipoproteins 18 19 proteins found astrocytes 20 21 glia bche oligodendrocytes 22 apoe microglia 23 proteins occur ad plaques intra extracellular neurofibrillary tangles association amyloid angiopathy 7 8 24 25 furthermore bche apoe implicated certain models neurite growth 26 31 case apoe differences e3 e4 isoforms 29 31 case bche suggested nature attached sugar residues may important 26 28 noted k variant bche additional threonine residue position 539 whether potential o glycosylation site indeed phosphorylation site remains shown furthermore threonine residue high propensity beta sheet formation 32 lysozyme conversion isoleucine residue threonine causes amyloidosis 33 conversion alanine residue threonine transthyretin 34
0.34592706.9302273.html.plaintext.txt	27	various potential interactions bche apolipoprotein e apoe proteins produced quantity liver secreted circulation 1 17 apoe probably also bche interact lipoproteins 18 19 proteins found astrocytes 20 21 glia bche oligodendrocytes 22 apoe microglia 23 proteins occur ad plaques intra extracellular neurofibrillary tangles association amyloid angiopathy 7 8 24 25 furthermore bche apoe implicated certain models neurite growth 26 31 case apoe differences e3 e4 isoforms 29 31 case bche suggested nature attached sugar residues may important 26 28 noted k variant bche additional threonine residue position 539 whether potential o glycosylation site indeed phosphorylation site remains shown furthermore threonine residue high propensity beta sheet formation 32 lysozyme conversion isoleucine residue threonine causes amyloidosis 33 conversion alanine residue threonine transthyretin 34
0.34592706.9302273.html.plaintext.txt	28	evidence cited provides pointers future work test hypothesis bche apoe may interact interaction influenced allelic variants implications clinical genetics
0.34592706.9302273.html.plaintext.txt	29	evidence cited provides pointers future work test hypothesis bche apoe may interact interaction influenced allelic variants implications clinical genetics
0.34592706.9302273.html.plaintext.txt	30	replication findings particularly important since 6 caucasian population carry bche k apoe epsilon4 assuming respective allelic frequencies 012 9 11 015 17 35 thus subject confirmation results several millions elderly carry genes high risk developing ad especially aged 75 years pointed roses 36 ability identify risk individuals major social ethical implications since apoe epsilon4 established risk factor cardiovascular disease important see whether carriers also bche k greater risk cardiovascular disease study would clinical relevance could also increase understanding role vascular risk factors 37 aetiology ad materials methods
0.34592706.9302273.html.plaintext.txt	31	examined 282 caucasians oxford region recruited oxford project investigate memory ageing optima 38 eighty eight autopsy confirmed cerad 39 definite probable ad cases 74 late ie 65 years 14 early onset 29 pathologically confirmed cases dementias 12 vascular five parkinsons five non specific neurodegeneration three picks one progressive supranuclear palsy normal pressure hydrocephalus huntingtons glioma 61 living cases diagnosed possible ad probable ad nincdsadrda 40 criteria 31 late 30 early onset 104 controls without cognitive impairment camdex 41 scores 80 14 died ad pathology necropsy subjects genotyped blind diagnosis using blood samples pcr methods atypical k variants bche 42 apoe 43 acknowledgements
0.34592706.9302273.html.plaintext.txt	32	examined 282 caucasians oxford region recruited oxford project investigate memory ageing optima 38 eighty eight autopsy confirmed cerad 39 definite probable ad cases 74 late ie 65 years 14 early onset 29 pathologically confirmed cases dementias 12 vascular five parkinsons five non specific neurodegeneration three picks one progressive supranuclear palsy normal pressure hydrocephalus huntingtons glioma 61 living cases diagnosed possible ad probable ad nincdsadrda 40 criteria 31 late 30 early onset 104 controls without cognitive impairment camdex 41 scores 80 14 died ad pathology necropsy subjects genotyped blind diagnosis using blood samples pcr methods atypical k variants bche 42 apoe 43 acknowledgements
0.34592706.9302273.html.plaintext.txt	33	especially thank patients volunteers members optima department neuropathology radcliffe infirmary drs m cortina borja r clarke craig e sim work supported bristol myers squibb references 1 silver 1974 biology cholinesterases north holland publications amsterdam netherlands
0.34592706.9302273.html.plaintext.txt	34	correspondence addressed tel 44 1865 271883 fax 44 1865 271882 email davidsmithpharmoxacuk
0.34592706.9302273.html.plaintext.txt	35	correspondence addressed tel 44 1865 271883 fax 44 1865 271882 email davidsmithpharmoxacuk
0.3494895.15385439.html.plaintext.txt	0	allelic expression apoe human brain effects epsilon status promoter haplotypes nicholas j bray1 luke jehu1 valentina moskvina2 joseph d buxbaum3 stella dracheva3 vahram haroutunian34 julie williams12 paul r buckland1 michael j owen1 michael c odonovan1
0.3494895.15385439.html.plaintext.txt	1	allelic expression apoe human brain effects epsilon status promoter haplotypes nicholas j bray1 luke jehu1 valentina moskvina2 joseph d buxbaum3 stella dracheva3 vahram haroutunian34 julie williams12 paul r buckland1 michael j owen1 michael c odonovan1
0.3494895.15385439.html.plaintext.txt	2	1department psychological medicine 2biostatistics bioinformatics unit school medicine cardiff university cardiff cf14 4xn uk 3department psychiatry mount sinai school medicine new york ny 10021 usa 4mental illness research education clinical centres mirecc bronx veterans affairs medical centre bronx new york ny 10468 usa
0.3494895.15385439.html.plaintext.txt	3	received august 9 2004 accepted september 11 2004
0.3494895.15385439.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references 4 haplotype apoe undisputed genetic risk factor late onset alzheimers disease load proposed least two polymorphisms promoter apoe gene 219g 491a might also contribute disease susceptibility modulate impact structural changes apoe protein altering expression order assess extent cis acting influences apoe expression human brain highly quantitative measures allele discrimination applied cortical rna individuals heterozygous epsilon alleles small significant increase expression 4 allele observed relative 3 2 alleles p 00001 similar differences observed brain tissue confirmed load subjects cortical regions ba10 frontopolar ba20 inferior temporal stratification 43 allelic expression ratios according heterozygosity 219g promoter polymorphism revealed significantly lower relative expression haplotypes containing 219t allele p002 data indicate human brain cis acting variance apoe expression accounted 4 haplotype additional small cis acting influences associated promoter genotype
0.3494895.15385439.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references 4 haplotype apoe undisputed genetic risk factor late onset alzheimers disease load proposed least two polymorphisms promoter apoe gene 219g 491a might also contribute disease susceptibility modulate impact structural changes apoe protein altering expression order assess extent cis acting influences apoe expression human brain highly quantitative measures allele discrimination applied cortical rna individuals heterozygous epsilon alleles small significant increase expression 4 allele observed relative 3 2 alleles p 00001 similar differences observed brain tissue confirmed load subjects cortical regions ba10 frontopolar ba20 inferior temporal stratification 43 allelic expression ratios according heterozygosity 219g promoter polymorphism revealed significantly lower relative expression haplotypes containing 219t allele p002 data indicate human brain cis acting variance apoe expression accounted 4 haplotype additional small cis acting influences associated promoter genotype
0.3494895.15385439.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references apolipoprotein e apoe serves central role lipid metabolism major apolipoprotein synthesized brain 1 apoe protein exists three common isoforms designated apoe2 apoe3 apoe4 resulting two non synonymous single nucleotide polymorphisms apoe gene isoforms differentially impact variety biological parameters including plasma cholesterol levels 2 neurite outgrowth 3 amyloid deposition 4
0.3494895.15385439.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods references apolipoprotein e apoe serves central role lipid metabolism major apolipoprotein synthesized brain 1 apoe protein exists three common isoforms designated apoe2 apoe3 apoe4 resulting two non synonymous single nucleotide polymorphisms apoe gene isoforms differentially impact variety biological parameters including plasma cholesterol levels 2 neurite outgrowth 3 amyloid deposition 4
0.3494895.15385439.html.plaintext.txt	8	possession 4 allele apoe gene encoding apoe4 undisputed genetic risk factor common late onset form alzheimers disease load increasing risk dose dependent manner 56 however 4 allele neither necessary sufficient expression disease large proportion 4 homozygotes surviving 80 years show cognitive impairment 7 2 allele encoding apoe2 confers protective effect 8
0.3494895.15385439.html.plaintext.txt	9	possession 4 allele apoe gene encoding apoe4 undisputed genetic risk factor common late onset form alzheimers disease load increasing risk dose dependent manner 56 however 4 allele neither necessary sufficient expression disease large proportion 4 homozygotes surviving 80 years show cognitive impairment 7 2 allele encoding apoe2 confers protective effect 8
0.3494895.15385439.html.plaintext.txt	10	postulated addition structural changes apoe cis acting variation within apoe regulatory sequence might also contribute disease susceptibility influencing gene expression transgenic mouse models indicate apoe dosage significantly influence pathological hallmarks human alzheimers disease including amyloid deposition neuritic degeneration 910 furthermore cis acting regulatory variants human apoe potential influence load susceptibilty suggested study variation quantitative measures peripheral lipid metabolism better explained considering genotype data additional polymorphic sites vicinity apoe rather 2 4 status alone 11 however noted implications study alzheimers disease unknown unclear aspects apoe function indexed peripheral lipid metabolism relevant load pathogenesis moreover extent cis acting influences apoe expression human brain also currently unclear
0.3494895.15385439.html.plaintext.txt	11	postulated addition structural changes apoe cis acting variation within apoe regulatory sequence might also contribute disease susceptibility influencing gene expression transgenic mouse models indicate apoe dosage significantly influence pathological hallmarks human alzheimers disease including amyloid deposition neuritic degeneration 910 furthermore cis acting regulatory variants human apoe potential influence load susceptibilty suggested study variation quantitative measures peripheral lipid metabolism better explained considering genotype data additional polymorphic sites vicinity apoe rather 2 4 status alone 11 however noted implications study alzheimers disease unknown unclear aspects apoe function indexed peripheral lipid metabolism relevant load pathogenesis moreover extent cis acting influences apoe expression human brain also currently unclear
0.3494895.15385439.html.plaintext.txt	12	powerful method investigating cis acting influences gene expression involves comparing relative level mrna transcript individuals heterozygous expressed polymorphism within subjects approach allow detection genuine cis acting effects whilst controlling trans acting factors confound measures total expression samples one study using rflp based assay reported evidence intrinsic effects epsilon status apoe mrna expression brain 3 expression greatly increased relative 4 34 heterozygotes 12 elevated 3 expression observed load cases controls although former magnitude difference smaller however findings replicated subsequent study potential methodological shortcomings rflp based assays clearly demonstrated 13
0.3494895.15385439.html.plaintext.txt	13	powerful method investigating cis acting influences gene expression involves comparing relative level mrna transcript individuals heterozygous expressed polymorphism within subjects approach allow detection genuine cis acting effects whilst controlling trans acting factors confound measures total expression samples one study using rflp based assay reported evidence intrinsic effects epsilon status apoe mrna expression brain 3 expression greatly increased relative 4 34 heterozygotes 12 elevated 3 expression observed load cases controls although former magnitude difference smaller however findings replicated subsequent study potential methodological shortcomings rflp based assays clearly demonstrated 13
0.3494895.15385439.html.plaintext.txt	14	molecular genetic studies provide support association load two polymorphisms promoter apoe denoted 491a 219g also known th1e47cs 14 16 polymorphisms shown influence apoe expression vitro 17 raising possibility association direct result cis acting effects gene expression rather virtue linkage disequilibrium ld
0.3494895.15385439.html.plaintext.txt	15	molecular genetic studies provide support association load two polymorphisms promoter apoe denoted 491a 219g also known th1e47cs 14 16 polymorphisms shown influence apoe expression vitro 17 raising possibility association direct result cis acting effects gene expression rather virtue linkage disequilibrium ld
0.3494895.15385439.html.plaintext.txt	16	given importance apoe risk factor load potential importance variation apoe expression undertaken thorough investigation allelic expression apoe human brain using highly quantitative measures allele discrimination 1819 large series heterozygous samples objectives establish whether epsilon status influences apoe expression brain determine extent apoe expression subject cis acting influences particular effects promoter polymorphisms current interest alzheimers disease research
0.3494895.15385439.html.plaintext.txt	17	given importance apoe risk factor load potential importance variation apoe expression undertaken thorough investigation allelic expression apoe human brain using highly quantitative measures allele discrimination 1819 large series heterozygous samples objectives establish whether epsilon status influences apoe expression brain determine extent apoe expression subject cis acting influences particular effects promoter polymorphisms current interest alzheimers disease research
0.3494895.15385439.html.plaintext.txt	18	results top abstract introduction results discussion materials methods references analysed three sets samples comprising total 202 brain samples 142 unrelated individuals initial set 60 non ad samples 15 34 heterozygotes 11 23 heterozygotes two 24 heterozygotes eleven 34 heterozygotes identified second sample 22 load subjects 2 alleles observed thirteen third set 60 samples mixture psychiatric diagnosis used within subject comparisons brain regions 34 heterozygotes four 23 heterozygotes observed allele frequencies three groups shown table 1
0.3494895.15385439.html.plaintext.txt	19	results top abstract introduction results discussion materials methods references analysed three sets samples comprising total 202 brain samples 142 unrelated individuals initial set 60 non ad samples 15 34 heterozygotes 11 23 heterozygotes two 24 heterozygotes eleven 34 heterozygotes identified second sample 22 load subjects 2 alleles observed thirteen third set 60 samples mixture psychiatric diagnosis used within subject comparisons brain regions 34 heterozygotes four 23 heterozygotes observed allele frequencies three groups shown table 1
0.3494895.15385439.html.plaintext.txt	20	view table table 1 observed allele frequencies genotyped polymorphisms sample groups measures apoe allele specific expression performed using expressed snps 334t c 472c 3 allele determined haplotype 334t 472c 2 allele 334t 472t 4 allele 334c 472c use polymorphisms within mrna sequence permits discrimination alleles transcribed chromosome
0.3494895.15385439.html.plaintext.txt	21	corrected cdna ratios 34 23 heterozygotes shown table 2 analysis corrected cdna ratios initial sample 15 34 heterozygotes showed small significant elevation c allele snp 334t c 4 relative allele 3 three replication experiments repeat assays showed good reproducibility individual cdna allele ratios average co efficient variation sdmean 004 combining data 15 individuals across experiments expression 4 allele increased cdna average 14 relative 3 allele mean corrected ratio114 p 00001 individual ratios ranging 6 25 relative increase fig 1
0.3494895.15385439.html.plaintext.txt	22	corrected cdna ratios 34 23 heterozygotes shown table 2 analysis corrected cdna ratios initial sample 15 34 heterozygotes showed small significant elevation c allele snp 334t c 4 relative allele 3 three replication experiments repeat assays showed good reproducibility individual cdna allele ratios average co efficient variation sdmean 004 combining data 15 individuals across experiments expression 4 allele increased cdna average 14 relative 3 allele mean corrected ratio114 p 00001 individual ratios ranging 6 25 relative increase fig 1
0.3494895.15385439.html.plaintext.txt	23	view table figure 1 comparison corrected genomic cdna ratios assayed snp 334t c 34 subjects individuals c allele determines 4 allele determines 3 ratio therefore expressed level 43 column 2 shows cdna data points non ad cases n15 column 3 shows cdna data points confirmed load cases n11 data genomic dna averages two measurements individual sample data cdna averages six estimates individual sample non ad load cases level 4 significantly greater 3 cdna p 00001 differences observed extent allelic distortion non ad load cases p076
0.3494895.15385439.html.plaintext.txt	24	expression ratios derived 11 34 heterozygotes load sample yielded similar pattern average 15 relative increase 4 compared 3 expression p 00001 good reproducibility individual cdna ratios across assays sdmean004 averaged increases ranging 9 19 fig 1 significant differences observed ratios derived initial sample load cases p076
0.3494895.15385439.html.plaintext.txt	25	ratios obtained additional 13 34 heterozygotes tissue ba10 ba20 available showed significant increase expression 4 allele ba10 mean increase11 p 00001 ba20 mean increase10 p 00001 within subject comparisons two brain regions indicated significant differences extent allelic imbalance paired test p028
0.3494895.15385439.html.plaintext.txt	26	ratios obtained additional 13 34 heterozygotes tissue ba10 ba20 available showed significant increase expression 4 allele ba10 mean increase11 p 00001 ba20 mean increase10 p 00001 within subject comparisons two brain regions indicated significant differences extent allelic imbalance paired test p028
0.3494895.15385439.html.plaintext.txt	27	smaller difference observed relative expression 2 3 alleles snp 472c initial sample 11 23 heterozygotes fig 2 average increase 472c 3 allele 472t 2 allele across experiments 4 ratio104 ranging equal expression ratio1 10 relative increase 3 allele ratio110 although meets conventional criteria significance p004 increase relative 3 expression observed four 23 heterozygotes usa sample tissue derived either ba10 ba20 mean ratios100 099 respectively combining data 15 samples frontal cortex yielded mean 32 ratio 103 p006
0.3494895.15385439.html.plaintext.txt	28	view larger version 12k figure 2 comparison corrected genomic cdna ratios assayed snp 472c non ad 23 subjects n11 individuals c allele determines 3 allele determines 2 ratio therefore expressed level 32 data genomic dna averages two measurements individual sample data cdna averages six estimates individual sample level 3 allele slightly higher 2 cdna p004
0.3494895.15385439.html.plaintext.txt	29	view larger version 12k figure 2 comparison corrected genomic cdna ratios assayed snp 472c non ad 23 subjects n11 individuals c allele determines 3 allele determines 2 ratio therefore expressed level 32 data genomic dna averages two measurements individual sample data cdna averages six estimates individual sample level 3 allele slightly higher 2 cdna p004
0.3494895.15385439.html.plaintext.txt	30	two initial 60 samples 24 heterozygotes therefore heterozygous snps 334t c 472c allowed comparison allele ratios derived two separate assays absence alternative splicing comparable despite amplified assayed using different primer sets cdna ratios corrected average genomic assay 114 110 one sample 112 108 sample snps 334t c 472c respectively thus cases calculated ratios differed 4 two independent assays sample small statistical analysis expected observations relative expression 4 3 32 4 allele expressed higher level 2 case
0.3494895.15385439.html.plaintext.txt	31	two initial 60 samples 24 heterozygotes therefore heterozygous snps 334t c 472c allowed comparison allele ratios derived two separate assays absence alternative splicing comparable despite amplified assayed using different primer sets cdna ratios corrected average genomic assay 114 110 one sample 112 108 sample snps 334t c 472c respectively thus cases calculated ratios differed 4 two independent assays sample small statistical analysis expected observations relative expression 4 3 32 4 allele expressed higher level 2 case
0.3494895.15385439.html.plaintext.txt	32	investigate influence known promoter polymorphisms allelic expression 60 unrelated caucasians 22 caucasian load cases genotyped promoter snps 491a 219g observed allele frequencies presented table 1 although variants potential regulatory significance exist eg 427t c 113g c particular polymorphisms selected basis strongest prior evidence association load 16 sample used within subject comparisons brain regions included analysis ethnically heterogeneous use samples different genetic backgrounds potentially problematic calculating conditional diplotype probabilities diplotypes less likely follow hardy weinberg expectations
0.3494895.15385439.html.plaintext.txt	33	investigate influence known promoter polymorphisms allelic expression 60 unrelated caucasians 22 caucasian load cases genotyped promoter snps 491a 219g observed allele frequencies presented table 1 although variants potential regulatory significance exist eg 427t c 113g c particular polymorphisms selected basis strongest prior evidence association load 16 sample used within subject comparisons brain regions included analysis ethnically heterogeneous use samples different genetic backgrounds potentially problematic calculating conditional diplotype probabilities diplotypes less likely follow hardy weinberg expectations
0.3494895.15385439.html.plaintext.txt	34	determine variance relative 4 expression attributable heterozygosity promoter sites corrected cdna ratios obtained analysis 34 heterozygotes snp334t c stratified according whether individuals heterozygous homozygous two promoter loci
0.3494895.15385439.html.plaintext.txt	35	ratios derived 13 219g heterozygotes 13 219g homozygotes compared using two factorial anova load diagnosis included factor 13 219g homozygotes nine homozygous 219t allele four homozygous 219g allele average increase 4 allele relative 3 12 219g heterozygotes range 6 23 compared 16 219g homozygotes range 9 25 fig 3 significant main effect heterozygosity versus homozygosity 219g polymorphism observed p002 significant effect load diagnosis p043 knowledge phase required allow inference direction effect 219g alleles diplotypes unambiguous respect individuals homozygous promoter polymorphism heterozygous assayed site however given observed haplotype frequencies 219g t334t c double heterozygotes probability 219g nucleotide phase 334t 3 219t nucleotide phase 334c 4 085 219g heterozygotes showed reduced relative increase 4 expression compared 219g homozygotes case heterozygotes 219t allele predicted phase 4 allele 85 cases infer 219t allele associated reduced apoe expression compared 219g allele
0.3494895.15385439.html.plaintext.txt	36	ratios derived 13 219g heterozygotes 13 219g homozygotes compared using two factorial anova load diagnosis included factor 13 219g homozygotes nine homozygous 219t allele four homozygous 219g allele average increase 4 allele relative 3 12 219g heterozygotes range 6 23 compared 16 219g homozygotes range 9 25 fig 3 significant main effect heterozygosity versus homozygosity 219g polymorphism observed p002 significant effect load diagnosis p043 knowledge phase required allow inference direction effect 219g alleles diplotypes unambiguous respect individuals homozygous promoter polymorphism heterozygous assayed site however given observed haplotype frequencies 219g t334t c double heterozygotes probability 219g nucleotide phase 334t 3 219t nucleotide phase 334c 4 085 219g heterozygotes showed reduced relative increase 4 expression compared 219g homozygotes case heterozygotes 219t allele predicted phase 4 allele 85 cases infer 219t allele associated reduced apoe expression compared 219g allele
0.3494895.15385439.html.plaintext.txt	37	view larger version 13k figure 3 comparison corrected 43 cdna ratios 219g homozygotes 219g heterozygotes assayed snp 334t c ratios derived 34 heterozygotes also heterozygous snp 219g show lower ratios 43 expression 34 heterozygotes homozygous snp 219g p002
0.3494895.15385439.html.plaintext.txt	38	view larger version 13k figure 3 comparison corrected 43 cdna ratios 219g homozygotes 219g heterozygotes assayed snp 334t c ratios derived 34 heterozygotes also heterozygous snp 219g show lower ratios 43 expression 34 heterozygotes homozygous snp 219g p002
0.3494895.15385439.html.plaintext.txt	39	26 34 heterozygotes included analysis six heterozygous 491a polymorphism one homozygous 491t allele 19 homozygous 491a allele average increase 4 allele relative 3 16 491a heterozygotes range 9 25 compared 14 491a homozygotes range 6 23 fig 4 differences allele ratio approach statistical significance p057 significant effect load diagnosis p073 however given individual genotypes snps 334t c 219g four six 491a heterozygotes probability 491t nucleotide phase 334t 3 allele 491a nucleotide phase 334c 4 allele 061 phase probability much greater chance likely phase reversed proportion cases distorting directional effect 4 expression 491a heterozygote greatest phase certainty p099 predicted possess 491a nucleotide phase 219g 334c 4 491t nucleotide phase 219g 334t 3 sample individual homozygous high expression 219g allele whereas heterozygous 491a polymorphism showed greatest elevation relative 334c 4 expression assayed samples 25
0.3494895.15385439.html.plaintext.txt	40	26 34 heterozygotes included analysis six heterozygous 491a polymorphism one homozygous 491t allele 19 homozygous 491a allele average increase 4 allele relative 3 16 491a heterozygotes range 9 25 compared 14 491a homozygotes range 6 23 fig 4 differences allele ratio approach statistical significance p057 significant effect load diagnosis p073 however given individual genotypes snps 334t c 219g four six 491a heterozygotes probability 491t nucleotide phase 334t 3 allele 491a nucleotide phase 334c 4 allele 061 phase probability much greater chance likely phase reversed proportion cases distorting directional effect 4 expression 491a heterozygote greatest phase certainty p099 predicted possess 491a nucleotide phase 219g 334c 4 491t nucleotide phase 219g 334t 3 sample individual homozygous high expression 219g allele whereas heterozygous 491a polymorphism showed greatest elevation relative 334c 4 expression assayed samples 25
0.3494895.15385439.html.plaintext.txt	41	view larger version 13k figure 4 comparison corrected 43 cdna ratios 491a homozygotes 491a heterozygotes assayed snp 334t c significant differences observed two groups p057
0.3494895.15385439.html.plaintext.txt	42	view larger version 13k figure 4 comparison corrected 43 cdna ratios 491a homozygotes 491a heterozygotes assayed snp 334t c significant differences observed two groups p057
0.3494895.15385439.html.plaintext.txt	43	discussion top abstract introduction results discussion materials methods references using highly quantitative method allele discrimination 1819 compared relative expression apoe 2 3 4 alleles brain rna individual heterozygotes comparing relative expression alleles within individuals assay perfect internal control variables rna quality disease status exception multiplicative effects risk factors gene expression cell loss result degenerative changes trans acting effects loci environmental factors eg cause death drug treatment nutritional status etc variables expected influence allelic variant mrna equally assay therefore permits detection small cis acting influences gene expression even background large inter individual variation total gene expression feature previously observed studies total apoe mrna expression 20 advantage assay robust secondary effects gene expression example possession allele influences disease result impaired protein function might trans acting homeostatic mechanisms result compensatory increase gene expression
0.3494895.15385439.html.plaintext.txt	44	discussion top abstract introduction results discussion materials methods references using highly quantitative method allele discrimination 1819 compared relative expression apoe 2 3 4 alleles brain rna individual heterozygotes comparing relative expression alleles within individuals assay perfect internal control variables rna quality disease status exception multiplicative effects risk factors gene expression cell loss result degenerative changes trans acting effects loci environmental factors eg cause death drug treatment nutritional status etc variables expected influence allelic variant mrna equally assay therefore permits detection small cis acting influences gene expression even background large inter individual variation total gene expression feature previously observed studies total apoe mrna expression 20 advantage assay robust secondary effects gene expression example possession allele influences disease result impaired protein function might trans acting homeostatic mechanisms result compensatory increase gene expression
0.3494895.15385439.html.plaintext.txt	45	found increased expression 4 allele 3 allele 34 heterozygotes finding replicated two additional samples load subjects mixed population subjects neuropsychiatric disorders also observed small increase relative 3 expression 23 individuals finding replicate small number neuropsychiatric patients genotype observed although comprehensive survey different brain regions analysis frontal temporal cortex yielded evidence differences neuroanatomical region
0.3494895.15385439.html.plaintext.txt	46	found increased expression 4 allele 3 allele 34 heterozygotes finding replicated two additional samples load subjects mixed population subjects neuropsychiatric disorders also observed small increase relative 3 expression 23 individuals finding replicate small number neuropsychiatric patients genotype observed although comprehensive survey different brain regions analysis frontal temporal cortex yielded evidence differences neuroanatomical region
0.3494895.15385439.html.plaintext.txt	47	relatively small difference allele ratio observed 34 heterozygotes study stark contrast findings previous study 12 rflp based design used study large increase observed level 3 relative 4 mrna control load samples although smaller differences seen load group data compatible subsequent study 13 major differences expression two alleles found either control load 34 heterozygotes also notable subsequent study 13 average 4 relative increase 4 expression found maximum 22 using rflp based design similar previous study also showed estimation allele ratio using method critically dependent number pcr cycles due digestion resistant heteroduplex formation suggesting former results due artefact primer extension method used present study unaffected problem thus present data likely provide accurate estimate relative allelic expression brain apoe
0.3494895.15385439.html.plaintext.txt	48	relatively small difference allele ratio observed 34 heterozygotes study stark contrast findings previous study 12 rflp based design used study large increase observed level 3 relative 4 mrna control load samples although smaller differences seen load group data compatible subsequent study 13 major differences expression two alleles found either control load 34 heterozygotes also notable subsequent study 13 average 4 relative increase 4 expression found maximum 22 using rflp based design similar previous study also showed estimation allele ratio using method critically dependent number pcr cycles due digestion resistant heteroduplex formation suggesting former results due artefact primer extension method used present study unaffected problem thus present data likely provide accurate estimate relative allelic expression brain apoe
0.3494895.15385439.html.plaintext.txt	49	small increase 4 expression observed study could possibly reflect intrinsic effect alleles transcription efficiency rna stability alternatively finding may reflect strong ld 2 4 conferring haplotype untested regulatory variant may many 11 increased representation 4 allele unlikely resulted differences pcr primer extension efficiency controlled corrected concurrent assay genomic dna conditions although genomic control cannot applied limit potential confounding differential rt efficiency neither phenomenon likely explain observed differences 34 heterozygotes inter individual differences ratios largely preserved separate rt reactions
0.3494895.15385439.html.plaintext.txt	50	small increase 4 expression observed study could possibly reflect intrinsic effect alleles transcription efficiency rna stability alternatively finding may reflect strong ld 2 4 conferring haplotype untested regulatory variant may many 11 increased representation 4 allele unlikely resulted differences pcr primer extension efficiency controlled corrected concurrent assay genomic dna conditions although genomic control cannot applied limit potential confounding differential rt efficiency neither phenomenon likely explain observed differences 34 heterozygotes inter individual differences ratios largely preserved separate rt reactions
0.3494895.15385439.html.plaintext.txt	51	finding increased expression 4 allele rna level consistent recent study encoded apoe4 isoform found account elevated proportion total apoe protein csf 34 heterozygotes 21 finding contrast measures apoe4 plasma 221 associated lower protein expression suggesting important allele specific differences cns periphery control synthesis andor degradation apoe
0.3494895.15385439.html.plaintext.txt	52	finding increased expression 4 allele rna level consistent recent study encoded apoe4 isoform found account elevated proportion total apoe protein csf 34 heterozygotes 21 finding contrast measures apoe4 plasma 221 associated lower protein expression suggesting important allele specific differences cns periphery control synthesis andor degradation apoe
0.3494895.15385439.html.plaintext.txt	53	magnitude 4 expression found virtually identical initial sample sample confirmed load cases initial sample selected specific control group load sample although contain individual diagnosis ad possible individuals might developed disease survived old age however differences observed sample confirmed load cases consistent previous comparisons using age matched control groups terms relative 4 rna expression 13 relative level apoe4 protein 21 suggesting common risk factors load influence risk disease altering apoe expression selectively interact markedly increase expression specific apoe mrna species
0.3494895.15385439.html.plaintext.txt	54	magnitude 4 expression found virtually identical initial sample sample confirmed load cases initial sample selected specific control group load sample although contain individual diagnosis ad possible individuals might developed disease survived old age however differences observed sample confirmed load cases consistent previous comparisons using age matched control groups terms relative 4 rna expression 13 relative level apoe4 protein 21 suggesting common risk factors load influence risk disease altering apoe expression selectively interact markedly increase expression specific apoe mrna species
0.3494895.15385439.html.plaintext.txt	55	though significant influence cis acting polymorphisms steady state levels apoe mrna cerebral cortex small maximum relative difference expression observed study 25 56 apoe heterozygotes assayed study provided 99 power detect effect distinct regulatory variant occurring general population frequency 005 almost 90 power detect effect one present frequency 002 degree power effectively excludes existence even fairly rare polymorphisms around apoe exerting large direct effects net apoe mrna expression
0.3494895.15385439.html.plaintext.txt	56	though significant influence cis acting polymorphisms steady state levels apoe mrna cerebral cortex small maximum relative difference expression observed study 25 56 apoe heterozygotes assayed study provided 99 power detect effect distinct regulatory variant occurring general population frequency 005 almost 90 power detect effect one present frequency 002 degree power effectively excludes existence even fairly rare polymorphisms around apoe exerting large direct effects net apoe mrna expression
0.3494895.15385439.html.plaintext.txt	57	third objective study determine apoe mrna levels vivo influenced polymorphisms affect transcription activity vitro several studies associated load stratification observed 43 allele ratios according heterozygosity promoter polymorphisms indicated small statistically significant effect 219g polymorphism allelic expression consistent functional effect brain 219t allele previously associated reduced transcriptional activity vitro 17 reduced plasma apoe vivo 22 present finding reduced ratio 43 expression probability 4 allele phase 219t allele 3 allele phase 219g allele suggests 219t allele also decreases apoe expression brain measures total expression data allow us distinguish direct indirect association consistency finding vitro studies suggests direct effect
0.3494895.15385439.html.plaintext.txt	58	third objective study determine apoe mrna levels vivo influenced polymorphisms affect transcription activity vitro several studies associated load stratification observed 43 allele ratios according heterozygosity promoter polymorphisms indicated small statistically significant effect 219g polymorphism allelic expression consistent functional effect brain 219t allele previously associated reduced transcriptional activity vitro 17 reduced plasma apoe vivo 22 present finding reduced ratio 43 expression probability 4 allele phase 219t allele 3 allele phase 219g allele suggests 219t allele also decreases apoe expression brain measures total expression data allow us distinguish direct indirect association consistency finding vitro studies suggests direct effect
0.3494895.15385439.html.plaintext.txt	59	conditional probabilities diplotypes suggest 15 219g heterozygotes ie two 13 higher expression 219g allele phase 4 34 individuals know individual diplotypes analysis misclassified cannot accurately assess impact estimate magnitude effect however assume two heterozygotes displaying least reduction 43 ratio misclassified obtain estimate maximum possible size effect excluding analysis reveals mean net effect 219t allele 6 reduction relative 4 expression stress analysis provides guide maximum effect cannot conclude effect size compelling case exclude single individual analysis
0.3494895.15385439.html.plaintext.txt	60	491a allele 491a g promoter polymorphism reported show higher transcriptional activity vitro 17 associated increased measures total apoe expression plasma 23 brain 24 present study heterozygosity site significantly influence relative 4 expression one direction noted however power detect small directional effect would diminished small sample size low predicted consistency phase interestingly although single observation assayed samples one showing greatest elevation relative 334c 4 expression 25 also sample high probability 099 491a high expression predicted vitro nucleotide phase 219g high expression vitro study 334c high expression study
0.3494895.15385439.html.plaintext.txt	61	491a allele 491a g promoter polymorphism reported show higher transcriptional activity vitro 17 associated increased measures total apoe expression plasma 23 brain 24 present study heterozygosity site significantly influence relative 4 expression one direction noted however power detect small directional effect would diminished small sample size low predicted consistency phase interestingly although single observation assayed samples one showing greatest elevation relative 334c 4 expression 25 also sample high probability 099 491a high expression predicted vitro nucleotide phase 219g high expression vitro study 334c high expression study
0.3494895.15385439.html.plaintext.txt	62	study illustrates importance complementing vivo vitro work vitro work requires analysis effects variants alien genomic cellular contexts therefore findings must examined compatibility vivo nevertheless without vitro work associations observed impossible attribute vivo effects expression specific variants would require effect cis acting variants haplotype controlled effectively impossible task relevant variants could legion distributed across large genomic sequences
0.3494895.15385439.html.plaintext.txt	63	study illustrates importance complementing vivo vitro work vitro work requires analysis effects variants alien genomic cellular contexts therefore findings must examined compatibility vivo nevertheless without vitro work associations observed impossible attribute vivo effects expression specific variants would require effect cis acting variants haplotype controlled effectively impossible task relevant variants could legion distributed across large genomic sequences
0.3494895.15385439.html.plaintext.txt	64	summarize using relatively large series brain samples demonstrated common influences apoe expression attributable cis acting polymorphism small also effectively excluded existence even fairly rare cis acting haplotypes large effect variance occur accounted 4 haplotype 4 allele apoe expressed significantly higher level 3 highly reproducible appears independent ad status also shown 219g promoter allele associated higher expression apoe mrna vivo finding compatible previous vitro studies study provides important functional vivo plausibility existing body association data suggesting 219t promoter polymorphism may modulate risk ad independent apoe epsilon status 16 however though demonstration functionality enhances case strong genetic support samples larger currently available single group required force conclusion extremely small effects observed relevant load susceptibility
0.3494895.15385439.html.plaintext.txt	65	summarize using relatively large series brain samples demonstrated common influences apoe expression attributable cis acting polymorphism small also effectively excluded existence even fairly rare cis acting haplotypes large effect variance occur accounted 4 haplotype 4 allele apoe expressed significantly higher level 3 highly reproducible appears independent ad status also shown 219g promoter allele associated higher expression apoe mrna vivo finding compatible previous vitro studies study provides important functional vivo plausibility existing body association data suggesting 219t promoter polymorphism may modulate risk ad independent apoe epsilon status 16 however though demonstration functionality enhances case strong genetic support samples larger currently available single group required force conclusion extremely small effects observed relevant load susceptibility
0.3494895.15385439.html.plaintext.txt	66	materials methods top abstract introduction results discussion materials methods references samples initial experiments performed using post mortem frontal temporal cortex 60 unrelated anonymized caucasians 50 uk mrc london neurodegenerative diseases brain bank 10 sweden department clinical neuroscience karolinska institute stockholm free diagnosis psychiatric neurological disorder time death 15 34 heterozygotes 12m 3f mean age55 sd20 11 23 heterozygotes 9m 4f mean age61 sd18 two 24 heterozygotes 2f mean age65 sd35 load sample consisted post mortem temporal cortex 22 unrelated anonymized uk caucasians neuropathological diagnosis late onset load obtained mrc london neurodegenerative diseases brain bank 11 34 heterozygotes 3m 8f mean age77 sd12 2 heterozygotes observed within subject comparisons expression brain regions made using sample 13 34 heterozygotes 10m 3f drawn additional 60 unrelated anonymized individuals mixed ethnicity mixed neuropsychiatric diagnoses usa mount sinai school medicine department psychiatry alzheimers disease schizophrenia brain bank also four 23 heterozygotes 2m 2f tissue available cortical regions ba10 frontopolar ba20 inferior temporal 60 individuals samples genomic dna extracted using standard phenol chloroform procedures total rna extracted using rnawiztm isolation reagent ambion total rna treated dnase prior reverse transcription using random decamers retroscripttm kit ambion
0.3494895.15385439.html.plaintext.txt	67	materials methods top abstract introduction results discussion materials methods references samples initial experiments performed using post mortem frontal temporal cortex 60 unrelated anonymized caucasians 50 uk mrc london neurodegenerative diseases brain bank 10 sweden department clinical neuroscience karolinska institute stockholm free diagnosis psychiatric neurological disorder time death 15 34 heterozygotes 12m 3f mean age55 sd20 11 23 heterozygotes 9m 4f mean age61 sd18 two 24 heterozygotes 2f mean age65 sd35 load sample consisted post mortem temporal cortex 22 unrelated anonymized uk caucasians neuropathological diagnosis late onset load obtained mrc london neurodegenerative diseases brain bank 11 34 heterozygotes 3m 8f mean age77 sd12 2 heterozygotes observed within subject comparisons expression brain regions made using sample 13 34 heterozygotes 10m 3f drawn additional 60 unrelated anonymized individuals mixed ethnicity mixed neuropsychiatric diagnoses usa mount sinai school medicine department psychiatry alzheimers disease schizophrenia brain bank also four 23 heterozygotes 2m 2f tissue available cortical regions ba10 frontopolar ba20 inferior temporal 60 individuals samples genomic dna extracted using standard phenol chloroform procedures total rna extracted using rnawiztm isolation reagent ambion total rna treated dnase prior reverse transcription using random decamers retroscripttm kit ambion
0.3494895.15385439.html.plaintext.txt	68	genotyping genotyping apoe 234 performed using rflp based assay described previously 25 genotyping snp 491a performed using snapshot primer extension amplification primers 5 gcctagccccactttctttt 3 5 cacagtgggcgaatcactta 3 extension primer 5 cgaatcacttaaggtcaggag 3 snp 219g genotyped using primers 5 agaatggaggagggtgtccg 3 5 actcaaggatcccagacttg 3 followed restriction digestion hpaii econ1
0.3494895.15385439.html.plaintext.txt	69	genotyping genotyping apoe 234 performed using rflp based assay described previously 25 genotyping snp 491a performed using snapshot primer extension amplification primers 5 gcctagccccactttctttt 3 5 cacagtgggcgaatcactta 3 extension primer 5 cgaatcacttaaggtcaggag 3 snp 219g genotyped using primers 5 agaatggaggagggtgtccg 3 5 actcaaggatcccagacttg 3 followed restriction digestion hpaii econ1
0.3494895.15385439.html.plaintext.txt	70	allele expression assay genomic dna subjects initially genotyped described order identify heterozygotes snps 334t c 4 heterozygotes 472c 2 heterozygotes individual allelic expression experiment cdna heterozygotes assayed two separate rt reactions alongside duplicates corresponding genomic dna samples experiment repeated two separate occasions ie total three experiments dnase treated rna samples yield detectable product absence rt step assays relative 4 expression 182 bp fragment containing snp 334t c amplified cdna genomic dna using primers 5 gcctacaaatcggaactgga 3 5 agctcctcggtgctctgg 3 assays relative 2 expression 67 bp fragment containing snp 472c amplified cdna genomic dna using primers 5 ctgcgtaagcggctcctc 3 5 ccccggcctggtacactg 3 pcrs carried total reaction volume 12 microl containing either cdna genomic dna template 1xpcr buffer dntps 01 mm primers 024 mm 03 u hot star taq polymerase qiagen 6 dmso 35 cycles annealing temperature 60 degrees c amplified samples incubated 1 u shrimp alkaline phosphatase amersham 2 u exonuclease amersham 45 min 37 degrees c 15 min 85 degrees c prior primer extension reactions primer extension carried using snapshot multiplex kit applied biosystems extension primer snp 334t c 5 gcgcggacatggaggacgtg 3 extension primer snp 472c 5 ccgatgacctgcagaag 3 primer extension reactions performed total volume 10 microl containing 2 microl treated pcr product 45 microl snapshot kit 25 microl water 1 pm extension primer primer extension thermocycling conditions consisted initial step 95 degrees c 2 min followed 25 cycles 95 degrees c 5 43 degrees c 5 60 degrees c 5 following primer extension reaction products treated 05 u shrimp alkaline phosphatase amersham 45 min 37 degrees c 15 min 85 degrees c aliquots 1 microl snapshot reaction product combined 9 microl hi di formamide loaded onto 3100 dna sequencer applied biosystems products electrophoresed 36 cm capillary array 60 degrees c data processed using genescan analysis version 37 software applied biosystems peak heights allele specific extended primers determined using genotyper version 25 software applied biosystems ratios used index relative expression two alleles individual sample analytic conditions used genomic dna cdna average ratios observed genomic dna experiment representing 1 1 ratio two alleles could used correct allelic ratios obtained cdna analyses inequalities allelic representation specific assay 26
0.3494895.15385439.html.plaintext.txt	71	allele expression assay genomic dna subjects initially genotyped described order identify heterozygotes snps 334t c 4 heterozygotes 472c 2 heterozygotes individual allelic expression experiment cdna heterozygotes assayed two separate rt reactions alongside duplicates corresponding genomic dna samples experiment repeated two separate occasions ie total three experiments dnase treated rna samples yield detectable product absence rt step assays relative 4 expression 182 bp fragment containing snp 334t c amplified cdna genomic dna using primers 5 gcctacaaatcggaactgga 3 5 agctcctcggtgctctgg 3 assays relative 2 expression 67 bp fragment containing snp 472c amplified cdna genomic dna using primers 5 ctgcgtaagcggctcctc 3 5 ccccggcctggtacactg 3 pcrs carried total reaction volume 12 microl containing either cdna genomic dna template 1xpcr buffer dntps 01 mm primers 024 mm 03 u hot star taq polymerase qiagen 6 dmso 35 cycles annealing temperature 60 degrees c amplified samples incubated 1 u shrimp alkaline phosphatase amersham 2 u exonuclease amersham 45 min 37 degrees c 15 min 85 degrees c prior primer extension reactions primer extension carried using snapshot multiplex kit applied biosystems extension primer snp 334t c 5 gcgcggacatggaggacgtg 3 extension primer snp 472c 5 ccgatgacctgcagaag 3 primer extension reactions performed total volume 10 microl containing 2 microl treated pcr product 45 microl snapshot kit 25 microl water 1 pm extension primer primer extension thermocycling conditions consisted initial step 95 degrees c 2 min followed 25 cycles 95 degrees c 5 43 degrees c 5 60 degrees c 5 following primer extension reaction products treated 05 u shrimp alkaline phosphatase amersham 45 min 37 degrees c 15 min 85 degrees c aliquots 1 microl snapshot reaction product combined 9 microl hi di formamide loaded onto 3100 dna sequencer applied biosystems products electrophoresed 36 cm capillary array 60 degrees c data processed using genescan analysis version 37 software applied biosystems peak heights allele specific extended primers determined using genotyper version 25 software applied biosystems ratios used index relative expression two alleles individual sample analytic conditions used genomic dna cdna average ratios observed genomic dna experiment representing 1 1 ratio two alleles could used correct allelic ratios obtained cdna analyses inequalities allelic representation specific assay 26
0.3494895.15385439.html.plaintext.txt	72	statistical analysis differences allelic expression tested comparing genomic ratios cdna ratios heterozygous samples group comparisons analyzed test two tailed diagnosis included factor two factorial anova
0.3494895.15385439.html.plaintext.txt	73	statistical analysis differences allelic expression tested comparing genomic ratios cdna ratios heterozygous samples group comparisons analyzed test two tailed diagnosis included factor two factorial anova
0.3494895.15385439.html.plaintext.txt	74	predicted haplotype frequencies calculated using eh plus 27 formed basis calculation individual diplotype probabilities calculate probability individual carries specific diplotype first reconstructing possible combinations diplotypes individual given observed genotypes locus use expected distribution diplotype frequencies given observed haplotypes frequencies within specific sample identify probable diplotype individual probability diplotype within individual frequency diplotype divided sum frequencies possible diplotypes
0.3494895.15385439.html.plaintext.txt	75	predicted haplotype frequencies calculated using eh plus 27 formed basis calculation individual diplotype probabilities calculate probability individual carries specific diplotype first reconstructing possible combinations diplotypes individual given observed genotypes locus use expected distribution diplotype frequencies given observed haplotypes frequencies within specific sample identify probable diplotype individual probability diplotype within individual frequency diplotype divided sum frequencies possible diplotypes
0.3494895.15385439.html.plaintext.txt	76	calculation power detect effects unknown regulatory variants based binomial distribution hardy weinberg equilibrium regulatory snp ld marker snp probability individual homozygous putative regulatory locus alleles hardy weinberg equilibrium p2q2 p q two allele frequencies probability n individuals homozygous therefore undetected assay regulatory polymorphism p2q2n also applies n individuals selected heterozygosity marker locus relationship ie ld genotypes locus power detect least one heterozygote 1 p2q2n marker regulatory snp ld higher proportion people selected heterozygosity marker also heterozygous regulatory snp power increased
0.3494895.15385439.html.plaintext.txt	77	calculation power detect effects unknown regulatory variants based binomial distribution hardy weinberg equilibrium regulatory snp ld marker snp probability individual homozygous putative regulatory locus alleles hardy weinberg equilibrium p2q2 p q two allele frequencies probability n individuals homozygous therefore undetected assay regulatory polymorphism p2q2n also applies n individuals selected heterozygosity marker locus relationship ie ld genotypes locus power detect least one heterozygote 1 p2q2n marker regulatory snp ld higher proportion people selected heterozygosity marker also heterozygous regulatory snp power increased
0.3494895.15385439.html.plaintext.txt	78	acknowledgements grateful mrc london neurodegenerative diseases brain bank uk department clinical neuroscience karolinska institute stockholm sweden donating brain tissue work funded medical research council uk
0.3494895.15385439.html.plaintext.txt	79	acknowledgements grateful mrc london neurodegenerative diseases brain bank uk department clinical neuroscience karolinska institute stockholm sweden donating brain tissue work funded medical research council uk
0.3494895.15385439.html.plaintext.txt	80	footnotes correspondence addressed tel 44 2920743242 fax 44 2920746554 email odonovanmcatcardiffacuk
0.3494895.15385439.html.plaintext.txt	81	footnotes correspondence addressed tel 44 2920743242 fax 44 2920746554 email odonovanmcatcardiffacuk
0.3494895.15385439.html.plaintext.txt	82	references top abstract introduction results discussion materials methods references koch donarski n goetze k kreckel m stuerenburg hj buhmann c beisiegel u 2001 characterization four lipoprotein classes human cerebrospinal fluid j lipid res 42 1143 1151abstractfree full text
0.36174858.15888448.html.plaintext.txt	0	low density lipoprotein receptor regulates level central nervous system human murine apolipoprotein e modify amyloid plaque pathology pdapp mice john d fryera ronald b demattosb lynn m mccormickc mark odella michael l spinnera kelly r balesb steven m paulbde patrick m sullivanf maia parsadaniana guojun bucg david m holtzmanahij
0.36174858.15888448.html.plaintext.txt	1	departments aneurologyh molecular biology pharmacologyc pediatrics gcell biology physiology ihope center neurological disorders washington university school medicine st louis missouri 63110 bneuroscience discovery research eli lilly co lilly research laboratories indianapolis indiana 46285 departments ofd pharmacology toxicology ande psychiatry indiana university school medicine indianapolis indiana 46285 fbryan alzheimers disease research center division neurology department medicine duke university medical center durham north carolina 27710
0.36174858.15888448.html.plaintext.txt	2	departments aneurologyh molecular biology pharmacologyc pediatrics gcell biology physiology ihope center neurological disorders washington university school medicine st louis missouri 63110 bneuroscience discovery research eli lilly co lilly research laboratories indianapolis indiana 46285 departments ofd pharmacology toxicology ande psychiatry indiana university school medicine indianapolis indiana 46285 fbryan alzheimers disease research center division neurology department medicine duke university medical center durham north carolina 27710
0.36174858.15888448.html.plaintext.txt	3	received publication february 24 2005 revised form april 25 2005
0.36174858.15888448.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references apolipoprotein e apoe chaperone amyloid peptide regulates deposition structure deposits brain alzheimer disease ad primary apoe receptor regulates levels apoe brain unknown report low density lipoprotein receptor ldlr regulates cellular uptake central nervous system levels astrocyte derived apoe cells lacking ldlr unable appreciably endocytose astrocyte secreted apoe containing lipoprotein particles moreover cells overexpressing ldlr showed dramatic increase apoe endocytosis degradation also found ldlr knock ldlr mice significant 50 increase level apoe cerebrospinal fluid extracellular pools brain however pdapp mouse model ad bred onto ldlr background observe significant change brain levels either onset deposition interestingly human apoe3 apoe4 apoe2 knock mice bred ldlr background 210 380 increase respectively level apoe cerebrospinal fluid results demonstrate central nervous system levels human murine apoe directly regulated ldlr although increase murine apoe caused ldlr deficiency sufficient affect levels deposition 10 months age pdapp mice remains possibility increase human apoe3 apoe4 levels caused ldlr deficiency affect process could hold promise therapeutic targets ad
0.36174858.15888448.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references apolipoprotein e apoe chaperone amyloid peptide regulates deposition structure deposits brain alzheimer disease ad primary apoe receptor regulates levels apoe brain unknown report low density lipoprotein receptor ldlr regulates cellular uptake central nervous system levels astrocyte derived apoe cells lacking ldlr unable appreciably endocytose astrocyte secreted apoe containing lipoprotein particles moreover cells overexpressing ldlr showed dramatic increase apoe endocytosis degradation also found ldlr knock ldlr mice significant 50 increase level apoe cerebrospinal fluid extracellular pools brain however pdapp mouse model ad bred onto ldlr background observe significant change brain levels either onset deposition interestingly human apoe3 apoe4 apoe2 knock mice bred ldlr background 210 380 increase respectively level apoe cerebrospinal fluid results demonstrate central nervous system levels human murine apoe directly regulated ldlr although increase murine apoe caused ldlr deficiency sufficient affect levels deposition 10 months age pdapp mice remains possibility increase human apoe3 apoe4 levels caused ldlr deficiency affect process could hold promise therapeutic targets ad
0.36174858.15888448.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references alzheimer disease ad1 progressive neurodegenerative disease common cause dementia one key pathological hallmarks ad deposition 39 43 amino acid amyloid peptide form diffuse thioflavine scongo red negative fibrillar thioflavine scongo red positive plaques abundance data suggests conversion soluble insoluble forms early event pathogenesis ad peptide generated cleavage larger amyloid precursor protein app predominant species a40 andto lesser extent a42 1 although accounting 1 cases early onset autosomal dominant forms ad identified share common feature overall increase levels relative elevation fibrillogenic a42 throughout life ultimately resulting early deposition plaque formation identification familial ad cases led generation several app transgenic mouse models recapitulate many aspects deposition associated pathology 2
0.36174858.15888448.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references alzheimer disease ad1 progressive neurodegenerative disease common cause dementia one key pathological hallmarks ad deposition 39 43 amino acid amyloid peptide form diffuse thioflavine scongo red negative fibrillar thioflavine scongo red positive plaques abundance data suggests conversion soluble insoluble forms early event pathogenesis ad peptide generated cleavage larger amyloid precursor protein app predominant species a40 andto lesser extent a42 1 although accounting 1 cases early onset autosomal dominant forms ad identified share common feature overall increase levels relative elevation fibrillogenic a42 throughout life ultimately resulting early deposition plaque formation identification familial ad cases led generation several app transgenic mouse models recapitulate many aspects deposition associated pathology 2
0.36174858.15888448.html.plaintext.txt	8	1993 4 allele apoe found genetic risk factor common form ad late onset ad well cerebral amyloid angiopathy whereas 2 allele shown protective 3 abundant data suggest apoe linked ad cerebral amyloid angiopathy due ability act chaperone 4 influence metabolism acting binding molecule apoe influences amount deposition conformation aggregates well clearance toxicity vivo 5 8 furthermore level apoe brain directly influences aforementioned processes 5 8 example app transgenic mice lacking apoe develop less deposition virtually fibrillar deposits 5 9 10 thus understanding cellular events receptors regulate apoe levels brain may give important insights ad pathogenesis
0.36174858.15888448.html.plaintext.txt	9	1993 4 allele apoe found genetic risk factor common form ad late onset ad well cerebral amyloid angiopathy whereas 2 allele shown protective 3 abundant data suggest apoe linked ad cerebral amyloid angiopathy due ability act chaperone 4 influence metabolism acting binding molecule apoe influences amount deposition conformation aggregates well clearance toxicity vivo 5 8 furthermore level apoe brain directly influences aforementioned processes 5 8 example app transgenic mice lacking apoe develop less deposition virtually fibrillar deposits 5 9 10 thus understanding cellular events receptors regulate apoe levels brain may give important insights ad pathogenesis
0.36174858.15888448.html.plaintext.txt	10	apoe expressed high levels liver central nervous system cns present lipoprotein particles furthermore apoe cns derived within cns plasma 11 however cns apoe containing lipoproteins differ found periphery amount sialation perhaps importantly type lipoprotein particle associates 12 plasma apoe low density lipoproteins vldls subset high density lipoproteins also contain apoproteins contrast cns apoe high density lipoprotein like lipoproteins secreted primarily astrocytes released cells contain apoe sole apolipoprotein constituent 12 13 despite information whether specific apoe receptors regulate level apoe brain mediate apoe dependent clearance apoe binding proteins unknown nearly 20 years ago brown goldstein 14 elucidated role low density lipoprotein receptor ldlr receptor mediated endocytosis lipoproteins plasma including apoe subsequently members ldlr family identified many expressed brain shown vitro bind endocytose lipid rich lipoproteins contain apoe 15 determine whether ldlr family members influence level cns apoe metabolism ad mouse model recently bred mice lacking 39 kda receptor associated protein rap 16 increase aggregation deposition found mice rap endoplasmic reticulum chaperone protein known influence folding level ldlr family members study levels ldlr related protein lrp ldlr examined found reduced brain mice lacking rap 16 additionally overexpression functional lrp mini receptor pdapp model led increase levels soluble advanced stages deposition detectable change deposition measured histologically 17 thus whether ldlr family members responsible brain apoe metabolism whether play role regulating levels vivo remains unclear herein investigate role ldlr regulation cns derived apoe well brain levels mouse model ad
0.36174858.15888448.html.plaintext.txt	11	apoe expressed high levels liver central nervous system cns present lipoprotein particles furthermore apoe cns derived within cns plasma 11 however cns apoe containing lipoproteins differ found periphery amount sialation perhaps importantly type lipoprotein particle associates 12 plasma apoe low density lipoproteins vldls subset high density lipoproteins also contain apoproteins contrast cns apoe high density lipoprotein like lipoproteins secreted primarily astrocytes released cells contain apoe sole apolipoprotein constituent 12 13 despite information whether specific apoe receptors regulate level apoe brain mediate apoe dependent clearance apoe binding proteins unknown nearly 20 years ago brown goldstein 14 elucidated role low density lipoprotein receptor ldlr receptor mediated endocytosis lipoproteins plasma including apoe subsequently members ldlr family identified many expressed brain shown vitro bind endocytose lipid rich lipoproteins contain apoe 15 determine whether ldlr family members influence level cns apoe metabolism ad mouse model recently bred mice lacking 39 kda receptor associated protein rap 16 increase aggregation deposition found mice rap endoplasmic reticulum chaperone protein known influence folding level ldlr family members study levels ldlr related protein lrp ldlr examined found reduced brain mice lacking rap 16 additionally overexpression functional lrp mini receptor pdapp model led increase levels soluble advanced stages deposition detectable change deposition measured histologically 17 thus whether ldlr family members responsible brain apoe metabolism whether play role regulating levels vivo remains unclear herein investigate role ldlr regulation cns derived apoe well brain levels mouse model ad
0.36174858.15888448.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references apoe labeling vitro assays immunoaffinity purification astrocyte secreted apoe containing lipoprotein particles described previously 18 apoe degradation studies astrocyte secreted apoe3 containing lipoprotein particles labeled 125i using iodo gen kit pierce chinese hamster ovary cells lack endogenous lrp lrp null used stably express ldlr lrp mini receptor apoer2 vldl receptor 19 degradation 125i labeled apoe3 measured radioactivity soluble 20 trichloroacetic acid cell culture supernatant previously described 19 1 microm unlabeled rap used determine specificity concentration inhibits ldlr family members apoe endocytosis assays apoe lipoprotein particles labeled fluorescent hydrocarbon probe dii previously described 20 wild type mouse embryonic fibroblast cells mouse embryonic fibroblast cells lacking ldlr lrp receptors used dii studies 21 22 dii labeled apoe applied 1 h room temperature washed pbs fixed 4 paraformaldehyde
0.36174858.15888448.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references apoe labeling vitro assays immunoaffinity purification astrocyte secreted apoe containing lipoprotein particles described previously 18 apoe degradation studies astrocyte secreted apoe3 containing lipoprotein particles labeled 125i using iodo gen kit pierce chinese hamster ovary cells lack endogenous lrp lrp null used stably express ldlr lrp mini receptor apoer2 vldl receptor 19 degradation 125i labeled apoe3 measured radioactivity soluble 20 trichloroacetic acid cell culture supernatant previously described 19 1 microm unlabeled rap used determine specificity concentration inhibits ldlr family members apoe endocytosis assays apoe lipoprotein particles labeled fluorescent hydrocarbon probe dii previously described 20 wild type mouse embryonic fibroblast cells mouse embryonic fibroblast cells lacking ldlr lrp receptors used dii studies 21 22 dii labeled apoe applied 1 h room temperature washed pbs fixed 4 paraformaldehyde
0.36174858.15888448.html.plaintext.txt	14	animal tissue preparation analysis tissue plasma cholesterol csf apoe 3 month old ldlr ldlr mice identical c57bl6j background used 23 analysis human apoe isoforms ldlr mice first bred wild type sjl mice generate ldlr mice mixed c57bl6j x sjl background mice bred human apoe expressing mice 24 maintained c57bl6j x sjl background mice analyzed human apoe experiments identical background analysis utilized pdapp mice overexpress human app751 familial ad mutation position 717 appv717f control neuron specific platelet derived growth factor promoter 25 crossed pdapp ldlr mice ldlr mice generate pdapp ldlr pdapp ldlr mice littermates mixed genetic background described previously 7 hereafter mice referred pdapp study hemizygous pdapp transgene pdapp animals anesthetized pentobarbital 150 mgkg intraperitoneal perfused transcardially 01 m pbs containing heparin 3 unitsml ph 74 one hemibrain immersion fixed pbs containing 4 paraformaldehyde overnight 4 degrees c fixation brain cryoprotected pbs containing 30 sucrose 4 degrees c brain regions hemisphere dissected frozen powdered dry ice analysis complete protease inhibitors roche applied science used indicated pbs soluble analysis tissue first dounce homogenized ice cold pbs protease inhibitors immediately spun 5 min 20000 x g carbonate soluble analysis pbs insoluble pellet homogenized ice cold 100 mm carbonate 50 mm nacl ph 115 protease inhibitors immediately spun 10 min 20000 x g carbonate insoluble analysis carbonate insoluble pellet lysed 3 h rotation 5 m guanidine 50 mm tris protease inhibitors experimental protocols approved animal studies committee washington university
0.36174858.15888448.html.plaintext.txt	15	animal tissue preparation analysis tissue plasma cholesterol csf apoe 3 month old ldlr ldlr mice identical c57bl6j background used 23 analysis human apoe isoforms ldlr mice first bred wild type sjl mice generate ldlr mice mixed c57bl6j x sjl background mice bred human apoe expressing mice 24 maintained c57bl6j x sjl background mice analyzed human apoe experiments identical background analysis utilized pdapp mice overexpress human app751 familial ad mutation position 717 appv717f control neuron specific platelet derived growth factor promoter 25 crossed pdapp ldlr mice ldlr mice generate pdapp ldlr pdapp ldlr mice littermates mixed genetic background described previously 7 hereafter mice referred pdapp study hemizygous pdapp transgene pdapp animals anesthetized pentobarbital 150 mgkg intraperitoneal perfused transcardially 01 m pbs containing heparin 3 unitsml ph 74 one hemibrain immersion fixed pbs containing 4 paraformaldehyde overnight 4 degrees c fixation brain cryoprotected pbs containing 30 sucrose 4 degrees c brain regions hemisphere dissected frozen powdered dry ice analysis complete protease inhibitors roche applied science used indicated pbs soluble analysis tissue first dounce homogenized ice cold pbs protease inhibitors immediately spun 5 min 20000 x g carbonate soluble analysis pbs insoluble pellet homogenized ice cold 100 mm carbonate 50 mm nacl ph 115 protease inhibitors immediately spun 10 min 20000 x g carbonate insoluble analysis carbonate insoluble pellet lysed 3 h rotation 5 m guanidine 50 mm tris protease inhibitors experimental protocols approved animal studies committee washington university
0.36174858.15888448.html.plaintext.txt	16	biochemical histological analysis a40 a42 quantified enzyme linked immunosorbent assay described previously 26 deposition assessed immunostaining 3d6 antibody recognizing amino acids 1 5 stereological analysis previously described 7 apoe measured cortical tissue dounce homogenized briefly pbs protease inhibitors spun immediately 20000 x g 5 min murine apoe quantified using sandwich enzyme linked immunosorbent assay pooled c57bl6j plasma serving standard apoe set 68 microgml 27 sensitivity 5 ngml human apoe quantified using enzyme linked immunosorbent assay protocol except standard used purified apoe isolated human vldl biodesign sako 96 well microtiter plates coated overnight 4 degrees c 20 microgml monoclonal anti apoe antibody wue4 28 washes performed 8 timeswell pbs standard microplate washer plates washed blocked 1 dry milk pbs 60 min 37 degrees c plates washed samples standards loaded 05 bovine serum albumin pbs 0025 tween 20 containing protease inhibitors incubated 90 min 37 degrees c plates washed incubated goat anti apoe antiserum calbiochem 1500 dilution 05 bovine serum albumin pbs 0025 tween 20 90 min 37 degrees c plates washed horseradish peroxidase conjugated horse anti goat antibody 15000 dilution vector laboratories burlingame ca incubated 90 min room temperature plates washed tetramethylbenzidine substrate sigma added absorbance monitored 650 nm amplex red kit molecular probes eugene used measure total cholesterol content
0.36174858.15888448.html.plaintext.txt	17	biochemical histological analysis a40 a42 quantified enzyme linked immunosorbent assay described previously 26 deposition assessed immunostaining 3d6 antibody recognizing amino acids 1 5 stereological analysis previously described 7 apoe measured cortical tissue dounce homogenized briefly pbs protease inhibitors spun immediately 20000 x g 5 min murine apoe quantified using sandwich enzyme linked immunosorbent assay pooled c57bl6j plasma serving standard apoe set 68 microgml 27 sensitivity 5 ngml human apoe quantified using enzyme linked immunosorbent assay protocol except standard used purified apoe isolated human vldl biodesign sako 96 well microtiter plates coated overnight 4 degrees c 20 microgml monoclonal anti apoe antibody wue4 28 washes performed 8 timeswell pbs standard microplate washer plates washed blocked 1 dry milk pbs 60 min 37 degrees c plates washed samples standards loaded 05 bovine serum albumin pbs 0025 tween 20 containing protease inhibitors incubated 90 min 37 degrees c plates washed incubated goat anti apoe antiserum calbiochem 1500 dilution 05 bovine serum albumin pbs 0025 tween 20 90 min 37 degrees c plates washed horseradish peroxidase conjugated horse anti goat antibody 15000 dilution vector laboratories burlingame ca incubated 90 min room temperature plates washed tetramethylbenzidine substrate sigma added absorbance monitored 650 nm amplex red kit molecular probes eugene used measure total cholesterol content
0.36174858.15888448.html.plaintext.txt	18	western blotting tissue samples homogenized radioimmune precipitation assay buffer 150 mm nacl 50 mm tris 25 mm edta 1 triton x 100 05 deoxycholic acid 01 sds ph 8 protease inhibitors passed 10 times 33 gauge needle incubated 1 h room temperature rotation insoluble material pelleted centrifugation 20000 x g protein content supernatant quantified using bca kit pierce protein 30 microglane run sds page gels transferred nitrocellulose western blotting using standard techniques detect full length app c terminal fragments app blot probed ct15 generous gift dr ed koo university california san diego ca rabbit polyclonal antibody raised c terminal 15 amino acids app 29 detect lrp blots probed rabbit anti lrp antibody 17 images captured using kodak imagestation 440cf densitometric analysis bands performed using kodak 1d image analysis software eastman kodak co new haven ct
0.36174858.15888448.html.plaintext.txt	19	statistical analysis data reported mean plus minus se analyzed using prism version 400 software graphpad san diego ca
0.36174858.15888448.html.plaintext.txt	20	results top abstract introduction materials methods results discussion references begin determine whether one two major apoe receptors brain ldlr lrp could regulate apoe levels brain purified astrocyte secreted apoe containing lipoprotein particles described previously 18 determined ability endocytosed mouse embryonic fibroblasts derived wild type ldlr lrp double knock ldlr lrp mouse embryos 21 dii labeled apoe lipoprotein particles readily taken endocytic vesicles wild type lrp cells fig 1a punctate pattern staining typical receptor mediated endocytosis represents endosomallysosomal distribution endocytosed ligands however cells ldlr double knock ldlr lrp cells showed appreciable endocytosis astrocyte secreted apoe containing lipoprotein particles fig 1a clarify role ldlr family members mediating receptor mediated endocytosis astrocyte derived apoe used chinese hamster ovary cells lack endogenous lrp stably transfected ldlr lrp mini receptors apoer2 vldl receptor analyze potential uptake degradation apoe containing lipoprotein particles 19 cells expressing different ldlr family members shown previously bind endocytose control ligands 19 receptors main candidate apoe receptors expressed brain 15 application 125i labeled astrocyte secreted apoe containing lipoprotein particles cells overexpressing ldlr resulted large increase rap inhibitable endocytosis degradation apoe fig 1b however cells overexpressing ldlr family members vector alone result appreciable uptake degradation astrocyte derived apoe fig 1b
0.36174858.15888448.html.plaintext.txt	21	results top abstract introduction materials methods results discussion references begin determine whether one two major apoe receptors brain ldlr lrp could regulate apoe levels brain purified astrocyte secreted apoe containing lipoprotein particles described previously 18 determined ability endocytosed mouse embryonic fibroblasts derived wild type ldlr lrp double knock ldlr lrp mouse embryos 21 dii labeled apoe lipoprotein particles readily taken endocytic vesicles wild type lrp cells fig 1a punctate pattern staining typical receptor mediated endocytosis represents endosomallysosomal distribution endocytosed ligands however cells ldlr double knock ldlr lrp cells showed appreciable endocytosis astrocyte secreted apoe containing lipoprotein particles fig 1a clarify role ldlr family members mediating receptor mediated endocytosis astrocyte derived apoe used chinese hamster ovary cells lack endogenous lrp stably transfected ldlr lrp mini receptors apoer2 vldl receptor analyze potential uptake degradation apoe containing lipoprotein particles 19 cells expressing different ldlr family members shown previously bind endocytose control ligands 19 receptors main candidate apoe receptors expressed brain 15 application 125i labeled astrocyte secreted apoe containing lipoprotein particles cells overexpressing ldlr resulted large increase rap inhibitable endocytosis degradation apoe fig 1b however cells overexpressing ldlr family members vector alone result appreciable uptake degradation astrocyte derived apoe fig 1b
0.36174858.15888448.html.plaintext.txt	22	view larger version 26k fig 1 ldlr regulates cellular uptake astrocyte secreted apoe dii labeled astrocyte secreted apoe3 containing lipoprotein particles readily endocytosed wild type lrp mouse embryonic fibroblast cells ldlr double null ldlr lrp mouse embryonic fibroblast cells b astrocyte secreted apoe lipoprotein particles labeled 125i applied chinese hamster ovary lrp null cells overexpressing ldlr family members rap inhibitable binding 125i labeled apoe3 calculated presented percentage pcdna31 vector control cells overexpressing ldlr able endocytose degrade apoe evidenced trichloroacetic acid soluble counts cell culture supernatant percentage control p 0001 analysis variance post hoc tukey test
0.36174858.15888448.html.plaintext.txt	23	determine potential role ldlr brain apoe metabolism vivo used sandwich enzyme linked immunosorbent assay measure level murine apoe extracellular space brain csf wild type ldlr ldlr knock ldlr mice apoe secreted brain extracellular space expected receptor ldlr involved endocytosis absent extracellular levels would elevated example apoe elevated severalfold plasma ldlr mice 23 well humans familial hypercholesterolemia resulting reduced ldlr expression andor function 30 31 found ldlr mice 53 increase csf levels apoe relative ldlr mice fig 2a furthermore found apoe levels cortical tissue homogenized pbs reflection extracellular pools apoe significantly increased 57 ldlr mice compared ldlr mice fig 2b together vitro vivo data suggest ldlr plays important role apoe receptor mediates uptake degradation level apoe brain
0.36174858.15888448.html.plaintext.txt	24	determine potential role ldlr brain apoe metabolism vivo used sandwich enzyme linked immunosorbent assay measure level murine apoe extracellular space brain csf wild type ldlr ldlr knock ldlr mice apoe secreted brain extracellular space expected receptor ldlr involved endocytosis absent extracellular levels would elevated example apoe elevated severalfold plasma ldlr mice 23 well humans familial hypercholesterolemia resulting reduced ldlr expression andor function 30 31 found ldlr mice 53 increase csf levels apoe relative ldlr mice fig 2a furthermore found apoe levels cortical tissue homogenized pbs reflection extracellular pools apoe significantly increased 57 ldlr mice compared ldlr mice fig 2b together vitro vivo data suggest ldlr plays important role apoe receptor mediates uptake degradation level apoe brain
0.36174858.15888448.html.plaintext.txt	25	view larger version 16k fig 2 ldlr regulates level apoe cns level endogenous apoe csf 3 month old mice 184 plus minus 008 microgml ldlr mice n 8 versus 120 plus minus 017 microgml ldlr mice n 7 p 001 unpaired two tailed test b level endogenous apoe cortical pbs homogenates 065 plus minus 005 microgmg ldlr mice n 8 versus 041 plus minus 008 microgmg ldlr mice n 7 p 001 unpaired two tailed test
0.36174858.15888448.html.plaintext.txt	26	ldlr mice elevated extracellular levels apoe brain apoe acts chaperone soluble insoluble wanted determine effect ldlr deposition vivo determine whether ldlr direct effect aggregation deposition vivo used pdapp mouse model ad generate pdapp ldlr pdapp ldlr mice littermates pdapp mice express human app transgene containing familial ad mutation amino acid 717 overproduce particularly a42 hippocampus mice amount soluble insoluble increases age dependent manner beginning 6 9 months age plaques begin deposit 25 32 first examined levels a40 a42 young pdapp ldlr pdapp ldlr mice 3 months age well deposition begins pbs soluble levels a40 a42 hippocampus significantly different two genotypes fig 3a carbonate soluble levels a40 a42 hippocampus also significantly different two genotypes fig 3b
0.36174858.15888448.html.plaintext.txt	27	ldlr mice elevated extracellular levels apoe brain apoe acts chaperone soluble insoluble wanted determine effect ldlr deposition vivo determine whether ldlr direct effect aggregation deposition vivo used pdapp mouse model ad generate pdapp ldlr pdapp ldlr mice littermates pdapp mice express human app transgene containing familial ad mutation amino acid 717 overproduce particularly a42 hippocampus mice amount soluble insoluble increases age dependent manner beginning 6 9 months age plaques begin deposit 25 32 first examined levels a40 a42 young pdapp ldlr pdapp ldlr mice 3 months age well deposition begins pbs soluble levels a40 a42 hippocampus significantly different two genotypes fig 3a carbonate soluble levels a40 a42 hippocampus also significantly different two genotypes fig 3b
0.36174858.15888448.html.plaintext.txt	28	next examined pdapp ldlr pdapp ldlr mice 10 months age determine effect ldlr deposition area hippocampus covered immunoreactive deposits tissue sections 31 higher 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4a increase statistically significant similar results found thioflavine positive fibrillar deposits comparable results found cortex data shown biochemical analysis carbonate soluble levels hippocampus revealed slight nonsignificant increases a40 17 a42 53 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4b carbonate insoluble levels hippocampus also revealed slight nonsignificant increases a40 51 a42 10 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4c whereas ldlr mice increase plasma cholesterol 79 compared wild type ldlr mice fig 5a differences either brain csf cholesterol fig 5 b c also evidence processing app fig 5d levels total app protein data shown different genotypes additionally hippocampal lrp levels altered absence ldlr data shown thus although level murine apoe elevated 50 extracellular cns pools ldlr mice data suggest degree change level apoe sufficiently increased significantly affect levels young ages early stages deposition pdapp transgenic mice
0.36174858.15888448.html.plaintext.txt	29	next examined pdapp ldlr pdapp ldlr mice 10 months age determine effect ldlr deposition area hippocampus covered immunoreactive deposits tissue sections 31 higher 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4a increase statistically significant similar results found thioflavine positive fibrillar deposits comparable results found cortex data shown biochemical analysis carbonate soluble levels hippocampus revealed slight nonsignificant increases a40 17 a42 53 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4b carbonate insoluble levels hippocampus also revealed slight nonsignificant increases a40 51 a42 10 10 month old pdapp ldlr mice compared pdapp ldlr mice fig 4c whereas ldlr mice increase plasma cholesterol 79 compared wild type ldlr mice fig 5a differences either brain csf cholesterol fig 5 b c also evidence processing app fig 5d levels total app protein data shown different genotypes additionally hippocampal lrp levels altered absence ldlr data shown thus although level murine apoe elevated 50 extracellular cns pools ldlr mice data suggest degree change level apoe sufficiently increased significantly affect levels young ages early stages deposition pdapp transgenic mice
0.36174858.15888448.html.plaintext.txt	30	view larger version 22k fig 3 ldlr affect levels hippocampus young pdapp mice level pbs soluble a40 significantly different pdapp ldlr mice 0072 plus minus 0024 ngmg compared pdapp ldlr mice 0084 plus minus 0025 ngmg level pbs soluble a42 also significantly different pdapp ldlr mice 0067 plus minus 0015 ngmg compared pdapp ldlr mice 0052 plus minus 0009 ngmg b level carbonate soluble a40 significantly different pdapp ldlr mice 0184 plus minus 0041 ngmg compared pdapp ldlr mice 0238 plus minus 0037 ngmg level carbonate soluble a42 also significantly different pdapp ldlr mice 0159 plus minus 0018 ngmg compared pdapp ldlr mice 0186 plus minus 0023 ngmg
0.36174858.15888448.html.plaintext.txt	31	explore possibility ldlr may differentially regulate level human apoe isoforms cns compared murine apoe bred human apoe2 apoe3 apoe4 targeted replacement mice knock onto ldlr mouse background confirm previous findings noted mice 33 assessed plasma cholesterol apoe found significantly elevated absence ldlr genotypes data shown determine extent ldlr regulates human apoe levels extracellular space cns measured apoe levels csf found levels human apoe3 human apoe4 csf significantly higher 210 380 respectively absence ldlr fig 6a level human apoe2 csf significantly altered presence absence ldlr fig 6a expected human apoe2 isoform exhibits 2 binding ldlr 34 however interesting note level human apoe2 substantially higher apoe3 apoe4 csf fig 6a despite increase human apoe levels absence ldlr significant increase level brain cholesterol mice fig 6b
0.36174858.15888448.html.plaintext.txt	32	explore possibility ldlr may differentially regulate level human apoe isoforms cns compared murine apoe bred human apoe2 apoe3 apoe4 targeted replacement mice knock onto ldlr mouse background confirm previous findings noted mice 33 assessed plasma cholesterol apoe found significantly elevated absence ldlr genotypes data shown determine extent ldlr regulates human apoe levels extracellular space cns measured apoe levels csf found levels human apoe3 human apoe4 csf significantly higher 210 380 respectively absence ldlr fig 6a level human apoe2 csf significantly altered presence absence ldlr fig 6a expected human apoe2 isoform exhibits 2 binding ldlr 34 however interesting note level human apoe2 substantially higher apoe3 apoe4 csf fig 6a despite increase human apoe levels absence ldlr significant increase level brain cholesterol mice fig 6b
0.36174858.15888448.html.plaintext.txt	33	view larger version 16k fig 4 ldlr affect deposition pdapp mice 10 months age percentage cross sectional area hippocampus covered immunoreactive deposits significantly different pdapp ldlr mice 166 compared pdapp ldlr mice 218 b level carbonate soluble a40 significantly different pdapp ldlr mice 0312 plus minus 0085 ngmg compared pdapp ldlr mice 0366 plus minus 0072 ngmg level carbonate soluble a42 also significantly different pdapp ldlr mice 417 plus minus 066 ngmg compared pdapp ldlr mice 640 plus minus 100 ngmg c level carbonate insoluble a40 significantly different pdapp ldlr mice 624 plus minus 080 ngmg compared pdapp ldlr mice 945 plus minus 122 ngmg level carbonate soluble a42 also significantly different pdapp ldlr mice 262 plus minus 58 ngmg compared pdapp ldlr mice 288 plus minus 47 ngmg
0.36174858.15888448.html.plaintext.txt	34	view larger version 19k fig 5 ldlr influences levels plasma cholesterol effect hippocampal csf cholesterol app processing level total plasma cholesterol 692 plus minus 463 mgdl ldlr mice n 6 compared 124 plus minus 882 mgdl ldlr mice n 6 p 0001 unpaired two tailed test level total cholesterol hippocampus b csf c app processing assessed semiquantitative western blotting c terminal fragment ctf d significantly different genotypes n 5 7group
0.36174858.15888448.html.plaintext.txt	35	view larger version 27k fig 6 ldlr influences levels human apoe3 apoe4 apoe2 cerebrospinal fluid level apoe cerebrospinal fluid measured human apoe2 apoe3 itsup apoe4 targeted replacement mice knock presence ldlr absence ldlr endogenous ldlr level human apoe significantly higher apoe2 mice 554 plus minus 078 microgml compared apoe3 194 plus minus 025 microgml apoe4 128 plus minus 026 microgml mice p 0001 analysis variance post hoc tukey test expected previous studies level human apoe significantly different apoe2 ldlr apoe2 ldlr mice level human apoe significantly higher apoe3 ldlr mice 404 plus minus 051 microgml compared apoe3 ldlr mice 194 plus minus 025 microgml p 005 analysis variance post hoc tukey test level human apoe also significantly higher apoe4 ldlr mice 481 plus minus 047 microgml compared apoe3 ldlr mice 128 plus minus 026 microgml p 0001 analysis variance post hoc tukey test b level total cholesterol cortex increased human apoe2 apoe3 apoe4 knock mice absence ldlr interestingly human apoe3 slight significant decrease level cholesterol cortex absence ldlr p 005
0.36174858.15888448.html.plaintext.txt	36	discussion top abstract introduction materials methods results discussion references present study found ldlr ldlr family members able efficiently bind endocytose degrade astrocyte secreted apoe containing lipoprotein particles ldlr mice 50 higher levels apoe csf extracellular pools brain tissue however pdapp mouse model ad bred onto ldlr background significant increase levels a40 a42 young ages deposition begins additionally significant increase deposition defined immunohistochemical biochemical measures 10 month old pdapp ldlr pdapp ldlr mice interestingly using human apoe knock mice found increase level apoe3 apoe4 apoe2 ldlr background much greater murine apoe ldlr background
0.36174858.15888448.html.plaintext.txt	37	discussion top abstract introduction materials methods results discussion references present study found ldlr ldlr family members able efficiently bind endocytose degrade astrocyte secreted apoe containing lipoprotein particles ldlr mice 50 higher levels apoe csf extracellular pools brain tissue however pdapp mouse model ad bred onto ldlr background significant increase levels a40 a42 young ages deposition begins additionally significant increase deposition defined immunohistochemical biochemical measures 10 month old pdapp ldlr pdapp ldlr mice interestingly using human apoe knock mice found increase level apoe3 apoe4 apoe2 ldlr background much greater murine apoe ldlr background
0.36174858.15888448.html.plaintext.txt	38	vitro data indicate ldlr family members including lrp vldl receptor apoer2 able appreciably internalize degrade astrocyte secreted apoe containing lipoproteins previous work clearly demonstrated ldlr family members able efficiently bind endocytose apoe reconstituted large cholesterol rich lipoprotein particles termed vldl 35 however vldl particles differ astrocyte secreted apoe lipid composition presence apoproteins amount sialation 12 apolipoprotein lipidation state alter receptor binding characteristics example previous studies shown recombinant apoe absence lipid prefers binding lrp ldlr 22 form apoe shown present physiological conditions together results indicate lipid content form apoe lipoprotein particles alter receptor binding specificity also demonstrate ldlr important apoe receptor regulates human murine apoe endocytosis levels brain although results study rule ldlr family members contribute way level apoe brain clearly show ldlr plays important role brain apoe metabolism
0.36174858.15888448.html.plaintext.txt	39	vitro data indicate ldlr family members including lrp vldl receptor apoer2 able appreciably internalize degrade astrocyte secreted apoe containing lipoproteins previous work clearly demonstrated ldlr family members able efficiently bind endocytose apoe reconstituted large cholesterol rich lipoprotein particles termed vldl 35 however vldl particles differ astrocyte secreted apoe lipid composition presence apoproteins amount sialation 12 apolipoprotein lipidation state alter receptor binding characteristics example previous studies shown recombinant apoe absence lipid prefers binding lrp ldlr 22 form apoe shown present physiological conditions together results indicate lipid content form apoe lipoprotein particles alter receptor binding specificity also demonstrate ldlr important apoe receptor regulates human murine apoe endocytosis levels brain although results study rule ldlr family members contribute way level apoe brain clearly show ldlr plays important role brain apoe metabolism
0.36174858.15888448.html.plaintext.txt	40	recent studies shown increasing decreasing cellular cholesterol influence cellular secretion 36 although ldlr mice elevated plasma cholesterol levels found level brain cholesterol unaffected mice previously reported 37 exact mechanism apoe affects ad pathogenesis unclear however large body evidence suggests one mechanism influences age onset ad acting chaperone soluble insoluble thereby influencing clearance fibrillogenesis 3 5 7 32 current results suggest although ldlr regulates extracellular levels apoe brain 50 increase level murine apoe endogenous levels sufficient alter levels young ages early stages deposition pdapp mice 10 months age may represent ceiling effect level murine apoe indicate larger increase level murine apoe may necessary effect change levels model alternatively pathways apoe mediated clearance play much larger role metabolism lrp bulk flow along interstitial fluid drainage pathways unfortunately lrp mice die early embryonic stages thus effect endogenous lrp brain apoe levels difficult assess shown study additionally ldlr may play role deposition later stages deposition found lrp pdapp mice 17 also possible ldlr may differentially regulate human apoe isoforms cns greater extent murine apoe therefore influence levels deposition interesting independent effect ldlr level apoe csf human apoe2 mice significantly higher apoe3 apoe4 mice suggests humans ldlr may play important role regulating cns apoe levels ad pathogenesis studies human csf reported significant differences level human apoe individuals expressing apoe3 apoe4 alleles level csf apoe apoe22 homozygous individuals assessed knowledge given apoe2 associated decreased risk developing ad intriguing possibility absolute level apoe present brain individuals could account decrease risk human murine apoe differ 25 amino acid level human apoe isoforms murine apoe isolated vldl shown differentially bind ldlr 33 using pdapp mouse model previous studies group shown expression human apoe isoforms control glial fibrillary acidic protein promoter results significant delay deposition compared mice expressing endogenous murine apoe 7 32 recently human apoe knock mice used study crossed pdapp mice delay deposition isoform dependent effect deposition e4 e3 e2 found 38 additionally recently replicated result appsw mouse model ad utilizing apoe3 apoe4 knock mice used study 39 clearly human apoe isoforms affect metabolism deposition differently murine apoe whether due altered clearance andor structure vivo remains determined determining role ldlr receptors clearance pathways brain also involved regulating apoe levels central understanding apoe influences metabolism ad pathogenesis
0.36174858.15888448.html.plaintext.txt	41	recent studies shown increasing decreasing cellular cholesterol influence cellular secretion 36 although ldlr mice elevated plasma cholesterol levels found level brain cholesterol unaffected mice previously reported 37 exact mechanism apoe affects ad pathogenesis unclear however large body evidence suggests one mechanism influences age onset ad acting chaperone soluble insoluble thereby influencing clearance fibrillogenesis 3 5 7 32 current results suggest although ldlr regulates extracellular levels apoe brain 50 increase level murine apoe endogenous levels sufficient alter levels young ages early stages deposition pdapp mice 10 months age may represent ceiling effect level murine apoe indicate larger increase level murine apoe may necessary effect change levels model alternatively pathways apoe mediated clearance play much larger role metabolism lrp bulk flow along interstitial fluid drainage pathways unfortunately lrp mice die early embryonic stages thus effect endogenous lrp brain apoe levels difficult assess shown study additionally ldlr may play role deposition later stages deposition found lrp pdapp mice 17 also possible ldlr may differentially regulate human apoe isoforms cns greater extent murine apoe therefore influence levels deposition interesting independent effect ldlr level apoe csf human apoe2 mice significantly higher apoe3 apoe4 mice suggests humans ldlr may play important role regulating cns apoe levels ad pathogenesis studies human csf reported significant differences level human apoe individuals expressing apoe3 apoe4 alleles level csf apoe apoe22 homozygous individuals assessed knowledge given apoe2 associated decreased risk developing ad intriguing possibility absolute level apoe present brain individuals could account decrease risk human murine apoe differ 25 amino acid level human apoe isoforms murine apoe isolated vldl shown differentially bind ldlr 33 using pdapp mouse model previous studies group shown expression human apoe isoforms control glial fibrillary acidic protein promoter results significant delay deposition compared mice expressing endogenous murine apoe 7 32 recently human apoe knock mice used study crossed pdapp mice delay deposition isoform dependent effect deposition e4 e3 e2 found 38 additionally recently replicated result appsw mouse model ad utilizing apoe3 apoe4 knock mice used study 39 clearly human apoe isoforms affect metabolism deposition differently murine apoe whether due altered clearance andor structure vivo remains determined determining role ldlr receptors clearance pathways brain also involved regulating apoe levels central understanding apoe influences metabolism ad pathogenesis
0.36174858.15888448.html.plaintext.txt	42	footnotes work supported national institutes health grants ag13956 p50 ag05681 ag11355 metlife foundation eli lilly co costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.36174858.15888448.html.plaintext.txt	43	footnotes work supported national institutes health grants ag13956 p50 ag05681 ag11355 metlife foundation eli lilly co costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.36174858.15888448.html.plaintext.txt	44	j correspondence addressed dept neurology campus box 8111 660 euclid ave st louis mo 63110 tel 314 362 9872 fax 314 362 2826 e mail holtzmanatwustledu u d
0.36174858.15888448.html.plaintext.txt	45	j correspondence addressed dept neurology campus box 8111 660 euclid ave st louis mo 63110 tel 314 362 9872 fax 314 362 2826 e mail holtzmanatwustledu u d
0.36174858.15888448.html.plaintext.txt	46	1 abbreviations used ad alzheimer disease ldlr low density lipoprotein receptor apoe apolipoprotein e app amyloid precursor protein amyloid lrp low density lipoprotein receptor related protein csf cerebrospinal fluid cns central nervous system vldl low density lipoprotein rap receptor associated protein pbs phosphate buffered saline
0.36174858.15888448.html.plaintext.txt	47	references top abstract introduction materials methods results discussion references selkoe d j 2002 j clin investig 1101375 1381free full text hock b j jr lamb b 2001 trends genet 17s7 s12crossrefmedline order article via infotrieve corder e h saunders m strittmatter w j schmechel d e gaskell p c small g w roses d haines j l pericak vance m 1993 science 261921 923medline order article via infotrieve wisniewski ghiso j frangione b 1997 neurobiol dis 4313 328crossrefmedline order article via infotrieve bales k r verina dodel r c du y altstiel l bender m hyslop p johnstone e m little p cummins d j piccardo p ghetti b paul m 1997 nat genet 17263 264medline order article via infotrieve holtzman d m bales k r wu bhat p parsadanian m fagan m chang l k sun y paul m 1999 j clin investig 103r15 r21medline order article via infotrieve holtzman d m bales k r tenkova fagan m parsadanian m sartorius l j mackey b olney j mckeel d wozniak d paul m 2000 proc natl acad sci u 972892 2897abstractfree full text demattos r b cirrito j r parsadanian m may p c odell m taylor j w harmony j aronow b j bales k r paul m holtzman d m 2004 neuron 41193 202crossrefmedline order article via infotrieve bales k r verina cummins d j du y dodel r c saura j fishman c e delong c piccardo p petegnief v ghetti b paul m 1999 proc natl acad sci u 9615233 15238abstractfree full text holtzman d m fagan m mackey b tenkova sartorius l paul m bales k ashe k h irizarry m c hyman b 2000 ann neurol 47 739 74730co2 8linktypedoi crossrefmedline order article via infotrieve linton m f gish r hubl butler e esquivel c bry w boyles j k wardell m r young g 1991 j clin investig 88 270 281medline order article via infotrieve pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917148 161medline order article via infotrieve pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 26214352 14360abstractfree full text brown m goldstein j l 1986 science 23234 47medline order article via infotrieve beffert u stolt p c herz j 2004 j lipid res 45403 409abstractfree full text van uden e mallory m veinbergs alford m rockenstein e masliah e 2002 j neurosci 229298 9304abstractfree full text zerbinatti c v wozniak d f cirrito j cam j osaka h bales k r zhuo m paul m holtzman d m bu g 2004 proc natl acad sci u 1011075 1080abstractfree full text demattos r b brendza r p heuser j e kierson m cirrito j r fryer j sullivan p m fagan m han x holtzman d m 2001 neurochem int 39 415 425crossrefmedline order article via infotrieve li y lu w marzolo m p bu g 2001 j biol chem 27618000 18006abstractfree full text pitas r e innerarity l weinstein j n mahley r w 1981 arteriosclerosis 1 177 185abstract reblin niemeier meyer n willnow e kronenberg f dieplinger h greten h beisiegel u 1997 j lipid res 382103 2110abstract narita m holtzman d m fagan m ladu m j yu l han x gross r w bu g schwartz l 2002 j biochem tokyo 132743 749abstract ishibashi brown m goldstein j l gerard r d hammer r e herz j 1993 j clin investig 92883 893medline order article via infotrieve sullivan p m mezdour h aratani y knouff c najib j reddick r l quarfordt h maeda n 1997 j biol chem 27217972 17980abstractfree full text games d adams d alessandrini r barbour r berthelette p blackwell c carr clemens j donaldson gillespie f guido hagopian johnson wood k khan k lee m leibowitz p lieberburg little masliah e mcconlogue l montoya zavala m mucke l paganini l penniman e power m schenk d seubert p snyder b soriano f tan h vitale j wadsworth wolozin b zhao j 1995 nature 373523 527crossrefmedline order article via infotrieve demattos r b bales k r cummins d j dodart j c paul m holtzman d m 2001 proc natl acad sci u 988850 8855abstractfree full text lusis j taylor b quon d zollman leboeuf r c 1987 j biol chem 2627594 7604abstractfree full text krul e tikkanen m j schonfeld g 1988 j lipid res 291309 1325abstract sisodia koo e h hoffman p n perry g price d l 1993 j neurosci 133136 3142abstract gibson j c goldberg r b rubinstein ginsberg h n brown w v baker joffe b seftel h c 1987 arteriosclerosis 7401 407abstract kajinami k mabuchi h koizumi j takeda r 1992 clin chim acta 211 93 99crossrefmedline order article via infotrieve fagan m watson m parsadanian m bales k r paul m holtzman d m 2002 neurobiol dis 9305 318crossrefmedline order article via infotrieve knouff c briand o lestavel clavey v altenburg m maeda n 2004 biochim biophys acta 16848 17medline order article via infotrieve schneider w j kovanen p brown m goldstein j l utermann g weber w havel r j kotite l kane j p innerarity l mahley r w 1981 j clin investig 681075 1085medline order article via infotrieve mahley r w 1988 science 240622 630medline order article via infotrieve wolozin b 2004 neuron 41 7 10crossrefmedline order article via infotrieve quan g xie c dietschy j m turley d 2003 brain res dev brain res 146 87 98medline order article via infotrieve bales k r dodart j c delong c wu x schmechel d e sullivan p m paul m 2002 soc neurosci abstr 8836 fryer j d simmons k parsadanian m bales k r paul m sullivan p m holtzman d m 2005 j neurosci 252803 2810abstractfree full text
0.36494276.15269217.html.plaintext.txt	0	abca1 required normal central nervous system apoe levels lipidation astrocyte secreted apoe suzanne e wahrle hong jiang maia parsadanian justin legleiter xianlin han john d fryer tomasz kowalewski david m holtzman
0.36494276.15269217.html.plaintext.txt	1	abca1 required normal central nervous system apoe levels lipidation astrocyte secreted apoe suzanne e wahrle hong jiang maia parsadanian justin legleiter xianlin han john d fryer tomasz kowalewski david m holtzman
0.36494276.15269217.html.plaintext.txt	2	program neurosciences department neurology department medicine department molecular biology pharmacology center study nervous system injury alzheimers disease research center washington university st louis missouri 63110 department chemistry carnegie mellon university pittsburgh pennsylvania 15213
0.36494276.15269217.html.plaintext.txt	3	program neurosciences department neurology department medicine department molecular biology pharmacology center study nervous system injury alzheimers disease research center washington university st louis missouri 63110 department chemistry carnegie mellon university pittsburgh pennsylvania 15213
0.36494276.15269217.html.plaintext.txt	4	received publication july 14 2004
0.36494276.15269217.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references abca1 atp binding cassette protein transports cellular cholesterol phospholipids onto high density lipoproteins hdl plasma lack abca1 humans mice causes abnormal lipidation increased catabolism hdl resulting low plasma apoa apoa ii hdl herein used abca1 mice ask whether abca1 involved lipidation hdl central nervous system cns apoe abundant cns apolipoprotein present hdl like lipoproteins csf found abca1 mice greatly decreased apoe levels cortex 80 reduction csf 98 reduction csf abca1 mice significantly reduced cholesterol well small apoe containing lipoproteins suggesting abnormal lipidation apoe astrocytes primary producer cns apoe cultured abca1 mice nascent lipoprotein particles collected abca1 astrocytes secreted lipoprotein particles markedly decreased cholesterol apoe smaller apoe containing particles particles abca1 astrocytes findings demonstrate abca1 plays critical role cns apoe metabolism since apoe isoforms levels strongly influence alzheimers disease pathology risk data suggest abca1 may novel therapeutic target
0.36494276.15269217.html.plaintext.txt	6	abstract top abstract introduction experimental procedures results discussion references abca1 atp binding cassette protein transports cellular cholesterol phospholipids onto high density lipoproteins hdl plasma lack abca1 humans mice causes abnormal lipidation increased catabolism hdl resulting low plasma apoa apoa ii hdl herein used abca1 mice ask whether abca1 involved lipidation hdl central nervous system cns apoe abundant cns apolipoprotein present hdl like lipoproteins csf found abca1 mice greatly decreased apoe levels cortex 80 reduction csf 98 reduction csf abca1 mice significantly reduced cholesterol well small apoe containing lipoproteins suggesting abnormal lipidation apoe astrocytes primary producer cns apoe cultured abca1 mice nascent lipoprotein particles collected abca1 astrocytes secreted lipoprotein particles markedly decreased cholesterol apoe smaller apoe containing particles particles abca1 astrocytes findings demonstrate abca1 plays critical role cns apoe metabolism since apoe isoforms levels strongly influence alzheimers disease pathology risk data suggest abca1 may novel therapeutic target
0.36494276.15269217.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references abca1 founding member atp binding cassette abc1 family transporters largest group transmembrane transporters 48 known family members humans 1 abc transporters share homology atp binding domain use atp translocate wide variety substrates across extra intracellular membranes 2 defects abc transporters cause least 14 known genetic diseases 3
0.36494276.15269217.html.plaintext.txt	8	introduction top abstract introduction experimental procedures results discussion references abca1 founding member atp binding cassette abc1 family transporters largest group transmembrane transporters 48 known family members humans 1 abc transporters share homology atp binding domain use atp translocate wide variety substrates across extra intracellular membranes 2 defects abc transporters cause least 14 known genetic diseases 3
0.36494276.15269217.html.plaintext.txt	9	abca1 transports cellular cholesterol phospholipids cells onto high density lipoproteins hdl plasma 4 5 humans loss function mutations abca1 cause tangiers disease 6 9 characterized accumulation cholesterol lymphatic tissues increased catabolism abnormally lipidated hdl resulting low levels plasma hdl hdl associated apolipoproteins apoa ii apoa ii 10 11 abca1 knock mice abca1 produced mice similar phenotype patients tangiers disease 12
0.36494276.15269217.html.plaintext.txt	10	abca1 transports cellular cholesterol phospholipids cells onto high density lipoproteins hdl plasma 4 5 humans loss function mutations abca1 cause tangiers disease 6 9 characterized accumulation cholesterol lymphatic tissues increased catabolism abnormally lipidated hdl resulting low levels plasma hdl hdl associated apolipoproteins apoa ii apoa ii 10 11 abca1 knock mice abca1 produced mice similar phenotype patients tangiers disease 12
0.36494276.15269217.html.plaintext.txt	11	however neither tangiers disease patients abca1 mice examined determine whether abca1 plays role lipidation metabolism lipoproteins central nervous system cns abundant apolipoprotein cns apolipoprotein e apoe produced within cns primarily astrocytes extent microglia 13 17 apoe present brain tissue cerebrospinal fluid csf present hdl like particles 18 20 analyzing brain tissue csf plasma primary astrocyte cultures abca1 mice determined deletion abca1 markedly affects metabolism apoe cholesterol cns nascent lipoprotein particles secreted cultured astrocytes findings implications neurological diseases involving apoe alzheimers disease
0.36494276.15269217.html.plaintext.txt	12	however neither tangiers disease patients abca1 mice examined determine whether abca1 plays role lipidation metabolism lipoproteins central nervous system cns abundant apolipoprotein cns apolipoprotein e apoe produced within cns primarily astrocytes extent microglia 13 17 apoe present brain tissue cerebrospinal fluid csf present hdl like particles 18 20 analyzing brain tissue csf plasma primary astrocyte cultures abca1 mice determined deletion abca1 markedly affects metabolism apoe cholesterol cns nascent lipoprotein particles secreted cultured astrocytes findings implications neurological diseases involving apoe alzheimers disease
0.36494276.15269217.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references animals tissue preparation mice heterozygous abca1 null allele dba background obtained jackson laboratory bar harbor strain name dba1 abca1tm1jdm mice similar abnormalities found humans tangiers disease greatly reduced plasma hdl 12 heterozygous mice bred one another generate littermates abca1 genotypes wild type abca1 heterozygous abca1 knock abca1 animals used vivo experiments 10 14 weeks old fluid tissue analysis animals anesthetized pentobarbital csf collected cisterna magna described 21 blood collected cardiac puncture animals perfused pbs heparin 3 unitsml regional brain dissection performed brain samples frozen dry ice
0.36494276.15269217.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references animals tissue preparation mice heterozygous abca1 null allele dba background obtained jackson laboratory bar harbor strain name dba1 abca1tm1jdm mice similar abnormalities found humans tangiers disease greatly reduced plasma hdl 12 heterozygous mice bred one another generate littermates abca1 genotypes wild type abca1 heterozygous abca1 knock abca1 animals used vivo experiments 10 14 weeks old fluid tissue analysis animals anesthetized pentobarbital csf collected cisterna magna described 21 blood collected cardiac puncture animals perfused pbs heparin 3 unitsml regional brain dissection performed brain samples frozen dry ice
0.36494276.15269217.html.plaintext.txt	15	apoe elisa sandwich elisa mouse apoe developed sensitivity 1 ngml 96 well plates coated overnight 05 microgwell mouse monoclonal antibody wu e 4 raised apoe 22 washed pbs blocked 1 milk pbs washed brain samples sonicated 005 tween pbs 1x complete protease inhibitor mixture 1x protease inhibitors roche applied science debris pelleted 10000 x g x 15 min spin supernatant diluted 01 bovine serum albumin 0025 tween pbs conditioned medium plasma csf diluted directly 01 bovine serum albumin 0025 tween pbs standards based pooled plasma c57bl6 mice containing 68 microgml apoe reported previously 23 following sample incubation plate washed 3 microgwell biotinylated goat anti apoe added antibody calbiochem catalog number 178479 biotinylated using biotin maleimide reagent vector laboratories burlingame ca incubation secondary antibody plate washed poly horseradish peroxidase streptavidin pierce added 16000 incubated plate washed developed tetramethylbenzidine sigma read 650 nm biotek 600 plate reader bio tek instruments winooski vt
0.36494276.15269217.html.plaintext.txt	16	apoe elisa sandwich elisa mouse apoe developed sensitivity 1 ngml 96 well plates coated overnight 05 microgwell mouse monoclonal antibody wu e 4 raised apoe 22 washed pbs blocked 1 milk pbs washed brain samples sonicated 005 tween pbs 1x complete protease inhibitor mixture 1x protease inhibitors roche applied science debris pelleted 10000 x g x 15 min spin supernatant diluted 01 bovine serum albumin 0025 tween pbs conditioned medium plasma csf diluted directly 01 bovine serum albumin 0025 tween pbs standards based pooled plasma c57bl6 mice containing 68 microgml apoe reported previously 23 following sample incubation plate washed 3 microgwell biotinylated goat anti apoe added antibody calbiochem catalog number 178479 biotinylated using biotin maleimide reagent vector laboratories burlingame ca incubation secondary antibody plate washed poly horseradish peroxidase streptavidin pierce added 16000 incubated plate washed developed tetramethylbenzidine sigma read 650 nm biotek 600 plate reader bio tek instruments winooski vt
0.36494276.15269217.html.plaintext.txt	17	real time rt pcr mouse apoe following perfusion animals samples cortex placed rnalater ambion austin tx stored 4 degrees c rna extracted using rneasy lipid tissue kit qiagen valencia ca column dnase digestion rna quantified bio rad smartspec 3000 bio rad forward primer used mouse apoe 5 ccgtgctgttggtcacattgctgacaggat 3 reverse primer 5 gttcttgtgtgacttgggagctctgcagct 3 18 primerprobe reagent used normalization rna levels abi foster city ca brilliant sybr green qrt pcr master mix kit 1 step stratagene la jolla ca used reverse transcription rt pcr reaction master mix rtrnase block mix added 1 microm forward reverse primers 15 microgml rna apoe 18 rt pcr samples cycled abi prism 7000 sequence detection system following temperatures 1 50 degrees c 30 min 2 95 degrees c 10 min 3 96 degrees c 30 4 54 degrees c 1 min 5 72 degrees c 30 min 6 repeat steps 3 5 40 times standard curves critical threshold versus log concentration plotted rna wild type mouse cortex relative transcript levels calculated using abi software accompanied prism 7000
0.36494276.15269217.html.plaintext.txt	18	real time rt pcr mouse apoe following perfusion animals samples cortex placed rnalater ambion austin tx stored 4 degrees c rna extracted using rneasy lipid tissue kit qiagen valencia ca column dnase digestion rna quantified bio rad smartspec 3000 bio rad forward primer used mouse apoe 5 ccgtgctgttggtcacattgctgacaggat 3 reverse primer 5 gttcttgtgtgacttgggagctctgcagct 3 18 primerprobe reagent used normalization rna levels abi foster city ca brilliant sybr green qrt pcr master mix kit 1 step stratagene la jolla ca used reverse transcription rt pcr reaction master mix rtrnase block mix added 1 microm forward reverse primers 15 microgml rna apoe 18 rt pcr samples cycled abi prism 7000 sequence detection system following temperatures 1 50 degrees c 30 min 2 95 degrees c 10 min 3 96 degrees c 30 4 54 degrees c 1 min 5 72 degrees c 30 min 6 repeat steps 3 5 40 times standard curves critical threshold versus log concentration plotted rna wild type mouse cortex relative transcript levels calculated using abi software accompanied prism 7000
0.36494276.15269217.html.plaintext.txt	19	apoj western blot samples cortex sonicated 1x radioimmune precipitation buffer 1x protease inhibitors radioimmune precipitation buffer insoluble material removed spinning 10000 x g x 15 min 25 microg total proteinwell run 10 bis tris gel invitrogen transferred onto nitrocellulose membrane blot probed rabbit anti apoj antibody developed laboratory 24 washed probed anti rabbit igg linked horseradish peroxidase amersham biosciences bands visualized enhanced chemiluminescence pierce imaged kodak image station eastman kodak co
0.36494276.15269217.html.plaintext.txt	20	apoj western blot samples cortex sonicated 1x radioimmune precipitation buffer 1x protease inhibitors radioimmune precipitation buffer insoluble material removed spinning 10000 x g x 15 min 25 microg total proteinwell run 10 bis tris gel invitrogen transferred onto nitrocellulose membrane blot probed rabbit anti apoj antibody developed laboratory 24 washed probed anti rabbit igg linked horseradish peroxidase amersham biosciences bands visualized enhanced chemiluminescence pierce imaged kodak image station eastman kodak co
0.36494276.15269217.html.plaintext.txt	21	cholesterol phospholipid analyses brain samples prepared cholesterol analysis sonication pbs homogenized whole brain suspension subjected enzymatic analysis total cholesterol using amplex red cholesterol kit molecular probes eugene results using homogenized brain suspension identical using chloroform extracted lipids brain data shown csf astrocyte conditioned medium diluted reaction buffer assayed free cholesterol measured using kit omitting cholesterol esterase enzyme esterified cholesterol calculated total cholesterol minus free cholesterol quantification phospholipids species performed electrospray ionization mass spectrometry described previously 25
0.36494276.15269217.html.plaintext.txt	22	cholesterol phospholipid analyses brain samples prepared cholesterol analysis sonication pbs homogenized whole brain suspension subjected enzymatic analysis total cholesterol using amplex red cholesterol kit molecular probes eugene results using homogenized brain suspension identical using chloroform extracted lipids brain data shown csf astrocyte conditioned medium diluted reaction buffer assayed free cholesterol measured using kit omitting cholesterol esterase enzyme esterified cholesterol calculated total cholesterol minus free cholesterol quantification phospholipids species performed electrospray ionization mass spectrometry described previously 25
0.36494276.15269217.html.plaintext.txt	23	histological analysis tissue sections cut coronal plane 50 microm freezing sliding microtome mounted superfrost plus slides fisher oil red o staining neutral fat slides dipped consecutively 70 ethanol 1 immersed 5 min 1 oil red o sigma 35 ethanol 50 acetone slides washed water counterstained 2 min harris hematoxylin sigma washed water slides dipped ammonia water 005 ammonium hydroxide blue washed mounted staining cresyl violet nuclei luxol fast blue identify myelin performed described previously 26 27
0.36494276.15269217.html.plaintext.txt	24	histological analysis tissue sections cut coronal plane 50 microm freezing sliding microtome mounted superfrost plus slides fisher oil red o staining neutral fat slides dipped consecutively 70 ethanol 1 immersed 5 min 1 oil red o sigma 35 ethanol 50 acetone slides washed water counterstained 2 min harris hematoxylin sigma washed water slides dipped ammonia water 005 ammonium hydroxide blue washed mounted staining cresyl violet nuclei luxol fast blue identify myelin performed described previously 26 27
0.36494276.15269217.html.plaintext.txt	25	non denaturing gradient gel electrophoresis samples csf astrocyte conditioned medium acm mixed 11 native sample buffer electrophoresed 4 20 tris glycine gel invitrogen proteins known hydrated diameters used size standards amersham biosciences catalog number 17044501 proteins transferred nitrocellulose membrane apoe immunoblotting membrane probed goat anti mouse apoe antibody 1100 m 20 santa cruz biotechnology santa cruz ca washed probed horse anti goat igg linked horseradish peroxidase 11000 vector laboratories apoa immunoblotting membrane probed rabbit anti mouse apoa antibody 1500 biodesign saco washed probed goat anti rabbit igg linked horseradish peroxidase 11000 bio rad bands visualized enhanced chemiluminescence sigma imaged kodak image station kodak
0.36494276.15269217.html.plaintext.txt	26	non denaturing gradient gel electrophoresis samples csf astrocyte conditioned medium acm mixed 11 native sample buffer electrophoresed 4 20 tris glycine gel invitrogen proteins known hydrated diameters used size standards amersham biosciences catalog number 17044501 proteins transferred nitrocellulose membrane apoe immunoblotting membrane probed goat anti mouse apoe antibody 1100 m 20 santa cruz biotechnology santa cruz ca washed probed horse anti goat igg linked horseradish peroxidase 11000 vector laboratories apoa immunoblotting membrane probed rabbit anti mouse apoa antibody 1500 biodesign saco washed probed goat anti rabbit igg linked horseradish peroxidase 11000 bio rad bands visualized enhanced chemiluminescence sigma imaged kodak image station kodak
0.36494276.15269217.html.plaintext.txt	27	primary astrocyte cultures primary cultures forebrain astrocytes 95 pure prepared individual neonatal 1 3 day old mice described previously 28 astrocytes grown dulbeccos modified eagles mediumf 12 containing 10 fetal bovine serum 10 heat inactivated horse serum 1 mm sodium pyruvate 100 unitsml penicillin 100 microgml streptomycin 250 ngml fungizone 10 ngml epidermal growth factor sigma
0.36494276.15269217.html.plaintext.txt	28	primary astrocyte cultures primary cultures forebrain astrocytes 95 pure prepared individual neonatal 1 3 day old mice described previously 28 astrocytes grown dulbeccos modified eagles mediumf 12 containing 10 fetal bovine serum 10 heat inactivated horse serum 1 mm sodium pyruvate 100 unitsml penicillin 100 microgml streptomycin 250 ngml fungizone 10 ngml epidermal growth factor sigma
0.36494276.15269217.html.plaintext.txt	29	obtain acm confluent astrocyte cultures washed twice sterile pbs serum free medium added dulbeccos modified eagles mediumf 12 1 n2 supplement invitrogen 1 mm sodium pyruvate 100 unitsml penicillin 100 microgml streptomycin 250 ngml fungizone cells incubated 3 days media collected spun 2000 x g x 10 min remove cellular debris 01 sodium azide 1x protease inhibitors added acm stored 4 degrees c analysis following harvesting acm astrocytes scraped flasks washed pbs pelleted sonicated pbs
0.36494276.15269217.html.plaintext.txt	30	obtain acm confluent astrocyte cultures washed twice sterile pbs serum free medium added dulbeccos modified eagles mediumf 12 1 n2 supplement invitrogen 1 mm sodium pyruvate 100 unitsml penicillin 100 microgml streptomycin 250 ngml fungizone cells incubated 3 days media collected spun 2000 x g x 10 min remove cellular debris 01 sodium azide 1x protease inhibitors added acm stored 4 degrees c analysis following harvesting acm astrocytes scraped flasks washed pbs pelleted sonicated pbs
0.36494276.15269217.html.plaintext.txt	31	fractionation acm acm concentrated 40 fold 10 kda molecular mass cut spin concentrator millipore billerica ma 1 ml concentrated acm subjected gel filtration chromatography using biologic system bio rad tandem superose 6 hr 1030 columns amersham biosciences 015 nacl 0001 edta 002 sodium azide described previously 29
0.36494276.15269217.html.plaintext.txt	32	fractionation acm acm concentrated 40 fold 10 kda molecular mass cut spin concentrator millipore billerica ma 1 ml concentrated acm subjected gel filtration chromatography using biologic system bio rad tandem superose 6 hr 1030 columns amersham biosciences 015 nacl 0001 edta 002 sodium azide described previously 29
0.36494276.15269217.html.plaintext.txt	33	atomic force microscopy afm fraction 37 abca1 acm fraction 51 abca1 stored 4 degrees c afm analysis samples analyzed situ afm described previously 30
0.36494276.15269217.html.plaintext.txt	34	atomic force microscopy afm fraction 37 abca1 acm fraction 51 abca1 stored 4 degrees c afm analysis samples analyzed situ afm described previously 30
0.36494276.15269217.html.plaintext.txt	35	results top abstract introduction experimental procedures results discussion references plasma cns apolipoprotein levels abca1 mice previous studies shown near absence plasma hdl apoa abca1 mice consistent role abca1 cellular cholesterol phospholipid efflux onto plasma hdl 12 apoe also constituent plasma hdl measured plasma apoe levels found decreased 96 54 abca1 abca1 mice respectively compared wild type littermates fig 1a
0.36494276.15269217.html.plaintext.txt	36	results top abstract introduction experimental procedures results discussion references plasma cns apolipoprotein levels abca1 mice previous studies shown near absence plasma hdl apoa abca1 mice consistent role abca1 cellular cholesterol phospholipid efflux onto plasma hdl 12 apoe also constituent plasma hdl measured plasma apoe levels found decreased 96 54 abca1 abca1 mice respectively compared wild type littermates fig 1a
0.36494276.15269217.html.plaintext.txt	37	view larger version 21k fig 1 levels apoe apoj abca1 mice c apoe levels plasma csf cortex measured elisa cortical apoe levels normalized total protein tp d relative mrna levels apoe determined real time rt pcr normalized 18 rna relative mrna level apoe cortex 0 d n 5 mice per genotype e levels apoj cortex determined western blotting 25 microg total protein mouse n 6 abca1 n 5 abca1 bands visible cortical homogenate apoj mouse ns significant
0.36494276.15269217.html.plaintext.txt	38	unlike plasma contains variety lipoprotein classes apoa major apoprotein constituent hdl csf hdl like lipoproteins apoe abundant apoprotein apoe csf derived cns plasma 13 determine whether abca1 plays role cns apoe metabolism measured apoe levels csf brain abca1 deficient mice interestingly apoe levels csf reduced similar extent plasma abca1 mice 98 abca1 mice 46 reductions apoe levels relative wild type littermates fig 1b brain tissue apoe levels cortex reduced 80 13 abca1 mice respectively compared wild type littermates fig 1c real time rt pcr apoe mrna performed cortex abca1 mice determine whether differences apoe protein levels related gene expression differences apoe mrna levels three genotypes fig 1d suggesting abca1 affects apoe levels post transcriptionally cns
0.36494276.15269217.html.plaintext.txt	39	unlike plasma contains variety lipoprotein classes apoa major apoprotein constituent hdl csf hdl like lipoproteins apoe abundant apoprotein apoe csf derived cns plasma 13 determine whether abca1 plays role cns apoe metabolism measured apoe levels csf brain abca1 deficient mice interestingly apoe levels csf reduced similar extent plasma abca1 mice 98 abca1 mice 46 reductions apoe levels relative wild type littermates fig 1b brain tissue apoe levels cortex reduced 80 13 abca1 mice respectively compared wild type littermates fig 1c real time rt pcr apoe mrna performed cortex abca1 mice determine whether differences apoe protein levels related gene expression differences apoe mrna levels three genotypes fig 1d suggesting abca1 affects apoe levels post transcriptionally cns
0.36494276.15269217.html.plaintext.txt	40	second abundant apoprotein produced cns apolipoprotein j clusterin present hdl like particles csf 19 determine whether abca1 plays role metabolism apoj similar manner apoe measured apoj levels plasma csf cortex found significant differences among different abca1 genotypes fig 1e data shown apoa major component plasma hdl synthesized primarily periphery enters cns small quantities relation high plasma concentration 14 levels greatly decreased csf cortex abca1 mice see fig 3b also data shown since apoa levels plasma abca1 mice near zero 14 cns apoa derived mostly plasma expected result
0.36494276.15269217.html.plaintext.txt	41	second abundant apoprotein produced cns apolipoprotein j clusterin present hdl like particles csf 19 determine whether abca1 plays role metabolism apoj similar manner apoe measured apoj levels plasma csf cortex found significant differences among different abca1 genotypes fig 1e data shown apoa major component plasma hdl synthesized primarily periphery enters cns small quantities relation high plasma concentration 14 levels greatly decreased csf cortex abca1 mice see fig 3b also data shown since apoa levels plasma abca1 mice near zero 14 cns apoa derived mostly plasma expected result
0.36494276.15269217.html.plaintext.txt	42	view larger version 45k fig 3 analysis csf acm determination lipoprotein size csf acm run non denaturing gradient gels probed apoe c apoa b 1 microl csf abca1 mice loaded lane 20 microl abca1 apoe csf loaded b 20 microl csf abca1 apoa 1 microl csf abca1 mice loaded run lane c 20 microl acm abca1 astrocytes loaded run lane apoe acm control bands data shown d e apoe total cholesterol tc acm measured elisa enzymatic assay respectively normalized total protein tp astrocyte cell lysates ns significant
0.36494276.15269217.html.plaintext.txt	43	lipids csf cortex abca1 mice since major function abca1 outside cns transport cholesterol phospholipids onto hdl examined whether abca1 deficiency altered levels cholesterol phospholipids within cns found total cholesterol csf reduced 24 abca1 mice compared wild type littermates fig 2a likely abca1 deficiency results decreased levels hdl lipoprotein class normally carries proportion cholesterol csf contrast csf total cholesterol levels brain tissue cortex significantly different abca1 mice fig 2b cholesterol esters cortex represented less 5 total cholesterol also significantly different data shown anionic phospholipids choline glycerophospholipids sphingomyelins ethanolamine glycerophospholipids measured cortex electrospray ionization mass spectrometry vary significantly abca1 mice n 5 group data shown
0.36494276.15269217.html.plaintext.txt	44	lipids csf cortex abca1 mice since major function abca1 outside cns transport cholesterol phospholipids onto hdl examined whether abca1 deficiency altered levels cholesterol phospholipids within cns found total cholesterol csf reduced 24 abca1 mice compared wild type littermates fig 2a likely abca1 deficiency results decreased levels hdl lipoprotein class normally carries proportion cholesterol csf contrast csf total cholesterol levels brain tissue cortex significantly different abca1 mice fig 2b cholesterol esters cortex represented less 5 total cholesterol also significantly different data shown anionic phospholipids choline glycerophospholipids sphingomyelins ethanolamine glycerophospholipids measured cortex electrospray ionization mass spectrometry vary significantly abca1 mice n 5 group data shown
0.36494276.15269217.html.plaintext.txt	45	view larger version 74k fig 2 lipids cns abca1 mice b total cholesterol tc levels measured csf cortex enzymatic assay normalized total protein levels cortex genotype n 5 mice tp total protein ns significant c images brain sections stained oil red o
0.36494276.15269217.html.plaintext.txt	46	determine whether lipid buildup brain stained 3 month old abca1 brain sections oil red o evidence abnormal lipid deposition abca1 mice fig 2c standard histological staining methods including cresyl violet nuclei luxol fast blue myelin also revealed abnormalities brains abca1 mice data shown
0.36494276.15269217.html.plaintext.txt	47	determine whether lipid buildup brain stained 3 month old abca1 brain sections oil red o evidence abnormal lipid deposition abca1 mice fig 2c standard histological staining methods including cresyl violet nuclei luxol fast blue myelin also revealed abnormalities brains abca1 mice data shown
0.36494276.15269217.html.plaintext.txt	48	lipoprotein particles csf astrocyte conditioned media abca1 mice addition evaluating effects abca1 deficiency levels lipids apoe cns vivo studied apoe apoa containing lipoproteins csf nascent apoe containing lipoproteins produced astrocytes examine abca1 deficiency affected properties determined size distribution apoe apoa containing lipoproteins mouse csf non denaturing gradient gel electrophoresis described previously 21 apoe csf wild type mice hdl like particles 10 17 nm diameter abundant sizes 13 16 nm fig 3a apoe particles abca1 csf similar size wild type however addition apoe levels csf abca1 markedly reduced apoe present within particles size distribution different wild type mice addition population particles 13 16 nm diameter csf abca1 mice also population smaller apoe containing particles 7 8 nm diameter suggesting poorly lipidated apoa also greatly reduced csf abca1 mice small amount present particles 73 nm compared particles 8 11 nm csf abca1 mice fig 3b
0.36494276.15269217.html.plaintext.txt	49	lipoprotein particles csf astrocyte conditioned media abca1 mice addition evaluating effects abca1 deficiency levels lipids apoe cns vivo studied apoe apoa containing lipoproteins csf nascent apoe containing lipoproteins produced astrocytes examine abca1 deficiency affected properties determined size distribution apoe apoa containing lipoproteins mouse csf non denaturing gradient gel electrophoresis described previously 21 apoe csf wild type mice hdl like particles 10 17 nm diameter abundant sizes 13 16 nm fig 3a apoe particles abca1 csf similar size wild type however addition apoe levels csf abca1 markedly reduced apoe present within particles size distribution different wild type mice addition population particles 13 16 nm diameter csf abca1 mice also population smaller apoe containing particles 7 8 nm diameter suggesting poorly lipidated apoa also greatly reduced csf abca1 mice small amount present particles 73 nm compared particles 8 11 nm csf abca1 mice fig 3b
0.36494276.15269217.html.plaintext.txt	50	abca1 mice low csf apoe levels altered particle size distribution led us investigate whether primary alteration nascently produced apoe containing hdl astrocytes cells produce majority apoe cns compared total cholesterol apoe acm derived primary astrocyte cultures abca1 mice found total levels apoe acm vary abca1 genotype fig 3e however levels total cholesterol significantly lower abca1 acm fig 3d suggests apoe secreted normal levels abca1 astrocytes apoe normally lipidated absence abca1
0.36494276.15269217.html.plaintext.txt	51	abca1 mice low csf apoe levels altered particle size distribution led us investigate whether primary alteration nascently produced apoe containing hdl astrocytes cells produce majority apoe cns compared total cholesterol apoe acm derived primary astrocyte cultures abca1 mice found total levels apoe acm vary abca1 genotype fig 3e however levels total cholesterol significantly lower abca1 acm fig 3d suggests apoe secreted normal levels abca1 astrocytes apoe normally lipidated absence abca1
0.36494276.15269217.html.plaintext.txt	52	examine extent lipidation apoe containing particles acm subjected size analysis non denaturing gradient gel electrophoresis followed western blotting apoe demonstrated apoe containing lipoprotein populations 12 11 8 nm acm abca1 mice much smaller lipoproteins acm abca1 mice 73 7 nm fig 3c data suggested apoe containing particles abca1 acm likely lipid poor
0.36494276.15269217.html.plaintext.txt	53	examine extent lipidation apoe containing particles acm subjected size analysis non denaturing gradient gel electrophoresis followed western blotting apoe demonstrated apoe containing lipoprotein populations 12 11 8 nm acm abca1 mice much smaller lipoproteins acm abca1 mice 73 7 nm fig 3c data suggested apoe containing particles abca1 acm likely lipid poor
0.36494276.15269217.html.plaintext.txt	54	analyze lipid composition astrocyte secreted lipoproteins acm fractionated size exclusion chromatography apoe elisas cholesterol assays different fractions demonstrated lipoproteins abca1 acm contain less apoe smaller markedly less cholesterol abca1 acm fig 4 b lipoprotein associated apoe reduced abca1 acm 80 compared abca1 acm expected 75 apoe abca1 acm fractions 31 41 corresponding hdl size range however 75 lipoprotein associated apoe abca1 acm fractions 45 55 corresponds much smaller particles smaller lipoprotein particles derived abca1 astrocytes cholesterol poor compared abca1 particles 069 microg total cholesterol microg apoe abca1 versus 23 microg total cholesterol microg apoe abca1
0.36494276.15269217.html.plaintext.txt	55	analyze lipid composition astrocyte secreted lipoproteins acm fractionated size exclusion chromatography apoe elisas cholesterol assays different fractions demonstrated lipoproteins abca1 acm contain less apoe smaller markedly less cholesterol abca1 acm fig 4 b lipoprotein associated apoe reduced abca1 acm 80 compared abca1 acm expected 75 apoe abca1 acm fractions 31 41 corresponding hdl size range however 75 lipoprotein associated apoe abca1 acm fractions 45 55 corresponds much smaller particles smaller lipoprotein particles derived abca1 astrocytes cholesterol poor compared abca1 particles 069 microg total cholesterol microg apoe abca1 versus 23 microg total cholesterol microg apoe abca1
0.36494276.15269217.html.plaintext.txt	56	view larger version 34k fig 4 fractionation size analysis lipoproteins acm following size exclusion gel filtration fractions subjected analysis apoe total cholesterol tc acm measured elisa enzymatic assay respectively normalized total protein tp astrocyte cell lysates b genotype n 4 fraction 37 fr 37 abca1 acm fraction 51 fr 51 abca1 acm subjected atomic force microscopy determine appearance size lipoprotein particles c volumes lipoprotein particles obtained afm corrected finite size tip
0.36494276.15269217.html.plaintext.txt	57	confirm size shape abnormal abca1 particles afm performed size exclusion chromatography fractions abca1 abca1 acm highest apoe levels afm tool choice allows characterization three dimensional shape nanoparticles nearly physiological conditions use study lipoprotein particles protocols needed obtain reliable volume measurements recently described elsewhere 31 afm images obtained demonstrate abundant apoe containing particles abca1 acm significantly smaller abca1 acm fig 4c
0.36494276.15269217.html.plaintext.txt	58	confirm size shape abnormal abca1 particles afm performed size exclusion chromatography fractions abca1 abca1 acm highest apoe levels afm tool choice allows characterization three dimensional shape nanoparticles nearly physiological conditions use study lipoprotein particles protocols needed obtain reliable volume measurements recently described elsewhere 31 afm images obtained demonstrate abundant apoe containing particles abca1 acm significantly smaller abca1 acm fig 4c
0.36494276.15269217.html.plaintext.txt	59	discussion top abstract introduction experimental procedures results discussion references study analyzed brain tissue csf plasma primary astrocyte cultures abca1 mice determine whether deletion abca1 affects metabolism apoe cholesterol phospholipids cns nascent lipoprotein particles secreted astrocytes found abca1 mice greatly decreased apoe levels plasma 96 reduction csf 98 reduction cortex 80 reduction compared abca1 mice decreased apoe levels plasma brain observed similar seen others2 decreased apoe levels cns related apoe gene expression likely result increased catabolism abnormally lipidated apoe containing hdl lipoproteins produced cns occurs abnormally lipidated apoa apoa ii secreted liver rapidly catabolized plasma tangiers disease patients 10 11
0.36494276.15269217.html.plaintext.txt	60	discussion top abstract introduction experimental procedures results discussion references study analyzed brain tissue csf plasma primary astrocyte cultures abca1 mice determine whether deletion abca1 affects metabolism apoe cholesterol phospholipids cns nascent lipoprotein particles secreted astrocytes found abca1 mice greatly decreased apoe levels plasma 96 reduction csf 98 reduction cortex 80 reduction compared abca1 mice decreased apoe levels plasma brain observed similar seen others2 decreased apoe levels cns related apoe gene expression likely result increased catabolism abnormally lipidated apoe containing hdl lipoproteins produced cns occurs abnormally lipidated apoa apoa ii secreted liver rapidly catabolized plasma tangiers disease patients 10 11
0.36494276.15269217.html.plaintext.txt	61	although alterations cns apoe levels profound differences total cns lipids subtle present csf brain tissue abca1 mice differences free cholesterol esterified cholesterol phospholipids showed evidence lipid deposition histological staining results suggest abca1 play major role regulating global cellular lipid levels brain tissue vivo regulation performed additional molecules however csf abca1 mice significantly reduced cholesterol showing abca1 important regulating extracellular lipid levels cns
0.36494276.15269217.html.plaintext.txt	62	although alterations cns apoe levels profound differences total cns lipids subtle present csf brain tissue abca1 mice differences free cholesterol esterified cholesterol phospholipids showed evidence lipid deposition histological staining results suggest abca1 play major role regulating global cellular lipid levels brain tissue vivo regulation performed additional molecules however csf abca1 mice significantly reduced cholesterol showing abca1 important regulating extracellular lipid levels cns
0.36494276.15269217.html.plaintext.txt	63	conditioned media collected primary cultures astrocytes derived abca1 mice showed although total levels apoe secreted astrocytes affected abca1 genotype secretion cholesterol media markedly reduced abca1 cultures consistent abca1 role transporting astrocyte derived cellular cholesterol onto lipoproteins function may occur astrocyte secretory pathway extracellularly analysis nascent lipoprotein particles isolated conditioned media primary astrocyte cultures demonstrated abca1 astrocytes secrete apoe containing particles markedly smaller size reduced cholesterol apoe demonstrating abca1 required main cellular producer apoe cns normally lipidate apoe apoe produced cns cells astrocytes reach csf abca1 mice fraction particles present also abnormally small although normal size thus appears mechanism require abca1 lipidate apoe reaches csf however fact csf apoe levels abca1 2 normal suggests non abca1 mediated pathway inefficient apoe particles produced absence abca1 mediated lipidation rapidly metabolized cns
0.36494276.15269217.html.plaintext.txt	64	conditioned media collected primary cultures astrocytes derived abca1 mice showed although total levels apoe secreted astrocytes affected abca1 genotype secretion cholesterol media markedly reduced abca1 cultures consistent abca1 role transporting astrocyte derived cellular cholesterol onto lipoproteins function may occur astrocyte secretory pathway extracellularly analysis nascent lipoprotein particles isolated conditioned media primary astrocyte cultures demonstrated abca1 astrocytes secrete apoe containing particles markedly smaller size reduced cholesterol apoe demonstrating abca1 required main cellular producer apoe cns normally lipidate apoe apoe produced cns cells astrocytes reach csf abca1 mice fraction particles present also abnormally small although normal size thus appears mechanism require abca1 lipidate apoe reaches csf however fact csf apoe levels abca1 2 normal suggests non abca1 mediated pathway inefficient apoe particles produced absence abca1 mediated lipidation rapidly metabolized cns
0.36494276.15269217.html.plaintext.txt	65	apoe apoj two major apoproteins produced astrocytes secreted unique apoe apoj containing particles 33 apoe secreted astrocytes present particles contain approximately equal mass apoe cholesterol phospholipids 21 furthermore virtually cholesterol phospholipids secreted astrocytes associated apoe 33 contrast apoj secreted astrocytes little associated cholesterol phospholipids 21 found present normal levels brains abca1 mice thus apoj particles stable absence abca1 possibly normally lipid poor require extensive lipidation stability
0.36494276.15269217.html.plaintext.txt	66	apoe apoj two major apoproteins produced astrocytes secreted unique apoe apoj containing particles 33 apoe secreted astrocytes present particles contain approximately equal mass apoe cholesterol phospholipids 21 furthermore virtually cholesterol phospholipids secreted astrocytes associated apoe 33 contrast apoj secreted astrocytes little associated cholesterol phospholipids 21 found present normal levels brains abca1 mice thus apoj particles stable absence abca1 possibly normally lipid poor require extensive lipidation stability
0.36494276.15269217.html.plaintext.txt	67	data demonstrate complete loss abca1 profoundly affects apoe levels cns additionally since abca1 mice intermediate apoe levels subtle alterations abca1 gene dosage andor functionality may affect apoe metabolism apoe genotype major risk factor alzheimers disease ad cerebral amyloid angiopathy caa 34 36 apoe genotype may also influence neurologic prognosis intracerebral hemorrhage 37 traumatic brain injury 38 multiple sclerosis 39 effects apoe ad caa likely mediated large part role apoe role amyloid chaperone influences clearance fibrillogenesis 40 amyloid precursor protein transgenic mice develop many pathological changes seen ad caa level apoe regardless species genotype markedly influences time onset conformation amount peptide accumulates brain age 41 45 example amyloid precursor protein transgenic mice crossed apoe mice animals lacking apoe almost fibrillar deposition neuritic plaques caa apoe mice less 50 much related pathology apoe mice 41 44 results show alterations cns apoe levels little 50 massive effects ad like pathology cns since abca1 regulates level apoe well state lipidation modulation abca1 levels function likely directly influence apoea interactions along deposition negative consequences brain addition effects abca1 apoe recent studies also suggest abca1 influence cellular production 46 48 effects likely independent apoe since alterations abca1 expression levels affect cell types express apoe several studies also suggest direct link abca1 polymorphisms risk ad 32 49 50
0.36494276.15269217.html.plaintext.txt	68	data demonstrate complete loss abca1 profoundly affects apoe levels cns additionally since abca1 mice intermediate apoe levels subtle alterations abca1 gene dosage andor functionality may affect apoe metabolism apoe genotype major risk factor alzheimers disease ad cerebral amyloid angiopathy caa 34 36 apoe genotype may also influence neurologic prognosis intracerebral hemorrhage 37 traumatic brain injury 38 multiple sclerosis 39 effects apoe ad caa likely mediated large part role apoe role amyloid chaperone influences clearance fibrillogenesis 40 amyloid precursor protein transgenic mice develop many pathological changes seen ad caa level apoe regardless species genotype markedly influences time onset conformation amount peptide accumulates brain age 41 45 example amyloid precursor protein transgenic mice crossed apoe mice animals lacking apoe almost fibrillar deposition neuritic plaques caa apoe mice less 50 much related pathology apoe mice 41 44 results show alterations cns apoe levels little 50 massive effects ad like pathology cns since abca1 regulates level apoe well state lipidation modulation abca1 levels function likely directly influence apoea interactions along deposition negative consequences brain addition effects abca1 apoe recent studies also suggest abca1 influence cellular production 46 48 effects likely independent apoe since alterations abca1 expression levels affect cell types express apoe several studies also suggest direct link abca1 polymorphisms risk ad 32 49 50
0.36494276.15269217.html.plaintext.txt	69	summary shown abca1 required normal cns apoe levels vivo well production normally lipidated apoe containing lipoproteins astrocytes since apoe levels cns profoundly influence ad caa pathology vivo modulation abca1 function levels may novel therapeutic target ad caa diseases cns
0.36494276.15269217.html.plaintext.txt	70	summary shown abca1 required normal cns apoe levels vivo well production normally lipidated apoe containing lipoproteins astrocytes since apoe levels cns profoundly influence ad caa pathology vivo modulation abca1 function levels may novel therapeutic target ad caa diseases cns
0.36494276.15269217.html.plaintext.txt	71	footnotes work supported national institutes health grants ag13956 p50 ag05681 ns034467 d m h costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.36494276.15269217.html.plaintext.txt	72	correspondence addressed washington university school medicine dept neurology 660 euclid ave box 8111 st louis mo 63110 tel 314 362 9872 fax 314 362 1771 e mail holtzmanatneurowustledu u d
0.36494276.15269217.html.plaintext.txt	73	1 abbreviations used abc atp binding cassette amyloid peptide acm astrocyte conditioned medium afm atomic force microscopy ad alzheimers disease caa cerebral amyloid angiopathy cns central nervous system csf cerebrospinal fluid hdl high density lipoprotein rt reverse transcription elisa enzyme linked immunosorbent assay pbs phosphate buffered saline apoe apolipoprotein e bis tris 2 bis2 hydroxyethylamino 2 hydroxy methylpropane 13 diol
0.36494276.15269217.html.plaintext.txt	74	acknowledgments thank ravi rajaram kirsten jansen mike spinner dr anne cross dr anne fagan hua cheng technical assistance helpful advice
0.36494276.15269217.html.plaintext.txt	75	references top abstract introduction experimental procedures results discussion references dean m rzhetsky allikmets r 2001 genome res 11 1156 1166abstractfree full text higgins c f 2001 res microbiol 152 205 210crossrefmedline order article via infotrieve klein sarkadi b varadi 1999 biochim biophys acta 1461 237 262medline order article via infotrieve schmitz g langmann 2001 curr opin lipidol 12 129 140crossrefmedline order article via infotrieve wang n tall r 2003 arterioscler thromb vasc biol 23 1178 1184abstractfree full text brooks wilson marcil m clee m zhang l h roomp k van dam m yu l brewer c collins j molhuizen h o loubser o ouelette b f fichter k ashbourne excoffon k j sensen c w scherer mott denis m martindale d frohlich j morgan k koop b pimstone kastelein j j genest j jr hayden m r 1999 nat genet 22 336 345crossrefmedline order article via infotrieve remaley rust rosier m knapper c naudin l broccardo c peterson k m koch c arnould prades c duverger n funke h assman g dinger m dean m chimini g santamarina fojo fredrickson d denefle p brewer h b jr 1999 proc natl acad sci u 96 12685 12690abstractfree full text bodzioch m orso e klucken j langmann bottcher diederich w drobnik w barlage buchler c porsch ozcurumez m kaminski w e hahmann h w oette k rothe g aslanidis c lackner k j schmitz g 1999 nat genet 22 347 351crossrefmedline order article via infotrieve rust rosier m funke h real j amoura z piette j c deleuze j f brewer h b duverger n denefle p assmann g 1999 nat genet 22 352 355crossrefmedline order article via infotrieve schaefer e j anderson d w zech l lindgren f bronzert b rubalcaba e brewer h b jr 1981 j lipid res 22 217 228abstract schaefer e j blum c b levy r jenkins l l alaupovic p foster d m brewer h b jr 1978 n engl j med 299 905 910abstract mcneish j aiello r j guyot d turi gabel c aldinger c hoppe k l roach m l royer l j de wet j broccardo c chimini g francone o l 2000 proc natl acad sci u 97 4245 4250abstractfree full text linton m f gish r hubl butler e esquivel c bry w boyles j k wardell m r young g 1991 j clin invest 88 270 281medline order article via infotrieve boyles j k pitas r e wilson e mahley r w taylor j m 1985 j clin invest 76 1501 1513medline order article via infotrieve newman c dawson p rudel l l williams d l 1985 j biol chem 260 2452 2457abstract pitas r e boyles j k lee h foss d mahley r w 1987 biochim biophys acta 917 148 161medline order article via infotrieve stone d j rozovsky morgan e anderson c p hajian h finch c e 1997 exp neurol 143 313 318crossrefmedline order article via infotrieve pitas r e boyles j k lee h hui d weisgraber k h 1987 j biol chem 262 14352 14360abstractfree full text ladu m j gilligan m lukens j r cabana v g reardon c van eldik l j holtzman d m 1998 j neurochem 70 2070 2081medline order article via infotrieve borghini barja f pometta d james r w 1995 biochim biophys acta 1255 192 200medline order article via infotrieve demattos r b brendza r p heuser j e kierson m cirrito j r fryer j sullivan p m fagan m han x holtzman d m 2001 neurochem int 39 415 425crossrefmedline order article via infotrieve krul e tikkanen m j schonfeld g 1988 j lipid res 29 1309 1325abstract lusis j taylor b quon d zollman leboeuf r c 1987 j biol chem 262 7594 7604abstractfree full text han b h demattos r b dugan l l kim han j brendza r p fryer j d kierson m cirrito j quick k harmony j aronow b j holtzman d m 2001 nat med 7 338 343crossrefmedline order article via infotrieve han x yang j cheng h ye h gross r w 2004 anal biochem 330 317 331crossrefmedline order article via infotrieve holtzman d m li y w dearmond j mckinley m p gage f h epstein c j mobley w c 1992 proc natl acad sci u 89 1383 1387abstract duerstock b 2004 j neurosci methods 134 101 107crossrefmedline order article via infotrieve rose k goldberg m p choi d w 1993 vitro biological methods methods toxicology tyson c frazier j m eds vol 1a pp 46 60 academic press san diego fagan m younkin l h morris j c fryer j d cole g younkin g holtzman d m 2000 ann neurol 48 201 21030co2 x 2 8linktypedoi crossrefmedline order article via infotrieve fryer j d taylor j w demattos r b bales k r paul m parsadanian m holtzman d m 2003 j neurosci 23 7889 7896abstractfree full text fukumoto h deng irizarry m c fitzgerald m l rebeck g w 2002 j biol chem 277 48508 48513abstractfree full text koldamova r p lefterov m ikonomovic m d skoko j lefterov p isanski b dekosky lazo j 2003 j biol chem 278 13244 13256abstractfree full text sun y yao j kim w tall r 2003 j biol chem 278 27688 27694abstractfree full text ho hong rhyne j zeller k miller m 2002 biochim biophys acta 1587 60 64medline order article via infotrieve wollmer m streffer j r lutjohann d tsolaki m iakovidou v hegi pasch jung h h bergmann k nitsch r m hock c papassotiropoulos 2003 neurobiol aging 24 421 426crossrefmedline order article via infotrieve
0.3697104.9700208.html.plaintext.txt	0	pronounced impact th1e47cs mutation compared 491 mutation neural apoe gene expression risk developing alzheimers disease
0.3697104.9700208.html.plaintext.txt	1	jean charles lambert claudine berr1 florence pasquier2 andre delacourte3 bernard frigard4 dominique cottel jordi perez tur5 vincent mouroux michel mohr6 danielle cecyre7 douglas galasko8 corinne lendon9 judes poirier7 john hardy5 david mann10 philippe amouyel marie christine chartier harlin
0.3697104.9700208.html.plaintext.txt	2	inserm cjf95 05 institut pasteur de lille 1 rue du professeur calmette bp 245 59019 lille cedex france 1inserm u360 hopital de la salpetriere 75651 paris cedex 13 france 2chr et u de lille clinique neurologique centre de la memoire hopital salengro 59037 lille cedex france 3inserm u422 place de verdun 59045 lille cedex france 4centre de geriatrie de wasquehal rue salvador allende bp 165 59444 wasquehal france 5birdsall building mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa 6institut de pathologie 1 place de lhopital bp 22 67064 strasbourg cedex france 7mcgill centre studies aging 6875 la salle boulevard verdun quebec canada h4h 1r3 8department neurosciences university california san diego 3350 la jolla village drive san diego ca 9216 usa 9departments psychiatry neurology genetics washington university school medicine st louis mo 63310 usa 10department pathological sciences stopford building university manchester oxford road manchester m13 9pt uk
0.3697104.9700208.html.plaintext.txt	3	received june 1 1998 revised accepted july 8 1998
0.3697104.9700208.html.plaintext.txt	4	possession apolipoprotein e apoe epsis4 allele frequently associated genetic susceptibility factor alzheimers disease ad recently new polymorphisms regulatory region apoe gene described analysed effects three mutations 491 427 ct th1e47cs disease risk large case control study tested impacts apoe allelic expression brain tissues th1e47cs allele associated increased risk occurrence ad 491 allele associated decreased risk independently apoe epsis2epsis3epsis4 polymorphism effect however impact th1e47cs mutation strongest 427 ct polymorphism associated disease ad subjects heterozygous epsis4 allele analysis allelic expression showed relative expression levels epsis4 allele higher corresponding controls consistent epidemiological data relative level expression epsis4 allele modified accordingly presence absence two main promoter polymorphisms indicating vivo deleterious effect th1e47cs allele protective effect 491 allele population data indicate addition qualitative effect apoe epsis2epsis3epsis4 polymorphisms ad occurrence quantitative variation expression alleles due functional apoe promoter mutations key determinant ad development
0.3697104.9700208.html.plaintext.txt	5	possession apolipoprotein e apoe epsis4 allele frequently associated genetic susceptibility factor alzheimers disease ad recently new polymorphisms regulatory region apoe gene described analysed effects three mutations 491 427 ct th1e47cs disease risk large case control study tested impacts apoe allelic expression brain tissues th1e47cs allele associated increased risk occurrence ad 491 allele associated decreased risk independently apoe epsis2epsis3epsis4 polymorphism effect however impact th1e47cs mutation strongest 427 ct polymorphism associated disease ad subjects heterozygous epsis4 allele analysis allelic expression showed relative expression levels epsis4 allele higher corresponding controls consistent epidemiological data relative level expression epsis4 allele modified accordingly presence absence two main promoter polymorphisms indicating vivo deleterious effect th1e47cs allele protective effect 491 allele population data indicate addition qualitative effect apoe epsis2epsis3epsis4 polymorphisms ad occurrence quantitative variation expression alleles due functional apoe promoter mutations key determinant ad development
0.3697104.9700208.html.plaintext.txt	6	presence least one apolipoprotein e apoe epsis4 allele major genetic susceptibility factor late onset familial sporadic alzheimers disease ad risk factor accounts 45 60 cases 1 indeed epsis4 allele associated increased risk ad allele dose dependant manner 23 conversely epsis2 allele protects disease 45 mechanisms apoe isoforms implicated human nervous system physiology influence pathogenesis ad fully understood 26 8 effect apoe epsis2epsis3epsis4 alleles may due intrinsic biochemical properties isoforms coded alleles genetic variants influencing apoe allele expression may account increase decrease level risk ad hypothesis supported firstly preliminary observations relative overexpression epsis4 allele compared epsis3 allele brain patients ad compared controls 9 secondly th1e47cs 491 polymorphisms located apoe promoter described associated ad risk 1011 moreover effect two polymorphisms ad occurrence described separately case control studies prompted us analyse relative contribution two promoter polymorphisms also third located position 427 apoe promoter together epsis2epsis3epsis4 alleles towards ad risk large case control study 509 controls 573 ad cases furthermore investigated possible influences two main polymorphisms apoe epsis2epsis3epsis4 allelic relative expression brain tissues approach vivo functionality brain samples 49 ad cases 45 controls
0.3697104.9700208.html.plaintext.txt	7	presence least one apolipoprotein e apoe epsis4 allele major genetic susceptibility factor late onset familial sporadic alzheimers disease ad risk factor accounts 45 60 cases 1 indeed epsis4 allele associated increased risk ad allele dose dependant manner 23 conversely epsis2 allele protects disease 45 mechanisms apoe isoforms implicated human nervous system physiology influence pathogenesis ad fully understood 26 8 effect apoe epsis2epsis3epsis4 alleles may due intrinsic biochemical properties isoforms coded alleles genetic variants influencing apoe allele expression may account increase decrease level risk ad hypothesis supported firstly preliminary observations relative overexpression epsis4 allele compared epsis3 allele brain patients ad compared controls 9 secondly th1e47cs 491 polymorphisms located apoe promoter described associated ad risk 1011 moreover effect two polymorphisms ad occurrence described separately case control studies prompted us analyse relative contribution two promoter polymorphisms also third located position 427 apoe promoter together epsis2epsis3epsis4 alleles towards ad risk large case control study 509 controls 573 ad cases furthermore investigated possible influences two main polymorphisms apoe epsis2epsis3epsis4 allelic relative expression brain tissues approach vivo functionality brain samples 49 ad cases 45 controls
0.3697104.9700208.html.plaintext.txt	8	expected possession epsis4 allele strongly associated ad odds ratio 540 95 confidence interval ci 411 709 p 00001 presence epsis2 allele exhibited protective effect 047 95 ci 031 070 p 00003 frequency th1e47cs allele increased ad cases compared controls chi2 231 p 00001 table 1 risk developing ad carriers least one allele 213 95 ci 161 283 conversely frequency 491 allele decreased patients compared controls chi2 95 p 0002 genotype allele frequencies 491 polymorphism similar observed north american population differed spanish sample 11 develop ad subjects bearing least one 491 allele 067 95 ci 052 088 p 0004 association disease detected 427 ct polymorphism eliminate possible confounding effects apoe epsis4 allele association th1e47cs 491 polymorphisms ad controlled effects allele using logistic regression adjusted presence absence epsis4 allele adjustment risk associated possession least one th1e47cs allele persisted 156 95 ci 115 211 p 0004 risk associated 491 allele 082 95 ci 062 110 p 019 observation suggested effect th1e47cs allele independent epsis4 allele 491 allele however since th1e47cs g epsis2 alleles complete disequilibrium table 2 also performed logistic regression including protective deleterious effects epsis2 epsis4 alleles respectively risk associated th1e47cs allele still persisted 141 95 ci 103 192 p 003
0.3697104.9700208.html.plaintext.txt	9	expected possession epsis4 allele strongly associated ad odds ratio 540 95 confidence interval ci 411 709 p 00001 presence epsis2 allele exhibited protective effect 047 95 ci 031 070 p 00003 frequency th1e47cs allele increased ad cases compared controls chi2 231 p 00001 table 1 risk developing ad carriers least one allele 213 95 ci 161 283 conversely frequency 491 allele decreased patients compared controls chi2 95 p 0002 genotype allele frequencies 491 polymorphism similar observed north american population differed spanish sample 11 develop ad subjects bearing least one 491 allele 067 95 ci 052 088 p 0004 association disease detected 427 ct polymorphism eliminate possible confounding effects apoe epsis4 allele association th1e47cs 491 polymorphisms ad controlled effects allele using logistic regression adjusted presence absence epsis4 allele adjustment risk associated possession least one th1e47cs allele persisted 156 95 ci 115 211 p 0004 risk associated 491 allele 082 95 ci 062 110 p 019 observation suggested effect th1e47cs allele independent epsis4 allele 491 allele however since th1e47cs g epsis2 alleles complete disequilibrium table 2 also performed logistic regression including protective deleterious effects epsis2 epsis4 alleles respectively risk associated th1e47cs allele still persisted 141 95 ci 103 192 p 003
0.3697104.9700208.html.plaintext.txt	10	assume level expression apoe alleles increased decreased due cis mutations promoter region hypothesis two major implications promoter mutations may modulate expression apoe alleles leading increase decrease deleterious protective risk associated epsis4 epsis2 allele respectively ii given determines risk importance relative level expression alleles apoe suggested preliminary data 12 promoter mutations differential effects detectable mainly apoe epsis2epsis3epsis4 heterozygous individuals verify assumptions studied developing ad apoe heterozygous homozygous individuals using logistic regression adjusted age sex presence least one 491 one th1e47 allele apoe epsis2epsis3epsis4 homozygotes effect found 113 95 ci 077 165 099 95 ci 068 144 th1e47 491 alleles respectively conversely apoe epsis2epsis3epsis4 heterozygotes individuals bearing least one th1e47 allele increased risk developing ad 357 95 ci 222 575 p 00001 individuals bearing least one 491 allele exhibited protective effect 057 95 ci 037 090 p 0014 consistent initial hypothesis
0.3697104.9700208.html.plaintext.txt	11	assume level expression apoe alleles increased decreased due cis mutations promoter region hypothesis two major implications promoter mutations may modulate expression apoe alleles leading increase decrease deleterious protective risk associated epsis4 epsis2 allele respectively ii given determines risk importance relative level expression alleles apoe suggested preliminary data 12 promoter mutations differential effects detectable mainly apoe epsis2epsis3epsis4 heterozygous individuals verify assumptions studied developing ad apoe heterozygous homozygous individuals using logistic regression adjusted age sex presence least one 491 one th1e47 allele apoe epsis2epsis3epsis4 homozygotes effect found 113 95 ci 077 165 099 95 ci 068 144 th1e47 491 alleles respectively conversely apoe epsis2epsis3epsis4 heterozygotes individuals bearing least one th1e47 allele increased risk developing ad 357 95 ci 222 575 p 00001 individuals bearing least one 491 allele exhibited protective effect 057 95 ci 037 090 p 0014 consistent initial hypothesis
0.3697104.9700208.html.plaintext.txt	12	table 1 apoe th1e47cs 491 allele genotype distributions allele genotype apoe epsis2 epsis3 epsis4 epsis2epsis2a epsis2epsis3 epsis2epsis4 epsis3epsis3 epsis3epsis4 epsis4epsis4 controls 75 007 832 082 111 011 4 001 57 011 10 002 344 068 88 017 6 001 ad 40 003 699 061 407 036 16 003 24 004 223 039 237 041 73 013 th1egr47cs g gga gt tt controls 562 055 456 045 162 032 238 047 109 021 ad 515 045 631 055 103 018 308 054 162 028 427 tcb c tt tc cc controls 874 091 88 009 396 082 82 017 3 001 ad 1000 092 86 008 458 084 84 016 1 000 491 aac tt controls 833 082 185 018 343 067 147 029 19 004 ad 993 087 153 013 432 075 129 023 12 002 allele genotype numbers frequencies presentedthe genotypic distributions control population hardy weinberg equilibrium ap 10 4 bnot significant cp 0005
0.3697104.9700208.html.plaintext.txt	13	table 2 combination 491 th1e47cs apoe polymorphism alleles controls ad cases apoe th1e47cs polymorphism combination n epsis2epsis3a epsis3epsis3 epsis3epsis4 epsis4epsis4 epsis2epsis4 ad cases gg 103 5 60 30 3 5 gt 306 11 113 136 27 19 tt 139 49 70 43 n 571 16 222 236 73 24 control cases gg 162 41 100 16 5 gt 238 20 170 40 2 5 tt 109 73 32 4 n 509 61 343 88 6 10 apoe 491 polymorphism combination n epsis2epsis3a epsis3epsis3 epsis3epsis4 epsis4epsis4 epsis2epsis4 ad cases aa 431 6 157 190 67 11 128 8 58 44 6 12 tt 12 2 7 2 1 n 261 16 222 102 28 24 control cases aa 342 24 242 65 5 6 147 34 89 19 1 4 tt 20 3 12 4 n 509 61 343 88 6 10 th1e47cs 491 polymorphism combination n agragr agrsigma sigmasigma ad cases gg 103 79 22 2 gt 307 226 75 6 tt 162 127 31 4 n 572 432 128 12 control cases gg 162 111 48 3 gt 238 162 67 9 tt 109 69 32 8 n 509 342 147 20 athree individuals epsis2epsis2 control 491 epsis4 alleles present degree linkage disequilibrium 26 75 control ad populations respectively th1e47cs g epsis2 alleles complete linkage disequilibrium populations th1e47cs epsis4 alleles show linkage disequilibrium 44 populations linkage disequilibrium found 491 th1e47cs polymorphisms
0.3697104.9700208.html.plaintext.txt	14	location polymorphisms within regulatory region apoe gene potential effect vitro reported hepatoma cells suggested polymorphisms may play role control apoe expression levels brain order test hypothesis obtained 94 ad control brain tissues heterozygous apoe measured percentage expression level three apoe alleles controls epsis4 allele strongly underexpressed compared epsis3 epsis2 allele epsis3epsis4 epsis2epsis4 brain samples respectively epsis2 epsis3 expressions almost similar epsis2epsis3 samples fig 1 suggested preliminary data 9 clear consistent increase relative epsis4 allelic expression epsis3epsis4 patients epsis3epsis4 controls 349 plus minus 27 versus 229 plus minus 24 respectively p 10 4 significant decrease relative epsis2 expression demonstrated epsis2epsis3 ad brains compared epsis2epsis3 controls 328 plus minus 45 versus 478 plus minus 39 respectively p 0002 increased expression epsis4 allele also detected epsis2epsis4 ad controls 460 plus minus 54 versus 280 plus minus 28 respectively p 001 measured values epsis2epsis4 ad cases controls corresponded expected values estimated genotypes reinforcing observations see materials methods arrows fig 1
0.3697104.9700208.html.plaintext.txt	15	location polymorphisms within regulatory region apoe gene potential effect vitro reported hepatoma cells suggested polymorphisms may play role control apoe expression levels brain order test hypothesis obtained 94 ad control brain tissues heterozygous apoe measured percentage expression level three apoe alleles controls epsis4 allele strongly underexpressed compared epsis3 epsis2 allele epsis3epsis4 epsis2epsis4 brain samples respectively epsis2 epsis3 expressions almost similar epsis2epsis3 samples fig 1 suggested preliminary data 9 clear consistent increase relative epsis4 allelic expression epsis3epsis4 patients epsis3epsis4 controls 349 plus minus 27 versus 229 plus minus 24 respectively p 10 4 significant decrease relative epsis2 expression demonstrated epsis2epsis3 ad brains compared epsis2epsis3 controls 328 plus minus 45 versus 478 plus minus 39 respectively p 0002 increased expression epsis4 allele also detected epsis2epsis4 ad controls 460 plus minus 54 versus 280 plus minus 28 respectively p 001 measured values epsis2epsis4 ad cases controls corresponded expected values estimated genotypes reinforcing observations see materials methods arrows fig 1
0.3697104.9700208.html.plaintext.txt	16	figure 1 differential expression apoe mrna three heterozygous genotypes ad control cases average level expression indicated bold line category brain sample rt pcr semi quantitation repeated least twice bold arrows indicate expected values epsis4 allele percentage epsis2epsis4 samples calculated epsis2 epsis4 percentage epsis2epsis3 epsis3epsis4 ad control cases respectively
0.3697104.9700208.html.plaintext.txt	17	previous epidemiological data suggest 491 polymorphism th1e47cs polymorphism may good candidates mediate allelic distortions particular estimation associated combination epsis4 th1e47cs allele chromosome indicate estimated increased risk 17 heterozygous epsis3epsis4 individuals presenting haplotype described previously 10 thus epsis4 allele associated th1e47cs allele chromosome epsis3 allele associated th1e47cs g allele relative epsis4epsis3 mrna ratio significantly increased associated ad conversely epsis4 epsis3 alleles control th1e47cs allele either g level expression similar thus expected stronger distortion th1e47cs heterozygotes homozygotes argument clearly illustrated experimental data table 3 approach valid 491 mutation
0.3697104.9700208.html.plaintext.txt	18	previous epidemiological data suggest 491 polymorphism th1e47cs polymorphism may good candidates mediate allelic distortions particular estimation associated combination epsis4 th1e47cs allele chromosome indicate estimated increased risk 17 heterozygous epsis3epsis4 individuals presenting haplotype described previously 10 thus epsis4 allele associated th1e47cs allele chromosome epsis3 allele associated th1e47cs g allele relative epsis4epsis3 mrna ratio significantly increased associated ad conversely epsis4 epsis3 alleles control th1e47cs allele either g level expression similar thus expected stronger distortion th1e47cs heterozygotes homozygotes argument clearly illustrated experimental data table 3 approach valid 491 mutation
0.3697104.9700208.html.plaintext.txt	19	influence polymorphisms relative mrna expression level could observed cases fig 2 table 3 affected patients carrying th1e47cs gt 491 genotypes highest lowest relative levels expression epsis4 expression respectively fig 1 table 3 difference levels expression cases pronounced th1e47cs gt bearers 491 bearers 366 plus minus 22 versus 335 plus minus 13 respectively p 0004 fig 2
0.3697104.9700208.html.plaintext.txt	20	figure 2 differential expression epsis4 allele epsis3epsis4 ad control cases according th1e47cs genotype ad cases denoted triangles controls circles closed symbols open symbols correspond 491 aa genotypes respectively discussion
0.3697104.9700208.html.plaintext.txt	21	deleterious effect th1e47cs allele protective effect 491 allele described recently 1011 confirmed large case control study effects obvious apoe heterozygous population homozygous population data surprising two reasons would expect apoe epsis4 homozygotes high expressing promoter alleles chromosomes higher risk developing ad epsis4 homozygotes low expressing promoter alleles however small size epsis4epsis4 control population allow impact brought forward ii consequence measured epsis2epsis3epsis4 homozygous individuals mainly depended epsis3epsis3 population effect found latter population whatever studied promoter polymorphism furthermore apoe3 isoform considered isoform lesser effect ad pathology
0.3697104.9700208.html.plaintext.txt	22	deleterious effect th1e47cs allele protective effect 491 allele described recently 1011 confirmed large case control study effects obvious apoe heterozygous population homozygous population data surprising two reasons would expect apoe epsis4 homozygotes high expressing promoter alleles chromosomes higher risk developing ad epsis4 homozygotes low expressing promoter alleles however small size epsis4epsis4 control population allow impact brought forward ii consequence measured epsis2epsis3epsis4 homozygous individuals mainly depended epsis3epsis3 population effect found latter population whatever studied promoter polymorphism furthermore apoe3 isoform considered isoform lesser effect ad pathology
0.3697104.9700208.html.plaintext.txt	23	table 3 relative epsis4 allele expression according th1e47cs 491 polymorphisms ad control brain samples n ad n controlsa th1e47cs gg 4 335 plus minus 17 4 225 plus minus 25 gt 19 363 plus minus 21b 11 226 plus minus 19 tt 10 324 plus minus 14 10 228 plus minus 27 491 aa 26 353 plus minus 27 15 228 plus minus 22 7 335 plus minus 13c 10 225 plus minus 23 anot significant bp 10 4 cp 011
0.3697104.9700208.html.plaintext.txt	24	confirm deleterious effect 491 aa genotype described epsis3epsis3 spanish population 11 discrepancy may explained significant difference 491 genotype distribution observed spanish french american control populations since ad genotypic frequency similar three studied populations deleterious effect aa genotype epsis3epsis3 group may due distribution spanish control population
0.3697104.9700208.html.plaintext.txt	25	confirm deleterious effect 491 aa genotype described epsis3epsis3 spanish population 11 discrepancy may explained significant difference 491 genotype distribution observed spanish french american control populations since ad genotypic frequency similar three studied populations deleterious effect aa genotype epsis3epsis3 group may due distribution spanish control population
0.3697104.9700208.html.plaintext.txt	26	impacts two promoter polymorphisms apoe epsis4 allele studied simultaneously multiple logistic regression model demonstrated th1e47cs allele modified risk developing ad independently epsis4 allele suggesting 491 polymorphisms may play weaker role compared th1e47cs development ad location polymorphisms regulatory region apoe gene effects transcriptional activity hepatoma cells 12 impacts ad population prompted us test hypothesis may modulate apoe expression levels brain therefore partly responsible marked allelic distortion apoe mrna observed ad brain compared controls heterozygous genotypes indeed epsis4 allele overexpressed epsis3epsis4 epsis2epsis4 ad cases epsis2 allele underexpressed epsis2epsis3 ad cases compared respective controls consistent effects deduced case control study epsis4 allele expression ad brain also correlated polymorphisms regulatory region apoe fig 2 th1e47cs allele may increase relative expression epsis4 allele ad 491 allele may decrease
0.3697104.9700208.html.plaintext.txt	27	impacts two promoter polymorphisms apoe epsis4 allele studied simultaneously multiple logistic regression model demonstrated th1e47cs allele modified risk developing ad independently epsis4 allele suggesting 491 polymorphisms may play weaker role compared th1e47cs development ad location polymorphisms regulatory region apoe gene effects transcriptional activity hepatoma cells 12 impacts ad population prompted us test hypothesis may modulate apoe expression levels brain therefore partly responsible marked allelic distortion apoe mrna observed ad brain compared controls heterozygous genotypes indeed epsis4 allele overexpressed epsis3epsis4 epsis2epsis4 ad cases epsis2 allele underexpressed epsis2epsis3 ad cases compared respective controls consistent effects deduced case control study epsis4 allele expression ad brain also correlated polymorphisms regulatory region apoe fig 2 th1e47cs allele may increase relative expression epsis4 allele ad 491 allele may decrease
0.3697104.9700208.html.plaintext.txt	28	numerous studies reported contradictory findings brain cerebrospinal fluid csf concerning apoe protein level difficult speculate link apoe mrna apoe protein levels 13 17 however suggested yamada et al apoe expression may decreased epsis4 gene dosage ad epsis3 homozygous ad cases expressed apoe mrna epsis4epsis4 ad cases epsis3epsis4 presenting intermediate mrna level 18 similar trend found proteins ad brains 14 plasma j poirier personal communication indicating protein mrna levels may directly correlated disease underlining importance apoe level apoe expression shown correlate abeta peptide deposition transgenic mice 1920
0.3697104.9700208.html.plaintext.txt	29	numerous studies reported contradictory findings brain cerebrospinal fluid csf concerning apoe protein level difficult speculate link apoe mrna apoe protein levels 13 17 however suggested yamada et al apoe expression may decreased epsis4 gene dosage ad epsis3 homozygous ad cases expressed apoe mrna epsis4epsis4 ad cases epsis3epsis4 presenting intermediate mrna level 18 similar trend found proteins ad brains 14 plasma j poirier personal communication indicating protein mrna levels may directly correlated disease underlining importance apoe level apoe expression shown correlate abeta peptide deposition transgenic mice 1920
0.3697104.9700208.html.plaintext.txt	30	observation may important since previous reports showed apoe gene expression increased 2 3 fold ad brains compared controls regardless apoe genotype 1821 epsis3epsis4 ad cases epsis3 epsis4 alleles would overexpressed epsis4 allele due promoter mutations still overexpressed epsis3 allele exacerbation apoe epsis4 expression level may foster intrinsic deleterious effect apoe4 isoform ad instance promoting abeta aggregation 2622
0.3697104.9700208.html.plaintext.txt	31	observation may important since previous reports showed apoe gene expression increased 2 3 fold ad brains compared controls regardless apoe genotype 1821 epsis3epsis4 ad cases epsis3 epsis4 alleles would overexpressed epsis4 allele due promoter mutations still overexpressed epsis3 allele exacerbation apoe epsis4 expression level may foster intrinsic deleterious effect apoe4 isoform ad instance promoting abeta aggregation 2622
0.3697104.9700208.html.plaintext.txt	32	expression level modulation may intended neurodegenerative disease also neural development indeed observed strong underexpression epsis4 allele compared epsis3 allele controls although role apoe maturation ageing completely understood yet fact apoe deficient homozygous mice exhibit reversible dendritic alterations significant learning deficits morris water maze suggests neurotrophic capabilities apoe 23 25 however abilities isoform may different since apoe4 isoform effects apoe3 isoform neurite outgrowth 26 instance apoe3 apoe4 may stabilize neuronal cytoskeleton 7
0.3697104.9700208.html.plaintext.txt	33	expression level modulation may intended neurodegenerative disease also neural development indeed observed strong underexpression epsis4 allele compared epsis3 allele controls although role apoe maturation ageing completely understood yet fact apoe deficient homozygous mice exhibit reversible dendritic alterations significant learning deficits morris water maze suggests neurotrophic capabilities apoe 23 25 however abilities isoform may different since apoe4 isoform effects apoe3 isoform neurite outgrowth 26 instance apoe3 apoe4 may stabilize neuronal cytoskeleton 7
0.3697104.9700208.html.plaintext.txt	34	global assessment modulation apoe expression difficult indeed date five polymorphisms described apoe promoter region 1012 two three polymorphisms studied seem play role ad two remaining allelic frequencies 1 12 therefore cannot explain effects observed case control mrna studies however remains possible unknown polymorphisms modulate apoe mrna level new mutations may far away promoter polymorphisms instance brain tissue specific element 2728 interaction putative polymorphisms modifying apoe expression difficult model various combinations different mutations may confer large apoe expression heterogeneity two levels absolute level apoe expression ii percentage expression one allele compared heterozygous individuals adding complexity association apoe ad therefore variation apoe expression induced apoe promoter polymorphisms may partly explain heterogeneity impact epsis4 allele different ethnic groups 129
0.3697104.9700208.html.plaintext.txt	35	global assessment modulation apoe expression difficult indeed date five polymorphisms described apoe promoter region 1012 two three polymorphisms studied seem play role ad two remaining allelic frequencies 1 12 therefore cannot explain effects observed case control mrna studies however remains possible unknown polymorphisms modulate apoe mrna level new mutations may far away promoter polymorphisms instance brain tissue specific element 2728 interaction putative polymorphisms modifying apoe expression difficult model various combinations different mutations may confer large apoe expression heterogeneity two levels absolute level apoe expression ii percentage expression one allele compared heterozygous individuals adding complexity association apoe ad therefore variation apoe expression induced apoe promoter polymorphisms may partly explain heterogeneity impact epsis4 allele different ethnic groups 129
0.3697104.9700208.html.plaintext.txt	36	materials methods populations
0.3697104.9700208.html.plaintext.txt	37	ad control samples caucasians originating france diagnoses probable ad established according dsm iii r nindcs adrda criteria n 573 age 738 plus minus 81 years age onset 704 plus minus 79 years 359 men 3031 caucasian controls defined subjects without dms iii r dementia criteria integrity cognitive functions n 509 age 743 plus minus 99 years 359 men individual relatives signed informed consent
0.3697104.9700208.html.plaintext.txt	38	ad control samples caucasians originating france diagnoses probable ad established according dsm iii r nindcs adrda criteria n 573 age 738 plus minus 81 years age onset 704 plus minus 79 years 359 men 3031 caucasian controls defined subjects without dms iii r dementia criteria integrity cognitive functions n 509 age 743 plus minus 99 years 359 men individual relatives signed informed consent
0.3697104.9700208.html.plaintext.txt	39	consisted 45 controls age 803 plus minus 86 years 449 men 49 late onset ad cases age 765 plus minus 93 years age onset 684 plus minus 100 years 444 men selected according apoe genotype eighty eight samples extracted frontal cortex six occipital cortex difference relative expressions observed regions mean age 784 plus minus 87 years ad cases genotyped epsis3epsis4 759 plus minus 75 years controls diagnoses confirmed neuropathological examination
0.3697104.9700208.html.plaintext.txt	40	491 427 ct th1e47cs apoe genotypes produced pcr followed restriction enzyme digestion amplified dna described 10 1232
0.3697104.9700208.html.plaintext.txt	41	total rna extraction brain tissues heterozygous apoe genotype performed described 33 using rneasy mini kit qiagen germany digested dnase eurogentec belgium dna contamination observed dnase digestion detected pcr digested product apoe mrnas amplified rt pcr allele quantitation performed described previously 9 measuring ratio expression two alleles heterozygotes order avoid problems due post mortem delay agonal state cell population density
0.3697104.9700208.html.plaintext.txt	42	total rna extraction brain tissues heterozygous apoe genotype performed described 33 using rneasy mini kit qiagen germany digested dnase eurogentec belgium dna contamination observed dnase digestion detected pcr digested product apoe mrnas amplified rt pcr allele quantitation performed described previously 9 measuring ratio expression two alleles heterozygotes order avoid problems due post mortem delay agonal state cell population density
0.3697104.9700208.html.plaintext.txt	43	sas software release 610 used sas institute cary nc univariate analysis performed using pearsons chi2 test multivariate analysis coded genotypes subject dummy variables according tested hypotheses least one th1e47cs allele tttggg least one 491 allele ttataa least one epsis4 allele effects variables disease assessed multiple logistic regression model adjusted age gender comparison allelic expression performed using wilcoxon test
0.3697104.9700208.html.plaintext.txt	44	calculated expected range values epsis4 percentage epsis2epsis4 ad control individuals using extreme values obtained epsis2 epsis4 percentages epsis3epsis4 epsis2epsis3 ad control samples respectively epsis3 allele used reference
0.3697104.9700208.html.plaintext.txt	45	30 american psychiatric association 1987 diagnostic statistical manual mental disorders third edition revised dsm iii r american psychatric association washington dc
0.3697104.9700208.html.plaintext.txt	46	correspondence addressed tel 33 3 20 87 72 28 fax 33 3 20 87 78 94 email marie christinechartieratpasteur lillefr u d page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 aug 1998 copyright oxford university press 1998
0.3697104.9700208.html.plaintext.txt	47	correspondence addressed tel 33 3 20 87 72 28 fax 33 3 20 87 78 94 email marie christinechartieratpasteur lillefr u d page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 aug 1998 copyright oxford university press 1998
0.37081465.15229191.html.plaintext.txt	0	independent effects apoe cholesterol metabolism brain ass levels alzheimer disease mouse model karen m mann12 fayanne e thorngate3 yuko katoh fukui4 hiroki hamanaka5 david l williams3 shinobu fujita6 bruce lamb12
0.37081465.15229191.html.plaintext.txt	1	1department genetics case western reserve university cleveland oh 44106 usa 2center human genetics university memory aging center ireland cancer center university hospitals cleveland cleveland oh 44106 usa 3department pharmacological sciences university medical center stony brook university stony brook ny 11794 usa 4department developmental biology national institute basic biology myodaiji cho okazaki 444 8585 japan 5center neural science new york university new york ny 10003 6621 usa 6mitsubishi kagaku institute life sciences machida tokyo japan
0.37081465.15229191.html.plaintext.txt	2	received march 30 2004 accepted june 15 2004
0.37081465.15229191.html.plaintext.txt	3	abstract top abstract introduction results discussion materials methods references apoe 4 allele significant genetic risk factor associated alzheimers disease date epidemiological studies demonstrated inheritance one 4 alleles affects age onset severity pathology development dosage apoe 2 3 alleles however appear protective effects 4 although much biology apoe peripheral cholesterol metabolism understood role brain cholesterol metabolism impact ad development less defined several apoe transgenic models generated study effects apoe alleles app processing ass pathology however models potential limitations confound understanding effects apolipoprotein e apoe levels cholesterol metabolism disease development circumvent limitations taken genomic based approach better understand relationship apoe alleles cholesterol ass metabolism characterized apoe knock mice express human allele endogenous regulatory elements defined c57bl6j background mice significantly different serum cholesterol levels steady state brain apoe levels yet equivalent brain cholesterol levels however presence human apoe significantly increases brain ass levels genomic based model ad irrespective genotype data indicate independent role apoe cholesterol metabolism periphery relative cns altered levels cholesterol apoe mice insufficient influence ass metabolism mouse model alzheimers disease
0.37081465.15229191.html.plaintext.txt	4	abstract top abstract introduction results discussion materials methods references apoe 4 allele significant genetic risk factor associated alzheimers disease date epidemiological studies demonstrated inheritance one 4 alleles affects age onset severity pathology development dosage apoe 2 3 alleles however appear protective effects 4 although much biology apoe peripheral cholesterol metabolism understood role brain cholesterol metabolism impact ad development less defined several apoe transgenic models generated study effects apoe alleles app processing ass pathology however models potential limitations confound understanding effects apolipoprotein e apoe levels cholesterol metabolism disease development circumvent limitations taken genomic based approach better understand relationship apoe alleles cholesterol ass metabolism characterized apoe knock mice express human allele endogenous regulatory elements defined c57bl6j background mice significantly different serum cholesterol levels steady state brain apoe levels yet equivalent brain cholesterol levels however presence human apoe significantly increases brain ass levels genomic based model ad irrespective genotype data indicate independent role apoe cholesterol metabolism periphery relative cns altered levels cholesterol apoe mice insufficient influence ass metabolism mouse model alzheimers disease
0.37081465.15229191.html.plaintext.txt	5	introduction top abstract introduction results discussion materials methods references apolipoprotein e apoe functions lipid chaperone facilitates cellular uptake cholesterol lipoproteins receptor mediated endocytosis apoe gene located human chromosome 19q132 polymorphic locus represented three common alleles 2 3 4 three alleles encode three apoe isoforms 34 kda differ amino acid positions 112 158 two amino acid substitutions confer slightly different functions respective proteins e2 isoform encoded 2 allele contains cys position 158 comparison arg found e3 e4 isoforms substitution cys arg alters positive ion potential within receptor binding domain thus decreases affinity e2 protein ldl receptor 1 normal binding capacity 12 consequently level circulating e2 protein significantly higher e3 contrast level e4 protein significantly lower e3 presumably consequence isoform specific differences lipid binding uptake ability apoe bind receptors include ldlr lrp vldlr megalin members ldl receptor family dictates efficiency molecules delivered appropriate cells turned
0.37081465.15229191.html.plaintext.txt	6	introduction top abstract introduction results discussion materials methods references apolipoprotein e apoe functions lipid chaperone facilitates cellular uptake cholesterol lipoproteins receptor mediated endocytosis apoe gene located human chromosome 19q132 polymorphic locus represented three common alleles 2 3 4 three alleles encode three apoe isoforms 34 kda differ amino acid positions 112 158 two amino acid substitutions confer slightly different functions respective proteins e2 isoform encoded 2 allele contains cys position 158 comparison arg found e3 e4 isoforms substitution cys arg alters positive ion potential within receptor binding domain thus decreases affinity e2 protein ldl receptor 1 normal binding capacity 12 consequently level circulating e2 protein significantly higher e3 contrast level e4 protein significantly lower e3 presumably consequence isoform specific differences lipid binding uptake ability apoe bind receptors include ldlr lrp vldlr megalin members ldl receptor family dictates efficiency molecules delivered appropriate cells turned
0.37081465.15229191.html.plaintext.txt	7	apoe 4 first shown association studies genetic risk factor cardiovascular disease presumably role conferring high circulating cholesterol levels mainly form ldl individuals one copies allele 34 subsequently apoe 4 found associated increased risk late onset alzheimers disease load 56 furthermore presence one 4 alleles decreases age disease onset much 10 years 7
0.37081465.15229191.html.plaintext.txt	8	apoe 4 first shown association studies genetic risk factor cardiovascular disease presumably role conferring high circulating cholesterol levels mainly form ldl individuals one copies allele 34 subsequently apoe 4 found associated increased risk late onset alzheimers disease load 56 furthermore presence one 4 alleles decreases age disease onset much 10 years 7
0.37081465.15229191.html.plaintext.txt	9	one hypothesis link apoe genotype cardiovascular disease ad involves contribution cholesterol homeostasis diseases role apoe process several studies implicated role cholesterol production ass primary constituent senile plaques ad brain 8 12 high serum cholesterol levels mice transgenic app precursor protein ass peptide correlate increased brain ass levels severe plaque load 1314 retrospective epidemiological studies demonstrated decreased ad risk human populations statin therapy lower cholesterol levels reviewed 15 although effect may indirect several studies shown statins alter ass levels serum 1617 several studies reported association elevated serum cholesterol levels ad risk levels ass 1819 independent apoe genotype studies however failed demonstrate correlation serum cholesterol levels ad development 20 apoe 4 may affect ad risk conferring high cholesterol levels thereby increasing ass production ad patients 4 allele increased levels ass1 40 brains csf extensive plaque pathology 2122 interestingly 2 allele confers low cholesterol levels also considered protective ad development 7
0.37081465.15229191.html.plaintext.txt	10	one hypothesis link apoe genotype cardiovascular disease ad involves contribution cholesterol homeostasis diseases role apoe process several studies implicated role cholesterol production ass primary constituent senile plaques ad brain 8 12 high serum cholesterol levels mice transgenic app precursor protein ass peptide correlate increased brain ass levels severe plaque load 1314 retrospective epidemiological studies demonstrated decreased ad risk human populations statin therapy lower cholesterol levels reviewed 15 although effect may indirect several studies shown statins alter ass levels serum 1617 several studies reported association elevated serum cholesterol levels ad risk levels ass 1819 independent apoe genotype studies however failed demonstrate correlation serum cholesterol levels ad development 20 apoe 4 may affect ad risk conferring high cholesterol levels thereby increasing ass production ad patients 4 allele increased levels ass1 40 brains csf extensive plaque pathology 2122 interestingly 2 allele confers low cholesterol levels also considered protective ad development 7
0.37081465.15229191.html.plaintext.txt	11	several apoe transgenic mouse models generated efforts gain insight role apoe ad 23 26 models utilize various promoters drive expression human apoe cdnas neurons glia approach several limitations concerning regulation apoe brain periphery first apoe transgenic studies attempted normalize apoe levels apoe 3 4 transgenic lines respect 23 endogenous levels 24 however several human studies suggest levels apoe vary genotype may impact ad pathogenesis second apoe transgenic lines bred onto apoe null background confers high circulating cholesterol levels given role apoe peripheral cholesterol metabolism growing evidence cholesterol levels influencing brain ass metabolism unclear absence apoe affects ad pathology animals importantly consensus impact apoe genotype ad pathogenesis studies perhaps owing complications different promoters altered levels apoe brain combined complications mixed genetic background models
0.37081465.15229191.html.plaintext.txt	12	several apoe transgenic mouse models generated efforts gain insight role apoe ad 23 26 models utilize various promoters drive expression human apoe cdnas neurons glia approach several limitations concerning regulation apoe brain periphery first apoe transgenic studies attempted normalize apoe levels apoe 3 4 transgenic lines respect 23 endogenous levels 24 however several human studies suggest levels apoe vary genotype may impact ad pathogenesis second apoe transgenic lines bred onto apoe null background confers high circulating cholesterol levels given role apoe peripheral cholesterol metabolism growing evidence cholesterol levels influencing brain ass metabolism unclear absence apoe affects ad pathology animals importantly consensus impact apoe genotype ad pathogenesis studies perhaps owing complications different promoters altered levels apoe brain combined complications mixed genetic background models
0.37081465.15229191.html.plaintext.txt	13	apoe knock ki mice provide unique model understanding apoe allele behaves development alzheimers disease obtained mice previously published hamanaka et al 27 order characterize behavior human apoe alleles defined genetic background present apoe protein abundance cholesterol lipoprotein data young animals expressing apoe 2 3 4 defined c57bl6j background demonstrate significant differences protein abundance mirrors human data well significant differences serum cholesterol levels absence effect app processing presence apoe significantly increases levels ass cholesterol brain irrespective allele genomic based mouse model provides evidence neither cholesterol levels apoe abundance alone sufficient influence ass metabolism young animals
0.37081465.15229191.html.plaintext.txt	14	apoe knock ki mice provide unique model understanding apoe allele behaves development alzheimers disease obtained mice previously published hamanaka et al 27 order characterize behavior human apoe alleles defined genetic background present apoe protein abundance cholesterol lipoprotein data young animals expressing apoe 2 3 4 defined c57bl6j background demonstrate significant differences protein abundance mirrors human data well significant differences serum cholesterol levels absence effect app processing presence apoe significantly increases levels ass cholesterol brain irrespective allele genomic based mouse model provides evidence neither cholesterol levels apoe abundance alone sufficient influence ass metabolism young animals
0.37081465.15229191.html.plaintext.txt	15	results top abstract introduction results discussion materials methods references generation genetically defined apoe ki mice apoe 4 allele significant genetic risk factor alzheimers disease identified date much work done mouse understand different alleles apoe affect onset development pathology ad mouse model however transgenic models several limitations confound study apoe gene regulation gene function mouse models ad circumvent limitations took advantage apoe ki animals generated mitsubishi kagaku institute life science japan 27 targeted allele placed human cdna apoe allele frame endogenous exon 1 sequence part exon 2 allowed control human apoe expression endogenous regulatory elements time removing mouse apoe coding sequence apoe 4 ki mice generated strategy previously published 27 demonstrated human apoe mice expressed serum astrocytes correct histological pattern apoe ki mice originally maintained mixed c57bl6129p2 background contained neo selection cassette targeted allele work lab others demonstrated genetic background greatly influence phenotypic expression particularly regards ass generation deposition 28 addition several lines evidence shown strong promoter neo influence expression targeted locus well neighboring genes 2930 reasons apoe ki lines backcrossed onto defined c57bl6j b6 inbred background also mated zp3 cre transgenic mice congenic b6 background 31 remove neo cassette cre mediated loxp excision cre transgene transferred onto apoe ki background expression cre mouse oocytes apoe ki females excised floxed neo cassette targeted allele females mated b6 males resulting offspring inherited targeted allele lacking neo tag demonstrated polymerase chain reaction pcr assay using primers neo southern blot data shown animals lacking cre transgene identified subsequent progeny apoe ki line backcrossed five generations n5 incipient congenic 98 homogeneous 32 animals intercrossed obtain populations apoe 22 33 44 mice hereafter referred 2 ki 3 ki 4 ki respectively animals pcr genotyped basis presence human apoe using human specific primers absence endogenous apoe locus demonstrated pcr using mouse apoe specific primers data shown mice characterized 6 8 weeks age variety parameters order understand apoe allele behaves mouse respect steady state protein levels cholesterol metabolism impacts app processing ass metabolism
0.37081465.15229191.html.plaintext.txt	16	results top abstract introduction results discussion materials methods references generation genetically defined apoe ki mice apoe 4 allele significant genetic risk factor alzheimers disease identified date much work done mouse understand different alleles apoe affect onset development pathology ad mouse model however transgenic models several limitations confound study apoe gene regulation gene function mouse models ad circumvent limitations took advantage apoe ki animals generated mitsubishi kagaku institute life science japan 27 targeted allele placed human cdna apoe allele frame endogenous exon 1 sequence part exon 2 allowed control human apoe expression endogenous regulatory elements time removing mouse apoe coding sequence apoe 4 ki mice generated strategy previously published 27 demonstrated human apoe mice expressed serum astrocytes correct histological pattern apoe ki mice originally maintained mixed c57bl6129p2 background contained neo selection cassette targeted allele work lab others demonstrated genetic background greatly influence phenotypic expression particularly regards ass generation deposition 28 addition several lines evidence shown strong promoter neo influence expression targeted locus well neighboring genes 2930 reasons apoe ki lines backcrossed onto defined c57bl6j b6 inbred background also mated zp3 cre transgenic mice congenic b6 background 31 remove neo cassette cre mediated loxp excision cre transgene transferred onto apoe ki background expression cre mouse oocytes apoe ki females excised floxed neo cassette targeted allele females mated b6 males resulting offspring inherited targeted allele lacking neo tag demonstrated polymerase chain reaction pcr assay using primers neo southern blot data shown animals lacking cre transgene identified subsequent progeny apoe ki line backcrossed five generations n5 incipient congenic 98 homogeneous 32 animals intercrossed obtain populations apoe 22 33 44 mice hereafter referred 2 ki 3 ki 4 ki respectively animals pcr genotyped basis presence human apoe using human specific primers absence endogenous apoe locus demonstrated pcr using mouse apoe specific primers data shown mice characterized 6 8 weeks age variety parameters order understand apoe allele behaves mouse respect steady state protein levels cholesterol metabolism impacts app processing ass metabolism
0.37081465.15229191.html.plaintext.txt	17	protein abundance apoe ki mice levels steady state apoe brain liver serum three ki mouse lines determined western blot analysis using human specific apoe antibody parallel western blots recombinant e2 e3 e4 serial dilutions 625 125 25 50 microg protein run determine affinity antibody isoform standard curves fluorescent units isoform revealed little difference detection e4 appeared detected slightly less well data shown levels apoe protein ki animal compared standard homogenate serum standard homozygous 3 ki animal figure 1 illustrates differences apoe levels compared across lines ratio steady state levels sample relative standard apoe 2 ki animals average 2 fold higher steady state level apoe brain fasted liver compared 3 ki 4 ki animals fig 1a b p 0001 three lines significantly different levels apoe brain levels steady state apoe brain confirmed human specific apoe elisa using standard curve recombinant e2 e3 e4 quantitate levels isoform 2 ki animals demonstrated 2 fold increase level brain apoe method well p 0001 although e3 e4 significantly different difference shown western blotting 3 4 lines may explained slightly lower affinity antibody recombinant e4 level apoe fasted serum 2 ki animals also significantly higher found 3 ki 4 ki animals western blotting fig 1d p 001 relationship genotype apoe levels ki mice recapitulates observed human serum 33 35
0.37081465.15229191.html.plaintext.txt	18	protein abundance apoe ki mice levels steady state apoe brain liver serum three ki mouse lines determined western blot analysis using human specific apoe antibody parallel western blots recombinant e2 e3 e4 serial dilutions 625 125 25 50 microg protein run determine affinity antibody isoform standard curves fluorescent units isoform revealed little difference detection e4 appeared detected slightly less well data shown levels apoe protein ki animal compared standard homogenate serum standard homozygous 3 ki animal figure 1 illustrates differences apoe levels compared across lines ratio steady state levels sample relative standard apoe 2 ki animals average 2 fold higher steady state level apoe brain fasted liver compared 3 ki 4 ki animals fig 1a b p 0001 three lines significantly different levels apoe brain levels steady state apoe brain confirmed human specific apoe elisa using standard curve recombinant e2 e3 e4 quantitate levels isoform 2 ki animals demonstrated 2 fold increase level brain apoe method well p 0001 although e3 e4 significantly different difference shown western blotting 3 4 lines may explained slightly lower affinity antibody recombinant e4 level apoe fasted serum 2 ki animals also significantly higher found 3 ki 4 ki animals western blotting fig 1d p 001 relationship genotype apoe levels ki mice recapitulates observed human serum 33 35
0.37081465.15229191.html.plaintext.txt	19	view larger version 25k figure 1 analysis apoe abundance apoe ki animals relative levels apoe brain fasted liver fasted serum apoe ki lines assayed males females 6 8 weeks age protein extracts brain fasted liver made 1 chaps protease inhibitors apoe levels brain n8 fasted liver b n8 fasted serum d n6 assayed western blot analysis using human specific apoe antibody calbiochem apoe quantitation expressed ratio apoe abundance sample relative standard total protein concentration 2 ki apoe levels significantly increased brain fasted liver b p 0001 one factor anova post tukey compared 3 ki 4 ki levels 2 ki apoe levels also significantly increased fasted serum d p 001 one factor anova followed dunns post test 3 ki levels brain significantly increased 4 ki levels p 001 one factor anova post tukey representative western blot apoe abundance brain fasted liver c demonstrates relative 4 fold increase apoe liver versus brain 2 fold higher levels 2 ki homogenates compared 3 ki 4 ki homogenates apoe brain levels also measured human specific elisa e 2 ki levels significantly increased 3 ki 4 ki levels p 0001 one factor anova post tukey
0.37081465.15229191.html.plaintext.txt	20	view larger version 25k figure 1 analysis apoe abundance apoe ki animals relative levels apoe brain fasted liver fasted serum apoe ki lines assayed males females 6 8 weeks age protein extracts brain fasted liver made 1 chaps protease inhibitors apoe levels brain n8 fasted liver b n8 fasted serum d n6 assayed western blot analysis using human specific apoe antibody calbiochem apoe quantitation expressed ratio apoe abundance sample relative standard total protein concentration 2 ki apoe levels significantly increased brain fasted liver b p 0001 one factor anova post tukey compared 3 ki 4 ki levels 2 ki apoe levels also significantly increased fasted serum d p 001 one factor anova followed dunns post test 3 ki levels brain significantly increased 4 ki levels p 001 one factor anova post tukey representative western blot apoe abundance brain fasted liver c demonstrates relative 4 fold increase apoe liver versus brain 2 fold higher levels 2 ki homogenates compared 3 ki 4 ki homogenates apoe brain levels also measured human specific elisa e 2 ki levels significantly increased 3 ki 4 ki levels p 0001 one factor anova post tukey
0.37081465.15229191.html.plaintext.txt	21	cholesterol metabolism apoe ki mice examine allele affects cholesterol metabolism mouse serum cholesterol triglyceride levels measured 6 h fast using enzymatic assay analysis cholesterol levels 20 animals genotype mixed sex demonstrated inverse relationship genotype phenotype relative human data 2 ki animals highest cholesterol mean 234 mgdl triglycerides mean 115 mgdl contrast 4 ki animals lowest cholesterol mean 67 mgdl whereas 3 ki animals significantly differ b6 wild type animals table 1 triglyceride levels 3 ki 4 ki b6 animals statistically indistinguishable
0.37081465.15229191.html.plaintext.txt	22	cholesterol metabolism apoe ki mice examine allele affects cholesterol metabolism mouse serum cholesterol triglyceride levels measured 6 h fast using enzymatic assay analysis cholesterol levels 20 animals genotype mixed sex demonstrated inverse relationship genotype phenotype relative human data 2 ki animals highest cholesterol mean 234 mgdl triglycerides mean 115 mgdl contrast 4 ki animals lowest cholesterol mean 67 mgdl whereas 3 ki animals significantly differ b6 wild type animals table 1 triglyceride levels 3 ki 4 ki b6 animals statistically indistinguishable
0.37081465.15229191.html.plaintext.txt	23	view table table 1 fasted serum cholesterol triglyceride levels apoe genotype understand different apoe isoforms participate peripheral cholesterol metabolism mouse generated lipoprotein profiles fplc ki line distribution apoe cholesterol analyzed profile fasted serum three animals sex pooled analysis genotype sex difference apparent data shown profiles genotype shown figure 2 apoe 3 ki 4 ki profiles differ b6 wild type animals majority circulating cholesterol found hdl fraction whereas vldl ldlidl fractions minimal contrast 2 ki profiles demonstrated although levels hdl cholesterol remained equal found lines cholesterol distribution extended ldlidl fraction highest level vldl fraction thus increased total cholesterol levels 2 ki mice due increase vldl ldlidl cholesterol
0.37081465.15229191.html.plaintext.txt	24	view larger version 25k figure 2 fplc analysis lipoprotein profiles apoe ki animals fasted serum three animals sex apoe line pooled fractionated fplc superose 6 column fplc profiles generated males females line two separate experiments representative results shown figure vldl peak around 20 min b6 endogenous apoe apoewt b 4 ki c 3 ki profiles contains little cholesterol compared vldl fraction d 2 ki profile large peak 40 min represents hdl fraction cholesterol levels four groups relatively equal fraction e distribution apoe lipoprotein fractions analyzed western blot analysis using human specific apoe antibody calbiochem five fractions lipoprotein peak pooled equal volumes combined fractions loaded lane representative western blot apoe abundance shown absence apoe vldl fractions apoewt 3 ki 4 ki distinct compared abundance apoe 2 ki profile majority apoe 4 ki profile found hdl fraction contrast 3 ki apoewt profiles show majority apoe apoe ldlidl fraction
0.37081465.15229191.html.plaintext.txt	25	view larger version 25k figure 2 fplc analysis lipoprotein profiles apoe ki animals fasted serum three animals sex apoe line pooled fractionated fplc superose 6 column fplc profiles generated males females line two separate experiments representative results shown figure vldl peak around 20 min b6 endogenous apoe apoewt b 4 ki c 3 ki profiles contains little cholesterol compared vldl fraction d 2 ki profile large peak 40 min represents hdl fraction cholesterol levels four groups relatively equal fraction e distribution apoe lipoprotein fractions analyzed western blot analysis using human specific apoe antibody calbiochem five fractions lipoprotein peak pooled equal volumes combined fractions loaded lane representative western blot apoe abundance shown absence apoe vldl fractions apoewt 3 ki 4 ki distinct compared abundance apoe 2 ki profile majority apoe 4 ki profile found hdl fraction contrast 3 ki apoewt profiles show majority apoe apoe ldlidl fraction
0.37081465.15229191.html.plaintext.txt	26	distribution apoe protein lipoprotein fraction determined western blot analysis five fractions lipoprotein class including peak fraction pooled run conditions apoe quantitation tissues resulting data shown figure 2e apoe detected vldl fractions 3 ki 4 ki non transgenic control profiles reflected low levels cholesterol fraction levels apoe highest ldlidl fraction followed hdl fraction 4 ki profiles demonstrated highest levels apoe hdl fraction may reflect preferential binding e4 larger lipoproteins mouse plasma enriched large apoe rich hdl absent normal human plasma 36 contrast profiles high levels apoe observed fractions 2 ki profile consistent high levels cholesterol found distributed fractions
0.37081465.15229191.html.plaintext.txt	27	distribution apoe protein lipoprotein fraction determined western blot analysis five fractions lipoprotein class including peak fraction pooled run conditions apoe quantitation tissues resulting data shown figure 2e apoe detected vldl fractions 3 ki 4 ki non transgenic control profiles reflected low levels cholesterol fraction levels apoe highest ldlidl fraction followed hdl fraction 4 ki profiles demonstrated highest levels apoe hdl fraction may reflect preferential binding e4 larger lipoproteins mouse plasma enriched large apoe rich hdl absent normal human plasma 36 contrast profiles high levels apoe observed fractions 2 ki profile consistent high levels cholesterol found distributed fractions
0.37081465.15229191.html.plaintext.txt	28	app processing ass metabolism brain cholesterol apoe ki mice examine effects different apoe alleles app biochemistry apoe ki mice crossed r140 app transgenic line congenic b6 background r140 line yac based transgenic model ad expresses appswe proper spatial temporal manner 37 homozygous r140 transgenic animals display ass deposition 135 months age apoe ki animals crossed r140 transgenic animals generate animals homozygous apoe allele hemizygous app brains 28 day old apoeapoe r140 animals subsequently denoted apoer140 2r140 etc utilized examine levels app processing intermediates ass
0.37081465.15229191.html.plaintext.txt	29	app processing ass metabolism brain cholesterol apoe ki mice examine effects different apoe alleles app biochemistry apoe ki mice crossed r140 app transgenic line congenic b6 background r140 line yac based transgenic model ad expresses appswe proper spatial temporal manner 37 homozygous r140 transgenic animals display ass deposition 135 months age apoe ki animals crossed r140 transgenic animals generate animals homozygous apoe allele hemizygous app brains 28 day old apoeapoe r140 animals subsequently denoted apoer140 2r140 etc utilized examine levels app processing intermediates ass
0.37081465.15229191.html.plaintext.txt	30	levels app holo protein c terminal fragments ctfs determined using 369 app c terminal antibody differences holo app observed lines fig 3a b addition relative amount app ctfs expressed ratio ctfsstotal ctfs determined apoer140 line r140 animals endogenous apoe fig 3c despite significant differences serum cholesterol among three apoer140 lines fig 4a difference ratios ctfsstotal ctfs likewise app ctf ratios unchanged presence apoe apoe animals 28 days age
0.37081465.15229191.html.plaintext.txt	31	levels app holo protein c terminal fragments ctfs determined using 369 app c terminal antibody differences holo app observed lines fig 3a b addition relative amount app ctfs expressed ratio ctfsstotal ctfs determined apoer140 line r140 animals endogenous apoe fig 3c despite significant differences serum cholesterol among three apoer140 lines fig 4a difference ratios ctfsstotal ctfs likewise app ctf ratios unchanged presence apoe apoe animals 28 days age
0.37081465.15229191.html.plaintext.txt	32	view larger version 29k figure 3 app processing apoer140 animals app processing products analyzed 6 m urea homogenates half brains apoer140 animals 28 days age western blotting app antibody 369 used assay levels holo app ctfs apoer140 line n5 line well r140 animals endogenous apoe n3 representative western blot shown app quantitation b expressed ratio app abundance sample relative endogenous levels wild type extract total protein concentration analysis holo app levels demonstrated difference lines p 005 one factor anova relative ratios ctfss total app ctfs c unaffected apoe genotype p 005 one factor anova four five animals per group
0.37081465.15229191.html.plaintext.txt	33	view larger version 20k figure 4 total cholesterol brain ass1 40 levels apoer140 animals measurements total cholesterol serum brain brain ass levels obtained animals 28 days age serum cholesterol assayed apoer140 r140 animals endogenous apoe colorimetric assay thermotrace results confirmed app transgene affect serum cholesterol metabolism 2r140 animals 2 fold higher levels total cholesterol 3r140 4r140 b6r140 animals p 0001 one factor anova followed post tukey b levels total brain cholesterol measured 6 m urea homogenates half brains colorimetic assay thermotrace presence human apoe2 4 significantly increases brain cholesterol r140 animals p 005 one factor anova e3r140 brain cholesterol levels also elevated compared b6r140 animals although significant p 005 one factor anova c levels ass1 40 brain measured 5 m guanidine extracts half brains elisa biosource significantly different apoer140 lines p 005 one factor anova n8 line apoer140 lines significantly increased ass1 40 levels compared b6r140 animals n11 p 001 e2 versus b6 p 0001 e3 versus b6 p 005 e4 versus b6 one factor anova post tukey 2r140 increased 307 3r140 350 4r140 257
0.37081465.15229191.html.plaintext.txt	34	view larger version 20k figure 4 total cholesterol brain ass1 40 levels apoer140 animals measurements total cholesterol serum brain brain ass levels obtained animals 28 days age serum cholesterol assayed apoer140 r140 animals endogenous apoe colorimetric assay thermotrace results confirmed app transgene affect serum cholesterol metabolism 2r140 animals 2 fold higher levels total cholesterol 3r140 4r140 b6r140 animals p 0001 one factor anova followed post tukey b levels total brain cholesterol measured 6 m urea homogenates half brains colorimetic assay thermotrace presence human apoe2 4 significantly increases brain cholesterol r140 animals p 005 one factor anova e3r140 brain cholesterol levels also elevated compared b6r140 animals although significant p 005 one factor anova c levels ass1 40 brain measured 5 m guanidine extracts half brains elisa biosource significantly different apoer140 lines p 005 one factor anova n8 line apoer140 lines significantly increased ass1 40 levels compared b6r140 animals n11 p 001 e2 versus b6 p 0001 e3 versus b6 p 005 e4 versus b6 one factor anova post tukey 2r140 increased 307 3r140 350 4r140 257
0.37081465.15229191.html.plaintext.txt	35	levels serum cholesterol apoer140 line n8 backcross generation determined previously mentioned similar results absence r140 transgene 2r140 mice significantly higher cholesterol levels compared lines however 4r140 animals slightly higher levels cholesterol relative 3r140 animals r140 animals endogenous apoe fig 4a difference compared data table 1 n5 generation likely illustrates genetic background effect cholesterol metabolism 4 ki mice
0.37081465.15229191.html.plaintext.txt	36	levels serum cholesterol apoer140 line n8 backcross generation determined previously mentioned similar results absence r140 transgene 2r140 mice significantly higher cholesterol levels compared lines however 4r140 animals slightly higher levels cholesterol relative 3r140 animals r140 animals endogenous apoe fig 4a difference compared data table 1 n5 generation likely illustrates genetic background effect cholesterol metabolism 4 ki mice
0.37081465.15229191.html.plaintext.txt	37	levels steady state ass1 40 assessed elisa half brain extracts given increased serum cholesterol conferred diet effectively increases ass1 40 brain 14 expectation 2r140 animals serum cholesterol levels nearly twice 3r140 4r140 animals would greatest amount ass1 40 however significant difference ass1 40 levels three apoer140 lines observed fig 4c data suggest fundamental distinction genetic dietary control cholesterol levels effects ass1 40 metabolism interestingly three apoer140 lines demonstrated significantly increased levels ass1 40 relative b6r140 animals endogenous apoe thus presence human apoe r140 line led increased ass1 40 steady state levels 28 days age
0.37081465.15229191.html.plaintext.txt	38	levels steady state ass1 40 assessed elisa half brain extracts given increased serum cholesterol conferred diet effectively increases ass1 40 brain 14 expectation 2r140 animals serum cholesterol levels nearly twice 3r140 4r140 animals would greatest amount ass1 40 however significant difference ass1 40 levels three apoer140 lines observed fig 4c data suggest fundamental distinction genetic dietary control cholesterol levels effects ass1 40 metabolism interestingly three apoer140 lines demonstrated significantly increased levels ass1 40 relative b6r140 animals endogenous apoe thus presence human apoe r140 line led increased ass1 40 steady state levels 28 days age
0.37081465.15229191.html.plaintext.txt	39	levels total brain cholesterol measured enzymatic assay normalized concentration protein extracted mg cholesterolmg protein average levels brain cholesterol 2r140 3r140 4r140 animals higher average brain cholesterol r140 animals endogenous apoe fig 4b p 005 2r140 versus r140 4r140 versus r140 increase brain cholesterol apoer140 animals appeared coincide increased ass1 40 levels suggesting link apoe brain cholesterol ass metabolism despite high levels serum cholesterol 2r140 animals brain cholesterol levels indistinguishable 3r140 4r140 animals cholesterol data lend evidence hypothesis peripheral brain cholesterol levels independently regulated
0.37081465.15229191.html.plaintext.txt	40	levels total brain cholesterol measured enzymatic assay normalized concentration protein extracted mg cholesterolmg protein average levels brain cholesterol 2r140 3r140 4r140 animals higher average brain cholesterol r140 animals endogenous apoe fig 4b p 005 2r140 versus r140 4r140 versus r140 increase brain cholesterol apoer140 animals appeared coincide increased ass1 40 levels suggesting link apoe brain cholesterol ass metabolism despite high levels serum cholesterol 2r140 animals brain cholesterol levels indistinguishable 3r140 4r140 animals cholesterol data lend evidence hypothesis peripheral brain cholesterol levels independently regulated
0.37081465.15229191.html.plaintext.txt	41	discussion top abstract introduction results discussion materials methods references current study examines effects three common human apoe alleles apoe protein levels cholesterol metabolism app processing ass metabolism show apoe ki mice defined c57bl6j background significantly different levels apoe serum tissues well significantly different cholesterol levels apoe increases ass levels genomic based app transgenic mouse absence changes app processing unlike previously reported apoe transgenic models express normalized levels apoe brain genomic based approach allows us address two hypotheses surrounding role apoe 4 risk factor ad apoe genotype ad risk humans correlate serum cholesterol levels steady state levels apoe protein apoe 4 significant genetic risk factor ad associated high circulating cholesterol levels reduced steady state apoe levels contrast apoe 2 protective ad incidentally confers low serum cholesterol levels high levels apoe thus apoe may affect ad risk involvement cholesterol metabolism shown diet studies mouse directly affect ass production alternatively brain apoe levels may influence clearance efficiency ass peptide subsequent deposition
0.37081465.15229191.html.plaintext.txt	42	discussion top abstract introduction results discussion materials methods references current study examines effects three common human apoe alleles apoe protein levels cholesterol metabolism app processing ass metabolism show apoe ki mice defined c57bl6j background significantly different levels apoe serum tissues well significantly different cholesterol levels apoe increases ass levels genomic based app transgenic mouse absence changes app processing unlike previously reported apoe transgenic models express normalized levels apoe brain genomic based approach allows us address two hypotheses surrounding role apoe 4 risk factor ad apoe genotype ad risk humans correlate serum cholesterol levels steady state levels apoe protein apoe 4 significant genetic risk factor ad associated high circulating cholesterol levels reduced steady state apoe levels contrast apoe 2 protective ad incidentally confers low serum cholesterol levels high levels apoe thus apoe may affect ad risk involvement cholesterol metabolism shown diet studies mouse directly affect ass production alternatively brain apoe levels may influence clearance efficiency ass peptide subsequent deposition
0.37081465.15229191.html.plaintext.txt	43	apoe abundance much known apoe biology humans particularly role lipid metabolism apoe primarily synthesized liver brain additional sites include adrenal gland kidney 3839 apoe genotype shown correlate apoe abundance periphery 3340 42 2 allele confers high apoe whereas 4 allele confers low apoe respect 3 levels effect apoe alleles apoe abundance brain csf less clear owing conflicting reports many studies concentrating abundance apoe ad brains relative controls irrespective apoe genotype 354344
0.37081465.15229191.html.plaintext.txt	44	apoe abundance much known apoe biology humans particularly role lipid metabolism apoe primarily synthesized liver brain additional sites include adrenal gland kidney 3839 apoe genotype shown correlate apoe abundance periphery 3340 42 2 allele confers high apoe whereas 4 allele confers low apoe respect 3 levels effect apoe alleles apoe abundance brain csf less clear owing conflicting reports many studies concentrating abundance apoe ad brains relative controls irrespective apoe genotype 354344
0.37081465.15229191.html.plaintext.txt	45	demonstrate western blot analysis elisa steady state levels apoe tissues serum three ki lines genotype dependent reflect human data serum apoe levels 2 ki animals significantly higher levels apoe tissues examined p 0001 findings particularly data brain illustrate innate differences behavior three human apoe alleles mouse arguing relevance genomic based apoe model understanding apoe function differences brain apoe levels ki mice may important implications apoe influences pathology development ad mouse model recent report sullivan et al 45 showing brain apoe levels genotype independent different set apoe ki animals contradicts data however reported apoe lines contain neo cassette targeted allele may affect protein expression additional difference inclusion human apoe intron 1 targeted allele mice may contain additional endo genous regulatory elements comparisons mice necessary determine innate differences two models
0.37081465.15229191.html.plaintext.txt	46	demonstrate western blot analysis elisa steady state levels apoe tissues serum three ki lines genotype dependent reflect human data serum apoe levels 2 ki animals significantly higher levels apoe tissues examined p 0001 findings particularly data brain illustrate innate differences behavior three human apoe alleles mouse arguing relevance genomic based apoe model understanding apoe function differences brain apoe levels ki mice may important implications apoe influences pathology development ad mouse model recent report sullivan et al 45 showing brain apoe levels genotype independent different set apoe ki animals contradicts data however reported apoe lines contain neo cassette targeted allele may affect protein expression additional difference inclusion human apoe intron 1 targeted allele mice may contain additional endo genous regulatory elements comparisons mice necessary determine innate differences two models
0.37081465.15229191.html.plaintext.txt	47	apoe cholesterol metabolism mice addition protein levels show apoe genotype also impacts cholesterol levels periphery 4 ki animals fasted cholesterol levels slightly b6 wild type animals whereas 2 ki animals 2 fold higher cholesterol levels 3 ki b6 wild type cholesterol levels significantly differ data recapitulate shown apoe ki models 46 48 opposite findings humans 4 allele associated high 2 low cholesterol levels data highlight innate differences mouse human cholesterol metabolism include utilization different lipoproteins transport cholesterol data also contrast initial report 4 ki mice hamanaka et al 27 showing 25 fold increase levels circulating cholesterol relative wild type controls discrepancy data may attributed several factors first perhaps notable difference genetic background two studies several lines evidence demonstrate strong genetic component cholesterol metabolism mouse 46 48 complex trait involves genes work additive manner well epistatically 49 analysis cholesterol ki mice subsequent backcrosses argues background effects demonstrated comparing cholesterol levels 4n5 animals 4r140 animals n8 backcross generation table 1 versus fig 4 second ki mice report longer transmit neo cassette targeted allele although direct evidence suggest presence neo affects function apoe cholesterol metabolism mice cannot ruled finally differences diet methodology two studies may also impact reported cholesterol levels
0.37081465.15229191.html.plaintext.txt	48	apoe cholesterol metabolism mice addition protein levels show apoe genotype also impacts cholesterol levels periphery 4 ki animals fasted cholesterol levels slightly b6 wild type animals whereas 2 ki animals 2 fold higher cholesterol levels 3 ki b6 wild type cholesterol levels significantly differ data recapitulate shown apoe ki models 46 48 opposite findings humans 4 allele associated high 2 low cholesterol levels data highlight innate differences mouse human cholesterol metabolism include utilization different lipoproteins transport cholesterol data also contrast initial report 4 ki mice hamanaka et al 27 showing 25 fold increase levels circulating cholesterol relative wild type controls discrepancy data may attributed several factors first perhaps notable difference genetic background two studies several lines evidence demonstrate strong genetic component cholesterol metabolism mouse 46 48 complex trait involves genes work additive manner well epistatically 49 analysis cholesterol ki mice subsequent backcrosses argues background effects demonstrated comparing cholesterol levels 4n5 animals 4r140 animals n8 backcross generation table 1 versus fig 4 second ki mice report longer transmit neo cassette targeted allele although direct evidence suggest presence neo affects function apoe cholesterol metabolism mice cannot ruled finally differences diet methodology two studies may also impact reported cholesterol levels
0.37081465.15229191.html.plaintext.txt	49	characterization lipoprotein profiles reported 3 4 ki mice demonstrated majority cholesterol distributed hdl fraction similar b6 wild type animals data suggest presence human apoe 3 4 disrupt mouse cholesterol metabolism observation also made maeda colleagues 50 52 comparison profiles published hamanaka et al highlights distinction 4 ki model characterized contrast data hamanaka et al showed cholesterol distributed lipoprotein classes 4 ki mice including vldl ldl profile actually similar 2 ki animals presented animals significantly higher cholesterol levels appear transport excess circulating cholesterol vldl ldl fractions suggesting impaired cholesterol metabolism noted increase triglyceride levels 2 ki animals also suggests development type iii hyperlipoproteinemia complex disorder characterized high cholesterol triglyceride levels affects 10 humans homozygous 2 allele 53 suggested sullivan et al others 5154 condition manifests 2 ki mice owing presence additional genetic factors mouse genome interact 2 allele
0.37081465.15229191.html.plaintext.txt	50	characterization lipoprotein profiles reported 3 4 ki mice demonstrated majority cholesterol distributed hdl fraction similar b6 wild type animals data suggest presence human apoe 3 4 disrupt mouse cholesterol metabolism observation also made maeda colleagues 50 52 comparison profiles published hamanaka et al highlights distinction 4 ki model characterized contrast data hamanaka et al showed cholesterol distributed lipoprotein classes 4 ki mice including vldl ldl profile actually similar 2 ki animals presented animals significantly higher cholesterol levels appear transport excess circulating cholesterol vldl ldl fractions suggesting impaired cholesterol metabolism noted increase triglyceride levels 2 ki animals also suggests development type iii hyperlipoproteinemia complex disorder characterized high cholesterol triglyceride levels affects 10 humans homozygous 2 allele 53 suggested sullivan et al others 5154 condition manifests 2 ki mice owing presence additional genetic factors mouse genome interact 2 allele
0.37081465.15229191.html.plaintext.txt	51	qualitative western blot analysis 3 4 ki fplc profiles demonstrated behavior e3 mice maintained low cholesterol diet follows endogenous apoe found mainly idlldl hdl fraction e4 appears enriched hdl fraction observation may reflect another difference mouse human cholesterol metabolism e4 isoform greater affinity large lipoproteins humans chylomicrons vldl e2 e3 hand prefer smaller lipoproteins primarily found associated hdl smallest lipoprotein class importantly mouse plasma enriched large apoe rich hdl absent normal human plasma 36 may e4 preference particles two isoforms mice show enrichment apoe vldl observed maeda colleagues discrepancy data may explained differences genetic background diet comparisons two sets apoe ki models including levels protein required thoroughly explain results
0.37081465.15229191.html.plaintext.txt	52	qualitative western blot analysis 3 4 ki fplc profiles demonstrated behavior e3 mice maintained low cholesterol diet follows endogenous apoe found mainly idlldl hdl fraction e4 appears enriched hdl fraction observation may reflect another difference mouse human cholesterol metabolism e4 isoform greater affinity large lipoproteins humans chylomicrons vldl e2 e3 hand prefer smaller lipoproteins primarily found associated hdl smallest lipoprotein class importantly mouse plasma enriched large apoe rich hdl absent normal human plasma 36 may e4 preference particles two isoforms mice show enrichment apoe vldl observed maeda colleagues discrepancy data may explained differences genetic background diet comparisons two sets apoe ki models including levels protein required thoroughly explain results
0.37081465.15229191.html.plaintext.txt	53	cholesterol app processing order identify effects apoe allele app processing ass production particularly regard cholesterol metabolism apoe abundance crossed apoe ki animals r140 appswe transgenic animals several studies established link cholesterol app processing 105556 refolo et al 13 demonstrated cholesterol influences cleavage app beta secretase vivo hypercholesterolemia increasing ctfss levels however neither levels holo app ctfs altered apoer140 animals 28 days age lack effect app processing 2 ki animals unexpected considering high serum cholesterol levels
0.37081465.15229191.html.plaintext.txt	54	analysis ass1 40 levels animals provided evidence serum cholesterol alone enough affect app processing young age given strong evidence high cholesterol levels increasing ass production 13 predicted 2 ki animals 2 fold increase total serum cholesterol would demonstrate much higher levels ass 3 ki 4 ki mice however similar ctf data levels ass1 40 brain indistinguishable across lines several possible explanations results first data present come 28 day old animals age post weaning prior sexual maturity possible ability cholesterol affect app processing ass metabolism time age dependent successful diet studies chronically fed mice high cholesterol diets several weeks 1314 chronic exposure high serum cholesterol levels several weeks months may required affect ass metabolism apoer140 animals assaying levels ass1 40 older animals useful understand age component cholesterol effects apoe app processing
0.37081465.15229191.html.plaintext.txt	55	analysis ass1 40 levels animals provided evidence serum cholesterol alone enough affect app processing young age given strong evidence high cholesterol levels increasing ass production 13 predicted 2 ki animals 2 fold increase total serum cholesterol would demonstrate much higher levels ass 3 ki 4 ki mice however similar ctf data levels ass1 40 brain indistinguishable across lines several possible explanations results first data present come 28 day old animals age post weaning prior sexual maturity possible ability cholesterol affect app processing ass metabolism time age dependent successful diet studies chronically fed mice high cholesterol diets several weeks 1314 chronic exposure high serum cholesterol levels several weeks months may required affect ass metabolism apoer140 animals assaying levels ass1 40 older animals useful understand age component cholesterol effects apoe app processing
0.37081465.15229191.html.plaintext.txt	56	second show peripheral cholesterol metabolism affect cns cholesterol regulation despite differences serum cholesterol three apoer140 lines described manuscript brain cholesterol levels indistinguishable animals finding supported large body evidence demonstrating cholesterol metabolism periphery fundamentally different independent central nervous system involving different lipoproteins apolipoproteins 57 59 argues effect peripheral cholesterol processes brain
0.37081465.15229191.html.plaintext.txt	57	second show peripheral cholesterol metabolism affect cns cholesterol regulation despite differences serum cholesterol three apoer140 lines described manuscript brain cholesterol levels indistinguishable animals finding supported large body evidence demonstrating cholesterol metabolism periphery fundamentally different independent central nervous system involving different lipoproteins apolipoproteins 57 59 argues effect peripheral cholesterol processes brain
0.37081465.15229191.html.plaintext.txt	58	apoe alzheimers disease manuscript highlights first report apoe mouse model utilizes endogenous regulation study native apoe levels cholesterol metabolism relation alzheimers disease importantly correlation apoe genotype apoe steady state levels cholesterol metabolism observed humans uncoupled ki mice allows us dissect two aspects apoe function may impact development ad cholesterol metabolism ass clearance apoe abundance brains 4 ki animals low animals normal serum cholesterol levels animals allow us study effects low apoe levels absence high cholesterol often observed humans inherit 4 allele likewise 2 ki animals high serum cholesterol high brain apoe levels animals useful determine effects high cholesterol independent low apoe levels future experiments assess effects age diet apoer140 lines cholesterol metabolism particularly brain apoe abundance well ass metabolism amyloid deposition
0.37081465.15229191.html.plaintext.txt	59	apoe alzheimers disease manuscript highlights first report apoe mouse model utilizes endogenous regulation study native apoe levels cholesterol metabolism relation alzheimers disease importantly correlation apoe genotype apoe steady state levels cholesterol metabolism observed humans uncoupled ki mice allows us dissect two aspects apoe function may impact development ad cholesterol metabolism ass clearance apoe abundance brains 4 ki animals low animals normal serum cholesterol levels animals allow us study effects low apoe levels absence high cholesterol often observed humans inherit 4 allele likewise 2 ki animals high serum cholesterol high brain apoe levels animals useful determine effects high cholesterol independent low apoe levels future experiments assess effects age diet apoer140 lines cholesterol metabolism particularly brain apoe abundance well ass metabolism amyloid deposition
0.37081465.15229191.html.plaintext.txt	60	materials methods top abstract introduction results discussion materials methods references mice original stocks apoe 2 3 4 ki animals produced mitsubishi kagaku institute life sciences 4 ki animals previously published 27 apoe characterization male ki animals line backcrossed two generations onto c57bl6j background male progeny n2 generation crossed zp3 cre transgenic animals congenic c57bl6j background 31 female progeny cross n3 generation selected basis presence human apoe zp3 cre transgene additional backcross animals yielded progeny n4 generation selected basis presence apoe absence neo cassette targeted allele males cross backcrossed n5 animals intercrossed obtain homozygous ki animals allele animals used characterization studies human apoe mouse longer carried zp3 cre transgene analysis app processing ass metabolism apoe ki animals backcrossed n7 generation crossed b6r140 app transgenic mice congenic c57bl6j background subsequent progeny intercrossed obtain mice homozygous apoe hemizygous app transgene mice maintained normal chow diet labdiets 5021 95 fat accordance iacuc regulations
0.37081465.15229191.html.plaintext.txt	61	materials methods top abstract introduction results discussion materials methods references mice original stocks apoe 2 3 4 ki animals produced mitsubishi kagaku institute life sciences 4 ki animals previously published 27 apoe characterization male ki animals line backcrossed two generations onto c57bl6j background male progeny n2 generation crossed zp3 cre transgenic animals congenic c57bl6j background 31 female progeny cross n3 generation selected basis presence human apoe zp3 cre transgene additional backcross animals yielded progeny n4 generation selected basis presence apoe absence neo cassette targeted allele males cross backcrossed n5 animals intercrossed obtain homozygous ki animals allele animals used characterization studies human apoe mouse longer carried zp3 cre transgene analysis app processing ass metabolism apoe ki animals backcrossed n7 generation crossed b6r140 app transgenic mice congenic c57bl6j background subsequent progeny intercrossed obtain mice homozygous apoe hemizygous app transgene mice maintained normal chow diet labdiets 5021 95 fat accordance iacuc regulations
0.37081465.15229191.html.plaintext.txt	62	cholesterol triglyceride measurements serum cholesterol triglyceride measurements obtained animals fasted 6 h retro ortbital sinus bleed measurements obtained using infinity cholesterol reagent infinity triglyceride reagent respectively thermotrace arlington tx usa according manufacturers instructions brain cholesterol hemispheres extracted homogenization 6 m urea buffer 6 m urea 100 mm tris ph 74 1 mm dtt 1 mm edta 05 m aebsf 1 sds reported levin allerhand et al 14 brain cholesterol measured using inifinity cholesterol reagent thermotrace diluting homogenates 1 1 pbs brain cholesterol concentrations expressed mg cholesterol relative mg protein measured bca assay pierce rockford il usa
0.37081465.15229191.html.plaintext.txt	63	cholesterol triglyceride measurements serum cholesterol triglyceride measurements obtained animals fasted 6 h retro ortbital sinus bleed measurements obtained using infinity cholesterol reagent infinity triglyceride reagent respectively thermotrace arlington tx usa according manufacturers instructions brain cholesterol hemispheres extracted homogenization 6 m urea buffer 6 m urea 100 mm tris ph 74 1 mm dtt 1 mm edta 05 m aebsf 1 sds reported levin allerhand et al 14 brain cholesterol measured using inifinity cholesterol reagent thermotrace diluting homogenates 1 1 pbs brain cholesterol concentrations expressed mg cholesterol relative mg protein measured bca assay pierce rockford il usa
0.37081465.15229191.html.plaintext.txt	64	fplc analysis lipoprotein profiles cholesterol distribution apoe ki animals fasted serum three animals genotype sex pooled fractionation superose 6 column pharmacia kalamazoo mi usa previously described 60
0.37081465.15229191.html.plaintext.txt	65	western blot analysis analysis apoe levels tissues brain liver homogenates prepared 1 chaps protease inhibitors 1 microm pepstatin 45 microgml leupeptin 30 microgml aprotinin 1 mm aebsf brain fasted liver homogenates run 4 12 bis tris gradient gels invitrogen carlsbad ca usa reducing conditions according manufacturers instructions equal concentrations protein determined bca assay loaded every gel linear standard curve serially diluted control 3 ki known concentration run every gel normalize across gels r2090 protein transferred immobilon p membranes millipore bedford ma usa probed anti human polyclonal apoe antibody calbiochem lajolla ca usa followed hrp conjugated secondary antibody detected using ecl pierce film apoe antibody used extensively detect human apoe mouse immunohistochemistry western blotting elisa 26465152 apoe protein levels serum tissue quantitated calculating intensity sample relative standard concentration imagequant software used analysis protein abundance
0.37081465.15229191.html.plaintext.txt	66	western blot analysis analysis apoe levels tissues brain liver homogenates prepared 1 chaps protease inhibitors 1 microm pepstatin 45 microgml leupeptin 30 microgml aprotinin 1 mm aebsf brain fasted liver homogenates run 4 12 bis tris gradient gels invitrogen carlsbad ca usa reducing conditions according manufacturers instructions equal concentrations protein determined bca assay loaded every gel linear standard curve serially diluted control 3 ki known concentration run every gel normalize across gels r2090 protein transferred immobilon p membranes millipore bedford ma usa probed anti human polyclonal apoe antibody calbiochem lajolla ca usa followed hrp conjugated secondary antibody detected using ecl pierce film apoe antibody used extensively detect human apoe mouse immunohistochemistry western blotting elisa 26465152 apoe protein levels serum tissue quantitated calculating intensity sample relative standard concentration imagequant software used analysis protein abundance
0.37081465.15229191.html.plaintext.txt	67	levels apoe unfractionated serum determined loading equal concentrations protein fasted serum samples diluted pbs onto bis tris gels non reducing conditions following analytical paradigm tissues apoe serum fractionated fplc analyzed qualitatively combining equal volumes peak fraction 2 volumes lipoprotein class apoe detected using human specific apoe antibody visualized ecl using film
0.37081465.15229191.html.plaintext.txt	68	levels apoe unfractionated serum determined loading equal concentrations protein fasted serum samples diluted pbs onto bis tris gels non reducing conditions following analytical paradigm tissues apoe serum fractionated fplc analyzed qualitatively combining equal volumes peak fraction 2 volumes lipoprotein class apoe detected using human specific apoe antibody visualized ecl using film
0.37081465.15229191.html.plaintext.txt	69	relative levels holo app determined using brain homogenates prepared 6 m urea mentioned earlier equal concentrations protein every sample loaded onto 7 tris acetate gels invitrogen run according manufacturers instructions linear standard curve serially diluted homogenate b6 non transgenic animal run every gel normalize across gels r2090 protein transferred mentioned earlier membranes probed c terminal antibody human app 369 gift sam gandy thomas jefferson university intensity app protein band determined ecl detected using fluor max imaging machine biorad hercules ca usa quantitated quantity one software biorad app ctfs determined extracts run 4 12 bis tris gradient gels mentioned earlier using 369 antibody quantitation carried film mentioned earlier
0.37081465.15229191.html.plaintext.txt	70	relative levels holo app determined using brain homogenates prepared 6 m urea mentioned earlier equal concentrations protein every sample loaded onto 7 tris acetate gels invitrogen run according manufacturers instructions linear standard curve serially diluted homogenate b6 non transgenic animal run every gel normalize across gels r2090 protein transferred mentioned earlier membranes probed c terminal antibody human app 369 gift sam gandy thomas jefferson university intensity app protein band determined ecl detected using fluor max imaging machine biorad hercules ca usa quantitated quantity one software biorad app ctfs determined extracts run 4 12 bis tris gradient gels mentioned earlier using 369 antibody quantitation carried film mentioned earlier
0.37081465.15229191.html.plaintext.txt	71	elisa levels human apoe brain measured human specific apoe elisa mbl international according manufacturers instructions homogenates made 1 chaps mentioned earlier run duplicate detected using pan apoe antibody standard curves recombinant e2 e3 e4 run duplicate plate levels apoe determined using standard curve respective isoform
0.37081465.15229191.html.plaintext.txt	72	elisa levels human apoe brain measured human specific apoe elisa mbl international according manufacturers instructions homogenates made 1 chaps mentioned earlier run duplicate detected using pan apoe antibody standard curves recombinant e2 e3 e4 run duplicate plate levels apoe determined using standard curve respective isoform
0.37081465.15229191.html.plaintext.txt	73	levels ass1 40 measured human specific ass1 40 elisa biosource international according manufacturers instructions half brains homogenized 5 m guanidine 100 mm tris ph 80 incubated room temperature 35 4 h ensure complete protein extraction samples diluted standardsample buffer centrifuged loaded triplicate onto elisa plate
0.37081465.15229191.html.plaintext.txt	74	levels ass1 40 measured human specific ass1 40 elisa biosource international according manufacturers instructions half brains homogenized 5 m guanidine 100 mm tris ph 80 incubated room temperature 35 4 h ensure complete protein extraction samples diluted standardsample buffer centrifuged loaded triplicate onto elisa plate
0.37081465.15229191.html.plaintext.txt	75	statistics statistical analysis carried using prism graphpad software san diego ca usa specific test used analysis indicated appropriate figure legend
0.37081465.15229191.html.plaintext.txt	76	statistics statistical analysis carried using prism graphpad software san diego ca usa specific test used analysis indicated appropriate figure legend
0.37081465.15229191.html.plaintext.txt	77	acknowledgements authors acknowledge minesuke yokoyama rika migishima yoshiko motegi yoko nakahara aya takeshita mariko kobayashi involved initial generation apoe 2 3 4 ki animals thank sam gandy thomas jefferson university providing 369 app antibody barbara knowles jackson labs zp3 cre animals also thank ireland cancer center university hospitals cleveland ohio use equipment work supported part nih training grant gm08613 kmm nih grant r01 ag14451 alzheimers association grant iirg 02 3750 american health assistance founding grant btl university memory aging center p50 ag08012 ireland cancer center ca 43703 nih grant r01 hl32868 dlw
0.37081465.15229191.html.plaintext.txt	78	acknowledgements authors acknowledge minesuke yokoyama rika migishima yoshiko motegi yoko nakahara aya takeshita mariko kobayashi involved initial generation apoe 2 3 4 ki animals thank sam gandy thomas jefferson university providing 369 app antibody barbara knowles jackson labs zp3 cre animals also thank ireland cancer center university hospitals cleveland ohio use equipment work supported part nih training grant gm08613 kmm nih grant r01 ag14451 alzheimers association grant iirg 02 3750 american health assistance founding grant btl university memory aging center p50 ag08012 ireland cancer center ca 43703 nih grant r01 hl32868 dlw
0.37081465.15229191.html.plaintext.txt	79	footnotes correspondence addressed department genetics case western reserve university 10900 euclid avenue cleveland oh 44106 4955 usa tel 1 2163682979 fax 1 2163683432 email btlatcwruedu
0.37081465.15229191.html.plaintext.txt	80	footnotes correspondence addressed department genetics case western reserve university 10900 euclid avenue cleveland oh 44106 4955 usa tel 1 2163682979 fax 1 2163683432 email btlatcwruedu
0.37081465.15229191.html.plaintext.txt	81	references top abstract introduction results discussion materials methods references weisgraber kh innerarity tl mahley rw 1982 abnormal lipoprotein receptor binding activity human e apoprotein due cysteine arginine interchange single site j biol chem 257 2518 2521free full text
0.37081465.15229191.html.plaintext.txt	82	article abstract free full text pdf versions article 13171959 recent ddh199v1 alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager search citing articles isi web science 2 request permissions google scholar articles mann k m articles lamb b pubmed pubmed citation articles mann k m articles lamb b online issn 1460 2083 print issn 0964 6906 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.37510666.12551940.html.plaintext.txt	0	hepatocyte derived apoe effective non hepatocyte derived apoe remnant lipoprotein clearance robert l raffai alyssa h hasty yuwei wang shelley e mettler david sanan macrae f linton sergio fazio karl h weisgraber
0.37510666.12551940.html.plaintext.txt	1	gladstone institutes cardiovascular disease neurological disease san francisco california 94141 9100 cardiovascular research institute department pathology university california san francisco california 94143 department medicine vanderbilt university nashville tennessee 37232
0.37510666.12551940.html.plaintext.txt	2	received publication december 18 2002 revised form january 23 2003
0.37510666.12551940.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	4	importance hepatocyte derived apolipoprotein apo e clearance remnant lipoproteins liver controversial address controversy compared remnant clearance two mouse models apoe primarily derived either hepatocytes extrahepatic source hypomorphic apoe mice universally express reduced levels apoe tissues liver remaining primary source apoe mouse model hepatocyte derived apoe compared apoe mice transplanted mouse bone marrow model primarily non hepatocyte derived apoe immunohistochemical analysis liver sections revealed hepatocyte derived apoe model detectable levels apoe hepatic sinusoidal surfaces non hepatocyte derived apoe model plasma apoe levels similar hepatocyte derived model 2 fold total plasma cholesterol 4 fold total plasma triglycerides 8 fold higher levels apob48 similar apoe mice hepatocyte derived non hepatocyte derived apoe models delayed clearance infused bolus 125i labeled remnants compared wild type mice however 3 h plasma remnants reached wild type levels hepatocyte derived apoe model accumulated 70 plus minus 5 wild type levels remnants liver non hepatocyte derived apoe model accumulated 38 plus minus 4 results demonstrate existence role hepatically derived localized apoe remnant clearance role likely represents enrichment remnants sequestered hepatocyte hepatocyte derived apoe facilitating receptor mediated internalization introduction top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	5	importance hepatocyte derived apolipoprotein apo e clearance remnant lipoproteins liver controversial address controversy compared remnant clearance two mouse models apoe primarily derived either hepatocytes extrahepatic source hypomorphic apoe mice universally express reduced levels apoe tissues liver remaining primary source apoe mouse model hepatocyte derived apoe compared apoe mice transplanted mouse bone marrow model primarily non hepatocyte derived apoe immunohistochemical analysis liver sections revealed hepatocyte derived apoe model detectable levels apoe hepatic sinusoidal surfaces non hepatocyte derived apoe model plasma apoe levels similar hepatocyte derived model 2 fold total plasma cholesterol 4 fold total plasma triglycerides 8 fold higher levels apob48 similar apoe mice hepatocyte derived non hepatocyte derived apoe models delayed clearance infused bolus 125i labeled remnants compared wild type mice however 3 h plasma remnants reached wild type levels hepatocyte derived apoe model accumulated 70 plus minus 5 wild type levels remnants liver non hepatocyte derived apoe model accumulated 38 plus minus 4 results demonstrate existence role hepatically derived localized apoe remnant clearance role likely represents enrichment remnants sequestered hepatocyte hepatocyte derived apoe facilitating receptor mediated internalization introduction top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	6	plasma remnant lipoproteins metabolic end products intestine derived chylomicrons hepatocyte derived low density lipoprotein 1 3 apolipoprotein apo1 e mediates uptake remnants liver binding ldl receptor ldlr ldlr related protein lrp heparan sulfate proteoglycans hspg 4 7 inefficient clearance leads accumulation remnants plasma contributes premature atherosclerosis 8 9
0.37510666.12551940.html.plaintext.txt	7	plasma remnant lipoproteins metabolic end products intestine derived chylomicrons hepatocyte derived low density lipoprotein 1 3 apolipoprotein apo1 e mediates uptake remnants liver binding ldl receptor ldlr ldlr related protein lrp heparan sulfate proteoglycans hspg 4 7 inefficient clearance leads accumulation remnants plasma contributes premature atherosclerosis 8 9
0.37510666.12551940.html.plaintext.txt	8	liver major source plasma apoe extrahepatic tissues primarily macrophages contribute 10 plasma levels 10 hepatocyte derived apoe proposed promote remnant clearance uptake two step process referred secretion capture 3 11 12 first step portion newly secreted apoe interacts hspg remains bound hepatocyte cell surfaces remainder released space disse serves enrich lipoproteins 11 13 presence apoe hepatocytes thought promote trapping sequestration remnants 6 11 support mechanism distinct dynamic pools apoe hepatocyte cell surfaces recently reported vitro 14 second step sequestered remnants enriched hepatocyte derived apoe internalized hepatocytes processes mediated receptors including ldlr lrp 7 15 19 interactions hspg alone 11 20 21 apoehspg interactions disrupted vivo intravenous heparinase infusion remnant clearance severely inhibited supporting importance secretion capture role apoe remnant clearance 22 23
0.37510666.12551940.html.plaintext.txt	9	liver major source plasma apoe extrahepatic tissues primarily macrophages contribute 10 plasma levels 10 hepatocyte derived apoe proposed promote remnant clearance uptake two step process referred secretion capture 3 11 12 first step portion newly secreted apoe interacts hspg remains bound hepatocyte cell surfaces remainder released space disse serves enrich lipoproteins 11 13 presence apoe hepatocytes thought promote trapping sequestration remnants 6 11 support mechanism distinct dynamic pools apoe hepatocyte cell surfaces recently reported vitro 14 second step sequestered remnants enriched hepatocyte derived apoe internalized hepatocytes processes mediated receptors including ldlr lrp 7 15 19 interactions hspg alone 11 20 21 apoehspg interactions disrupted vivo intravenous heparinase infusion remnant clearance severely inhibited supporting importance secretion capture role apoe remnant clearance 22 23
0.37510666.12551940.html.plaintext.txt	10	importance hepatically synthesized localized apoe thus secretion capture role apoe recently questioned 24 moreover evidence mouse models expressing apoe exclusively extrahepatic sources suggests hepatic apoe expression absolutely required remnant clearance normal plasma cholesterol levels 25 27 finally clear whether hepatic apoe expression required remnant clearance mice lacking ldlr 24 28 29
0.37510666.12551940.html.plaintext.txt	11	importance hepatically synthesized localized apoe thus secretion capture role apoe recently questioned 24 moreover evidence mouse models expressing apoe exclusively extrahepatic sources suggests hepatic apoe expression absolutely required remnant clearance normal plasma cholesterol levels 25 27 finally clear whether hepatic apoe expression required remnant clearance mice lacking ldlr 24 28 29
0.37510666.12551940.html.plaintext.txt	12	previously reported 30 generation hypomorphic apoe hypoe mice express reduced levels arg 61 apoe similar human apoe4 displays apoe4 domain interaction reduction apoe levels caused neomycin neo cassette flanked loxp sites apoe intron 3 however expression pattern hypomorphic allele remains normal liver producing majority apoe mice 30 excision neo cassette cre mediated gene repair restores normal expression allele tissues 31 despite 2 5 wild type plasma apoe levels hypoe mice display nearly normal lipoprotein profile however apoe mice similar plasma apoe levels transplantation varying amounts wild type bone marrow remnants accumulate 32 plasma apoe levels exceeded 10 wild type levels remnant levels approached normal efficient remnant clearance hypoe mice suggests importance hepatocyte derived apoe secretion capture role apoe
0.37510666.12551940.html.plaintext.txt	13	previously reported 30 generation hypomorphic apoe hypoe mice express reduced levels arg 61 apoe similar human apoe4 displays apoe4 domain interaction reduction apoe levels caused neomycin neo cassette flanked loxp sites apoe intron 3 however expression pattern hypomorphic allele remains normal liver producing majority apoe mice 30 excision neo cassette cre mediated gene repair restores normal expression allele tissues 31 despite 2 5 wild type plasma apoe levels hypoe mice display nearly normal lipoprotein profile however apoe mice similar plasma apoe levels transplantation varying amounts wild type bone marrow remnants accumulate 32 plasma apoe levels exceeded 10 wild type levels remnant levels approached normal efficient remnant clearance hypoe mice suggests importance hepatocyte derived apoe secretion capture role apoe
0.37510666.12551940.html.plaintext.txt	14	study designed address controversy concerning importance hepatically derived localized apoe remnant clearance vivo models end remnant clearance assessed hypoe mice model hepatocyte derived apoe apoe mice expressing similar levels arg 61 apoe bone marrow transplantation model non hepatocyte derived apoe results demonstrate remnant clearance efficient hepatocyte derived apoe model provide vivo evidence importance hepatically derived localized apoe remnant clearance experimental procedures top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	15	study designed address controversy concerning importance hepatically derived localized apoe remnant clearance vivo models end remnant clearance assessed hypoe mice model hepatocyte derived apoe apoe mice expressing similar levels arg 61 apoe bone marrow transplantation model non hepatocyte derived apoe results demonstrate remnant clearance efficient hepatocyte derived apoe model provide vivo evidence importance hepatically derived localized apoe remnant clearance experimental procedures top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	16	hepatocyte derived apoe mouse model generation hypoe mice hepatocyte derived apoe model previously described 30 briefly neo cassette flanked loxp sites inserted apoe intron 3 gene targeting embryonic stem cells help follow replacement human equivalent thr 61 arginine aimed creating model apoe4 31 presence neo cassette apoe intron 3 results reduced apoe mrna levels tissues organs 30 apoe mrna levels liver brain spleen targeted mice 5 wild type mice resulting plasma apoe levels equal 005 012 mgdl 2 5 wild type levels determined western blot analysis using mouse apoe standards liver remaining primary source apoe however following cre mediated excision neo cassette targeted mice normal expression arg 61 apoe allele restored mice weaned 21 days age housed barrier facility 12 h light12 h dark cycle fed chow diet containing 45 fat ralston purina st louis mo
0.37510666.12551940.html.plaintext.txt	17	hepatocyte derived apoe mouse model generation hypoe mice hepatocyte derived apoe model previously described 30 briefly neo cassette flanked loxp sites inserted apoe intron 3 gene targeting embryonic stem cells help follow replacement human equivalent thr 61 arginine aimed creating model apoe4 31 presence neo cassette apoe intron 3 results reduced apoe mrna levels tissues organs 30 apoe mrna levels liver brain spleen targeted mice 5 wild type mice resulting plasma apoe levels equal 005 012 mgdl 2 5 wild type levels determined western blot analysis using mouse apoe standards liver remaining primary source apoe however following cre mediated excision neo cassette targeted mice normal expression arg 61 apoe allele restored mice weaned 21 days age housed barrier facility 12 h light12 h dark cycle fed chow diet containing 45 fat ralston purina st louis mo
0.37510666.12551940.html.plaintext.txt	18	non hepatocyte derived apoe mouse model mice expressing arg 61 apoe primarily peripheral source generated transplanting cre deleted arg 61 mouse bone marrow lethally irradiated apoe mice bone marrow collected flushing femurs tibias rpmi 1640 containing 2 fetal bovine serum 10 unitsml heparin sigma cells washed counted resuspended rpmi used immediately transplantation lethally irradiated apoe recipient mice cells 5 x 106 volume 300 microl injected tail vein 4 h irradiation 900 rads cesium gamma source
0.37510666.12551940.html.plaintext.txt	19	non hepatocyte derived apoe mouse model mice expressing arg 61 apoe primarily peripheral source generated transplanting cre deleted arg 61 mouse bone marrow lethally irradiated apoe mice bone marrow collected flushing femurs tibias rpmi 1640 containing 2 fetal bovine serum 10 unitsml heparin sigma cells washed counted resuspended rpmi used immediately transplantation lethally irradiated apoe recipient mice cells 5 x 106 volume 300 microl injected tail vein 4 h irradiation 900 rads cesium gamma source
0.37510666.12551940.html.plaintext.txt	20	immunohistochemistry mice fasted 4 h anesthetized avertin flush perfused pbs ph 72 3 paraformaldehyde pbs ph 72 room temperature 5 min hardened liver lobes cut slices 2 3 mm thick fixed overnight immersion 3 paraformaldehyde pbs ph 72 4 degrees c slices briefly washed pbs ph 72 drained placed molds tissue tek compound sakura finetek torrance ca frozen liquid nitrogen blocks held 70 degrees c cut 6 8 microm thick sections leica frigocut 2800 cryostat mounted glass slides
0.37510666.12551940.html.plaintext.txt	21	immunohistochemistry mice fasted 4 h anesthetized avertin flush perfused pbs ph 72 3 paraformaldehyde pbs ph 72 room temperature 5 min hardened liver lobes cut slices 2 3 mm thick fixed overnight immersion 3 paraformaldehyde pbs ph 72 4 degrees c slices briefly washed pbs ph 72 drained placed molds tissue tek compound sakura finetek torrance ca frozen liquid nitrogen blocks held 70 degrees c cut 6 8 microm thick sections leica frigocut 2800 cryostat mounted glass slides
0.37510666.12551940.html.plaintext.txt	22	slides immunostained follows room temperature unless otherwise indicated sections incubated sequence rabbit polyclonal anti mouse apoe antiserum 31 11000 overnight 4 degrees c biotinylated goat anti rabbit igg zymed laboratories inc south san francisco ca 04 microgml streptavidin horseradish peroxidase conjugate tyramide signal amplification kit tsa fluorescein system nel 701 perkinelmer life sciences 1500 finally fluorescein tyramide kit 1100 slides coverslipped application vectashield anti fade mounting medium vector h 1000 vector laboratories burlingame ca imaged epifluorescence using nikon e600 microscope equipped spot 2 digital camera diagnostic instruments sterling heights mi
0.37510666.12551940.html.plaintext.txt	23	slides immunostained follows room temperature unless otherwise indicated sections incubated sequence rabbit polyclonal anti mouse apoe antiserum 31 11000 overnight 4 degrees c biotinylated goat anti rabbit igg zymed laboratories inc south san francisco ca 04 microgml streptavidin horseradish peroxidase conjugate tyramide signal amplification kit tsa fluorescein system nel 701 perkinelmer life sciences 1500 finally fluorescein tyramide kit 1100 slides coverslipped application vectashield anti fade mounting medium vector h 1000 vector laboratories burlingame ca imaged epifluorescence using nikon e600 microscope equipped spot 2 digital camera diagnostic instruments sterling heights mi
0.37510666.12551940.html.plaintext.txt	24	lipid lipoprotein determination lipids lipoproteins measured age matched male mice fasted 4 h anesthetized bled retro orbital puncture lipoproteins fractionated fast performance liquid chromatography fplc superose 6 column amersham biosciences plasma lipoprotein fractions examined agarose gel electrophoresis universal gel8 helena laboratories beaumont tx cholesterol triglyceride levels plasma fplc fractions determined colorimetric assays spectrum abbott irving tx triglycerides roche molecular biochemicals respectively statistical significance differences lipid levels determined students test
0.37510666.12551940.html.plaintext.txt	25	lipid lipoprotein determination lipids lipoproteins measured age matched male mice fasted 4 h anesthetized bled retro orbital puncture lipoproteins fractionated fast performance liquid chromatography fplc superose 6 column amersham biosciences plasma lipoprotein fractions examined agarose gel electrophoresis universal gel8 helena laboratories beaumont tx cholesterol triglyceride levels plasma fplc fractions determined colorimetric assays spectrum abbott irving tx triglycerides roche molecular biochemicals respectively statistical significance differences lipid levels determined students test
0.37510666.12551940.html.plaintext.txt	26	apoe apob quantitation fasted mouse plasma subjected sds page 10 20 4 15 gels transferred nitrocellulose western blotting performed rabbit antiserum mouse apoe 31 apob 30 western blots incubated primary antibodies 12000 bound primary antibodies detected horseradish peroxidase conjugated anti rabbit antibody invitrogen signals generated incubating membranes chemiluminescent reagent amersham biosciences exposing x ray film kodak rochester ny signals quantified phosphorimaging quantification software quantity one bio rad
0.37510666.12551940.html.plaintext.txt	27	apoe apob quantitation fasted mouse plasma subjected sds page 10 20 4 15 gels transferred nitrocellulose western blotting performed rabbit antiserum mouse apoe 31 apob 30 western blots incubated primary antibodies 12000 bound primary antibodies detected horseradish peroxidase conjugated anti rabbit antibody invitrogen signals generated incubating membranes chemiluminescent reagent amersham biosciences exposing x ray film kodak rochester ny signals quantified phosphorimaging quantification software quantity one bio rad
0.37510666.12551940.html.plaintext.txt	28	remnant lipoprotein clearance study remnant lipoproteins prepared plasma adjusted density d 104 gml fasted apoe mice plasma centrifuged beckman ultracentrifuge tl 1003 rotor 80000 rpm 16 h 8 degrees c remnants isolated recentrifuged two additional 16 h periods d 104 gml ensure removal plasma albumin purity remnant preparation examined sds page staining coomassie blue revealed apob48 major protein component followed apoai apob100 present trace amounts remnants labeled na125i amersham biosciences modification iodine monochloride method first described mcfarlane 33 125i labeled remnants extensively dialyzed pbs ph 72 adjusted specific activity 65000 cpm microg protein labeled remnants 24 microg protein volume 400 microl pbs injected tail vein recipient mice wild type hepatocyte derived apoe model non hepatocyte derived apoe model apoe mice n 3group blood 50 microl collected retro orbital venous plexus heparinized tubes 1 5 15 30 60 180 min injection 125i labeled remnants aliquots plasma analyzed radioactivity gamma counter packard total counts calculated assuming plasma represents 35 total body weight 34 180 min mice anesthetized avertin flush perfused pbs ph 72 whole livers collected amount 125i liver determined results top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	29	remnant lipoprotein clearance study remnant lipoproteins prepared plasma adjusted density d 104 gml fasted apoe mice plasma centrifuged beckman ultracentrifuge tl 1003 rotor 80000 rpm 16 h 8 degrees c remnants isolated recentrifuged two additional 16 h periods d 104 gml ensure removal plasma albumin purity remnant preparation examined sds page staining coomassie blue revealed apob48 major protein component followed apoai apob100 present trace amounts remnants labeled na125i amersham biosciences modification iodine monochloride method first described mcfarlane 33 125i labeled remnants extensively dialyzed pbs ph 72 adjusted specific activity 65000 cpm microg protein labeled remnants 24 microg protein volume 400 microl pbs injected tail vein recipient mice wild type hepatocyte derived apoe model non hepatocyte derived apoe model apoe mice n 3group blood 50 microl collected retro orbital venous plexus heparinized tubes 1 5 15 30 60 180 min injection 125i labeled remnants aliquots plasma analyzed radioactivity gamma counter packard total counts calculated assuming plasma represents 35 total body weight 34 180 min mice anesthetized avertin flush perfused pbs ph 72 whole livers collected amount 125i liver determined results top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	30	detection apoe hepatocyte cell surfaces liver impact tissue source apoe remnant clearance assessed studying two mouse models expressing low levels plasma apoe derived primarily liver hepatocytes primarily peripheral source first examined liver associated apoe mouse models like wild type mice hepatocyte derived apoe model detectable levels apoe bound hepatic sinusoidal surfaces although reduced levels fig 1 contrast similar apoe mice non hepatocyte derived apoe model little detectable apoe bound hepatic sinusoidal surfaces however unlike apoe mice non hepatocyte derived apoe model apoe immunoreactive cells liver sections likely represent macrophage derived kupfer cells expressing apoe cells taken apoe circulation thus enrichment apoe hepatic sinusoidal surfaces required local apoe expression present hepatocyte derived apoe model
0.37510666.12551940.html.plaintext.txt	31	detection apoe hepatocyte cell surfaces liver impact tissue source apoe remnant clearance assessed studying two mouse models expressing low levels plasma apoe derived primarily liver hepatocytes primarily peripheral source first examined liver associated apoe mouse models like wild type mice hepatocyte derived apoe model detectable levels apoe bound hepatic sinusoidal surfaces although reduced levels fig 1 contrast similar apoe mice non hepatocyte derived apoe model little detectable apoe bound hepatic sinusoidal surfaces however unlike apoe mice non hepatocyte derived apoe model apoe immunoreactive cells liver sections likely represent macrophage derived kupfer cells expressing apoe cells taken apoe circulation thus enrichment apoe hepatic sinusoidal surfaces required local apoe expression present hepatocyte derived apoe model
0.37510666.12551940.html.plaintext.txt	32	view larger version 145k fig 1 localization apoe mouse liver livers wild type hepatocyte derived apoe model non hepatocyte derived apoe model apoe mice perfused saline fixed paraformadehyde prepared cryosectioning apoe detected immunofluorescence viewed inverted light microscope scale bar 100 microm
0.37510666.12551940.html.plaintext.txt	33	plasma apoe levels hepatocyte derived non hepatocyte derived apoe models despite different levels liver associated apoe hepatocyte derived non hepatocyte derived apoe models expressed similarly low levels apoe plasma corresponding 2 5 wild type apoe levels hepatocyte derived apoe model 2 fold non hepatocyte derived apoe model fig 2
0.37510666.12551940.html.plaintext.txt	34	view larger version 16k fig 2 relative levels apoe mouse plasma plasma 1 microl fasted mice resolved sds page apoe detected western blotting lane 1 recombinant mouse apoe lanes 2 3 plasma two hepatocyte derived apoe mice lanes 4 5 plasma two non hepatocyte derived apoe mice
0.37510666.12551940.html.plaintext.txt	35	plasma lipid lipoprotein levels hepatocyte derived non hepatocyte derived apoe models tissue source apoe resulted marked difference plasma lipid lipoprotein levels plasma cholesterol levels non hepatocyte derived apoe model 2 fold higher hepatocyte derived apoe model 230 plus minus 50 versus 98 plus minus 18 mgdl n 6 p 002 plasma triglyceride levels 4 fold higher non hepatocyte derived apoe model hepatocyte derived apoe model 176 plus minus 27 versus 45 plus minus 12 mgdl n 6 p 003 fractionation mouse plasma showed marked difference lipoprotein profiles fig 3 non hepatocyte derived apoe mice transported 60 80 plasma cholesterol remnant lipoproteins contrast hepatocyte derived apoe mice transported 30 40 plasma cholesterol remnant lipoproteins 30 like wild type mice transport majority plasma cholesterol high density lipoprotein 17 thus non hepatocyte derived apoe model transports 2 3 fold remnant lipoprotein associated cholesterol less high density lipoprotein cholesterol hepatocyte derived model agarose gel electrophoresis mouse plasma confirmed normal lipoprotein profile hepatocyte derived apoe model accumulation remnants non hepatocyte derived model data shown
0.37510666.12551940.html.plaintext.txt	36	plasma lipid lipoprotein levels hepatocyte derived non hepatocyte derived apoe models tissue source apoe resulted marked difference plasma lipid lipoprotein levels plasma cholesterol levels non hepatocyte derived apoe model 2 fold higher hepatocyte derived apoe model 230 plus minus 50 versus 98 plus minus 18 mgdl n 6 p 002 plasma triglyceride levels 4 fold higher non hepatocyte derived apoe model hepatocyte derived apoe model 176 plus minus 27 versus 45 plus minus 12 mgdl n 6 p 003 fractionation mouse plasma showed marked difference lipoprotein profiles fig 3 non hepatocyte derived apoe mice transported 60 80 plasma cholesterol remnant lipoproteins contrast hepatocyte derived apoe mice transported 30 40 plasma cholesterol remnant lipoproteins 30 like wild type mice transport majority plasma cholesterol high density lipoprotein 17 thus non hepatocyte derived apoe model transports 2 3 fold remnant lipoprotein associated cholesterol less high density lipoprotein cholesterol hepatocyte derived model agarose gel electrophoresis mouse plasma confirmed normal lipoprotein profile hepatocyte derived apoe model accumulation remnants non hepatocyte derived model data shown
0.37510666.12551940.html.plaintext.txt	37	view larger version 17k fig 3 plasma lipoprotein profiles hepatocyte derived non hepatocyte derived apoe models plasma 100 microl four fasted mice pooled fractionated fplc fractions corresponding remnant high density lipoprotein distribution plasma cholesterol levels indicated
0.37510666.12551940.html.plaintext.txt	38	distribution apoe among classes plasma lipoproteins mouse models determined pooling plasma fplc fractions lipoprotein classes followed western blotting shown fig 4 apoe present remnant fractions mouse models demonstrates distribution pattern apoe among plasma lipoprotein classes mouse models identical
0.37510666.12551940.html.plaintext.txt	39	view larger version 29k fig 4 distribution apoe various lipoprotein classes hepatocyte derived non hepatocyte derived apoe models plasma 100 microl four fasted mice pooled separated lipoprotein classes fplc low density lipoprotein fractions 5 8 intermediate density lipoprotein idl fractions 9 12 ldl fractions 13 16 hdl fractions 17 24 see fig 3 apoe detected sds page western blotting
0.37510666.12551940.html.plaintext.txt	40	sds page western blot analysis mouse plasma demonstrated models accumulate apob48 non hepatocyte derived apoe model 8 fold plasma apob48 hepatocyte derived apoe model models similar levels plasma apob100 lower wild type mice fig 5 results consistent rapid removal apob48 containing remnants hepatocyte derived apoe model non hepatocyte derived apoe model taken together results demonstrate remnant clearance effective hepatocyte derived apoe model non hepatocyte derived model due hepatically derived localized apoe
0.37510666.12551940.html.plaintext.txt	41	sds page western blot analysis mouse plasma demonstrated models accumulate apob48 non hepatocyte derived apoe model 8 fold plasma apob48 hepatocyte derived apoe model models similar levels plasma apob100 lower wild type mice fig 5 results consistent rapid removal apob48 containing remnants hepatocyte derived apoe model non hepatocyte derived apoe model taken together results demonstrate remnant clearance effective hepatocyte derived apoe model non hepatocyte derived model due hepatically derived localized apoe
0.37510666.12551940.html.plaintext.txt	42	view larger version 53k fig 5 relative levels apob100 apob48 mouse plasma plasma 1 microl fasted mice resolved sds page apob detected western blotting lane 1 wild type mouse plasma lane 2 apoe mouse plasma lanes 3 4 plasma two hepatocyte derived apoe mice lanes 5 7 plasma three non hepatocyte derived apoe mice
0.37510666.12551940.html.plaintext.txt	43	uptake i125 labeled remnant lipoproteins mice importance source apoe synthesis remnant uptake assessed measuring plasma clearance liver uptake 125i labeled apoe deficient mouse remnants fig 6a although hepatocyte derived apoe model non hepatocyte derived apoe model overall delay remnant clearance relative wild type mice hepatocyte derived apoe model reached wild type levels 3 h moreover livers hepatocyte derived apoe model n 3 contained 70 plus minus 5 total radioactivity found wild type mouse livers whereas livers non hepatocyte derived apoe model n 3 contained 38 plus minus 4 3 h
0.37510666.12551940.html.plaintext.txt	44	view larger version 15k fig 6 clearance apoe deficient remnants mice 125i labeled apoe deficient mouse remnants injected mice via tail vein blood samples collected various time points presence remnants plasma presented percentage injected dose remaining plasma values represent mean plus minus sd three mice time point b experiment performed hepatocyte derived apoe model well apoe wild type mice
0.37510666.12551940.html.plaintext.txt	45	contrary wild type mice initial rates remnant clearance hepatocyte derived apoe apoe null mice identical indicating initial rates models affected levels hepatically localized apoe number apoe molecules per remnant fig 6 b rather difference rate remnant clearance two models apparent later time points diverging first 30 min results demonstrate apoe synthesized liver hepatocytes favors overall greater capacity liver mediated remnant uptake apoe synthesized extrahepatic tissue moreover results support role apoe enrichment remnants sequestered surface hepatocytes consistent plasma lipoprotein profiles fasted mice show significant accumulation remnants non hepatocyte derived apoe model hepatocyte derived apoe model fig 3 discussion top abstract introduction experimental procedures results discussion references
0.37510666.12551940.html.plaintext.txt	46	study presents vivo evidence demonstrates site apoe synthesis significantly influences remnant clearance consequently plasma cholesterol triglyceride levels mice hepatically derived localized apoe hepatocyte derived apoe model found effective macrophage derived apoe non hepatocyte derived apoe model promoting plasma clearance liver uptake apob48 containing remnants moreover low levels hepatically derived localized apoe hepatocyte derived apoe model influenced late initial part remnant clearance
0.37510666.12551940.html.plaintext.txt	47	study presents vivo evidence demonstrates site apoe synthesis significantly influences remnant clearance consequently plasma cholesterol triglyceride levels mice hepatically derived localized apoe hepatocyte derived apoe model found effective macrophage derived apoe non hepatocyte derived apoe model promoting plasma clearance liver uptake apob48 containing remnants moreover low levels hepatically derived localized apoe hepatocyte derived apoe model influenced late initial part remnant clearance
0.37510666.12551940.html.plaintext.txt	48	hepatocyte derived apoe model expresses arg 61 apoe non hepatocyte derived apoe model generated using cre deleted arg 61 bone marrow allow direct comparison hepatocyte derived apoe model mice cre mediated excision neo cassette apoe intron 3 results normal apoe expression levels tissues including macrophages 31 normal lipid lipoprotein levels cre deleted arg 61 mice suggest arg 61 apoe wild type apoe equally effective remnant clearance 31
0.37510666.12551940.html.plaintext.txt	49	hepatocyte derived apoe model expresses arg 61 apoe non hepatocyte derived apoe model generated using cre deleted arg 61 bone marrow allow direct comparison hepatocyte derived apoe model mice cre mediated excision neo cassette apoe intron 3 results normal apoe expression levels tissues including macrophages 31 normal lipid lipoprotein levels cre deleted arg 61 mice suggest arg 61 apoe wild type apoe equally effective remnant clearance 31
0.37510666.12551940.html.plaintext.txt	50	immunohistochemical analysis liver sections demonstrated hepatocyte derived apoe model contained significant levels hepatically localized apoe whereas non hepatocyte derived apoe model hepatically localized apoe hepatocyte derived apoe model likely originated mostly hepatocytes expression pattern hypomorphic apoe allele hepatocyte derived apoe model normal liver producing majority apoe mice 30 however cannot exclude possibility hepatically localized apoe hepatocyte derived apoe model originated periphery
0.37510666.12551940.html.plaintext.txt	51	immunohistochemical analysis liver sections demonstrated hepatocyte derived apoe model contained significant levels hepatically localized apoe whereas non hepatocyte derived apoe model hepatically localized apoe hepatocyte derived apoe model likely originated mostly hepatocytes expression pattern hypomorphic apoe allele hepatocyte derived apoe model normal liver producing majority apoe mice 30 however cannot exclude possibility hepatically localized apoe hepatocyte derived apoe model originated periphery
0.37510666.12551940.html.plaintext.txt	52	higher plasma lipid lipoprotein levels non hepatocyte derived apoe model relative hepatocyte derived apoe model despite similarly low apoe plasma levels consistent efficient clearance remnants hepatocyte derived model non hepatocyte derived apoe model accumulated 2 fold plasma cholesterol 4 fold plasma triglycerides hepatocyte derived apoe model 8 fold greater accumulation apob48 containing remnants non hepatocyte derived apoe model also consistent site apoe synthesis influencing remnant clearance despite models similar levels plasma apoe hepatocyte derived apoe model low levels hepatic apoe synthesis overcome significant degree deficiency remnant clearance seen non hepatocyte derived apoe model contrast wild type mice similar apoe mice models equally low levels plasma apob100 low levels plasma apoe two models apparently failed sufficiently enrich apob48 containing remnants apoe causing become poor competitors apob100 containing ldl binding ldlr
0.37510666.12551940.html.plaintext.txt	53	higher plasma lipid lipoprotein levels non hepatocyte derived apoe model relative hepatocyte derived apoe model despite similarly low apoe plasma levels consistent efficient clearance remnants hepatocyte derived model non hepatocyte derived apoe model accumulated 2 fold plasma cholesterol 4 fold plasma triglycerides hepatocyte derived apoe model 8 fold greater accumulation apob48 containing remnants non hepatocyte derived apoe model also consistent site apoe synthesis influencing remnant clearance despite models similar levels plasma apoe hepatocyte derived apoe model low levels hepatic apoe synthesis overcome significant degree deficiency remnant clearance seen non hepatocyte derived apoe model contrast wild type mice similar apoe mice models equally low levels plasma apob100 low levels plasma apoe two models apparently failed sufficiently enrich apob48 containing remnants apoe causing become poor competitors apob100 containing ldl binding ldlr
0.37510666.12551940.html.plaintext.txt	54	alternatively reduced levels apob100 models may result decreased apob100 secretion liver however hepatic apoe expression reported influence production rate apob48 apob100 mice 35 finding levels apob48 far greater non hepatocyte derived apoe model hepatocyte derived apoe model emphasizes importance hepatically derived localized apoe remnant clearance non hepatocyte derived apoe model likely secretes reduced levels apob48 similar apoe mice 35 thus direct assessment apob secretion rates models necessary confirm possibility lastly remnant clearance models may influenced recently described recycling pathway apoe liver hepatocytes 36 however 6 internalized apoe reported re secreted hepatocytes pathway likely plays minor role mediating remnant clearance models low levels plasma apoe
0.37510666.12551940.html.plaintext.txt	55	alternatively reduced levels apob100 models may result decreased apob100 secretion liver however hepatic apoe expression reported influence production rate apob48 apob100 mice 35 finding levels apob48 far greater non hepatocyte derived apoe model hepatocyte derived apoe model emphasizes importance hepatically derived localized apoe remnant clearance non hepatocyte derived apoe model likely secretes reduced levels apob48 similar apoe mice 35 thus direct assessment apob secretion rates models necessary confirm possibility lastly remnant clearance models may influenced recently described recycling pathway apoe liver hepatocytes 36 however 6 internalized apoe reported re secreted hepatocytes pathway likely plays minor role mediating remnant clearance models low levels plasma apoe
0.37510666.12551940.html.plaintext.txt	56	directly comparing remnant clearance hepatocyte derived non hepatocyte derived apoe models confirmed conclusions drawn steady state plasma lipid lipoprotein levels indicate hepatocyte derived apoe effective non hepatocyte derived apoe remnant clearance compared wild type mice initial phase remnant clearance similarly reduced mouse models comparable apoe null mice initial phase likely reflects binding sequestration remnants hepatocyte cell surfaces space disse levels apoe molecules per remnant well levels hepatically localized apoe hepatocyte derived apoe model appear contribute significantly process moreover differences lipoprotein pool sizes models affect rapid initial clearance remnants however near normal level remnant clearance 3 h hepatocyte derived apoe model suggests hepatically derived localized apoe contribute substantially slower component remnant clearance likely represents liver uptake indeed livers hepatocyte derived apoe model contained 70 plus minus 5 normal 125i levels whereas livers non hepatocyte derived apoe model contained 38 plus minus 4
0.37510666.12551940.html.plaintext.txt	57	directly comparing remnant clearance hepatocyte derived non hepatocyte derived apoe models confirmed conclusions drawn steady state plasma lipid lipoprotein levels indicate hepatocyte derived apoe effective non hepatocyte derived apoe remnant clearance compared wild type mice initial phase remnant clearance similarly reduced mouse models comparable apoe null mice initial phase likely reflects binding sequestration remnants hepatocyte cell surfaces space disse levels apoe molecules per remnant well levels hepatically localized apoe hepatocyte derived apoe model appear contribute significantly process moreover differences lipoprotein pool sizes models affect rapid initial clearance remnants however near normal level remnant clearance 3 h hepatocyte derived apoe model suggests hepatically derived localized apoe contribute substantially slower component remnant clearance likely represents liver uptake indeed livers hepatocyte derived apoe model contained 70 plus minus 5 normal 125i levels whereas livers non hepatocyte derived apoe model contained 38 plus minus 4
0.37510666.12551940.html.plaintext.txt	58	hepatocyte derived apoe model apoe poor remnants sequestered hepatocytes likely become enriched newly secreted apoe space disse passive exchange existing hepatically localized apoe allowing accelerated receptor mediated internalization ldlr lrp hspg alone however non hepatocyte derived apoe model large proportion sequestered apoe poor remnants likely redistribute accumulate circulation due absence apoe enrichment space disse inefficient receptor mediated uptake
0.37510666.12551940.html.plaintext.txt	59	hepatocyte derived apoe model apoe poor remnants sequestered hepatocytes likely become enriched newly secreted apoe space disse passive exchange existing hepatically localized apoe allowing accelerated receptor mediated internalization ldlr lrp hspg alone however non hepatocyte derived apoe model large proportion sequestered apoe poor remnants likely redistribute accumulate circulation due absence apoe enrichment space disse inefficient receptor mediated uptake
0.37510666.12551940.html.plaintext.txt	60	studies remnant clearance isolated mouse liver perfusion model recently questioned importance hepatic synthesis localization apoe thus importance secretion capture role apoe remnant clearance 24 livers apoe mice cleared infused bolus apoe containing rat chylomicron remnants efficiently wild type mice unlike livers apoe mice abundant levels apoe localized hepatocyte cell surfaces 24 recent data model suggested apoehspg interactions hepatocyte cell surfaces required efficient remnant uptake 29 rather apoelrp interactions proposed mediate direct sequestration internalization remnants
0.37510666.12551940.html.plaintext.txt	61	studies remnant clearance isolated mouse liver perfusion model recently questioned importance hepatic synthesis localization apoe thus importance secretion capture role apoe remnant clearance 24 livers apoe mice cleared infused bolus apoe containing rat chylomicron remnants efficiently wild type mice unlike livers apoe mice abundant levels apoe localized hepatocyte cell surfaces 24 recent data model suggested apoehspg interactions hepatocyte cell surfaces required efficient remnant uptake 29 rather apoelrp interactions proposed mediate direct sequestration internalization remnants
0.37510666.12551940.html.plaintext.txt	62	interestingly parallel results observed mouse liver perfusion model 24 absence hepatically localized apoe non hepatocyte derived apoe model apoe mice influence early phase remnant clearance relative hepatocyte derived apoe model indeed three mouse models displayed similarly delayed initial rates remnant clearance relative wild type mice however shortcoming liver perfusion model results cannot necessarily extrapolated explain steady state levels remnants mice example apoe null mice perfused liver effectively cleared infused bolus remnants whereas steady state mice accumulate remnants plasma contrast vivo models directly focus steady state levels remnants mice
0.37510666.12551940.html.plaintext.txt	63	interestingly parallel results observed mouse liver perfusion model 24 absence hepatically localized apoe non hepatocyte derived apoe model apoe mice influence early phase remnant clearance relative hepatocyte derived apoe model indeed three mouse models displayed similarly delayed initial rates remnant clearance relative wild type mice however shortcoming liver perfusion model results cannot necessarily extrapolated explain steady state levels remnants mice example apoe null mice perfused liver effectively cleared infused bolus remnants whereas steady state mice accumulate remnants plasma contrast vivo models directly focus steady state levels remnants mice
0.37510666.12551940.html.plaintext.txt	64	conclusion vivo study mice expressing apoe hepatic versus extrahepatic sources demonstrates underscores importance hepatically derived localized apoe efficient remnant clearance liver remnant clearance operates close sub optimal level hepatocyte derived apoe model model informative revealing relative contributions ldlr lrp remnant clearance context low levels plasma apoe hepatocyte derived apoe model also serve determine contribution proteins known ligands remnant clearance hepatic lipase 37 38 acknowledgements
0.37510666.12551940.html.plaintext.txt	65	conclusion vivo study mice expressing apoe hepatic versus extrahepatic sources demonstrates underscores importance hepatically derived localized apoe efficient remnant clearance liver remnant clearance operates close sub optimal level hepatocyte derived apoe model model informative revealing relative contributions ldlr lrp remnant clearance context low levels plasma apoe hepatocyte derived apoe model also serve determine contribution proteins known ligands remnant clearance hepatic lipase 37 38 acknowledgements
0.37510666.12551940.html.plaintext.txt	66	work supported part nih grant hl47660 k h w grant 10kt 0318 university california tobacco related disease research program fellowship heart stroke foundation canada r l r nih grants 57986 f 53989 m f lthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.37510666.12551940.html.plaintext.txt	67	correspondence addressed gladstone inst cardiovascular disease po box 419100 san francisco ca 94141 9100 tel 415 826 7500 fax 415 285 5632 e mail kweisgrabergladstoneucsfedu
0.37510666.12551940.html.plaintext.txt	68	published jbc papers press january 27 2003 doi 101074jbcm212873200
0.37510666.12551940.html.plaintext.txt	69	abbreviations used apo apolipoprotein hypoe hypomorphic apoe neo neomycin fplc fast performance liquid chromatography hspg heparan sulfate proteoglycans ldl low density lipoprotein ldlr ldl receptor lrp ldlr related protein pbs phosphate buffered saline
0.37510666.12551940.html.plaintext.txt	70	references top abstract introduction experimental procedures results discussion references 1 mahley r w 1988 science 240 622 630medline order article via infotrieve 2 mahley r w hussain m m 1991 curr opin lipidol 2 170 176 3 mahley r w ji z 1999 j lipid res 40 1 16abstractfree full text 4 beisiegel u weber w ihrke g herz j stanley k k 1989 nature 341 162 164crossrefmedline order article via infotrieve 5 brown m herz j kowal r c goldstein j l 1991 curr opin lipidol 2 65 72 6 ji z brecht w j miranda r d hussain m m innerarity l mahley r w 1993 j biol chem 268 10160 10167abstractfree full text 7 kowal r c herz j goldstein j l esser v brown m 1989 proc natl acad sci u 86 5810 5814abstract 8 zilversmit d b 1979 circulation 60 473 485abstract 9 mahley r w rall c jr 2001 metabolic molecular bases inherited disease scriver c r beaudet l sly w valle d childs b kinzler k w vogelstein b eds 8th ed vol 2 pp 2835 2862 mcgraw hill new york 10 linton m f gish r hubl butler e esquivel c bry w boyles j k wardell m r young g 1991 j clin invest 88 270 281medline order article via infotrieve 11 ji z fazio lee y l mahley r w 1994 j biol chem 269 2764 2772abstractfree full text 12 shimano h namba y ohsuga j kawamura m yamamoto k shimada m gotoda harada k yazaki y yamada n 1994 j clin invest 93 2215 2223medline order article via infotrieve 13 hamilton r l wong j guo l krisans havel r j 1990 j lipid res 31 1589 1603abstract 14 burgess j w marcel y l 2001 j lipid res 42 1413 1420abstractfree full text 15 choi y fong l g kirven m j cooper d 1991 j clin invest 88 1173 1181medline order article via infotrieve 16 choi y cooper d 1993 j biol chem 268 15804 15811abstractfree full text 17 ishibashi herz j maeda n goldstein j l brown m 1994 proc natl acad sci u 91 4431 4435abstract 18 herz j qiu q oesterle de silva h v shafi havel r j 1995 proc natl acad sci u 92 4611 4615abstract 19 rohlmann gotthardt m hammer r e herz j 1998 j clin invest 101 689 695abstractfree full text 20 williams k j fless g m petrie k snyder m l brocia r w swenson l 1992 j biol chem 267 13284 13292abstractfree full text 21 ebara conde k kako y liu y xu y ramakrishnan r goldberg j shachter n 2000 j clin invest 105 1807 1818abstractfree full text 22 ji z sanan d mahley r w 1995 j lipid res 36 583 592abstract 23 windler e greeve j robenek h rinninger f greten h jackle 1996 hepatology 24 344 351medline order article via infotrieve 24 yu k c w jiang y chen w cooper d 2000 j lipid res 41 1715 1727abstractfree full text 25 linton m f atkinson j b fazio 1995 science 267 1034 1037medline order article via infotrieve 26 boisvert w spangenberg j curtiss l k 1995 j clin invest 96 1118 1124medline order article via infotrieve 27 thorngate f e rudel l l walzem r l williams d l 2000 arterioscler thromb vasc biol 20 1939 1945abstractfree full text 28 linton m f hasty h babaev v r fazio 1998 j clin invest 101 1726 1736abstractfree full text 29 yu k c w chen w cooper d 2001 j clin invest 107 1387 1394abstractfree full text 30 raffai r l weisgraber k h 2002 j biol chem 277 11064 11068abstractfree full text 31 raffai r l dong l m farese r v jr weisgraber k h 2001 proc natl acad sci u 98 11587 11591abstractfree full text 32 hasty h linton m f swift l l fazio 1999 j lipid res 40 1529 1538abstractfree full text 33 mcfarlane 1958 nature 182 53 34 hussain m m maxfield f r mas oliva j tabas ji z innerarity l mahley r w 1991 j biol chem 266 13936 13940abstractfree full text 35 maugeais c tietge u j f tsukamoto k glick j m rader d j 2000 j lipid res 41 1673 1679abstractfree full text 36 swift l l farkas m h major valyi nagy k linton m f fazio 2001 j biol chem 276 22965 22970abstractfree full text 37 shafi brady e bensadoun havel r j 1994 j lipid res 35 709 720abstract 38 dichek h l johnson m akeefe h lo g sage e yap c e mahley r w 2001 j lipid res 42 201 210abstractfree full text
0.37510666.12551940.html.plaintext.txt	71	copyright 2003 american society biochemistry molecular biology inc
0.38120866.16091415.html.plaintext.txt	0	sense antisense transcripts apolipoprotein e gene normal apoe knockout mice expression spinal cord injury corresponding human transcripts alexander seitz dmitri gourevitch xiang ming zhang lise clark pan chen maja kragol natasha levenkova john rux stefan samulewicz ellen heber katz
0.38120866.16091415.html.plaintext.txt	1	wistar institute philadelphia pa 19104 usa
0.38120866.16091415.html.plaintext.txt	2	correspondence addressed tel 1 2158983710 fax 1 2158983868 email heberkatzatwistarupennedu
0.38120866.16091415.html.plaintext.txt	3	correspondence addressed tel 1 2158983710 fax 1 2158983868 email heberkatzatwistarupennedu
0.38120866.16091415.html.plaintext.txt	4	received june 17 2005 revised july 20 2005 accepted august 1 2005
0.38120866.16091415.html.plaintext.txt	5	abstract top abstract introduction results discussion materials methods references apolipoprotein e apoe gene linked maladies hypercholesterolemia cns injury disease study present evidence addition known transcript apoe s1 translates apoe three additional transcripts mice two transcripts apoe s2 apoe s3 predicted transmembrane proteins transcribed sense strand apoe as1 transcribed antisense strand complementary exon 4 apoe s1 open reading frame apoe as1 conserved human mouse antisense transcript falls within region human epsilon 4 allele linked familial onset form alzheimers disease also demonstrate expression apoe s3 apoe as1 apoe knockout mice apoe s1 apoe s2 get transcribed previously identified apoe s1 upregulated mice spinal cord injury study show spinal cord injured c57bl6 mice apoe s1 apoe s3 transcripts 10 fold upregulated antisense apoe as1 100 fold upregulated compared normal levels data suggest alternate transcripts involved molecular pathogenesis cns disease perhaps apoe expression general show apoe s2 as1 also transcribed human
0.38120866.16091415.html.plaintext.txt	6	abstract top abstract introduction results discussion materials methods references apolipoprotein e apoe gene linked maladies hypercholesterolemia cns injury disease study present evidence addition known transcript apoe s1 translates apoe three additional transcripts mice two transcripts apoe s2 apoe s3 predicted transmembrane proteins transcribed sense strand apoe as1 transcribed antisense strand complementary exon 4 apoe s1 open reading frame apoe as1 conserved human mouse antisense transcript falls within region human epsilon 4 allele linked familial onset form alzheimers disease also demonstrate expression apoe s3 apoe as1 apoe knockout mice apoe s1 apoe s2 get transcribed previously identified apoe s1 upregulated mice spinal cord injury study show spinal cord injured c57bl6 mice apoe s1 apoe s3 transcripts 10 fold upregulated antisense apoe as1 100 fold upregulated compared normal levels data suggest alternate transcripts involved molecular pathogenesis cns disease perhaps apoe expression general show apoe s2 as1 also transcribed human
0.38120866.16091415.html.plaintext.txt	7	introduction top abstract introduction results discussion materials methods references molecule apolipoprotein e apoe originally found liver associates plasma lipoproteins 34 kda glycosylated protein first shown plasma protein involved systemic lipid metabolism cholesterol transport 1 molecule two structural domains n terminus residues 1 191 bind low density lipoprotein ldl receptor interact heparin sulfate proteoglycans cell surface c terminus residues 222 299 high affinity lipids responsible lipoprotein binding 2 4 subunits connected flexible unstructured region encompassing amino acids 191 216 3
0.38120866.16091415.html.plaintext.txt	8	introduction top abstract introduction results discussion materials methods references molecule apolipoprotein e apoe originally found liver associates plasma lipoproteins 34 kda glycosylated protein first shown plasma protein involved systemic lipid metabolism cholesterol transport 1 molecule two structural domains n terminus residues 1 191 bind low density lipoprotein ldl receptor interact heparin sulfate proteoglycans cell surface c terminus residues 222 299 high affinity lipids responsible lipoprotein binding 2 4 subunits connected flexible unstructured region encompassing amino acids 191 216 3
0.38120866.16091415.html.plaintext.txt	9	apoe also synthesized secreted tissues including cns spleen kidney adrenal glands large intestine lung 56 associated cardiovascular cns disease use different alleles gene 7 10 cns 4 apoe allelic form identified shown associated alzheimers disease 9
0.38120866.16091415.html.plaintext.txt	10	apoe also synthesized secreted tissues including cns spleen kidney adrenal glands large intestine lung 56 associated cardiovascular cns disease use different alleles gene 7 10 cns 4 apoe allelic form identified shown associated alzheimers disease 9
0.38120866.16091415.html.plaintext.txt	11	apoe thought important normal functioning neural tissue response injury although exact mechanisms clear shown synthesized secreted astrocytes 611 monocytes 1213 finding apoe neurons brain 14 explained presence apoe receptors reflect uptake molecule 15 using spinal cord injury model 16 previously showed apoe mrna protein levels upregulated spinal cord injury mouse 17
0.38120866.16091415.html.plaintext.txt	12	apoe thought important normal functioning neural tissue response injury although exact mechanisms clear shown synthesized secreted astrocytes 611 monocytes 1213 finding apoe neurons brain 14 explained presence apoe receptors reflect uptake molecule 15 using spinal cord injury model 16 previously showed apoe mrna protein levels upregulated spinal cord injury mouse 17
0.38120866.16091415.html.plaintext.txt	13	effects knocking apoe gene studied mice 18 creation knockout involved insertion neomycin resistance gene homologous recombination place exon 3 part intron 3 apoe gene mice heterozygous knockout gene reported healthy 3 months age produce homozygous knockouts expected frequency homozygous knockout progeny appear healthy despite absence apoe plasma
0.38120866.16091415.html.plaintext.txt	14	effects knocking apoe gene studied mice 18 creation knockout involved insertion neomycin resistance gene homologous recombination place exon 3 part intron 3 apoe gene mice heterozygous knockout gene reported healthy 3 months age produce homozygous knockouts expected frequency homozygous knockout progeny appear healthy despite absence apoe plasma
0.38120866.16091415.html.plaintext.txt	15	present study show evidence two additional mouse sense transcripts generated apoe gene could transmembrane proteins antisense transcript open reading frame exon 4 conserved mouse human antisense protein falls within region epsilon 4 allele linked familial onset form alzheimers disease 919 also demonstrate expression one sense antisense apoe transcripts apoe knockout mice furthermore show transcripts upregulated b6 mice spinal cord injury follow upregulation apoe finally find one additional sense transcripts antisense transcript corresponding rnas exist human
0.38120866.16091415.html.plaintext.txt	16	present study show evidence two additional mouse sense transcripts generated apoe gene could transmembrane proteins antisense transcript open reading frame exon 4 conserved mouse human antisense protein falls within region epsilon 4 allele linked familial onset form alzheimers disease 919 also demonstrate expression one sense antisense apoe transcripts apoe knockout mice furthermore show transcripts upregulated b6 mice spinal cord injury follow upregulation apoe finally find one additional sense transcripts antisense transcript corresponding rnas exist human
0.38120866.16091415.html.plaintext.txt	17	results top abstract introduction results discussion materials methods references database support new apoe gene products mouse previously showed apoe mrna protein levels upregulated spinal cord injury mouse 17 examining cell types involved situ hybridization carried using apoe antisense sense probes exon 4 tissue sections probes produced signal suggesting presence antisense transcript exon 4 complete picture looked additional transcripts using silico approach
0.38120866.16091415.html.plaintext.txt	18	results top abstract introduction results discussion materials methods references database support new apoe gene products mouse previously showed apoe mrna protein levels upregulated spinal cord injury mouse 17 examining cell types involved situ hybridization carried using apoe antisense sense probes exon 4 tissue sections probes produced signal suggesting presence antisense transcript exon 4 complete picture looked additional transcripts using silico approach
0.38120866.16091415.html.plaintext.txt	19	gene2est blast server 39 used align ests mouse human rat genomic sequences corresponding apoe gene d004661 mappings visualized artemis 40 search well rt pcr sequencing efforts uncovered several new transcripts relative original known transcript current model mouse apoe gene including sense antisense transcripts well primer rna probe locations used subsequent experiments represented figure 1 positional information made reference genomic sequence apoe d00466 corrected two deletions discussed subsequently
0.38120866.16091415.html.plaintext.txt	20	view larger version 23k figure 1 representation apoe gene mouse accession d004661 two corrections made deletion c position 2882 tg c ctc c 2898 tgg c ccc known transcript named apoe s1 start stop sites translation indicated black lines bars predicted transmembrane regions shown solid black rectangle apoe s1 s2 use frame apoe s3 uses different frame apoe as1 translates protein antisense direction gene primers shown 5 location also shown location neo insert apoe knockout mouse c57bl6j apoetm1unc jackson 18 b representation human apoe gene accession m10065 apoe s2 corresponds mouse transcript however protein translated identical apoe s1 antisense trancript highly conserved human mouse two alternative stop codons shown as1 molecule one 3819 open one allelic variations table 1
0.38120866.16091415.html.plaintext.txt	21	view larger version 23k figure 1 representation apoe gene mouse accession d004661 two corrections made deletion c position 2882 tg c ctc c 2898 tgg c ccc known transcript named apoe s1 start stop sites translation indicated black lines bars predicted transmembrane regions shown solid black rectangle apoe s1 s2 use frame apoe s3 uses different frame apoe as1 translates protein antisense direction gene primers shown 5 location also shown location neo insert apoe knockout mouse c57bl6j apoetm1unc jackson 18 b representation human apoe gene accession m10065 apoe s2 corresponds mouse transcript however protein translated identical apoe s1 antisense trancript highly conserved human mouse two alternative stop codons shown as1 molecule one 3819 open one allelic variations table 1
0.38120866.16091415.html.plaintext.txt	22	apoe s2 est accession nos ai049252 bf236692 ai313990 aa537923 lacks exon 1 translation start site atg 99 bases upstream apoe s1 exon 2 thereafter amino acid sequence identical apoe s1 starting transcription manner upstream exon 2 transforms secretory signal peptide transmembrane helix thus apoe s2 could encode 352 amino acid protein molecular weight 403 kda transmembrane helix amino acids 43 65 sosui 23 blastp similarity search apoe s2 ncbis non redundant protein sequence database nr return hits
0.38120866.16091415.html.plaintext.txt	23	apoe s2 est accession nos ai049252 bf236692 ai313990 aa537923 lacks exon 1 translation start site atg 99 bases upstream apoe s1 exon 2 thereafter amino acid sequence identical apoe s1 starting transcription manner upstream exon 2 transforms secretory signal peptide transmembrane helix thus apoe s2 could encode 352 amino acid protein molecular weight 403 kda transmembrane helix amino acids 43 65 sosui 23 blastp similarity search apoe s2 ncbis non redundant protein sequence database nr return hits
0.38120866.16091415.html.plaintext.txt	24	third transcript apoe s3 est accession nos aa067884 ai614580 codes transmembrane protein well using published sequence mouse gene d004661 predicted translational start atg 117 bases apoe s1 exon 4 using reading frame apoe s1 within exon 4 however sequencing could account two bases published sequence d004661 c position 2882 ttg c ctc c 2898 tgg c ccc confirmed genomic mrna level corrected sequence apoe s3 still predicts open reading frame however resulting amino acid sequence entirely different apoe s1 even shared part exon 4 apoe s3 using different reading frame apoe s3 translated 156 amino acids long molecular weight 159 kda predicted transmembrane helix sosui 23 amino acids 16 38
0.38120866.16091415.html.plaintext.txt	25	third transcript apoe s3 est accession nos aa067884 ai614580 codes transmembrane protein well using published sequence mouse gene d004661 predicted translational start atg 117 bases apoe s1 exon 4 using reading frame apoe s1 within exon 4 however sequencing could account two bases published sequence d004661 c position 2882 ttg c ctc c 2898 tgg c ccc confirmed genomic mrna level corrected sequence apoe s3 still predicts open reading frame however resulting amino acid sequence entirely different apoe s1 even shared part exon 4 apoe s3 using different reading frame apoe s3 translated 156 amino acids long molecular weight 159 kda predicted transmembrane helix sosui 23 amino acids 16 38
0.38120866.16091415.html.plaintext.txt	26	antisense transcript apoe as1 complimentary apoe s3 fig 1a translational start site near stop codon apoe s1 frame open throughout exon 4 polya signal 2744 encodes 219 amino acid long soluble protein molecular weight 266 kda 23 conserved domain database search return hits 24 ncbi blastp protein search uncovered low level similarity proteins last 100 amino acids class helical cytokine receptor member 2 tetraodon nigroviridis accession aar256651 highest score 40
0.38120866.16091415.html.plaintext.txt	27	used neural network promoter prediction software 25 predict promoters transcriptional start sites apoe s2 apoe s3 apoe as1 appropriate targets found program however predict correct promoter transcriptional start apoe s1
0.38120866.16091415.html.plaintext.txt	28	used neural network promoter prediction software 25 predict promoters transcriptional start sites apoe s2 apoe s3 apoe as1 appropriate targets found program however predict correct promoter transcriptional start apoe s1
0.38120866.16091415.html.plaintext.txt	29	expression new apoe derived transcripts mouse expression predicted forms apoe initially tested rt pcr reverse transcription reactions rna variety tissues primed oligo dt amplified transcript specific pairs pcr primers fig 2a although approach could differentiate sense antisense transcripts illustrate tissue specific expression pattern different apoe transcripts apoe s1 present tissues tested apoe s2 expressed almost exclusively liver marginal levels expression cerebellum parotis kidney lung thymus apoe s3 antisense apoe as1 found liver thymus lower levels lung parotis heart small intestine marginal levels appear skeletal muscle cerebellum brainstem rest organs brain ear spleen adrenal gland bone marrow fat negative
0.38120866.16091415.html.plaintext.txt	30	expression new apoe derived transcripts mouse expression predicted forms apoe initially tested rt pcr reverse transcription reactions rna variety tissues primed oligo dt amplified transcript specific pairs pcr primers fig 2a although approach could differentiate sense antisense transcripts illustrate tissue specific expression pattern different apoe transcripts apoe s1 present tissues tested apoe s2 expressed almost exclusively liver marginal levels expression cerebellum parotis kidney lung thymus apoe s3 antisense apoe as1 found liver thymus lower levels lung parotis heart small intestine marginal levels appear skeletal muscle cerebellum brainstem rest organs brain ear spleen adrenal gland bone marrow fat negative
0.38120866.16091415.html.plaintext.txt	31	view larger version 50k figure 2 rt pcr showing expression levels different transcripts variety tissues primers used apoe s1 52f 40r apoe s2 40f 40r apoe s3as1 44f 40r gapdh 47f 47r controls samples omitted enzyme rt reaction included primer pair negative data shown b c directional specific rt pcr demonstrating presence sense apoe s3 antisense transcripts apoe as1 liver b apoe s3 rt primer used 45r pcr 69f 70r lane 1 rt lane 2 rt c apoe as1 rt primer used 44f pcr 69f 45r lanes 1 4 49f 46r lanes 2 5 49f 40r lanes 3 6 lanes 1 3 rt lanes 4 6 rt products gel purified sequence verified
0.38120866.16091415.html.plaintext.txt	32	view larger version 50k figure 2 rt pcr showing expression levels different transcripts variety tissues primers used apoe s1 52f 40r apoe s2 40f 40r apoe s3as1 44f 40r gapdh 47f 47r controls samples omitted enzyme rt reaction included primer pair negative data shown b c directional specific rt pcr demonstrating presence sense apoe s3 antisense transcripts apoe as1 liver b apoe s3 rt primer used 45r pcr 69f 70r lane 1 rt lane 2 rt c apoe as1 rt primer used 44f pcr 69f 45r lanes 1 4 49f 46r lanes 2 5 49f 40r lanes 3 6 lanes 1 3 rt lanes 4 6 rt products gel purified sequence verified
0.38120866.16091415.html.plaintext.txt	33	distinguish apoe s3as1 rt pcr performed liver rna using rt subsequent pcr primers specifically amplify apoe s3 apoe as1 fig 2b c apoe s3 fig 2b apoe as1 fig 2c present liver
0.38120866.16091415.html.plaintext.txt	34	presence apoe s1 apoe s2 apoe s3 apoe as1 also confirmed northern analysis fig 4a d probes designed hybridize specific target addition binding sense probe 3 fig 1 apoe as1 also hybridized sense probe 4 c57bl6 liver data shown confirming antisense transcript least extends start stop codon
0.38120866.16091415.html.plaintext.txt	35	view larger version 55k figure 4 northern blot analysis demonstrating expression apoe transcripts normal knockout mice using 32p labeled rna probes specific message probe locations see figure 1 apoe s1 antisense probe 1 b apoe s2 antisense probe 2 show signal arrow normal signal knockout c apoe s3 antisense probe 3 d apoe as1 sense probe 3 found liver mouse strains however much lower levels knockout
0.38120866.16091415.html.plaintext.txt	36	view larger version 55k figure 4 northern blot analysis demonstrating expression apoe transcripts normal knockout mice using 32p labeled rna probes specific message probe locations see figure 1 apoe s1 antisense probe 1 b apoe s2 antisense probe 2 show signal arrow normal signal knockout c apoe s3 antisense probe 3 d apoe as1 sense probe 3 found liver mouse strains however much lower levels knockout
0.38120866.16091415.html.plaintext.txt	37	expression new apoe derived transcripts apoe knockout mice apoe knockout mouse important tool determining role apoe variety systems therefore wanted investigate effect knocking gene expression apoe transcripts knockout mouse used study apoe gene disrupted upstream exon 4 fig 1
0.38120866.16091415.html.plaintext.txt	38	expression new apoe derived transcripts apoe knockout mice apoe knockout mouse important tool determining role apoe variety systems therefore wanted investigate effect knocking gene expression apoe transcripts knockout mouse used study apoe gene disrupted upstream exon 4 fig 1
0.38120866.16091415.html.plaintext.txt	39	employed oligo dt primed rt pcr transcript specific pcr primers investigate whether apoe transcripts could detected apoe knockout mouse apoe s3as1 could amplified method fig 3a furthermore expression profile differed wild type apoe s3as1 could amplified normal brain spleen fig 2
0.38120866.16091415.html.plaintext.txt	40	employed oligo dt primed rt pcr transcript specific pcr primers investigate whether apoe transcripts could detected apoe knockout mouse apoe s3as1 could amplified method fig 3a furthermore expression profile differed wild type apoe s3as1 could amplified normal brain spleen fig 2
0.38120866.16091415.html.plaintext.txt	41	view larger version 60k figure 3 rt pcr apoe knockout tissue rt primed oligo dt primers used figure 2 product seen row 3 demonstrates existence sense apoe s3 andor antisense apoe as1 transcript apoe knockout mice c57bl6j apoetm1unc jackson controls used samples omitted enzyme rt reaction included primer pair negative data shown b demonstration specific sense antisense transcripts liver s3 lanes 3 4 rt carried using primer 45r as1 lanes 1 2 rt carried using primer 44f rt reactions pcr amplified using primers 69f 40r control reactions performed absence rt
0.38120866.16091415.html.plaintext.txt	42	view larger version 60k figure 3 rt pcr apoe knockout tissue rt primed oligo dt primers used figure 2 product seen row 3 demonstrates existence sense apoe s3 andor antisense apoe as1 transcript apoe knockout mice c57bl6j apoetm1unc jackson controls used samples omitted enzyme rt reaction included primer pair negative data shown b demonstration specific sense antisense transcripts liver s3 lanes 3 4 rt carried using primer 45r as1 lanes 1 2 rt carried using primer 44f rt reactions pcr amplified using primers 69f 40r control reactions performed absence rt
0.38120866.16091415.html.plaintext.txt	43	use specific rt pcr primers revealed apoe s3 apoe as1 expressed liver knockout fig 3b northern blot analysis also demonstrates presence apoe as1 knockout mouse although knockout seems affect transcription level apoe s3 almost detection limit technique fig 4c apoe as1 mrna fig 4d present knockout wild type mice
0.38120866.16091415.html.plaintext.txt	44	functional expression new apoe transcripts follow previous studies showing apoe expression following spinal cord injury c57bl6 mice 17 examined expression various transcripts apoe gene spinal cord injury apoe s2 could demonstrated brain marginal levels cerebellum fig 2a using rt pcr apoe s2 also could detected uninjured injured spinal cord data shown however northern blot analysis shows expression two newly identified products gene apoe s3 apoe as1 within week injury fig 5a b
0.38120866.16091415.html.plaintext.txt	45	functional expression new apoe transcripts follow previous studies showing apoe expression following spinal cord injury c57bl6 mice 17 examined expression various transcripts apoe gene spinal cord injury apoe s2 could demonstrated brain marginal levels cerebellum fig 2a using rt pcr apoe s2 also could detected uninjured injured spinal cord data shown however northern blot analysis shows expression two newly identified products gene apoe s3 apoe as1 within week injury fig 5a b
0.38120866.16091415.html.plaintext.txt	46	view larger version 60k figure 5 expression profiles apoe transcripts spinal cord injury upper panel showing northern blot analyses apoe s3 antisense probe 3 fig 1 b apoe as1 sense probe 4 fig 1 upregulation spinal cord injury animals injured transection th8 9 followed 7 14 21 days lower box showing levels gapdh c f real time rt pcr showing expression levels different transcripts spinal cord injury rt designed exclusively amplify transcripts shown c d rt primed 45r pcr shown c carried primer pair 52f 41r show levels apoe s1 d 44f 40r apoe s3 e rt primed 45f amplified 46f 46r demonstrating levels expression apoe as1 normalize included gene specific primer gapdh 48r rt reactions background correction levels obtained amplifying gapdh 47f 47r f exclude levels seen due different levels genomic background included experiment samples lacked enzyme rt reaction amplifying genomic apoe gapdh
0.38120866.16091415.html.plaintext.txt	47	view larger version 60k figure 5 expression profiles apoe transcripts spinal cord injury upper panel showing northern blot analyses apoe s3 antisense probe 3 fig 1 b apoe as1 sense probe 4 fig 1 upregulation spinal cord injury animals injured transection th8 9 followed 7 14 21 days lower box showing levels gapdh c f real time rt pcr showing expression levels different transcripts spinal cord injury rt designed exclusively amplify transcripts shown c d rt primed 45r pcr shown c carried primer pair 52f 41r show levels apoe s1 d 44f 40r apoe s3 e rt primed 45f amplified 46f 46r demonstrating levels expression apoe as1 normalize included gene specific primer gapdh 48r rt reactions background correction levels obtained amplifying gapdh 47f 47r f exclude levels seen due different levels genomic background included experiment samples lacked enzyme rt reaction amplifying genomic apoe gapdh
0.38120866.16091415.html.plaintext.txt	48	real time rt pcr rna extracted injured c57bl6 mice actually reveals increase expression species early 4 days post injury maximal expression around 2 weeks fig 5c f highest level apoe s1 apoe s3 10 fold upregulated compared normal levels contrast apoe as1 100 fold upregulated
0.38120866.16091415.html.plaintext.txt	49	detection apoe s2 protein western blot analysis apoe s2 protein includes apoe s1 protein sequence antibodies apoe s1 also bind apoe s2 therefore western blot exposed apoe antiserum addition 34 kda band depicting apoe s1 mouse liver serum fig 6a b mouse serum antibody bound protein 40 kda arrow fig 6b size predicted apoe s2 apoe s2 protein present apoe knockout specificity demonstrated including knockout samples negative controls blot binding 34 40 kda proteins absent apoe knockout mice demonstrating specificity even though apoe s2 protein could detected liver western blot analysis likely secreted liver apoe s2 message almost exclusively expressed liver organs investigated one cannot however rule another organ represented figure 2 source protein possible protein levels liver detection limits western blot analysis though protein secreted blood accumulates detected
0.38120866.16091415.html.plaintext.txt	50	detection apoe s2 protein western blot analysis apoe s2 protein includes apoe s1 protein sequence antibodies apoe s1 also bind apoe s2 therefore western blot exposed apoe antiserum addition 34 kda band depicting apoe s1 mouse liver serum fig 6a b mouse serum antibody bound protein 40 kda arrow fig 6b size predicted apoe s2 apoe s2 protein present apoe knockout specificity demonstrated including knockout samples negative controls blot binding 34 40 kda proteins absent apoe knockout mice demonstrating specificity even though apoe s2 protein could detected liver western blot analysis likely secreted liver apoe s2 message almost exclusively expressed liver organs investigated one cannot however rule another organ represented figure 2 source protein possible protein levels liver detection limits western blot analysis though protein secreted blood accumulates detected
0.38120866.16091415.html.plaintext.txt	51	view larger version 21k figure 6 western blot demonstrating apoe s1 protein liver b serum lower band apoe s2 protein upper bandarrow b serum knockout samples included negative controls
0.38120866.16091415.html.plaintext.txt	52	view larger version 21k figure 6 western blot demonstrating apoe s1 protein liver b serum lower band apoe s2 protein upper bandarrow b serum knockout samples included negative controls
0.38120866.16091415.html.plaintext.txt	53	transcripts human gene finally investigate whether corresponding transcripts mouse apoe s2 s3 as1 transcripts also present human rt pcr analysis carried human liver rna resulting model human gene transcription products shown figure 1b human apoe s2 could amplified rt primed oligo 1r subsequent pcr primed either 6f 5r lane 1 fig 7a 7f 5r lane 2 fig 7a human apoe s2 sequence also backed est accession ca771535 contrast mouse human protein translated apoe s2 apoe s1
0.38120866.16091415.html.plaintext.txt	54	transcripts human gene finally investigate whether corresponding transcripts mouse apoe s2 s3 as1 transcripts also present human rt pcr analysis carried human liver rna resulting model human gene transcription products shown figure 1b human apoe s2 could amplified rt primed oligo 1r subsequent pcr primed either 6f 5r lane 1 fig 7a 7f 5r lane 2 fig 7a human apoe s2 sequence also backed est accession ca771535 contrast mouse human protein translated apoe s2 apoe s1
0.38120866.16091415.html.plaintext.txt	55	view larger version 60k figure 7 rt pcr human liver samples apoe s2 expression rt primed 1r pcr 6f 5r lanes 1 3 7f 5r lanes 2 4 b apoe as1 expression rt primed 3f pcr 8f 1r lower band lane 1 as1 upper band apoe gene transcript products gel purified sequence verified
0.38120866.16091415.html.plaintext.txt	56	view larger version 60k figure 7 rt pcr human liver samples apoe s2 expression rt primed 1r pcr 6f 5r lanes 1 3 7f 5r lanes 2 4 b apoe as1 expression rt primed 3f pcr 8f 1r lower band lane 1 as1 upper band apoe gene transcript products gel purified sequence verified
0.38120866.16091415.html.plaintext.txt	57	human sequence corresponding apoe s3 could amplified rt using 1r subsequent pcr primer combinations 3f 2r 8f 2r 4f 2r yield products transcribed apoe gene
0.38120866.16091415.html.plaintext.txt	58	human sequence corresponding apoe s3 could amplified rt using 1r subsequent pcr primer combinations 3f 2r 8f 2r 4f 2r yield products transcribed apoe gene
0.38120866.16091415.html.plaintext.txt	59	presence human apoe as1 demonstrated rt primed 3f followed pcr primer 8f 1r lane 1 fig 7b two products amplified reaction sequencing lower band confirmed originating apoe as1 message upper band product apoe gene translated human mouse proteins highly conserved
0.38120866.16091415.html.plaintext.txt	60	discussion top abstract introduction results discussion materials methods references study shown multiple rnas sense antisense orientation produced mouse human apoe gene thereby adding gene growing list genes known transcribed strands list conservatively estimated number 1600 8 genes contained human genome 26 recent paper chen et al 27 show 22 clusters transcribe sense antisense pairs highest number far supported est evidence matching accession numbers data found apoe one genes however number genes transcribe strands identified far show antisense transcription greatly underestimated contribution genomic complexity
0.38120866.16091415.html.plaintext.txt	61	discussion top abstract introduction results discussion materials methods references study shown multiple rnas sense antisense orientation produced mouse human apoe gene thereby adding gene growing list genes known transcribed strands list conservatively estimated number 1600 8 genes contained human genome 26 recent paper chen et al 27 show 22 clusters transcribe sense antisense pairs highest number far supported est evidence matching accession numbers data found apoe one genes however number genes transcribe strands identified far show antisense transcription greatly underestimated contribution genomic complexity
0.38120866.16091415.html.plaintext.txt	62	one set apoe transcripts identified code putative transmembrane proteins one frame shifted antisense rna sense antisense messages sequences recognized translation start sites therefore could exist protein examples demonstrating expression antisense message shown variety genes reviewed 28 29 including urocortin 30 cardiac troponin 31 basic fibroblast growth factor bfgf 32 scenario describe apoe closely resembles bfgf expression bfgf gene locus known transcribed multiple mrna products including least one antisense transcript antisense transcript may involved regulating gene expression hybridizing sense transcript still nucleus perhaps affecting developmental patterns tissue differentiation 32 bfgf transcript isolated xenopus could also however translated 25 kda protein yet unknown function 33 point unclear whether newly identified apoe transcripts including antisense transcript fact translated except apoe s2 protein found serum beyond translated protein transcripts could participate regulating others levels process like rnai
0.38120866.16091415.html.plaintext.txt	63	one set apoe transcripts identified code putative transmembrane proteins one frame shifted antisense rna sense antisense messages sequences recognized translation start sites therefore could exist protein examples demonstrating expression antisense message shown variety genes reviewed 28 29 including urocortin 30 cardiac troponin 31 basic fibroblast growth factor bfgf 32 scenario describe apoe closely resembles bfgf expression bfgf gene locus known transcribed multiple mrna products including least one antisense transcript antisense transcript may involved regulating gene expression hybridizing sense transcript still nucleus perhaps affecting developmental patterns tissue differentiation 32 bfgf transcript isolated xenopus could also however translated 25 kda protein yet unknown function 33 point unclear whether newly identified apoe transcripts including antisense transcript fact translated except apoe s2 protein found serum beyond translated protein transcripts could participate regulating others levels process like rnai
0.38120866.16091415.html.plaintext.txt	64	marking yet another similarity bfgf antisense transcript present human mouse 33 apoe antisense transcript say reading frame also open humans consequently possibility antisense message actually translated protein protein predicted sequence m10065 198 amino acids signal peptide predicted signalp 30 hmm program 34 probability 0973 contrast mouse as1 protein program predicts signal peptide probability 0265 even deleting first 21 amino acids mouse protein human protein lacks increases probability 038 therefore even though human sequence probably enters secretory pathway mouse sequence seems lack signal peptide programs like signalp 30 hmm focusing prediction classical signal peptides one cannot exclude presence signal motifs mouse protein
0.38120866.16091415.html.plaintext.txt	65	marking yet another similarity bfgf antisense transcript present human mouse 33 apoe antisense transcript say reading frame also open humans consequently possibility antisense message actually translated protein protein predicted sequence m10065 198 amino acids signal peptide predicted signalp 30 hmm program 34 probability 0973 contrast mouse as1 protein program predicts signal peptide probability 0265 even deleting first 21 amino acids mouse protein human protein lacks increases probability 038 therefore even though human sequence probably enters secretory pathway mouse sequence seems lack signal peptide programs like signalp 30 hmm focusing prediction classical signal peptides one cannot exclude presence signal motifs mouse protein
0.38120866.16091415.html.plaintext.txt	66	apoe antisense protein encoded exon 4 exon accounts three major allelic variants humans allelic variations sense protein defined substitution arginine positively charged polar amino acid cysteine non polar amino acid positions 112 158 protein 3536 putative antisense protein arginine substituted histidine positively charged polar amino acids therefore two variants probably affecting function antisense protein less sense protein therefore conservative antisense direction however studies allelic variations implications disease always conducted reference sense protein prominent variations table 1 might lead functional relevant changes one dramatic change variation positions 3817 3819 sequence position reference m10065 substitution tag gct antisense strand opens reading frame translation continue another 113 amino acids e4 allele published paik et al 35 emi et al 36 contains stop codon positions 3817 3819 however point clear allelic variation opens reading frame linked major allelic forms like e4 e3 e2 genotype observed haplotypes see table 1 37 relative frequencies apoe sequence variants within e4 e3 e2 genotypes see table 3 38 therefore involvement putative antisense protein diseases correlated allelic variants cannot excluded example alzheimers disease specific molecular pathway apoe modifies expression disease remains elusive 19 furthermore sequence variations different alleles 34 conservative sense direction might lead amino acid substitutions even stop signals antisense direction
0.38120866.16091415.html.plaintext.txt	67	apoe antisense protein encoded exon 4 exon accounts three major allelic variants humans allelic variations sense protein defined substitution arginine positively charged polar amino acid cysteine non polar amino acid positions 112 158 protein 3536 putative antisense protein arginine substituted histidine positively charged polar amino acids therefore two variants probably affecting function antisense protein less sense protein therefore conservative antisense direction however studies allelic variations implications disease always conducted reference sense protein prominent variations table 1 might lead functional relevant changes one dramatic change variation positions 3817 3819 sequence position reference m10065 substitution tag gct antisense strand opens reading frame translation continue another 113 amino acids e4 allele published paik et al 35 emi et al 36 contains stop codon positions 3817 3819 however point clear allelic variation opens reading frame linked major allelic forms like e4 e3 e2 genotype observed haplotypes see table 1 37 relative frequencies apoe sequence variants within e4 e3 e2 genotypes see table 3 38 therefore involvement putative antisense protein diseases correlated allelic variants cannot excluded example alzheimers disease specific molecular pathway apoe modifies expression disease remains elusive 19 furthermore sequence variations different alleles 34 conservative sense direction might lead amino acid substitutions even stop signals antisense direction
0.38120866.16091415.html.plaintext.txt	68	view table table 1 sequence variations human apoe gene accession m10065 relation apoe s1 as1 protein intron 3 exon 4 even though sequence work thus far suggests human apoe s2 translated protein apoe s1 allelic variation might cause open reading frame similar one seen c57bl6 mice leading presence transmembrane version apoe
0.38120866.16091415.html.plaintext.txt	69	knockout organisms created investigate phenotypic changes may take place organism absence gene data suggest genetic manipulation used generate apoe knockout eliminated expression apoe s1 apoe s2 transcripts found apoe s3 putative transmembrane protein sequence completely different known apoe protein apoe as1 protein potentially produced antisense transcript still expressed knockout possible region gene responsible transcripts particular exon 4 disrupted insertion neo gene knockout roles transcripts currently unknown addition work must done determine whether translated vivo
0.38120866.16091415.html.plaintext.txt	70	knockout organisms created investigate phenotypic changes may take place organism absence gene data suggest genetic manipulation used generate apoe knockout eliminated expression apoe s1 apoe s2 transcripts found apoe s3 putative transmembrane protein sequence completely different known apoe protein apoe as1 protein potentially produced antisense transcript still expressed knockout possible region gene responsible transcripts particular exon 4 disrupted insertion neo gene knockout roles transcripts currently unknown addition work must done determine whether translated vivo
0.38120866.16091415.html.plaintext.txt	71	indication potentially important role apoe s3 apoe as1 antisense messages cns disease comes data mouse spinal cord injury model 1617 response spinal injury transcripts upregulated follow expression pattern apoe s1 however apoe as1 10 fold upregulated either apoe s1 s3 might also involved influencing translation would useful know either alternate mrnas translated response spinal injury
0.38120866.16091415.html.plaintext.txt	72	indication potentially important role apoe s3 apoe as1 antisense messages cns disease comes data mouse spinal cord injury model 1617 response spinal injury transcripts upregulated follow expression pattern apoe s1 however apoe as1 10 fold upregulated either apoe s1 s3 might also involved influencing translation would useful know either alternate mrnas translated response spinal injury
0.38120866.16091415.html.plaintext.txt	73	apoe lipoprotein class proteins responsible carrying cholesterol fats bloodstream little packages essential normal breakdown molecules particular apoe major component specific lipoproteins called low density lipoproteins vldls major function vldls remove excess cholesterol blood carry liver processing maintaining normal levels cholesterol essential prevention cardiovascular diseases including heart attacks stroke least three slightly different versions apoe gene major versions alleles called 2 3 4 common allele 3 found half population researchers found people familial hypercholesterolemia condition causes high levels cholesterol increased risk heart attacks strokes two copies 2 allele allele seems one several genetic factors play part disorder addition apoe allelic version 4 risk factor coronary artery disease people inherit least one copy apoe 4 allele increased risk developing type 2 alzheimers disease first appears later life studies shown people inherit two copies apoe 4 highest chance developing disease yet known allele affects persons risk alzheimers disease however found increases number amyloid plaques characteristic disease 919
0.38120866.16091415.html.plaintext.txt	74	apoe lipoprotein class proteins responsible carrying cholesterol fats bloodstream little packages essential normal breakdown molecules particular apoe major component specific lipoproteins called low density lipoproteins vldls major function vldls remove excess cholesterol blood carry liver processing maintaining normal levels cholesterol essential prevention cardiovascular diseases including heart attacks stroke least three slightly different versions apoe gene major versions alleles called 2 3 4 common allele 3 found half population researchers found people familial hypercholesterolemia condition causes high levels cholesterol increased risk heart attacks strokes two copies 2 allele allele seems one several genetic factors play part disorder addition apoe allelic version 4 risk factor coronary artery disease people inherit least one copy apoe 4 allele increased risk developing type 2 alzheimers disease first appears later life studies shown people inherit two copies apoe 4 highest chance developing disease yet known allele affects persons risk alzheimers disease however found increases number amyloid plaques characteristic disease 919
0.38120866.16091415.html.plaintext.txt	75	finally est evidence apoe alternative splice variant human exist 41 one est corresponds last exon different apoe s2 s3 validated rt pcr showed expressed lung cancer strongly normal tissue
0.38120866.16091415.html.plaintext.txt	76	finally est evidence apoe alternative splice variant human exist 41 one est corresponds last exon different apoe s2 s3 validated rt pcr showed expressed lung cancer strongly normal tissue
0.38120866.16091415.html.plaintext.txt	77	conclusion apoe protein may play vital role occurrence diverse group maladies appears apoe gene characterized complex expression pattern multiple start sites sense antisense direction open reading frame transcripts may translated proteins work must done determine whether antisense transcript involved regulating expression post transcriptionally translated novel protein addition given significance exon 4 various allelic versions apoe knockout exon may give insight role
0.38120866.16091415.html.plaintext.txt	78	conclusion apoe protein may play vital role occurrence diverse group maladies appears apoe gene characterized complex expression pattern multiple start sites sense antisense direction open reading frame transcripts may translated proteins work must done determine whether antisense transcript involved regulating expression post transcriptionally translated novel protein addition given significance exon 4 various allelic versions apoe knockout exon may give insight role
0.38120866.16091415.html.plaintext.txt	79	materials methods top abstract introduction results discussion materials methods references rt pcr mouse tissue dissected co2 euthanized 8 week old female c57bl6 mice apoe knockout mice c57bl6j apoetm1unc jackson laboratory bar harbor usa stored 80 degrees c use rna isolated homogenizing pooled tissue two animals trizol gibco brl following manufacturers instructions rna treated 30 min dnase promega remove dna might copurified rna concentration determined od260 readings three micrograms total rna reverse transcribed 42 degrees c 20 microl cocktail included 1 u rnase 02 microm dntps 1 microm oligo dt 200 u superscript reverse transcriptase gibco brl 1x rt buffer control reactions omitted rt enzyme samples brought 200 microl h2o pcr 20 microl reaction used including 50 mm tris hcl ph 84 750 microgml bovine serum albumin 05 microm primer 02 mm deoxyribonucleoside triphosphate 08 u taq dna polymerase platinum taq life technologies inc primers used pcr included apoe s1 52f 40r apoe s2 40f 40r apoe s3as1 44f 40r gapdh 47f 47r included positive control table 2 pcr products sequence verified
0.38120866.16091415.html.plaintext.txt	80	materials methods top abstract introduction results discussion materials methods references rt pcr mouse tissue dissected co2 euthanized 8 week old female c57bl6 mice apoe knockout mice c57bl6j apoetm1unc jackson laboratory bar harbor usa stored 80 degrees c use rna isolated homogenizing pooled tissue two animals trizol gibco brl following manufacturers instructions rna treated 30 min dnase promega remove dna might copurified rna concentration determined od260 readings three micrograms total rna reverse transcribed 42 degrees c 20 microl cocktail included 1 u rnase 02 microm dntps 1 microm oligo dt 200 u superscript reverse transcriptase gibco brl 1x rt buffer control reactions omitted rt enzyme samples brought 200 microl h2o pcr 20 microl reaction used including 50 mm tris hcl ph 84 750 microgml bovine serum albumin 05 microm primer 02 mm deoxyribonucleoside triphosphate 08 u taq dna polymerase platinum taq life technologies inc primers used pcr included apoe s1 52f 40r apoe s2 40f 40r apoe s3as1 44f 40r gapdh 47f 47r included positive control table 2 pcr products sequence verified
0.38120866.16091415.html.plaintext.txt	81	view table table 2 primers mouse apoe genbank accession d004661 mouse gapdh m32599 human apoe m10065 rt pcr human human liver rna obtained stratagene catalog 540017 enzymatic reactions carried described earlier apoe s2 rt carried primer 1r pcr primers 6f 5r 7f 5r apoe as1 rt carried primer 3f pcr primers 8f 1r fig 1
0.38120866.16091415.html.plaintext.txt	82	gene sense antisense specific reverse transcription mouse rna extracted either exsanguinated liver spinal cord trizol treated dnase re extracted phenolchloroform precipitated alcohol samples time point pooled equally according od260 reverse transcription carried 075 microg time point 10 microl reaction described earlier exception gene specific primers used selectively amplify apoe exon 4 sense strand used primers 45r 48r gapdh control ii antisense used primers 45f 48r gapdh control control reactions omitted reverse transcriptase reverse transcription carried 42 degrees c 1 h samples brought 100 microl h2o passed though chroma spin 100 size exclusion column clontech exclude unused primers re extracted phenolchloroform precipitated alcohol
0.38120866.16091415.html.plaintext.txt	83	gene sense antisense specific reverse transcription mouse rna extracted either exsanguinated liver spinal cord trizol treated dnase re extracted phenolchloroform precipitated alcohol samples time point pooled equally according od260 reverse transcription carried 075 microg time point 10 microl reaction described earlier exception gene specific primers used selectively amplify apoe exon 4 sense strand used primers 45r 48r gapdh control ii antisense used primers 45f 48r gapdh control control reactions omitted reverse transcriptase reverse transcription carried 42 degrees c 1 h samples brought 100 microl h2o passed though chroma spin 100 size exclusion column clontech exclude unused primers re extracted phenolchloroform precipitated alcohol
0.38120866.16091415.html.plaintext.txt	84	real time rt pcr mouse real time rt pcr mouse 20 carried lightcycler roche 21 determine amount apoe s1 rt primed 45r pcr primers 52f 41r antisense exon 4 rt primed 45f pcr primers 46f 46r well apoe s3 rt primed 45r pcr primers 44f 40r reaction set using faststart dna master sybr green kit roche according instructions 10 microl cocktail magnesium concentration 2 mm period 10 min 95 degrees c used denature inactivate taq start antibody cycling carried 45 times using 95 degrees c 10 61 degrees c 10 72 degrees c 20 acquisition temperature set 85 degrees c 10 levels quantified basis fluorescence intercalated syber green dye dsdna cycle quality control includes exponential curves melting product analysis ensure amplification one template well size analysis gel electrophoresis
0.38120866.16091415.html.plaintext.txt	85	real time rt pcr mouse real time rt pcr mouse 20 carried lightcycler roche 21 determine amount apoe s1 rt primed 45r pcr primers 52f 41r antisense exon 4 rt primed 45f pcr primers 46f 46r well apoe s3 rt primed 45r pcr primers 44f 40r reaction set using faststart dna master sybr green kit roche according instructions 10 microl cocktail magnesium concentration 2 mm period 10 min 95 degrees c used denature inactivate taq start antibody cycling carried 45 times using 95 degrees c 10 61 degrees c 10 72 degrees c 20 acquisition temperature set 85 degrees c 10 levels quantified basis fluorescence intercalated syber green dye dsdna cycle quality control includes exponential curves melting product analysis ensure amplification one template well size analysis gel electrophoresis
0.38120866.16091415.html.plaintext.txt	86	northern hybridization mouse total rna extracted trizol treated dnase 10 microg run denaturing 35 polyacrylamide urea 8 m gels 1xtbe buffer electroblotting done onto hydrobond n amersham pharmacia 025xtbe 150 ma 50 v 15 h rna checked uv light integrity evenness transfer rna immobilized onto membrane backing vacuum 80 degrees c 30 min sense antisense specific rna probes synthesized t7 t3 polymerase using epicintres riboscribe kit gel purified pcr products generated gene specific primers table 2 included either t7 t3 promoter served templates generating probes location probes indicated figure 1 t7 t3 reactions 20 microl1 microg template atp gtp ctp 05 mm 15 microm utp 10 mm dtt 5 microci microl 32putp polymerase 05 u microl carried 37 degrees c 3 h followed 15 min dnase treatment 37 degrees c probes purified chroma spin 100 size exclusion column clontech aliquot run 2 agarose checking size labeling hybridization carried ultrahyb ambion hybridization buffer overnight 68 degrees c 1 h blocking rotating chambers membranes washed 2x5 min 65 degrees c 2xssc 01 sds followed 2x15 min 68 degrees c 01xssc 01 sds signal collected phosphor screens scanned storm scanner molecular dynamics
0.38120866.16091415.html.plaintext.txt	87	northern hybridization mouse total rna extracted trizol treated dnase 10 microg run denaturing 35 polyacrylamide urea 8 m gels 1xtbe buffer electroblotting done onto hydrobond n amersham pharmacia 025xtbe 150 ma 50 v 15 h rna checked uv light integrity evenness transfer rna immobilized onto membrane backing vacuum 80 degrees c 30 min sense antisense specific rna probes synthesized t7 t3 polymerase using epicintres riboscribe kit gel purified pcr products generated gene specific primers table 2 included either t7 t3 promoter served templates generating probes location probes indicated figure 1 t7 t3 reactions 20 microl1 microg template atp gtp ctp 05 mm 15 microm utp 10 mm dtt 5 microci microl 32putp polymerase 05 u microl carried 37 degrees c 3 h followed 15 min dnase treatment 37 degrees c probes purified chroma spin 100 size exclusion column clontech aliquot run 2 agarose checking size labeling hybridization carried ultrahyb ambion hybridization buffer overnight 68 degrees c 1 h blocking rotating chambers membranes washed 2x5 min 65 degrees c 2xssc 01 sds followed 2x15 min 68 degrees c 01xssc 01 sds signal collected phosphor screens scanned storm scanner molecular dynamics
0.38120866.16091415.html.plaintext.txt	88	primers rt pcr primers designed using software primer 3wwwcgi v 02 22 applied apoe genomic sequence genbank accession d004661 specificity determined size sequence verification product location primer pair seen figure 1 primer sequences shown table 2 used amplify templates vitro transcription rna probes t7 5 taatacgactcactataggg 3 t3 5 aattaaccctcactaaaggg 3 promoter added primers synthesized desalted integrated dna technologies coralville ia usa
0.38120866.16091415.html.plaintext.txt	89	spinal cord injuries experiments female c57bl6 mice jackson laboratory used age 8 10 weeks animals injured using previously described surgical model complete spinal cord transection including meninges cut dura model 1617 short animals anesthetized ketamine xylazine 100 15 mgkg ip respectively skin surgically scrubbed chlorohexadine hair surgical field removed complete transection cord carried level th8 9 using microscalpel 5 mm blade depth 15 degrees catalog 37 7515 roboz surgical instruments two sham two unoperated controls three animals per time point used real time rt pcr analysis injury site th7 10 northern analysis 10 microg dnase treated trizol extracted total rna one animal per time point used dissected spinal cord tissue stored 80 degrees c use
0.38120866.16091415.html.plaintext.txt	90	spinal cord injuries experiments female c57bl6 mice jackson laboratory used age 8 10 weeks animals injured using previously described surgical model complete spinal cord transection including meninges cut dura model 1617 short animals anesthetized ketamine xylazine 100 15 mgkg ip respectively skin surgically scrubbed chlorohexadine hair surgical field removed complete transection cord carried level th8 9 using microscalpel 5 mm blade depth 15 degrees catalog 37 7515 roboz surgical instruments two sham two unoperated controls three animals per time point used real time rt pcr analysis injury site th7 10 northern analysis 10 microg dnase treated trizol extracted total rna one animal per time point used dissected spinal cord tissue stored 80 degrees c use
0.38120866.16091415.html.plaintext.txt	91	western blot mouse liver serum samples collected c57bl6 apoe ko mice jackson laboratory age 4 5 months serum blood collected tail vein left coagulate 2 h 4 degrees c separation liver collected wet ice homogenized glass homogenizer mixed lysis buffer containing proteinase inhibitor cocktail completetm boehringer mannheim 1xpbs 01 sds 4 degrees c total protein concentration sera liver samples determined using standard lowry protein assay procedure dc protein assay kit biorad laboratories catalog 500 0116 equilibrated total protein concentration 10 mgml protein samples mixed 4xsds gel loading buffer boiled 10 min loaded onto 10 sds page liver samples 20 30 microg per well lane loaded onto 12 gel serum samples 20 30 microgwell gel electroblotted immobilon p millipore 25 mm tris oh 250 mm glycine 10 methanol 8 v 30 ma overnight blot blocked pbs tween 20 0005 5 milk 1 h detect apoe s1 apoe s2 blots incubated goat anti apoe antibody 1300 sc 6384 santa cruz biotechnology overnight 4 degrees c secondary antibody hrp labeled mouse monoclonal anti goatsheep antibody used sigma 9452 1 h rt following concentration liver 15000 serum 17000 blot developed using chemiluminescence kit boehringer mannheim chemiluminescent signal scanned digitalized
0.38120866.16091415.html.plaintext.txt	92	western blot mouse liver serum samples collected c57bl6 apoe ko mice jackson laboratory age 4 5 months serum blood collected tail vein left coagulate 2 h 4 degrees c separation liver collected wet ice homogenized glass homogenizer mixed lysis buffer containing proteinase inhibitor cocktail completetm boehringer mannheim 1xpbs 01 sds 4 degrees c total protein concentration sera liver samples determined using standard lowry protein assay procedure dc protein assay kit biorad laboratories catalog 500 0116 equilibrated total protein concentration 10 mgml protein samples mixed 4xsds gel loading buffer boiled 10 min loaded onto 10 sds page liver samples 20 30 microg per well lane loaded onto 12 gel serum samples 20 30 microgwell gel electroblotted immobilon p millipore 25 mm tris oh 250 mm glycine 10 methanol 8 v 30 ma overnight blot blocked pbs tween 20 0005 5 milk 1 h detect apoe s1 apoe s2 blots incubated goat anti apoe antibody 1300 sc 6384 santa cruz biotechnology overnight 4 degrees c secondary antibody hrp labeled mouse monoclonal anti goatsheep antibody used sigma 9452 1 h rt following concentration liver 15000 serum 17000 blot developed using chemiluminescence kit boehringer mannheim chemiluminescent signal scanned digitalized
0.38120866.16091415.html.plaintext.txt	93	acknowledgement work generously supported grant f m kirby foundation commonwealth universal research enhancement program pennsylvania department health
0.38120866.16091415.html.plaintext.txt	94	references top abstract introduction results discussion materials methods references mahley rw 1988 apolipoprotein e cholesterol transport protein expanding role cell biology science 240 622 630isimedline
0.38120866.16091415.html.plaintext.txt	95	article abstract full text pdf versions article 14182661 recent ddi296v1 alert article cited alert correction posted services email article friend similar articles journal similar articles pubmed alert new issues journal add personal archive download citation manager request permissions google scholar articles seitz articles heber katz e pubmed pubmed citation articles seitz articles heber katz e online issn 1460 2083 print issn 0964 6906 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.4035247.9467014.html.plaintext.txt	0	new polymorphism apoe promoter associated risk developing alzheimers disease
0.4035247.9467014.html.plaintext.txt	1	jean charles lambert1 florence pasquier2 dominique cottel1 bernard frigard3 philippe amouyel1 marie christine chartier harlin1
0.4035247.9467014.html.plaintext.txt	2	1inserm cjf95 05 institut pasteur de lille 1 rue du professeur calmette 59019 lille cedex france 2chr et u de lille clinique neurologique centre de la memoire hopital salengro 59037 lille cedex france 3centre de geriartrie de wasquehal molinel rue salvador allende bp 165 59444 wasquehal france
0.4035247.9467014.html.plaintext.txt	3	received october 28 1997 revised accepted december 19 1997
0.4035247.9467014.html.plaintext.txt	4	epsis4 allele apolipoprotein e gene apoe one main allele apoe polymorphism major risk factor development alzheimers disease however several data suggest genetic factors within apoe locus may also modulate risk associated polymorphism look new mutations apoe promoter susceptible modify risk associated apoe epsis4 allele characterised grarrt mutation 186 bp apoe gene tata box named th1e47cs new polymorphism located consensus sequence potential transcriptional th1e47 factor binding site studied impact new polymorphism markers apoe locus large case control study observed th1e47cs modulated influence apoe epsis4 allele risk alzheimers disease
0.4035247.9467014.html.plaintext.txt	5	epsis4 allele apolipoprotein e gene apoe one main allele apoe polymorphism major risk factor development alzheimers disease however several data suggest genetic factors within apoe locus may also modulate risk associated polymorphism look new mutations apoe promoter susceptible modify risk associated apoe epsis4 allele characterised grarrt mutation 186 bp apoe gene tata box named th1e47cs new polymorphism located consensus sequence potential transcriptional th1e47 factor binding site studied impact new polymorphism markers apoe locus large case control study observed th1e47cs modulated influence apoe epsis4 allele risk alzheimers disease
0.4035247.9467014.html.plaintext.txt	6	apolipoprotein e gene apoe key player lipid transport exists three main alleles general population epsis2 epsis3 epsis4 polymorphisms correspond mutations coding sequence apoe gene resulting amino acid substitutions arg cys positions 112 158 protein gene located chromosome 19 position q132 implication chromosome 19 alzheimers disease ad suspected least three occasions 1 3 report association late onset ad apoe epsis4 allele 4 numerous studies confirmed finding extended observation early onset ad 5 7 established carrying epsis4 allele increases risk ad allele dose dependent manner shifts age onset disease earlier ages 8 conversely bearing epsis2 allele confers protection disease 5910 thus apoe genotype appears important biological marker ad susceptibility accounting 45 60 ad genetic variability
0.4035247.9467014.html.plaintext.txt	7	apolipoprotein e gene apoe key player lipid transport exists three main alleles general population epsis2 epsis3 epsis4 polymorphisms correspond mutations coding sequence apoe gene resulting amino acid substitutions arg cys positions 112 158 protein gene located chromosome 19 position q132 implication chromosome 19 alzheimers disease ad suspected least three occasions 1 3 report association late onset ad apoe epsis4 allele 4 numerous studies confirmed finding extended observation early onset ad 5 7 established carrying epsis4 allele increases risk ad allele dose dependent manner shifts age onset disease earlier ages 8 conversely bearing epsis2 allele confers protection disease 5910 thus apoe genotype appears important biological marker ad susceptibility accounting 45 60 ad genetic variability
0.4035247.9467014.html.plaintext.txt	8	several biological mechanisms proposed underlie association e4 isoform would facilitate limit amyloid substance deposition 1112 isoform may protect oxidative stress contrast e2 isoform 13 also suggested e2 e3 isoforms would prevent aggregation tau protein limiting abnormal phosphorylation leading constitution paired helical filament e4 isoform would 14
0.4035247.9467014.html.plaintext.txt	9	several biological mechanisms proposed underlie association e4 isoform would facilitate limit amyloid substance deposition 1112 isoform may protect oxidative stress contrast e2 isoform 13 also suggested e2 e3 isoforms would prevent aggregation tau protein limiting abnormal phosphorylation leading constitution paired helical filament e4 isoform would 14
0.4035247.9467014.html.plaintext.txt	10	however none hypotheses fully explained many 50 homozygous subjects survive 80 years develop ad observation suggests factors influence apoe associated risk indeed genetic environmental factors family history gender smoking oestrogen cholesterol level polymorphisms located apoe receptor genes instance 15 20 may modify apoe associated risk however recent reports suggest additional genetic factors within apoe locus may also modulate risk firstly genetic study markers vicinity apoe locus demonstrated combination three polymorphisms increases estimation apoe associated risk ad compared apoe polymorphism alone 5 secondly distortion allelic expression apoe gene observed brain affected patients indeed relative expression epsis4 allele increased 15 fold epsis3epsis4 bearer ad patients compared epsis3epsis4 bearer controls 21
0.4035247.9467014.html.plaintext.txt	11	however none hypotheses fully explained many 50 homozygous subjects survive 80 years develop ad observation suggests factors influence apoe associated risk indeed genetic environmental factors family history gender smoking oestrogen cholesterol level polymorphisms located apoe receptor genes instance 15 20 may modify apoe associated risk however recent reports suggest additional genetic factors within apoe locus may also modulate risk firstly genetic study markers vicinity apoe locus demonstrated combination three polymorphisms increases estimation apoe associated risk ad compared apoe polymorphism alone 5 secondly distortion allelic expression apoe gene observed brain affected patients indeed relative expression epsis4 allele increased 15 fold epsis3epsis4 bearer ad patients compared epsis3epsis4 bearer controls 21
0.4035247.9467014.html.plaintext.txt	12	together data suggest potential existence one additional genetic susceptibility factors apoe sequence modifying risk associated apoe epsis4 allele occurrence ad detailed sequence analyses study apoe locus needed characterise additional genetic factors instance mui et al reported polymorphism 1e1 first intron apoe gene strong linkage disequilibrium apoe epsis4 allele 22
0.4035247.9467014.html.plaintext.txt	13	together data suggest potential existence one additional genetic susceptibility factors apoe sequence modifying risk associated apoe epsis4 allele occurrence ad detailed sequence analyses study apoe locus needed characterise additional genetic factors instance mui et al reported polymorphism 1e1 first intron apoe gene strong linkage disequilibrium apoe epsis4 allele 22
0.4035247.9467014.html.plaintext.txt	14	go hunt polymorphisms sequenced 375 bp upstream apoe tata box detected new polymorphism whose impact ad risk together apoe epsis4 allele investigated large case control study results
0.4035247.9467014.html.plaintext.txt	15	sequencing 375 bp upstream tata box apoe found grarrt polymorphism position 186 tata box located potential consensus binding sequence th1e47 heterodimer transcriptional factor fig 1 23 location named th1e47cs polymorphism th1e47 consensus sequence polymorphism
0.4035247.9467014.html.plaintext.txt	16	figure 1 autoradiograph sequencing gel part apoe promoter heterozygous th1e47cs individual showing grarrt base pair change b comparison apoe promoter sequence including th1e47cs polymorphism consensus sequence predicted binding site th1e47cs heterodimer 21 predicted positions th1 e47 binding site indicated top based known half site specificity e47 predicted th1 grarrt mutation boxed located half site specificity e47 nucleotide positions numbered relative canonical e box sequence
0.4035247.9467014.html.plaintext.txt	17	studied association th1e47cs polymorphism ad large case control study 310 cases age 746 plus minus 93 years 293 controls age 735 plus minus 109 years analysed th1e47cs polymorphism together apoe 1e1 d19s178 repeat polymorphisms distributions polymorphisms presented table 1 deviation hardy weinberg equilibrium observed polymorphisms expected epsis4 allele strongly associated ad 467 95 ic 328 667 epsis2 allele exhibited protective effect 027 95 ci 014 052 control population th1e47cs g allele common one 0531 contrast ad population 0468 allelic genotypic distributions significantly different ad cases compared control cases p 003 p 0007 respectively th1e47cs allele associated increased risk developing ad 129 ci 95 102 163 179 ci 95 121 265 p 0002 individuals bearing least one allele 1e1 polymorphism allelic genotypic distributions similar ones reported mui et al 20 significantly different ad control populations p 0002 p 00005 respectively 1e1 c allele associated decreased risk developing ad 056 ci 95 040 078 p 00003 difference allelic genotypic distributions d19s178 repeat alleles observed p 090 p 095 respectively
0.4035247.9467014.html.plaintext.txt	18	calculated pairwise linkage disequilibriums d19s178 th1e47cs 1e1 apoe polymorphisms table 2 expected significant linkage disequilibriums existed th1e47cs 1e1 apoe polymorphisms d19s178 independent polymorphisms although weak linkage disequilibrium existed apoe control population
0.4035247.9467014.html.plaintext.txt	19	calculated pairwise linkage disequilibriums d19s178 th1e47cs 1e1 apoe polymorphisms table 2 expected significant linkage disequilibriums existed th1e47cs 1e1 apoe polymorphisms d19s178 independent polymorphisms although weak linkage disequilibrium existed apoe control population
0.4035247.9467014.html.plaintext.txt	20	estimated haplotypes generated four polymorphisms using myriad haplotype algorithm among 16 theoretical haplotypes 15 observed table 3a haplotypes observed ad cases three nos 2 5 7 represented controls difference distribution estimated haplotype frequencies cases controls tested likelihood ratio test 13 degrees freedom chi2 696 take account strong association apoe epsis4 allele ad compared estimated haplotype distributions epsis3epsis3 epsis3epsis4 ad control subgroups table 3b c subgroup epsis3epsis3 epsis3epsis4 genotype bearers respectively estimated haplotype distributions significantly different ad control subjects likelihood test chi2 374 df 8 chi2 160 df 6 respectively suggesting potential independent effect polymorphisms
0.4035247.9467014.html.plaintext.txt	21	estimated haplotypes generated four polymorphisms using myriad haplotype algorithm among 16 theoretical haplotypes 15 observed table 3a haplotypes observed ad cases three nos 2 5 7 represented controls difference distribution estimated haplotype frequencies cases controls tested likelihood ratio test 13 degrees freedom chi2 696 take account strong association apoe epsis4 allele ad compared estimated haplotype distributions epsis3epsis3 epsis3epsis4 ad control subgroups table 3b c subgroup epsis3epsis3 epsis3epsis4 genotype bearers respectively estimated haplotype distributions significantly different ad control subjects likelihood test chi2 374 df 8 chi2 160 df 6 respectively suggesting potential independent effect polymorphisms
0.4035247.9467014.html.plaintext.txt	22	table 1 distribution combination different polymorphism alleles controls ad cases allele frequency genotype frequency apoea n epsis2 epsis3 epsis4 epsis2epsis2 epsis2epsis3 epsis2epsis4 epsis3epsis3 epsis3epsis4 epsis4epsis4 control cases 308 0081 0805 0114 0003 0133 0230 0649 0179 0130 ad cases 292 0034 0639 0327 0034 0034 0425 0393 0113 th1e47cs n gb ggc gt tt control cases 310 0531 0469 0320 0422 0258 ad cases 279 0468 0532 0208 0520 0272 1e1 n gd c gge gc cc control cases 307 0615 0385 0388 0456 0156 ad cases 293 0711 0289 0533 0382 0085 d19s178f n l ll ls ss control cases 272 0498 0502 0246 0504 0250 ad cases 276 0507 0493 0257 0500 0243 n epsis2epsis3g epsis3epsis3 epsis3epsis4 epsis4epsis4 epsis2epsis4 apoe 1e1 polymorphism combination ad cases cc 22 1 20 1 gc 100 4 50 46 gg 139 4 44 56 27 8 total 261 9 114 102 28 8 control cases cc 41 0 41 0 gc 112 12 76 24 gg 100 25 50 15 3 7 total 253 37 167 39 3 7 apoe th1e47cs polymorphism combination ad cases gg 55 4 36 13 1 1 gt 134 5 54 60 8 7 tt 78 24 29 19 total 261 9 114 102 28 8 control cases gg 85 25 52 5 3 gt 108 11 76 16 1 4 tt 60 1 39 18 2 total 253 36 167 39 3 7 ap 0001 bp 003 ortt 129 ci 95 102 163 cp 0007 dp 0002 orgg 144 ci 95 114 184 ep 00005 fns gone individual epsis2epsis2 control cases
0.4035247.9467014.html.plaintext.txt	23	table 2 pairwise linkage disequilibrium 19q132 chromosomal region d19s178 th1e47cs 1e1 apoe ad cases d19s178 10 06 06 th1e47cs 7 84 58 1e1 6 79 61 apoe 6 49 54 controls d19s178 05 01 12 th1e47cs 3 119 19 1e1 1 86 37 apoe 32 42 apoe polymorphism analysed biallelic marker ie allele 4 versus allele 2 3 diagonal delta standardised linkage disequilibrium coefficient diagonal dprime percentage linkage disequilibrium coefficient maximum possible value given allele frequencies
0.4035247.9467014.html.plaintext.txt	24	table 3 polymorphism haplotype estimations along 19q132 chromosomal region haplotype polymorphisms estimated haplotype frequencies d19s178 th1e47cs 1e1 apoe ad cases controls expected controls general population 1 g epsis4 0130 0032 0029 2 c epsis4 0004 0000 0019a 3 g g epsis4 0031 0006 0035a 4 l g epsis4 0100 0043 0027 5 l c epsis4 0005 0000 0018a 6 l g g epsis4 0044 0022 0033 7 l g c epsis4 0003 0000 0021a 8 g epsis4 0018 0009 0114a 9 c epsis4 0127 0183 0072a 10 g g epsis4 0184 0267 0142a 11 g c epsis4 0000 0011 0087a 12 l g epsis4 0020 0014 0113a 13 l c epsis4 0128 0170 0070a 14 l g g epsis4 0195 0224 0136a 15 l g c epsis4 0011 0019 0084a number chromosomes 522 506 b population genotyped epsis3epsis3 1 g 0035 0014 0129a 2 c 0192 0239 0116a 3 g g 0259 0268 0151a 4 g c 0009 0013 0136a 5 l g 0027 0010 0113a 6 l c 0193 0198 0103a 7 l g g 0285 0234 0133a 8 l g c 0000 0024 0119a number chromosomes 228 334 c population genotyped epsis3epsis4 1 g 0184 0154 0207 2 c 0102 0148 0092 3 g g 0169 0145 0103 4 g c 0000 0000 0046 5 l g 0179 0204 0254 6 l c 0113 0158 0127 7 l g g 0237 0188 0113 8 l g c 0015 0000 0056 number chromosomes 204 78 ap 001
0.4035247.9467014.html.plaintext.txt	25	whole population ad 261 controls 253 estimated developing ad subjects least one allele genotype polymorphism separately table 4 expected significant effect observed except d19s178 determine effect th1e47cs 1e1 polymorphisms due linkage disequilibrium existing apoe polymorphism performed multivariate logistic regression taking account age gender four polymorphisms model effects th1e47cs 1e1 polymorphisms persisted even increased reinforcing hypothesis several genetic susceptibility factors within apoe locus
0.4035247.9467014.html.plaintext.txt	26	whole population ad 261 controls 253 estimated developing ad subjects least one allele genotype polymorphism separately table 4 expected significant effect observed except d19s178 determine effect th1e47cs 1e1 polymorphisms due linkage disequilibrium existing apoe polymorphism performed multivariate logistic regression taking account age gender four polymorphisms model effects th1e47cs 1e1 polymorphisms persisted even increased reinforcing hypothesis several genetic susceptibility factors within apoe locus
0.4035247.9467014.html.plaintext.txt	27	table 4 adjusted odds ratio estimated multiple logistic regression 95 ci d19s178ss lsll th1e47cstt gtgg 1e1cc gcgg apoewith epsis4without epsis4 non adjusted 094 063 141p 076 179 121 265p 0002 056 040 078p 00003 432 298 628p 00001 adjusted 082 046 146 190 128 283 058 041 082 466 314 693 age gender p 050 p 0002 p 0002 p 00001 adjusted gender age 087 038 200 251 138 456 043 025 074 322 206 502 polymorphisms p 075 p 0001 p 0002 p 00001
0.4035247.9467014.html.plaintext.txt	28	assume level expression apoe alleles increased due cis mutations promoter region hypothesis three major implications promoter mutation may modulate expression apoe alleles leading increased deleterious risk epsis4 increased protective effect epsis2 ii given determines risk importance relative level expression alleles apoe promoter mutation differential effect apoe heterozygous homozygous genotypes iii effect cis mutation heterozygous individuals depend phase polymorphism apoe epsis alleles ie haplotype heterozygous th1e47cs apoe epsis4 genotype bearers epsis4 allele may combined either th1e47cs g allele one combinations may increase relative expression level epsis4 allele decrease relative expression level epsis3 allele combination inverse influence thus epsis3epsis4 genotype bearers risk developing ad different th1e47cs heterozygous homozygous individuals test assumptions studied gender age adjusted developing ad th1e47cs heterozygous genotype bearers compared homozygous th1e47cs individuals th1e47cs heterozygous genotype associated increased risk developing ad heterozygous apoe individuals 240 ci 95 140 412 p 0001 homozygous apoe individuals 102 ci 95 067 157 p 091 particular epsis3epsis4 sub population table 5 risk developing ad heterozygous th1e47cs individuals increased compared homozygous th1e47cs individuals 190 ci 95 097 370 p 006 ad 107 controls 54 increased risk became significant larger epsis3epsis4 population 207 95 ci 121 354 p 0008 ad 152 controls 91 however risk obtained heterozygous 1e1 individuals significant compared homozygous 1e1 individuals 062 95 ci 036 105 p 007 assess contribution polymorphism risk developing ad epsis3epsis4 population performed multiple logistic regression detected increased risk tendency developing ad heterozygous th1e47cs 189 ci 95 107 335 p 0027 heterozygous 1e1 bearers 075 95 ci 043 133 p 033 altogether data suggest th1e47cs polymorphism could modify relative level expression apoe alleles
0.4035247.9467014.html.plaintext.txt	29	order approach influence phase th1e47cs apoe polymorphisms ad risk estimated frequencies haplotypes th1e47cs g allele associated epsis4 allele ad controls epsis3epsis4 bearer populations described materials methods apoe epsis3epsis4 th1e47cs gt bearers 576 controls estimated epsis4 alleles chromosome proportion 697 case group leading estimated 17 discussion
0.4035247.9467014.html.plaintext.txt	30	order approach influence phase th1e47cs apoe polymorphisms ad risk estimated frequencies haplotypes th1e47cs g allele associated epsis4 allele ad controls epsis3epsis4 bearer populations described materials methods apoe epsis3epsis4 th1e47cs gt bearers 576 controls estimated epsis4 alleles chromosome proportion 697 case group leading estimated 17 discussion
0.4035247.9467014.html.plaintext.txt	31	recently hypothesis others mutations nearby apoe gene fuelled new physiological data difference allelic expression apoe gene observed 19 suggesting non coding polymorphisms regulatory regions apoe gene could modify risk developing ad looking new polymorphisms found grarrt polymorphism located position 7 degenerative e box consensus fig 1 23 influenced effect apoe polymorphisms ad expected way
0.4035247.9467014.html.plaintext.txt	32	recently hypothesis others mutations nearby apoe gene fuelled new physiological data difference allelic expression apoe gene observed 19 suggesting non coding polymorphisms regulatory regions apoe gene could modify risk developing ad looking new polymorphisms found grarrt polymorphism located position 7 degenerative e box consensus fig 1 23 influenced effect apoe polymorphisms ad expected way
0.4035247.9467014.html.plaintext.txt	33	th1e47cs 1e1 polymorphisms associated ad studied separately although strong linkage disequilibrium existed epsis4 th1e47cs 1e1 g alleles effect polymorphisms persisted introduced logistic regression model observation suggested risk associated apoe epsis alleles may modulated according combination polymorphisms least one th1e47cs 1e1 c allele significantly modified risk developing ad whole population furthermore impact epsis4 allele seemed decreased suggesting part effect may attributed promoter polymorphisms another argument brought forward estimating risk associated phase estimated risk developing disease epsis3epsis4 genotype bearers similar according combination th1e47cs apoe epsis alleles chromosome results accordance previous data suggest epsis3epsis4 individuals preferentially develop ad expressed epsis4 allele greater level thus cis mutation apoe promoter may favour relative expression level epsis4 allele potentially deleterious action e4 isoform
0.4035247.9467014.html.plaintext.txt	34	th1e47cs 1e1 polymorphisms associated ad studied separately although strong linkage disequilibrium existed epsis4 th1e47cs 1e1 g alleles effect polymorphisms persisted introduced logistic regression model observation suggested risk associated apoe epsis alleles may modulated according combination polymorphisms least one th1e47cs 1e1 c allele significantly modified risk developing ad whole population furthermore impact epsis4 allele seemed decreased suggesting part effect may attributed promoter polymorphisms another argument brought forward estimating risk associated phase estimated risk developing disease epsis3epsis4 genotype bearers similar according combination th1e47cs apoe epsis alleles chromosome results accordance previous data suggest epsis3epsis4 individuals preferentially develop ad expressed epsis4 allele greater level thus cis mutation apoe promoter may favour relative expression level epsis4 allele potentially deleterious action e4 isoform
0.4035247.9467014.html.plaintext.txt	35	th1e47cs polymorphism characterised binding site basic helix loop helix transcription factor e47 factor e47 belongs class proteins ubiquitously expressed form combinatorial interactions class b proteins control tissue specific gene expression 24 particular e47 expressed brain associated multiple class b protein implicated development maintenance mammalian nervous system 25 27 little known th1 factor identified screen mouse embryo cdna library homologous protein drosophila partner drosophila class protein daughterless expression essential neurogenesis 28
0.4035247.9467014.html.plaintext.txt	36	th1e47cs polymorphism characterised binding site basic helix loop helix transcription factor e47 factor e47 belongs class proteins ubiquitously expressed form combinatorial interactions class b proteins control tissue specific gene expression 24 particular e47 expressed brain associated multiple class b protein implicated development maintenance mammalian nervous system 25 27 little known th1 factor identified screen mouse embryo cdna library homologous protein drosophila partner drosophila class protein daughterless expression essential neurogenesis 28
0.4035247.9467014.html.plaintext.txt	37	nevertheless essential determine vitro vivo functionality transcriptional factor sequence binding furthermore effect new polymorphism susceptible modulate risk associated apoe alleles must confirmed epidemiological studies profound analysis performed determine haplotypes conclusion th1e47cs polymorphism located within putative regulatory element apoe promoter could contribute apoe expression level polymorphisms regulatory sequences gene may exist extended screening regulatory regions needs developed regulation apoe gene could important deciphering mechanisms involvement apoe alleles particular better define subjects higher risk developing ad population methods populations
0.4035247.9467014.html.plaintext.txt	38	nevertheless essential determine vitro vivo functionality transcriptional factor sequence binding furthermore effect new polymorphism susceptible modulate risk associated apoe alleles must confirmed epidemiological studies profound analysis performed determine haplotypes conclusion th1e47cs polymorphism located within putative regulatory element apoe promoter could contribute apoe expression level polymorphisms regulatory sequences gene may exist extended screening regulatory regions needs developed regulation apoe gene could important deciphering mechanisms involvement apoe alleles particular better define subjects higher risk developing ad population methods populations
0.4035247.9467014.html.plaintext.txt	39	ad control samples caucasian originating france sixteen cases european countries different ethnic origins influence genotype distributions diagnoses probable ad established according dsm iii r nincs adrda criteria n 293 age 746 plus minus 93 range 51 98 age onset 7102 plus minus 89 range 49 94 322 men 2930 caucasian controls defined subjects without dms iii r dementia criteria integrity cognitive functions n 310 age 735 plus minus 109 range 59 105 374 men individual relatives signed informed consent number subjects tested different polymorphisms varied followed th1e47cs study 279 ad cases 310 controls 1e1 study 293 ad cases 307 controls d19s178 study 272 ad cases 279 controls
0.4035247.9467014.html.plaintext.txt	40	ad control samples caucasian originating france sixteen cases european countries different ethnic origins influence genotype distributions diagnoses probable ad established according dsm iii r nincs adrda criteria n 293 age 746 plus minus 93 range 51 98 age onset 7102 plus minus 89 range 49 94 322 men 2930 caucasian controls defined subjects without dms iii r dementia criteria integrity cognitive functions n 310 age 735 plus minus 109 range 59 105 374 men individual relatives signed informed consent number subjects tested different polymorphisms varied followed th1e47cs study 279 ad cases 310 controls 1e1 study 293 ad cases 307 controls d19s178 study 272 ad cases 279 controls
0.4035247.9467014.html.plaintext.txt	41	order increase statistical power study analysis heterozygous individuals increased number individuals epsis3epsis4 genotype adding new epsis3epsis4 subjects independent populations total 152 ad 91 control cases 733 plus minus 85 703 plus minus 85 years respectively sequencing
0.4035247.9467014.html.plaintext.txt	42	direct sequencing performed 70770 sequenase version 20 dna sequencing kit amersham life science using gamma 35sdatp apoe pcr products obtained described aso technique see reactions run 6 acrylamide8 m urea gel 1 2 h 60 w gels exposed x ray film genetic analysis
0.4035247.9467014.html.plaintext.txt	43	direct sequencing performed 70770 sequenase version 20 dna sequencing kit amersham life science using gamma 35sdatp apoe pcr products obtained described aso technique see reactions run 6 acrylamide8 m urea gel 1 2 h 60 w gels exposed x ray film genetic analysis
0.4035247.9467014.html.plaintext.txt	44	genomic dna extracted white blood cells analysed th1e47cs polymorphism distribution together two polymorphisms located 19q132 chromosomal region flanking th1e47cs polymorphism 1e1 polymorphism located 115 kb downstream th1e47cs polymorphism anonymous repeat dna marker d19s178 located 24 cm upstream apoe gene frequency d19s178 repeat alleles dichotomised long 167 short alleles 5
0.4035247.9467014.html.plaintext.txt	45	genomic dna extracted white blood cells analysed th1e47cs polymorphism distribution together two polymorphisms located 19q132 chromosomal region flanking th1e47cs polymorphism 1e1 polymorphism located 115 kb downstream th1e47cs polymorphism anonymous repeat dna marker d19s178 located 24 cm upstream apoe gene frequency d19s178 repeat alleles dichotomised long 167 short alleles 5
0.4035247.9467014.html.plaintext.txt	46	four markers amplified polymerase chain reaction perkin elmer cetus thermal cycler anonymous repeat dna marker d19s178 1e1 polymorphism apoe polymorphism tested previously described 82231 th1e47cs polymorphism create destroy restriction enzyme sites two techniques used confirm results first one consisted designing mismatch primer contained one mismatched base pair four bases away 3prime end forward primer five bases polymorphism incorporated pcr product primer produced bstn cut site g present cut site present polymorphic site briefly pcr step performed 40 cycles 1 min 94 degrees c 1 min 15 54 degrees c 1 min 72 degrees c cycle forward primer 5prime agaatggaggagggtgcctg 3prime reverse primer 5prime actcaaggatcccagacttg 3prime total volume 50 microl containing 125 u taq dna polymerase 02 mm dntp 1 dmso 05 mm mgcl2 twenty five microl pcr product digested 1 u bstn 60 degrees c overnight digestion products visualised 12 polyacrylamide gel th1e47cs allele characterised 49 bp fragment g allele 31 bp fragment second technique consisted performing allele specific oligonucleotide aso hybridisation 375 bp fragment containing th1e47cs polymorphism amplified using forward primer 5prime tactttctttctgggatccagg 3prime reverse primer 5prime actcaaggatcccagacttg 3prime pcr performed total volume 50 microl 35 cycles 1 min 94 degrees c 1 min 50 degrees c 1 min 72 degrees c cycle containing 125 u taq polymerase 02 mm dntp 1 mm mgcl2 two primers 5prime gcccagtaatccagacaccc 3prime 5prime gcccagtaatacagacaccc 3prime g allele detection respectively 5prime end labelled dig boerhinger mannheim allele specific hybridisation obtained washing 3 min 01 sds 05 x ssc solution 61 degrees c 62 degrees c g allele hybridisation respectively detection realised described supplier boerhinger mannheim statistical analysis
0.4035247.9467014.html.plaintext.txt	47	four markers amplified polymerase chain reaction perkin elmer cetus thermal cycler anonymous repeat dna marker d19s178 1e1 polymorphism apoe polymorphism tested previously described 82231 th1e47cs polymorphism create destroy restriction enzyme sites two techniques used confirm results first one consisted designing mismatch primer contained one mismatched base pair four bases away 3prime end forward primer five bases polymorphism incorporated pcr product primer produced bstn cut site g present cut site present polymorphic site briefly pcr step performed 40 cycles 1 min 94 degrees c 1 min 15 54 degrees c 1 min 72 degrees c cycle forward primer 5prime agaatggaggagggtgcctg 3prime reverse primer 5prime actcaaggatcccagacttg 3prime total volume 50 microl containing 125 u taq dna polymerase 02 mm dntp 1 dmso 05 mm mgcl2 twenty five microl pcr product digested 1 u bstn 60 degrees c overnight digestion products visualised 12 polyacrylamide gel th1e47cs allele characterised 49 bp fragment g allele 31 bp fragment second technique consisted performing allele specific oligonucleotide aso hybridisation 375 bp fragment containing th1e47cs polymorphism amplified using forward primer 5prime tactttctttctgggatccagg 3prime reverse primer 5prime actcaaggatcccagacttg 3prime pcr performed total volume 50 microl 35 cycles 1 min 94 degrees c 1 min 50 degrees c 1 min 72 degrees c cycle containing 125 u taq polymerase 02 mm dntp 1 mm mgcl2 two primers 5prime gcccagtaatccagacaccc 3prime 5prime gcccagtaatacagacaccc 3prime g allele detection respectively 5prime end labelled dig boerhinger mannheim allele specific hybridisation obtained washing 3 min 01 sds 05 x ssc solution 61 degrees c 62 degrees c g allele hybridisation respectively detection realised described supplier boerhinger mannheim statistical analysis
0.4035247.9467014.html.plaintext.txt	48	pairwise linkage disequilibriums measured collapsed data estimation two marker haplotype frequencies maximum likelihood procedure d19s178 th1e47cs 1e1 apoe coded biallelic marker ie allele epsis4 versus allele epsis2 epsis3 34 standardised disequilibrium delta percent maximum possible value disequilibrium computed outlined thompson et al 35 statistical significance linkage disequilibrium considered p 0001 level since multiple non independent pairwise comparisons performed extended haplotype frequencies four markers estimated collapsed data using myriad haplotype algorithm described mclean morton 36 implemented computer program cox et al 37 comparisons haplotype frequencies cases controls tested likelihood ratio test estimated frequencies compared expected basis equilibrium pearsons chi2 fisher exact test necessary 38 multivariate analysis coded genotypes subject dummy variables according tested hypotheses least one d19s178 short allele sssl versus ll least one th1e47cs allele tttg versus gg least one 1e1 c allele ccgc versus gg least one epsis4 allele effects variables disease tested multiple logistic regression model adjusted age gender estimation risk developing ad according combination th1e47cs epsis4 alleles epsis3epsis4 subgroup
0.4035247.9467014.html.plaintext.txt	49	according three polymorphisms presented table 3c defined epsis3epsis4 sub populations fi xi yi 1 fi frequency haplotype 1 8 defined table 3c xi frequency epsis3 allele found haplotype yi frequency epsis4 allele found haplotype
0.4035247.9467014.html.plaintext.txt	50	estimation performed epsis3epsis4 sub population equal total proportion epsis3 epsis4 alleles 2
0.4035247.9467014.html.plaintext.txt	51	given 1e1 c allele strong linkage disequilibrium apoe epsis polymorphism tables 2 3 associated epsis3 allele y2 y4 y6 y8 0 thus x2 x4 x6 x8 values directly obtained table 3c fi xi equation 2 obtain 3
0.4035247.9467014.html.plaintext.txt	52	given 1e1 c allele strong linkage disequilibrium apoe epsis polymorphism tables 2 3 associated epsis3 allele y2 y4 y6 y8 0 thus x2 x4 x6 x8 values directly obtained table 3c fi xi equation 2 obtain 3
0.4035247.9467014.html.plaintext.txt	53	xi directly approached haplotype distribution estimated epsis3epsis3 subgroup
0.4035247.9467014.html.plaintext.txt	54	xiprime frequency haplotype epsis3epsis3 ad control subgroup xi value estimated follows 4 equation 4 5
0.4035247.9467014.html.plaintext.txt	55	yi value deduced equation 1 thus estimated frequency four possible phases th1e47cs gt apoe epsis3epsis4 heterozygous ad control sub populations follows epsis4 th1e47cs allele x1 x3 epsis4 th1e47cs g allele x2 x4 epsis3 th1e47cs allele y1 y2 y5 y6 epsis3 th1e47cs g allele y3 y4 y7 y8 acknowledgements
0.4035247.9467014.html.plaintext.txt	56	yi value deduced equation 1 thus estimated frequency four possible phases th1e47cs gt apoe epsis3epsis4 heterozygous ad control sub populations follows epsis4 th1e47cs allele x1 x3 epsis4 th1e47cs g allele x2 x4 epsis3 th1e47cs allele y1 y2 y5 y6 epsis3 th1e47cs g allele y3 y4 y7 y8 acknowledgements
0.4035247.9467014.html.plaintext.txt	57	29 american psychiatric association 1987 diagnostic statistical manual mental disorders third edition revised dms iii r american psychatric association ed washington dc
0.4035247.9467014.html.plaintext.txt	58	33 apoe alzheimer disease meta analysis consortium 1997 effects age gender ethnicity association apolipoprotein e genotype alzheimer disease j med assoc 278 1349 1356
0.4035247.9467014.html.plaintext.txt	59	correspondence addressed tel 33 3 20 87 77 10 fax 33 3 20 87 78 94 email philippeamouyelpasteur lillefr page run oxford university press great clarendon street oxford ox2 6dp part oup journalscomments feedback www adminatoupcouk u d last modification 14 feb 1998copyright oxford university press 1998
0.4035247.9467014.html.plaintext.txt	60	correspondence addressed tel 33 3 20 87 77 10 fax 33 3 20 87 78 94 email philippeamouyelpasteur lillefr page run oxford university press great clarendon street oxford ox2 6dp part oup journalscomments feedback www adminatoupcouk u d last modification 14 feb 1998copyright oxford university press 1998
0.407656.9328480.html.plaintext.txt	0	distortion allelic expression apolipoprotein e alzheimers disease
0.407656.9328480.html.plaintext.txt	1	jean charles lambert12 jordi perez tur13 marie joelle dupire1 douglas galasko4 david mann5 philippe amouyel2 john hardy3 andre delacourte1 marie christine chartier harlin12
0.407656.9328480.html.plaintext.txt	2	1inserm unite 422 place de verdun 59045 lille cedex france 2inserm cjf95 05 institut pasteur de lille 1 rue de calmette 59019 lille cedex france 3birdsall building mayo clinic jacksonville 4500 san pablo road jacksonville fl 32224 usa 4ucsd medical centre pulman ambulatory care centre 9350 campus point drive la jolla ca 92037 usa 5department pathological sciences stopford building university manchester oxford road manchester m13 9pt uk
0.407656.9328480.html.plaintext.txt	3	received july 25 1997 revised accepted august 2 1997
0.407656.9328480.html.plaintext.txt	4	apoe epsis4 allele strong genetic susceptibility factor alzheimers disease interaction biological factors may modulate effect apoe isoforms however previous work suggested genetic variability within apoe locus influencing effect epsis4 allele may exist variability could modify expression apoe gene particular level expression apoe alleles could important determinant disease pathogenesis test hypothesis examined levels expression apoe heterozygotes ad controls using new method semi quantitation report relative epsis4 mrna expression increased ad compared controls suggest genetic variability neural expression apoe contributes disease risk introduction
0.407656.9328480.html.plaintext.txt	5	apoe epsis4 allele strong genetic susceptibility factor alzheimers disease interaction biological factors may modulate effect apoe isoforms however previous work suggested genetic variability within apoe locus influencing effect epsis4 allele may exist variability could modify expression apoe gene particular level expression apoe alleles could important determinant disease pathogenesis test hypothesis examined levels expression apoe heterozygotes ad controls using new method semi quantitation report relative epsis4 mrna expression increased ad compared controls suggest genetic variability neural expression apoe contributes disease risk introduction
0.407656.9328480.html.plaintext.txt	6	epsis4 allele apoe gene major risk factor late onset alzheimers disease load 1 also implicated risk factor early onset disease populations 23 previous studies described epsis4 homozygotes higher risk developing disease epsis3epsis4 heterozygotes however individuals bearing one two epsis4 alleles inevitably develop disease detailed genetic analysis around apoe locus suggested existence genetic variability region could contribute disease risk 4 two possible explanations observations another genetically variable locus vicinity apoe gene involved pathogenesis disease ii genetic variability control expression apoe gene 4
0.407656.9328480.html.plaintext.txt	7	epsis4 allele apoe gene major risk factor late onset alzheimers disease load 1 also implicated risk factor early onset disease populations 23 previous studies described epsis4 homozygotes higher risk developing disease epsis3epsis4 heterozygotes however individuals bearing one two epsis4 alleles inevitably develop disease detailed genetic analysis around apoe locus suggested existence genetic variability region could contribute disease risk 4 two possible explanations observations another genetically variable locus vicinity apoe gene involved pathogenesis disease ii genetic variability control expression apoe gene 4
0.407656.9328480.html.plaintext.txt	8	little examination mrna expression apoe ad 56 available evidence suggests apoe expression increased neuronal damage 78 bulk expression occurs astrocytes 5 expression believed part compensatory mechanism aimed aiding reafferentation reactive synaptogenesis 9 studies examined expression apoe protein ad cases controls relative apoe genotype 910 bertrand et al suggested amount apoe protein could inversely correlated number epsis4 alleles carried subjects higher levels observed epsis3 homozygotes lower epsis4 homozygotes intermediate levels epsis3epsis4 heterozygotes 10
0.407656.9328480.html.plaintext.txt	9	little examination mrna expression apoe ad 56 available evidence suggests apoe expression increased neuronal damage 78 bulk expression occurs astrocytes 5 expression believed part compensatory mechanism aimed aiding reafferentation reactive synaptogenesis 9 studies examined expression apoe protein ad cases controls relative apoe genotype 910 bertrand et al suggested amount apoe protein could inversely correlated number epsis4 alleles carried subjects higher levels observed epsis3 homozygotes lower epsis4 homozygotes intermediate levels epsis3epsis4 heterozygotes 10
0.407656.9328480.html.plaintext.txt	10	hypothesised since epsis4 homozygotes higher risk developing disease epsis3epsis4 heterozygotes high proportion individuals latter genotype reach greater age without developing ad likely explanation genetic variability neural expression apoe locus epsis3epsis4 heterozygote individuals high epsis4 expressors andor low epsis3 expressors likely develop ad individuals high epsis3 expressors andor low epsis4 expressors
0.407656.9328480.html.plaintext.txt	11	identification apoe allele transcription products easily achieved rt pcr using restriction fragment length polymorphism developed semi quantitative assay measure allelic expression apoe mrna rt pcr using silver staining 11 method quantitation applied brains heterozygote subjects collected various centres used assess percentage epsis4 mrna expression epsis3epsis4 epsis2epsis4 subjects epsis2 mrna expression epsis2epsis3 individuals carried ad cases controls results
0.407656.9328480.html.plaintext.txt	12	identification apoe allele transcription products easily achieved rt pcr using restriction fragment length polymorphism developed semi quantitative assay measure allelic expression apoe mrna rt pcr using silver staining 11 method quantitation applied brains heterozygote subjects collected various centres used assess percentage epsis4 mrna expression epsis3epsis4 epsis2epsis4 subjects epsis2 mrna expression epsis2epsis3 individuals carried ad cases controls results
0.407656.9328480.html.plaintext.txt	13	selected series epsis3epsis4 epsis2epsis4 epsis2epsis3 ad cases n 14 controls n 12 order measure relative level expression apoe allele frontal cortex fig 1 observed epsis3 mrna expression consistently greater epsis4 mrna expression cases fig 2 addition clear consistent difference epsis4 allelic expression ratio ad cases controls fig 2 ad cases showing higher relative expression epsis4 mrna controls 344 plus minus 26 versus 226 plus minus 18 respectively p 0001 mann whitney test regarding heterozygous genotypes small size group prevented us reaching definite conclusion nevertheless trend towards situation observed epsis3epsis4 group could noted increase expression epsis4 allele epsis2epsis4 group 426 plus minus 37 ad cases versus 289 plus minus 12 control whereas nothing apparent epsis2epsis3 group 390 plus minus 14 ad case versus 458 plus minus 43 controls furthermore difference allelic expression ratio epsis2epsis4 epsis3epsis4 ad cases observed since epsis2epsis4 patients showed 125 fold increase epsis4 allele ratio p 001 mann whitney test
0.407656.9328480.html.plaintext.txt	14	figure 1 semi quantitation epsis4 allele ratio control case final epsis4 allele ratio calculated data 2142
0.407656.9328480.html.plaintext.txt	15	figure 1 semi quantitation epsis4 allele ratio control case final epsis4 allele ratio calculated data 2142
0.407656.9328480.html.plaintext.txt	16	figure 2 differential expression apoe mrna three heterozygote genotypes alzheimers disease cases controls epsis2 mrna percentage measured epsis2epsis3 population epsis4 mrna percentage epsis3epsis4 epsis2epsis4 population average level expression indicated bold line category brain sample rt pcr semi quantitation repeated three times
0.407656.9328480.html.plaintext.txt	17	figure 2 differential expression apoe mrna three heterozygote genotypes alzheimers disease cases controls epsis2 mrna percentage measured epsis2epsis3 population epsis4 mrna percentage epsis3epsis4 epsis2epsis4 population average level expression indicated bold line category brain sample rt pcr semi quantitation repeated three times
0.407656.9328480.html.plaintext.txt	18	important note measurement ratio expression two alleles heterozygotes likely much robust measurement determination absolute levels mrna expression tissue since latter profoundly affected post mortem delay agonal state cell population density
0.407656.9328480.html.plaintext.txt	19	seen figure 2 level expression epsis3 allele consistently higher epsis4 allele ad group well control group data suggest either differential stability different mrna species genetic variability expression two alleles disequilibrium coding polymorphism however addition clear consistent difference epsis4 allelic expression ratio ad cases controls results consistent notion part least genetic risk developing ad encoded apoe locus relates expression protein brain would seem heterozygote individuals express relatively high proportion epsis4 allele greater risk developing disease expressing relatively low proportion observation different alleles apoe equally expressed may importance formulation hypotheses relating role apoe pathogenesis ad general present much speculation experimentation designed determine nature role different alleles apoe pathogenesis ad previously suggested e4 isoform may facilitate 12 limit 13 amyloid substance deposition isoform would protect oxidative stress conversely e2 isoform 14 finally suggested e2 e3 isoforms may prevent aggregation tau protein e4 isoform may prevent paired helical filament formation 15 however hypotheses based premise apoe allele isoforms equally expressed present similar concentrations brain isoform specific differences could enhanced different representation isoform individual
0.407656.9328480.html.plaintext.txt	20	seen figure 2 level expression epsis3 allele consistently higher epsis4 allele ad group well control group data suggest either differential stability different mrna species genetic variability expression two alleles disequilibrium coding polymorphism however addition clear consistent difference epsis4 allelic expression ratio ad cases controls results consistent notion part least genetic risk developing ad encoded apoe locus relates expression protein brain would seem heterozygote individuals express relatively high proportion epsis4 allele greater risk developing disease expressing relatively low proportion observation different alleles apoe equally expressed may importance formulation hypotheses relating role apoe pathogenesis ad general present much speculation experimentation designed determine nature role different alleles apoe pathogenesis ad previously suggested e4 isoform may facilitate 12 limit 13 amyloid substance deposition isoform would protect oxidative stress conversely e2 isoform 14 finally suggested e2 e3 isoforms may prevent aggregation tau protein e4 isoform may prevent paired helical filament formation 15 however hypotheses based premise apoe allele isoforms equally expressed present similar concentrations brain isoform specific differences could enhanced different representation isoform individual
0.407656.9328480.html.plaintext.txt	21	date seems difficult link apoe mrna apoe protein levels several studies explored issue reporting contradictory findings brain 1016 cerebrospinal fluid 1718 plasma 19 even apoe level tested according apoe genotype none previous studies able determine relative ratio different isoforms thus results comparable development isoform specific monoclonal antibodies would help determine whether variation observed population also present protein level 20
0.407656.9328480.html.plaintext.txt	22	date seems difficult link apoe mrna apoe protein levels several studies explored issue reporting contradictory findings brain 1016 cerebrospinal fluid 1718 plasma 19 even apoe level tested according apoe genotype none previous studies able determine relative ratio different isoforms thus results comparable development isoform specific monoclonal antibodies would help determine whether variation observed population also present protein level 20
0.407656.9328480.html.plaintext.txt	23	two major findings work first expression epsis3 allele consistently higher expression epsis4 allele second expression epsis4 allele beyond certain level seems greatly influence vulnerability individual alzheimers disease
0.407656.9328480.html.plaintext.txt	24	two major findings work first expression epsis3 allele consistently higher expression epsis4 allele second expression epsis4 allele beyond certain level seems greatly influence vulnerability individual alzheimers disease
0.407656.9328480.html.plaintext.txt	25	interesting note apoe regulated consequence insult poirier et al showed increase level expression apoe mrna rat lesioning cerebral cortex 6 similarly diedrich et al showed apoe mrna increased ad brains 5 together results support event may lead increase apoe mrna parallel distortion allelic expression distortion allelic expression may specific brain possibly restricted certain areas 21 suggests neural genetic susceptibility ad associated apoe gene
0.407656.9328480.html.plaintext.txt	26	interestingly templeton reached similar conclusion using cladistic analysis previously reported genetic data 4 using haplotype data markers surrounding apoe locus including apoe polymorphism templeton showed coding polymorphism apoe gene sufficient explain increased risk ad 22 data suggest influence non coding polymorphism apoe expression may supply rest answer materials methods rna extraction
0.407656.9328480.html.plaintext.txt	27	interestingly templeton reached similar conclusion using cladistic analysis previously reported genetic data 4 using haplotype data markers surrounding apoe locus including apoe polymorphism templeton showed coding polymorphism apoe gene sufficient explain increased risk ad 22 data suggest influence non coding polymorphism apoe expression may supply rest answer materials methods rna extraction
0.407656.9328480.html.plaintext.txt	28	fourteen late onset ad cases caucasian origin mean age 741 plus minus 118 years five male nine female 12 controls mean age 830 plus minus 106 years five male seven female selected function apoe genotype 23 mean age sampling 756 plus minus 88 years ad cases genotyped epsis3epsis4 776 plus minus 110 years controls genotyped epsis3epsis4 diagnoses confirmed neuropathological examination
0.407656.9328480.html.plaintext.txt	29	total rna extraction performed frontal lobe samples described gilmour et al 24 digested dnase eurogentec dna contamination observed dnase digestion detected pcr digested product rt pcr amplification apoe mrnas
0.407656.9328480.html.plaintext.txt	30	total rna extraction performed frontal lobe samples described gilmour et al 24 digested dnase eurogentec dna contamination observed dnase digestion detected pcr digested product rt pcr amplification apoe mrnas
0.407656.9328480.html.plaintext.txt	31	rt reaction performed 1 h 30 min 37 degrees c using f4 primer 5prime acagaattcgccccggcctggta 3prime 50 pmol 1 mug total rna template m mlv reverse transcriptase following conditions described supplier gibcobrl pcr step carried f6 primer 5prime taagcttggcacggctgtccaagga 3prime 50 pmol final volume 10 mul 30 cycles 1 min 94 degrees c 1 min 58 degrees c 1 min 72 degrees c cycle remain linear range reaction briefly pcr performed total volume 25 mul containing 125 u taq dna polymerase 02 mm dntp 4 mm dtt 01 mm mgcl2 004 triton x 100 10 vv glycerol using whole rt reaction template electrophoresis
0.407656.9328480.html.plaintext.txt	32	rt reaction performed 1 h 30 min 37 degrees c using f4 primer 5prime acagaattcgccccggcctggta 3prime 50 pmol 1 mug total rna template m mlv reverse transcriptase following conditions described supplier gibcobrl pcr step carried f6 primer 5prime taagcttggcacggctgtccaagga 3prime 50 pmol final volume 10 mul 30 cycles 1 min 94 degrees c 1 min 58 degrees c 1 min 72 degrees c cycle remain linear range reaction briefly pcr performed total volume 25 mul containing 125 u taq dna polymerase 02 mm dntp 4 mm dtt 01 mm mgcl2 004 triton x 100 10 vv glycerol using whole rt reaction template electrophoresis
0.407656.9328480.html.plaintext.txt	33	rt pcr dna digested 12 u cfoi endonuclease promega dna fragments resolved 8 polyacrylamide gel acrylamidebisacrylamide 191 4 h 12 vcm range 6 02 mul rt pcr product loaded silver staining
0.407656.9328480.html.plaintext.txt	34	gel fixed 90 min 10 vv ethanol 05 vv acetic acid two washings deionised water gel placed silver nitrate solution 1 mgml 25 min gel washed twice deionised water dna polymorphism fragments stained 30 min 0037 formaldehyde vv hydroxyde nitrate 15 mgml finally reaction stopped sodium carbonate solution 15 mgml developer silver nitrate solutions prepared extemporaneously gel digitalised sharp jx 325 high resolution colour scanner fragment intensity measured using image master software pharmacia appropriate background subtract allele quantitation
0.407656.9328480.html.plaintext.txt	35	percentage epsis4 allele calculated equation described ref 11
0.407656.9328480.html.plaintext.txt	36	roman n o sup epsilon roman 4 m r n roman n o sup epsilon roman 4 m r n roman n o sup epsilon roman 2 o r epsilon roman 3 m r n roman alpha sup prime epsilon roman 4 m r n roman alpha sup prime epsilon roman 4 m r n alpha sup prime epsilon roman 2 o r epsilon roman 3 m r n
0.407656.9328480.html.plaintext.txt	37	noepsis4 mrna noepsis3 mrna initial number epsis3 epsis4 mrnas alphaprimeepsis4 mrna alphaprimeepsis2 epsis3 mrna coefficients allowing silver staining phenomenon saturation due staining integrated normalised coefficient proportionality correcting length difference restriction fragments digestion cfoi epsis3 epsis2 epsis4 alleles characterised 91 83 72 bp fragments respectively coefficient therefore calculated 9172 epsis3epsis4 individuals 8372 epsis2epsis4 individuals 9183 epsis2epsis3 population
0.407656.9328480.html.plaintext.txt	38	noepsis4 mrna noepsis3 mrna initial number epsis3 epsis4 mrnas alphaprimeepsis4 mrna alphaprimeepsis2 epsis3 mrna coefficients allowing silver staining phenomenon saturation due staining integrated normalised coefficient proportionality correcting length difference restriction fragments digestion cfoi epsis3 epsis2 epsis4 alleles characterised 91 83 72 bp fragments respectively coefficient therefore calculated 9172 epsis3epsis4 individuals 8372 epsis2epsis4 individuals 9183 epsis2epsis3 population
0.407656.9328480.html.plaintext.txt	39	epsis2 epsis3 alleles give restriction length fragment 91 bp aodepsis2 mrna odepsis3 mrna od91 bp
0.407656.9328480.html.plaintext.txt	40	initial epsis2 allele percentage epsis2epsis3 population calculated
0.407656.9328480.html.plaintext.txt	41	roman n o sup epsilon roman 2 m r n roman n o sup epsilon roman 2 m r n roman n o sup epsilon roman 3 m r n roman alpha sup roman prime epsilon roman 2 m r n alpha prime sup 9 1 roman b p
0.407656.9328480.html.plaintext.txt	42	details calculations modelling method described ref 11 tested viability approach apoe alleles using genomic dna template different parameters initial concentrations dna template initial percentage allele compared another 11
0.407656.9328480.html.plaintext.txt	43	linear regressions necessary perform ratio percentage mann whitney u test performed using sas software release 604 sas institute inc cary nc usa references 1 saunders strittmatter wj schmechel d st george hyslop ph pericak vance ma joo sh rosi bl gusella jf crapper maclachlan dr alberts mj hulette c crain b goldgaber d roses ad 1993 association apolipoprotein e allele epsis4 late onset familial sporadic alzheimers disease neurology 43 1467 1472 medline abstract
0.407656.9328480.html.plaintext.txt	44	correspondence addressed inserm cjf95 05 institut pasteur de lille 1 rue de calmette 59019 lille cedex france tel 33 3 20 87 72 28 fax 33 3 20 87 78 94 email marie christinechartier harlinpasteur lillefr page maintained oup admin last updated sat oct 18 134119 bst 1997 part oup journals world wide web service copyright oxford university press 1997
0.407656.9328480.html.plaintext.txt	45	correspondence addressed inserm cjf95 05 institut pasteur de lille 1 rue de calmette 59019 lille cedex france tel 33 3 20 87 72 28 fax 33 3 20 87 78 94 email marie christinechartier harlinpasteur lillefr page maintained oup admin last updated sat oct 18 134119 bst 1997 part oup journals world wide web service copyright oxford university press 1997
0.42286012.9811931.html.plaintext.txt	0	risk alzheimers disease correlates transcriptional activity apoe gene
0.42286012.9811931.html.plaintext.txt	1	departamento de biologia molecular centro de biologia molecular severo ochoa csic uam universidad autonoma de madrid cantoblanco 28049 madrid spain 1servicio de neurologia hospital universitario la paz uam 28034 madrid spain 2departments psychiatry neurology genetics washington university school medicine st louis mo 63110 usa
0.42286012.9811931.html.plaintext.txt	2	received may 21 1998 revised accepted august 18 1998
0.42286012.9811931.html.plaintext.txt	3	epsis4 allele apolipoprotein e apoe gene apoe protein widely accepted major genetic risk factor late onset form alzheimers disease ad recent evidence points variations apoe levels another important factor previously reported common variant regulatory region apoe 491a associated risk late onset ad report analyze association another apoe promoter polymorphism 427tc ad two case control clinical samples demonstrate correlation apoe promoter transcriptional activity risk ad association studies show allelic variant 427c haplotype 491a 427c apoe promoter associated increased risk ad study transcriptional activity common haplotypes defined combination 491 427 alleles indicated risk late onset ad positively correlates transcriptional activity apoe gene suggesting increases local expression apoe could responsible association apoe promoter polymorphism ad
0.42286012.9811931.html.plaintext.txt	4	epsis4 allele apolipoprotein e apoe gene apoe protein widely accepted major genetic risk factor late onset form alzheimers disease ad recent evidence points variations apoe levels another important factor previously reported common variant regulatory region apoe 491a associated risk late onset ad report analyze association another apoe promoter polymorphism 427tc ad two case control clinical samples demonstrate correlation apoe promoter transcriptional activity risk ad association studies show allelic variant 427c haplotype 491a 427c apoe promoter associated increased risk ad study transcriptional activity common haplotypes defined combination 491 427 alleles indicated risk late onset ad positively correlates transcriptional activity apoe gene suggesting increases local expression apoe could responsible association apoe promoter polymorphism ad
0.42286012.9811931.html.plaintext.txt	5	alzheimers disease ad common cause dementia elderly exists familial sporadic forms genetic studies led identification three genes beta amyloid precursor protein app 1 presenilin 1 2 presenilin 2 3 mutated cause autosomal dominant forms familial ad however mutations three genes responsible small fraction ad cases vast majority patients ad presents late age onset shows non mendelian inheritance absence mendelian inheritance indicates late onset ad complex disease genetic non genetic factors likely interacting epsis4 allele apolipoprotein e apoe gene apoe protein associated increased risk developing ad 4 however many ad cases apoe epsis4 alleles thus likely additional ad risk factors genetic environmental still identified
0.42286012.9811931.html.plaintext.txt	6	alzheimers disease ad common cause dementia elderly exists familial sporadic forms genetic studies led identification three genes beta amyloid precursor protein app 1 presenilin 1 2 presenilin 2 3 mutated cause autosomal dominant forms familial ad however mutations three genes responsible small fraction ad cases vast majority patients ad presents late age onset shows non mendelian inheritance absence mendelian inheritance indicates late onset ad complex disease genetic non genetic factors likely interacting epsis4 allele apolipoprotein e apoe gene apoe protein associated increased risk developing ad 4 however many ad cases apoe epsis4 alleles thus likely additional ad risk factors genetic environmental still identified
0.42286012.9811931.html.plaintext.txt	7	screened genetic variability proximal promoter region apoe nt 1017 406 observed three new polymorphic sites 491 427 219 5 previously described one 113 6 within region recently reported one variants 491a associated risk ad 7 report allelic variant 427c apoe promoter also associated ad whereas found significant association 219 113 polymorphisms risk ad results others suggested 219 polymorphism acts modifier apoe4 associated risk 8 study transcriptional activity haplotypes defined combination 491 427 alleles indicates risk late onset ad correlates transcriptional activity apoe gene
0.42286012.9811931.html.plaintext.txt	8	screened genetic variability proximal promoter region apoe nt 1017 406 observed three new polymorphic sites 491 427 219 5 previously described one 113 6 within region recently reported one variants 491a associated risk ad 7 report allelic variant 427c apoe promoter also associated ad whereas found significant association 219 113 polymorphisms risk ad results others suggested 219 polymorphism acts modifier apoe4 associated risk 8 study transcriptional activity haplotypes defined combination 491 427 alleles indicates risk late onset ad correlates transcriptional activity apoe gene
0.42286012.9811931.html.plaintext.txt	9	screening transcriptional regulatory region apoe gene novel polymorphic site 427tc identified 5 possible genetic association polymorphism risk ad studied spanish case control sample previously observed association polymorphism position 491 apoe promoter risk ad 7
0.42286012.9811931.html.plaintext.txt	10	screening transcriptional regulatory region apoe gene novel polymorphic site 427tc identified 5 possible genetic association polymorphism risk ad studied spanish case control sample previously observed association polymorphism position 491 apoe promoter risk ad 7
0.42286012.9811931.html.plaintext.txt	11	genotype allele distributions 427tc polymorphism shown table 1 tc genotype c allele frequent although differences achieved statistical significance ad group controls suggesting associated increased risk ad odds ratio 187 95 confidence interval ci 090 391 tc genotype 178 95 ci 088 362 c allele
0.42286012.9811931.html.plaintext.txt	12	genotype allele distributions 427tc polymorphism shown table 1 tc genotype c allele frequent although differences achieved statistical significance ad group controls suggesting associated increased risk ad odds ratio 187 95 confidence interval ci 090 391 tc genotype 178 95 ci 088 362 c allele
0.42286012.9811931.html.plaintext.txt	13	table 1 apoe 427tc genotype allele frequencies f spain age onset 60 years apoe4 status genotype n f allele n f tt tc cc c whole sample cases 90 082 20 018 0 200 091 20 009 controls 118 089 14 011 0 250 095 14 005 apoe4 non carriers cases 28 072 11 028 0 67 086 11 014 controls 103 090 12 010 0 218 095 12 005 carriers cases 62 087 9 013 0 133 094 9 006 controls 15 088 2 012 0 32 094 2 006 2 x 2 chi2 tests compare tt tc genotype frequency ad versus controls performed whole sample p 005 apoe4 carriers p 005 apoe4 non carriers p 0007
0.42286012.9811931.html.plaintext.txt	14	order determine whether variation risk ad associated 427tc polymorphism independent risk conferred apoe4 sample stratified basis absence presence apoe4 allele table 1 difference frequency 427c allele 427tc genotype observed ad patients controls bearing one two apoe4 alleles 427c allele clearly associated increased risk ad individuals bearing apoe4 alleles 300 95 ci 126 707 similarly 427tc genotype associated 3 fold increase risk ad subpopulation 337 95 ci 135 845 indicating variation risk ad conferred 427tc polymorphism apparent individuals carrying apoe4 allele trend observed us group individuals bearing apoe4 alleles 140 95 ci 065 301 tc genotype although differences allelic frequencies achieve statistical significance population
0.42286012.9811931.html.plaintext.txt	15	order determine whether variation risk ad associated 427tc polymorphism independent risk conferred apoe4 sample stratified basis absence presence apoe4 allele table 1 difference frequency 427c allele 427tc genotype observed ad patients controls bearing one two apoe4 alleles 427c allele clearly associated increased risk ad individuals bearing apoe4 alleles 300 95 ci 126 707 similarly 427tc genotype associated 3 fold increase risk ad subpopulation 337 95 ci 135 845 indicating variation risk ad conferred 427tc polymorphism apparent individuals carrying apoe4 allele trend observed us group individuals bearing apoe4 alleles 140 95 ci 065 301 tc genotype although differences allelic frequencies achieve statistical significance population
0.42286012.9811931.html.plaintext.txt	16	since 427tc 491at polymorphisms located close within proximal 5prime flanking region apoe gene appeared associated risk developing ad analyzed effect ad risk combined haplotypes first analyzed 491 427 haplotype distribution spanish us samples combined digestion apoe fragment spanning nt 512 285 drai alui performed allowed identification four haplotypes 10 genotypes defined combination 491 427 alleles haplotype 491 427 common followed c subjects c haplotype found either sample distribution haplotypes genotypes close expected hardy weinberg equilibrium chi2 test p 05 furthermore statistically significant evidence linkage disequilibrium polymorphisms detected chi2 test p 03 frequent genotype ta followed tt ta c three genotypes accounted 92 spanish st louis control populations frequency genotypes tt ct 5 frequencies genotypes ranged 0 2 distribution major haplotypes genotypes spanish st louis samples shown table 2
0.42286012.9811931.html.plaintext.txt	17	since 427tc 491at polymorphisms located close within proximal 5prime flanking region apoe gene appeared associated risk developing ad analyzed effect ad risk combined haplotypes first analyzed 491 427 haplotype distribution spanish us samples combined digestion apoe fragment spanning nt 512 285 drai alui performed allowed identification four haplotypes 10 genotypes defined combination 491 427 alleles haplotype 491 427 common followed c subjects c haplotype found either sample distribution haplotypes genotypes close expected hardy weinberg equilibrium chi2 test p 05 furthermore statistically significant evidence linkage disequilibrium polymorphisms detected chi2 test p 03 frequent genotype ta followed tt ta c three genotypes accounted 92 spanish st louis control populations frequency genotypes tt ct 5 frequencies genotypes ranged 0 2 distribution major haplotypes genotypes spanish st louis samples shown table 2
0.42286012.9811931.html.plaintext.txt	18	since previous study revealed differences transcription associated 491 polymorphism 57 examined functional characteristics major 491 427 haplotypes present populations apoe proximal promoter activity three haplotypes c measured u87 human astrocytoma cells using luciferase based transient transfection system employed previous studies 5719 shown figure 1 transcriptional activity haplotypes c increased 30 100 respectively haplotype suggesting presence alleles conferring increased risk ad 491a 427c associated increased constitutive levels apoe promoter activity human astrocytoma cells three haplotypes c thus named minus even x plus respectively according transcriptional activity additional information obtained using oligonucleotide probes corresponding 491 427 allelic forms electrophoretic mobility shift assays freshly prepared nuclear extracts u87 cells shown figure 2 one three specific band shifts detected 427t probe arrows detected 427c probe suggesting c substitution hinders binding probe nuclear protein finding agreement data obtained previous work using 491 probes 7 strongly suggests differential transcriptional activities three 491 427 haplotypes encountered astrocytoma cells consequence differential binding nuclear proteins present cells
0.42286012.9811931.html.plaintext.txt	19	since previous study revealed differences transcription associated 491 polymorphism 57 examined functional characteristics major 491 427 haplotypes present populations apoe proximal promoter activity three haplotypes c measured u87 human astrocytoma cells using luciferase based transient transfection system employed previous studies 5719 shown figure 1 transcriptional activity haplotypes c increased 30 100 respectively haplotype suggesting presence alleles conferring increased risk ad 491a 427c associated increased constitutive levels apoe promoter activity human astrocytoma cells three haplotypes c thus named minus even x plus respectively according transcriptional activity additional information obtained using oligonucleotide probes corresponding 491 427 allelic forms electrophoretic mobility shift assays freshly prepared nuclear extracts u87 cells shown figure 2 one three specific band shifts detected 427t probe arrows detected 427c probe suggesting c substitution hinders binding probe nuclear protein finding agreement data obtained previous work using 491 probes 7 strongly suggests differential transcriptional activities three 491 427 haplotypes encountered astrocytoma cells consequence differential binding nuclear proteins present cells
0.42286012.9811931.html.plaintext.txt	20	table 2 apoe 491 427 major genotype haplotype frequencies f age onset 60 years genotype n f haplotype n f ta tt ta c c spain madrid cases 68 062 17 015 20 018 173 079 27 012 2 009 controls 62 047 50 038 10 008 184 070 66 025 14 005 usa st louis cases 104 065 24 015 27 017 259 080 33 010 30 009 controls 96 055 42 024 23 013 258 073 60 017 32 009 2 x 2 chi2 test ta c versus tt spain p 00001 usa p 0050 2 x 2 chi2 test ta versus tt spain p 00003 usa p 0027
0.42286012.9811931.html.plaintext.txt	21	figure 1 transcriptional activity 491 427 haplotypes apoe promoter luciferasebeta galactosidase activity ratios pxp2 constructs containing x c apoe haplotypes transfected u87 astrocytoma cells expressed percentages activity construct data means plus minus sem six determinations representative five experiments
0.42286012.9811931.html.plaintext.txt	22	figure 2 protein binding 427tc allelic forms apoe promoter 32p labeled 427t 427c probes incubated u87 nuclear extract ne subjected electrophoretic mobility shift assays competition experiments performed pre incubating nuclear extract 50 fold excess unlabeled oligonucleotide addition probe arrows specific shift bands asterisk non specific band results representative four independent experiments
0.42286012.9811931.html.plaintext.txt	23	association apoe promoter activity risk ad analyzed spanish population stratified according apoe status table 3 strong association ad risk promoter activity three predominant genotypes x xx x observed spanish non apoe4 individuals taking reference x individuals risk ad found increase 6 18 fold xx x individuals respectively statistical significance data evaluated logistic regression model analysis subgroup non e4 carriers showed highly significant association ad risk promoter activity p 10 10 yielded predicted ors 43 95 ci 29 63 18 95 ci 8 40 genotypes xx x respectively fig 3a
0.42286012.9811931.html.plaintext.txt	24	association apoe promoter activity risk ad analyzed spanish population stratified according apoe status table 3 strong association ad risk promoter activity three predominant genotypes x xx x observed spanish non apoe4 individuals taking reference x individuals risk ad found increase 6 18 fold xx x individuals respectively statistical significance data evaluated logistic regression model analysis subgroup non e4 carriers showed highly significant association ad risk promoter activity p 10 10 yielded predicted ors 43 95 ci 29 63 18 95 ci 8 40 genotypes xx x respectively fig 3a
0.42286012.9811931.html.plaintext.txt	25	figure 3 association risk ad apoe promoter genotypes spanish b us non apoe4 subpopulations risks represented log odds scale taking reference genotype x bears weakest expressing haplotype bars represent calculated ors superimposed line represents ors estimated logistic regression model error bars indicate 95 cis
0.42286012.9811931.html.plaintext.txt	26	finally hypothesis ad risk increases promoter transcriptional activity measured transfection assays tested st louis population although association less impressive encountered spanish population similar dependence developing ad promoter activity three predominant genotypes detected non e4 subpopulation table 3 logistic regression analysis indicated highly statistically significant association ad risk promoter activity p 10 10 ors 14 95 ci 13 15 20 95 ci 19 22 genotypes xx x respectively fig 3b
0.42286012.9811931.html.plaintext.txt	27	finally hypothesis ad risk increases promoter transcriptional activity measured transfection assays tested st louis population although association less impressive encountered spanish population similar dependence developing ad promoter activity three predominant genotypes detected non e4 subpopulation table 3 logistic regression analysis indicated highly statistically significant association ad risk promoter activity p 10 10 ors 14 95 ci 13 15 20 95 ci 19 22 genotypes xx x respectively fig 3b
0.42286012.9811931.html.plaintext.txt	28	paper report association polymorphisms proximal region apoe promoter risk ad previously reported association homozygosity 491a allele risk ad 7 show 427c allele also associated risk ad furthermore combination two alleles 491a 427c haplotype generates high risk ad particular spanish population individuals bearing apoe4 alleles effect observed st louis sample although relative risk lower spanish sample difference relative risk probably attributable differences frequencies apoe promoter haplotypes two control populations since two ad samples show similar frequencies promoter haplotypes well documented population based differences apoe4 allele frequency 910 give rise population differences relative risk ad associated allele consistently samples associated apoe4 spanish population 83 double st louis sample 31 7 based data anticipate wide variation relative risk ad associated apoe promoter polymorphism different populations already noted apoe4 allele 11 dividing sample basis presence absence apoe4 revealed promoter polymorphisms apoe4 independent risk factors indeed risk due promoter polymorphism prominent individuals without apoe4 alleles
0.42286012.9811931.html.plaintext.txt	29	paper report association polymorphisms proximal region apoe promoter risk ad previously reported association homozygosity 491a allele risk ad 7 show 427c allele also associated risk ad furthermore combination two alleles 491a 427c haplotype generates high risk ad particular spanish population individuals bearing apoe4 alleles effect observed st louis sample although relative risk lower spanish sample difference relative risk probably attributable differences frequencies apoe promoter haplotypes two control populations since two ad samples show similar frequencies promoter haplotypes well documented population based differences apoe4 allele frequency 910 give rise population differences relative risk ad associated allele consistently samples associated apoe4 spanish population 83 double st louis sample 31 7 based data anticipate wide variation relative risk ad associated apoe promoter polymorphism different populations already noted apoe4 allele 11 dividing sample basis presence absence apoe4 revealed promoter polymorphisms apoe4 independent risk factors indeed risk due promoter polymorphism prominent individuals without apoe4 alleles
0.42286012.9811931.html.plaintext.txt	30	table 3 apoe 491 427 major genotype distribution apoe epsis4 carriers non carriers age onset 60 years apoe4 status spain madrid n f usa st louis n f ta tt ta c ta tt ta c cases 21 054 3 008 11 029 42 057 16 021 14 019 controls 52 045 45 039 9 008 67 052 35 027 15 012 cases 47 066 14 020 9 013 62 071 8 009 13 014 controls 10 059 5 029 1 006 29 060 7 014 8 017 2 x 2 chi2 test ta c versus tt apoe4 non carriers spain p 000001 usa p 005 significant 2 x 2 chi2 test ta versus tt apoe4 non carriers spain p 00024 usa p 005 significant p values apoe4 carriers 005 significant samples
0.42286012.9811931.html.plaintext.txt	31	apoe expression regulated complex interactions developmental hormonal dietary factors 12 15 regulation apoe expression investigated thoroughly hepatoma cells shown elements required efficient expression located 5prime proximal region first intron 16 18 recently demonstrated region also drives efficient expression apoe astrocytoma cells 19 data presented report strongly suggest allelic polymorphism transcriptional regulatory region apoe may contribute differences levels apoe synthesis astrocytes specifically data indicate single base substitutions corresponding 491 427 apoe polymorphic sites produce differences transcriptional activity apoe promoter due differential binding nuclear proteins well documented single nucleotide changes within promoter region dramatically affect transcriptional activity mediated transcription factors 20 22
0.42286012.9811931.html.plaintext.txt	32	apoe expression regulated complex interactions developmental hormonal dietary factors 12 15 regulation apoe expression investigated thoroughly hepatoma cells shown elements required efficient expression located 5prime proximal region first intron 16 18 recently demonstrated region also drives efficient expression apoe astrocytoma cells 19 data presented report strongly suggest allelic polymorphism transcriptional regulatory region apoe may contribute differences levels apoe synthesis astrocytes specifically data indicate single base substitutions corresponding 491 427 apoe polymorphic sites produce differences transcriptional activity apoe promoter due differential binding nuclear proteins well documented single nucleotide changes within promoter region dramatically affect transcriptional activity mediated transcription factors 20 22
0.42286012.9811931.html.plaintext.txt	33	data presented strongly suggest existence direct correlation risk ad apoe promoter activity astrocytic cells ie higher expression apoe higher risk ad increasing evidence suggesting increased levels apoe associated ad pathogenesis several studies reported apoe levels elevated brain plasma ad patients 23 25 intracellular accumulation apoe also correlated neuronal cell death intracellular abeta stabilization 26 recent studies also demonstrated level apoe expression modify cytotoxic effects apoe propensity abeta deposit murine brain apoe concentrations found cerebrospinal fluid protects neuronal cells abeta peptides higher apoe concentrations could lead neuronal cell death 27 crossing apoe knockout mice mice overexpressing human mutant app gene indicates abeta deposition correlates positively apoe dose suggests apoe may facilitate abeta peptide deposition vivo 28
0.42286012.9811931.html.plaintext.txt	34	despite evidence implicating apoe4 single important genetic determinant susceptibility late onset ad pathogenic role well understood amino acid substitutions associated e2 e3 e4 apoe isoforms lead differences predicted three dimensional structure apoe likely alter functional properties molecule several potential mechanisms action apoe4 ad risk proposed based apoe isoform specific differences observed several assays developed brain cells 28 35 however date adequate explanation variation risk ad associated different apoe isoforms
0.42286012.9811931.html.plaintext.txt	35	despite evidence implicating apoe4 single important genetic determinant susceptibility late onset ad pathogenic role well understood amino acid substitutions associated e2 e3 e4 apoe isoforms lead differences predicted three dimensional structure apoe likely alter functional properties molecule several potential mechanisms action apoe4 ad risk proposed based apoe isoform specific differences observed several assays developed brain cells 28 35 however date adequate explanation variation risk ad associated different apoe isoforms
0.42286012.9811931.html.plaintext.txt	36	based upon data presented elsewhere suggest two independent mechanisms ad risk modified apoe gene first involves variants coding region alter functional properties apoe molecule second involves promoter region variants result quantitative differences apoe expression two factors associated ad risk independently ie one produce risk may interact resulting overall risk individuals bearing apoe4 high expressing apoe promoter forms would depend relative contribution two risk factors
0.42286012.9811931.html.plaintext.txt	37	based upon data presented elsewhere suggest two independent mechanisms ad risk modified apoe gene first involves variants coding region alter functional properties apoe molecule second involves promoter region variants result quantitative differences apoe expression two factors associated ad risk independently ie one produce risk may interact resulting overall risk individuals bearing apoe4 high expressing apoe promoter forms would depend relative contribution two risk factors
0.42286012.9811931.html.plaintext.txt	38	summary data strongly suggest risk ad associated apoe promoter polymorphisms directly correlates transcriptional activity gene speculate increases local expression apoe due apoe promoter polymorphisms could lead enhanced deposition abeta peptide brain thus explaining increased risk ad correct drugs either control apoe synthesis inhibit abeta production deposition may useful treatment ad
0.42286012.9811931.html.plaintext.txt	39	summary data strongly suggest risk ad associated apoe promoter polymorphisms directly correlates transcriptional activity gene speculate increases local expression apoe due apoe promoter polymorphisms could lead enhanced deposition abeta peptide brain thus explaining increased risk ad correct drugs either control apoe synthesis inhibit abeta production deposition may useful treatment ad
0.42286012.9811931.html.plaintext.txt	40	materials methods study subjects
0.42286012.9811931.html.plaintext.txt	41	test sample consisted 132 healthy controls age onset 72 plus minus 7 years mean plus minus sd 110 late onset sporadic ad cases 68 plus minus 5 years madrid region spain recruited neurology service hospital la paz madrid replication sample composed 175 healthy controls 78 plus minus 9 years 160 ad 3637 cases 75 plus minus 8 years st louis metropolitan region usa recruited alzheimers disease research center washington university samples included individuals caucasian origin
0.42286012.9811931.html.plaintext.txt	42	test sample consisted 132 healthy controls age onset 72 plus minus 7 years mean plus minus sd 110 late onset sporadic ad cases 68 plus minus 5 years madrid region spain recruited neurology service hospital la paz madrid replication sample composed 175 healthy controls 78 plus minus 9 years 160 ad 3637 cases 75 plus minus 8 years st louis metropolitan region usa recruited alzheimers disease research center washington university samples included individuals caucasian origin
0.42286012.9811931.html.plaintext.txt	43	genotyping 491at 427tc apoe polymorphisms
0.42286012.9811931.html.plaintext.txt	44	apoe region 512 285 amplified nested pcr using mismatched primer generate drai site specific 491a allele briefly pcr used amplify 1423 bp fragment transcriptional regulatory region spanning 1017 406 relative transcriptional start site 16 primers 5prime caaggtcacacagctggcaac 3prime 5prime tccaatcgacggctagctacc 3prime used amplify whole transcriptional regulatory region nested pcr used difficulty reliably amplifying 512 285 fragment directly genomic dna 1423 bp pcr product therefore used template following reaction forward mismatched primer 5prime tgttggccaggctggttttaa 3prime reverse primer 5prime cctcctttcctgaccctgtcc 3prime analyze 491 427 genotypes well 491 427 haplotype product digested drai alui restriction enzymes together apoe isoform genotyping performed described 3839
0.42286012.9811931.html.plaintext.txt	45	apoe region 512 285 amplified nested pcr using mismatched primer generate drai site specific 491a allele briefly pcr used amplify 1423 bp fragment transcriptional regulatory region spanning 1017 406 relative transcriptional start site 16 primers 5prime caaggtcacacagctggcaac 3prime 5prime tccaatcgacggctagctacc 3prime used amplify whole transcriptional regulatory region nested pcr used difficulty reliably amplifying 512 285 fragment directly genomic dna 1423 bp pcr product therefore used template following reaction forward mismatched primer 5prime tgttggccaggctggttttaa 3prime reverse primer 5prime cctcctttcctgaccctgtcc 3prime analyze 491 427 genotypes well 491 427 haplotype product digested drai alui restriction enzymes together apoe isoform genotyping performed described 3839
0.42286012.9811931.html.plaintext.txt	46	5prime region positions 1017 406 apoe gene cloned pxp2 luciferase reporter plasmid described 19 pcr based site directed mutagenesis used replace 491 c 427 using modification described method 40 constructs transfected u87 human astrocytoma cells luciferase beta galactosidase activities extracts determined described 19
0.42286012.9811931.html.plaintext.txt	47	5prime region positions 1017 406 apoe gene cloned pxp2 luciferase reporter plasmid described 19 pcr based site directed mutagenesis used replace 491 c 427 using modification described method 40 constructs transfected u87 human astrocytoma cells luciferase beta galactosidase activities extracts determined described 19
0.42286012.9811931.html.plaintext.txt	48	electrophoretic mobility shift assays emsa
0.42286012.9811931.html.plaintext.txt	49	emsa oligonucleotide probes u87 nuclear extracts performed described 57 oligonucleotides 5prime gctggtctcaaatctcctgaccttaa 3prime 5prime acaggcgtgagctcaccgcccccagc 3prime used study nuclear protein binding 491 427 sites respectively
0.42286012.9811931.html.plaintext.txt	50	emsa oligonucleotide probes u87 nuclear extracts performed described 57 oligonucleotides 5prime gctggtctcaaatctcctgaccttaa 3prime 5prime acaggcgtgagctcaccgcccccagc 3prime used study nuclear protein binding 491 427 sites respectively
0.42286012.9811931.html.plaintext.txt	51	genotype allelehaplotype distributions analyzed 2 x 2 chi2 test relative risks ors 95 cis calculated described 41 logistic regression model used estimate relative risks ad major apoe promoter genotypes function transcriptional activity
0.42286012.9811931.html.plaintext.txt	52	genotype allelehaplotype distributions analyzed 2 x 2 chi2 test relative risks ors 95 cis calculated described 41 logistic regression model used estimate relative risks ad major apoe promoter genotypes function transcriptional activity
0.42286012.9811931.html.plaintext.txt	53	thank p alonso hospital ramon y cajal madrid kind collaboration sample collection p barreiro tella e diez tejedor hospital la paz madrid advice clinical work faculty staff washington university alzheimers disease research center patient evaluation sample collection thank j baty washington university division biostatistics advice statistical analysis thank f mayor continuous encouragement help thank patients healthy individuals participated research work supported boehringer ingelheim espana fondo de investigacion sanitaria grant 95 0022 nih ag05681 ag03991 alzheimers association nettie rebecca brown foundation metropolitan life foundation institutional grant fundacion ramon areces cbmso acknowledged mja recipient fellowship fondo de investigacion sanitaria mag recipient fellowship spanish ministerio de educacion y ciencia cll post doctoral fellow washington university alzheimers disease research center amg recipient nih career development award ag00634
0.42286012.9811931.html.plaintext.txt	54	ad alzheimers disease apoe apolipoprotein e apoe apolipoprotein e gene app beta amyloid precursor protein ci confidence interval odds ratio
0.42286012.9811931.html.plaintext.txt	55	correspondence addressed tel 34 91 397 84 71 fax 34 91 397 48 70 email fvaldiviesoat cbmuames u d first two authors contributed equally work page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 nov 1998 copyright oxford university press 1998
0.42286012.9811931.html.plaintext.txt	56	correspondence addressed tel 34 91 397 84 71 fax 34 91 397 48 70 email fvaldiviesoat cbmuames u d first two authors contributed equally work page run oxford university press great clarendon street oxford ox2 6dp part oup journals comments feedback www adminatoupcouk u d last modification 12 nov 1998 copyright oxford university press 1998
0.5179277.15126630.html.plaintext.txt	0	cathepsin d involved regulation transglutaminase 1 epidermal differentiation friederike egberts1 michael heinrich2 jens michael jensen1 supandi winoto morbach2 stephan pfeiffer3 marc wickel2 michael schunck1 judith steude2 paul saftig4 ehrhardt proksch1 stefan schutze2
0.5179277.15126630.html.plaintext.txt	1	1 department dermatology university hospital schleswig holstein campus kiel 24105 kiel germany 2 institute immunology university hospital schleswig holstein campus kiel 24105 kiel germany 3 central microscopy centrum biology university kiel 24118 kiel germany 4 department biochemistry university kiel 24118 kiel germany
0.5179277.15126630.html.plaintext.txt	2	author correspondence e mail schuetzeatimmunologieuni kielde u d
0.5179277.15126630.html.plaintext.txt	3	summary top summary introduction materials methods results discussion references previously demonstrated aspartate protease cathepsin d activated ceramide derived acid sphingomyelinase increased expression cathepsin d skin reported wound healing psoriasis skin tumors explored specific functions cathepsin d epidermal differentiation protein expression enzymatic activity cathepsin d increased differentiated keratinocytes stratified organotypic cultures mouse skin epidermal barrier repair treatment cultured keratinocytes exogenous cathepsin d increased activity transglutaminase 1 known cross link cornified envelope proteins involucrin loricrin epidermal differentiation inhibition cathepsin d pepstatin suppressed activity transglutaminase 1 cathepsin d deficient mice revealed reduced transglutaminase 1 activity reduced protein levels cornified envelope proteins involucrin loricrin also amount distribution cornified envelope proteins involucrin loricrin filaggrin keratins k1 k5 significantly altered cathepsin d deficient mice stratum corneum morphology cathepsin d deficient mice impaired increased numbers corneocyte layers faint staining cornified envelope similar human skin disease lamellar ichthyosis findings suggest functional link cathepsin d activation transglutaminase 1 activity protein expression cornified envelope proteins epidermal differentiation
0.5179277.15126630.html.plaintext.txt	4	summary top summary introduction materials methods results discussion references previously demonstrated aspartate protease cathepsin d activated ceramide derived acid sphingomyelinase increased expression cathepsin d skin reported wound healing psoriasis skin tumors explored specific functions cathepsin d epidermal differentiation protein expression enzymatic activity cathepsin d increased differentiated keratinocytes stratified organotypic cultures mouse skin epidermal barrier repair treatment cultured keratinocytes exogenous cathepsin d increased activity transglutaminase 1 known cross link cornified envelope proteins involucrin loricrin epidermal differentiation inhibition cathepsin d pepstatin suppressed activity transglutaminase 1 cathepsin d deficient mice revealed reduced transglutaminase 1 activity reduced protein levels cornified envelope proteins involucrin loricrin also amount distribution cornified envelope proteins involucrin loricrin filaggrin keratins k1 k5 significantly altered cathepsin d deficient mice stratum corneum morphology cathepsin d deficient mice impaired increased numbers corneocyte layers faint staining cornified envelope similar human skin disease lamellar ichthyosis findings suggest functional link cathepsin d activation transglutaminase 1 activity protein expression cornified envelope proteins epidermal differentiation
0.5179277.15126630.html.plaintext.txt	5	key words barrier function cathepsin d cornified envelope epidermal differentiation involucrin loricrin filaggrin keratin sphingomyelinase transglutaminase
0.5179277.15126630.html.plaintext.txt	6	introduction top summary introduction materials methods results discussion references goal epidermal differentiation form epidermal permeability barrier prevents excessive water loss entry harmful substances body barrier localized stratum corneum two compartment system protein enriched terminally differentiated keratinocytes corneocytes lipid enriched intercellular bilayers elias friend 1975 downing 1992
0.5179277.15126630.html.plaintext.txt	7	introduction top summary introduction materials methods results discussion references goal epidermal differentiation form epidermal permeability barrier prevents excessive water loss entry harmful substances body barrier localized stratum corneum two compartment system protein enriched terminally differentiated keratinocytes corneocytes lipid enriched intercellular bilayers elias friend 1975 downing 1992
0.5179277.15126630.html.plaintext.txt	8	insoluble protein envelope located beneath plasma membrane keratinocytes cross linked cellular transglutaminase 1 tg1 terminal differentiation epidermis involucrin early marker terminal differentiation soluble protein precursor cross linked cornified envelope ce synthesized keratinocytes upper spinous layers watt 1983 eckert et al 1993 kanitakis et al 1987 negi et al 1981 rice green 1979 steinert marekov 1997 hyperproliferative diseases like psoriasis premature expression involucrin found lower spinous layers thewes et al 1991 another main component ce loricrin expressed later stage differentiation watt 1983 cross linked epidermal proteins cystatin elafin filaggrin
0.5179277.15126630.html.plaintext.txt	9	insoluble protein envelope located beneath plasma membrane keratinocytes cross linked cellular transglutaminase 1 tg1 terminal differentiation epidermis involucrin early marker terminal differentiation soluble protein precursor cross linked cornified envelope ce synthesized keratinocytes upper spinous layers watt 1983 eckert et al 1993 kanitakis et al 1987 negi et al 1981 rice green 1979 steinert marekov 1997 hyperproliferative diseases like psoriasis premature expression involucrin found lower spinous layers thewes et al 1991 another main component ce loricrin expressed later stage differentiation watt 1983 cross linked epidermal proteins cystatin elafin filaggrin
0.5179277.15126630.html.plaintext.txt	10	extracellular lipids barrier predominantly ceramides synthesized keratinocytes stored epidermal lamellar bodies secreted intercellular space stratum corneum elias 1983 beside structural role ceramide known important intracellular signal mediator various cytokines particular tumor necrosis factor tnf liu et al 1997 perry hannun 1998 tnf binding p55 tnf receptor tnf r55 results activation endolysosomal acid sphingomyelinase wiegmann et al 1994 kronke et al 1996 increase intracellular ceramide levels followed different cellular responses depending cell type degree activation differentiation proliferation programmed cell death apoptosis kronke et al 1996 jarvis et al 1994 kolesnick golde 1994 geilen et al 1997 wakita et al 1994 suggested functional role tnf ceramide derived acid sphingomyelinase cutaneous permeability barrier repair experimentally induced injury skin detected high levels sphingomyelinase ceramides barrier disruption well significant delay barrier repair tnf r55 deficient mice jensen et al 1999 understanding various biological effects ceramides important know direct intracellular targets
0.5179277.15126630.html.plaintext.txt	11	extracellular lipids barrier predominantly ceramides synthesized keratinocytes stored epidermal lamellar bodies secreted intercellular space stratum corneum elias 1983 beside structural role ceramide known important intracellular signal mediator various cytokines particular tumor necrosis factor tnf liu et al 1997 perry hannun 1998 tnf binding p55 tnf receptor tnf r55 results activation endolysosomal acid sphingomyelinase wiegmann et al 1994 kronke et al 1996 increase intracellular ceramide levels followed different cellular responses depending cell type degree activation differentiation proliferation programmed cell death apoptosis kronke et al 1996 jarvis et al 1994 kolesnick golde 1994 geilen et al 1997 wakita et al 1994 suggested functional role tnf ceramide derived acid sphingomyelinase cutaneous permeability barrier repair experimentally induced injury skin detected high levels sphingomyelinase ceramides barrier disruption well significant delay barrier repair tnf r55 deficient mice jensen et al 1999 understanding various biological effects ceramides important know direct intracellular targets
0.5179277.15126630.html.plaintext.txt	12	recently found aspartatic protease cathepsin d ctsd novel specific intracellular binding protein ceramide derived acid sphingomyelinase heinrich et al 1999 ceramide enhances proteolytic activity ctsd ctsd main aspartatic protease endolysosomes synthesized translocated endoplasmic reticulum inactive pre proenzyme 52 kda processed enzymatically active intermediate proenzyme 48 kda finally converted mature form 32 kda lysosomes fujita et al 1991 ctsd involved proteolytic activation well proteolytic degradation intracellular proteins diment et al 1988 lazarus et al 1974 sato et al 1997 increased levels ctsd correlated tumor cell invasion metastasis malignant melanoma squamous cell carcinoma human breast cancer kageshita et al 1995 kawada 1997 reports suggest ctsd may play role metastasizing process malignant cells destructive effects extracellular matrix therefore ctsd activity used predict recurrence breast cancer tandon et al 1990 hela cell cultures ctsd mediator programmed cell death induced various cytokines overexpression ctsd induced cell death without external stimuli ctsd inhibitor pepstatin suppressed cell death system deiss et al 1996 findings supported vivo studies ctsd deficient mice generated gene targeting mice developed normally first 2 weeks afterwards exhibited progressive atrophy intestinal mucosa followed massive intestinal necrosis profound destruction lymphoid cells mice died state anorexia age 4 weeks though lysosomal bulk proteolysis maintained possibly due compensatory activation related lysosomal proteases saftig et al 1995
0.5179277.15126630.html.plaintext.txt	13	skin ctsd plays role extracellular intracellular catabolism hyperproliferative skin disorders psoriasis increased expression mature form ctsd reported returning normal resolution psoriasis psoralen long wave ultraviolet radiation puva light treatment kawada et al 1997 chen et al 2000 suggested ctsd may involved control cell differentiation normal development horikoshi et al found increased expression increased activity ctsd isoforms skin depending stage epidermal differentiation horikoshi et al 1998 ctsd enzyme active acid ph maximum ph 3 may work transition stratum granulosum stratum corneum stratum corneum produces acid environment ph 55 ohmann valquist 1994 despite results function cellular substrates ctsd epidermal differentiation still unknown
0.5179277.15126630.html.plaintext.txt	14	skin ctsd plays role extracellular intracellular catabolism hyperproliferative skin disorders psoriasis increased expression mature form ctsd reported returning normal resolution psoriasis psoralen long wave ultraviolet radiation puva light treatment kawada et al 1997 chen et al 2000 suggested ctsd may involved control cell differentiation normal development horikoshi et al found increased expression increased activity ctsd isoforms skin depending stage epidermal differentiation horikoshi et al 1998 ctsd enzyme active acid ph maximum ph 3 may work transition stratum granulosum stratum corneum stratum corneum produces acid environment ph 55 ohmann valquist 1994 despite results function cellular substrates ctsd epidermal differentiation still unknown
0.5179277.15126630.html.plaintext.txt	15	present study explored functional role ctsd skin permeability barrier repair epidermal differentiation using keratinocyte cell culture wild type ctsd deficient mice particular examined functional role ctsd activation keratinocyte tg1 key enzyme processing ce proteins involucrin loricrin filaggrin epidermal differentiation
0.5179277.15126630.html.plaintext.txt	16	present study explored functional role ctsd skin permeability barrier repair epidermal differentiation using keratinocyte cell culture wild type ctsd deficient mice particular examined functional role ctsd activation keratinocyte tg1 key enzyme processing ce proteins involucrin loricrin filaggrin epidermal differentiation
0.5179277.15126630.html.plaintext.txt	17	materials methods top summary introduction materials methods results discussion references mice cells male hairless mice crl hrhrbr 4 12 weeks age supplied charles river sulzfeld germany ctsd deficient mice c57bl6 obtained gene targeting described saftig et al 1995 progeny heterozygous ctsd deficient mice genotyped pcr genomic dna tail biopsies animals maintained conventionally standardized conditions study protocols approved university kiel committee animal care normal human keratinocytes stratified keratinocytes organotypic raft cultures obtained human foreskins primary keratinocytes maintained serum free keratinocyte growth medium kgm clonetics san diego usa supplemented 007 mm calcium grown 60 80 confluency also immortalized hacat keratinocytes used boukamp et al 1988 human raft cultured epidermis prepared described previously steude et al 2002 briefly primary dermal fibroblasts keratinocytes prepared foreskin grown described previously mielke et al 1990 third passage fibroblasts 5 7x105 resuspended ice cold collagen solution containing 53 mg collagen type 1x dulbecco minimal eagles medium dmem gibco brl 2 mm l glutamine gibco brl 05 nahco3 667 mm hepes 003 m naoh submerge cultured dmem 10 fetal bovine serum 5 days third passage keratinocytes 5x105 seeded onto collagen lattices submerge cultured 4 days keratinocyte growth medium kgm bullet kit biowhittaker europe belgium 5 fetal bovine serum raft cultures lifted air medium interphase incubated keratinocyte growth medium without bovine pituitary extract egf additional 5 fetal bovine serum 125 mm cacl2 growth factors added medium medium including growth factors renewed every 2 3 days raft cultures harvested frozen 70 degrees c
0.5179277.15126630.html.plaintext.txt	18	materials methods top summary introduction materials methods results discussion references mice cells male hairless mice crl hrhrbr 4 12 weeks age supplied charles river sulzfeld germany ctsd deficient mice c57bl6 obtained gene targeting described saftig et al 1995 progeny heterozygous ctsd deficient mice genotyped pcr genomic dna tail biopsies animals maintained conventionally standardized conditions study protocols approved university kiel committee animal care normal human keratinocytes stratified keratinocytes organotypic raft cultures obtained human foreskins primary keratinocytes maintained serum free keratinocyte growth medium kgm clonetics san diego usa supplemented 007 mm calcium grown 60 80 confluency also immortalized hacat keratinocytes used boukamp et al 1988 human raft cultured epidermis prepared described previously steude et al 2002 briefly primary dermal fibroblasts keratinocytes prepared foreskin grown described previously mielke et al 1990 third passage fibroblasts 5 7x105 resuspended ice cold collagen solution containing 53 mg collagen type 1x dulbecco minimal eagles medium dmem gibco brl 2 mm l glutamine gibco brl 05 nahco3 667 mm hepes 003 m naoh submerge cultured dmem 10 fetal bovine serum 5 days third passage keratinocytes 5x105 seeded onto collagen lattices submerge cultured 4 days keratinocyte growth medium kgm bullet kit biowhittaker europe belgium 5 fetal bovine serum raft cultures lifted air medium interphase incubated keratinocyte growth medium without bovine pituitary extract egf additional 5 fetal bovine serum 125 mm cacl2 growth factors added medium medium including growth factors renewed every 2 3 days raft cultures harvested frozen 70 degrees c
0.5179277.15126630.html.plaintext.txt	19	permeability barrier disruption disruption permeability barrier induced hairless mice tape stripping tesafilm beiersdorf hamburg germany remove cells stratum corneum resulting superficial wound 20 30 fold increase transepidermal water loss tewl marker barrier disruption achieved meeco electronic water analyzer meeco inc warrington pa spruit malten 1966 grubauer et al 1989 barrier recovery calculated follows barrier recovery 100 xh baseline1000h baseline xhtewl x hours barrier disruption ohtewl directly barrier disruption baselinenormal tewl skin without barrier disruption hairy ctsd deficient mice fur carefully removed shaving prior barrier disruption shaving result irritation barrier disruption experiment least three animals treated least three animals served control different times barrier disruption 0 24 hours tewl marker barrier repair measured skin samples 4 cm2 obtained
0.5179277.15126630.html.plaintext.txt	20	permeability barrier disruption disruption permeability barrier induced hairless mice tape stripping tesafilm beiersdorf hamburg germany remove cells stratum corneum resulting superficial wound 20 30 fold increase transepidermal water loss tewl marker barrier disruption achieved meeco electronic water analyzer meeco inc warrington pa spruit malten 1966 grubauer et al 1989 barrier recovery calculated follows barrier recovery 100 xh baseline1000h baseline xhtewl x hours barrier disruption ohtewl directly barrier disruption baselinenormal tewl skin without barrier disruption hairy ctsd deficient mice fur carefully removed shaving prior barrier disruption shaving result irritation barrier disruption experiment least three animals treated least three animals served control different times barrier disruption 0 24 hours tewl marker barrier repair measured skin samples 4 cm2 obtained
0.5179277.15126630.html.plaintext.txt	21	measurements basal tewl measurements basal tewl performed using tewameter courage khazaka germany described previously jensen et al 2000 sensitivity tewameter small changes tewl seen basal conditions higher meeco water analyzer
0.5179277.15126630.html.plaintext.txt	22	topical application pepstatin normal mouse skin immediately barrier disruption 100 microl pepstatin 01 propylene glycolisopropanol 73 vv applied topically vehicle application served control tewl determined different time points barrier disruption 0 24 hours skin samples 4 cm2 taken
0.5179277.15126630.html.plaintext.txt	23	topical application pepstatin normal mouse skin immediately barrier disruption 100 microl pepstatin 01 propylene glycolisopropanol 73 vv applied topically vehicle application served control tewl determined different time points barrier disruption 0 24 hours skin samples 4 cm2 taken
0.5179277.15126630.html.plaintext.txt	24	isolation epidermal samples acute barrier disruption flank skin treated untreated sites excised immediately placed epidermal side onto covered petri dish containing crushed ice skin pieces scraped scalpel blade remove subcutaneous fat immersed 37 degrees c 40 minutes 10 mm edta calcium magnesium free phosphate buffered saline pbs thereafter epidermis peeled dermis gentle scraping scalpel blade 15 20 mg epidermis disrupted 350 ml buffer h 150 mm kcl 5 mm naf 1 mm phenylmethylsulfonylfluoride 20 microm pepstatin 20 microm leupeptin 20 microm antipain boehringer complete 1100 hepes ph 74 electric glass homogenizer potter braun melsungen germany 600 rpm 4 minutes cells homogenized passing 28 g needle followed sonication three times 10 seconds analyze involucrin loricrin expression entire skin sample excised subcutaneous fat removed skin disrupted ultrathurrax ika labortechnik staufen germany tris buffer 85 mm nacl 50 mm tris ph 74 homogenized potter described subsequently probes boiled 10 minutes lysates cleared centrifugation 5 minutes 20000 g
0.5179277.15126630.html.plaintext.txt	25	isolation epidermal samples acute barrier disruption flank skin treated untreated sites excised immediately placed epidermal side onto covered petri dish containing crushed ice skin pieces scraped scalpel blade remove subcutaneous fat immersed 37 degrees c 40 minutes 10 mm edta calcium magnesium free phosphate buffered saline pbs thereafter epidermis peeled dermis gentle scraping scalpel blade 15 20 mg epidermis disrupted 350 ml buffer h 150 mm kcl 5 mm naf 1 mm phenylmethylsulfonylfluoride 20 microm pepstatin 20 microm leupeptin 20 microm antipain boehringer complete 1100 hepes ph 74 electric glass homogenizer potter braun melsungen germany 600 rpm 4 minutes cells homogenized passing 28 g needle followed sonication three times 10 seconds analyze involucrin loricrin expression entire skin sample excised subcutaneous fat removed skin disrupted ultrathurrax ika labortechnik staufen germany tris buffer 85 mm nacl 50 mm tris ph 74 homogenized potter described subsequently probes boiled 10 minutes lysates cleared centrifugation 5 minutes 20000 g
0.5179277.15126630.html.plaintext.txt	26	isolation culture cells keratinocyte culture cells harvested incubation trypsin edta scraped pbs pelleted centrifugation 5 minutes 800 g homogenized buffer h sonicated centrifugation supernatants stored 80 degrees c
0.5179277.15126630.html.plaintext.txt	27	isolation culture cells keratinocyte culture cells harvested incubation trypsin edta scraped pbs pelleted centrifugation 5 minutes 800 g homogenized buffer h sonicated centrifugation supernatants stored 80 degrees c
0.5179277.15126630.html.plaintext.txt	28	determination ctsd tg1 involucrin loricrin protein concentration measured bicinchoninic acid protein assay pierce rockford usa equal protein samples electrophoresed 75 125 polyacrylamide gels transferred onto nitrocellulose filters 100 v 45 minutes mini transblot biorad munich germany ctsd cell cultures detected incubation 1 hour room temperature polyclonal rabbit anti human ctsd antibody dilution 11000 tbst calbiochem oncogene science usa ctsd mice detected rabbit anti mouse ctsd antibody kindly provided r pohlmann university munster germany tg1 goat anti human polyclonal antibody kindly provided y kim p steinert nih bethesda md see kim et al 1995 involucrin loricrin detected rabbit anti mouse antibodies prb 142c prb 145p respectively covance inc ca usa distributed hiss diagnostics freiburg germany secondary antibody complexes visualized using chemiluminescent detection system ecl amersham braunschweig germany quantified densitometry pc bas tina software
0.5179277.15126630.html.plaintext.txt	29	determination ctsd tg1 involucrin loricrin protein concentration measured bicinchoninic acid protein assay pierce rockford usa equal protein samples electrophoresed 75 125 polyacrylamide gels transferred onto nitrocellulose filters 100 v 45 minutes mini transblot biorad munich germany ctsd cell cultures detected incubation 1 hour room temperature polyclonal rabbit anti human ctsd antibody dilution 11000 tbst calbiochem oncogene science usa ctsd mice detected rabbit anti mouse ctsd antibody kindly provided r pohlmann university munster germany tg1 goat anti human polyclonal antibody kindly provided y kim p steinert nih bethesda md see kim et al 1995 involucrin loricrin detected rabbit anti mouse antibodies prb 142c prb 145p respectively covance inc ca usa distributed hiss diagnostics freiburg germany secondary antibody complexes visualized using chemiluminescent detection system ecl amersham braunschweig germany quantified densitometry pc bas tina software
0.5179277.15126630.html.plaintext.txt	30	ctsd assay estimate activity cellular ctsd assay performed using parathyroid hormone pth specific substrate previously described heinrich et al 1999 digestion pth results cleavage hormone phe34 val35 yielding pth 1 34 pth 35 84 fragments pth proteolysis detected immunoblotting using monoclonal antibody could blocked aspartate protease inhibitor pepstatin selective inhibitor ctsd 2 microg lysate protein incubated indicated times 50 ng pth 37 degrees c volume 20 microl acidic buffer 100 mm sodium acetate 100 mm kcl ph 42 demonstrate ctsd specificity reactions 05 microm pepstatin added assay indicated one sample containing pth acidic buffer without lysate served control reactions stopped boiling samples 3 minutes tris tricine sds sample buffer 2 ss mercaptoethanol 12 glycerol 50 mm tris ph 68 4 sodium dodecyl sulfate 001 coomassie g proteins separated 15 sds page transferred onto nitrocellulose filters immunoblotting performed using anti pth mouse antibody specific fragment 1 34 biogenesis anti mouse secondary horseradish peroxidase conjugate blots developed using ecl detection reagent amersham
0.5179277.15126630.html.plaintext.txt	31	tg1 assay mouse epidermis disrupted ultrathurrax ika labortechnik staufen germany homogenized potter described buffer containing 20 mm sodium phosphate ph 72 05 mm edta 10 mm dithiothreitol 50 microgml phenylmethylsulfonylfluoride epidermal cells lysed buffer sonication epidermal tg1 activity measured described previously hohl et al 1998 briefly 5 microg tissue extract added 95 microl solution containing 05 m sodium borate ph 9 5 microl 10 mm edta ph 8 5 microl 100 mm cacl2 20 microl dimethylcasein 10 mgml 25 microl 10 triton x 100 05 microl 1 m dithiotreitol 28 microl 100 microm putrescine 1 microl 14 n 3h putrescine dihydrochloride 1 mciml 10 30 cimmol nen 482 microl h2o incubation 28 degrees c 30 minutes 80 microl applied cellulose filter papers whatman washed sequentially 10 tca 01 putrescine 5 tca 005 putrescine 95 ethanol radioactivity determined liquid scintillation counting tg1 activity expressed pmol 3hputrescine incorporated dimethylcaseine per hour mg protein evaluation effects ctsd tg1 activity membrane fractions prepared lysates homogenates centrifuged 25000 g 4 degrees c 30 minutes pellet re extracted sonication buffer supplemented 1 triton x 100 10 minutes incubation 37 degrees c lysate centrifuged supernatant membrane fraction collected tg1 activity membrane fraction measured described whole tissue extracts
0.5179277.15126630.html.plaintext.txt	32	skin histology chemical fixation embedding light electron microscopy follows skin samples prefixed overnight modified karnovskys medium elias friend 1975 4 degrees c washed twice 02 m sodium cacodylate buffer 10 minutes postfixed 1 wv oso4 0133 m sodium cacodylate buffer containing 05 wv k4fecn6 4 degrees c 45 minutes subsequently specimens dehydrated ethanol series embedded epon 812 luft 1961 polymerization carried overnight 60 degrees c semi thin sections cut ultra microtome leica uct leica bensheim germany staining investigated zeiss axioskop 40 zeiss gottingen germany transmission mode electron microscopy ultra thin sections cut post stained according method reynolds reynolds 1963 subsequently investigated philips cm 10 electron microscope
0.5179277.15126630.html.plaintext.txt	33	skin histology chemical fixation embedding light electron microscopy follows skin samples prefixed overnight modified karnovskys medium elias friend 1975 4 degrees c washed twice 02 m sodium cacodylate buffer 10 minutes postfixed 1 wv oso4 0133 m sodium cacodylate buffer containing 05 wv k4fecn6 4 degrees c 45 minutes subsequently specimens dehydrated ethanol series embedded epon 812 luft 1961 polymerization carried overnight 60 degrees c semi thin sections cut ultra microtome leica uct leica bensheim germany staining investigated zeiss axioskop 40 zeiss gottingen germany transmission mode electron microscopy ultra thin sections cut post stained according method reynolds reynolds 1963 subsequently investigated philips cm 10 electron microscope
0.5179277.15126630.html.plaintext.txt	34	immunohistochemistry skin samples fixed formaldehyde embedded paraffin 5 microm sections incubated 3 h2o2 5 minutes block endogenous peroxidase activity rinsed microwave irradiated 650 w antigen detection according method hazelbag et al hazelbag et al 1995 blocking unspecific antibody binding incubation 20 pig serum dako germany primary antibodies applied 30 minutes room temperature primary antibodies anti keratin k1 1500 anti keratin k5 11000 anti keratin k6 1500 anti involucrin 11000 anti loricrin 1500 anti filaggrin 11000 hohl 1993 rosenthal et al 1992 primary antibodies purchased hiss diagnostics germany strep ab complexhrp used third antibody followed incubation diaminobenzidine substrate peroxidase
0.5179277.15126630.html.plaintext.txt	35	immunohistochemistry skin samples fixed formaldehyde embedded paraffin 5 microm sections incubated 3 h2o2 5 minutes block endogenous peroxidase activity rinsed microwave irradiated 650 w antigen detection according method hazelbag et al hazelbag et al 1995 blocking unspecific antibody binding incubation 20 pig serum dako germany primary antibodies applied 30 minutes room temperature primary antibodies anti keratin k1 1500 anti keratin k5 11000 anti keratin k6 1500 anti involucrin 11000 anti loricrin 1500 anti filaggrin 11000 hohl 1993 rosenthal et al 1992 primary antibodies purchased hiss diagnostics germany strep ab complexhrp used third antibody followed incubation diaminobenzidine substrate peroxidase
0.5179277.15126630.html.plaintext.txt	36	results top summary introduction materials methods results discussion references increased protein levels activity ctsd differentiated keratinocyte cultures investigate functional role ctsd epidermal differentiation first investigated amount enzyme activity ctsd primary undifferentiated keratinocytes differentiated stratified keratinocyte cell cultures steude et al 2002 asselineau et al 1986 western blotting specific bioassay primary keratinocytes three known isoforms ctsd 52 kda 48 kda 32 kda detected 48 kda form main product 20 day old stratified cultures expressing various signature proteins keratinocyte cornification differentiation steude et al 2002 found significant increase 52 kda 48 kda ctsd forms fig 1a 52 kda protein represents enzymatically inactive pre pro ctsd form 48 kda protein active membrane bound enzyme fujita et al 1991
0.5179277.15126630.html.plaintext.txt	37	view larger version 22k fig 1 increase protein expression activity ctsd differentiated keratinocyte cultures protein expression ctsd isoforms primary differentiated keratinocytes determined cell lysates western blotting using anti ctsd antibodies increase prepro enzymatically active pro forms differentiated keratinocytes b ctsd activity measured vitro enzyme assay keratinocyte lysates using parathyroid hormone pth ctsd specific substrate amount pth absence sample protein used control level pth protein determined western blotting using anti pth mab peptide 1 34 quantified two dimensional laser scanning densitometry molecular dynamics personal densitometer ctsd activity calculated amount pth cleavedhour increased differentiated keratinocytes
0.5179277.15126630.html.plaintext.txt	38	enzymatic activity ctsd primary differentiated keratinocytes correlated amount ctsd protein significantly enhanced 20 day stratified cultures estimated cleavage ctsd specific substrate pth 84 amino acid polypeptide heinrich et al 1999 resulting generation 34 amino acid fragment amount pth decreased upper part fig 1b ctsd activity calculated amount pth cleavedhour increased differentiated keratinocytes fig 1b results indicate ctsd protein enzymatic activity correlate stage keratinocyte differentiation vitro
0.5179277.15126630.html.plaintext.txt	39	enzymatic activity ctsd primary differentiated keratinocytes correlated amount ctsd protein significantly enhanced 20 day stratified cultures estimated cleavage ctsd specific substrate pth 84 amino acid polypeptide heinrich et al 1999 resulting generation 34 amino acid fragment amount pth decreased upper part fig 1b ctsd activity calculated amount pth cleavedhour increased differentiated keratinocytes fig 1b results indicate ctsd protein enzymatic activity correlate stage keratinocyte differentiation vitro
0.5179277.15126630.html.plaintext.txt	40	increased epidermal expression increased activity ctsd experimental injury skin hairless mice evaluate possible role ctsd skin epidermal differentiation vivo determined protein levels activity ctsd epidermal barrier repair following experimental barrier disruption tape stripping following experimental skin injury expression active intermediate 48 kda proenzyme fig 2a black bars mature 32 kda form fig 2b black bars significantly increased 3 hours 5 hours 185 215 p 005 n4 48 kda form 204 260 p 005 n4 32 kda form respectively estimated western blotting
0.5179277.15126630.html.plaintext.txt	41	increased epidermal expression increased activity ctsd experimental injury skin hairless mice evaluate possible role ctsd skin epidermal differentiation vivo determined protein levels activity ctsd epidermal barrier repair following experimental barrier disruption tape stripping following experimental skin injury expression active intermediate 48 kda proenzyme fig 2a black bars mature 32 kda form fig 2b black bars significantly increased 3 hours 5 hours 185 215 p 005 n4 48 kda form 204 260 p 005 n4 32 kda form respectively estimated western blotting
0.5179277.15126630.html.plaintext.txt	42	view larger version 25k fig 2 increased epidermal expression ctsd experimental skin injury acute disruption permeability barrier induced tape stripping immediately pepstatin carrier solution applied skin samples obtained different times expression active intermediate mature form b ctsd examined sds page western blotting using polyclonal anti ctsd antibody quantified two dimensional laser scanning densitometry
0.5179277.15126630.html.plaintext.txt	43	inhibition ctsd topical application ctsd inhibitor pepstatin suppressed increase amount intermediate mature enzyme barrier disruption fig 2ab grey bars
0.5179277.15126630.html.plaintext.txt	44	increase ctsd protein paralleled enhanced ctsd enzyme activity 3 hours 5 hours skin injury determined pth cleavage assays fig 3 topical application pepstatin resulted decrease enzymatic activity 6 hours treatment data shown together data demonstrate increased protein expression increased enzyme activity ctsd skin repair epidermal differentiation
0.5179277.15126630.html.plaintext.txt	45	view larger version 32k fig 3 increased activity ctsd experimental skin injury acute disruption permeability barrier induced tape stripping immediately barrier disruption pepstatin carrier solution applied skin samples obtained directly tape stripping 0 hours 3 5 hours ctsd activity measured specific parathyroid hormone pth enzyme assays level pth protein determined western blotting using anti pth mab peptide 1 34 amount pth assay starting point used control ctsd activity calculated amount pth cleavedhour
0.5179277.15126630.html.plaintext.txt	46	tg1 activity stimulated exogenous ctsd keratinocytes culture epidermal differentiation ce proteins involucrin loricrin filaggrin cross linked formation glutamyllysine isodipeptide bonds catalyzed tg1 kim et al 1995 addition described tg1 catalyzes covalent ester binding hydroxyceramide involucrin nemes et al 1999 thus enzyme mediates key functions epidermal differentiation since ctsd may involved regulation activity tg1 negi et al 1981 negi et al 1990 investigated possible direct involvement ctsd proteolytic activation tg1 since high molecular mass tg1 precursor protein membrane bound chakravarty rice 1989 steinert et al 1996b upon terminal differentiation keratinocytes tg1 cleaved two sites leading active form rice et al 1990 kim et al 1995 steinert et al 1996a steinert et al 1996b prepared membrane fraction lysates hacat cells starting material enzymatic activity tg1 measured membrane preparation addition exogenous ctsd absence presence pepstatin vitro tg1 assay based cross linking 3hputrescine dimethylcasein substrate hohl et al 1998 shown fig 4 tg1 activity increased exogenous ctsd enzymatic activation blocked pepstatin result suggests ctsd mediated proteolytic activation membrane bound tg1 precursor molecule leading enzymatically active tg1 fragments observation supports functional link ctsd tg1 activities
0.5179277.15126630.html.plaintext.txt	47	view larger version 15k fig 4 ctsd stimulates transglutaminase 1 tg1 activity primary keratinocytes vitro isolated membranes hacat cells left untreated black squares treated pepstatin black circles purified ctsd absence black triangles presence pepstatin white triangles 30 minutes subsequently measured tg1 enzymatic activity vitro enzyme assay using dimethylcasein 14n 3h putrescine substrates results three experiments performed triplicate shown mean plus minus sem
0.5179277.15126630.html.plaintext.txt	48	topical application ctsd inhibitor pepstatin tg inhibitor monodansyl cadaverin significantly delayed permeability barrier repair investigate physiological significance ctsd epidermal differentiation next examined barrier recovery following experimental skin injury topical application ctsd inhibitor pepstatin different times barrier disruption tape stripping 0 24 hours tewl marker barrier repair measured grubauer et al 1989 experimental barrier disruption endogenous barrier repair commenced rapid decrease tewl leading 60 barrier recovery occurred hairless mice within 5 hours followed slower kinetics barrier recovery within next 24 hours topically application ctsd inhibitor pepstatin immediately barrier disruption led significant delay barrier repair 1 3 5 7 24 hours treatment fig 5a
0.5179277.15126630.html.plaintext.txt	49	topical application ctsd inhibitor pepstatin tg inhibitor monodansyl cadaverin significantly delayed permeability barrier repair investigate physiological significance ctsd epidermal differentiation next examined barrier recovery following experimental skin injury topical application ctsd inhibitor pepstatin different times barrier disruption tape stripping 0 24 hours tewl marker barrier repair measured grubauer et al 1989 experimental barrier disruption endogenous barrier repair commenced rapid decrease tewl leading 60 barrier recovery occurred hairless mice within 5 hours followed slower kinetics barrier recovery within next 24 hours topically application ctsd inhibitor pepstatin immediately barrier disruption led significant delay barrier repair 1 3 5 7 24 hours treatment fig 5a
0.5179277.15126630.html.plaintext.txt	50	view larger version 17k fig 5 topical application ctsd inhibitor pepstatin tg inhibitor monodansyl cadaverin mdc b significantly delays permeability barrier repair acute disruption permeability barrier induced tape stripping 20 30 fold increase tewl transepidermal water losstranscutaneous water loss occurred immediately barrier disruption pepstatin monodansyl cadaverin carrier solution applied recovery tewl determined different times treatment results three experiments performed triplicates shown
0.5179277.15126630.html.plaintext.txt	51	addition functional role tg1 cutaneous differentiation permeability barrier repair examined topical application tg1 inhibitor monodansyl cadaverin experimental skin injury different times barrier disruption tape stripping tewl determined marker barrier repair application monodansyl cadaverin found significant delay barrier repair 1 3 5 7 24 hours treatment fig 5b results show inhibition ctsd tg1 activity influences epidermal differentiation delays permeability barrier repair
0.5179277.15126630.html.plaintext.txt	52	addition functional role tg1 cutaneous differentiation permeability barrier repair examined topical application tg1 inhibitor monodansyl cadaverin experimental skin injury different times barrier disruption tape stripping tewl determined marker barrier repair application monodansyl cadaverin found significant delay barrier repair 1 3 5 7 24 hours treatment fig 5b results show inhibition ctsd tg1 activity influences epidermal differentiation delays permeability barrier repair
0.5179277.15126630.html.plaintext.txt	53	reduced tg1 enzymatic activity defective tg processing ctsd deficient mice based observation ctsd able activate tg1 vitro fig 4 next explored possible role ctsd regulation tg1 expression ctsd deficient mice vivo using specific tg1 enzyme assay found significantly decreased tg1 activity epidermis heterozygous ctsd mice reduced homozygous ctsd mice fig 6 order investigate whether decreased tg1 activity ctsd mice caused defective processing tg1 precursor molecule analyzed distribution tg1 protein western blotting using specific anti tg1 antibody strongly band approximately 35 kda detected epidermis wild type mice band significantly decreased skins ctsd deficient heterozygous even homozygous mice fig 7 ctsd mice 150 kda protein strongly expressed instead also seen ctsd mice completely absent wild type mice finding suggest defective processing 150 kda tg1 precursor protein epidermis ctsd deficient mice points functional role ctsd maturation 150 kda tg1 precursor enzymatic active 35 kda form vivo
0.5179277.15126630.html.plaintext.txt	54	reduced tg1 enzymatic activity defective tg processing ctsd deficient mice based observation ctsd able activate tg1 vitro fig 4 next explored possible role ctsd regulation tg1 expression ctsd deficient mice vivo using specific tg1 enzyme assay found significantly decreased tg1 activity epidermis heterozygous ctsd mice reduced homozygous ctsd mice fig 6 order investigate whether decreased tg1 activity ctsd mice caused defective processing tg1 precursor molecule analyzed distribution tg1 protein western blotting using specific anti tg1 antibody strongly band approximately 35 kda detected epidermis wild type mice band significantly decreased skins ctsd deficient heterozygous even homozygous mice fig 7 ctsd mice 150 kda protein strongly expressed instead also seen ctsd mice completely absent wild type mice finding suggest defective processing 150 kda tg1 precursor protein epidermis ctsd deficient mice points functional role ctsd maturation 150 kda tg1 precursor enzymatic active 35 kda form vivo
0.5179277.15126630.html.plaintext.txt	55	view larger version 14k fig 6 reduced transglutaminase 1 tg1 activity ctsd deficient mice tg1 enzymatic activity determined epidermal lysates wild type heterozygous ctsd deficient mice vitro assay using dimethylcasein 14n 3h putrescine substrates results three experiments performed triplicate shown mean plus minus sem
0.5179277.15126630.html.plaintext.txt	56	view larger version 28k fig 7 absence 35 kda tg1 protein ctsd deficient mice tg1 protein levels determined epidermal samples wild type heterozygous homozygous ctsd deficient mice western blotting using anti tg1 antibody quantified densitometry
0.5179277.15126630.html.plaintext.txt	57	reduced levels involucrin loricrin ctsd deficient mice next investigated whether ctsd deficiency also results changes expression involucrin early marker loricrin late marker epidermal differentiation watt 1983 yoneda et al 1992 steinert marekov 1997 epidermal samples wild type mice involucrin fig 8a loricrin fig 8b expressed 65 kda 50 kda proteins respectively estimated western blotting ctsd mice levels proteins clearly reduced ctsd mice completely absent suggesting crucial function ctsd appearance 65 kda involucrin 50 kda loricrin epidermis
0.5179277.15126630.html.plaintext.txt	58	reduced levels involucrin loricrin ctsd deficient mice next investigated whether ctsd deficiency also results changes expression involucrin early marker loricrin late marker epidermal differentiation watt 1983 yoneda et al 1992 steinert marekov 1997 epidermal samples wild type mice involucrin fig 8a loricrin fig 8b expressed 65 kda 50 kda proteins respectively estimated western blotting ctsd mice levels proteins clearly reduced ctsd mice completely absent suggesting crucial function ctsd appearance 65 kda involucrin 50 kda loricrin epidermis
0.5179277.15126630.html.plaintext.txt	59	view larger version 34k fig 8 reduced ce protein expression ctsd deficient mice skin sections wild type heterozygous homozygous ctsd deficient mice obtained expression involucrin loricrin b determined epidermal samples western blotting using anti involucrin anti loricrin antibodies
0.5179277.15126630.html.plaintext.txt	60	changes immunohistology differentiation related proteins ctsd mice examine protein expression localization differentiation related epidermal proteins performed immunohistology using specific antibodies shown fig 9 keratin k1 staining healthy skin found suprabasal layers epidermis whereas keratin k5 expressed epidermal basal cells ctsd mice focal extension k1 staining basal layer staining k5 focally extended upper epidermal layers ctsd mice entire nucleated epidermis stained ctsd mice also thickness epidermis stratum granulosum stratum spinosum stratum basale reduced whereas thickening stratum corneum hyperkeratosis evident ctsd mice results show changes protein expression basal differentiation related keratins ctsd deficient mice
0.5179277.15126630.html.plaintext.txt	61	view larger version 118k fig 9 immunohistology revealed distinct changes expression keratins ce proteins ctsd deficient mice keratin k1 staining healthy skin found suprabasal layers epidermis whereas keratin k5 expressed epidermal basal cells ctsd mice focal extension k1 staining basal layer focal extension k5 upper epidermal layers keratin k6 faintly stained normal mouse skin ctsd ctsd mouse skin involucrin filaggrin antibodies showed strong staining upper stratum spinosum stratum granulosum whereas loricrin antibody showed staining stratum granulosum solely wild type mouse skin three antibodies staining intensity reduced ctsd mice even reduced ctsd mice
0.5179277.15126630.html.plaintext.txt	62	keratin k6 known involved proliferation shows faint probably unspecific staining normal mouse skin staining found heterozygous homozygous mouse skin reveals abnormal cornification seen light microscopy ctsd mice related hyperproliferation
0.5179277.15126630.html.plaintext.txt	63	keratin k6 known involved proliferation shows faint probably unspecific staining normal mouse skin staining found heterozygous homozygous mouse skin reveals abnormal cornification seen light microscopy ctsd mice related hyperproliferation
0.5179277.15126630.html.plaintext.txt	64	involucrin antibody showed strong continuous staining upper stratum spinosum stratum granulosum wild type mice ctsd ctsd mice involucrin staining markedly reduced band like staining locally interrupted
0.5179277.15126630.html.plaintext.txt	65	involucrin antibody showed strong continuous staining upper stratum spinosum stratum granulosum wild type mice ctsd ctsd mice involucrin staining markedly reduced band like staining locally interrupted
0.5179277.15126630.html.plaintext.txt	66	loricrin antibody produced strong staining stratum granulosum ctsd ctsd mice found focally reduced staining
0.5179277.15126630.html.plaintext.txt	67	loricrin antibody produced strong staining stratum granulosum ctsd ctsd mice found focally reduced staining
0.5179277.15126630.html.plaintext.txt	68	filaggrin similar involucrin stained strongly upper stratum spinosum stratum granulosum wild type mice slight reduction staining intensity found ctsd mice staining intensity clearly reduced staining focally absent ctsd mice reveals reduced expression ce proteins
0.5179277.15126630.html.plaintext.txt	69	filaggrin similar involucrin stained strongly upper stratum spinosum stratum granulosum wild type mice slight reduction staining intensity found ctsd mice staining intensity clearly reduced staining focally absent ctsd mice reveals reduced expression ce proteins
0.5179277.15126630.html.plaintext.txt	70	studies show functional link ctsd activity expression epidermal differentiation related proteins
0.5179277.15126630.html.plaintext.txt	71	structural changes stratum corneum transition stratum granulosum stratum corneum changes tewl ctsd deficient mice biological consequences ctsd deficiency reduction tg1 activity alterations ce protein levels analyzed histological examination semi thin skin sections derived wild type ctsd mice epidermis wild type heterozygous mice data shown exhibited well known regular arrangement corneocytes stratum corneum contrast stratum corneum ctsd mice irregular structure different layers stratum corneum disrupted singular corneocytes undulated furthermore stratum corneum layers fig 10 part changes also evident fig 9 ultrastructure epidermis analyzed electron microscopy revealing distinct changes morphology stratum corneum transition stratum granulosum stratum corneum ctsd mice wild type mice found normal distances stratum corneum layers normal ce seen dark lines around corneocytes fig 11a arrow ctsd mice distances stratum corneum layers broader faint staining ce thickened corneocytes axial direction fig 11b arrow measurements tewl basal conditions mice age 20 days ctsd mice life expectancy 28 days tewameter revealed small increase significant tewl ctsd mice 17 ctsd mice 11 wild type mice tewl 109 plus minus 17 gm 2h n13 ctsd tewl 127 plus minus 12 gm 2h n10 ctsd tewl 122 plus minus 17 gm 2h n6 together results show increase thickness number stratum corneum layers ultrastructural changes ctsd mice ichthyotic skin phenotype ctsd mice largely compensates defect protein expression shown small increase basal tewl
0.5179277.15126630.html.plaintext.txt	72	structural changes stratum corneum transition stratum granulosum stratum corneum changes tewl ctsd deficient mice biological consequences ctsd deficiency reduction tg1 activity alterations ce protein levels analyzed histological examination semi thin skin sections derived wild type ctsd mice epidermis wild type heterozygous mice data shown exhibited well known regular arrangement corneocytes stratum corneum contrast stratum corneum ctsd mice irregular structure different layers stratum corneum disrupted singular corneocytes undulated furthermore stratum corneum layers fig 10 part changes also evident fig 9 ultrastructure epidermis analyzed electron microscopy revealing distinct changes morphology stratum corneum transition stratum granulosum stratum corneum ctsd mice wild type mice found normal distances stratum corneum layers normal ce seen dark lines around corneocytes fig 11a arrow ctsd mice distances stratum corneum layers broader faint staining ce thickened corneocytes axial direction fig 11b arrow measurements tewl basal conditions mice age 20 days ctsd mice life expectancy 28 days tewameter revealed small increase significant tewl ctsd mice 17 ctsd mice 11 wild type mice tewl 109 plus minus 17 gm 2h n13 ctsd tewl 127 plus minus 12 gm 2h n10 ctsd tewl 122 plus minus 17 gm 2h n6 together results show increase thickness number stratum corneum layers ultrastructural changes ctsd mice ichthyotic skin phenotype ctsd mice largely compensates defect protein expression shown small increase basal tewl
0.5179277.15126630.html.plaintext.txt	73	view larger version 97k fig 10 ctsd deficient mice exhibited impaired stratum corneum morphology microscopic analysis semi thin skin sections ctsd wild type mice revealed normal stratum corneum morphology ctsd deficient mice b disrupted stratum corneum increased number corneocyte layers
0.5179277.15126630.html.plaintext.txt	74	view larger version 94k fig 11 ultrastructural changes stratum corneum transition stratum granulosum stratum corneum ctsd mice electron microscopy shows wild type mice cornified envelope ce clearly visible dark lines around corneocytes arrow ctsd mice b broadening intercellular spaces stratum corneum sc faint staining ce arrow corneocytes thickened axial direction sg stratum granulosum
0.5179277.15126630.html.plaintext.txt	75	discussion top summary introduction materials methods results discussion references recently demonstrated activation tnf signal transduction pathway including tnf r55 acid sphingomyelinase second messenger ceramide skin permeability barrier repair jensen et al 1999 tnf acid sphingomyelinase involved cell signaling growth differentiation apoptosis aggarwal natarajan 1996 vitro identified endolysosomal aspartate protease ctsd specific ceramide binding protein ceramide enhances ctsd proteolytic activity heinrich et al 1999 existence ctsd skin shown previously function elucidated increased activity ctsd isoforms depending stage epidermal differentiation described horikoshi et al 1999 also increased expression mature form ctsd reported kawada et al 1997 psoriasis disease characterized addition inflammation epidermal hyperproliferation altered differentiation furthermore psoriasis premature expression ce protein involucrin known thewes et al 1991
0.5179277.15126630.html.plaintext.txt	76	examined role specific targets ctsd epidermal differentiation first performed vitro studies determining protein expression activity ctsd primary differentiated stratified organotypic cultured keratinocytes found significant increase ctsd protein levels increase enzymatic activity ctsd differentiated compared primary keratinocytes suggesting function ctsd epidermal differentiation vitro
0.5179277.15126630.html.plaintext.txt	77	examined role specific targets ctsd epidermal differentiation first performed vitro studies determining protein expression activity ctsd primary differentiated stratified organotypic cultured keratinocytes found significant increase ctsd protein levels increase enzymatic activity ctsd differentiated compared primary keratinocytes suggesting function ctsd epidermal differentiation vitro
0.5179277.15126630.html.plaintext.txt	78	explore possible link ctsd epidermal differentiation vivo investigated epidermal expression enzymatic activity ctsd experimental skin injury permeability barrier repair wild type mice found significantly increased epidermal expression active intermediate well mature form ctsd 3 hours 5 hours permeability barrier disruption caused increased processing increased synthesis enzyme accordance noted significant increase epidermal ctsd enzyme activity different times skin injury topical application pepstatin inhibitor ctsd heinrich et al 1999 prevented increase protein expression activity ctsd significantly delayed permeability barrier repair experimental disruption results clearly show involvement ctsd epidermal repair process injury
0.5179277.15126630.html.plaintext.txt	79	explore possible link ctsd epidermal differentiation vivo investigated epidermal expression enzymatic activity ctsd experimental skin injury permeability barrier repair wild type mice found significantly increased epidermal expression active intermediate well mature form ctsd 3 hours 5 hours permeability barrier disruption caused increased processing increased synthesis enzyme accordance noted significant increase epidermal ctsd enzyme activity different times skin injury topical application pepstatin inhibitor ctsd heinrich et al 1999 prevented increase protein expression activity ctsd significantly delayed permeability barrier repair experimental disruption results clearly show involvement ctsd epidermal repair process injury
0.5179277.15126630.html.plaintext.txt	80	kinetics ctsd processing activation demonstrated increased expression 1 5 hours treatment corresponded activation sphingomyelinase amount epidermal ceramides barrier perturbation jensen et al 1999 previous study significant increase acid sphingomyelinase activation elevated epidermal ceramide content 1 4 hours barrier disruption demonstrated jensen et al 1999 thus acid sphingomyelinase derived ceramide may linked ctsd activity permeability barrier repair
0.5179277.15126630.html.plaintext.txt	81	epidermis follows programmed transformation keratinocytes proliferating basal cells spinous granular horny layers permeability barrier resides finally desquamation occurs starting granular layer aspartatic proteinases ctsd activated lysosomes participate massive degradation process accompanying cornification recent observations identified ctsd located lamellar bodies within keratinocytes ishida yamamoto et al 2004 involucrin loricrin cross linked tg1 form insoluble rigid ce steinert marekov 1997 ctsd reported activate tg1 thereby contribute enzymatic processes cornification negi et al 1981 horikoshi et al 1999 findings supported extended vitro vivo results found ctsd dependent activation tg1 keratinocyte membrane preparation furthermore activity tg1 severely diminished epidermis ctsd mice compared wild type mice enzymatic activity tg1 correlated expression 35 kda protein wild type mice detected immunoblotting 35 kda protein undetectable epidermis ctsd mice observed expression 150 kda tg1 protein instead less protein ctsd mice none wild type control mice observations suggest involvement ctsd processing higher molecular weight precursor generate enzymatically active 35 kda tg1 form see model fig 12 recent report iizuka et al iizuka et al 2003 studied proteolytically activated tg1 epidermis using cleavage site directed antibodies 33 kda fragment identified western blotting mainly found cytosol keratinocytes differentiated cells stratum corneum skin iizuka et al 2003 second fragment resided plasma membrane keratinocytes regions skin including suprabasal layer spinous layer granular layer stratum corneum differentiation related 33 kda tg1 fragment study could protein 35 kda fragment detected ctsd mice ctsd mice
0.5179277.15126630.html.plaintext.txt	82	epidermis follows programmed transformation keratinocytes proliferating basal cells spinous granular horny layers permeability barrier resides finally desquamation occurs starting granular layer aspartatic proteinases ctsd activated lysosomes participate massive degradation process accompanying cornification recent observations identified ctsd located lamellar bodies within keratinocytes ishida yamamoto et al 2004 involucrin loricrin cross linked tg1 form insoluble rigid ce steinert marekov 1997 ctsd reported activate tg1 thereby contribute enzymatic processes cornification negi et al 1981 horikoshi et al 1999 findings supported extended vitro vivo results found ctsd dependent activation tg1 keratinocyte membrane preparation furthermore activity tg1 severely diminished epidermis ctsd mice compared wild type mice enzymatic activity tg1 correlated expression 35 kda protein wild type mice detected immunoblotting 35 kda protein undetectable epidermis ctsd mice observed expression 150 kda tg1 protein instead less protein ctsd mice none wild type control mice observations suggest involvement ctsd processing higher molecular weight precursor generate enzymatically active 35 kda tg1 form see model fig 12 recent report iizuka et al iizuka et al 2003 studied proteolytically activated tg1 epidermis using cleavage site directed antibodies 33 kda fragment identified western blotting mainly found cytosol keratinocytes differentiated cells stratum corneum skin iizuka et al 2003 second fragment resided plasma membrane keratinocytes regions skin including suprabasal layer spinous layer granular layer stratum corneum differentiation related 33 kda tg1 fragment study could protein 35 kda fragment detected ctsd mice ctsd mice
0.5179277.15126630.html.plaintext.txt	83	view larger version 41k fig 12 model role ctsd epidermal differentiation epidermal differentiation aspartate protease ctsd stratum granulosum sg activated cleaves membrane bound 150 kda precursor transglutaminase 1 tg1 producing active 35 kda form tg1 turn mediates cross linking cornified envelope ce proteins involucrin loricrin ce sc stratum corneum ss stratum spinosum sb stratum basale
0.5179277.15126630.html.plaintext.txt	84	functional significance tg1 epidermal homeostasis demonstrated delay permeability barrier repair inhibition tg1 monodansyl cadaverin similar effects observed inhibition ctsd pepstatin inhibition acid sphingomyelinase imipramine jensen et al 1999 suggesting importance possible associated function three enzymes barrier formation differentiation
0.5179277.15126630.html.plaintext.txt	85	functional significance tg1 epidermal homeostasis demonstrated delay permeability barrier repair inhibition tg1 monodansyl cadaverin similar effects observed inhibition ctsd pepstatin inhibition acid sphingomyelinase imipramine jensen et al 1999 suggesting importance possible associated function three enzymes barrier formation differentiation
0.5179277.15126630.html.plaintext.txt	86	epidermal differentiation including formation ce proteins involucrin loricrin crucially involved permeability barrier repair ekanayake mudiyanselage et al 1998 soluble ce protein involucrin expressed spinous layer early stage keratinocyte differentiation loricrin insoluble ce precursor expressed later differentiation process intracellular granules
0.5179277.15126630.html.plaintext.txt	87	link ctsd dependent activation keratinocyte tg1 expression ce proteins confirmed ctsd mice mice found significantly reduced involucrin loricrin protein levels experimental skin injury parallel reduced activity tg1 results agreement effects observed application ctsd inhibitor pepstatin data shown since high molecular mass tg1 precursor protein present ctsd wild type mice ctsd appears mediate proteolysis enzymatically inactive tg1 active enzyme thus deficient mice also reveal functional link ctsd expression maturation activation tg1 appearance involucrin loricrin epidermis
0.5179277.15126630.html.plaintext.txt	88	link ctsd dependent activation keratinocyte tg1 expression ce proteins confirmed ctsd mice mice found significantly reduced involucrin loricrin protein levels experimental skin injury parallel reduced activity tg1 results agreement effects observed application ctsd inhibitor pepstatin data shown since high molecular mass tg1 precursor protein present ctsd wild type mice ctsd appears mediate proteolysis enzymatically inactive tg1 active enzyme thus deficient mice also reveal functional link ctsd expression maturation activation tg1 appearance involucrin loricrin epidermis
0.5179277.15126630.html.plaintext.txt	89	morphologically ctsd mice exhibited epidermal hyperkeratosis sign disturbed epidermal differentiation skin symptoms may explained diminished ability corneocytes bind intercellular lipids caused reduced expression involucrin loricrin stratum corneum previously shown ce proteins particular involucrin covalently bind hydroxy ceramides ceramides form scaffold attachment free ceramides cholesterol free fatty acids provides stratum corneum lipid bilayers permeability barrier function downing 1992 steinert marekov 1997 morphological disruption corneocyte layers found ctsd mice fig 10b disruptions started interface stratum granulosumstratum corneum place normally lipid bilayers extrude lipids intercellular space ultrastructural analysis epidermis ctsd mice revealed broadening distances sc layers faint staining ce thickened corneocytes axial direction demonstrates influence ctsd corneocytes possibly lipid organization stratum corneum together morphological findings suggest important role ctsd epidermal differentiation
0.5179277.15126630.html.plaintext.txt	90	morphologically ctsd mice exhibited epidermal hyperkeratosis sign disturbed epidermal differentiation skin symptoms may explained diminished ability corneocytes bind intercellular lipids caused reduced expression involucrin loricrin stratum corneum previously shown ce proteins particular involucrin covalently bind hydroxy ceramides ceramides form scaffold attachment free ceramides cholesterol free fatty acids provides stratum corneum lipid bilayers permeability barrier function downing 1992 steinert marekov 1997 morphological disruption corneocyte layers found ctsd mice fig 10b disruptions started interface stratum granulosumstratum corneum place normally lipid bilayers extrude lipids intercellular space ultrastructural analysis epidermis ctsd mice revealed broadening distances sc layers faint staining ce thickened corneocytes axial direction demonstrates influence ctsd corneocytes possibly lipid organization stratum corneum together morphological findings suggest important role ctsd epidermal differentiation
0.5179277.15126630.html.plaintext.txt	91	evaluate consequences ctsd deficiency reduced tg1 activity detail analyzed distribution various epidermal keratins ce proteins immunohistology extended expression basal differentiation related keratins k5 k1 sign disturbed differentiation found ctsd deficient mice previous studies found expression differentiation marker k1 disturbed acute tape stripping chronic metabolic essential fatty acid deficient diet efad barrier disruption however models also found increase expression proliferation associated keratin k6 also k16 ekanayake mudiyanselage et al 1998 expression k6 besides changes basal differentiation related keratins also known psoriasis hagemann proksch 1996 ctsd mice k6 absent though thickening horny layer clearly visible therefore ctsd mice may similarities called retention hyperkeratosis ichthyosis called hyperproliferation associated keratosis psoriasis accordance mice heterozygous truncated keratin k10 model ichthyosis called epidermolytic hyperkeratosis caused point mutations suprabasal k1 k10 cheng et al 1992 chipev et al 1992 rothnagel et al 1992 yang et al 1997 suga et al 1998 ishida yamamoto et al 2000 show k6k16 protein expression flank skin porter et al 1998 ichthyosis group skin disorders different causes showing disturbed epidermal differentiation variable effects permeability barrier lavrijsen et al 1993
0.5179277.15126630.html.plaintext.txt	92	evaluate consequences ctsd deficiency reduced tg1 activity detail analyzed distribution various epidermal keratins ce proteins immunohistology extended expression basal differentiation related keratins k5 k1 sign disturbed differentiation found ctsd deficient mice previous studies found expression differentiation marker k1 disturbed acute tape stripping chronic metabolic essential fatty acid deficient diet efad barrier disruption however models also found increase expression proliferation associated keratin k6 also k16 ekanayake mudiyanselage et al 1998 expression k6 besides changes basal differentiation related keratins also known psoriasis hagemann proksch 1996 ctsd mice k6 absent though thickening horny layer clearly visible therefore ctsd mice may similarities called retention hyperkeratosis ichthyosis called hyperproliferation associated keratosis psoriasis accordance mice heterozygous truncated keratin k10 model ichthyosis called epidermolytic hyperkeratosis caused point mutations suprabasal k1 k10 cheng et al 1992 chipev et al 1992 rothnagel et al 1992 yang et al 1997 suga et al 1998 ishida yamamoto et al 2000 show k6k16 protein expression flank skin porter et al 1998 ichthyosis group skin disorders different causes showing disturbed epidermal differentiation variable effects permeability barrier lavrijsen et al 1993
0.5179277.15126630.html.plaintext.txt	93	expression involucrin loricrin well filaggrin significantly reduced heterozygote homozygote epidermis ctsd deficient mice filaggrin deficiency well known ichthyosis vulgaris gunzel et al 1991 defective interaction keratin filaggrin also seen epidermolytic hyperkeratosis abnormal distribution loricrin detected genetic diseases involving loricrin loricrin keratoderma vohwinkels syndrome maestrini et al 1996 suga et al 2000 loricrin mutation vohwinkels keratoderma unique variant ichthyosis korge et al 1997 defects cross linking loricrin detected tg1 deficient mice animal model lamellar ichthyosis matsuki et al 1998
0.5179277.15126630.html.plaintext.txt	94	expression involucrin loricrin well filaggrin significantly reduced heterozygote homozygote epidermis ctsd deficient mice filaggrin deficiency well known ichthyosis vulgaris gunzel et al 1991 defective interaction keratin filaggrin also seen epidermolytic hyperkeratosis abnormal distribution loricrin detected genetic diseases involving loricrin loricrin keratoderma vohwinkels syndrome maestrini et al 1996 suga et al 2000 loricrin mutation vohwinkels keratoderma unique variant ichthyosis korge et al 1997 defects cross linking loricrin detected tg1 deficient mice animal model lamellar ichthyosis matsuki et al 1998
0.5179277.15126630.html.plaintext.txt	95	evaluation barrier function ctsd mice measurements tewl revealed constitutive defect suggest development ichthyosiform skin compensates defective stratum corneum morphology deficiency differentiation related proteins recently similar results reported mice lacking tg1 matsuki et al 1998 skin tg1 deficient mice die neonates lacks normal insoluble ce impaired barrier function neonatal tg1 mouse skin taut erythrodermic transplanted tg1 mouse skin resembled seen severe ichthyosis epidermal hyperplasia marked hyperkeratosis abnormalities barrier structures remained tewl decreased control levels ichthyosiform skin authors suggested ichthyosiform skin phenotype tg1 deficiency develops massive hyperkeratosis physical compensation defective cutaneous permeability barrier kuramoto et al 2002 compensatory mechanisms maintaining skin barrier function absence major ce protein also described loricrin deficient mouse model koch et al 2000 also targeted ablation murine involucrin gene show defects barrier function mice developed normally possessed apparently normal epidermis hair follicles generated ces could distinguished wild type mice djian et al 2000 jensen et al 1999b complexity redundancy epithelial barrier function discussed steinert steinert 2000 ctsd mouse model broader impact skin morphology either involucrin loricrin deficiency notably similarities skin ctsd mice skin tg1 mice human skin disease lamellar ichthyosis lamellar ichthyosis mutation tg1 gene resulting reduction epidermal involucrin described hohl et al 1993 huber et al 1995 similarities explained strongly reduced tg1 expression skin ctsd mice
0.5179277.15126630.html.plaintext.txt	96	evaluation barrier function ctsd mice measurements tewl revealed constitutive defect suggest development ichthyosiform skin compensates defective stratum corneum morphology deficiency differentiation related proteins recently similar results reported mice lacking tg1 matsuki et al 1998 skin tg1 deficient mice die neonates lacks normal insoluble ce impaired barrier function neonatal tg1 mouse skin taut erythrodermic transplanted tg1 mouse skin resembled seen severe ichthyosis epidermal hyperplasia marked hyperkeratosis abnormalities barrier structures remained tewl decreased control levels ichthyosiform skin authors suggested ichthyosiform skin phenotype tg1 deficiency develops massive hyperkeratosis physical compensation defective cutaneous permeability barrier kuramoto et al 2002 compensatory mechanisms maintaining skin barrier function absence major ce protein also described loricrin deficient mouse model koch et al 2000 also targeted ablation murine involucrin gene show defects barrier function mice developed normally possessed apparently normal epidermis hair follicles generated ces could distinguished wild type mice djian et al 2000 jensen et al 1999b complexity redundancy epithelial barrier function discussed steinert steinert 2000 ctsd mouse model broader impact skin morphology either involucrin loricrin deficiency notably similarities skin ctsd mice skin tg1 mice human skin disease lamellar ichthyosis lamellar ichthyosis mutation tg1 gene resulting reduction epidermal involucrin described hohl et al 1993 huber et al 1995 similarities explained strongly reduced tg1 expression skin ctsd mice
0.5179277.15126630.html.plaintext.txt	97	initial characterization ctsd deficient mice atopic changes ileal mucosa leading insufficient mucosal barrier observed limit epithelium central connective tissue normally formed basement membrane undetectable mice saftig et al 1995 together results prove importance ctsd barrier function epithelial differentiation different organs
0.5179277.15126630.html.plaintext.txt	98	initial characterization ctsd deficient mice atopic changes ileal mucosa leading insufficient mucosal barrier observed limit epithelium central connective tissue normally formed basement membrane undetectable mice saftig et al 1995 together results prove importance ctsd barrier function epithelial differentiation different organs
0.5179277.15126630.html.plaintext.txt	99	summary vitro vivo results suggest crucial involvement aspartate protease ctsd activation keratinocyte tg1 regulation ce protein expression epidermal differentiation summarized model shown fig 12 findings may important development new treatment modalities skin diseases altered epidermal differentiation pattern
0.5179277.15126630.html.plaintext.txt	100	acknowledgments greatly appreciate assistance andrea hethke claudia neumann dr xu ping wang work supported deutsche forschungsgemeinschaft sonderforschungsbereich sfb 415 granted ep b2 ss a11 respectively wish thank katherine houghton reviewing text article
0.5179277.15126630.html.plaintext.txt	101	acknowledgments greatly appreciate assistance andrea hethke claudia neumann dr xu ping wang work supported deutsche forschungsgemeinschaft sonderforschungsbereich sfb 415 granted ep b2 ss a11 respectively wish thank katherine houghton reviewing text article
0.5179277.15126630.html.plaintext.txt	102	references top summary introduction materials methods results discussion references
0.54427505.15198969.html.plaintext.txt	0	estrogen alzheimer disease apolipoprotein connection neil j maclusky
0.54427505.15198969.html.plaintext.txt	1	center reproductive sciences columbia university medical center new york new york 10032
0.54427505.15198969.html.plaintext.txt	2	address correspondence requests reprints dr neil j maclusky center reproductive sciences columbia university medical center 630 west 168th street new york new york 10032 e mail nm274atcolumbiaedu u d
0.54427505.15198969.html.plaintext.txt	3	contribution estrogens prevention neurodegenerative disorders attracted considerable attention last years result conflicting data clinical trials shown protective effects postmenopausal estrogen based hormone replacement therapy hrt whereas others including recently concluded women health initiative trial revealed significant benefit although reason apparently discrepant results remains subject heated debate growing body evidence suggests individual women may exhibit variable neuroprotective responses hrt part interactions known risk factors neurodegenerative disease one risk factor modulates effects hrt rates cognitive decline aging women expression pattern allelic variants apolipoprotein e apoe paper nathan et al 1 issue endocrinology indicates may case trophic effects natural ovarian estrogen estradiol 17ss neurite growth cultured mouse cerebral cortical neurons reported critically dependent apoe expression moreover responses estradiol 17ss shown dependent type apoe present whereas estradiol 17ss neurotrophic presence human apoe 2 apoe 3 apoe 4 variant associated progression late onset alzheimer disease support response
0.54427505.15198969.html.plaintext.txt	4	contribution estrogens prevention neurodegenerative disorders attracted considerable attention last years result conflicting data clinical trials shown protective effects postmenopausal estrogen based hormone replacement therapy hrt whereas others including recently concluded women health initiative trial revealed significant benefit although reason apparently discrepant results remains subject heated debate growing body evidence suggests individual women may exhibit variable neuroprotective responses hrt part interactions known risk factors neurodegenerative disease one risk factor modulates effects hrt rates cognitive decline aging women expression pattern allelic variants apolipoprotein e apoe paper nathan et al 1 issue endocrinology indicates may case trophic effects natural ovarian estrogen estradiol 17ss neurite growth cultured mouse cerebral cortical neurons reported critically dependent apoe expression moreover responses estradiol 17ss shown dependent type apoe present whereas estradiol 17ss neurotrophic presence human apoe 2 apoe 3 apoe 4 variant associated progression late onset alzheimer disease support response
0.54427505.15198969.html.plaintext.txt	5	concept hrt might beneficial effects aging brain evolved initially studies laboratory animals almost 3 decades ago estradiol 17ss shown exert neurotrophic effects tissue explants derived developing mouse hypothalamus preoptic area 2 synaptogenic effects estradiol 17ss later demonstrated occur adult brain including regions brain hippocampus important cognitive function 3 4 various models neuronal damage natural synthetic estrogens reported enhance cell survival 5 whereas estradiol 17ss treatment shown enhance nonamyloidogenic processing alzheimer amyloid precursor protein 6 estradiol 17ss also found positive effects maintenance neurotransmitter systems undergo degeneration alzheimer disease 7 parkinson disease 8 taken together observations provided strong mechanistic support concept postmenopausal hrt might slow prevent neurodegenerative processes
0.54427505.15198969.html.plaintext.txt	6	concept hrt might beneficial effects aging brain evolved initially studies laboratory animals almost 3 decades ago estradiol 17ss shown exert neurotrophic effects tissue explants derived developing mouse hypothalamus preoptic area 2 synaptogenic effects estradiol 17ss later demonstrated occur adult brain including regions brain hippocampus important cognitive function 3 4 various models neuronal damage natural synthetic estrogens reported enhance cell survival 5 whereas estradiol 17ss treatment shown enhance nonamyloidogenic processing alzheimer amyloid precursor protein 6 estradiol 17ss also found positive effects maintenance neurotransmitter systems undergo degeneration alzheimer disease 7 parkinson disease 8 taken together observations provided strong mechanistic support concept postmenopausal hrt might slow prevent neurodegenerative processes
0.54427505.15198969.html.plaintext.txt	7	clinical trials general provided mixed support hypothesis simultaneously highlighting potential health risks long term postmenopausal hrt use 1 9 10 11 part problem appears human beings unlike laboratory animals effects hrt may confounded variety factors modulate oppose actions hormones one particularly important genetic factor appears expression pattern apoe expression different apoe alleles previously demonstrated affect risk atherosclerosis 12 well rate progression several human neurodegenerative diseases 13 14 including alzheimer dementia 15 intriguingly patterns apoe expression also found significantly influence responses hrt 16
0.54427505.15198969.html.plaintext.txt	8	clinical trials general provided mixed support hypothesis simultaneously highlighting potential health risks long term postmenopausal hrt use 1 9 10 11 part problem appears human beings unlike laboratory animals effects hrt may confounded variety factors modulate oppose actions hormones one particularly important genetic factor appears expression pattern apoe expression different apoe alleles previously demonstrated affect risk atherosclerosis 12 well rate progression several human neurodegenerative diseases 13 14 including alzheimer dementia 15 intriguingly patterns apoe expression also found significantly influence responses hrt 16
0.54427505.15198969.html.plaintext.txt	9	mechanism underlying interaction remained uncertain one possibility might reflect known effects apoe expression atherosclerotic processes 12 cerebral vascular compromise secondarily affecting rate cognitive decline 16 alternative hypothesis however suggested studies aimed elucidating effects estradiol 17ss apoe expression nerve cells studies mice demonstrated expression apoe different brain regions varied stage female reproductive cycle 17 consistent hypothesis estradiol 17ss might induce apoe expression brain already demonstrated apoe blood 18 addition apoe 3 found produce effects like estradiol 17ss cultured neurons 19 moreover neuroprotective effects estradiol 17ss abolished transgenic mice homozygous deletion apoe gene 20 observations raised possibility apoe might represent integral component mechanisms mediating trophic responses neurons estrogen exposure
0.54427505.15198969.html.plaintext.txt	10	mechanism underlying interaction remained uncertain one possibility might reflect known effects apoe expression atherosclerotic processes 12 cerebral vascular compromise secondarily affecting rate cognitive decline 16 alternative hypothesis however suggested studies aimed elucidating effects estradiol 17ss apoe expression nerve cells studies mice demonstrated expression apoe different brain regions varied stage female reproductive cycle 17 consistent hypothesis estradiol 17ss might induce apoe expression brain already demonstrated apoe blood 18 addition apoe 3 found produce effects like estradiol 17ss cultured neurons 19 moreover neuroprotective effects estradiol 17ss abolished transgenic mice homozygous deletion apoe gene 20 observations raised possibility apoe might represent integral component mechanisms mediating trophic responses neurons estrogen exposure
0.54427505.15198969.html.plaintext.txt	11	study nathan et al 1 demonstrate indeed case growth promoting effects estradiol 17ss depend expression apoe also highly dependent nature apoe subtype cultured cells adult mouse cerebral cortex estradiol 17ss increased apoe levels neurite outgrowth hormone effect neurite outgrowth mice lacking apoe gene apoe 4 exogenously supplied apoe 2 apoe variant associated reduced risk alzheimer disease increased age onset increased neurite length apoe 3 presence estradiol 17ss cultures mice transgenic human apoe 3 capable responding estradiol 17ss whereas mice expressing apoe 4 relatively insensitive similarly apoe 3 accumulated neurons greater extent apoe 4 effective facilitating neuronal uptake fatty acid data consistent hypothesis apoe may play integral role supporting neurotrophic effects estradiol 17ss patterns apoe expression may profound impact sensitivity brain estrogen action
0.54427505.15198969.html.plaintext.txt	12	observations important implications future studies effects hrt expression specific apoe alleles required estrogen exert neurotrophic neuroprotective effects pattern apoe allele expression likely important determining effectiveness estrogen based hrt synergism apoe subtype expression effects hrt already demonstrated respect progression atherosclerosis postmenopausal women estrogen use appears particularly beneficial patients apoe 4 allele 12 situation may well true effects neurodegenerative processes yaffe et al 16 administered cognitive function tests number years women either taking estrogen based hrt taken hrt time past never used hrt women express apoe 4 variant postmenopausal estrogen use reduced risk age related cognitive impairment almost 50 compared women never used estrogen contrast apoe 4 positive women show significant estrogen response 16 data consistent hypothesis analysis apoe variant expression may predictive whether hrt likely long term beneficial cognitive effects
0.54427505.15198969.html.plaintext.txt	13	observations important implications future studies effects hrt expression specific apoe alleles required estrogen exert neurotrophic neuroprotective effects pattern apoe allele expression likely important determining effectiveness estrogen based hrt synergism apoe subtype expression effects hrt already demonstrated respect progression atherosclerosis postmenopausal women estrogen use appears particularly beneficial patients apoe 4 allele 12 situation may well true effects neurodegenerative processes yaffe et al 16 administered cognitive function tests number years women either taking estrogen based hrt taken hrt time past never used hrt women express apoe 4 variant postmenopausal estrogen use reduced risk age related cognitive impairment almost 50 compared women never used estrogen contrast apoe 4 positive women show significant estrogen response 16 data consistent hypothesis analysis apoe variant expression may predictive whether hrt likely long term beneficial cognitive effects
0.54427505.15198969.html.plaintext.txt	14	much remains done one key questions remains answered extent data presented nathan et al 1 extrapolated normal brain work nathan et al used cultures dispersed neuronal glial cells adult mouse cerebral cortex important future determine whether effects estrogens aging brain involve comparable apoe dependent mechanisms published evidence consistent view effects estradiol 17ss recovery mature brain injury require apoe thus mice enhancement synaptic sprouting estradiol 17ss response entorhinal cortex lesions dependent apoe expression 21 however neuronal damage perhaps including cellular damage inevitably incurred preparation primary cell cultures may result reexpression estrogen receptor mechanisms normally expressed development 22 hence remains established whether findings extrapolated regulation neuronal growth survival uninjured brain postulated nathan et al 1 dementia trauma degeneration repair may dynamic balance cognitive decline occurring degenerative processes predominate however significant trophic responses estradiol 17ss also observed conditions neurodegeneration probably minimal 3 4 responses may contribute effects estrogens cognitive performance 23 remains determined whether apoe involved trophic actions estradiol 17ss normal physiological opposed pathological conditions
0.54427505.15198969.html.plaintext.txt	15	second question apoe regulated steroids estradiol 17ss wide range estrogens progestins used hrt postmenopausal women 10 11 remains determined different steroids affect apoe expression question specificity apoe response critical possibility combinations hormonal agents could abrogate beneficial effects natural estrogens example nilsen brinton 24 reported whereas progesterone 19 norprogesterone potentiate neuroprotective effects estradiol 17ss opposite effect observed medroxyprogesterone acetate synthetic progestin used women health initiative trial whether apoe expression affected steroids also important fact estradiol 17ss hormonal steroid neuroprotective neurotrophic properties recent work suggests androgens may confer protection neurodegenerative processes men higher free testosterone levels appear lower risk developing alzheimer disease 25 whereas reduced levels principal adrenal androgen dehydroepiandrosterone reported alzheimer disease patients 26 laboratory studies androgens progestins reported elicit neurotrophic neuroprotective effects variety experimental conditions 24 27 28 although cases effects may involve either interactions estrogen intermediate estrogen biosynthesis others clearly 27 intriguing hypothesis future study apoe expression may represent common link steroid activated neurotrophic responses effects androgens like estrogens may influenced apoe genotype interestingly possibility already raised preliminary clinical studies demonstrated interactions testosterone apoe 4 expression men alzheimer disease well association apoe 4 circulating testosterone levels men without disease 29 observations raise possibility relationship apoe expression gonadal steroids may multifactorial apoe 4 allele directly affecting risk neurodegenerative disease via effects neuronal growth survival well indirectly via reductions testicular androgen secretion
0.54427505.15198969.html.plaintext.txt	16	second question apoe regulated steroids estradiol 17ss wide range estrogens progestins used hrt postmenopausal women 10 11 remains determined different steroids affect apoe expression question specificity apoe response critical possibility combinations hormonal agents could abrogate beneficial effects natural estrogens example nilsen brinton 24 reported whereas progesterone 19 norprogesterone potentiate neuroprotective effects estradiol 17ss opposite effect observed medroxyprogesterone acetate synthetic progestin used women health initiative trial whether apoe expression affected steroids also important fact estradiol 17ss hormonal steroid neuroprotective neurotrophic properties recent work suggests androgens may confer protection neurodegenerative processes men higher free testosterone levels appear lower risk developing alzheimer disease 25 whereas reduced levels principal adrenal androgen dehydroepiandrosterone reported alzheimer disease patients 26 laboratory studies androgens progestins reported elicit neurotrophic neuroprotective effects variety experimental conditions 24 27 28 although cases effects may involve either interactions estrogen intermediate estrogen biosynthesis others clearly 27 intriguing hypothesis future study apoe expression may represent common link steroid activated neurotrophic responses effects androgens like estrogens may influenced apoe genotype interestingly possibility already raised preliminary clinical studies demonstrated interactions testosterone apoe 4 expression men alzheimer disease well association apoe 4 circulating testosterone levels men without disease 29 observations raise possibility relationship apoe expression gonadal steroids may multifactorial apoe 4 allele directly affecting risk neurodegenerative disease via effects neuronal growth survival well indirectly via reductions testicular androgen secretion
0.54427505.15198969.html.plaintext.txt	17	perhaps intriguing aspect observations nathan et al 1 however potential development novel strategies replacement therapy designed directly target regulation neural apoe expression adverse effects conventional hrt primarily associated responses involve brain including alterations coagulation factors enhancing risk stroke well trophic effects reproductive organs resulting increased risks breast endometrial cancer 10 11 regulation apoe expression indeed critical component mechanisms mediating neuroprotective responses estradiol 17ss direct targeting apoe regulation brain might mimic beneficial central effects hormone without adverse risks associated conventional hrt approach seems least potentially feasible receptor systems mediating effects estrogens central apoe synthesis may well different found nonneural estrogen target organs thus estradiol 17 estrogen weak systemic hormonal activity fully capable inducing apoe synthesis release mouse cerebral cortex cultured glial cells 30 31 better understanding molecular mechanisms underlying effects estrogen apoe expression evolves may possible identify agents selectively regulate apoe expression brain significant adverse effects tissues elsewhere body
0.54427505.15198969.html.plaintext.txt	18	perhaps intriguing aspect observations nathan et al 1 however potential development novel strategies replacement therapy designed directly target regulation neural apoe expression adverse effects conventional hrt primarily associated responses involve brain including alterations coagulation factors enhancing risk stroke well trophic effects reproductive organs resulting increased risks breast endometrial cancer 10 11 regulation apoe expression indeed critical component mechanisms mediating neuroprotective responses estradiol 17ss direct targeting apoe regulation brain might mimic beneficial central effects hormone without adverse risks associated conventional hrt approach seems least potentially feasible receptor systems mediating effects estrogens central apoe synthesis may well different found nonneural estrogen target organs thus estradiol 17 estrogen weak systemic hormonal activity fully capable inducing apoe synthesis release mouse cerebral cortex cultured glial cells 30 31 better understanding molecular mechanisms underlying effects estrogen apoe expression evolves may possible identify agents selectively regulate apoe expression brain significant adverse effects tissues elsewhere body
0.54427505.15198969.html.plaintext.txt	19	footnotes abbreviations apoe apolipoprotein e hrt hormone replacement therapy
0.54427505.15198969.html.plaintext.txt	20	accepted publication april 7 2004
0.54427505.15198969.html.plaintext.txt	21	references top references nathan bp barsukova ag shen f mcasey m struble rg 2004 estrogen facilitates neurite extension via apolipoprotein e cultured adult mouse cortical neurons endocrinology 1453065 3073abstractfree full text toran allerand cd 1976 sex steroids development newborn mouse hypothalamus preoptic area vitro implication sexual differentiation brain res 189413 427crossref woolley cs mcewen bs 1992 estradiol mediates fluctuation hippocampal synapse density estrous cycle adult rat j neurosci 122549 2554abstract hao j janssen wg tang y roberts ja mckay h lasley b allen pb greengard p rapp pr kordower jh hof pr morrison jh 2003 estrogen increases number spinophilin immunoreactive spines hippocampus young aged female rhesus monkeys j comp neurol 465540 550crossrefmedline green ps simpkins jw 2000 neuroprotective effects estrogens potential mechanisms action int j dev neurosci 18347 358crossrefmedline jaffe ab toran allerand cd greengard p gandy se 1994 estrogen regulates metabolism alzheimer amyloid ss precursor protein j biol chem 26913065 13068abstractfree full text luine vn 1985 estradiol increases choline acetyltransferase activity specific basal forebrain nuclei projection areas female rats exp neurol 89484 490medline leranth c roth rh elsworth jd naftolin f horvath tl redmond jr de 2000 estrogen essential maintaining nigrostriatal dopamine neurons primates implications parkinson disease memory j neurosci 208604 8609abstractfree full text shumaker sa legault c rapp sr thal l wallace rb ockene jk hendrix sl jones bn 3rd assaf ar jackson rd kotchen jm wassertheil smoller wactawski wende j whims investigators 2003 estrogen plus progestin incidence dementia mild cognitive impairment postmenopausal women women health initiative memory study randomized controlled trial jama 2892651 2662abstractfree full text beral v 2003 breast cancer hormone replacement therapy million women study lancet 362419 427crossrefmedline nelson hd humphrey ll nygren p teutsch sm allan jd 2002 postmenopausal hormone replacement therapy scientific review jama 288872 881abstractfree full text lehtimaki dastidar p jokela h koivula lehtinen ehnholm c punnonen r 2002 effect long term hormone replacement therapy atherosclerosis progression postmenopausal women relates functional apolipoprotein e genotype j clin endocrinol metab 874147 4153abstractfree full text fazekas f strasser fuchs kollegger hberger kristoferitsch w schmidt h enzinger c schiefermeier m schwarz c kornek b reindl m huber k grass r wimmer g vass k pfeiffer kh hartung hp schmidt r 2001 apolipoprotein e 4 associated rapid progression multiple sclerosis neurology 57853 857abstractfree full text tang g xie h xu l hao y lin d ren d 2002 genetic study apolipoprotein e gene 1 antichymotrypsin gene sporadic parkinson disease j med genet 114446 449crossrefmedline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma 1993 gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science 261921 923medline yaffe k haan m byers tangen c kuller l 2000 estrogen use apoe cognitive decline evidence gene environment interaction neurology 541949 1954abstractfree full text struble rg rosario er kircher mlludwig sm mcadamis pj watabe k mcasey cady c nathan bp 2003 regionally specific modulation brain apolipoprotein e mouse estrous cycle exogenous 17ss estradiol exp neurol 183638 644crossrefmedline srivastava ra krul es lin rc schonfeld g 1997 regulation lipoprotein metabolism estrogen inbred strains mice occurs primarily posttranscriptional mechanisms mol cell biochem 173161 168crossrefmedline nathan bp jiang y wong gk shen f brewer gj struble rg 2002 apolipoprotein e4 inhibits apolipoprotein e3 promotes neurite outgrowth cultured adult mouse cortical neurons low density lipoprotein receptor related protein brain res 92896 105crossrefmedline horsburgh k macrae im carswell h 2002 estrogen neuroprotective via apolipoprotein e dependent mechanism mouse model global ischemia j cereb blood flow metab 221189 1195crossrefmedline stone dj rozovsky morgan te anderson cp finch ce 1998 increased synaptic sprouting response estrogen via apolipoprotein e dependent mechanism implications alzheimer disease j neurosci 183180 3185abstractfree full text toran allerand cd guan x maclusky nj horvath tl diano singh m connolly jr es nethrapalli tinnikov aa 2002 er x novel plasma membrane associated putative estrogen receptor regulated development ischemic brain injury j neurosci 228391 8401abstractfree full text sandstrom nj williams cl 2004 spatial memory retention enhanced acute continuous estradiol replacement horm behav 45128 135crossrefmedline nilsen j brinton rd 2002 impact progestins estrogen induced neuroprotection synergy progesterone 19 norprogesterone antagonism medroxyprogesterone acetate endocrinology 143205 212abstractfree full text moffat sd zonderman ab metter ej kawas c blackman mr harman sm resnick sm 2004 free testosterone risk alzheimer disease older men neurology 62188 193abstractfree full text sunderland merril cr harrington mg lawlor ba molchan se martinez r murphy dl 1989 reduced plasma dehydroepiandrosterone concentrations alzheimer disease lancet 2570medline leranth c hajszan maclusky nj 2004 androgens increase spine synapse density ca1 hippocampal subfield ovariectomized female rats j neurosci 24495 499abstractfree full text bastianetto ramassamy c poirier j quirion r 1999 dehydroepiandrosterone dhea protects hippocampal cells oxidative stress induced damage brain res mol brain res 6635 41medline hogervorst e lehmann dj warden dr mcbroom j smith ad 2002 apolipoprotein e 4 testosterone interact risk alzheimer disease men int j geriatr psychiatry 17938 940crossrefmedline levin allerhand j mcewen bs lominska ce lubahn db korach ks smith jd 2001 brain region specific regulation mouse apolipoprotein e pharmacological estrogen treatments j neurochem 79796 803crossrefmedline rozovsky hoving anderson cp o callaghan j finch ce 2002 equine estrogens induce apolipoprotein e glial fibrillary acidic protein mixed glial cultures neurosci lett 323191 194crossrefmedline
0.54427505.15198969.html.plaintext.txt	22	references top references nathan bp barsukova ag shen f mcasey m struble rg 2004 estrogen facilitates neurite extension via apolipoprotein e cultured adult mouse cortical neurons endocrinology 1453065 3073abstractfree full text toran allerand cd 1976 sex steroids development newborn mouse hypothalamus preoptic area vitro implication sexual differentiation brain res 189413 427crossref woolley cs mcewen bs 1992 estradiol mediates fluctuation hippocampal synapse density estrous cycle adult rat j neurosci 122549 2554abstract hao j janssen wg tang y roberts ja mckay h lasley b allen pb greengard p rapp pr kordower jh hof pr morrison jh 2003 estrogen increases number spinophilin immunoreactive spines hippocampus young aged female rhesus monkeys j comp neurol 465540 550crossrefmedline green ps simpkins jw 2000 neuroprotective effects estrogens potential mechanisms action int j dev neurosci 18347 358crossrefmedline jaffe ab toran allerand cd greengard p gandy se 1994 estrogen regulates metabolism alzheimer amyloid ss precursor protein j biol chem 26913065 13068abstractfree full text luine vn 1985 estradiol increases choline acetyltransferase activity specific basal forebrain nuclei projection areas female rats exp neurol 89484 490medline leranth c roth rh elsworth jd naftolin f horvath tl redmond jr de 2000 estrogen essential maintaining nigrostriatal dopamine neurons primates implications parkinson disease memory j neurosci 208604 8609abstractfree full text shumaker sa legault c rapp sr thal l wallace rb ockene jk hendrix sl jones bn 3rd assaf ar jackson rd kotchen jm wassertheil smoller wactawski wende j whims investigators 2003 estrogen plus progestin incidence dementia mild cognitive impairment postmenopausal women women health initiative memory study randomized controlled trial jama 2892651 2662abstractfree full text beral v 2003 breast cancer hormone replacement therapy million women study lancet 362419 427crossrefmedline nelson hd humphrey ll nygren p teutsch sm allan jd 2002 postmenopausal hormone replacement therapy scientific review jama 288872 881abstractfree full text lehtimaki dastidar p jokela h koivula lehtinen ehnholm c punnonen r 2002 effect long term hormone replacement therapy atherosclerosis progression postmenopausal women relates functional apolipoprotein e genotype j clin endocrinol metab 874147 4153abstractfree full text fazekas f strasser fuchs kollegger hberger kristoferitsch w schmidt h enzinger c schiefermeier m schwarz c kornek b reindl m huber k grass r wimmer g vass k pfeiffer kh hartung hp schmidt r 2001 apolipoprotein e 4 associated rapid progression multiple sclerosis neurology 57853 857abstractfree full text tang g xie h xu l hao y lin d ren d 2002 genetic study apolipoprotein e gene 1 antichymotrypsin gene sporadic parkinson disease j med genet 114446 449crossrefmedline corder eh saunders strittmatter wj schmechel de gaskell pc small gw roses ad haines jl pericak vance ma 1993 gene dose apolipoprotein e type 4 allele risk alzheimer disease late onset families science 261921 923medline yaffe k haan m byers tangen c kuller l 2000 estrogen use apoe cognitive decline evidence gene environment interaction neurology 541949 1954abstractfree full text struble rg rosario er kircher mlludwig sm mcadamis pj watabe k mcasey cady c nathan bp 2003 regionally specific modulation brain apolipoprotein e mouse estrous cycle exogenous 17ss estradiol exp neurol 183638 644crossrefmedline srivastava ra krul es lin rc schonfeld g 1997 regulation lipoprotein metabolism estrogen inbred strains mice occurs primarily posttranscriptional mechanisms mol cell biochem 173161 168crossrefmedline nathan bp jiang y wong gk shen f brewer gj struble rg 2002 apolipoprotein e4 inhibits apolipoprotein e3 promotes neurite outgrowth cultured adult mouse cortical neurons low density lipoprotein receptor related protein brain res 92896 105crossrefmedline horsburgh k macrae im carswell h 2002 estrogen neuroprotective via apolipoprotein e dependent mechanism mouse model global ischemia j cereb blood flow metab 221189 1195crossrefmedline stone dj rozovsky morgan te anderson cp finch ce 1998 increased synaptic sprouting response estrogen via apolipoprotein e dependent mechanism implications alzheimer disease j neurosci 183180 3185abstractfree full text toran allerand cd guan x maclusky nj horvath tl diano singh m connolly jr es nethrapalli tinnikov aa 2002 er x novel plasma membrane associated putative estrogen receptor regulated development ischemic brain injury j neurosci 228391 8401abstractfree full text sandstrom nj williams cl 2004 spatial memory retention enhanced acute continuous estradiol replacement horm behav 45128 135crossrefmedline nilsen j brinton rd 2002 impact progestins estrogen induced neuroprotection synergy progesterone 19 norprogesterone antagonism medroxyprogesterone acetate endocrinology 143205 212abstractfree full text moffat sd zonderman ab metter ej kawas c blackman mr harman sm resnick sm 2004 free testosterone risk alzheimer disease older men neurology 62188 193abstractfree full text sunderland merril cr harrington mg lawlor ba molchan se martinez r murphy dl 1989 reduced plasma dehydroepiandrosterone concentrations alzheimer disease lancet 2570medline leranth c hajszan maclusky nj 2004 androgens increase spine synapse density ca1 hippocampal subfield ovariectomized female rats j neurosci 24495 499abstractfree full text bastianetto ramassamy c poirier j quirion r 1999 dehydroepiandrosterone dhea protects hippocampal cells oxidative stress induced damage brain res mol brain res 6635 41medline hogervorst e lehmann dj warden dr mcbroom j smith ad 2002 apolipoprotein e 4 testosterone interact risk alzheimer disease men int j geriatr psychiatry 17938 940crossrefmedline levin allerhand j mcewen bs lominska ce lubahn db korach ks smith jd 2001 brain region specific regulation mouse apolipoprotein e pharmacological estrogen treatments j neurochem 79796 803crossrefmedline rozovsky hoving anderson cp o callaghan j finch ce 2002 equine estrogens induce apolipoprotein e glial fibrillary acidic protein mixed glial cultures neurosci lett 323191 194crossrefmedline
0.976726.15003956.html.plaintext.txt	0	meta analysis association cathepsin d ala224val gene polymorphism risk alzheimer disease huge gene disease association review christos ntais1 anastasia polycarpou1 john p ioannidis123
0.976726.15003956.html.plaintext.txt	1	1 clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece 2 biomedical research institute foundation research technology hellas ioannina greece 3 institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.976726.15003956.html.plaintext.txt	2	1 clinical molecular epidemiology unit department hygiene epidemiology university ioannina school medicine ioannina greece 2 biomedical research institute foundation research technology hellas ioannina greece 3 institute clinical research health policy studies department medicine tufts new england medical center tufts university school medicine boston ma
0.976726.15003956.html.plaintext.txt	3	received publication august 5 2003 accepted publication october 10 2003
0.976726.15003956.html.plaintext.txt	4	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon 2 cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis 14 studies 16 comparisons ctsd genotyping 3174 alzheimer disease cases 3298 controls overall random effects odds ratio versus c allele 117 95 confidence interval ci 095 144 study heterogeneity p 001 significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio 111 95 ci 091 135 p 029 summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e 4 allele apoe4 increased susceptibility alzheimer disease conferred apoe4 carriage tended prominent presence allele random effects 607 95 ci 419 879 409 95 ci 315 531 carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoe4 effect cannot excluded
0.976726.15003956.html.plaintext.txt	5	abstract top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references c polymorphism exon 2 cathepsin d gene encoding cathepsin d ctsd implicated risk factor alzheimer disease authors performed meta analysis 14 studies 16 comparisons ctsd genotyping 3174 alzheimer disease cases 3298 controls overall random effects odds ratio versus c allele 117 95 confidence interval ci 095 144 study heterogeneity p 001 significant study heterogeneity evidence significant association first hypothesis generating study excluded calculations odds ratio 111 95 ci 091 135 p 029 summary odds ratio carriers versus noncarriers similar subjects carrying carrying apolipoprotein e 4 allele apoe4 increased susceptibility alzheimer disease conferred apoe4 carriage tended prominent presence allele random effects 607 95 ci 419 879 409 95 ci 315 531 carriers noncarriers respectively meta analysis shows ctsd polymorphism major risk factor alzheimer disease although small effect enhancement apoe4 effect cannot excluded
0.976726.15003956.html.plaintext.txt	6	alzheimer disease cathepsin d ctsd epidemiology genetics meta analysis polymorphism genetics
0.976726.15003956.html.plaintext.txt	7	abbreviations abbreviations ci confidence interval odds ratio
0.976726.15003956.html.plaintext.txt	8	introduction top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references editor note paper also available website human genome epidemiology network httpwwwcdcgovgenomicshugenetdefaulthtm
0.976726.15003956.html.plaintext.txt	9	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein 1 2 cathepsin d gene ctsd located short arm chromosome 11 11p155 consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.976726.15003956.html.plaintext.txt	10	gene top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references cathepsin d intracellular acid protease exhibits beta secretase activity vitro implicated processing amyloid precursor protein tau protein 1 2 cathepsin d gene ctsd located short arm chromosome 11 11p155 consists nine exons synthesis beta amyloid peptide putative key event pathogenesis alzheimer disease beta amyloid derives precursor protein via proteolytic cleavage secretases therefore postulated variants genes coding enzymes involved proteolytic cleavage amyloid precursor protein degradation clearance beta amyloid central nervous system may potential risk factors alzheimer disease
0.976726.15003956.html.plaintext.txt	11	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position 224 exon 2 polymorphism results ala38 val substitution cathepsin d profragment 3 polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study 3 moreover allele associated 50 percent decrease beta amyloid peptide 1 42 levels cerebrospinal fluid patients alzheimer disease 4 finally polymorphism recently reported significantly associated general intelligence healthy elderly people 5
0.976726.15003956.html.plaintext.txt	12	gene variants top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references ctsd gene contains polymorphic c transition site position 224 exon 2 polymorphism results ala38 val substitution cathepsin d profragment 3 polymorphism associated increased secretion altered intracellular maturation cathep sin d profragment one study 3 moreover allele associated 50 percent decrease beta amyloid peptide 1 42 levels cerebrospinal fluid patients alzheimer disease 4 finally polymorphism recently reported significantly associated general intelligence healthy elderly people 5
0.976726.15003956.html.plaintext.txt	13	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease 6 19 also controversy whether polymorphism may interact apolipoprotein e 4 allele apoe4 best known genetic determinant sporadic alzhei mer disease 20 single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.976726.15003956.html.plaintext.txt	14	molecular epidemiologic studies presented seemingly contradictory results concerning potential role ctsd polymorphism alzheimer disease 6 19 also controversy whether polymorphism may interact apolipoprotein e 4 allele apoe4 best known genetic determinant sporadic alzhei mer disease 20 single studies may underpowered detect interactions even overall effects given amount accumulated data deemed important perform quantitative synthesis evidence using rigorous methods thus conducted comprehensive meta analysis available studies relating ctsd polymorphism risk alzheimer disease
0.976726.15003956.html.plaintext.txt	15	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately 1 percent 65 69 years increasing 40 percent elderly 85 years age 21 22 mutations amyloid precursor protein presenilin 1 presenilin 2 genes account 5 percent cases result autosomally dominant pattern expressed complete penetrance early manifestations 23 alzheimer disease probably slightly common females 24 proven postulated risk factors include head injury particular among males 25 well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome 26 27 conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women 27 physical activity diets high levels vitamins b6 b12 folate red wine moderate quantities may protective 27 prevalence alzheimer disease varies considerably among different population groups 28 least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available 23 29 among conclusive evidence several studies meta analysis thereof apoe4 strong risk factor developing alzheimer disease male female subjects early onset 65 years late onset disease 20 approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoe4 attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature 30 35 suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism 30 intronic promoter region polymorphisms presenilin 1 late onset disease 31 insertion deletion polymorphism missense mutation alpha 2 macroglobulin gene 32 several polymorphisms protein tau gene 33 associations modest effect size odds ratios ors 130 135 claimed meta analyses low density lipoprotein receptor related protein gene exon 3 polymorphism 34 insertion deletion polymorphism angiotensin converting enzyme gene 35
0.976726.15003956.html.plaintext.txt	16	disease top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references alzheimer disease common cause progressive cognitive impairment elderly annual incidence approximately 1 percent 65 69 years increasing 40 percent elderly 85 years age 21 22 mutations amyloid precursor protein presenilin 1 presenilin 2 genes account 5 percent cases result autosomally dominant pattern expressed complete penetrance early manifestations 23 alzheimer disease probably slightly common females 24 proven postulated risk factors include head injury particular among males 25 well family history low income low education low occupational status depression exposure aluminum drinking water hypertension syndrome 26 27 conversely use nonsteroidal antiinflammatory drugs treat arthritis associated reduced risk alzhei mer disease estrogen use postmenopausal women 27 physical activity diets high levels vitamins b6 b12 folate red wine moderate quantities may protective 27 prevalence alzheimer disease varies considerably among different population groups 28 least dozens polymorphisms examined relation sporadic alzheimer disease published reviews available 23 29 among conclusive evidence several studies meta analysis thereof apoe4 strong risk factor developing alzheimer disease male female subjects early onset 65 years late onset disease 20 approximately fivefold increase odds developing alzheimer disease single studies also implicated polymorphisms important although reported odds ratios much smaller seen apoe4 attempts replication subsequent research conclusive meta analyses polymorphisms already appeared literature 30 35 suggest significant overall associations several polymorphisms including myeloperoxidase gene promoter polymorphism 30 intronic promoter region polymorphisms presenilin 1 late onset disease 31 insertion deletion polymorphism missense mutation alpha 2 macroglobulin gene 32 several polymorphisms protein tau gene 33 associations modest effect size odds ratios ors 130 135 claimed meta analyses low density lipoprotein receptor related protein gene exon 3 polymorphism 34 insertion deletion polymorphism angiotensin converting enzyme gene 35
0.976726.15003956.html.plaintext.txt	17	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january 1994 september 2003 search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.976726.15003956.html.plaintext.txt	18	meta analysis methods top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references identification eligibility relevant studies considered studies examined association ctsd polymorphism alzheimer disease sources included medline embase january 1994 september 2003 search strategy based combinations alzheimer disease ctsd cathepsin d polymorphism allele genetics references retrieved articles also screened
0.976726.15003956.html.plaintext.txt	19	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.976726.15003956.html.plaintext.txt	20	case control studies eligible determined distribution ctsd genotypes alzheimer disease cases regardless age onset concurrent control group dementia free subjects using molecular method genotyping cases alzheimer disease eligible regardless whether family history alzhei mer disease however excluded family based studies pedigrees several affected cases per family analysis based linkage considerations
0.976726.15003956.html.plaintext.txt	21	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.976726.15003956.html.plaintext.txt	22	data extraction two investigators independently extracted data reached consensus items following information sought report authors journal year publication country origin selection characteristics alzheimer disease cases controls demographics ethnic group study population eligible genotyped cases controls number cases controls ctsd genotype studies including subjects different ethnic groups data extracted separately ethnicity whenever possible furthermore examined whether matching used whether specific mention blinding personnel performed genotyping clinical status subjects whether genotyping method validated
0.976726.15003956.html.plaintext.txt	23	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.976726.15003956.html.plaintext.txt	24	meta analysis primary analysis compared alzheimer disease cases controls contrast versus c alleles analysis aims detect overall differences also examined contrast extremes homozygotes tt versus cc finally examined contrast tt versus ct cc contrast ct tt versus cc contrasts correspond recessive dominant effects respectively allele
0.976726.15003956.html.plaintext.txt	25	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic 36 heterogeneity considered significant p 010 data combined using fixed effects mantel haenszel random effects dersimonian laird models 37 random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present 37
0.976726.15003956.html.plaintext.txt	26	odds ratio used metric choice genetic contrast estimated study heterogeneity across eligible comparisons using chi square based q statistic 36 heterogeneity considered significant p 010 data combined using fixed effects mantel haenszel random effects dersimonian laird models 37 random effects incorporate estimate study variance tend provide wider confidence intervals results constituent studies differ among absence study heterogeneity two methods provide identical results random effects appropriate heterogeneity present 37
0.976726.15003956.html.plaintext.txt	27	also performed cumulative meta analysis 38 recursive cumulative meta analysis 39 40 evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations 41 inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient 42 evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones 43 finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.976726.15003956.html.plaintext.txt	28	also performed cumulative meta analysis 38 recursive cumulative meta analysis 39 40 evaluate whether summary odds ratio versus c contrast changed time data accumulated whether strength association changed first hypothesis generating study excluded calculations 41 inverted funnel plots begg mazumdar publication bias diagnostic nonparametric correlation coefficient 42 evaluated whether magnitude observed association related variance study whether large studies gave different results compared smaller ones 43 finally evaluated whether summary results different analysis limited studies intensive efforts exclude alzheimer disease controls clearly performed neuropsychological testing controls
0.976726.15003956.html.plaintext.txt	29	previous investigations alluded possibility allele may interact apoe4 allele conferring susceptibility alzheimer disease 7 9 thus also evaluated effect allele carriage risk alzheimer disease separately apoe4 positive apoe4 negative subjects moreover evaluated genetic effect conferred presence apoe4 separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.976726.15003956.html.plaintext.txt	30	previous investigations alluded possibility allele may interact apoe4 allele conferring susceptibility alzheimer disease 7 9 thus also evaluated effect allele carriage risk alzheimer disease separately apoe4 positive apoe4 negative subjects moreover evaluated genetic effect conferred presence apoe4 separately subjects carrying allele carrying allele odds ratios combined fixed random effects models described data reported communicated primary investigators obtain information whenever possible
0.976726.15003956.html.plaintext.txt	31	analyses performed spss 110 spss inc chicago illinois meta analyst joseph lau boston massachusetts software whenever 0 values 2 x 2 table added 05 four cells odds ratio could calculated p values two tailed
0.976726.15003956.html.plaintext.txt	32	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified 6 19 profiled table 1 two eligible studies 6 15 contained subjects two different ethnic groups total 16 separate comparisons considered considerable diversity ethnic groups eleven studies 6 15 19 selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies 16 18 selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study 17 clarify exact criteria used diagnosis alzheimer disease five studies 13 17 also included autopsy confirmed alzheimer disease cases two studies 7 16 mentioned included cases family history alzheimer disease eight studies 9 14 18 19 specifically excluded patients remaining clarify background family history one study 6 mentioned 61 percent alzheimer disease cases late onset disease age onset 65 years five studies 8 12 14 19 specifically included late onset alzheimer disease cases one study 18 specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.976726.15003956.html.plaintext.txt	33	meta analysis results top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references eligible studies fourteen studies probing relation ctsd polymorphism alzheimer disease susceptibility identified 6 19 profiled table 1 two eligible studies 6 15 contained subjects two different ethnic groups total 16 separate comparisons considered considerable diversity ethnic groups eleven studies 6 15 19 selected alzheimer disease cases according criteria national institute neurological communicative disorders stroke alzheimer disease related disorders association nincds adrda two studies 16 18 selected alzhei mer disease cases according diagnostic statistical manual mental disorders dsm iiir dsm iv criteria one study 17 clarify exact criteria used diagnosis alzheimer disease five studies 13 17 also included autopsy confirmed alzheimer disease cases two studies 7 16 mentioned included cases family history alzheimer disease eight studies 9 14 18 19 specifically excluded patients remaining clarify background family history one study 6 mentioned 61 percent alzheimer disease cases late onset disease age onset 65 years five studies 8 12 14 19 specifically included late onset alzheimer disease cases one study 18 specifically excluded patients remaining clarify age onset controls diagnosis alzheimer disease amount additional screening general physical neurologic examination psychiatric interview neuropsychological testing blood cerebrospinal fluid studies computed tomography scan mini mental state examination score exclude alzheimer disease differed substantially across studies
0.976726.15003956.html.plaintext.txt	34	view table table 1 characteristics studies included meta analysis specific matching age described five studies 10 12 15 one study also matched sex 10 one study 7 specifically mentioned blinding personnel performed genotyping appropriate molecular methods genotyping used studies used polymerase chain reaction two studies 14 18 also used dynamic allele specific hybridization
0.976726.15003956.html.plaintext.txt	35	meta analysis database eligible studies summarized table 2 included total 3175 cases alzheimer disease 3334 controls 3174 3298 respectively genotype data allele highly represented among controls american descent overall prevalence 86 percent 95 percent confidence interval ci 71 101 controls european 78 percent 95 percent ci 70 86 asian 09 percent 95 percent ci 03 15 descent significant heterogeneity prevalence rates allele even across control subjects european descent rate 143 percent among hispanic americans 104 percent italy 101 percent spain lower rates northern european countries 76 percent united kingdom 63 percent sweden 61 percent germany lowest prevalence rate 45 percent polish population overall prevalence tt homozygosity 03 percent 08 percent 02 percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity 166 percent 140 percent 15 percent respective rates cc homozygosity 831 percent 852 percent 983 percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.976726.15003956.html.plaintext.txt	36	meta analysis database eligible studies summarized table 2 included total 3175 cases alzheimer disease 3334 controls 3174 3298 respectively genotype data allele highly represented among controls american descent overall prevalence 86 percent 95 percent confidence interval ci 71 101 controls european 78 percent 95 percent ci 70 86 asian 09 percent 95 percent ci 03 15 descent significant heterogeneity prevalence rates allele even across control subjects european descent rate 143 percent among hispanic americans 104 percent italy 101 percent spain lower rates northern european countries 76 percent united kingdom 63 percent sweden 61 percent germany lowest prevalence rate 45 percent polish population overall prevalence tt homozygosity 03 percent 08 percent 02 percent control subjects american european asian descent respectively respective prevalence rates ct heterozygosity 166 percent 140 percent 15 percent respective rates cc homozygosity 831 percent 852 percent 983 percent distribution genotypes control groups consistent hardy weinberg equilibrium studies
0.976726.15003956.html.plaintext.txt	37	view table table 2 distribution ctsd alleles among alzheimer disease cases controls included studies overall effects trend suggesting allele may confer increased susceptibility alzheimer disease figure 1 shown table 3 summary odds ratio 117 random effects p 014 significant heterogeneity among 16 study comparisons p 001 heterogeneity found evidence association tt genotype risk alzheimer disease relative cc genotype significant study heterogeneity evidence association alzhei mer disease discerned also recessive model examined effect trend association seen dominant model random effects 119 95 percent ci 097 147 p 010 study heterogeneity recessive model contrast significant heterogeneity p 005 still seen dominant model contrast subgroup analysis studies cases controls european descent yielded similar results 15 comparisons 11436 alleles 118 95 percent ci 096 146 p 012 p 001 heterogeneity
0.976726.15003956.html.plaintext.txt	38	view larger version 26k figure 1 meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown represents summary random effects estimate comparison along respective 95 confidence interval values 1 denote increased risk alzheimer disease allele
0.976726.15003956.html.plaintext.txt	39	view larger version 26k figure 1 meta analysis effect allele versus c allele risk alzheimer disease comparison presented name first author year publication h signifies hispanic subjects j signifies japanese subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown represents summary random effects estimate comparison along respective 95 confidence interval values 1 denote increased risk alzheimer disease allele
0.976726.15003956.html.plaintext.txt	40	view table table 3 summary odds ratios various contrasts bias diagnostics cumulative meta analysis recursive cumulative meta analysis magnitude summary odds ratio stable time changed considerably per year apparent dissipation postulated effect random effects summary vs c 205 end 1999 141 end 2000 116 end 2001 114 end 2002 117 2003 excluding first hypothesis generating study 9 found summary odds ratio became 111 95 percent ci 091 135 p 029 significant study heterogeneity p 005 evidence association even comparison homozygotes tt vs cc 096 95 percent ci 048 190 p 091 study heterogeneity relation effect size variance study suggesting larger studies agreed results smaller studies analyses limited studies intensive efforts exclude alzheimer disease controls yielded similar results 11 comparisons 10382 alleles 122 95 percent ci 096 154 p 010 p 002 heterogeneity
0.976726.15003956.html.plaintext.txt	41	interaction apoe genotype nine studies 7 9 11 14 16 18 obtained data ctsd apoe genotypes one study 8 separating male female subjects 10 comparisons became available
0.976726.15003956.html.plaintext.txt	42	interaction apoe genotype nine studies 7 9 11 14 16 18 obtained data ctsd apoe genotypes one study 8 separating male female subjects 10 comparisons became available
0.976726.15003956.html.plaintext.txt	43	nine comparative studies tended gave slightly inflated effect allele compared full meta analysis 14 comparisons summary random effects 123 vs 117 complete meta analysis thus inferences cautious among carriers high risk apoe4 allele allele carriers random effects odds ratio 138 95 percent ci 089 215 alzheimer disease compared subjects carrying allele among subjects carrying apoe4 allele respective odds ratio 113 95 percent ci 090 142 significant study heterogeneity apoe4 positive group p 007 two effect sizes overlapped widely
0.976726.15003956.html.plaintext.txt	44	among carriers allele presence apoe4 increased risk alzheimer disease 607 fold 95 percent ci 419 879 study heterogeneity among subjects without allele presence apoe4 increased risk alzheimer disease 409 fold 95 percent ci 315 531 significant study heterogeneity p 001 two estimates overlapped widely individual studies overall typically odds ratios larger group allele carriers figure 2
0.976726.15003956.html.plaintext.txt	45	view larger version 22k figure 2 meta analysis effect apoe4 allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective 95 confidence interval papassotiropoulos 2 1 pertain following respective references 7 9
0.976726.15003956.html.plaintext.txt	46	view larger version 22k figure 2 meta analysis effect apoe4 allele carriers noncarriers risk alzheimer disease ad comparison presented name first author m signifies male subjects f signifies female subjects comparison point estimate odds ratio accompanying 95 confidence interval ci shown filled squares represent carriers open circles represent noncarriers represents summary random effects estimate comparison along respective 95 confidence interval papassotiropoulos 2 1 pertain following respective references 7 9
0.976726.15003956.html.plaintext.txt	47	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data 14 case control studies 6000 genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence cannot exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also cannot exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoe4 however even true would pertain relatively small group subjects carry apoe4 ctsd alleles impact allele population level would small present
0.976726.15003956.html.plaintext.txt	48	discussion top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references meta analysis includes data 14 case control studies 6000 genotyped alzheimer disease cases controls proves ctsd polymorphism strong risk factor alzheimer disease current evidence cannot exclude allele ctsd polymorphism may increase modestly risk alzheimer disease significant heterogeneity results various studies however found bias might exist decreasing effect size data accumulated time moreover meta analysis also cannot exclude possibility presence ctsd allele may enhance increased susceptibility toward alzheimer disease conferred apoe4 however even true would pertain relatively small group subjects carry apoe4 ctsd alleles impact allele population level would small present
0.976726.15003956.html.plaintext.txt	49	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro 1 2 cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains 44 might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d 3 noted clear whether ctsd polymorphism functional consequences mature form enzyme although cannot exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome 11 region ctsd gene located 45 47
0.976726.15003956.html.plaintext.txt	50	meta analysis findings may interpreted postulated biologic context ctsd polymorphism cathepsin d intracellular acid protease beta secretase activity vitro 1 2 cleave amyloid precursor protein tau protein generate fragments intact microtubule binding domains 44 might play role pathogenesis paired helical filaments one study shown ctsd polymorphism associated increased secretion altered intracellular maturation procathepsin d 3 noted clear whether ctsd polymorphism functional consequences mature form enzyme although cannot exclude biologic effect ctsd polymorphism findings accordance results recent full genome scan showing significant linkage alzheimer disease short arm chromosome 11 region ctsd gene located 45 47
0.976726.15003956.html.plaintext.txt	51	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.976726.15003956.html.plaintext.txt	52	attention given design individual studies results meta analyses may affected methodological problems potential biases designs constituent studies nondifferential misclassification errors may dilute strength observed association alzheimer disease cases generally selected according appropriate criteria however young control subjects may developed alzheimer disease older ages choice appropriate age window assessing postulated genetic risk factor alzheimer disease difficult studies younger subjects may suitable identifying risk factors result early onset alzhei mer disease conversely selection younger subjects may less appropriate influence postulated genetic risk factor important late onset alzhei mer disease
0.976726.15003956.html.plaintext.txt	53	subgroup effects effect modification eg differential effects genetic polymorphism early vs late onset alzheimer disease cases familial vs sporadic disease complex interactions genes may also need considered 48 analyses addressed interactions apoe4 major known genetic determinant alzhei mer disease interactions genetic environmental factors studied trend stronger effect apoe4 presence allele carriage interesting light data suggesting carriage may affect general intelligence 5 however subgroup interaction analyses interpreted cautiously since differences subgroups may occur chance 49 validation would require studies even larger sample sizes several thousand included meta analysis finally population stratification may theoretically affected results constituent studies meta analysis 50 since documented frequency allele varied considerably among different ethnic groups even among different ethnic groups european descent however studies strictly ethnically defined population stratification effect unlikely considerable magnitude
0.976726.15003956.html.plaintext.txt	54	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding 23 29 reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings 41 51 52 even genetic associations replicated usually major public health impact would lead screening recommendations 53 nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.976726.15003956.html.plaintext.txt	55	increasing prevalence alzheimer disease worldwide crucial identify genetic risk factors neurodegenerative disease thus list identified polymorphisms may influence risk alzheimer disease continuously expanding 23 29 reported associations candidate genes date remain nonreplicated least controversial subsequent investigation early small genetic association studies may come spurious findings 41 51 52 even genetic associations replicated usually major public health impact would lead screening recommendations 53 nevertheless knowledge could improve understanding pathogenesis complex diseases alzheimer disease
0.976726.15003956.html.plaintext.txt	56	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction 9 dynamic allele specific hybridization 14 error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.976726.15003956.html.plaintext.txt	57	laboratory tests top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references methods used ctsd genotyping analyzed studies straightforward include polymerase chain reaction 9 dynamic allele specific hybridization 14 error rate due misclassification likely small future studies nevertheless ensure clearly report assessment genotyping performed blinded clinical status patient
0.976726.15003956.html.plaintext.txt	58	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.976726.15003956.html.plaintext.txt	59	population testing top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references date population testing ctsd polymorphism based results meta analysis testing would indicated given currently available data
0.976726.15003956.html.plaintext.txt	60	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.976726.15003956.html.plaintext.txt	61	acknowledgments authors thank jonathan prince patrizia mecocci anthony j brookes providing additional data studies
0.976726.15003956.html.plaintext.txt	62	notes correspondence dr john p ioannidis department hygiene epidemiology university ioannina school medicine ioannina 45110 greece e mail jioannidatccuoigr u d
0.976726.15003956.html.plaintext.txt	63	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport 199672163 6isimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res 199775011 19crossrefisimedline touitou capony f brouillet jp et al missense polymorphism ct224 human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer 199430a390 4isimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloid42 patients alzheimer disease related exon 2 polymorphism cathepsin d gene neuroreport 2002131291 4crossrefisimedline payton holland f diggle p et al cathepsin d exon 2 polymorphism associated general intelligence healthy older population mol psychiatry 2003814 18crossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett 200028961 5crossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol 200047399 40330co2 5 105179 82crossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett 1999262171 4crossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon 2 polymorphism sporadic alzheimer disease neurosci lett 1999273140 1crossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet 200211431 3crossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord 200316151 5crossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin 6 genes risk alzheimer disease neurosci lett 200028821 4crossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet 20019437 44crossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol 200149544 5 bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett 2002328273 6crossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon 2 polymorphism alzheimer disease ann neurol 200149114 1630co2 m disease highlight problems complex disease analysis trends genet 200117407 13crossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett 200334499 102crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama 19972781349 56abstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama 19952731354 9abstract cummings jl cole g alzheimer disease jama 20022872335 8free full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry 200047183 99crossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry 199855809 15abstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence 10 years partial replication j neurol neurosurg psychiatry 200374857 62abstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology 19995278 84abstractfree full text mcdowell alzheimer disease insights epidemiology aging milano 200113143 62isimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease 2 communities jama 2001285739 47abstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord 20021441 54crossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett 200232633 6crossrefisimedline dermaut b roks g theuns j et al variable expression presenilin 1 major determinant risk late onset alzheimer disease j neurol 2001248935 9crossrefisimedline koster mn dermaut b cruts m et al 2 macroglobulin gene ad population based study meta analysis neurology 200055678 84abstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett 200131492 6crossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon 3 polymorphism alzheimer disease neurosci lett 200131617 20crossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet 200312859 67abstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med 1997127820 6abstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press 1994 lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med 1992327248 54abstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol 199952281 91crossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u 200198831 6abstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet 200129306 9crossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics 1994501088 101isimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet 2003361567 71crossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem 1997692026 38isimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet 19998237 45abstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet 200096823 3033co2 9 12415 22abstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med 199211678 84isimedline cardon lr palmer lj population stratification spurious allelic association lancet 2003361598 604crossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet 200333177 82crossrefisimedline ioannidis jpa genetic associations false true trends mol med 20039135 8crossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol 2003157667 73free full text
0.976726.15003956.html.plaintext.txt	64	references top abstract introduction gene gene variants disease meta analysis methods meta analysis results discussion laboratory tests population testing references mcdermott jr gibson degradation alzheimer beta amyloid protein human cathepsin d neuroreport 199672163 6isimedline chevalier n vizzavona j marambaud p et al cathepsin d displays vitro beta secretase like specificity brain res 199775011 19crossrefisimedline touitou capony f brouillet jp et al missense polymorphism ct224 human cathepsin d pro fragment determined polymerase chain reaction single strand conformational polymorphism analysis possible consequences cancer cells eur j cancer 199430a390 4isimedline papassotiropoulos lewis hd bagli m et al cerebrospinal fluid levels ss amyloid42 patients alzheimer disease related exon 2 polymorphism cathepsin d gene neuroreport 2002131291 4crossrefisimedline payton holland f diggle p et al cathepsin d exon 2 polymorphism associated general intelligence healthy older population mol psychiatry 2003814 18crossrefisimedline crawford fc freeman mj schinka j et al genetic association cathepsin d alzheimer disease neurosci lett 200028961 5crossrefisimedline papassotiropoulos bagli m kurz et al genetic variation cathepsin d major risk factor alzheimer disease ann neurol 200047399 40330co2 5 105179 82crossrefisimedline papassotiropoulos bagli m feder o et al genetic polymorphism cathepsin d strongly associated risk developing sporadic alzheimer disease neurosci lett 1999262171 4crossrefisimedline mcilroy sp dynan kb mcgleenon bm et al cathepsin d gene exon 2 polymorphism sporadic alzheimer disease neurosci lett 1999273140 1crossrefisimedline mateo sanchez guerra m combarros o et al lack association cathepsin d genetic polymorphism alzheimer disease spanish sample j med genet 200211431 3crossrefisimedline ingegni nocentini g mariani e et al cathepsin d polymorphism italian elderly subjects sporadic late onset alzheimer disease dement geriatr cogn disord 200316151 5crossrefisimedline bhojak tj dekosky st ganguli m et al genetic polymorphisms cathespin d interleukin 6 genes risk alzheimer disease neurosci lett 200028821 4crossrefisimedline prince ja feuk l sawyer sl et al lack replication association findings complex disease analysis 15 polymorphisms prior candidate genes sporadic alzheimer disease eur j hum genet 20019437 44crossrefisimedline matsui morikawa y tojo m et al cathepsin d polymorphism associated alzheimer disease japanese ann neurol 200149544 5 bagnoli nacmias b tedde et al cathepsin d polymorphism italian sporadic familial alzheimer disease neurosci lett 2002328273 6crossrefisimedline bertram l guenette jones j et al evidence genetic association linkage cathepsin d ctsd exon 2 polymorphism alzheimer disease ann neurol 200149114 1630co2 m disease highlight problems complex disease analysis trends genet 200117407 13crossrefisimedline styczynska m religa d pfeffer et al simultaneous analysis five genetic risk factors polish patients alzheimer disease neurosci lett 200334499 102crossrefisimedline farrer la cupples la haines jl et al effects age sex ethnicity association apolipoprotein e genotype alzheimer disease meta analysis apoe alzheimer disease meta analysis consortium jama 19972781349 56abstract hebert le scherr pa beckett la et al age specific incidence alzheimer disease community population jama 19952731354 9abstract cummings jl cole g alzheimer disease jama 20022872335 8free full text st george hyslop ph molecular genetics alzheimer disease biol psychiatry 200047183 99crossrefisimedline gao hendrie hc hall ks et al relationships age sex incidence dementia alzheimer disease meta analysis arch gen psychiatry 199855809 15abstractfree full text fleminger oliver dl lovestone et al head injury risk factor alzheimer disease evidence 10 years partial replication j neurol neurosurg psychiatry 200374857 62abstractfree full text launer lj andersen k dewey et al rates risk factors dementia alzheimer disease neurology 19995278 84abstractfree full text mcdowell alzheimer disease insights epidemiology aging milano 200113143 62isimedline hendrie hc ogunniyi hall ks et al incidence dementia alzheimer disease 2 communities jama 2001285739 47abstractfree full text combarros o alvarez arcaya sanchez guerra m et al candidate gene association studies sporadic alzheimer disease dement geriatr cogn disord 20021441 54crossrefisimedline combarros o infante j llorca j et al myeloperoxidase gene alzheimer disease case control study meta analysis neurosci lett 200232633 6crossrefisimedline dermaut b roks g theuns j et al variable expression presenilin 1 major determinant risk late onset alzheimer disease j neurol 2001248935 9crossrefisimedline koster mn dermaut b cruts m et al 2 macroglobulin gene ad population based study meta analysis neurology 200055678 84abstractfree full text russ c powell jf zhao j et al microtubule associated protein tau gene alzheimer disease association study meta analysis neurosci lett 200131492 6crossrefisimedline sanchez guerra m combarros o infante j et al case control study meta analysis low density lipoprotein receptor related protein gene exon 3 polymorphism alzheimer disease neurosci lett 200131617 20crossrefisimedline kehoe pg katzov h feuk l et al haplotypes extending across ace associated alzheimer disease hum mol genet 200312859 67abstractfree full text lau j ioannidis jp schmid ch quantitative synthesis systematic reviews ann intern med 1997127820 6abstractfree full text petitti db meta analysis decision analysis cost effectiveness analysis new york ny oxford university press 1994 lau j antman em jimenez silva j et al cumulative meta analysis therapeutic trials myocardial infarction n engl j med 1992327248 54abstract ioannidis jp contopoulos ioannidis dg lau j recursive cumulative meta analysis diagnostic evolution total randomized evidence group individual patient data j clin epidemiol 199952281 91crossrefisimedline ioannidis j lau j evolution treatment effects time empirical insight recursive cumulative metaanalyses proc natl acad sci u 200198831 6abstractfree full text ioannidis jp ntzani ee trikalinos ta et al replication validity genetic association studies nat genet 200129306 9crossrefisimedline begg cb mazumdar m operating characteristics rank correlation test publication bias biometrics 1994501088 101isimedline ioannidis jp trikalinos ta ntzani ee et al genetic associations large versus small studies empirical assessment lancet 2003361567 71crossrefisimedline kenessey nacharaju p ko lw et al degradation tau lysosomal enzyme cathepsin d implication alzheimer neurofibrillary degeneration j neurochem 1997692026 38isimedline kehoe p wavrant de vrieze f crook r et al full genome scan late onset alzheimer disease hum mol genet 19998237 45abstractfree full text collins js perry rt watson b jr et al association haplotype tumor necrosis factor siblings late onset alzheimer disease nimh alzheimer disease genetics initiative j med genet 200096823 3033co2 9 12415 22abstractfree full text lehmann dj williams j mcbroom j et al using meta analysis explain diversity results genetic studies late onset alzheimer disease identify high risk subgroups neuroscience 2001108541 54crossrefisimedline oxman ad guyatt gh consumer guide subgroup analyses ann intern med 199211678 84isimedline cardon lr palmer lj population stratification spurious allelic association lancet 2003361598 604crossrefisimedline lohmueller ke pearce cl pike m et al meta analysis genetic association studies supports contribution common variants susceptibility common disease nat genet 200333177 82crossrefisimedline ioannidis jpa genetic associations false true trends mol med 20039135 8crossrefisimedline little j khoury mj bradley l et al human genome project complete develop handle pump j epidemiol 2003157667 73free full text
